News
Monthly Archives
Patent office appoints 150 patent examiners to expedite process of patent examinations
(Suja Nair-Shirodkar, Mumbai , 3-Feb-2012 , Pharmabiz)
To address the growing pressure from the increasing number of patent applications filed in the country the Controller General of Patents Designs and Trademarks recently issued an order to appoint 150 examiners of patents. More...
Patent war intensifies as Facebooks IPO approaches
(Reuters , 2-Feb-2012 , The Economic Times)
As it prepares for one of the biggest IPOs ever Facebook is coming under the same fierce attacks being waged against other big technology companies: patent lawsuits. More...
Apple loses bid against Galaxy Tab 10.1N Nexus
(Bloomberg , 2-Feb-2012 , The Times Of India)
The Munich Regional Court rejected the motion today in a case where Apple invoked a patent granted last year protecting technology related to touchscreens for tablets and smartphones. More...
Ahead of talks with EU concerns remain on drug export seizures
(P. T. Jyothi Datta , 2-Feb-2012 , Business Line)
Despite the assurance from European Union authorities that Indian drug consignments would be allowed to transit Ajanta Pharmas shipment was detained on alleged intellectual property violations in late 2011. More...
Can Ranbaxy recover from its US debacle?
(Joe C Mathew / New Delhi , 2-Feb-2012 , Business Standard)
The generic company that wins a chance to sell its drug by successfully invalidating the patent of someone elses medicine will have the sole rights to market the low cost version of that drug for six months immediately after the products goes off patent. More...
Govt planning to patent products manufactured by tribals
(PTI , 01-Feb-2012 , The Economic Times)
Aiming to preserve the indigenous knowledge of tribals and products manufactured by them with the help of natural resources government is planning to patent some of these under the Intellectual Property Rights. More...
Raghavendra Rathore to copyright bandhgalas
(Rochelle Pinto , 01-Feb-2012 , Hindustan Times)
Cases of designer copying designer in the fashion industry are too common to count. More...
Indian ideas power US business innovations
(Chitra Unnithan , 1-Feb-2012 , The Economic Times)
Over 50% of total patents filed for industrial innovations in the US have Indian brains behind them says a study by Indian Institute of Management Ahmedabad. More...
EU antitrust regulators probe Samsung over mobile patents
(Bloomberg / Brussels , 1-Feb-2012 , Business Standard)
Samsung Electronics Co is being probed by European Union antitrust regulators over licensing of patents to other mobile phone manufacturers. More...
Indian ideas power US business innovations
(Chitra Unnithan , 1-Feb-2012 , The Economic Times)
Over 50% of total patents filed for industrial innovations in the US have Indian brains behind them says a study by Indian Institute of Management Ahmedabad. More...
Patent plaintiffs target Facebook as IPO approaches
(Dan Levine , 1-Feb-2012 , Reuters)
As it prepares for one of the biggest IPOs ever Facebook is coming under the same fierce attacks being waged against other big technology companies: patent lawsuits. More...
Indian ideas power US business innovations says a study by IIM-Ahmedabad
(Chitra Unnithan , 01-Feb-2012 , The Economic Times)
Over 50% of total patents filed for industrial innovations in the US have Indian brains behind them says a study by Indian Institute of Management Ahmedabad. More...
Strides margin to improve on Ascent sale
(Ujjval Jauhari / Mumbai , 1-Feb-2012 , Business Standard)
Glaxo sources products from Strides for emerging markets while Pfizer is commercialising off patent products primarily injectibles licensed supplied by Strides for regulated markets like the US. More...
Wake up call for Indian drug makers
(P.T.JYOTHI DATTA , 31-Jan-2012 , Business Line)
India is a huge source for generic drugs or less expensive medicines that are not covered by patent protection unlike original innovative medicines. More...
Nestle Amul trademark battle is for Re 1 brand
(Vishal Dutta , 30-Jan-2012 , The Economic Times)
The slugfest between diary giants Amul and Nestle for ownership of A PLUS is afterall for a brand that is worth Re 1. More...
US settlement puts Indias Ranbaxy on the ropes
(Agence France Presse , 29-Jan-2012 , NDTV)
Indian drugs giant Ranbaxy faces a tough road ahead after US authorities imposed stiff conditions to settle a long legal battle over manufacturing safety violations at its plants analysts say. More...
India EU say making good progress on trade pact
(PTI , 29-Jan-2012 , The Economic Times)
Also the 27 nation bloc has been pressing India to agree for an intellectual property rights regime over and above what the country has agreed multilaterally in the World Trade Organisation. More...
With GI powers rich pickings for Mysore farmers
(M Raghuram , 28-Jan-2012 , DNA)
Farmers groups of farmers and farmers co operatives in the state will get rights to grow sell and export and process at least 11 horticultural products so far registered under geographical Indication. More...
Maharashtra leads in filing patents
(Kounteya Sinha , 28-Jan-2012 , The Times Of India)
Maharashtra beats all other states hollow when it comes to filing patents. More...
Ranbaxy stock tanks on court filing in US
(C.H. Unnikrishnan & Bloomberg , 28-Jan-2012 , Livemint)
For 13 of these the company was the first to challenge patents according to a presentation on its website. More...
Samsung loses again in German patent suit against Apple
(Reuters , 27-Jan-2012 , The Times of India)
Samsung Electronics Co Ltd said on Friday that a German court has ruled against it in a patent suit with Apple Inc over mobile technology the latest verdict in an intensifying global legal battle between the two technology giants. More...
Ranbaxy to pay heavily for future US violations
(Joe C Mathew / New Delhi , 27-Jan-2012 , Business Standard)
The 180 day market exclusivity is granted to the first company that challenges the patent of a medicine in the US. More...
Strides sells Australia SE Asia business to Watson Pharma
(BS Reporter / Bangalore , 25-Jan-2012 , Business Standard)
Rs 1965 cr deal helps it rake in 3.5 times its investment within four years More...
Several knotty issues in trade talks with EU
(Neeraj Thakur , 20-Jan-2012 , DNA)
Trade negotiations at the upcoming India European Union summit have assumed significance as the euro region caught in an economic maelstrom looks for greater access to Indian markets. More...
Pharma stocks offer safety and upside
(Devangshu Datta / New Delhi , 19-Jan-2012 , Business Standard)
Its global which means an understanding of the complexities of patent law is necessary. More...
Battle set for Kodaks patent portfolio
(Richard Waters and Chris Nuttall , 19-Jan-2012 , Financial Times)
Eastman Kodaks bankruptcy is set to trigger a battle between some of the largest smartphone makers and other technology groups for control of a patent portfolio that is considered core to digital photography according to US patent experts. More...
Agra inlay craftsmen seeks Geographical Indication tag for their products
(Sanjay Vijayakumar , 18-Jan-2012 , The Economic Times)
Agra craftsmen practising the marble inlay work found in famous works of architecture such as the Taj Mahal and Fatehpur Sikri have sought the Geographical Indication tag for their product. More...
Sony to trademark Why this kolaveri di
(Zeebiz Bureau , 18-Jan-2012 , ZeeBiz)
Music label Sony Music Entertainment is planning to trademark the songs first line Why this kolaveri di. More...
Compulsory license ensures patent rights & public health Expert
(Nandita Vijay, Bengaluru , 18-Jan-2012 , Pharmabiz)
Compulsory license specifically under Section 92A of the Patents Amendment Ordinance 2004 for export of pharmaceutical substances ensures a balance between patent rights and public health is maintained according to Bindu Sharma Patent Attorney Origiin IP Solutions LLP. More...
Agra inlay craftsmen seeks Geographical Indication tag for their products
(Sanjay Vijayakumar , 18-Jan-2012 , The Economic Times)
A Geographical Indication tag not only certifies a works geographical origin but also confirms adherence to some production standards. More...
Man gets patent for 22 note harmonium
(Prachi Pinglay , 17-Jan-2012 , Hindustan Times)
The humble harmonium is finally set to get its due. More...
India EU free trade agreement talks at final critical stage
(Elizabeth Roche , 17-Jan-2012 , Livemint)
Indian automobile and wine groups are opposed to major concessions to EU firms More...
Healthcare workers stress need for independent data on medicine prices
(P. T. Jyothi Datta , 16-Jan-2012 , Business Standard)
Patent drugs and their pricing have not been addressed medicines for critical and highly prevalent conditions in India such as cancer mental illness malaria and diabetes are not covered and the proposed system of fixing the average of the top three brands as the ceiling price could lead to cartelization the representative pointed out. More...
GI tag to boost Darjeeling tea exports
(Indrani Dutta , 16-Jan-2012 , The Hindu)
Darjeeling tea exports are set to increase by volume and value following its registration as a protected geographical indication PGI product from India. More...
Bayer asked to give cost data
(CH Unnikrishnan , 14-Jan-2012 , Livemint)
Natco Pharma had sought compulsory licensing of cancer drug saying most patients found it too expensive More...
KBL receives trademark registration for Jalverter
(BS Reporter / Mumbai/ Pune , 14-Jan-2012 , Business Standard)
Kirloskar Brothers Limited a fluid management company on Friday announced that it was granted registration of its trademark Jalverter a patented multipurpose off grid solar inverter by the Office of the Registrar of Trade Marks India. More...
Novartis cuts 2000 US jobs after patent loss
(AFP , 13-Jan-2012 , The Economic Times)
After cutting 2000 positions in late October mainly in Switzerland and the US the Basel based company has again downsized its American operation. More...
Sony Music Entertainment files trademark for Kolaveri Di
(Vishal Dutta , 13-Jan-2012 , The Economic Times)
Viral super hit Why this kolaveri di may soon become the first song in India to have its first line trademarked. More...
Microsoft reaches patent deal with LG
(IANS , 13-Jan-2012 , Zee News)
Microsoft Thursday announced a patent licensing agreement with LG Electronics covering tablets smartphones and other consumer devices running Googles Android or Chrome operating system. More...
IBM keeps top patent spot for 19th year as Asian rivals gain
(Bloomberg / New York , 12-Jan-2012 , Business Standard)
International Business Machines Corp won a record number of US patents in 2011 its 19th straight year on top as some Asian competitors advanced in the rankings at the expense of Microsoft Corp and Intel Corp. More...
Darjeeling Tea tag: EU India meet in February
(Sutanuka Ghosal , 12-Jan-2012 , The Economic Times)
EU has registered the term Darjeeling as a protected geographical indication (PGI) for black tea originating from the West Bengal region. More...
Scientists follow ancient literature to seek treatment for Parkinsons
(12-Jan-2012 , The Times of India)
But there are other molecules (not being disclosed yet as patent is pending) which are being tried on human cell lines. More...
Outlook for Indian pharma companies remain stable: CARE
(Divya Rajagopal , 11-Jan-2012 , The Economic Times)
According to Care drugs worth $235 billion are expected to go off patent in the next five years leaving the market open for off patent or generic drugs. More...
Markets cannot manage a knowledge economy
(Ananya Dutta , 11-Jan-2012 , Business Line)
Citing the example of Trade related Intellectual Property Rights (TRIPS) agreement he said that it was not developmentally oriented. More...
India US trade talks postponed indefinitely
(Asit Ranjan Mishra & Elizabeth Roche , 10-Jan-2012 , Livemint)
A recent report by the USTR in December identified Nehru Place in New Delhi as among the 30 most notorious IT markets of the world dealing in goods and services that infringe intellectual property rights. More...
Indian innovator harnesses sea waves for power
(ANS , 10-Jan-2012 , The Economic Times)
The World Intellectual Property Organisation Geneva a United Nations agency also approved and published the patent specifications for GPT. More...
Awareness about IPR is important
(Express News Service , The New Indian Express , 9-Jan-2012 , IBN Live)
A proper awareness about intellectual property rights is as important as awareness about land property rights said Raju Narayana Swamy secretary Department of Youth Affairs. More...
Modi groups firm barred from using Morgardshammar trademark
(PTI , 6-Jan-2012 , The Economic Times)
Modi groups Morgardshammar India a rolling mill equipment manufacturer has been restrained from using the Morgardshammar trademark by the Delhi High Court. More...
Smartphone battle: Google buys 217 IBM patents
(Reuters , 05-Jan-2012 , The Times of India)
Google confirmed that it has added more IBM patents to its technology arsenal as smartphone rivals increasingly battle in courts over innovations. More...
Pfizer fastest growing drug MNC in India
(Joe C Mathew / New Delhi , 5-Jan-2012 , Business Standard)
Globally the bulk of Pfizer revenues come from exclusive sale of patent protected medicines and not branded generics. More...
British firms bid to patent ginger foiled
(TNN , 4-Jan-2012 , The Times Of India)
India has foiled an attempt by a British pharmaceutical company to claim a patent on using ginger for the treatment of cold. More...
A European pill best avoided
(S. Srinivasan , 4-Jan-2012 , Business Line)
The more stringent intellectual property regime under consideration will impact generics producers. More...
Database helped thwart UK patent bid
(TNN , 4-Jan-2012 , The Times Of India)
India through the Traditional Knowledge Digital Library submitted its prior art evidences on April 25 2011. More...
No surprise that Nehru Place is one of the 30 markets violating IPR
(Shelley Singh , 3-Jan-2012 , The Economic Times)
Nearly half the worlds personal computers use software that is pirated. More...
Complex therapies in US lure pharma firms
(Priyanka Golikeri | Bangalore , 3-Jan-2012 , DNA)
The US market for pharmaceuticals is not just about patent expiries and billion- ollar drugs. More...
Getting your trademark - I
(02-Jan-2012 , Business Line)
With manufacturing costs going up and the value of the money depreciating companies are constantly competing to gain market share at the expense of the other. More...
Google Apple working on tech to make passwords redundant
(ANI , 02-Jan-2012 , The Times Of India)
Last week Apple applied to the US patent office to register facial recognition software so instead of sliding to unlock the iPhone iPad or iPod Touch one could simply point it at ones face. More...
HC rules in favour of Indian Co in trademark copyright case
(PTI , 2-Jan-2012 , The Economic Times)
The Bombay High Court has dismissed the Netherlandbased liquor groups plea seeking to restrain Tilaknagar Industries Ltd here from using trademarks Mansion House and Savoy Club on products sold in India. More...
Indian pharma companies obtains 144 ANDA approvals from US FDA in 2011
(Sanjay Pingle, Mumbai , 2-Jan-2012 , Pharmabiz)
Research based Indian pharma companies are set to capture a major share of the US domestic market with increasing number of filing of Abbreviated New Drugs Applications. More...
Bobbili veena gets special GI tag
(TNN , 31-Dec-2011 , The Times of India)
Now the famed Bobbili veena has earned a Geographical Indication certification from the central government. More...
Dr Reddys plans Lipitor generic launch in June
(KV Ramana | Hyderabad , 30-Dec-2011 , DNA)
Dr Reddys Laboratories will hit the US market with its much hyped Lipitor generic in the first quarter of next fiscal. More...
Shasun plans tie up with MNCs
(Gireesh Babu / Chennai , 30-Dec-2011 , Business Standard)
Shasun Pharmaceuticals Ltd is planning to expand its contract manufacturing business by partnering with multinational companies to manufacture their patented products for Indian and Asian drug markets. More...
Breaking the deadlock in WTO talks
(30-Dec-2011 , Livemint)
The eighth World Trade Organization ministerial conference concluded on 17 December with the chairman citing an improved atmosphere but no concrete moves forward on the Doha Round trade talks. More...
Another Bt cotton variant falls to fraud charges
(Zia Haq , 30-Dec-2011 , Hindustan Times)
Relying on Monsantos technology could have possible because its intellectual property rights protection of 15 years had ended freeing violators from legal tangles sources said. More...
Patents office appoints 94 examiners to speed up process
(Himanshu Darji & Vishal DuttaHimanshu Darji & Vishal Dutta , 29-Dec-2011 , The Economic Times)
The Indian Patents Office has appointed 94 design examiners to speed up the process of granting patents and clear a backlog of one lakh applications over the next three years. More...
Patents Bickerings With Rivals May Hurt Apple
(BLOOMBERG BUSINESSWEEK SAN FRANCISCO , 29-Dec-2011 , The Times of India)
Steve Jobs the co founder of Apple Inc. told his biographer that hed rather wage thermonuclear war with Google than make deals to share its technology with the maker of the Android operating system More...
IP office recast may roll back reforms fear stakeholders
(David Shaftel & C.H. Unnikrishnan , 28-Dec-2011 , Livemint)
Some 400 000 trademark applications are pending and the IP office has resorted to outsourcing or temporary hiring More...
Yahoos unit Overture Services Inc faces patent roadblock for paid search technology
(Sanjay Vijayakumar & Sangeetha Kandavel , 27-Dec-2011 , The Economic Times)
In a setback to internet major Yahoo the Intellectual Property Appellate Board in Chennai has rejected a patent filed for a paidsearch technology by its unit Overture Services Inc, after opposition from Rediff.com India. More...
Soon database on Indian bio resources
(Dipannita Das , 27-Dec-2011 , The Times of India)
The Unit for Research and Development of Information Products here has prepared a database of patents granted world wide to Indian bio resources including food crops forest trees marine organisms microbial resources livestock other animals and agro resources. More...
Government eases norms for gold silver mix in Kanchipuram sarees
(SANGEETHA KANDAVEL & SANJAY VIJAYAKUMAR , 27-Dec-2011 , The Economic Times)
Since 2005 Kanchipuram silk sarees have been protected by Geographical Indication label which not only certifies their geographical origin but also confirms adherence to some production standards. More...
Tilaknagar Industries wins trademark battle in Bombay HC
(India Infoline News Service , 27-Dec-2011 , India Infoline)
TI is a leading player in the IMFL industry with a dominant presence in South India and continues to successfully extend its footprints on a pan India basis More...
Compliance quality issues cast shadow on pharma deals
(Namrata Nandakumar & C.H. Unnikrishnan , 26-Dec-2011 , Livemint)
Quality and compliance issues over previous deals with Indian firms have hit the revenues of global drug makers More...
EU ruling on transit goodscase cheers Indian drug cos
(P. T. Jyothi Datta , 25-Dec-2011 , Business Line)
May end instances of non member consignments being seized More...
Healthy year for pharma sector on right policy prescriptions
(P. T. Jyothi Datta , 24-Dec-2011 , Business Line)
Quality pricing intellectual property issues are challenges in the new year More...
Patent firm sues German retailers over HTC phones
(Reuters , 23-Dec-2011 , The Economic Times)
Patent firm IPCom has sued German retailers for patent infringement for continuing to sell phones made by HTC the No. 4 smartphone maker globally. More...
Roche drags DRL to court over patents
(TNN , 23-Dec-2011 , The Times of India)
In yet another legal blow to pharma major Dr Reddys Laboratories Swiss healthcare giant Roche Holding AGs two US based arms have slapped a lawsuit on the Hyderabad based company for infringing on a US patent for anti viral drug Valcyte. More...
China tops U.S Japan to become top patent filer
( Lee Chyen Yee | Reuters , 22-Dec-2011 , Yahoo News)
China became the worlds top patent filer in 2011 surpassing the United States and Japan as it steps up innovation to improve its intellectual property rights track record a Thomson Reuters research report showed on Wednesday. More...
Goan Fenny set to lose its odour for better status
(PTI , 22-Dec-2011 , The Economic Times)
Fenny which is usually brewed from cashew or coconut has already attained Geographical Indication status following a protracted struggle by its ardent supporters. More...
Negative factors economic slowdown seriously retard growth of Indian pharma: Dr MD Nair
(Our Bureau, Bengaluru , 22-Dec-2011 , Pharmabiz)
Economic downturn reduced investments high costs of R&D and low productivity patent cliffs pressure on drug prices poor image of the industry and stricter regulatory controls have seriously affected the pharma sector pointed out Dr MD Nair pharma consultant. More...
The health of nations
(T S Vishwanath , 22-Dec-2011 , Business Standard)
Multilateral forums should address the fear that strong pharma patent protection can affect public health in developing countries More...
Ranbaxy Laboratories: Settlement takes away gains from Lipitor launch
(Kiran Kabtta Somvanshi , 22-Dec-2011 , The Economic Times)
Drug maker Ranbaxys fortunes have reversed swiftly with the cost of settlement with the USFDA almost wiping off the gains from the exclusive launch of Lipitor. More...
Android patent rulings signal trouble for Google
(Bloomberg , 21-Dec-2011 , The Times Of India)
Google Inc is facing potential setbacks in its efforts to get smartphone makers to stick with the Android operating system as legal rulings begin to roll in on patent infringement claims by Apple Inc and Microsoft Corp. More...
Pharmaceutical stocks to gain on depreciating rupee patents
(21-Dec-2011 , Livemint)
While the pharma sector has outperformed the broader market valuations have come off the peak More...
Microsoft wins patent decision against Android
(Bloomberg , 21-Dec-2011 , The Times of India)
Microsoft Corp won a ruling that Motorola Mobility Holdings Incs Android phones violate one of its smartphone patents while failing to convince a judge that six others are being infringed as well. More...
Apple wins patent row on some HTC phones
(Bloomberg / Washington , 21-Dec-2011 , Business Standard)
Apple Inc won a patent infringement ruling that bans some HTC Corp smartphones from the US starting next year bolstering efforts to prove that devices running Google Incs Android operating system copy the iPhone. More...
Delhis Nehru Place among top 30 markets that violate IPR
(Press Trust of India , 21-Dec-2011 , NDTV)
An official US report has identified Nehru Place in New Delhi among the top 30 notorious IT markets of the world dealing in goods and services infringing intellectual property rights. More...
Now Mysore Silk too will have fusion labels
(Vinobha K T , 21-Dec-2011 , The Times Of India)
KSIC which has obtained the geographical indication registration for Mysore silk in 2005 is the sole proprietor of the brand he said adding that traders merchants or unlicensed manufacturers are prohibited form using the brand name Mysore Silk he added. More...
Kodak patent ruling delayed amid cash worries
(AP , 20-Dec-2011 , The Economic Times)
A US arbiter for trade disputes is delaying a ruling on Eastman Kodak Co.s high stakes patent infringement claim against smartphone makers Apple Inc. and Research in Motion Ltd. More...
BT sues Google in US over patent infringement
(Reuters / London , 20-Dec-2011 , Business Standard)
British telecoms firm BT has launched legal action against Google in the United States over patent infringement in a number of key areas for the technology group such as mobile map services. More...
Apple vs Samsung: Samsung files new claims
(Reuters , 19-Dec-2011 , The Times Of India)
Samsung Electronics has filed new claims in its patent war with Apple Inc over alleged patent infringements in Germany a spokesman for the company said on Monday. More...
With new generic rivals Lipitors sales halved
(LINDA A. JOHNSON , 19-Dec-2011 , Business Week)
Two generic versions costing about a third less hit the market right away one made by Indias Ranbaxy Laboratories Ltd. and the other an authorized generic made by Pfizer and sold by its partner Watson Pharmaceuticals Inc. More...
Chennai HC rejects Roches patent suit against Matrix in light of lack of jurisdiction
(Our Bureau, Mumbai , 17-Dec-2011 , Pharmabiz)
Dr Gopakumar G Nair intellectual property and patent and trade mark attorney pointed out that under the recent judgement the HC held that Matrix by approaching the IPA Board Chennai did not give rise to a cause of action from Roche against Matrix as mere filing of an application for revocation in IPA Board Chennai cannot give rise to a cause of action especially since IPA Board has its headquarters at Chennai. More...
ITC to review ruling on HTC patent suit vs Apple
(Reuters , 17-Dec-2011 , The Economic Times)
The International Trade Commission said on Friday it will revisit in part a decision by an ITC administrative law judge who had found no violation by Apple of four HTC patents that include technologies for power management and phone dialing. More...
HC order hits Dunlops brand transfer plan
(Arnab Dutta & Manish Basu , 16-Dec-2011 , Livemint)
Tyre maker Dunlop India Ltds plan to transfer its rights to 100 odd trademarks to private firms owned by its promoter Pawan Kumar Ruia has been nixed at least for the time being by a Calcutta high court order. More...
NEW POLICY & PATENTED DRUGS
(P A Francis , 14-Dec-2011 , Pharmabiz)
After almost a decade of preparing notes and drafts officials in the Department of Pharmaceuticals could come out with a draft proposal for a new drug pricing policy last month. More...
Investors seem to shrug off Glenmarks crofelemer dispute
(Ravi Ananthanarayanan , 14-Dec-2011 , Livemint)
Glenmarks performance is expected to benefit from growing contribution from generic product sales in the US market similar to that of other Indian firms targeting a number of drugs going off patent. More...
Hoffman La Roche loses patent suit against Matrix Pharmaceuticals
(Divya Rajagopal , 14-Dec-2011 , The Economic Times)
Swiss drug company Hoffman La Roche has lost a patent infringement suit against Matrix Pharmaceuticals to prohibit the Indian firm from selling its anti cancer drug Tarceva. More...
Glenmark in legal row with Napo Pharma
(Special Correspondent , 14-Dec-2011 , Business Line)
It was a collaboration that would have resulted in a proud first for the Indian pharmaceutical industry but has landed in a legal tangle instead. More...
Madras HC dismisses Roche case against Intas
(P.T. Jyothi Datta , 13-Dec-2011 , Business Line)
Single sale of cancer drug by a retailer not authorised by Intas More...
India still needs a WTO
(Suman Bery , 13-Dec-2011 , Business Standard)
The Doha Round has been left behind but Indias trade requires a solid institutional structure More...
Kazaa creator sues Internet giants for patent infringement
(ANI , 12-Dec-2011 , The Times Of India)
A US based entrepreneur and a creator of file sharing application Kazaa Kevin Bermeister has sued several Internet giants including Google and YouTube for infringing their eight patents in their cloud computing products. More...
NGO asks European Commission not to push India to accept IP provisions in EU India FTA
(Ramesh Shankar, Mumbai , 12-Dec-2011 , Pharmabiz)
In a letter to to EC Commissioner for Trade Karel De Gucht the NGO DNP+ has expressed concern over the ECs alleged secret efforts to bring back intellectual property provisions like data exclusivity and investment provisions into the negotiations. More...
Eatery wins war to rid patent cover off low sugar sweet
(TNN , 11-Dec-2011 , The Times of India)
A popular eatery chain in thecity haswon a patent war with an entrepreneur duo who had patented a lowsugar low glycemic preparation as their own and restrained the food chain from preparing similar delicacy. More...
Samsung wins round in long legal fight with Apple
(Reuters , 09-Dec-2011 , The Economic Times)
Samsung Electronics Co won a round of its bruising global patent fight with Apple Inc on Friday when an Australian court lifted a ban on the sale of its Galaxy tablet computer in time for the busy Christmas shopping season. More...
India stands to gain from patent cliff
(Shilpa Kannan , 8-Dec-2011 , BBC News)
The patent cliff has begun. More...
Drug firms to gain from US patent expiries
(Joe C Mathew / New Delhi , 7-Dec-2011 , Business Standard)
Lipitor like exclusivity awaits Indian drug companies as 46 patents expire in 2012-15. More...
Expert calls to set up IPR cells at varsities
(Jaideep Deogharia , 7-Dec-2011 , The Times of India)
Mesra has got seven patents BAU has obtained registration for four varieties of rice from the patent office. More...
How policies can bypass Indias parliament
(Alam Srinivas , 07-Dec-2011 , BBC News)
The Congress led coalition pushed through critical amendments to the existing patents laws through an ordinance which was later passed by parliament with many amendments. More...
Bayer Indias Cipla settle trademark suit
(Zeba Siddiqui in Bangalore , 7-Dec-2011 , Reuters)
Bayer AGs healthcare unit said it settled trademark infringement cases with Indian drugmaker Cipla and Vanuatu based website operator Archipelago Suppliers concerning the German drugmakers pet products. More...
Amul sues Nestle for copying A+ brand
(Ratna Bhushan , 06-Dec-2011 , The Economic Times)
We own the rights to use a+ as a trademark and therefore do not see why anyone should object to our using it. More...
Elder Pharma to foray into Japanese market by FY12 end
(Press Trust of India / New Delhi , 06-Dec-2011 , Business Standard)
Drug firm Elder Pharmaceuticals today said it planned to enter the Japanese pharma market during the current fiscal as it had received accreditation from the Japanese Ministry of Health for its Patalganga facility. More...
Oranges: India ranks 64th in productivity
(06-Dec-2011 , Business Line)
Coorg orange grown in the Kodagu Hassan and Chikmagalur districts of Karnataka is awarded Geographical Indication owing to its characteristics such as medium sized fairly tight skinned orange yellow fruits having dark orange pulp being tender juicy with a rich flavour and excellent blend of acid and sugar. More...
Richcore Lifesciences launches first ever enzymatic clean technology Ecosol
(Nandita Vijay, Bangalore , 3-Dec-2011 , Pharmabiz)
Richcore currently enjoys a little safety with its patents and first mover advantage in developing traction for its novel applications he said. More...
Indian yoga guru sues student for copying technique
(Agencies , 02-Dec-2011 , Indian Express)
Kolkata born Bikram Choudhury is the founder of Bikram Yoga and has copyrighted his unique hot yoga classes. More...
Ranbaxy hits US with Lipitor copy
(C.H. Unnikrishnan & Namrata Nandakumar , 02-Dec-2011 , Livemint)
Ranbaxy and Watson Pharmaceuticals Inc. are the two companies allowed to sell generic versions of Lipitor for now. More...
NGOs experts to hold national consultation on generic drug production and challenges
(Joseph Alexander, New Delhi , 02-Dec-2011 , Pharmabiz)
A number of public interest groups and health activists will hold a two day national consultation here from December 6 on Generic drug production and access to medicines: Current challenges and prepare a roadmap to ensure affordability and accessibility of drugs in the country. More...
Apple vs Samsung suit full of secret combat
(Dan Levine and Carlyn Kolker , 02-Dec-2011 , Reuters)
The biggest legal battle for the technology industry is playing out in a federal court in Silicon Valley where Apple is trying to stop Samsung from selling Galaxy phones and tablets in the United States. More...
AU faculty to patent six compounds against HIV
(Rajiv Mani , 1-Dec-2011 , The Times of India)
In a major breakthrough against the dreaded AIDS virus a young faculty from department of Chemistry Allahabad University along with scientists from National AIDS Research Institute Pune would soon be patenting six new compounds that have proved patent against the dreaded AIDS spreading HIV. More...
US patents: Ittiam Systems has more than twice that of Infosys
(Hari Pulakkat , 1-Dec-2011 , The Economic Times)
Ittiam has an impressive pipeline of 60 patent applications pending for approval. More...
Jets patent challenge against Virgin dismissed
(P.R. Sanjai & C.H. Unnikrishnan , 01-Dec-2011 , Livemint)
The British carrier can now get the design and technology for its upper class seats patented in India More...
Civil society groups hold protest demonstration in Mumbai against Novartis
(Our Bureau, Mumbai , 1-Dec-2011 , Pharmabiz)
Novartis has taken the Indian government to the Supreme Court challenging the legal interpretation of a critical public health safeguard in the countrys patent law Section 3d that principally limits the patenting of new uses and new forms of old medicines in India. More...
Samsung scores win in patent case
(Reuters , 1-Dec-2011 , The Times Of India)
Samsung Electronics is set to resume selling its Galaxy tablet computer in Australia as early as Friday after the South Korean technology firm won a rare legal victory in a long running global patent war with Apple. More...
Ranbaxy gets USFDA approval for generic Lipitor
(PTI , 01-Dec-2011 , The Hindu)
Ranbaxy and Pfizer had settled all of their litigations worldwide over the Lipitor patent in 2008. More...
Lipitor goes off patent today Pfizer vs Ranbaxy led Indian pharmas war for blockbuster drugs intensifies
(Divya Rajagopal , 30-Nov-2011 , The Economic Times)
Indian pharma companies quest to make millions from the sale of copycat versions of blockbuster drugs may turn out to be a flop show as innovative companies raise defences to protect their turf. More...
Samsung wins appeal in Apple tablet battle
(AFP , 30-Nov-2011 , The Times Of India)
The Federal Court granted an interim order against the sale of the Galaxy 10.1 in October ruling that Apple had established a prima facie case that the South Korean company had breached touchscreen technology copyrights. More...
Copyright society moves HC against govt circular
(DNA Correspondent , 29-Nov-2011 , DNA)
A non government organisation with over 2500 members which is the sole copyright society in India has moved the Bombay High Court challenging the circular issued by the state de recognised the society and directing auditoriums not to pay its fees. More...
Supreme Court set to hear plea on patents
(Menaka Rao , 28-Nov-2011 , Hindustan Times)
The Supreme Court will start hearing in a case that could decide the cost of treating HIV Aids in the country. More...
Apple wins patent for intelligent dock connector
(Joe Aimonetti , 29-Nov-2011 , cnet)
Apple has just been granted a patent that details an intelligent dock connector able to properly adjust power levels for multiple connected devices from a single outlet source. More...
Higher US drug sales pep up revenue show
(Ram Prasad Sahu / Mumbai , 28-Nov-2011 , Business Standard)
Going ahead growth is likely to be sustained due to the upcoming launches of cholesterol lowering drug Lipitor and anti psychotic medicine Geodon among others. More...
Supreme Court to hear Novartis case on Section 3(d) of Indian patent law on Nov 29
(Ramesh Shankar, Mumbai , 28-Nov-2011 , Pharmabiz)
The next hearing of Novartis vs Union of India case in Supreme Court regarding interpretation on Section 3(d) of the Indian patent law will be held on November 29 2011. More...
Patent firm IPCom says to stop HTC German sales
(Reuters , 28-Nov-2011 , IBN Live)
German patent firm IPCom plans to halt as quickly as possible the sale of all HTC smartphones in Germany another blow to the Taiwanese firm just two days after it shocked markets by cutting its fourth quarter outlook. More...
PU claims breakthrough in anti ageing research
(Ritu Sharma , 27-Nov-2011 , Indian Express)
For this formulation and research it has already applied for patents with the Indian Patent Application. More...
THE END OF LIPITOR
(P A francis , 25-Nov-2011 , Pharmabiz)
Worlds top pharmaceutical company Pfizer Inc.stands to lose patent rights for its largest selling drug Lipitor in the US on November 30. More...
Bayer withdraws writ petition against Natco
(C.H. Unnikrishnan , 25-Nov-2011 , Livemint)
In a new twist to the ongoing legal battle between German drug multinational Bayer Healthcare AG and Hyderabad based cancer drug maker Natco Pharma Ltd over the compulsory licensing of Bayers cancer drug Nexavar the Delhi high court last week dismissed the foreign companys writ petition as withdrawn. More...
MNC monopoly mars critical drugs
(Joe C Mathew / New Delhi , 25-Nov-2011 , Business Standard)
Study says formulation for some critical ailments enormously priced. More...
Pfizer fights to retain Lipitor market share
(Divya Rajagopal , 24-Nov-2011 , The Economic Times)
Pfizer has offered to deliver Lipitor at a cut price of $4 directly to patients in its fight to retain market share of the worlds largest selling drug just days before the US patent for the medicine is due to expire. More...
Betting on innovation
(T S Vishwanath , 24-Nov-2011 , Business Standard)
A recent report by the World Intellectual Property Rights The Changing Face of Innovation provides some interesting insights to answer this question. More...
DoP looks to speed up functioning of panel on patented drug pricing ahead of pharma policy
(Joseph Alexander, New Delhi , 23-Nov-2011 , Pharmabiz)
After toying with the idea of fixing the prices of patented drugs through negotiations before marketing them in the country for nearly five years the Department of Pharmaceuticals now wants to speed up the working of the expert committee set up to suggest a mechanism in this regard. More...
Abbott Dabur GSK eye Jagdales energy drinks biz
(Boby Kurian & Reeba Zachariah , 23-Nov-2011 , The Times Of India)
The brand a patented fruit-based electrolyte drink competes in the broader energy drinks segment that include players like Gatorade from PepsiCo. More...
India EU finalise give & take in FTA
(Nayanima Basu / New Delhi , 22-Nov-2011 , Business Standard)
Negotiations for the ambitious India EU free trade agreement is on in full steam and in the final stages of give and take even as the euro zone crisis has gripped all its 27 member countries. More...
Zydus Cadila faces patent suit in US over drug Asocol
(ET Bureau , 18-Nov-2011 , The Economic Times)
US based Warner Chilcott Plc has moved court against Zydus Cadilas plan to produce a bowel inflammation drug Asocol. More...
Microsoft seeks patent on employee spy system
(Iain Thomson in San Francisco , 18-Nov-2011 , The Register)
Microsoft has filed a patent for a system that monitors the behavior of employees via computers phone calls and physical gestures and alerts human resources if anyone is behaving outside of preferred norms. More...
Lupin set to buy Japanese firm I'rom Pharma
(Our Bureau , 17-Nov-2011 , Business Line)
Country is worlds second largest individual drugs market More...
US oral contraceptive mkt draws Indian pharma
(Reghu Balakrishnan / Mumbai , 17-Nov-2011 , Business Standard)
Indian pharmaceutical companies which always wanted a big share in the global copycat drug market are betting high on the oral contraceptive market in America. More...
Now Hyderabad patent to auto meter tampering
(Rahul Devulapalli , 17-Nov-2011 , The Times Of India)
In the city your auto fare could vary depending on the brand of clothes you wear and not according to the rates on the fare chart issued by the Road Transport Authority. More...
Music industry to crackdown on copyright violations in Goa
(IANS , 17-Nov-2011 , Zee News)
A music copyright vigilante authority has threatened to launch Halla Bol along Goas coastal belt known for its music blaring beach shacks scorching raves and techno night party hang outs this year even as the tourist season is all set to begin in a few days. More...
Bayer to bring innovative products into India
(Our Bureau , 16-Nov-2011 , Business Line)
Germany headquartered Bayer AG is committed to bringing more products into India said Chairman Dr Marijn Dekkers even as he underlined the need to protect intellectual property rights in the country. More...
Coimbatore man applies for patent to 20 varieties of idlis
(Kumar Chellappan , 16-Nov-2011 , DNA)
If variety is the spice of life then nobody other than Kovai Iniyavan of Coimbatore has truly lived upto the adage. More...
Pharma brand launches slump this year
(Ram Prasad Sahu / Mumbai , 16-Nov-2011 , Business Standard)
The number of new molecules companies could target have come down and drug firms are careful of new launches due to patent regime restrictions. More...
Look out! Here comes Apples killer location services patent
(Erik Sherman , 16-Nov-2011 , CNET)
Apple has raised bludgeoning competitors with patents on key technologies to a fine art. More...
Intellectual property protection is key for investment in India
(Surabhi Agarwal , 15-Nov-2011 , Livemint)
Is the lack of a strong regime on software piracy and intellectual property hurting the Indian information technology industry in terms of attracting business? More...
India can boast of a healthy patent pipeline
(Our Bureau , 14-Nov-2011 , Business Line)
System to access patent information on cards More...
Utility patenting: Indias next move?
(C.H. Unnikrishnan , 14-Nov-2011 , Livemint)
The patent model suggests less stringent intellectual property protection to support incremental research More...
Gulf turmoil hit Indian tea exports
(Mithun Dasgupta , 13-Nov-2011 , DNA)
But there is some good news for exporters of Darjeeling tea with the European Union registering the product as a Protected Geographical Indication which aims to protect product names from misuse and imitation. More...
Ranbaxy Labs posts loss of Rs.465 crore
(Kaustubh Kulkarni/Reuters , 10-Nov-2011 , Livemint)
Lipitors patent protection expires 30 November after which two new versions of the drug are expected to be sold by Ranbaxy and Watson Pharmaceuticals. More...
Huawei in Android patent talks with Microsoft
(ANI , 08-Nov-2011 , The Times of India)
Chinas leading telecom company Huawei has confirmed that it is in talks with Microsoft over the use of Android software. More...
Google accuses Microsoft of abusing patents system
(ANI , 08-Nov-2011 , The Economic Times)
A Google lawyer has accused software giant Microsoft of abusing the patent system by using them only its products stop succeeding. More...
Mango Mazaa producer barred from branding it after Maaza
(PTI , 07-Nov-2011 , The Economic Times)
An Indian soft drink producer has been restrained by the Delhi High Court from naming its product as Mango Mazaa deceptively similar to multinational Coca Colas mango flavoured drink Maaza. More...
DIPP amends FDI policy on options in equity instruments by deleting Clause 3.3.2.1
(Suja Nair Shirodkar, Mumbai , 7-Nov-2011 , Pharmabiz)
According to Dr Gopakumar G Nair intellectual property and patent and trade mark attorney the real strength of India over the years have been a strong autonomous and non corrupt RBI. More...
Partnership is the new norm in pharma sector
(Joe C Mathew / New Delhi , 7-Nov-2011 , Business Standard)
Eight years earlier Ranbaxy the countrys largest drug company created a stir by challenging the patent on the worlds highest revenue earning medicine Lipitor in the US. More...
Kodak could run out of US cash in 12 without help - Moodys
(Liana B. Baker , 07-Nov-2011 , Reuters)
Without an infusion of cash from a sale of patents or some hundreds of millions of dollars in additional financing Eastman Kodak Co would run out of cash in the U.S. in 2012 according to a research note published on Monday by the credit agency Moodys. More...
Cadbury secures favourable HC order in trademark case
(PTI , 06-Nov-2011 , Business Line)
Cadbury India Ltd the domestic arm of U.S. confectionery major Kraft Foods Inc has secured a relief from the Delhi High Court which restrained a local garment manufacturer from promoting its apparel under the phonetically identical trademark Cadbeery. More...
Strong policy support, incentives are better option to pharma sector than FDI cap: Dr G G Nair
(Suja Nair Shirodkar, Mumbai , 5-Nov-2011 , Pharmabiz)
Pharma industry wants the government to give more incentives to this sector so that it would not be forced to look at the foreign direct investment route for growth. More...
Apple Samsung patent battle worries Brussels
(Alex Barker in Brussels and Richard Waters in San Francisco , 04-Nov-2011 , Financial Times)
Europes competition watchdog is investigating the increasingly aggressive legal tactics being used in Samsungs patent battle with Apple in what could pave the way for an in depth antitrust probe into the hotly contested intellectual property agreements that underpin the smartphone technology market. More...
Ranbaxys plan for Lipitor fuels speculation
(Joe C Mathew / New Delhi , 4-Nov-2011 , Business Standard)
With hardly four weeks for patent expiry of the worlds largest revenue earning drug Lipitor in the US speculation is rife as to how Ranbaxy will exploit this. More...
Kodak may need patent sale new debt to survive
(Liana B. Baker , 4-Nov-2011 , Reuters)
Eastman Kodak Co spooked investors on Thursday by warning it may need to raise new debt or complete a multibillion dollar patent sale to survive the next 12 months sinking shares by as much as 11.7 percent. More...
Sanofi battles through patent expiries restructuring looms
(Kevin Grogan , 03-Nov-2011 , Pharma Times)
Sanofi has posted financials for the third quarter this morning which show that net profit slipped 3.0% to 2.40 billion euros while sales edged up 5.0% to 8.75 billion euros. More...
Bitter row over Agras trademark sweet
(IANS , 02-Nov-2011 , Zee News)
No trip to Agra is complete without two essentials a glimpse of the Taj Mahal and a sampling of the famous Agra ka petha. More...
Investors want to see Kodaks cash
(Reuters , 02-Nov-2011 , The Times Of India)
Wall Street will be focused on how much cash Eastman Kodak has left on its balance sheet along with hints of progress on a multibillion dollar patent sale when More...
Pharma sector unlikely to sustain current premium over Sensex
(Nirmal Bang , 02-Nov-2011 , Livemint)
We believe the international growth drivers led by the US generics market which is in a multi year cyclical upturn given the impending patent cliff and emerging markets owing to favourable demographics and similarity with the domestic market still hold and would partially cushion any erosion in PE multiple. More...
Piramals US arm settles case with Baxter on inhaled anesthetic agent
(Our Bureau , 01-Nov-2011 , Business Line)
Suprane is Baxters product of Desflurane an anesthetic agent typically used in hospital settings. More...
Can Kodak rescue itself via a patent bonanza?
(Associated Press , 31-Oct-2011 , IBN Live)
Kodak the company that invented the first digital camera in 1975 and developed the photo technology inside most cellphones and digital devices is in the midst of the worst crisis in its 131 year history. More...
Civil society groups ask WHO members to drop IMPACT avoid counterfeit term
(Joseph Alexander, New Delhi , 31-Oct-2011 , Pharmabiz)
The term Counterfeit is defined by the WTO TRIPS Agreement as referring to a specific category of trademark violation1 and in some legislation to all other intellectual property violations as well. More...
Copyright issue: Hearing on Desiboyz adjourned
(PTI , 28-Oct-2011 , DNA)
The lawyer of the Bollywood director Rohit Dhawan today told the Bombay High Court that he would file reply to the petition by a Latur based script writer claiming copyright on the title and the story of the Dhawans upcoming film Desiboyz. More...
Lupin gets USFDA nod for oral contraceptive tablets
(PTI , 28-Oct-2011 , Business Line)
The approval for generic version of LoSeasonique tablets is the third approval for the Mumbai headquartered firm in the oral contraceptives portfolio. More...
Darjeeling tea gets EUs protected tag
(TNN , 27-Oct-2011 , The Times Of India)
The European Union EU has registered Indias Darjeeling tea with a Protected Geographical Indication. More...
Dr Reddys to push complex products, increase R&D spend
(KV Ramana , 26-Oct-2011 , DNA)
We do not want to limit ourselves just to the opportunities coming up through patent expiries. More...
Govt to give fin support to develop Intellectual Prop Rights
(PTI , 25-Oct-2011 , MSN)
The government will provide financial support to educational institutes and industry associations for conducting programmes to create awareness on Intellectual Property Rights. More...
Apple wins slide to unlock patent
(Joe Aimonetti , 25-Oct-2011 , cnet)
Many of the patent applications and grants we come across involving Apple relate to theoretical products that may never see the light of day. More...
Tide Water buys rights to Veedol trademark
(Manish Basu , 25-Oct-2011 , Livemint)
Tide can now expand Veedol sales across the world after buying trademark rights from BP. More...
Desi Boyz title in copyright violation row
(Rosy Sequeira , 25-Oct-2011 , The Times of India)
A scriptwriter has moved the Bombay high court alleging copyright violation in the title of the Akshay Kumar John Abraham starrer Desi Boyz which is slated for release next month . More...
Health groups ask govt to issue compulsory licenses to make HCV drugs affordable
(Our Bureau, Mumbai , 22-Oct-2011 , Pharmabiz)
A group of health activists in the country demanded to the government to either reject the patents given to Hepatitis drugs or to issue compulsory licensing to make these drugs accessible to the common people as Hepatitis C virus is emerging as a growing public health threat in India. More...
BlackBerry maker accused of infringing BBX trademark
(Pav Jordan and Alastair Sharp , 21-Oct-2011 , Reuters)
BBX the operating system that Research In Motion is counting on to revive its floundering BlackBerry franchise has run into trouble even before the company could install the system in its smartphone line. More...
Ra.One copyright issue heats up HC reserves order
(DNA Correspondent , 21-Oct-2011 , DNA)
Thus we moved the single bench of the high court which rejected our claim on October 12 and thus we moved an appeal. More...
How to register a trademark?
(Edlyn G D'Souza , 19-Oct-2011 , The Times Of India)
If youre starting a new business or trade a logo name or signature is the first thing you choose to separate yourself from the rest. More...
Pharma MNCs pills make Indian rivals sick
(Ram Prasad Sahu / Mumbai , 19-Oct-2011 , Business Standard)
Severe price cuts help multinationals ramp up growth gain market share. More...
After US Dr Reddys eyes Europe for Arixtra play
(KV Ramana , 19-Oct-2011 , DNA)
Dr Reddys Laboratories is looking to take its limited competition candidate fondaparinux sodium generic Arixtra to the European market. More...
Panel warns on pharma MNC demands
(Soma Das , 18-Oct-2011 , The Financial Express)
The committee acknowledges that prices of medicines have shot up in those countries where such IPR principles advocated by innovator pharma companies mostly from the US have been introduced. More...
Kodak to license over 1000 patents to Imax
(AP , 17-Oct-2011 , The Economic Times)
Eastman Kodak Co said that it will license thousands of patents to Imax in a deal that will supply the troubled photography company with millions of dollars. More...
Samsung loses Dutch bid to ban Apple products
(Reuters , 15-Oct-2011 , IBN Live)
A Dutch court on Friday turned down Samsung Electronics request for an injunction against all of Apples mobile products that use 3G telecommunications technology denying it revenge over a similar move by Apple. More...
US judge says Samsung tablets infringe Apple patents
(Reuters , 17-Oct-2011 , IBN Live)
A US judge said Samsungs Galaxy tablets infringe Apples iPad patents but also that Apple might have a problem establishing the validity of its patents. More...
US patent process may turn cheaper for pharma cos
(G. Naga Sridhar , 14-Oct-2011 , Business Line)
Indian pharma companies especially smaller ones can look forward to a cheaper patent filing and litigation process in the US. More...
Apple must show valid patents in Samsung case: Judge
(Reuters , 14-Oct-2011 , The Times Of India)
A US judge said that Samsung Electronics Galaxy tablets infringe Apple Incs iPad patents but added that Apple has a problem establishing the validity of its patents in the latest courtroom face off between the technology giants. More...
Public interest groups call for moratorium on pacts by patent pool with Indian generic companies
(Joseph Alexander, New Delhi , 13-Oct-2011 , Pharmabiz)
A host of public interest organisations have joined this coalition that has written to the UNITAID and the Medicine Patent Pool. More...
Dangers of FDI in pharma
(S. Srinivasan , 13-Oct-2011 , Business Line)
No matter what the Maira panel would have us believe foreign pharma firms will continue to buy out low cost domestic manufacturers and raise prices. More...
Four growth drivers beyond patent for pharma companies like Sun Pharma Sanofi
(Gauri Kamath , 13-Oct-2011 , The Economic Times)
It is not just Big Pharma that has to prepare for life after the patent cliff patent expiries on a slew of blockbuster drugs. More...
Dunlop India transferring trademarks to Ruia flagship
(Aveek Datta , 13-Oct-2011 , Livemint)
Dunlop India Ltd is transferring its rights to around 100 odd trademarks including Dunlop Falcon and Monotona to Ruia Sons Pvt. Ltd the flagship holding company of Pawan Kumar Ruia an entrepreneur who controls the beleaguered tyre maker. More...
Pharma brand launches in local market dips
(Khomba Singh , 12-Oct-2011 , The Economic Times)
New brand launches in the local drug market have declined over the last few years as the number of original drugs going off patent has come down and as Indian companies look at new business models to boost sales and increase profits. More...
Aurobindo Pharma gets royalty free licence for AIDS drug
(Joe C Mathew / New Delhi , 12-Oct-2011 , Business Standard)
Aurobindo Pharma has become the first major generic drug maker to gain royalty free production and supply rights for five AIDS medicines through an agreement with Geneva based Medicines Patent Pool. More...
Aurobindo first major generic drugs maker to tap into Patent Pool
(P.T. Jyothi Datta , 11-Oct-2011 , Business Line)
Generic drugs maker Aurobindo Pharma Ltd has signed an agreement with the global Medicines Patent Pool for the manufacture of several antiretroviral medicines making it one of the first major generic companies to tap into the patent pool. More...
Investors to lose from changes in pharmaceutical FDI policy
(Ravi Ananthanarayanan , 11-Oct-2011 , Livemint)
They are launching off patent drugs expanding their field force entering new product categories and markets and even going to rural markets. More...
Pharma acquisitions to be routed through CCI
(Special Correspondent , 11-Oct-2011 , The Hindu)
Move after concerns raised over acquisitions of Indian pharma companies by multinationals More...
India to retain 100% foreign pharma investment
(Lynne Taylor , 11-Oct-2011 , Pharma Times)
India will continue to permit 100% foreign direct investment in new pharmaceutical industry projects but foreign takeovers of Indian drugmakers will come under tighter scrutiny the cabinet agreed yesterday. More...
India pitches for including IPR equitable access in climate talks
(fe Bureau , 11-Oct-2011 , The Financial Express)
Taking a hard stance for the coming climate talks in Durban this December the government has submitted a proposal to the secretariat of the United Nations Framework Convention on Climate Change to include three contentious issues of unilateral trade measures intellectual property rights and equitable access to sustainable development for inclusion in the talks’ provisional agenda. More...
The murky world of intellectual property
(C.GOPINATH , 09-Oct-2011 , Business Line)
Patents are bought and sold through layers of shell companies and people will not talk for fear of being dragged to court. More...
DIPP moves note on making patents office independent
(ET Bureau , 8-Oct-2011 , The Economic Times)
Indias intellectual property office overseeing patents and trademarks should be granted autonomy to make it more responsive and effective a government department has suggested. More...
Patent and Trademarks may be split into separate entities
(PTI , 7-Oct-2011 , MoneyControl)
With a pileup of over 4.40 lakh applications for trademarks and 76000 for patents the government is mulling separate establishments for handling the claims for the two key Intellectual Property Rights IPRs. More...
Government moves to overhaul patent regime
(HT Correspondent , 07-Oct-2011 , Hindustan Times)
The government has invited comments from the public on reviewing the organisational structure of the office of the controller general of patents designs trademarks and geographical indications CGPDTM to make it more responsive to the needs of Intellectual Property holders and users while enhancing the effectiveness and efficiency of its operations. More...
MSF contends Novartis plea that case against sec 3d will not impact access to medicines
(Ramesh Shankar, Mumbai , 7-Oct-2011 , Pharmabiz)
On Novartis statement that Section 3d as it relates to evergreening is not applicable at all to Glivec the MSF countered that Novartis is seeking a patent in India on the salt form of imatinib Glivec. More...
Hyderabadi biryani looks for GI tag
(TNN , 5-Oct-2011 , The Times Of India)
Well the much relished dish is likely to get a Geographical Indication GI status soon that will have a logo or hologram to assure foodies that its the original Hyderabadi biryani laid out on the plate. More...
Sanofis acquired companies to retain local indentity
(C. H. Unnikrishnan , 5-Oct-2011 , Livemint)
Sanofi has undergone an impressive transformation over the last two and a half years and it had already put the bigger threat of patent expiry of some of its blockbuster drugs in the US and other key markets in the past he said More...
India looking to conclude FTA with EU this year: Anand Sharma
(PTI , 04-Oct-2011 , The Economic Times)
India today said it is looking to conclude the proposed comprehensive free trade pact with the European Union this year as the negotiations are in advanced stage with the 27 nation bloc. More...
National Pharmaceutical Pricing Authority may get power to verify landed cost of drugs
(Khomba Singh , 3-Oct-2011 , The Economic Times)
The drug price watchdog may get powers to verify landed cost of drugs that are under its control. More...
Kodak weighs options to clear path for sale
(TNN , 3-Oct-2011 , The Times Of India)
Eastman Kodak Co the unprofitable 131 year old camera maker is weighing options including a bankruptcy filing because of concerns raised by possible buyers of its patent portfolio said three people with direct knowledge of the process. More...
Branded generics strategy important to drive growth
(Viswanath Pilla & Namrata Nandakumar , 3-Oct-2011 , Livemint)
So most of them are facing the prospect of large revenue producing products coming off patent facing generics competition and at the same time their late stage pipelines are not adequate to fill the revenue yet. More...
For pharma MNCs India is an effective pill not a placebo
(D. SAMPATHKUMAR , 02-Oct-2011 , Business Line)
The strategic environment has got murkier for pharma MNCs with fairly new drugs working for fewer people and litigation problems to contend with too. More...
Khadi cloth still not protected by IPR
(Our Bureau , 1-Oct-2011 , Business Line)
Did you know that the popular Darjeeling tea Tirupathi laddu Kancheepuram Silk saree Pochampalli Ikat and basmati rice are all protected under the Geographical Indications but the Khadi cloth is yet to get protected in India? More...
Drug makers seek sops to crack off patent opportunity
(KV Ramana , 1-Oct-2011 , DNA)
The much hyped off patent opportunity worth $30 40 billion is likely to remain a tough nut to crack for the Indian pharmaceutical industry considering the roadblocks in the form of insufficient infrastructure and lack of proper policy framework at the government level. More...
Intellectual property laws in India suck: Rick Goings Tupperware
(Ratna Bhushan & Bhanu PandeRatna Bhushan & Bhanu Pande , 30-Sep-2011 , The Economic Times)
One thing that irks Goings about the country however is its intellectual property rights laws. More...
Bitter pill for Big Pharma
(Bhupesh Bhandari / New Delhi , 30-Sep-2011 , Business Standard)
There is evidence IPA Secretary General D G Shah says that Indian companies that got acquired by Big Pharma have scaled down their patent challenges in the West. More...
Microsoft Samsung to share mobile patents
(Bloomberg , 29-Sep-2011 , The Times Of India)
Microsoft Corp the software maker seeking to challenge Apple Inc and Google Incs dominance in smartphones agreed to share patents with handset maker Samsung Electronics Co. More...
Govt buries plan to empower CCI on IPR disclosures
(Vikas Dhoot , 29-Sep-2011 , The Economic Times)
In a major reprieve for innovation led firms in India the government has quietly dropped a controversial plan to empower the competition regulator to make intellectual property rights holders share their knowledge with competitors in specific circumstances. More...
Mosaid: Google is $11m patent buyer
(Reuters , 29-Sep-2011 , The Times Of India)
Canadian patent licensing company Mosaid has named Google as the buyer of five non strategic patent families it said it had sold two week ago for $11 million. More...
Samsung seeks Dutch ban on 3G iPhone iPad
(Roberta Cowan , Reuters , 28-Sep-2011 , Hindustan Times)
Samsung Electronics Co and Apple Inc fought the latest battle of their patent wars on Monday when the Korean firm urged a Dutch court to ban Apples iPads and iPhones in the Netherlands More...
Glenmark Pharma launches anti malaria drug in the US
(Reuters , 28-Sep-2011 , The Economic Times)
The Indian drugmaker had settled a patent litigation with GlaxoSmithKline in April 2010, which allows Glenmark to launch the generic tablets in the US on royalty bearing licence in the third quarter of calendar year 2011. More...
GSK open to acquiring reasonably priced company: GSK open to acquiring reasonably priced company: Andrew Witty CEO
(ET Bureau , 28-Sep-2011 , The Economic Times)
And as these companies stare at their expiring patents emerging markets can no longer be ignored. More...
Patent office to examine conflict between WIPO guidelines and Patents Act
(Hary M. Pillai , 28-Sep-2011 , Law et al news)
The Delhi High Court recently remanded back to the Controller General of Patents Designs Trademarks and Geographical Indication a petition in which the court felt existed a conflict between the WIPO Guidelines and the Patents Act and Rules. More...
Microsoft Samsung Patent Deal: Great News for Windows Phones
(Jared Newman , 28-Sep-2011 , PCWorld )
The success of Samsungs Galaxy S Android phones just became a cash cow for Microsoft thanks to a patent cross licensing agreement in which Microsoft gets paid for every Android phone or tablet Samsung sells. More...
Europe threatens to break off India free trade talks
(AFP , 27-Sep-2011 , The Economic Times)
But India and the EU have already been at odds over intellectual property rights involving life saving generic HIV AIDS drugs and other medicines which are produced by Indian companies. More...
India to be among top 10 pharma markets by 2015: E&Y
(PTI , 27-Sep-2011 , The Economic Times)
Emerging markets India and China will figure in the top 10 pharma markets of the world by 2015 an Ernst & Young report has said. More...
Patent tribunals admission places question mark against tribunals
(C.H. Unnikrishnan , 27-Sep-2011 , Livemint)
The case filed by P PIL questioned the independence of Ipab on the grounds that it was in violation of the constitutional separation of powers doctrin More...
CCI should clear pharma M&As
(Joe C Mathew & Nayanima Basu / New Delhi , 27-Sep-2011 , Business Standard)
The committee is also of the view that India must desist from any move to dilute the public interest clauses enshrined in the patent law. More...
Dr Reddys Laboratories abandons deal to buy JB Chemicals brands in Russia CIS
(ET Bureau , 27-Sep-2011 , The Economic Times)
Indian pharmaceutical firm Dr Reddys Laboratories called off a deal to acquire prescription portfolio of JB Chemicals and Pharmaceuticals in Russia owing to differences over valuation and other operational issues a senior company official said. More...
Dr Reddys calls off deal to buy JBCPLs Russia business
(Viswanath Pilla , 27-Sep-2011 , Livemint)
The changes will result in cost savings in government procurement of drugs and make medicines more affordable by giving consumers access to generics that are cheaper than patented drugs. More...
India Generics Companies Lead Pharmaceutical Innovation in Asia Pacific According to Thomson Reuters
(EDT , 26-Sep-2011 , Market Watch)
The change in approach is highlighted by the 72 percent increase in the number of Paragraph IV patent challenges raised by Indian companies between 2009 and 2010. More...
EU agrees for ambitious comprehensive pact with India
(PTI , 26-Sep-2011 , Zee News)
But India and the EU have been at odds over intellectual property rights in patent areas involving life saving generic HIV AIDS drugs and other medicines which are produced by Indian companies it added. More...
India EU trade talks high on Agenda
(Pallavi Aiyar & Nayanima Basu / Brussels/ New Delhi , 26-Sep-2011 , Business Standard)
According to the agenda, apart from tariffs on wines and spirits and automobiles there are wide gaps on intellectual property rights IPR specifically issues related to geographical indications liberalisation of services and government procurement. More...
R&D expenditure of 30 cos soars by 19% to Rs.3770 cr in 2011 with no new molecules yet
(Sanjay Pingle, Mumbai , 26-Sep-2011 , Pharmabiz)
The Indian majors like Dr Reddys Labs Lupin Glenmark Pharmaceutical Aurobindo Pharma and Sun Pharma received higher approvals for ANDAs from US FDA during the first 8 months of 2011. More...
French Cognac gets GI status
(Daniel P George , 24-Sep-2011 , The Times Of India)
The Geographical Indications Registry office in Chennai on Tuesday granted the French Cognac geographical indication status along with Villianur Teracotta Works and Tirukanur Papier Mache Craft both handicrafts from Puducherry. More...
Samsung to step up Apple patent war
(Associated Press , 24-Sep-2011 , IBN Live)
A top Samsung executive says the company will take a bolder stance in its patent battle with smartphone and tablet rival Apple which Samsung claims has been free riding on its patented wireless technologies. More...
Ind Swift set to tap global generic opportunity
(Our Bureau , 23-Sep-2011 , Business Line)
Patents are set to see their patents expire in the US over the next four years opening up an opportunity of about $ 99 billion. More...
US patents from MNCs have shot up while those filed by Indian companies and institutions are declining
(Hari Pulakkat , 22-Sep-2011 , The Economic Times)
With a global R&D budget of $6 billion it is no surprise that IBM is the worlds largest patent generator. More...
Eli Lilly scouting for partner to market oncology drugs
( KV Ramana , 22-Sep-2011 , DNA)
There are several products that would go off patent and we are working on them. More...
Speedy Singhs gets copyright protection
(Swati Deshpande , 22-Sep-2011 , The Times Of India)
The producers of the yet to be released Bollywood movie Speedy Singhs starring Akshay Kumar has landed a speedy relief even before any legal trouble can brew over copyright. More...
Why the world may prefer India to China
(Bala V Balachandran , 22-Sep-2011 , Business Standard)
Although the rate of patenting has been slow in India it hasnt led to unhindered copying of intellectual property. More...
Google Oracle patent talk makes slow progress
(Bloomberg , 22-Sep-2011 , The Economic Times)
Google and Oracles chief executive officers made little headway this week in negotiations aimed at resolving a lawsuit accusing the Web search company of patent infringement a person briefed on the talks said. More...
Bionic boon for the blind
(Durgesh Nandan Jha , 22-Sep-2011 , The Times Of India)
He holds the patent for the device along with his colleagues. More...
DuPont unit accuses Kaveri of gene piracy
(C.H. Unnikrishnan , 21-Sep-2011 , Livemint)
Pioneer Overseas Corp. has accused Hyderabad based Kaveri Seeds of copying the gene structure of a variety of corn developed by the Iowa US based firm. More...
China and India making inroads into biotech drugs
(Gardiner Harris , 21-Sep-2011 , The Hindu)
This could not only transform the care of patients in much of the world but also ignite a counterattack by major pharmaceutical companies and richer countries. More...
Sharma writes to PM on pharma M&A concerns
(Asit Ranjan Mishra , 21-Sep-2011 , Livemint)
The Indian generic pharma industry has in recent years posed a major challenge to the MNCs through production and export of low cost high quality medicines as well as patent challenges. More...
Samsung eyes iPhone 5 legal action
(Song Jung-a in Seoul , 21-Sep-2011 , The Financial Times)
Samsung Electronics is considering a legal move to block sales of Apple s long awaited iPhone 5 in some countries as the patent battle between the two technology companies steps up a gear. More...
Lupin enters oral contraceptives market in the US
(Our Bureau , 20-Sep-2011 , Business Line)
A couple of the OC filings would be patent challenges, he said More...
Sun Pharma resolves US units regulatory concerns
(P. T Jyothi Datta , 19-Sep-2011 , Business Line)
Co loses patent case to Sanofi on colon cancer drug More...
Patent trolls cost inventors half a trillion dollars
(David Goldman , 21-Sep-2011 , CNN Money)
Patent trolls companies that license patents but do not actually sell anything have long been looked on with fiery scorn in Silicon Valley. More...
Godrej Consumer Products wins case against a cybersquatter
(ET Bureau , 19-Sep-2011 , The Economic Times)
Godrej proved that the domain name registered by US based cybersquatter Chris Peri of Illinois was identical to its trademark and misleading the statement said. More...
China India making inroads in biotech drugs
(Gardiner Harris , 19-Sep-2011 , Hindustan Times)
Already the Obama administration has been trying to stop an effort by poorer nations to strike a new international bargain that would allow them to get around patent rights and import cheaper Indian and Chinese knock off drugs for cancer and other diseases as they did to fight Aids. More...
US court rules against Sun Pharma over cancer drug
(PTI , 19-Sep-2011 , The Economic Times)
French drugmaker Sanofi today said a US court has ruled in its favour in a patent litigation against Sun Pharmaceuticals over Eloxatin oxaliplatin a drug used to treat colon cancer. More...
Sanofi wins U.S. cancer drug patent ruling
(Elena Berton , 19-Sep-2011 , Reuters)
French drugmaker Sanofi has scored an important victory in a patent dispute with Sun Pharmaceuticals that will keep generic copies of its Eloxatin colon cancer drug off the United States market until August 2012. More...
US terms telecom IT procurement policy against WTO guidelines
(Surajeet Das Gupta / New Delhi , 19-Sep-2011 , Business Standard)
The American government has challenged the protection given to domestic manufacturers by the Indian government in the areas of information technology and telecom as breaching World Trade Organisation rules. More...
Evolution of IP valuation
(D. Murali , 19-Sep-2011 , Business Line)
Within the semi conductor industry a lot of patent wars and acquisitions have been fought and survived reminds Anu. More...
Bristol Myers to launch critical drugs in India
(Joe C Mathew / New Delhi , 18-Sep-2011 , Business Standard)
BMS had reentered India in 2004 after the country changed its patent laws to recognise product patents. More...
Indian generic drug firms pharma MNC patent fight to determine price of medicines
(Khomba Singh , 18-Sep-2011 , The Economic Times)
Last month former Solicitor General Gopal Subramanium launched an impassioned argument in the Supreme Court against the rejection of a patent to Glivec a leukemia drug made by pharma MNC Novartis. More...
GNA Patent Gurukul to conduct seminar on ‘current pharma patent regulatory opportunities and challenges in Europe’
(Our Bureau, Mumbai , 17-Sep-2011 , Pharmabiz)
GNA Patent Gurukul will be organising a one day seminar on current pharma patent regulatory opportunities and challenges in Europe on October 13 at IDMA Mumbai. More...
Patent issues lack of commitment risk Hulu sale
(Reuters , 17-Sep-2011 , The Times Of India)
The auction of online video site Hulu has been slowed by recent developments which could derail it completely according to sources familiar with the process. More...
Wockhardt Danone deal gets CCI nod
(Joe C Mathew / New Delhi , 17-Sep-2011 , Business Standard)
The agreement also involves transfer of nutrition related intellectual property owned by Wockhardt EU a wholly owned subsidiary that holds intellectual property rights for Wockhardt Group businesses including pharmaceuticals and healthcare. More...
Apple Microsoft fear: Google buys 1023 IBM patents
(AFP , 16-Sep-2011 , The Times Of India)
Google confirmed that it has added 1023 more IBM patents to its technology arsenal to fend off legal attacks by rivals such as Apple and Microsoft. More...
India rejects Wests criticism of trade policy
(PTI , 16-Sep-2011 , The Economic Times)
India today rejected the criticism of its trade policy especially by the US at the WTO and asked the members to judge the country by what it has done over the years. More...
Apple cant take away our leadership in India Samsung
(Pankaj Doval , 16-Sep-2011 , The Economic Times)
Samsung and Apple may be embroiled in numerous patent suits across the globe but the Korean consumer electronics gianta has said it has a clear edge in India and will retain its stronghold due to its wider reach and product portfolio and stronger brand profile. More...
Desi cos to gain as Big Pharma goes generic
(Rupali Mukherjee , 15-Sep-2011 , The Times Of India)
Faced with losses once its blockbusters start losing patents Big Pharma is now devising strategies to counter the impact. More...
Patent distribution should be transparent Chandy
(PTI , 15-Sep-2011 , IBN Live)
Kerala Chief Minister Oommen Chandy today said there should be a transparent mechanism to distribute patents developed by research institutions under government run institutions. More...
Patiala prof gets copyright for his Hindi to Punjabi software
(Jasneet Bindra , 15-Sep-2011 , Indian Express)
The copyright has been granted after more than a year by the Ministry of Human Resources and Developments Copyright Registrar office. More...
Google AOL Others Sued For Infringing Old Lycos Patents
(Eric Savitz , 15-Sep-2011 , Forbes)
And the great patent wars roll on. More...
Singing a different tune
(Ratnottama Sengupta , 15-Sep-2011 , The Times Of India)
While this comes as relief to the rights owners producers and music companies lyricists and composers are hoping that the amendment to the Copyright Act of 1957 will retain their rights as first owners. More...
Bharat Biotech in strategic play with Rotovac vaccine
(Viswanath Pilla , 14-Sep-2011 , Livemint)
The company which has 47 global product patents ploughs back 30% of its revenues into R&D. More...
Novartis executive to join Gates foundation
(Andrew Jack in London , 13-Sep-2011 , The Financial Times)
The decision is likely to herald fresh support for the drug companies commitment to tough intellectual property laws and support further Gates funding of their research including for Novartis which is already one of the most active in researching drugs and vaccines for diseases of the developing world. More...
Govt not properly briefed on Glivec patent suit: Drugmakers
(Khomba Singh , 13-Sep-2011 , The Economic Times)
The case was scheduled to resume hearing on September 6 but has been postponed after one of the judges recused himself from the case. More...
Wockhardt sees big opportunity in off patent drugs
(Press Trust of India / Mumbai , 12-Sep-2011 , Business Standard)
Troubled pharma player Wockhardt today said it sees huge opportunity in off patent medicines over the next few years. More...
India EU free trade talks resume today
(Nayanima Basu / New Delhi , 12-Sep-2011 , Business Standard)
India and the European Union are resuming talks on a free trade agreement from tomorrow. More...
Guj share in total Indian patents filed is 0.9%
(Jitendra Dave, DNA , 12-Sep-2011 , dailybhaskar)
For a state that often boasts of its entrepreneurial spirit Gujarat lags behind others when it comes to research innovation and protecting innovations. More...
Ciplas margin focus likely to yield benefits in the long term
(Ravi Ananthanarayanan , 12-Sep-2011 , Livemint)
The triggers for this change are fewer blockbuster products in the global research pipeline patent expiry of blockbuster products and a sluggish developed world economy. More...
Is the Google Motorola deal helping Microsoft?
(BALAJI NARASIMHAN , 12-Sep-2011 , Business Line)
The search giant acquired Motorola for patents but if it doesnt move carefully the play may help its competitor more than itself More...
Banarasi saree glitters in new found demand
(Binay Singh , 10-Sep-2011 , The Times of India)
The benefits of Geographical Indication certification have thus started showing for the handloom industry of this region. More...
Ranbaxy Laboratories to roll out Lipitor Clone in US on Nov 30
(ET Bureau , 09-Sep-2011 , The Economic Times)
Ranbaxy Laboratories rose more than 4% after a top company executive said the drugmaker is on track to launch a low cost version of the worlds largest selling drug Lipitor in the United States. More...
Trexime patent: Dr Reddys files appeal in US court
(Our Bureau , 8-Sep-2011 , Business Line)
Pharma major Dr Reddys Laboratories Ltd has filed an appeal in the district court of Texas in a patent infringement case with Pozen Inc on the generic version of Trexime sumatriptan naproxen sodium. More...
Macleods Novartis settle drug patent row
(Soma Das , 8-Sep-2011 , The Financial Express)
One of the fastest growing Indian drug makers Macleods Pharma has settled a patent dispute with Swiss pharma giant Novartis over the herpes drug Famvir Famciclovir in the US. More...
Aurobindo Pharma ties up with Russian firm
(Namrata Nandakumar , 8-Sep-2011 , Livemint)
Drug maker Aurobindo Pharma Ltd has formed an equal partnership with OJSC Diod a Russian maker of healthcare equipment and nutrition supplements to manufacture and market generic or off patent drugs taking advantage of changes in Russias public healthcare policy that seek to make that country less dependent on imports. More...
Teva defense of Copaxone starts today
(World News , 7-Sep-2011 , PharmaTimes)
The first trial in Tevas legal action against generic drugmakers seeking to market copycat versions of its big selling multiple sclerosis drug Copaxone in the USA is due to start later today. More...
Novartis’ case against Section 3(d) of Indias Patents Act enters final stage in Supreme Court
(Ramesh Shankar, Mumbai , 6-Sep-2011 , Pharmabiz)
The next hearing in the case will take place on September 6 2011. More...
A victory for Novartis could spell death for millions
(Priscilla Jebaraj , 6-Sep-2011 , The Hindu)
The Swiss pharma giant fighting in Supreme Court for patent on anti cancer drug More...
Suven gets four patent approvals for CNS molecules
(PTI , 6-Sep-2011 , Business Line)
Drug firm Suven Life Sciences on Monday said it has received four product patents in Australia and New Zealand for its new chemical entities which could be used for treating various central nervous disorders. More...
SC judge under attack from health activists
(Manoj Mitta , 6-Sep-2011 , The Times of India)
Two years ago, Justice Markandeya Katju of the Supreme Court had withdrawn from hearing a patent dispute vitally concerning pharmaceutical majors. More...
Medicines for all
(5-Sep-2011 , Livemint)
It has been pointed out that between 2011 and 2013 a large number of drugs are likely to go off patent in the US making it possible for local firms to produce cheaper generic versions. More...
Indians find cancer fighting protein in human body
(Snehal Rebello , 05-Sep-2011 , Hindustan Times)
Last October the team filed a patent for the chemically synthesised protein portion. More...
Removal of parallel imports clause may stir up debate
(C.H. Unnikrishnan , 4-Sep-2011 , Livemint)
The provision for importing books without infringing copyrights would have also helped students gain access to the latest affordable versions of text books from across the world. More...
Legal fraternity slams draft Bill to regulate practice
(Joe C Mathew / New Delhi , 04-Sep-2011 , Business Standard)
The government is planning a new accreditation and regulatory mechanism for legal services that has not been defined under the Advocates Act 1961. More...
Govt alarmed as MNC buyouts set to push up drug prices
(Kounteya Sinha , 04-Sep-2011 , The Times Of India)
The price of India made low cost generic drugs could be sky high soon. More...
Health Ministry wants FDI safeguards to keep drug prices low
(Aarti Dhar , 3-Sep-2011 , The Hindu)
As many as 61 drugs worth $80 billion are likely to go off patent in the U.S. between 2011 and 2013 making it possible for Indian companies to produce cheaper generic versions. More...
Pharmaceutical mega brand buyouts a sweet pill
(Reghu Balakrishnan / Mumbai , 2-Sep-2011 , Business Standard)
It may be Doktor Mom in Russia or Farex in India. More...
Piracy often brings down price of product
(Vivek Kaul , 02-Sep-2011 , The Economic Times)
The story goes that Kumar under his T Series brand initially brought out pirated cassettes of Hindi films for which HMV had the copyright. More...
DoP to set up NFDC to help SMEs to grab market with many patent expiries expected soon
(Joseph Alexander, New Delhi , 02-Sep-2011 , Pharmabiz)
With large number of drugs losing patents in the near future throwing up huge opportunities for Indian manufacturers of generic formulations the Department of Pharmaceuticals wants to set up at least one National Formulation Development Centre to assist the small and medium scale units to grab a decent pie from the emerging world market. More...
No deal in sight WTO tries to stay relevant
(Sidhartha , 01-Sep-2011 , The Times Of India)
When WTO chief Pascal Lamy comes to Asia next week he will make another pitch to revive the decade old Doha Round of trade liberalization talks and also seek inputs from India and China on additional work programme. More...
Kuthampully sarees get an IP address weave history
(Viju B , 01-Sep-2011 , The Times of India)
K Sreedharan got a booking order for 30 Kuthampully sarees from a Non Resident Indian settled in Canada last year. More...
Strategic Analysis of Indian Biosimilar Market - Impending Patent Expiries Encourage Companies to Ramp up Biosimilar Manufacturing Capabilities
(Eastern Daylight Time , 01-Sep-2011 , Business Wire)
Impending Patent Expiries Encourage Companies to Ramp up Biosimilar Manufacturing Capabilities More...
Pollution board chief cashed in on own patent
(Nitin Sethi , 01-Sep-2011 , The Times of India)
Central Pollution Control Board chairman SP Gautam sold a patent he held privately on a technology to the apex authority on a revenue sharing basis and then passed a directive in his official capacity asking the leather industry to buy the expensive and untested know how. More...
Pfizer Dr Reddys settle patent suit over Lipitor
(Khomba Singh , 01-Sep-2011 , The Economic Times)
Pfizer Inc and Dr Reddys Laboratories have settled a patent infringement suit related to the Indian drug makers launch of a generic version of the blockbuster drug Lipitor in the US. More...
Venus secures market for anti cancer product
(BS Reporter / New Delhi/ Chandigarh , 31-Aug-2011 , Business Standard)
The molecule patent protection of Sanofi Aventis has recently expired in major European countries while in rest of the countries the expiry of patent is due in November 2013. More...
Teva Pharma wins 1st round of patent battle against Natco
(Soma Das , 31-Aug-2011 , The Financial Express)
In a setback to Hyderabad based Natco Pharma the Israeli drug giant Teva Pharma claims to have won the first round of patent battle over the blockbuster multiple sclerosis drug Copaxone Glatiramer Aceatte in the United States. More...
India EU to renew trade talks in Brussels
(Asit Ranjan Mishra , 30-Aug-2011 , Livemint)
Indian and European Union negotiators will renew talks for a trade and investment agreement in Brussels on 12 14 September but experts said their differences are too wide to be overcome without a political push. More...
US patent expiries unlikely to be a big opportunity
(Priyanka Golikeri , 30-Aug-2011 , DNA)
In the next four years drugs with sales worth $157 billion will lose patent in the US opening the doors to generic competitors. More...
Kutchi shawl likely to get GI tag
(PTI , 29-Aug-2011 , IBN Live)
A Geographical Indication tag is on the cards for the colourful Kutchi shawls woven with motifs by artisan communities for past several generations in Kutch district of Gujarat. More...
India EU to renew trade talks in Brussels
(Asit Ranjan Mishra , 29-Aug-2011 , Livemint)
Differences over services agriculture chemicals intellectual property rights and government procurement are also yet to be resolved. More...
Payment for copyrighted goods not royalty: ITAT
(M Padmakshan , 29-Aug-2011 , The Economic Times)
However in its ruling a twomember bench of the ITAT said that the payment was not royalty because it was for the software which was a copyrighted article and not for the copyright itself. More...
Cipla may team up with MNCs
(TNN , 27-Aug-2011 , The Times Of India)
Hamied said that the government should work on three things to address the healthcare concerns of the country one bring in compulsory licensing when a government allows a pharma company to manufacture a patented drug without the consent of the patent owner two prevent a monopoly and thirdly prevent frivolous evergreening and incremental innovations by MNCs. More...
Granules India to augment APIs production expand market share of best sellers
(Deepika Amirapu , 26-Aug-2011 , The Economic Times)
They manufacture several off patent drugs such as Paracetamol Ibuprofen Metformin and Guaifenesin on a large scale for customers in the regulated and semi regulated markets. More...
Copycat climate
(26-Aug-2011 , Livemint)
Its ironic that Chinas telecom companies are on a patent overdrive. More...
Apple wins ban on 3 Samsung phones in 10 European nations
(Reuters , 26-Aug-2011 , The Economic Times)
Apple won an injunction in a Dutch court on Wednesday to stop Samsung Electronics from marketing three smartphone models in some European countries after alleging a breach of patents. More...
Cipla looking at global alliances to sell its products
(Our Bureau , 25-Aug-2011 , Business Line)
On the Unitaids patent pool Dr Hamied said there were issues regarding the markets open to a company that uses patents from the pool. More...
Cipla Lupin deny report on Takeda talks
(Reuters , 25-Aug-2011 , Livemint)
Emerging markets are set to become the main driver for the global pharmaceuticals industry as patents run out on many top drugs and sales stall in Western markets but acquisitions in those economies have not always come easy. More...
Google Motorola could be peak of patent price spike
(Reuters , 25-Aug-2011 , The Economic Times)
Now that Google has agreed to a $12.5 billion deal to buy Motorola Mobility scooping up a trove of 17000 phonerelated patents to give itself some ground to defend its Android operating system the most motivated buyer looks to be off the market. More...
Bharti Airtel Vodafone Essar Reliance communication and BSNL ask Trai to stay out of dealings with VAS firms
(Joji Thomas Philip , 25-Aug-2011 , The Economic Times)
The telco also pointed out that it would not just be counter productive but also extremely unscientific to determine a defined revenue percentage share on content because value of such applications were intellectual property rights driven and not on dry cost basis. More...
Patent ruling clears way for Tatas to market ultra strong steel in Europe
(Vidya Ram, Roudra Bhattacharya , 24-Aug-2011 , Business Line)
Tata Steels plans for marketing a new ultra high strength steel for the automotive industry gained impetus on Wednesday after a European patent court revoked a rivals patent. More...
Google Motorola and the patent wars
(L Gordon Crovitz , 24-Aug-2011 , Livemint)
The costs of the broken US patent system are often abstract but this month Google put a price tag on it: $12.5 billion. More...
PM calls for pvt investments in scientific research
(Our Bureau , 21-Aug-2011 , Business Line)
Urging the private sector to contribute significantly in spheres of research and development Dr Singh lamented the fact that the number of patents filed by Indians were very low compared with other developed nations or developing nations. More...
Cipla Dr Reddys under DCGI scanner for selling banned drugs
(Khomba Singh , 19-Aug-2011 , The Economic Times)
The countrys drug regulator has sent show cause notices to Cipla and Dr Reddys Laboratories for selling drugs banned by the government and is planning similar action against a few other top drug makers. More...
Suven Life secures four product patents
(BS Reporter / Chennai/ Hyderabad , 19-Aug-2011 , Business Standard)
Hyderabad based Suven Life Sciences has won four product patents for its new chemical entities designed for treatment of neurodegenerative diseases. More...
In search of the right medicine
(19-Aug-2011 , Business Line)
Drug price regulation will be better served when the Pharmaceuticals Policy sees the light of day and takes structural changes in industry into account. More...
Ranbaxy Laboratories may sell Lipitor rights if FDA delays nod
(Bloomberg , 19-Aug-2011 , The Economic Times)
Ranbaxy Laboratories may sell rights to make a generic version of Pfizer Incs Lipitor the worlds best selling medicine should it fail to win timely US approval for the cholesterol pill Credit Suisse AG said. More...
WHO disqualifies 3 vaccines of Panacea Biotec
(ET Bureau , 19-Aug-2011 , The Economic Times)
Panacea Biotec scrip fell 20% to Rs 144.90 on Thursday after the biotechnology firm disclosed that WHO has disqualified its three combination vaccines from supplying to the organisation. More...
UTILITY MODEL PATENTS
(P A Francis , 18-Aug-2011 , Pharmabiz)
Indias commerce ministry is reported to be considering a proposal to introduce a Utility Model for patents in the country as a new tool for granting intellectual property rights. More...
Lincoln Pharma launches ayurvedic product
(BS Reporter / Mumbai/ Ahmedabad , 18-Aug-2011 , Business Standard)
Ahmedabad based Lincoln Pharmaceuticals Ltd. recently announced the launch of its ayurvedic product named ISL Granuels that will serve the mother and child healthcare segment. More...
What Motorola India gets from Google deal
(TNN , 17-Aug-2011 , The Times of India)
Googles takeover of Motorola Mobility is expected to impact the Indian operations of Motorola Mobility. More...
What Motorola India gets from Google deal
(TNN , 17-Aug-2011 , The Times of India)
Googles takeover of Motorola Mobility is expected to impact the Indian operations of Motorola Mobility. More...
Motorola India may gain from Google deal
(TNN , 17-Aug-2011 , The Times of India)
Googles takeover of Motorola Mobility is expected to impact the Indian operations of Motorola Mobility. More...
Patent search
(Robert Cyran , 17-Aug-2011 , Business )
Google is spending $12.5 billion on insurance for itself but its partners may not feel at ease. More...
India on global R&D map
(Pranav N Desai , 16-Aug-2011 , Express Buzz)
Technological capabilities are enhanced by a learning that is determined not only by codified knowledge in R&D output such as publications patents and designs but also by interactive learning processes of international collaboration inward and outward foreign direct investments and by the general socio economic environment. More...
Motorola buy may not hurt Android partners in India
(Leslie D`Monte / Mumbai , 17-Aug-2011 , Business Standard)
After the completion of the deal Google would own both hardware and software units while simultaneously acquiring Motorola Mobilitys 17000 patents and an additional 7500 patent applicationsan arsenal that can help Google fight the Nokia Apple Microsoft trio which recently outbid it in acquiring Nortels patents. More...
Google Motorola deal more a patents buy say tech analysts
(Our Bureau , 16-Aug-2011 , Business Line)
Googles $12.5 billion purchase of Motorola Mobility is more a patents play than a hardware deal say technology analysts. More...
Monsanto expects a surge in demand for maize
(Nidhi Nath Srinivas , 16-Aug-2011 , The Economic Times)
It is attractive because of well developed intellectual property rights and a robust regulatory process. More...
Gopal Subramanium to represent Novartis
(Joe C Mathew / New Delhi , 15-Aug-2011 , Business Standard)
Patent case of the Swiss pharma major will be his first private assignment after resigning as Solicitor General. More...
European Union not keen to relax FTA visa curbs
(Sidhartha , 15-Aug-2011 , The Times of India)
The European Union is pushing for more foreign investment in a slew of sectors banking insurance legal accounting postal maritime and security services but is unwilling to allow a bigger number of Indian professionals to work in the 27 member union. More...
Bhalia wheat gets GI tag
(PTI , 15-Aug-2011 , Business Line)
Bhalia a long grain wheat variety rich in protein and grown under conserved soil moisture conditions in Bhal region of Gujarat has received the Geographical Indication tag a move which is likely to benefit more than 5000 farmers in the State. More...
Novartis imatinib patent battle resumes in Indian Supreme Court
(Article , 15-Aug-2011 , The PharmaLetter)
The controversial Novartis case in which the Swiss major Novartis challenged the manner in which Section 3(d) of Indias Patents Act is applied is now the subject of hearings at the Indian Supreme Court. More...
Gandhi Rice as trademark opposed by Indian lawyer
(Hary M. Pillai , 14-Aug-2011 , Law et al)
Lalit Bhasin a leading lawyer in India has taken upon himself to prevent an attempt for commercial exploitation of the name of father of the nation Mahatma Gandhi. More...
MNCs looking at more global partnerships with Indian cos to launch more products
(A Raju, Hyderabad , 13-Aug-2011 , Pharmabiz)
Global pharma majors are in the midst of a crisis with a decline in the number of blockbuster drugs low R&D productivity and patent expiries More...
Health ministry goes big on yoga funds studies on its benefits
(Kounteya Sinha , 13-Aug-2011 , The Times of India)
Meanwhile the Traditional Knowledge Digital Library has completed documenting 1300 asanas which will soon be uploaded making them public knowledge in order to protect them from western pirates. More...
ICARs IPR will be globally showcased through new company AGRINDIA
(Prabha Jagannathan , 12-Aug-2011 , The Economic Times)
The Union Cabinet has approved the proposal of Ministry of Agriculture Department of Agricultural Research & Education for setting up of a new company called AGRlNDIA. More...
Hindustan Unilever loses trademark case for Sunlight brand to little known Kerala based Thai Group
(Paramita Chatterjee & Ratna BhushanParamita Chatterjee & Ratna Bhushan , 12-Aug-2011 , The Economic Times)
The oldest brand in the portfolio of Anglo Dutch consumer products giant Unilever took a bath last week when its Indian affiliate Hindustan Unilever Ltd lost a trademark case for a 127 year old soap called Sunlight to a little known southern soap maker. More...
Hearing on Novartis case on Section 3(d) of Indian Patents Act begins in Supreme Court
(Ramesh Shankar, Mumbai , 12-Aug-2011 , Pharmabiz)
The Supreme Court has started hearing the controversial Novartis case in which the Swiss multinational pharmacuetical company has challenged the manner in which Section 3(d) of Indias Patents Act is applied. More...
Apple blocks Samsung from selling galaxy tablet in EU
(Reuters / Seoul/ San Francisco , 11-Aug-2011 , Business Standard)
The court order comes a week after Samsung was forced to delay the Australian launch of its latest Galaxy tablet because of a separate lawsuit alleging Samsung infringed on a number of Apples patents. More...
MSF raises concern over commerce ministrys move to introduce Utility Model for patenting
(Ramesh Shankar, Mumbai , 10-Aug-2011 , Pharmabiz)
The Médecins Sans Frontières an independent international medical humanitarian organization has expressed concern over the union commerce ministrys proposal to introduce Utility Model as an alternate tool for the protection of Intellectual Property Rights in India. More...
Final hearing in Novartis Glivec case begins in SC
(Nikhil Kanekal , 10-Aug-2011 , Livemint)
Novartis contends that its patent on the drug should be extended as it has increased its efficacy by 30% meaning that a persons capacity to absorb the newer version of the drug is that much better More...
DoP to convey concerns of industry over proposed FTAs TPPA to commerce ministry
(Joseph Alexander, New Delhi , 10-Aug-2011 , Pharmabiz)
The Department of Pharmaceuticals will take up issues with the Commerce Ministry regarding the proposed Trans Pacific Partnership Agreement which is likely to have adverse impact on the Indian pharma products and other such Free Trade Agreements in the pipeline. More...
Digital library to the rescue of traditional patents
(Jaideep Shenoy , 08-Aug-2011 , The Times of India)
Indias resilience in standing up to attempts by powers that be to seek patents for turmeric basmati rice wheat and all time favourite snack the idli has paid off big time at least for now. More...
EU demanding access to Indian service market is barrier to FTA
(PTI , 07-Aug-2011 , MSN)
The European Unions demand that it be given access to Indian market in services like banking postal legal and accounting would be a major road block for the India EU free trade pact under negotiations since June 2007 sources said. More...
Access to affordable generics poses huge challenge in public healthcare: KDPMA chief
(Nandita Vijay, Bangalore , 6-Aug-2011 , Pharmabiz)
While issues like unreliable supply system irrational prescription dispensing usage unfair health financing mechanism inadequate funding for research in neglected diseases have resulted in the high cost of drugs the patent regime enforced from 2005 has been one of the key deterrents for drug affordability. More...
Venus Remedies appoints consultants to out license two products
(Our Bureau , 05-Aug-2011 , Business Line)
After having got a product patent in the United States on its dry powder injectable antibiotic Vancoplus the Chandigarh based Venus Remedies expects to out license the product this financial year. More...
Ranbaxy dips 4% on Pfizers Lipitor move
(Rupali Mukherjee , 5-Aug-2011 , The Times of India)
Ranbaxy scrip suffered losses and closed lower on the BSE on Thursday on fears that Pfizer was reportedly planning to launch an overthe counter version of cholesterol lowering drug Lipitor once the drug loses patent protection in US in November this year. More...
Copyright judgment garners flak from industry
(Pooja Maheshwary , 04-Aug-2011 , Hindustan Times)
Last week the High Court had stated that the Indian Performing Right Society Limited that safeguards the copyright of music composers and lyricists is not entitled to demand royalty or licence fees from FM radio channels for the music they broadcast. More...
Venus Remedies gets US patent nod for research product
(Press Trust of India / New Delhi , 3-Aug-2011 , Business Standard)
Venus Remedies today said it has received its first patent approval from the United States Patent and Trademark Office for its product Vancoplus used for treating bacterial infections. More...
AstraZeneca Indias Balganesh to head CSIR project
(Jacob P. Koshy , 03-Aug-2011 , Livemint)
None of the entities can claim exclusive patent rights but because companies do not have to make huge and risky investments in research, they are more likely to agree to non-exclusive marketing licensing arrangements with CSIR and thus keep the cost of drugs low. More...
Pfizer files patent suit against Hetero
(BV Mahalakshmi , 03-Aug-2011 , The Financial Express)
Pfizer Inc has filed a patent infringement suit against Hyderabad based Hetero Drugs in a US court raising opposition against Indian pharma firm Heteros attempt to enter the lucrative market of its blockbuster drug Sildenafil citrate commonly called as Viagra used for treatment of impotence and rare disease pulmonary arterial hypertension. More...
EU for duty cuts in auto sector in FTA with India
(Press Trust of India / New Delhi , 3-Aug-2011 , Business Standard)
The government today said the European Union had requested India to cut import duties in several sectors including automobile in the proposed comprehensive market opening pact. More...
Natco Pharma files Indias first compulsory licence plea
(Khomba Singh , 2-Aug-2011 , The Economic Times)
Natco Pharma has applied for the countrys first compulsory licence to sell a generic version of Bayers patented medicine a development whose outcome is expected to determine how global drug makers price their costly drugs in India. More...
India EU FTA negotiations at advanced stage: Scindia
(Press Trust of India / New Delhi , 02-Aug-2011 , Business Standard)
Negotiations on a comprehensive free trade pact between India and the European Union which began in June 2007 have reached at an advanced and delicate stage Parliament was informed. More...
Lupin looks to acquire large LatAm firm
(C.H. Unnikrishnan , 2-Aug-2011 , Livemint)
Lupin Ltd Indias fifth largest drug maker is planning to acquire a large Latin American pharmaceutical company to enter a region where cheaper generic drugs outsell medicines sold by patent holders. More...
EU wants GI protection for 190 products
(Joe C Mathew / New Delhi , 2-Aug-2011 , Business Standard)
Anticipating a huge market opportunity once the comprehensive free trade agreement being negotiated is ratified the European Union has sought geographical indication protection for 190 products in India. More...
DoP to take up issue of non-tariff barriers by EU with commerce ministry for further actions
(Joseph Alexander, New Delhi , 2-Aug-2011 , Pharmabiz)
In the case of bulk drugs third party audits are being insisted upon as a result the companies are forced divulge their intellectual property infringing on the right to protect the data. More...
HC decides on own letters patent jurisdiction
(TNN , 1-Aug-2011 , The Times Of India)
In a significant judgment the high court of Bombay at Goa recently held that a letters patent appeal intra court appeal lies before a division bench of the court from a judgment of a single bench judge in a civil writ petition under Article 226 of the Constitution. More...
Junagadh Kesar mango gets GI tag as Gir Kesar
(PTI , 1-Aug-2011 , Business Line)
The famous saffron coloured Kesar variety of mango largely grown around the foothills of Girnar mountains in Gujarats Junagadh district has got global recognition as Gir Kesar mango after being granted the Geographical Indication tag. More...
The Pagadi Unravelled
(Shruti Nambiar , 1-Aug-2011 , Indian Express)
On September 4 2009 Geographical Indication Status a sign used on goods that have a specific geographical origin was accorded to a traditional Maharashtrian headgear. More...
India Japan implement economic pact aim to double trade
(IANS , 01-Aug-2011 , The Economic Times)
It covers more than 90 percent of trade a vast gamut of services investment intellectual property rights customs and other trade related issues. More...
Rovio sues Hulu for patent infringement
(Reuters , 30-Jul-2011 , The Times of India)
Rovi Corp sued Hulu, accusing the online video site of infringing patents that cover electronic program guides. More...
India EU reach understanding on seizure of Indian generic drugs at EU ports
(Our Bureau, Mumbai , 30-Jul-2011 , Pharmabiz)
India and the European Union have reached an interim settlement on the long pending issue of seizure of Indian generic drug shipments at the EU ports en route to Latin American and other countries on charges of counterfeiting and patents infringement. More...
India EU ink deal to end drug seizure for now
(TNN , 29-Jul-2011 , The Times Of India)
Finally EU has come around and we have agreed on an interim settlement... which means EU will not make any detention within its territory of pharmaceutical products coming from India. More...
EU agrees to stop confiscation of Indian generic drugs
(ET Bureau , 29-Jul-2011 , The Economic Times)
Indias long drawn dispute with theEuropean Union over confiscation ofIndian generic drugs in transit to other countries at European airports has been temporarily settled. More...
GI tag for Gir Kesar mango Bhalia wheat
(Daniel P George , 28-Jul-2011 , The Times of India)
Gir Kesar mango and Bhalia wheat from Gujarat have been accorded the geographical indication tag by the Geographical Indications Registry in Chennai. More...
EUs demand for additional concessions stalls trade talks
(Asit Ranjan Mishra , 28-Jul-2011 , Livemint)
The agreement is being opposed by non governmental organizations over concerns that the proposed trade related aspects of intellectual property rights in the deal will affect Indias ability to produce and export life saving generic drugs to developing and poor countries. More...
Himalaya Drug positions Liv. 52 HB as safe and cost effective for India’s 4 crore HBV patients
(Nandita Vijay, Bangalore , 28-Jul-2011 , Pharmabiz)
Himalaya Drug Companys Liv. 52 HB is Indias first US patent pending herbal formulation for Hepatitis B Virus infection. More...
Pharma companies may get tax sops for clinical trials patent filings
(Khomba Singh , 27-Jul-2011 , The Economic Times)
The Department of Pharmaceuticals is planning to recommend extension of tax benefits given to drugmakers for in house R&D and research work done outside the firm such asclinical trials bio equivalence studies regulatory approvals and patent filings which could benefit most Indian drug companies. More...
GI tags sought for M.P.s Nimari chilli Malwi potato
(PTI , 26-Jul-2011 , Business Line)
If things go according to plan Madhya Pradeshs famously bitter Nimari chillis and the Malwi potatoes that are favoured by potato chip manufacturers will soon get international recognition. More...
Music companies not composers own song rights: Bombay HC
(Shibu Thomas , 27-Jul-2011 , The Times Of India)
The judge however clarified that the owners of the copyright composers and lyricists do not lose all their rights when they allow it to be recorded. More...
CCSHAU Hisar gets a process patent
(Madhvi Sally , 26-Jul-2011 , The Economic Times)
Chaudhary Charan Singh Haryana Agricultural University CCSHAU Hisar has been issued a patent on a biotechnological process which enhances in vitro plantlets regeneration inair yarn plant announced the Vice Chancellor Dr. K.S. Khokhar. More...
Low cost innovations make life easier for rural poor
(T E Narasimhan / Chennai , 26-Jul-2011 , Business Standard)
This water is filtered in a specially designed integrated filtration system including a patented membrane from NCL which filters out all suspended matter including bacteria and viruses. More...
Lupin settles patent suit with Medicis, signs R&D pact
(Press Trust of India / New Delhi , 25-Jul-2011 , Business Standard)
Drug maker Lupin today said it had settled all patent litigation over Solodyn tablets with Medicis Pharmaceutical Corp and signed a pact with the US based firm for development of multiple therapeutic compounds. More...
CSIR keen to revive sick Bengal PSU pharma cos
(PTI , 24-Jul-2011 , Business Line)
The CSIR has formed a separate company CSIR Tech to commercialise its patents and knowledge which will act as a technology business incubator. More...
US to play key role in Dr Reddys generics business
(BS Reporter / Chennai/ Hyderabad , 23-Jul-2011 , Business Standard)
About 63 per cent of the companys new productline in generics pertains to those drugs that would be off patent by 2013 in the US GV Prasad vice chairman and chief executive officer of the Hyderabad based pharmaceutical major said at the AGM here. More...
GlaxoSmithKline launches two cancer drugs at reduced prices
(Our Bureau , 22-Jul-2011 , Business Line)
Both patent protected products will be imported from the UK. More...
Dr Reddys scouts ally for new chemical entity Balaglitazone
(KV Ramana , 22-Jul-2011 , DNA)
The product pipeline today covers about 63% of patent expiries. More...
Patents Granted in Indian Patent Office Plunge
(Guest Barista , 21-Jul-2011 , Patent Barista)
The Indian patents system having its seeds laid in the British era 1852 and undergoing sporadic replantations the 1912 1970 2005 Patents Act & amendments was appearing to grow tall and bear fruits until a noticeable downfall last year. More...
Patents and lawsuits threatening the free world of software
(ET Bureau , 21-Jul-2011 , The Economic Times)
Could something as pesky and well trivial as a patent ruling topple the mighty Android from its perch as the mostused operating system for smartphones. More...
Focus on pharmaceutical M&As back after Lupin negotiation buzz
(Reghu Balakrishnan / Mumbai , 20-Jul-2011 , Business Standard)
Apart from the lack of strong product pipeline and expiry of patents MNCs were hit by the strong stance taken by US FDA against innovative product approvals Krishnakumar added. More...
DoP takes steps to assess current status of regulatory matters relating to exports
(Joseph Alexander, New Delhi , 20-Jul-2011 , Pharmabiz)
The DoP has plans to fund IPA to set up a cell to deal with all issues related to IPR regulatory issues and other trade barriers. More...
Google slogan: Android Asia Action
(Vivek Sinha , 19-Jul-2011 , Hindustan Times)
Schmidt was unfazed by the patent suits filed against the firm by rivals such as Apple Microsoft and Oracle. More...
Govt to encourage SMEs to go in for patents
(PTI , 18-Jul-2011 , The Economic Times)
The government in collaboration with the UN body World Intellectual Property Organisation has commissioned a study to ascertain whether Indias small and medium enterprises are prepared to adopt the global IPR regime. More...
Auto wine duties hold up EU FTA
(Sidhartha , 18-Jul-2011 , The Times of India)
We have told them that we are unable to offer any concessions since we have not included these two sectors in our FTAs said a government official. More...
India EU trade deal to benefit textile garment exporters
(Nayanima Basu / New Delhi , 18-Jul-2011 , Business Standard)
European Union negotiators arrive in Delhi today to continue the final leg of talks. More...
Samsung wants Siemens unit banned in US
(Reuters , 18-Jul-2011 , The Times of India)
Samsung LED Co Ltd said it had filed a complaint with the US fair trade commission to ban imports of LED products from Siemens light bulb unit Osram and affiliates Osram Opto Semiconductors and Osram Sylvania Inc. More...
India a focus area for patents says GE
(BS Reporter / Chennai/ Hyderabad , 16-Jul-2011 , Business Standard)
US based technology company General Electric is looking to increase patent filings from its research and development centres in India along with those in China and Brazil as the intellectual property regimes are strengthened in these countries. More...
ICMR planning to acquire patents of traditional healing techniques for Andaman tribals
(Kounteya Sinha , 16-Jul-2011 , The Times of India)
Traditional healing techniques using indigenous medicinal plants practiced efficiently for hundreds of years by some of Indias most elusive tribes residing in the Andaman and Nicobar Islands is all set to become public. More...
Balancing public private interests must in intellectual property issues
(Our Bureau , 15-Jul-2011 , Business Line)
A fine balance between protection of private and public interests is vital in intellectual property management according to Ms Justice Prabha Sridevan Chairman Intellectual Property Appellate Board. More...
Kootol targets Microsoft Apple others over patent
(Josh Lowensohn , 15-Jul-2011 , cnet News)
More than 30 companies including the likes of Microsoft Apple and IBM have been targeted by India based Kootol Software for allegedly violating technology covered in a patent application. More...
Hilton loses trademark battle over title in India
(PTI & Nikhil Kanekal , 15-Jul-2011 , Livemint)
Hilton International Corp. which owns the international chain Hilton Hotels and Resorts lost a case in the Supreme Court on Monday thereby losing the exclusive right over the Hilton trademark in India. More...
Granules India forms JV firm with Belgian company for APIs
(Prabhu Mallikarjunan , 15-Jul-2011 , Livemint)
Belgian chemical company Ajinomoto Omnichem and Indian drug maker Granules India Ltd formed a 50 50 joint venture on Thursday to produce active pharmaceutical ingredients and intermediates for third parties seeking to tap demand for contract manufacturing in the generic drugs market. More...
Tattoo design registered on SRKs name!
(Meena Iyer , 14-Jul-2011 , The Times of India)
The D tattoo worn by King Khan in the upcoming Don 2 has been registered for copyright protection against his name. More...
EU not to seize Indian drug despatches using Europe as transit
(PTI , 13-Jul-2011 , The Economic Times)
European Union members will not seize Indian medicines passing through Europe on allegations of intellectual property right violations as per an understanding reached between India and EU. More...
Roche & Helsinn sue Dr Reddys for patent infringement
(Press Trust of India , 13-Jul-2011 , NDTV)
Roche Palo ALTO and Helsinn Healthcare SA filed a patent infringement litigation against Dr Reddys Laboratories for antinausea drug Aloxi. More...
Gilead Sciences Inc allows 4 Indian pharmaceutical companies Ranbaxy Laboratories Matrix Laboratories Hetero Drugs and Strides Arcolab to sell HIV Generics
(OUR BUREAU , 13-Jul-2011 , The Economic Times)
California based Gilead Sciences Inc has allowed four Indian companies to make and sell low cost versions of three of its new HIV drugs under a firstof its kind agreement between an innovator pharmaceutical firm and a United Nations backed patent sharing body. More...
EU not to seize Indian drug despatches using Europe as transit
(PTI , 13-Jul-2011 , MSN)
European Union members will not seize Indian medicines passing through Europe on allegations of intellectual property right violations as per an understanding reached between India and EU. More...
Dr Reddys Labs launches three generic products in USA
(Deepika Amirapu , 13-Jul-2011 , The Economic Times)
Indian drug firm Dr Reddys Laboratories has received the final approval from the USFDA to launch Fondaparinux Sodium injection used for treating and preventing deep vein thrombosis the company said in a statement. More...
ComMin for patent protection to Jugaad technology items
(PTI , 13-Jul-2011 , MSN)
The Commerce Ministry has favoured patent protection to low cost innovations like onion seed transplanter and clay refrigerator mitticool. More...
Why India ranks low in INNOVATION
(Sreelatha Menon , 13-Jul-2011 , Rediff)
Just 200 patent applications were made in 10 years. More...
India China to oppose barriers to affordable drugs
(Ananth Krishnan , 13-Jul-2011 , The Hindu)
India China and other members of the BRICS group of countries have agreed to stand together to oppose any moves by developed nations to tighten Intellectual Property Rights rules that could threaten access to affordable drugs in developing countries officials said on Tuesday following two days of talks. More...
BRIC nations pledge cheaper drugs for developing nations
(Kounteya Sinha , 12-Jul-2011 , The Times Of India)
According to Indian health minister Ghulam Nabi Azad Intellectual Property Right barriers including patents and data exclusivity cause delays in generic competition in the market which is one of the most efficient ways to bring prices down. More...
India seeks Polands help for removal of EU trade curbs
(Press Trust of India / New Delhi , 11-Jul-2011 , Business Standard)
India today sought help from Poland which holds the European Union Presidency for resolving trade obstacles for Indian agri exports to 27 EU countries. More...
Drug makers bet on local biosimilar markets
(Reghu Balakrishnan / Mumbai , 11-Jul-2011 , Business Standard)
A recent Standard Chartered Bank report, said By 2015 biologics with an estimated sales value of $60 billion are due to lose patent protection rising to $100 bn by 2020. More...
Industry vehemently objects to the implementation of Utility Models in India
(Suja Nair Shirodkar, Mumbai , 11-Jul-2011 , Pharmabiz)
Objecting strongly to the governments plan to introduce a new IPR in the country in the form of Utility Models or Petty Patents the Indian pharma industry has urged the government to re consider it as they fear that it will affect the impact of the well accepted patent laws in India. More...
Trade barriers should not prevent affordable health services
(PTI , 11-Jul-2011 , IBN Live)
India today cautioned against moves to enforce Intellectual Property Rights with the proposed anticounterfeiting task force saying trade barriers should not prevent equitable and affordable public health services. More...
Pressing for strong IPR regime in FTA with India: EU tells WTO
(PTI , 10-Jul-2011 , The Economic Times)
The European Union has informed the WTO that it is pressing for inclusion of strong IPR regime in the free trade agreement under negotiations with India even as the Commerce Ministry has maintained that New Delhi will not yield to the EU on this issue. More...
Ranbaxy US FDA inch closer to settlement
(Rupali Mukherjee & Partha SinhaRupali Mukherjee & Partha Sinha , 9-Jul-2011 , The Times Of India)
Ranbaxy holds the 180 day exclusivity rights for marketing a generic version of Lipitor in the US through a deal with current patent holder Pfizer. More...
Lalbaugcha Raja makers get patent for popular idol
(Vinay Dalvi , 8-Jul-2011 , Mumbai Mirror)
In its 77th year the immensely popular Lalbaugcha Raja that attracts millions of devotees each year has finally been protected by a patent. More...
Indian drug makers bet big on local biosimilar market
(Reghu Balakrishnan / Mumbai , 8-Jul-2011 , Business Standard)
By 2015 biologics with an estimated sales value of more than $60 billion are due to lose patent protection rising to over $100 billion by 2020. More...
Create scalable organisations that last
(Sanjay Anandaram , 8-Jul-2011 , The Financial Express)
Recently India granted geographical indication of origin status to Scotch whisky a legal protection that will help reinforce the authenticity of the product and enhance the market potential. More...
Government finalises rules of nuclear liability law
(PTI , 07-Jul-2011 , The Economic Times)
Government has finalised the much awaited rules of implementation of the nuclear liability law a move that could pave way for expansion of the atomic power sector by procuring equipment from foreign suppliers. More...
Chinas raw deal
(T S Vishwanath , 7-Jul-2011 , Business Standard)
The World Trade Organisation is turning into an important platform to target export bans on raw materials by member countries. More...
A deal still on the drawing board
(Biswajit Dhar , 6-Jul-2011 , Livemint)
The India EU free trade agreement is yet to see daylight. More...
India grants Scotch GI status to check counterfeit
(PTI , 5-Jul-2011 , The Times of India)
India has granted geographical indication of origin status to Scotch whisky a legal protection that will help prevent the sale of counterfeit products in the Indian market as well as reinforce the authenticity of the product for the consumer. More...
India has to play a critical role in HIV prevention
(Special Correspondent , 05-Jul-2011 , The Hindu)
Mr. Sidibe hoped India would resist pressure from other countries to place limits of TRIPs trade related aspects of intellectual property rights flexibilities. More...
Drug cos eye US entry after FDA checks
(Khomba Singh , 5-Jul-2011 , The Economic Times)
The US drug regulator has inspected the manufacturing plants of at least half a dozen Indian drugmakers raising hopes that these companies will be able to export medicines to the worlds largest drug market reports Khomba Singh from New Delhi. More...
Millions will die if India stops AIDS drugs U.N.
(Nita Bhalla , 05-Jul-2011 , Reuters)
The EU India trade deal includes measures that could delay or restrict competition from generic medicines by extending patent terms requiring data exclusivity and tightening border enforcement rules. More...
Google suffers major blow in Nortel patent loss
(IANS , 04-Jul-2011 , The Economic Times)
Google which initiated the bidding war for precious Nortel patents in April has suffered a huge blow with an Apple led consortium walking away with 6000 patents for $4.5 billion last week. More...
Glenmark settles litigation with Daiichi
(Our Bureau , 04-Jul-2011 , Business Line)
Glenmark has settled its litigation with Daiichi Sankyo Inc and Genzyme Corporation over the sale of Glenmarks generic version of Colesevelam Hydrochloride in the US. More...
Home grown jugaad set for patent cover
(Sidhartha , 4-Jul-2011 , The Times Of India)
Indias spirit of jugaad is finally going to get legal backing. More...
India rejects clause on litigation
(Asit Ranjan Mishra , 4-Jul-2011 , Livemint)
India should reject the EUs demand for inclusion of intellectual property in the definition of investment and the so called investor to state arbitration clause according to Leena Menghaney public health lawyer and India campaign coordinator for non-profit Medecins Sans Frontieres. More...
Opportunities outweigh risks
(fe Bureau , 4-Jul-2011 , The Financial Express)
Key risks: longer ANDA approval timelines rising FDA scrutiny. More...
The Copyright Amendment Bill 2010: on the death of books and the digital environment
(Aparna Viswanathan , 04-Jul-2011 , The Hindu)
The Copyright Amendment Bill 2010 introduces the parallel importation of books in accordance with Article 6 of the Trade Related Intellectual Property Rights Agreement a provision intended to provide readers in developing countries with books at cheaper prices. More...
Scotch Whisky gets GI status in India
(Agencies , 3-Jul-2011 , Indian Express)
India has granted geographical indication of origin status to Scotch Whisky a legal protection that will help prevent the sale of counterfeit products in the Indian market as well as reinforce the authenticity of the product for the consumer. More...
DRL haunted by past follies?
(Swati Bharadwaj-Chand , 3-Jul-2011 , The Times Of India)
Over the past two years lawsuits against DRL over alleged patent infringements in US courts have been piling up as it makes an aggressive play for the US generics market. More...
Pfizer files lawsuit against Aurobindo Pharma
(PBR Staff Writer , 1-Jul-2011 , Pharmaceutical Business Review)
Drug maker Pfizer has filed a lawsuit against India based drug manufacturer Aurobindo Pharma over generic Lipitor which is indicated as a treatment for cholesterol and for lowering stroke heart attack or other heart complications in patients type 2 diabetes. More...
Wockhardt gets USFDA nod for generic eye drops
(PTI , 01-Jul-2011 , Business Line)
The patent covering this product is under litigation in the US courts and Wockhardt will launch the product after resolution of the same the company said. More...
Nothing wrong in guarding ones forte
(S. Murlidharan , 30-Jun-2011 , Business Line)
A drug company is normally allowed a 20 year monopoly in most of the countries in the wake of the WTO norm to this effect when it successfully obtains a patent for its invention. More...
Pfizer sues Aurobindo Pharma over Lipitor
(Press Trust of India / Hyderabad , 30-Jun-2011 , Business Standard)
Global pharma giant Pfizer Inc has sued city based Aurobindo Pharma over the generic version of Lipitor sources close to the development said today. More...
India needs to nurture culture of innovation
(Rahul Wadke , 30-Jun-2011 , Business Line)
It is one of the top patent producers in the world. More...
Cipla wins pre-grant opposition against Novartis for dispersible tabs containing deferacirox
(Suja Nair Shirodkar, Mumbai , 30-Jun-2011 , Pharmabiz)
The Chennai patent office has granted a pre grant opposition in favour of Cipla for dispersible tablets containing 'deferacirox'. More...
U.S. Court Orders Seizure of Cipla Pet Drugs
(INTI LANDAURO And ASHUTOSH JOSHI , 30-Jun-2011 , The Wall Street Journal)
A U.S. court ordered the seizure of a pet drug made by pharmaceutical companies Cipla Ltd. and Velcera Inc. after ruling the drug violated a patent held by a unit of French giant Sanofi SA the French company said in a statement Thursday. More...
Cookie time
(Rohit Nautiyal , 28-Jun-2011 , The Financial Express)
Cadbury India retaliated and sued Britannia for trademark and copyright infringement of intellectual property rights. More...
Intellectual rights protection forecast: Technical workforce gives India cutting edge in cloud computing innovation
(Horacio Gutierrez , 27-Jun-2011 , The Economic Times)
There was a time when cloud was nothing more than the result of water droplets suspended above the surface of the Earth. More...
ICMR to commercialise its patented technology to isolate VSELs from bone marrow cord blood
(Ramesh Shankar, Mumbai , 27-Jun-2011 , Pharmabiz)
The Indian Council of Medical Research will soon commercialise its newly developed patent protected technology in which it has found a simple method to isolate Very Small Embryonic Like stem cells from bone marrow and cord blood without the use of sophisticated and expensive infrastructure. More...
KSCSTE on a mission to promote IP literacy in Kerala
(T. Nandakumar , 26-Jun-2011 , Business Line)
The Patent Information Centre Kerala an initiative of the Kerala State Council for Science Technology and Environment has drawn up an ambitious programme aimed to broad base IP literacy in Kerala and maximize the number of patents filed by universities research institutions grassroots innovators, educational institutions and individuals. More...
Health groups welcome exclusion of data exclusivity from India EU free trade pact
(Ramesh Shankar, Mumbai , 24-Jun-2011 , Pharmabiz)
The NGOs working in the health sector have welcomed Indias formal announcement that it will not accept data exclusivity as part of a Free Trade Agreement currently being negotiated with the European Union. More...
Lupin Natco tie up to market generic of GSK cancer drug
(Our Bureau , 23-Jun-2011 , Business Line)
Tykerb tablets go off patent in 2017 More...
T S Vishwanath: The grand key to Africa
(T S Vishwanath , 23-Jun-2011 , Business Standard)
Therefore when fully completed this FTA would be a comprehensive agreement covering intellectual property rights goods and services. More...
India EU agreement may restrict low cost drugs
(Khomba H , 22-Jun-2011 , The Economic Times)
Data exclusivity delays registration of generic versions of a medicine by up to 10 years even for drugs that do not deserve a patent under Indias law. More...
India pitches for stake in $50 bn pharma mkt in China
(Press Trust of India / Beijing , 22-Jun-2011 , Business Standard)
With China set to open up $50 billion pharmaceutical market India has made a strong pitch saying the burgeoning Indian pharma sector could step in for supplying affordable life saving medicines to its neighbour. More...
Strides anti infective gets US nod
(Our Bureau , 21-Jun-2011 , Business Line)
The product patent held in the US by Johnson & Johnsons company Ortho McNeil Janssen expired on June 20. More...
Avesthagen granted US patent
(Press Trust of India / Bangalore , 21-Jun-2011 , Business Standard)
Avesthagen has been granted patent by the US for breakthrough sunflower transformation and eco friendly safe selection method that can replace the traditional antibiotic marker technology in GM crops. More...
USFDA approves generic Levofloxacin Indian firms to benefit
(PTI , 21-Jun-2011 , Livemint)
The approval is for the generic tablet oral solution and injectable solution dosage forms of Levofloxacin US Food and Drug Administration said in a statement More...
Depomed diabetes drug gets another generic threat
(Reuters , 21-Jun-2011 , IBN Live)
Depomed said it would continue to vigorously enforce its intellectual property rights to Glumetza tablets. More...
Raymond moves HC wants FIR quashed in tech patent case
(Sunil Baghel , 21-Jun-2011 , Mumbai Mirror)
Textile major Raymond Ltd and its Chairman Emeritus have moved the Bombay High Court seeking to quash an FIR registered against them following a complaint by one Bhogilal Patel last November. More...
Effective intellectual property protections are key to future
(Suresh Sati & Roger Bate , 21-Jun-2011 , DNA)
India is on the brink of finalising a free trade agreement with the European Union. More...
Delhi HC awards punitive damages for infringement of trademark to Pfizer
(Suja Nair Shirodkar, Mumbai , 21-Jun-2011 , Pharmabiz)
Creating a benchmark that will help to deter companies from using phonetically and deceptively similar trademark the Delhi HC recently awarded payment of Rs.1 lakh as punitive damages to a subsidiary of Pfizer. More...
Europe should be generics global powerhouse - EGA
(Kevin Grogan , 20-Jun-2011 , Pharma Times)
Europes generic drugmakers are in danger of falling behind the likes of India and South Korea if they do not receive more support from the continents legislators. More...
FTA with Japan holds promise
(C.P. RAVINDRANATHAN , 20-Jun-2011 , Business Line)
Textiles leather products pharmaceuticals and chemicals exports from India could look up as a result. More...
Confusion abounds in haste to make officials property returns public
(Special Correspondent , 20-Jun-2011 , The Hindu)
Indian Foreign Services IPRs are easy to access More...
Exploring innovation potential in software
(D. Murali , 19-Jun-2011 , Business Line)
They define describe contextualise get IPRs intellectual property rights and then get to the development part. More...
Piramal Health looks at buyout for expansion
(Reghu Balakrishnan / Mumbai , 17-Jun-2011 , Business Standard)
Increase in outsourcing from developed to developing countries will continue as the innovator companies will lose patent protection from any of the blockbuster drugs over the next few years thereby forcing them to look for various alternatives such as cost control and introduction of generics to their portfolio the report said. More...
Celeb jewellery makers patented designs stolen sold
(Chandrima Pal , 17-Jun-2011 , Mumbai Mirror)
While I dont really care for most of the designs, what I am concerned about is the patented bangle which I was supposed to unveil at the upcoming gem and jewellery show More...
Nokia loses UK court bid to cancel patent for IPCom
(Bloomberg/New York , 17-Jun-2011 , Business Standard)
Nokia Oyj the worlds biggest maker of mobile phones by volume lost a UK court bid to invalidate a European patent that Germanys IPCom GmbH & Co claims is vital to the Finnish companys handset sales. More...
Why copy pasting is a brilliant business strategy
(Vivek Kaul , 17-Jun-2011 , The Economic Times)
The US Patent office had issued Patent 6269361 also known as the 361 patent to Overture in July 2001 More...
Oracle seeks billions in lawsuit against Google
(Reuters / San Francisco , 17-Jun-2011 , Business Standard)
Oracle Corp is seeking damages in the billions of dollars from Google Inc in a patent lawsuit over the smartphone market according to a court filing. More...
Akhtar takes copyright issue to global platform
(IANS , 17-Jun-2011 , The Times Of India)
Well known Bollywood writer Javed Akhtar has taken his fight for royalty to lyricists to an international platform. More...
Nortel Delays Mobile Patent Auction One Week As Bidders Get Ready
(Tom Krazit , 17-Jun-2011 , Yahoo)
Nortel will delay the start of a closely watched auction of 6000 mobile patents by a week as it evaluates what it called a significant level of interest from those hoping to bolster their portfolios More...
Controller general of patents P H Kurian resigns set to return to Kerala
(Our Bureau, Mumbai , 16-Jun-2011 , Pharmabiz)
The controller general of patents designs and trademarks at Indias Intellectual Property office P H Kurian has resigned from this post and is all set to return to Kerala where he was industries secretary before moving to the IP office in February 2009. More...
Scientists come up with new molecule that may lead to better drug for TB
(Special Correspondent , 16-Jun-2011 , The Hindu)
After filing for a patent in February the scientists have also sent a 64 page proposal to the ICMR to push the case for funded research to take the project forward. More...
Limited patents
(Robert Cyran , 16-Jun-2011 , Business Standard)
Nokias innovative past has hitched a ride on Apples future. More...
Kurian quits as patents office chief
(C.H. Unnikrishnan , 15-Jun-2011 , Livemint)
Kurian introduced transparency in the process of clearing patent trademark applications and granting IP rights a function that is becoming increasingly critical as Indias integration with the global economy More...
Patent office yet to upload information on working patents in India
(Suja Nair Shirodkar, Mumbai , 15-Jun-2011 , Pharmabiz)
According to Dr Gopakumar G Nair patent attorney and CEO Gopakumar Nair Associates this step is taken to ensure that the companies utilise the patents they have been granted rather than keeping it without use. More...
Patent expiry outsourcing to drive pharma growth: Study
(BV Mahalakshmi , 15-Jun-2011 , The Financial Express)
Patent expiry and outsourcing are expected to be the primary growth drivers for the Indian pharmaceutical industry a Care research says. More...
Indian regulator calls for central drug pricing
(Lynne Taylor , 15-Jun-2011 , Pharma Times)
Moreover patented drugs should be exempt from all duties and taxes and their marketing approval should be linked to the pricing negotiations so that import licenses for the product will only be granted after the price has been agreed, it says according to a report in Indias Business Standard newspaper. More...
Copyright issue goes global
(Subhash K Jha , 15-Jun-2011 , Mid Day)
Javed Akhtars efforts to secure rights for songwriters composers and authors in India was commended by Bee Gees singer Robin Gibb More...
Nokia Apple settle patent suits
(PTI , 14-Jun-2011 , Business Line)
Nokia Corp on Monday said it has agreed to settle all patent litigations with iPhone maker Apple Inc a move that will bolster the Finnishs firm profitability in the second quarter. More...
FDA warns Dr Reddys over Mexico plant standards
(Reuters , 14-Jun-2011 , IBN Live)
Indian generic drugmakers including rival Ranbaxy are poised to benefit as drugs worth about $100 billion lose patent protection over the next two years. More...
Country and region-specific Ceylon Tea
(14-Jun-2011 , Daily Mirror)
The tea industry in Sri Lanka is moving closer to protecting the value of Ceylon Tea by initiating action to obtain a Geographical Indication for the commodity from the World Trade Organization and for international registration in about 50 markets initially a very costly and time consuming initiative More...
Dr Reddys sees negligible effect of FDA curbs on simvastatin
(KV Ramana , 14-Jun-2011 , DNA)
Dr Reddys Laboratories sees the impact of fresh regulations by the US Foods and Drug Administration on prescription of 80 mg dose of cholesterol lowering statin drug simvastatin due to risk of muscle injury to be negligible on overall revenues More...
Some discoveries cant be patented
( Dr David G. Green , 14-Jun-2011 , Financial Times)
Sir The government thinks its patent box scheme under which earnings from patents will be subject to 10 per cent corporation tax will help to make the UK the most competitive tax regime in the Group of 20. More...
Indian scientists develop technology to manage ballast water
(P. Sunderarajan , 13-Jun-2011 , The Hindu)
In the new development that promises to be of far reaching significance the scientists have got a patent from the United States Patent Office for a treatment technology for the ballast water that is not only highly effective but is also all more eco friendly as it does not use any chemicals. More...
NPPa: Central agency must decide patented drug prices
(Joe C Mathew / New Delhi , 12-Jun-2011 , Business Standard)
Medicine price regulator National Pharmaceutical Pricing Authority has proposed the formation of a centralised agency to negotiate the prices of patented medicines. More...
US FDA restricts sale of cholesterol lowering drug Simvastatin
(BS Reporter / Mumbai , 11-Jun-2011 , Business Standard)
The patented version of Simvastatin Zocor manufactured by Merck was approved in 1991 and went off patent in 2006. More...
Huge opportunities exist in overseas markets for SMEs in pharma sector: Pharmexcil
(Peethaambaran Kunnathoor, Chennai , 11-Jun-2011 , Pharmabiz)
He said in the case of Generic Opportunity 450 molecules worth US$ 350 billion are going off patent in the coming years. More...
Indian CRAM market to clock $ 7.6 billion by 2012
(Jyothi Datta , 10-Jun-2011 , Business Line)
The growth of the outsourcing opportunity is being propelled by the loss of patent protection to the tune of $ 97 billion over 2011 2015 steady erosion in new product launches in relation to research spend and new launches not matching up to the earlier block busters drugs. More...
India calls upon international community to dismantle trade IP barriers to ensure flow of HIV drugs
(Our Bureau, New Delhi , 10-Jun-2011 , Pharmabiz)
India has called for proactive and collective action from the international community to dismantle trade and intellectual property right barriers and improve the availability of accessible affordable and quality drugs for the needy and impoverished across the world. More...
90% of Indian grants are yet to reach the market
(C.H. Unnikrishnan , 9-Jun-2011 , Livemint)
Of the 37334 patents granted enforced till Mar 2010 only 4189 have been commercially introduced says report. More...
State sets up innovation council
(BS Reporter / Chennai/ Bangalore/ Mysore , 9-Jun-2011 , Business Standard)
So far industries and businesses had to make repeated trips to Chennai for obtaining trademark rights under the Intellectual Property Rights after prolonged procedures. More...
AIDS groups criticise US/EU/Japan for putting profits of MNC drug makers before patients
(ET Bureau , 08-Jun-2011 , The Economic Times)
TRIPS prescribes certain minimum patenting standards that all member organizations have to respect. More...
India to be firm on IPR at AIDS meet
(Joe C Mathew / New Delhi , 8-Jun-2011 , Business Standard)
India is readying to take a zero tolerance position in the ongoing tussle between the developing and the developed world on a regime for Intellectual Property Rights at a three day United Nations General Assembly High Level Meeting on AIDS scheduled in New York from Thursday. More...
Health groups call for moratorium on FTAs TRIPS plus measures by developed nations
(Ramesh Shankar, Mumbai , 8-Jun-2011 , Pharmabiz)
Even as the global community meets in New York for the United Nations General Assembly High Level Meeting on HIV and AIDS from 8 to 10 June 2011 networks of People living with HIV health groups and treatment activists from around the world are calling for an immediate moratorium on all Free Trade Agreements and TRIPS plus measures. More...
We should increasingly work with China in the field of chemicals
(Promit Mukherjee , 8-Jun-2011 , DNA)
No patented chemicals have ever come under attack because all patented chemicals are held by Europe. More...
BARCODE FOR EXPORTS
(P A Francis , 8-Jun-2011 , Pharmabiz)
As per a DGFT notification barcoding is going to be mandatory on all pharmaceutical products exported out of the country from July 1. More...
Eli Lilly to settle dispute over drug copies
(Andrew Jack in London , 08-Jun-2011 , The Financial Times)
Eli Lilly is poised to make a cash payment to settle a long running dispute with Indian generic drugmakers over low cost copies of the US companys medicines that were impounded within the European Union. More...
Siemens sues Samsung LG on LED patent breaches
(Reuters , 06-Jun-2011 , The Economic Times)
Siemens lightbulb unit Osram is suing the Samsung and LG groups of companies for alleged infringement of patents on light emitting diodes technology the German group said on Monday. More...
Troikaa is looking for licensing partner in EU
(Sohini Das / Mumbai/ Ahmedabad , 3-Jun-2011 , Business Standard)
We charge a slight premium of Re 1 per dose as we have developed a patented technology or novel drug delivery system. More...
Creating an eye capturing business
(K Rajani Kanth / Hyderabad , 3-Jun-2011 , Business Standard)
Professor Daugmans patent will expire in July 2011 post which it will be an open market technology. More...
IPR rules and their uncertain effects
(Madhukar Sinha , 2-Jun-2011 , Business Line)
If TRIPS has not yielded some of the expected benefits the Anti Counterfeiting Trade Agreement that seeks cross border IPR protection only gives rise to another set of concerns. More...
Indian pharma ingredient firms in Japanese generics race
(Reghu Balakrishnan / Mumbai , 2-Jun-2011 , Business Standard)
Japan which has a government funded National Health Insurance scheme covering every citizen wanted to shift from costly patented products to cheaper generic versions. More...
Lupin strengthens biological products pipeline
(Our Bureau , 01-Jun-2011 , Business Line)
In licensing pact with Sydney based NeuClone for cell line technology More...
New Indian Express sued over promotion of Sunday Standard
(Anushree Chandran & Abhilasha Ojha , 1-Jun-2011 , Livemint)
Last year we filed a suit against them in the Bombay high court for infringement of the trademark said the executive. More...
Is Indian pharmaceutical industry losing its sheen? Promoters exit for attractive alternatives
(Gauri Kamath , 1-Jun-2011 , The Economic Times)
For years the Rs 871 crore JB Chemicals and Pharmaceuticals a Mumbai based generics drug company rode on the success of its cough and cold syrup Doktor Mom in Russia. More...
Drug makers Teva Pfizer settle patent dispute
(ET , 31-May-2011 , CNBC)
Teva Pharmaceutical Industries Ltd. said Tuesday it has settled a patent lawsuit brought by Pfizer Inc. over a drug for treating seizures and pain caused by shingles. More...
Global Fund calls for clauses in FTA to ensure access to medicines for AIDS malaria TB
(Joseph Alexander, New Delhi , 30-May-2011 , Pharmabiz)
Both call for the use of measures to contain costs and foster an open competitive market for health commodities including the use of TRIPS flexibilities patent pooling and voluntary licence agreements between patent holders and generic manufacturers. More...
Great job offers to students with campus patents experience
(TV Mahalingam, ET Bureau , 29-May-2011 , The Economic Times)
Swarup credits his blue chip job to both his degree in industrial production and a patent for an invention a refrigerator cum water purifier that has been filed in his name at the US and Indian patent offices. More...
Mylan plans direct entry into India
(C.H. Unnikrishnan , 28-May-2011 , Livemint)
Mylan which acquired the generic business of German drug giant Merck KGaA in 2008 in a global deal is currently the largest generic or off patent drug maker in the world. More...
Fresenius Kabis India unit now global R&D hub
(ET Bureau , 28-May-2011 , The Economic Times)
Fresenius Kabi Oncology has also entered into a contract R&D and manufacturing agreement with its parent Fresenius Kabi Germany and its affiliates for future products without affecting existing product business and intellectual property rights, it said in a disclosure to stock exchanges. More...
India for concluding package for LDCs by December under Doha round
(Sujay Mehdudia , 28-May-2011 , The Hindu)
Doha Round would not be concluded this year as planned in Davos More...
Heard on the Street: Suven Life Sciences climbs on Patent acquisitions
(ET Bureau , 27-May-2011 , The Economic Times)
Suven Life Sciences Climbs 5% on Foreign Patent Acquisitions More...
Microsoft chief Steve Ballmer says China piracy very costly
(AFP , 27-May-2011 , The Economic Times)
It kept the country on this years priority watch list for weak protection of intellectual property rights. More...
Details of patented drugs to be made public
(C.H. Unnikrishnan , 25-May-2011 , Livemint)
To increase transparency Indias patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price. More...
India EU free trade pact in final stage: Sharma
(PTI , 25-May-2011 , Business Line)
Indicating that differences persist between India and the European Union over their proposed free trade agreement the Commerce and Industry Minister Mr Anand Sharma said even the best of astrologers would not know about the timeline. More...
Takeda to buy Swiss drugmaker Nycomed for $13.6 bn
(James Topham and Ritsuko Shimizu / Reuters , 25-May-2011 , Livemint)
Takeda known for its top selling diabetes drug Actos which faces the upcoming expiry of its US patent will also gain a portfolio of over the counter consumer products. More...
Suven struggles to find partner to take Alzheimers drug to next stage
(Viswanath Pilla , 25-May-2011 , Livemint)
They still have to learn how to monetize various stages of clinical trials and how to protect their intellectual property rights. More...
Levis takes on private labels with Denizen
(Purvita Chatterjee , 24-May-2011 , Business Line)
In fact the decision to change the name of Signature to Denizen came about after Levis started fighting patent cases across markets for the brand name of Signature. More...
Venus gets European patent for painkiller injection
(Press Trust of India / New Delhi , 24-May-2011 , Business Standard)
Drug firm Venus Remedies today said it has received patent from the European Patent Office for ACHNIL its once a day painkiller injection. More...
Biodiversity of the state needs to be protected
(Express News Service , The New Indian Express , 24-May-2011 , IBNLIVE)
The chairman of Andhra Pradesh State Biodiversity Board R Hampaiah said that several countries have claimed patents on turmeric garlic basmati and several other agricultural products and animals like the Ongole Bull. More...
More foreigners than Indians receiving patents in India'
(PTI , 22-May-2011 , MSN)
There are more foreigners than Indians receiving patents in India prompting the government to say much needs to be done to encourage more domestic innovations. More...
Drug exporters need more time to implement barcode: Pharmexcil
(Peethaambaran Kunnathoor, Chennai , 20-May-2011 , Pharmabiz)
As regards infringement of patent Bhavin said whoever without authority makes or uses or offers to sell or sells or imports any patented invention during the term of the patent it is infringement. More...
Lincoln Pharma launches anti malarial drug ‘ARH 1’
(Our Bureau, Mumbai , 19-May-2011 , Pharmabiz)
The company has applied for a patent of ARH 1 in India as well as internationally. More...
Government moots patents for jugaad
(TNN , 17-May-2011 , The Times of India)
If the government has its way the small scale industrys spirit of jugaad could soon be giving competition to Phunsuk Wangdus Aamir Khans character in the hit movie 3 Idiots 400 patents. More...
Glenmark Pharma in $613 million licensing deal with Sanofi
(ET Bureau , 17-May-2011 , The Economic Times)
Mumbais Glenmark Pharmaceuticals has licensed a new biotech drug to Frances Sanofi which has the potential to generate revenues of $613 million or 2734 crore. More...
Indian American couple pleads guilty for selling fake drugs
(PTI , 17-May-2011 , The Times Of India)
An Indian American couple in New Jersey has pleaded guilty before a US court for selling counterfeit prescription drugs made in India federal authorities said. More...
Rajkumar Dogra a naval soldier & general manager is now a patent lawyer
(Amit Shanbaug , 16-May-2011 , The Economic Times)
This time as a patent lawyer a profession drastically different from his previous two occupations naval soldier and general manager. More...
MSN Labs to enter pain management market
(PTI , 16-May-2011 , Business Line)
The company so far has filed over 100 Indian and over 40 international patents. More...
Commerce min mulls registrar for traditional knowledge
(ENS Economic Bureau , 14-May-2011 , Indian Express)
To protect traditional knowledge in the field of medicine and music the ministry of commerce and industry today came out with a discussion paper suggesting that a registrar should be appointed to help knowledge holding community reap benefits of such information and prevent its unauthorised commercial use. More...
ICMR looks for partners to commercialise herbal composition to treat filariasis
(Joseph Alexander, New Delhi , 13-May-2011 , Pharmabiz)
An Indian patent has been filed. More...
Emerging economies: outside in and inside out
(13-May-2011 , Livemint)
China recently filed 977000 domestic patent applications. More...
SC bans production sale and use of Endsosulfan for eight weeks
(PTI , 13-May-2011 , The Hindu)
Endosulfan is an off patent organochlorine insecticide and acaricide. More...
Dr Reddys Q4 net profit doubles tops forecast
(Reuters , 13-May-2011 , The Economic Times)
Indian generic drug makers including Dr Reddys and rival Ranbaxy are poised to gain as drugs worth about $100 billion lose patent protection over the next two years but they have to contend with intense competition rising lawsuits from rivals and a stricter U.S. health regulator. More...
NBRI to scout for commercial partners for herbal innovations
(Virendra Singh Rawat / New Delhi/ Lucknow , 12-May-2011 , Business Standard)
NBRI would apply for national license and patent for the herbal drink before it scouts for suitable private partner for technology transfer. More...
Border push in EU FTA to hit pharma exports
(Priyanka Golikeri , 12-May-2011 , DNA)
In the quid pro quo of the free trade agreement currently being negotiated with the European Union India could end up giving in to a provision which could hamper its exports of pharmaceuticals. More...
No cheer for vodka brand that copied rivals bottle
(Sunil Baghel , 11-May-2011 , Mumbai Mirror)
Two vodka manufacturing companies Gorbatschow Wodka and John Distilleries fought an intellectual property rights see box case in the Bombay High Court over the design of their products bottles. More...
The push and pull in generic drugs
(10-May-2011 , Livemint)
On the one hand is the crucial process of drug discovery on the other the need to make medicines affordable More...
Learning with the Times: Endosulfan has chronic adverse effects on humans
(TNN , 9-May-2011 , The Times of India)
Endosulfan is a pesticide which was introduced in the 1950s and soon became a leading chemical to fight a broad spectrum of insects. More...
Suven Life sued for Ovide patent violation by Taro
(KV Ramana , 7-May-2011 , DNA)
US-based Taro Pharmaceuticals North America has sued Hyderabad based custom research and manufacturing services major Suven Life Sciences alleging an infringement of patent involving its head lice killer lotion Ovide. More...
Cultural rights in the digital age
(SHARANYA MANIVANNAN , 7-May-2011 , Business Line)
A pioneering academic in the field of intellectual property Canada based Dr. Mira T. Sundara Rajan is a polymath with an illustrious lineage. More...
Ranbaxy may pay $1bn to USFDA
(TNN , 6-May-2011 , The Times Of India)
Gurgaon based pharma major Ranbaxy Laboratories is said to be negotiating a settlement with US Food and Drug Administration to clear two of its manufacturing plants from which the US agency had halted sales. More...
Zydus Cadila aims to be a $3 bn company by 2015
(PTI , 06-May-2011 , The Economic Times)
Biosimilars or Follow on biologics are terms used to describe officially approved new versions of innovator biopharmaceutical products following patent expiry. More...
Sharing the spoils
(6-May-2011 , Mint)
In the lucrative US pharmaceutical market generic and patent holders of drugs have increasingly chosen to settle patent challenge disputes than to fight them in court More...
Chinese tech giants Huawei Technologies and ZTE in rare mobile phone patent court battle
(AP , 6-May-2011 , The Economic Times)
Two of Chinas biggest technology companies have launched a court battle in Europe over mobile phone patents in a rare public clash between firms Beijing is promoting as national champions. More...
Himalaya launches Liv.52 HB for treatment of Hepatitis B
(Announcement / Corporate , 05-May-2011 , Business Standard)
The Himalaya Drug Company one of Indias leading herbal health and personal care companies launched Liv.52 HB the first herbal drug for the effective management of Hepatitis B virus infection. More...
Govt asks exporters to move up the value chain
(Sidhartha , 05-May-2011 , The Times Of India)
Indias medium term export strategy is according top priority to changing the value proposition for pharmaceuticals electronics and auto component exports besides suggesting a plan to get a toehold into the high technology space. More...
India EU trade pact talks enter final phase
(Nayanima Basu / New Delhi , 05-May-2011 , Business Standard)
Talks to close a broad based comprehensive trade pact with the European Union has reached its final stage while both sides would be sitting for another round of negotiations by the middle of this month to agree on crucial areas where there are still some gaps. More...
Regulatory overkill stifling drug discovery: Experts
(Our Bureau , 05-May-2011 , Business Line)
Lead time was important for getting patents for original drug research she said. More...
Tea Board launches Ozone friendly tea, certification marks
(Athraja de Silva , 05-May-2011 , Daily Mirror)
Sri Lanka Tea Board ceremonially launched the new logo for Ozone Friendly Ceylon Tea together and Agro climatic regional names logos as Certification Marks under Geographical Indication to protect and add value to premium Ceylon Tea. More...
No time for copyright say Indian designers
(IANS , 4-May-2011 , The Times of India)
The more the fashion weeks the more the exposure and the more the chances of designs being copied. More...
Patent suit filed against Dr Reddy’s
(KV Ramana , 4-May-2011 , DNA)
Yet another US drugmaker has sued Dr Reddys Laboratories alleging patent infringement. More...
US court dismisses Mylan challenge on Ranbaxy Lipitor rights
(BS Reporter / New Delhi , 4-May-2011 , Business Standard)
In a major reprieve to Ranbaxy an American court has dismissed a petition from rival pharmaceutical firm Mylan to challenge the formers exclusive marketing rights over the generic version of Pfizers Lipitor. More...
ICMR seeks cos to commercialize its two new inventions against cancer dengue vector
(Joseph Alexander, New Delhi , 4-May-2011 , Pharmabiz)
The Indian Council of Medical Research has developed an anti neoplastic compound for possible treatment of cancer and an herbal composition against dengue vector. More...
US puts India Pak and China on IPR violation watch list
(PTI , 03-May-2011 , Business Line)
United States has placed India Pakistan China and nine other countries on the top priority watch list with regard to violations of intellectual property rights. More...
IPAB centre likely to come up in Mumbai Delhi and Kolkata
(Khomba Singh , 3-May-2011 , The Economic Times)
The government may need to set up permanent centres of the countrys nodal body monitoring disputes related to intellectual property rights and patents in Delhi Mumbai and Kolkata to expedite resolution of cases. More...
An end to endosulfan?
(Business Standard , 3-May-2011 , Sify)
Those voicing the interests of Indian farmers and the endosulfan industry have alleged that the hue and cry against it is the handiwork of NGOs funded by European patent holders of newer chemicals. More...
Alkem ties up with Swedens Karo Bio
(02-May-2011 , Business Line)
There will be a royalty payment to Karo once revenues are generated on the patent protected product Mr Shenoy said without giving details. More...
Technical institutes make beeline for patents
(Vijay C Roy / New Delhi/ Chandigarh , 2-May-2011 , Business Standard)
Realising the importance of Intellectual Property Rights universities technical and educational institutes in Punjab are getting their innovations patented. More...
India not to dilute stand on intellectual property rights
(IANS , 2-May-2011 , The Economic Times)
India has decided not to dilute its stand or take a position on intellectual property rights especially on pharmaceuticals beyond its domestic law and the current international commitments. More...
Domestic drug makers set to invoke compulsory licensing route by June
(Joe C Mathew & Nayanima Basu / New Delhi , 2-May-2011 , Business Standard)
Compulsory licensing provisions under the Indian Patent Act will be put to test soon as local drug makers are planning to use it to make low cost versions of patented drugs. More...
India to launch FTA negotiations with Australia
(The Hindu , 30-Apr-2011 , Business Line)
No IPR obligations beyond domestic laws More...
Glaxos Growth is Not an Accident: Andrew Witty
(Sudeshna Sen , 30-Apr-2011 , The Economic Times)
Andrew Witty global CEO of GlaxoSmithKline is a self confessed Indophile. More...
Nagesh Kumar: An innovation led growth model
(Nagesh Kumar , 30-Apr-2011 , Business Standard)
R&D subsidy to industry and protecting indigenous innovation can give India competitive edge More...
Scientists oppose European stem cell patent ban
(Bureau Report , 28-Apr-2011 , Zee News)
Research scientists hit out on Wednesday at a European Court of Justice case they say could block development of embryonic stem cell based therapies in Europe. More...
PMs Trade and Economic Committee to review trade treaties
(Sujay Mehdudia , 28-Apr-2011 , Business Line)
Even as a large number of consumer and NGO groups have come out in support of more transparency in sharing information on trade treaties the Prime Ministers Trade and Economic Relations Committee is meeting on Friday to review various treaties including the India EU free trade agreement. More...
Basmati exporter files two patents on parboiling technology
(Our Bureau , 27-Apr-2011 , Business Line)
Method reduces husk splitting; pares brokens range to 4-8% More...
PM to review next month proposed trade pact with EU
(PTI , 27-Apr-2011 , MSN )
Prime Minister Manmohan Singh will review the proposed bilateral trade and investment agreement between India and the EU at the meeting of the Trade and Economic Relations Committee on May 29. More...
Intellectual Property Association of South India launched
(PTI , 27-Apr-2011 , IBN Live)
There was a need for creating more awareness about intellectual property rights trademarks and patents to help the growth of the countrys economy Madras High Court Judge Justice P Jyothimani said today. More...
TRIPS Plus measures outside WTO framework not acceptable: Anand Sharma
(Our Bureau, Mumbai , 27-Apr-2011 , Pharmabiz)
Union commerce and industry minister Anand Sharma has reiterated Indias stand that it will not accept any Trips plus decision that is taken outside multilateral framework. More...
Purdue Pharma sues Ranbaxy over sale of cheaper pain drug in US
(Khomba Singh , 27-Apr-2011 , The Economic Times)
American drugmaker Purdue Pharma has sued Ranbaxy Laboratories to prevent Indias largest drugmaker from selling a generic or low priced version of its bestselling medicine pain reliever Oxycontin in the US. More...
Innovation deficit hurts India Inc
(M. D. Nair , 27-Apr-2011 , Business Line)
In all the surveys on innovations and outcomes India ranks low in the pecking order below even countries such as Brazil not to speak of China. More...
Suven Life bags seven patents for new molecules
(Reuters , 26-Apr-2011 , The Economic Times)
Suven Life Sciences said on Tuesday it has secured seven product patents for its new chemical entities in different geographies. More...
Lupin In License Pact With Abbott On Cholesterol Drug
(Rumman Ahmed , 26-Apr-2011 , The Wall street Journal)
Indias Lupin Ltd said Tuesday it and its units have agreed to buy licenses from U.S.based Abbott Laboratories and Frances Laboratoires Fournier S.A. for various patents on anti cholesterol drug fenofibrate in an attempt to ring fence its Antara brand from generic competition. More...
India should demand review of TRIPS: Isaac
(Express News Service , 26-Apr-2011 , Express Buzz)
India should demand the review of TRIPS a move which will be supported by a large number of countries especially in the sectors of common property patents and the pharmaceutical sector Finance Minister T M Thomas Isaac has said. More...
BHU attaches no special significance to day
(Binay Singh , 26-Apr-2011 , The Times of India)
The Banaras Hindu University that has its own Intellectual Property Rights Policy and IPR Cell held no special programmes to mark the World Intellectual Property Day on Tuesday. More...
GIIP wants govt to make major changes in Patent Act to promote IP in country
(Suja Nair Shirodkar, Mumbai , 26-Apr-2011 , Pharmabiz)
With a view to promote interest in Intellectual Property law and its scope in the country Global Institute of Intellectual Property wants the government to bring in substantial changes in the present IP law. More...
Adobe India doles out up to 200% bonus for innovative employees
(Shruti Sabharwal , 26-Apr-2011 , The Economic Times)
A patent is a measure of technical excellence and that probably is the biggest high. More...
The Round that went in circles
(26-Apr-2011 , Livemint)
What Pascal Lamy calls an unbridgeable political gap seems to be the final nail in the Doha trade talks coffin More...
Ranbaxy launches generic Olanzapine tablets in Spain
(PTI , 25-Apr-2011 , Business Line)
Drug major Ranbaxy Laboratories today said it has launched generic Olanzapine tablets used in treating central nervous system disorders in Spain. More...
Pfizer deal allows Dr Reddys to sell anti depression pill
(Bloomberg / Mumbai , 25-Apr-2011 , Business Standard)
The company has previously settled patent infringement suits regarding Effexor it filed against Teva Pharmaceutical Industries and Anchen Pharmaceuticals and Impax Laboratories Inc. More...
MNC may need govt nod to buy local pharma firm
(Khomba Singh , 25-Apr-2011 , The Economic Times)
The government may approve acquisitions of local drugmakers by global firms on a case by case basis on certain conditions to ensure availability of medicines at affordable prices, despite calls for restrictions on such deals in the wake of a spate of takeovers in the last three years. More...
MNC may need govt nod to buy local pharma firm
(Khomba Singh , 25-Apr-2011 , The Economic Times)
The government may approve acquisitions of local drugmakers by global firms on a case by case basis on certain conditions to ensure availability of medicines at affordable prices despite calls for restrictions on such deals in the wake of a spate of takeovers in the last three years. More...
MNC may need govt nod to buy local pharma firm
(Khomba Singh , 25-Apr-2011 , The Economic Times)
The government may approve acquisitions of local drugmakers by global firms on a case by case basis on certain conditions to ensure availability of medicines at affordable prices despite calls for restrictions on such deals in the wake of a spate of takeovers in the last three years. More...
Google loses Linux patent lawsuit
(Joseph Menn in San Francisco , 23-Apr-2011 , Financial Times)
Google has lost a Texas lawsuit that claims the core of Linux infringes on a privately held patent raising fears of a wave of similar claims against other users of the open source operating system More...
Dr Reddys reach settlement with Wyeth over Effexor
(PTI , 22-Apr-2011 , The Economic Times)
Dr Reddys Laboratories has reached a deal in New Jersey Federal Court yesterday with Wyeth LLC a wholly owned subsidiary of US based Pfizer over a patent litigation involving generic version of blockbuster anti depressant drug Effexor XR sources close to the development said. More...
Halt India EU FTA talks immediately
(Sujay Mehdudia , 22-Apr-2011 , Business Line)
Ska Keller a Green member of the European Parliament has warned that the proposed free trade agreement between India and European Union will have serious consequences for the Indian people. More...
Govt to reconstruct 44000 missing trademark files
(PTI , 21-Apr-2011 , Business Line)
The Government today said it will issue a public notice by next week to reconstruct 44000 missing files from the trademarks office. More...
Software firms pin hopes on proposed change in copyright Act to nail piracy
(Yogendra , 21-Apr-2011 , Livemint)
Dont ask for pirated software. More...
India EU FTA talks in crucial phase
(Surojit Gupta , 21-Apr-2011 , The Times of India)
Negotiations between India and the European Union for a Free Trade Agreement have entered a crucial phase and contours of the deal have started to emerge but there are still some issues which need to be resolved EU official say. More...
The companys off patent drugs business the cash cow supporting research was facing price pressures in some key markets.
(Gauri Kamath , 21-Apr-2011 , The Economic Times)
In the 1980s he founded what would become Indias secondlargest generics pharma company. More...
Firms pin hopes on proposed change in Copyright Act to tackle piracy
(Yogendra , 21-Apr-2011 , Livemint)
The anti piracy task force is working on a manual for law enforcement agencies to act against pirates More...
India videographs 200 yoga postures to prevent patent piracy
(PTI , 20-Apr-2011 , The Times of India)
India has made available a database describing 1300 yoga postures and videography of 200 popular among these as part of efforts to prevent patent pirates from exploiting it for commercial purposes. More...
Apple sues Samsung says stop copying us
(Dan Levine & Miyoung Kim / Reuters , 20-Apr-2011 , Livemint)
Samsung phones tablet copy iPhone and iPad lawsuit Apple attacks design interface application icons of Galaxy models More...
US drug recall not to have big financial impact on Lupin
(P.T.Jyothi Datta , 20-Apr-2011 , Business Line)
Drug maker Lupins recent voluntary recall of a batch of its hypertension drug Lisinopril in the US will not have a major financial impact on the company. More...
CSIR to ink patent deal with Japan today
(TNN , 20-Apr-2011 , The Times of India)
Council of Scientific and Industrial Research will on Wednesday sign an access agreement with Japan Patent Office for Traditional Knowledge Digital Library. More...
Kallam Anji Reddy | We are dominating the generics industry
(Viswanath Pilla & Anil Penna , 20-Apr-2011 , Livemint)
When Big Pharma discovered drugs way back I am talking about 25 years back when someone started to make generics they first said how can you equate a copycat to us even though the patent has expired. More...
Indigenous software helps keep global bio pirates at bay
(Kounteya Sinha , 20-Apr-2011 , The Times of India)
Special symbols to denote ancient Indian medicinal formulations are helping identify and catch bio pirates who are trying to illegally patent existing knowledge. More...
Patenting: India in poor position
(Special Correspondent , 19-Apr-2011 , The Hindu)
Ignorance lack of initiative are among the reasons More...
US Supreme Court hears Microsoft patent case
(PTI , 19-Apr-2011 , Business Line)
The US Supreme Court immersed itself in patent rules in a case pitting Microsoft against a Canadian technology company that claims some versions of Word violated its patent. More...
Orchid Chemicals settles case with Pfizer Inc stock down
(ET Bureau , 19-Apr-2011 , The Economic Times)
Hyderabad based Orchid Chemicals has reached an out of court settlement with world s largest drugmaker Pfizer Inc to sell a low cost version of the American firms patented anti depressant drug Effexor XR in the US market this fiscal. More...
India EU FTA to be stitched up within this year
(Special Correspondent , 18-Apr-2011 , The Hindu)
Union Commerce and Industry Minister Anand Sharma on Monday said talks between India and European Union had been intensified in an attempt to stitch up a free trade agreement within this year. More...
Pharma MNCs take JV route for India
(Reghu Balakrishnan / Mumbai , 17-Apr-2011 , Business Standard)
With the rising significance of India as one of the largest generic drug markets and escalating valuations which makes the pharmaceutical space here a tough acquisition target global pharma majors remain active for entering partnerships joint ventures and alliances with their Indian counterparts. More...
Drug makers may go for more compulsory licences
(P.T. Jyothi Datta , 15-Apr-2011 , Business Line)
The doors seem to have opened for more domestic drug companies to seek compulsory licences say industry experts after the Centre recently reiterated that it would assess each case for a CL independently under the Indian Patent Act that is equipped to handle such issues. More...
Pvt pharma firms knock CSIR to develop TB drug
(TNN , 15-Apr-2011 , The Times Of India)
In a first two pharmaceutical companies have expressed their desire to be a part of Council of Scientific and Industrial Researchs open source drug discovery project for tuberculosis. More...
Innovation Society eyes 3000 patents in 2 yrs
(Express News Service , 15-Apr-2011 , Indian Express)
The Gujarat Innovation Society to be inaugurated on Friday has a target of 3000 patent applications to be filed from the state in the next two years. More...
Patent office may outsource art searches to IITs
(Soma Das , 15-Apr-2011 , The Financial Express)
Shortly after putting in place a mechanism to outsource prior art searches to Council of Scientific and Industrial Research the Indian patent office is in talks with premier educational institute IITs for similar ties. More...
India EU free trade pact talks to conclude by year end
(PTI , 15-Apr-2011 , Business Line)
The European Union has exuded confidence that negotiations for the proposed free trade agreement between the 27 nation block and India would be concluded by the end of this year. More...
Now copyright free maps of States districts panchayats
(S. Anandan , 15-Apr-2011 , The Hindu)
Even as the Malayalam Loves Wikipedia campaign launched to expand the knowledge repositories of Malayalam Wikipedia with copyright free Malayalam related photographs continues to evoke overwhelming response from Wiki users and contributors a project meant to make available online free to use national map and maps of States districts and panchayats is making silent but significant strides. More...
Now copyright free maps of States districts panchayats
(S. Anandan , 15-Apr-2011 , The Hindu)
Even as the Malayalam Loves Wikipedia campaign launched to expand the knowledge repositories of Malayalam Wikipedia with copyright free Malayalam related photographs continues to evoke overwhelming response from Wiki users and contributors a project meant to make available online free to use national map and maps of States districts and panchayats is making silent but significant strides. More...
Cos flock to courts to resolve patent suits
(Chitra Unnithan , 14-Apr-2011 , The Times of India)
Mumbai based drugmaker Lupin filed a second suit last week in the US against Ranbaxy Laboratories to prevent the Gurgaon based drugmaker from launching fenofibrate a generic version of Lupins cholesterol lowering drug Antara in the US. More...
Govt plans to make public details of patented drugs
(Khomba Singh , 14-Apr-2011 , The Economic Times)
The government will make public details of every medicine patented in the country to bring transparency a move that will also help Indian drugmakers to challenge patent holders and sell low cost version of high priced patented drugs More...
Dr Reddys launch generic version of Allegra in US
(PTI , 14-Apr-2011 , Business Line)
In a bid to tap the $452 million Fexofenadine drug market Dr Reddys Laboratories today announced the launch of generic version of Allegra Fexofenadine HCl tablets in the US market. More...
Designs on industrial products
(T S Vishwanath / New Delhi , 14-Apr-2011 , Business Standard)
WIPO is mulling a treaty to harmonise protection of industrial designs at all levels More...
Takeda Pharma files patent infringement suit against Dr Reddys
(PTI , 12-Apr-2011 , IBN Live)
Global pharma major Takeda Pharmaceutical Co has filed a patent infringement suit against Indias second largest drug maker Dr Reddys Laboratories in a New York Court over the latters efforts to manufacture a generic version of acid reflux treatment drug Dexilant. More...
Indian pharma in tough battle for generic riches
(Reuters , 12-Apr-2011 , The Economic Times)
Indian makers of generic drugs have a fight on their hands as they scramble for access to the $100 billion worth of drugs coming off patent over the next two years. More...
No new norms on compulsory licensing
(Asit Ranjan Mishra , 12-Apr-2011 , Livemint)
Current guidelines under the TRIPS agreement Indian Patents Act are sufficient to issue such licences says DIPP More...
PharmaSecure in talks to offer anti counterfeit solutions
(Press Trust of India / Mumbai , 12-Apr-2011 , Business Standard)
PharmaSecure PAS India is in talks with several leading pharma companies to offer its anti counterfeit solutions of tracking and tracing medicines ahead of the government deadline of July 1. More...
44000 files of trademark registrations missing probe on
(Harish V Nair , 11-Apr-2011 , Hindustan Times)
In what could have a bearing on a large number of trademark disputes more than 44000 files have gone missing from Mumbai Delhi Chennai and Kolkata branches of the Trade Marks Registry. More...
Sun Pharma Merck venture to target emerging markets
(Our Bureau , 11-Apr-2011 , Business Line)
Branded generics are off patent drugs or medicines similar to an innovative drug, but after the exclusive patent period had lapsed that are nevertheless sold under a brandname. More...
MSF asks EU to confirm it will not push India to accept data exclusivity
(Ramesh Shankar, Mumbai , 11-Apr-2011 , Pharmabiz)
Deeply concerned over the new measures Europe is pushing to restrict the production of affordable generic medicines in India Médecins Sans Frontières has asked the EU to confirm that it will no longer push for India to accept data exclusivity. More...
Keep off the doodle copycats
(Anu Vaidyanathan , 10-Apr-2011 , Business Line)
What users may not know is that this doodle stands patented. More...
India will not accept any intellectual property talks outside WTO: Anand Sharma
(ET Bureau , 9-Apr-2011 , The Economic Times)
India will not accept any attempt made by groups of countries to discuss intellectual property rights outside the multilateral forum of the world trade organisation commerce and industry minister Anand Sharma has said. More...
Ranbaxy stocks up as USFDA opposes Mylans request
(ET Bureau , 08-Apr-2011 , The Economic Times)
The US drug regulator has opposed American firm Mylans request to strip Ranbaxy Laboratories of its six month exclusive rights to sell a low priced version of the worlds best selling drug Lipitor in the US. More...
Govt to soon announce manufacturing policy
(PTI , 08-Apr-2011 , The Economic Times)
The government on Friday said it will soon unveil a national manufacturing policy which aims at attracting overseas investments and increase the share of the sector in the economy. More...
Drug MNCs violating patent law?
(Rupali Mukherjee , 7-Apr-2011 , The Times Of India)
Five pharma MNCs including Pfizer Bayer Roche Schering and Bristol Myers Squibb have been accused of violating patent laws with regard to top selling patented anti cancer and hepatitis drugs sold in the country. More...
Drug firms may have breached patent norms
(C.H. Unnikrishnan , 7-Apr-2011 , Livemint)
Companies required to file information on working status of patents which is key to compulsory licensing More...
4000 pirated books worth 25 lakh seized 7 arrested
(TNN , 7-Apr-2011 , The Times Of India)
A case under various sections of the Indian Copyright Act has been registered against the suspects at the Deccan Gymkhana police station. More...
India against inclusion of data exclusivity in any FTA
(PTI , 06-Apr-2011 , The Economic Times)
India today said it was against the inclusion of data exclusivity provision in any of its free trade agreements as it would hurt the interests of the domestic generic drugs industry. More...
PM led council to deliberate on India Australia FTA
(Sanjeeb Mukherjee / New Delhi , 6-Apr-2011 , Business Standard)
A council headed by Prime Minister Manmohan Singh would deliberate on the feasibility of starting a dialogue on a Free Trade Agreement between India and Australia besides a more comprehensive agreement with Indonesia. More...
Amend drug seizure rules to end WTO case: India to EU nations
(PTI , 06-Apr-2011 , The Economic Times)
India today said it will withdraw its case from the WTO against EU on wrongful seizure of drug consignments of Indian companies only when all the members of the 27 nation bloc amend their rules to prevent recurrence of such incidents. More...
Reverse Engineering of Off Patent Tech
(TNN , 05-Apr-2011 , The Times Of India)
Tweaking designs of imported technology products that have gone off patent and reselling them in the local market can turn out to be a money spinner for technopreneurs. More...
Nortel patents: Google bids big
(Indo-Asian News Service , 05-Apr-2011 , Hindustan Times)
Fallen telecom giant Nortel on Monday said that Google is bidding $900 million to buy its patent portfolio. More...
Tweaking designs of products no longer under patents route to a profitable technology venture
(Omkar Sapre , 5-Apr-2011 , The Economic Times)
Tweaking designs of imported technology products that have gone off patent and reselling them in the local market can turn out to be a moneyspinner for technopreneurs. More...
Pharma firms turn to innovative marketing to boost demand
(Priyanka Pulla , 5-Apr-2011 , Livemint)
Drug makers are estimated to lose as much as $140 billion by 2016 because of the expiry of patent protection according to a 2007 report by market researcher Datamonitor. More...
Panel to address issues of pharma industry
(Nivedita Mookerji / New Delhi , 5-Apr-2011 , Business Standard)
An expert panel comprising top representatives of the health ministry the Department of Industrial Policy and Promotion, the National Pharmaceutical Pricing Authority various drug industry bodies and business chambers has been formed to bring out a report on a long term policy for the pharma sector. More...
Patient info in clinical trial not to be shared: CIC
(PTI , 5-Apr-2011 , MSN )
Data about patients participating in clinical trials cannot be shared the Central Information Commission has held while dismissing an RTI plea seeking details of stalled Human Papilloma Virus vaccine trials in the country. More...
PM panel to review India EU free trade pact on Wednesday
(PTI , 04-Apr-2011 , The Times Of India)
Ahead of crucial talks on India EU free trade agreement in Brussels the Prime Ministers Trade and Economic Relations Committee will review the issue on Wednesday. More...
A big part of HP Unix work happens in India
(TNN , 2-Apr-2011 , The Times Of India)
We encourage all of our engineers to patent any innovation or technology they have. More...
Jasmine fragrance spreads overseas
(KARWAR , 01-Apr-2011 , IBN Live)
Bhatkal jasmine should be included in geographical indication list to safeguard the interest of growers. More...
Marrying the medicines of the world
(Subir Roy / Bangalore , 1-Apr-2011 , Business Standard)
The patent pipeline particularly for blockbuster drugs that help fund future research is drying up. More...
SPIC urges PM to order inquiry into barcoding being made mandatory for pharma exports
(Ramesh Shankar, Mumbai , 1-Apr-2011 , Pharmabiz)
High quality drugs produced by Indian companies earlier have been categorized as counterfeits in the West if manufactured without approval from Patent holders with the purpose of stalling export of affordable generics from India. More...
India will not provide data exclusivity: Anand Sharma
(BS Reporter / New Delhi , 30-Mar-2011 , Business Standard)
The government on Tuesday took a firm stand on protection of intellectual property rights and the aspect of data exclusivity for drug manufacturers saying that the country would not extend data exclusivity that would hamper the domestic pharma industry. More...
Endosulfan ban: no clear battle lines drawn
(Priyanka Pulla , 30-Mar-2011 , Livemint)
Endosulfan is now off patent and brings in far lower margins. More...
India is big contributor of patents
(TNN , 29-Mar-2011 , The Times Of India)
HPs Bangalore centre has become one of the largest and most diverse sites of HP in the world. More...
GI status to spice up branding of unique crop varieties
(P K Krishnakumar , 29-Mar-2011 , The Economic Times)
The Spices Board under the ministry of commerce has registered pepper cardamom chilli ginger and turmeric as products that have unique flavour and attributes because they are grown in a specific geographical region of India. More...
A pill for generic troubles
(Biswajit Dhar , 29-Mar-2011 , Livemint)
Despite positive signals recent trends in the generic pharmaceuticals industry have been most disheartening More...
Natco Pharmas medicine gets orphan drug designation from USFDA
(Our Bureau , 28-Mar-2011 , Business Line)
The drug has been granted patents in nine countries including the US. More...
FTA will enhance R&D in Indias pharma sector
(BV Mahalakshmi , 28-Mar-2011 , The Financial Express)
Brian Ager the Director General of European Federation of Pharmaceutical Industries and Associations says that its global R&D pharmaceutical industry has no desire to restrict access to essential medicines. More...
Panel: Apple did not infringe Nokia patents
(Bloomberg , 26-Mar-2011 , The Times Of India)
Apple Inc won a US trade ruling in a patent fight brought by Nokia Oyj over technology used in mobile telephones. More...
GI tag: Varanasi Bhadohi lead in UP
(TNN , 25-Mar-2011 , The Times Of India)
While Varanasi Bhadohi region takes a lead in Uttar Pradesh by getting two GI tags for its famed products Banaras brocade and saree and handmade carpet of Bhadohi Karnataka is the leader in producing maximum number of GI registered products in the country. More...
Free trade pact with four European nations this year
(Sujay Mehdudia , 25-Mar-2011 , The Hindu)
India and the Europe Free Trade Association are likely to conclude a free trade agreement entailing a comprehensive bilateral trade and investment agreement by this year after fast tracking of the negotiations between the two groups. More...
Banaras brocade Bhadohi carpets to achieve new height internationally
(TNN , 25-Mar-2011 , The Times Of India)
The Chennai based office of the Geographical Indications Registry Ministry of Commerce and Industry Government of India organised a seminar cum workshop on awareness about GI and GI authorised users on Friday. More...
Authorised clones may hit Ranbaxys FTF bet
(Priyanka Golikeri , 24-Mar-2011 , DNA)
The proverb all that glitters is not gold seems apt for Ranbaxy Laboratories amid a flurry of patent expiries that are slated in the US market. More...
Now get live info of your trains position
(TNN , 24-Mar-2011 , The Times Of India)
The Geographical Indication Board which was in stalled at the Charbagh station on a trial basis is now fully functional. More...
Intellectual property rights need to be propagated
(Our Correspondent , 23-Mar-2011 , Business Line)
Lack of awareness on intellectual property rights is deep in tier II cities and is holding back the growth of small and medium scale enterprises said Mr N.V. Srinivasan Chairman Indo American Chamber of Commerce here recently. More...
India EU trade deal threatens access to life saving drugs
(ANI , 23-Mar-2011 , The Economic Times)
An expert has warned that a new trade agreement between India and Europe would block access to life saving drugs for billions of people living in developing countries. More...
India equipped to protect over 2 lakh formulations under Traditional Knowledge Digital Library
(Our Bureau , 23-Mar-2011 , Business Line)
The Union Minister of Science Technology and Earth Sciences Mr P.K Bansal said on Tuesday that India is equipped to protect over 2 lakh formulations under the Traditional Knowledge Digital Library. More...
India to help world protect ancient medicines
(fe Bureau , 24-Mar-2011 , The Financial Express)
On Tuesday India offered to share its expertise with other countries on effectively protecting the commercially valuable traditional systems of medicine such as Ayurveda from being patented by individuals and companies. More...
India to help world protect ancient medicines
(fe Bureau , 23-Mar-2011 , The Financial Express)
On Tuesday India offered to share its expertise with other countries on effectively protecting the commercially valuable traditional systems of medicine such as Ayurveda from being patented by individuals and companies. More...
Ranbaxy: Is the market overreacting to Mylans suit
(Srividhya Sivakumar,BL Research Bureau , 23-Mar-2011 , Business Line)
The stock price of Ranbaxy falling seven per cent on Monday following reports of Mylan suing the US FDA may be an overreaction More...
Willing to share TKDL model to protect traditional knowledge''
(PTI , 22-Mar-2011 , IBN Live)
India today offered to share its experiences in protecting traditional knowledge from being used to get patents with countries desirous of doing so. More...
Ranbaxy shares dive 7% as Mylan sues USFDA over Lipitor approval
(Rupali Mukherjee , 22-Mar-2011 , The Times Of India)
Ranbaxy Laboratories scrip plunged nearly 7% at around Rs 436 on the Bombay Stock Exchange close to the months lowest on Monday on speculation that its plans in launching generic Lipitor may hit a roadblock. More...
India to showcase mission to protect traditional knowledge
(PTI , 22-Mar-2011 , MSN)
India will showcase its unique mission to curb bio piracy and share its experience of protecting traditional knowledge in front of representatives from 38 countries at an international conference here. More...
Apple sues Amazon.com over APP STORE trademark
(Reuters , 22-Mar-2011 , The Economic Times)
Apple Inc has sued Amazon.com Inc in a bid to stop the online retailer from improperly using Apples APP STORE trademark according to a court filing. More...
Microsoft sues Barnes & Noble over Nook reader
(Bill Rigby , 21-Mar-2011 , Yahoo News)
Microsoft Corp filed lawsuits for patent infringement on Monday against bookseller Barnes & Noble Inc over its Nook electronic book reader widening the software companys legal assault on devices running on Google Incs Android system. More...
The war of generics
(Our Bureau , 21-Mar-2011 , Business Line )
Everyone wants to have his way on any drug that is going off patent. More...
Biocon boost from Optimers patent
(TNN , 18-Mar-2011 , The Times Of India)
Biocons drug development partner Optimer Pharmaceuticals has received a US patent for fidaxomicin an antibiotic used in the treatment of clostridium difficile infection. More...
Tamiflu patent: Gilead sues Natco Pharma
(PTI , 17-Mar-2011 , Business Line)
Gilead Sciences a California based bio pharmaceutical research firm along with its patent partner Roche Holding AG sued the Indian generic drug maker Natco Pharma here for allegedly infringing a US patent for Tamiflu a drug used in the treatment of bird and swine-flu infections. More...
Govt for legalising parallel import of copyright works publishers oppose
(Shamnad Basheer , 17-Mar-2011 , The Economic Times)
India is no exception and the industry is now up in arms against a government proposal to legalise the parallel import of copyright works through Copyright Amendment Bill 2010. More...
Time for European lessons
(T S Vishwanath , 17-Mar-2011 , Business Standard)
The latest matter to hit the headlines is the single patent regime. More...
Indias trade barriers hampering economic ties: EU
(IANS , 17-Mar-2011 , The Economic Times)
Indias restrictive trade policy is hampering the economic ties with the European Union says a report. More...
Research cost health data key to enforcement
(C.H. Unnikrishnan , 16-Mar-2011 , Livemint)
The enforcement of compulsory licence provisions for patented drugs in India will remain a damp squib in the absence of proper healthcare data available with the government and an accurate account of patent holders research cost on the drug according to senior officials at the patnt office responsible for granting such licences. More...
Govt constitutes taskforce to evolve strategy for pharma ind
(PTI , 16-Mar-2011 , MSN)
In order to give a boost to the Indian pharmaceuticals industry the government today constituted a taskforce to evolve a long term strategy for the sector including addressing issues relating to Intellectual Property Rights. More...
Health ministry sets up taskforce to address issues of pharma industry
(BS Reporter / New Delhi , 16-Mar-2011 , Business Standard)
Also the committee would evolve strategies to further the interests of Indian pharma industry in the light of issues related to Intellectual Property Rights and recommend strategies to capitalise the opportunity of drugs going off patent over the next 5 years a health ministry statement said. More...
Over 83000 patent applications pending for scrutiny
(PTI , 14-Mar-2011 , Business Line)
Over 83000 patent applications are pending for examination due to shortage of manpower Parliament was informed today. More...
India EU settle generics dispute pave way for FTA talks in April
(Amiti Sen , 15-Mar-2011 , The Economic Times)
India has sorted out most of its differences with the European Union on production of low cost generic medicines ahead of a crucial meeting on a proposed free trade pact next month a government official told ET. More...
Govt will protect interests of drug industry: Scindia
(Press Trust of India / New Delhi , 14-Mar-2011 , Business Standard)
Amid concerns expressed by the Indian industry the government today said in Parliament that it will protect the interest of the domestic drug industry while finalising the free trade pact with European Union. More...
Glenmark gets most approvals to sell generic drugs in US
(Khomba Singh , 14-Mar-2011 , The Economic Times)
In the first eleven months of the fiscal Glenmark secured nods to sell as many as 21 new generic medicines or low cost versions of off patent drugs in the US compared to 16 medicines by Aurobindo Pharma and 12 drugs by Sun Pharma the top Indian generic firm to receive USFDA approvals for the year ended March 2010. More...
Blockbuster Botoxs India connection
(Sanchita Sharma , 13-Mar-2011 , Hindustan Times)
This prompted Allergan to get a patent for marketing bimatoprost as a eyelash growth cosmetic product. More...
India patent office head count to jump 170 pc
(PTI , 12-Mar-2011 , MSN)
The India patents design and trade marks office is increasing its head count by 170 per cent to 457 in the next three months to cope with the growing pressure in number of applications. More...
Cadila Healthcare: Marginal benefits from Taxotere
(Malini Bhupta / Mumbai , 12-Mar-2011 , Business Standard)
Hospira Cadila Healthcares joint venture partner has received the final approval to market the generic Taxotere an oncology drug that went off the patent in November 2010. More...
SCMS bags patent
(Express News Service , 11-Mar-2011 , Express Buzz)
The SCMS lnstitute of Biotechnology has received the patent from the Government of India for developing a process for producing stevioside powder a natural remedy for diabetes from stevia leaves popularly known as honey leaves said Prof Pradeep More...
Efforts on to make patent offices totally transparent: DIPP
(Press Trust of India / New Delhi , 10-Mar-2011 , Business Standard)
With an aim to bring total transparency in the working of Indian patent offices the government is considering to make reports of examiners on applications public. More...
Compulsory licensing norms soon
(Asit Ranjan Mishra , 10-Mar-2011 , Livemint)
Foreign lobby groups oppose allowing govt to order manufacture of drugs without the patent holders consent More...
Its a tough fight for survival
(Binay Singh , 10-Mar-2011 , The Times of India)
Despite boasting of geographical indication certification the handmade carpet of Bhadohi has not benefited much. More...
Free trade deal with Europe will help MNCs sue India globally
(Priyanka Golikeri , 10-Mar-2011 , DNA)
If India signs the free trade agreement with the European Union in its current form the country would be opening its doors for getting sued internationally by foreign companies. More...
Popular drugs a waste of money?
(Kounteya Sinha & Mahendra Kumar Singh , 10-Mar-2011 , The Times Of India)
They are some of the most common drugs consumed in India. More...
Ideal Cures wins pre grant opposition against BPSI Holdings
(Suja Nair Shirodkar, Mumbai , 9-Mar-2011 , Pharmabiz)
Mumbai based Ideal Cures has won a pre grant opposition under section 25(1) of the Indian Patent Act against BPSI Holdings Inc parent company of Colorcon. More...
Senate passes America Invents Act
(PTI , 9-Mar-2011 , Business Line)
The United States Senate has voted overwhelmingly to approve a legislation to make the first reforms to its patent system in nearly six decades. More...
Cheap generic drugs eat into pharma cos sales
(News Service , 08-Mar-2011 , The Economic Times)
At the end of November Pfizer stands to lose a $10 billion a year revenue stream when the patent on its blockbuster cholesterol drug Lipitor expires and cheaper generics begin to cut into the company s huge sales. More...
Pochampally Ikat hit by triple whammy
(Itishree Samal / Hyderabad , 8-Mar-2011 , Business Standard)
The intricate tie and dye craft of silk and cotton weaving had received geographical indication status in 2005. More...
MNC pharma firms campaigning against Indian cos says govt
(PTI , 07-Mar-2011 , The Economic Times)
The government today said multi national companies are campaigning against domestic pharma industry as their interests were getting impacted due to increasing global presence of Indian firms in the generic segment. More...
US to press India for trade opening
(Press Trust of India / Washington , 06-Mar-2011 , Business Standard)
Other barriers range from prohibitions and restrictions on foreign investment in key sectors to inadequate protection and enforcement of intellectual property rights it said. More...
Dr Reddys eyes $1 bn revenue in next 3 years
(PTI , 06-Mar-2011 , Business Line)
The company had filed 141 ANDAs to the US FDA till December 2010. More...
Kraft takes a bite of local biscuit market
(TNN , 04-Mar-2011 , The Times Of India)
Incidentally Oreos launch in India was preceded by Kraft dragging Britannia to court over a trademark infringement case against the latters Treat O biscuit. More...
Thousands of HIV+ People organise protest march in Delhi against India EU free trade agreement
(Our Bureau, Mumbai , 4-Mar-2011 , Pharmabiz)
The most damaging measure to access to affordable medicines is so called data exclusivity which would act like a patent and block generic versions from the market even for drugs that are already off patent or do not merit a patent to begin with under Indias strict patent law. More...
HIV+ patients protest against controversial EU India FTA
(TNN , 3-Mar-2011 , The Times Of India)
Thousands of HIV positive people from India and across Asia marched from Ramlila ground to Jantar Mantar on Wednesday to protest against the free trade agreement between European Union and India which has provisions that would restrict access to affordable medicines. More...
Good news for king of fruits
(Paul Fernandes , 02-Mar-2011 , The Times Of India)
While Goas feni has secured geographical indication the registration of plant varieties is on a different keel. More...
Growth of emerging economies to continue in coming years
(PTI , 02-Mar-2011 , The Economic Times)
The remarkable growth of emerging economies like China India and Brazil has fundamentally changed the global economic landscape a US trade report has said adding that their growth is projected to continue in the coming years. More...
India EU kick off fresh talks on free trade agreement
(Pallavi Aiyar / Brussels , 02-Mar-2011 , Business Standard)
The chapter on intellectual property rights has generated some controversy with civil society groups claiming a deal that would bind India to TRIPS plus commitments would be detrimental to developing countries and their access to life saving drugs. More...
Google Microsoft join hands on patent
(Bloomberg , 2-Mar-2011 , The Times Of India)
Microsoft Corp and Google Inc rivals in the online search market joined to challenge the validity of a Texas companys patent on mapping technology. More...
Global health networks urge Novartis to end litigation on Glivec
(P.T. Jyothi Datta , 1-Mar-2011 , Business Line)
Novartis had challenged the rejection of its patent application in India. More...
SC dismisses Marico claim to low absorb trademark
(PTI , 1-Mar-2011 , The Economic Times)
The Supreme Court today dismissed the appeal of Marico Industries the maker of cooking oils Saffola and Sweekar challenging the use of the slogan low absorb by Agro Tech Foods an affiliate of American foods giant ConAgra Foods. More...
Apex court rejects Maricos claim on low absorb trademark
(PTI , 1-Mar-2011 , Business Line)
The Supreme Court has dismissed the appeal of Marico Industries maker of cooking oils Saffola and Sweekar challenging the use of the slogan low absorb by Agro Tech Foods an affiliate of American foods giant ConAgra Foods. More...
New forum for IPR attorneys
(TNN , 28-Feb-2011 , The Times of India)
With a view to better the functioning of various Intellectual Property Rights fora such as patent copyright trademark and national bio diversity authority a new association was launched here on Friday. More...
Biotech sector to see uptick in M&As: Grant Thornton
(BS Reporter / Chennai/ Hyderabad , 28-Feb-2011 , Business Standard)
Reeling under the pressures of imminent patent expiries the developed markets have relied on the acquisition or alliance route to sustain the growth. More...
After GI chikankari to get craftmark logo
(Express News Service , 27-Feb-2011 , Indian Express)
After the Geographical Indication registration chikankari craft of Lucknow will now get a distinct identity by getting a brand name and a logo. More...
Strategic use of IP would aid Indias growth
(PTI , 27-Feb-2011 , The Economic Times)
Against the backdrop of rising number of patent filings in India a top Microsoft official has said that strategic use of intellectual property would help in supporting the countrys overall growth. More...
Remainders of the day a case for parallel imports
(Guest View | Shamnad Basheer , 26-Feb-2011 , Livemint)
Provided that a copy of a work published in any country outside India with the permission of the author of the work and imported from that country shall not be deemed to be an infringing copy More...
Novartis asked to end challenge to Indian patent law
(Kevin Grogan , 25-Feb-2011 , Pharma Times)
Novartis has been urged to drop its persistent legal actions in India regarding patent coverage for its anticancer drug Glivec and a challenge to the countrys patent laws over fears the latter could hinder access to medicines More...
EUs pharma trade hoax
(Tahir Amin/Priti Radhakrishnan , 25-Feb-2011 , Business Line)
The proposed India EU trade pact is riddled with intellectual property provisions that would harm Indias 2005 Patent Act. More...
Venus Remedies gets patent for anti biotic drug from Mexico
(Press Trust of India / New Delhi , 24-Feb-2011 , Business Standard)
Drug maker Venus Remedies today said it has been granted patent for its anti biotic product Sulbactomax by the Mexican authorities. More...
Global drug makers making strong comeback in India
(PB Jayakumar / Mumbai , 24-Feb-2011 , Business Standard)
Armed with a product patent regime and a string of large acquisitions multinational drug companies are making a strong comeback in India. More...
Medicine patents: Drugmakers find find it hard to do business
(Kenji Hall , 24-Feb-2011 , Financial Times)
Among pharmaceutical industry insiders it is known as the patent cliff. More...
Aurobindo gets tentative USFDA nod for generic Venlafaxine
(PTI , 24-Feb-2011 , The Economic Times)
The company claimed that it had filed for the approval under Paragraph IV certification which would have given it 180 days of marketing exclusivity but it is currently under litigation in the US District Court of New Jersey. More...
Looking into takeovers of Indian pharma firms by MNCs: Govt
(PTI , 23-Feb-2011 , The Economic Times)
Concerns have been expressed that the recent takeovers of Indian pharmaceuticals companies by multi national firms would result in their gaining market supremacy affecting the prices of generic off patent drugs Minister of State for Commerce and Industry Jyotiraditya Scindia said in a written reply to Rajya Sabha. More...
Looking into takeovers of Indian pharma firms by MNCs: Govt
(PTI , 23-Feb-2011 , The Economic Times)
Concerns have been expressed that the recent takeovers of Indian pharmaceuticals companies by multi national firms would result in their gaining market supremacy affecting the prices of generic off patent drugs Minister of State for Commerce and Industry Jyotiraditya Scindia said in a written reply to Rajya Sabha. More...
CSIR slows down patent filing of its processes discoveries products with few takers
(Joseph Alexander, New Delhi , 23-Feb-2011 , Pharmabiz)
With huge number of patented processes leads discoveries and products developed by its different institutes relating to pharmaceuticals available but not having many takers the Council of Scientific and Industrial Research has slowed down the patent filing process. More...
Ind Swift project gets Japan govts nod
(BS Reporter / New Delhi/ Chandigarh , 22-Feb-2011 , Business Standard)
For the first time a large number of drugs patented by Japanese companies are going off patent. More...
Meet the Indian inventor who has 42 patents
(Shobha Warrier , 22-Feb-2011 , Rediff)
In 2005 when Rediff.com met Arvind Thiagarajan he was 25 year old young inventor with a couple of patents to his credit. More...
Sanofi Aventis plans to buy Generics OTC brands
(Khomba Singh , 21-Feb-2011 , The Economic Times)
French drugmaker Sanofi Aventis plans to buy branded generics and over the counter consumer healthcare brands in India as part of its strategy to scale up sales from new avenues a top company executive said. More...
Indian bottled water: just the tonic
(Anjli Raval , 21-Feb-2011 , The Financial Times)
Indias Intellectual Property Appellate Board which deals with trademark related issues said in a recent order that Tatas Mount Everest Mineral Water division could not trademark the term for its products. More...
India US to discuss trade irritants
(Nayanima Basu / New Delhi , 21-Feb-2011 , Business Standard)
The focus areas are standards anti dumping duties and practices small scale industries and protection and enforcement of intellectual property rights. More...
GIB to give live into about train positions
(Neha Shukla , 20-Feb-2011 , The Times Of India)
This will be made possible through the geographical indication board which will be installed at the station in near future. More...
Q&A: Roger L Williams MD & CEO United States Pharmacopeia
(Neha Shukla , 20-Feb-2011 , The Times Of India)
Any company in the US market can get into trouble in terms of good manufacturing practices or affiliated standards More...
A balanced IPR regime Key to promote technology driven agriculture
(Rana Kapoor , 20-Feb-2011 , Business Line)
As the world moves towards a knowledge driven economy protection of intellectual property rights has become a key motivator for innovation. More...
2(m) or not 2(m)
(Nilanjana S Roy / New Delhi , 19-Feb-2011 , Business Standard)
How a copyright amendment might change the way we read write and publish in India. More...
Abbott Ranbaxy settle patent suit
(Khomba Singh , 19-Feb-2011 , The Economic Times)
Abbott Laboratories has settled a patent litigation case against Ranbaxy Laboratories allowing the Indian pharmaceutical firm to launch a generic version of the US drugmakers cholesterol lowering medicine Tricor. More...
Consensus on import duty key to Doha round success
(Namrata Acharya / London , 19-Feb-2011 , Business Standard)
Zeroing in on an agreeable rate of exchange on import duties among member nations was key to concluding the talks on a global free trade agreement or the Doha round at the World Trade Organisation a top WTO spokesperson said today. More...
World Cup: Sponsors in fierce off field copyright battles
(Gouri Shah , 19-Feb-2011 , Livemint)
Copyright Integrity International the intellectual property rights firm enlisted by the International Cricket Council to protect sponsor interest is seeing some fierce rivalry off the field over the tournament that will kick off on Saturday in Dhaka. More...
Court restores status quo on Maricos trademark Manjal
(Bindu D. Menon , 18-Feb-2011 , Business Line)
The Madras High Court has restored status quo in the dispute regarding the wrongful removal of Maricos trademark Manjal from the trademarks register. More...
Global consolidation hits Indian contract drug manufacturing cos
(Khomba Singh , 18-Feb-2011 , The Economic Times)
Mergers & acquisitions in the global pharmaceutical industry that have led to reduction in outsourced research work have hit Indian contract drug manufacturing and research services or CRAMS companies. More...
Problems in trade talks with EU
(KAVALJIT SINGH , 18-Feb-2011 , Business Line)
EU is pushing India to relax controls on capital flows and conditions on investment such as export obligation and local content requirement. More...
Satyam to pay $125 million to settle US suit
(ET Bureau , 18-Feb-2011 , The Economic Times)
Close on the heels of a settlement of a class action law suit in the US for $125 million Mahindra Satyam is planning to sue the former Satyam management and the companys erstwhile auditor PriceWaterhouse for a possible monetary damages claim. More...
Roger L Williams United States Pharmacopeia
(K Rajani Kanth / Hyderabad , 18-Feb-2011 , Business Standard)
Indian manufacturers are critically important for the US market. More...
Controls on MRLs move to bar off patent Endosulfan to impact farmers
(Announcement / Corporate , 17-Feb-2011 , Business Standard)
In a media briefing held in Kolkata today a panel of agronomists and farmers expressed concern over the mounting pressure exerted on India not to oppose the European Union proposal to list endosulfan as a Persistent Organic Pollutant. More...
Tatas Mount Everest loses trademark dispute with Bisleri over Himalayan
(Ratna Bhushan , 17-Feb-2011 , The Economic Times)
Tata Groups Mount Everest has no exclusive right on the word Himalayan the countrys trademark dispute authority said following a petition from Ramesh Chauhans Bisleri International. More...
Ind-Swift Labs gets approvals for two products from PMDA Japan
(Our Bureau, Mumbai , 17-Feb-2011 , Pharmabiz)
It is for the first time that a large number of drugs patented by Japanese companies are going off patent. More...
Textiles pharma sectors to gain most from trade pact with Japan
(Our Bureau , 17-Feb-2011 , Business Line)
Indian pharmaceuticals will get access to a highly developed Japanese market and for the first time ever Japan has committed to give the same treatment for Indian generics off patent drugs as their domestic industry the statement said More...
Q&A: Brian Ager DG European Federation of Pharmaceutical Industries and Associations
(Pallavi Aiyar / February , 16-Feb-2011 , Business Standard)
India is an important trade partner and growing economic power. More...
Rahul Khullar Trade deficit is still worrying
(Asit Ranjan Mishra & Anil Padmanabhan , 16-Feb-2011 , Livemint)
Next week India plans to sign bilateral trade agreements with Japan and Malaysia to reduce barriers and increase trade even as the World Trade Organizations Doha round of trade talks make little progress. More...
Pharma sector injects fresh life into M&A space
(Rupali Mukherjee , 15-Feb-2011 , The Times Of India)
When Ajay Piramal promoter and chairman of Piramal Healthcare struck a deal with US based pharma biggie Abbott Inc for selling assets of the domestic formulation unit at over 9 times its sales little did he know it will set a benchmark. More...
Ahmedabad gives herbal hues to Levis
(TNN , 15-Feb-2011 , The Times Of India)
The company is certified by Global Organic Textile Standarda leading processing standard for textiles made from organic fibres worldwide and has a US and India patent for herbal dyeing. More...
Gary Locke US Commerce Secretary
(Nayanima Basu / New Delhi , 14-Feb-2011 , Business Standard)
It is the US Trade Representative that leads on trade negotiations in general. More...
WIPO to organise traditional knowledge meet in March
(Press Trust of India / New Delhi , 13-Feb-2011 , Business Standard)
The World Intellectual Property Organisation a specialised UN agency along with Indian government will organise a three day meet on traditional knowledge including ayurvedic medicine and unani next month. More...
Drugmakers rattled by EU austerity moves
(Priyanka Golikeri , 10-Feb-2011 , DNA)
Adithya Bhat manging director of business consulting firm Protiviti Consulting said the pricing pressures and austerity measures notwithstanding Indian companies can make the most of drugs going off patent in the EU. More...
China ranks 4th in patent application India lags
(PTI , 09-Feb-2011 , The Economic Times)
India remains a laggard in research and technological innovation as compared to China which has become the worlds fourth largest filer of patent applications in 2010 according to the data released by World Intellectual Property Organization today. More...
Natco challenges Gileads patent on Tamiflu
(BS Reporter / New Delhi , 9-Feb-2011 , Business Standard)
Hyderabad based Natco Pharma has challenged the patent for Tamiflu a drug to treat bird flu in the US. More...
DIPP bats for FDI curbs in pharma
(Surajeet Das Gupta / New Delhi , 9-Feb-2011 , Business Standard)
It said 61 drugs worth over $80 billion are going off patent making it possible for domestic companies to produce cheaper versions of those drugs. More...
Lincoln Pharma bets big on Pa 2 paracetamol tablets
(BS Reporter / Mumbai/ Ahmedabad , 8-Feb-2011 , Business Standard)
The company received patent for a nasal drug delivery system in India last month. More...
US asks India to lower tariffs remove barriers
(Elizabeth Roche , 8-Feb-2011 , Livemint)
Further changes to US export control policies towards India will continue in the months ahead says Locke More...
A poetic justice for copyright violations
(Sandhya Soman , 8-Feb-2011 , The Times Of India)
In every lecture that she delivers whether in Rome or Bangalore professor Mira T Sundara Rajan shows a photo of her great grandfather the poet C Subramania Bharati. More...
Delhi high court stops parasite Chinese company from using L&T logo
(Rakesh Bhatnagar , 7-Feb-2011 , DNA)
The Delhi high court wants Intellectual Property Rights and Enforcement Rules 2007 and Customs Act 1962 implemented in letter and spirit so that overseas sly operators can be stopped from cashing in on the goodwill and reputation of established Indian brands and duping consumers. More...
Mussels: From delicacy to arthritis cure
(Ullekh N P , 7-Feb-2011 , The Economic Times)
According to the research institute this product made by extracting anti inflammatory ingredients from green mussels could be a substitute for the regular aspirin containing anti inflammatory arthritis drugs with undesirable side effects. More...
Nobodys about to kill books
(Rahul Matthan , 7-Feb-2011 , Indian Express)
There is a proposal to amend the Copyright Act that will make it legal to import into India any book that has been validly published outside India even if an Indian publisher has been granted the exclusive licence to publish it in India. More...
MSMEs should focus on intellectual property rights
(TNN , 6-Feb-2011 , The Times of India)
With micro small and medium enterprises in Orissa giving more emphasis on production than on innovation and intellectual property rights the state government has called for a shift in focus. More...
Move faster on trade barriers US Commerce Secy to tell New Delhi
(Indira Kannan / New York , 5-Feb-2011 , Business Standard)
Answering a question from Business Standard the Secretary said the US had brought up the issue of tariff and non tariff barriers including restrictions on Foreign Direct Investment and concerns about Intellectual Property Rights during President Barack Obamas visit to India last November and will raise these again next week. More...
SC to hear Novartis plea on cancer drug patent
(Press Trust of India / New Delhi , 04-Feb-2011 , Business Standard)
The Supreme Court will start final hearing next month on a plea by Swiss pharma firm Novartis AG challenging the order of an appellate board, which upheld the governments denial of patent to its blood cancer drug Glivec. More...
SC to hear Novartis plea on cancer drug patent
(Press Trust of India / New Delhi , 04-Feb-2011 , Business Standard)
The Supreme Court will start final hearing next month on a plea by Swiss pharma firm Novartis AG challenging the order of an appellate board which upheld the governments denial of patent to its blood cancer drug Glivec. More...
Indian cos eye $4bn generic opportunity
(Rupali Mukherjee , 4-Feb-2011 , The Times Of India)
Around $3 4 billion worth opportunity will be up for grabs in the wake of blockbuster drugs going off patent losing patent protection in the US over 2011 2012. More...
India is developing good competition policy says WTO official
(PTI , 03-Feb-2011 , The Economic Times)
India is developing an effective competition policy and is also making significant efforts to strengthen its intellectual property rights regime a top WTO official has said. More...
Natco to take on Bayer on cancer drug Nexavar
(KV Ramana , 3-Feb-2011 , DNA)
Generic pharmaceuticals maker Natco Pharma is gearing up to take on German healthcare giant Bayer AG. More...
Pirated counterfeit products value to touch $1.78 tn in 2015
(PTI , 03-Feb-2011 , The Economic Times)
A number of G 20 economies may be missing out on higher FDI as a result of concerns over IPR Intellectual Property Rights enforcement. More...
Artists and musicians told to come together to safeguard their work
(Special Correspondent , 2-Feb-2011 , The Hindu)
A discussion on copyright in Chennai on Tuesday witnessed the forceful articulation of the need for artists and musicians to come together to safeguard their creative works. More...
India EU free trade pact to be concluded this year: Sharma
(Laxmi Devi , 1-Feb-2011 , MSN)
India today exuded confidence that negotiations for the proposed comprehensive market opening pact with the 27 nation European Union will conclude in 2011. More...
The decade in science
(Jacob P. Koshy , 1-Feb-2011 , Livemint)
Over at least the past seven years several multinational firms including Microsoft Corp. and International Business Machines Corp. have been setting up their key research centres in India often recruiting the brightest of Indian scientists and researchers to power their patent pipeline. More...
Dr Reddys gets court nod to launch Allegra D 24 tablets in US
(PTI , 31-Jan-2011 , MSN)
In September 2009 AMRI filed a patent infringement lawsuit against Dr Reddys for alleged infringement of one of AMRIs patents related to the manufacturing process for the active ingredient in Allegra D 24. More...
Ind Swift net profit up by 83.10%, Exports up 37.87%
(Announcement / Corporate , 31-Jan-2011 , Business Standard)
The Company is now in agreement with global players for the supply of blockbuster drugs like Clarithromycin Atorvastatin Fexofenadine Letrozole Anastrozole Rosuvastatin Pioglitazone Clopidogrel etc. to regulated markets on patent expiry. More...
Lupin global ride hinges on the Power of Five
(Priyanka Golikeri , 31-Jan-2011 , DNA)
The Mumbai based company is banking heavily on products belonging to therapeutic areas such as oral contraceptives ophthalmics dermatology biosimilars off patent versions of biologic drugs and asthma to be the driving force. More...
Dr Reddys says U.S. court clears generic Allegra sale
(Bharghavi Nagaraju , 31-Jan-2011 , Reuters)
The U.S. District Court of New Jersey lifted an injunction passed last June against the Indian drugmaker from selling a copycat version of the drug Dr Reddys said in a statement. More...
Vexed issues delaying free trade talks
(Asit Ranjan Mishra , 31-Jan-2011 , Livemint)
A free trade agreement with Australia will provide India access to markets in East Asia, allowing it to counterbalance the growth of strategic and economic rivals such as China in the region said the commerce ministry official cited earlier. More...
Hardware and software of innovation
(D. Murali , 29-Jan-2011 , The Hindu)
There is much that is dysfunctional in the US but there is also a great deal to be optimistic about writes Adam Segal in Advantage How American innovation can overcome the Asian challenge. More...
Cadila Healthcare: Buy
(Srividhya Sivakumar , 29-Jan-2011 , Business Line)
Good results bright prospects in the domestic and export markets and better growth expectations from its joint venture companies make Cadila Healthcare a good investment bet for the long term. More...
Pharma exports may touch a record Rs 50000 cr in 2010 11
(Joe C Mathew / New Delhi , 28-Jan-2011 , Business Standard)
Industry analysts say the growth will be driven by the US revenues where $36.7 billion worth drugs are expected to go off patent in 2011. More...
HC seeks Centre's response on patent board anomaly plea
(TNN , 28-Jan-2011 , The Times Of India)
The Madras high court has asked the additional solicitor general of South India M Ravindran to ascertain the Centres response to a public interest writ petition highlighting serious anomalies in the affairs of the Intellectual Property Appellate Board here. More...
A manufacturing strategy for India
(ARUN MAIRA , 28-Jan-2011 , The Economic Times)
In fact the Chinese government is framing IPR rules to further its own interests suspecting that the rules being imposed on it have been devised principally to protect foreign companies interests. More...
BJP drags PM into CVC row says govt claim patent lie
(PTI , 27-Jan-2011 , The Times of India)
BJP on Thursday slammed the government for claiming in the Supreme Court that the committee which chose P J Thomas as the CVC last year was not aware of corruption charges against him and sought an answer from Prime Minister Manmohan Singh for the patent lie. More...
IPA concerned over PMO's efforts to destabilize Indias IPR regime at the behest of EU
(Ramesh Shankar, Mumbai , 27-Jan-2011 , Pharmabiz)
The Indian Pharmaceutical Alliance an association of leading Indian pharma companies has raised alarm over the recent media reports that efforts are going on in the Prime Ministers Office to destabilize Indias IPR regime at the behest of European Union which the IPA cautioned the government will have serious implications on the public health access to medicines and the domestic generic industry. More...
Plea seeks to expose patent tribunal anomaly
(A Subramani and Pushpa Narayan , 27-Jan-2011 , The Times Of India)
A technical member of the Intellectual Property Appellate Board he was appointed to the post after he took credit for the cases argued during the British era. More...
Data exclusivity still key hurdle to India EU FTA
(Nayanima Basu & Joe C Mathew / New Delhi , 27-Jan-2011 , Business Standard)
Despite all official assurances the path towards a free trade agreement between India and the European Union this year remains ambiguous as both sides are unwilling to relax their stand on the biggest stumbling block the issue of data exclusivity. More...
Dont swallow this pill
(pritiradhakrishnan , 27-Jan-2011 , Indian Express)
Troubling news reports indicate that a newly minted Free Trade Agreement between the European Union and India would permit companies to circumvent visionary safeguards built into Indias 2005 Patents Act widely seen as one of the most progressive patent laws in the world. More...
US suggests removal of some key clauses in patent manual
(C.H. Unnikrishnan , 25-Jan-2011 , Livemint)
The changes being sought may not be in agreement with the terms of Indias laws on Intellectual property More...
Quality issues may hit pharma cos US prospects
(P.T. Jyothi Datta , 25-Jan-2011 , Business Line)
Quality concerns could upset the apple cart for Indian generic drug makers exporting to the US even as they look to tap the $96 billion worth opportunity emerging from drugs going off patent between 2011 and 2013. More...
Punjabs history came in way of GI pleas
(Jasneet Bindra , 25-Jan-2011 , Indian Express)
Punjab suous history has been a major roadblock in its run for geographical indication. More...
India EU negotiators to meet in Kerala to resolve FTA issues
(PTI , 25-Jan-2011 , The Economic Times)
Inclusion of intellectual property rights and social issues like environment and labour standards in the proposed Bilateral Investment and Trade Agreement are some of the main areas on which a consensus are yet to be achieved. More...
US generics demand to drive Indian pharma growth: Fitch
(24-Jan-2011 , Rediff)
It said that Indian pharmaceutical companies expect about $ 96 billion worth drugs to go off patent in the US in 2011 2013. More...
Natco may seek compulsory licence for Bayers cancer drug
(Khomba Singh , 24-Jan-2011 , The Economic Times)
Natco Pharma plans to seek a compulsory licence from the government to make Bayer AGs Nexavar in India invoking a provision in local laws that allows generic drugmakers to make and sell patented drugs cheaply if the medicine is unaffordable. More...
Music industry readies copyright database
(Reuters / London , 24-Jan-2011 , Business Standard)
The music industry is working to create a global repertoire database to make it easier and faster for new online music services to come to market. More...
India raise concern over WHOs failure to replace IMPACT with working group on counterfeit drugs
(Joseph Alexander, New Delhi , 24-Jan-2011 , Pharmabiz)
India has raised strong concern over the delay in setting up a working group by the World Health Organisation to address the problems of counterfeit and substandard medicines and adopt changes in the policy instead of leaving the task with controversial International Medical Products Anti Counterfeiting Taskforce. More...
The copyright wars
(Satya Prakash , 23-Jan-2011 , The Hindustan Times)
As India emerges as one of the biggest world publishing markets intellectual property rights become a more contentious issue with authors artists and other creative persons asserting their rights and the government attempting to bring the industry practices in tune with the international treaties in a more globalised environment. More...
Maharashtra plans to patent Worli sea link
(ET Bureau , 23-Jan-2011 , The Economic Times)
The Maharashtra State Road Development Corporation is in talks with a few international legal consultants to patent its iconic Bandra Worli Sea Link project with the intention to generate additional revenue. More...
Indian movies without songs possible?
(Leena Mulchandani , 22-Jan-2011 , The Economic Times)
Its supposed to amend the copyright laws in India but The Copyright Bill 2010 might just also amend the way movies are made. More...
EU still pushing data exclusivity through FTA India stands firm
(Joseph Alexander, New Delhi , 22-Jan-2011 , Pharmabiz)
European Union is still pushing India to accept TRIPS plus data exclusivity provisions through the proposed Free Trade Agreement though India is still firmly against it if the latest draft chapter on intellectual property rights is any indication. More...
FTA with EU only by year-end
(Special Correspondent , 21-Jan-2011 , Business Standard)
Although negotiations on the much awaited India European Union Free Trade Agreement are likely to be concluded by summer this year the formal signing will only happen by the end of this year at the India EU summit. More...
Wockhardt gets USFDA approval to market generic Protonix
(PTI , 21-Jan-2011 , The Economic Times)
Drug firm Wockhardt today said it has received final approval from the US health regulator US Food and Drug Administration to market generic pantoprazole tablets used for treating ulcers and hyperacidity in the American market. More...
THE PATENT PRESSURES
(P A Francis , 21-Jan-2011 , Pharmabiz)
India EU Trade and Investment Pact is going to be concluded some time in March this year and the prime minister is expected to visit Europe for signing the same. More...
Intellectual Property tribunals legality questioned
(P. T. Jyothi Datta , 21-Jan-2011 , Business Standard)
The writ petition alleges that the Board suffers from a lack of relevant IP expertise and that many of its orders are routinely overturned by High Courts. More...
Writ petition says IP tribunal incompetent
(Khomba Singh , 21-Jan-2011 , The Economic Times)
A group of patent lawyers have filed a writ petition challenging the legality of the countrys highest technical body for intellectual property disputes saying the members are incompetent to hear IP cases. More...
Signature campaign against copyright Bill
(Abhilasha Ojha , 21-Jan-2011 , Livemint)
The objective of the amendment is that opening up of markets without any boundaries or territories for films books and music More...
Changing our tune
(Shamnad Basheer , 21-Jan-2011 , Indian Express)
The Copyright Act protects Indian composers at home but not abroad. More...
Glenmark Pharma gets FDA approval to market generic malaria drug
(PBR Staff Writer , 19-Jan-2011 , PBR Regulatory Affairs)
Glenmark Pharmaceuticals has received US Food and Drug Administration approval for marketing atovaquone amd proguanil hydrochloride tablets to treat malaria. More...
Lincoln Pharma wins patent for NDDS
(BS Reporter / Mumbai/ Ahmedabad , 19-Jan-2011 , Business Standard)
Ahmedabad based Lincoln Pharmaceuticals Limited has received a patent for a Nasal Drug Delivery System in India that helps in arresting or preventing vomiting and nausea that will particularly help in chemotherapy induced nausea. More...
Dont swallow this pill
(Unni Karunakara , 19-Jan-2011 , The Times Of India)
But the Indian press now reports that the PMO under pressure to conclude the deal has asked the concerned government department to reconsider intellectual property provisions it had earlier rejected. More...
Indian Patents Act Undergoes Changes
(ag-IP-news , 18-Jan-2011 , ag-IP-news)
Abu Ghazaleh Intellectual Property announced in a press release that the Department of Industrial Policy and Promotion of the Indian Ministry of Commerce and Industry has published a notification in the official Gazette of India which is a draft of certain rules and does not carry the force of the law as yet these may be called Draft Patent Rules mendment 2010. More...
Trademark patent seekers get access to database
(Vikas Dhoot , 18-Jan-2011 , The Economic Times)
Patent and trademark seekers will no longer have to wait for weeks to get the go ahead for their applications from the governments patent registrar . More...
Glenmark loses patent case to Abbott in US
(PTI , 18-Jan-2011 , The Times of India)
Indian drug firm Glenmark has lost a patent case against US firm Abbott Laboratories over hypertension drug Tarka. More...
Govt probes irregularities in patent given to B Braun
(Thomas K Thomas , 18-Jan-2011 , Business Line)
The Department of Industrial Policy and Promotion has undertaken disciplinary action against top officials of the Patents & Designs office in Chennai for alleged irregularities in granting patent to German medical device maker B Braun for an intravenous device. More...
Indian companies urged to go for IPR
(Special Correspondent , 17-Jan-2011 , The Hindu)
Speakers on Monday said that Intellectual Property Rights could be used as a strategic weapon in the competitive world to prevent its abuse and urged the Indian companies to go for it. More...
Insurer liable till vehicle owners name is in register
(BS Reporter / New Delhi , 17-Jan-2011 , Business Standard)
The companies entered into a Trade Mark Licence Agreement under which the US firm had granted the Indian firm licence to use the trademark Penn for use in certain territories for certain products like golf balls accessories and inflatable balls. More...
Copyright infringements fakes dog FMCG sector
(Viveat Susan Pinto / Mumbai , 14-Jan-2011 , Business Standard)
When US-based Kraft Foods dragged biscuit major Britannia to court last week alleging trademark and copyright infringement of its Oreo brand of cookies many in the fast moving consumer goods industry werent surprised. More...
Govt may limit FDI in pharma sector at 49%
(Rupali Mukherjee , 14-Jan-2011 , The Times of India)
The Indian Patent Law allows product patents for all new molecules which have been patented after the year 1995. More...
Ranbaxy plant a step closer to rehabilitation by US FDA
(Radhieka Pandeya , 14-Jan-2011 , Livemint)
FDA may also want to speed up the process due to the approaching patent expiry of Pfizers blockbuster statin Lipitor said a Mumbai based analyst who didnt want to be named. More...
US to work with India to crackdown on pirated movies API
(PTI , 14-Jan-2011 , The Economic Times)
Observing that both the pirated Bollywood movies and the counterfeit pharmaceuticals have been causing huge financial losses Matthew King Deputy Director Homeland Security Investigations National Intellectual Property Rights Co ordination Center told foreign journalists that such a crackdown would intensify in 2011. More...
Many artifacts of region await GI status
(Binay Singh , 13-Jan-2011 , The Times of India)
In the days to come eastern UP is going to be a hub of GI tagged properties. More...
India needs robust legal framework in order to advance
(Mr Ranjit Shahani , 13-Jan-2011 , Financial Times)
In India some progress has been made in this area following the amendment to the India Patent Act in 2005. More...
Infosys cash dips by 3.77 pc to Rs 14819 crore in Q3
(PTI , 13-Jan-2011 , The Hindu)
Besides during the third quarter Infosys applied for 17 patent applications in India and US. With this Infosys has an aggregate of 270 patent applications in India and the US and has been granted 18 patents by the US Patent and Trademark office. More...
Discontent brews over Darjeeling tea label
(Manisha Pande , 12-Jan-2011 , Business Standard)
The Tea Boards control of the GI tag makes small farmers unhappy. More...
India rejects US companys patent for anti HIV drugs
(NDTV Correspondent , 10-Jan-2011 , NDTV India)
What serves as one of the biggest threats against people living with HIV AIDS is multinational drug companies producing lifesaving drugs pushing for patents so generic companies cannot produce them at much lower prices. More...
Azad calls upon pharma industry to grab US$ 80 billion off patent opportunity
(Our Bureau, Mumbai , 10-Jan-2011 , Pharmabiz)
Union minister of health and family welfare Gulam Nabi Azad called upon the pharma industry in the country to grab the opportunity being unfolded in the wake of around 60 products worth more than a whopping US$ 80 billion going off patent in a couple of years in the US and other regulated markets. More...
Student gets patent for innovative product
(Nikhila Henry , 8-Jan-2011 , The Times Of India)
Kondamudi Swarnarekha a student of BV Raju Institute of Technology is not just another techie in the making. More...
Saving yoga from patents
(Uttara Choudhury , 8-Jan-2011 , DNA)
I had taken my son to a birthday party in Manhattan when an Israeli woman in a flowing kurta gave me a beatific smile and said Yoga is very interesting. More...
Intellectual property
(Madhukar Sabnavis / New Delhi , 7-Jan-2011 , Business Standard)
The film Social Network may be a fictional or realistic account of the creation of Facebook. More...
Dr Reddys to contest Pfizers patent suit
(Press Trust Of India / New Delhi , 6-Jan-2011 , Business Standard)
Dr Reddys Laboratories will contest the patent infringement case filed against it by the global pharmaceutical giant Pfizer over its cholesterol lowering drug Atorvastatin said a company spokesperson today. More...
Kraft sues Britannia over Treat O biscuit being a copy of Oreo cookies
(Ratna Bhushan , 05-Jan-2011 , The Economic Times)
US based packaged food maker Kraft Foods on Tuesday sued Nusli Wadia owned Britannia Industries for trademark and copyright violations of its popular Oreo cookies. More...
Dr Reddys generic version of Lipitor hits Pfizer roadblock in US
(Our Bureau , 5-Jan-2011 , Business Line)
Global pharma major Pfizer has filed a petition in a US court against Dr Reddys Laboratories Ltd for patent infringement on the generic version of atorvastatin which is being sold under the brand Lipitor. More...
Natco seeks Pfizer nod for drug clone
(Khomba Singh , 5-Jan-2011 , The Economic Times)
Pfizer has time till May to reply as Indian patent law allows an innovator company to respond within six months of receiving a notice for voluntary license. More...
Merck KGaA focuses on diabetes in India lines up five products
(C.H. Unnikrishnan , 5-Jan-2011 , Livemint)
While a significantly large population and progressing economy are the key attractions for global drug makers in India a saturated growth and less number of high value and patent protected products for launch in the US and European markets are the other compelling factors that drive them into this market. More...
Microsoft patent to help you date celebrity look alike
(TOI Tech , 04-Jan-2011 , The Times Of India)
Wish you could search for your favourite celebrity look alike on all those online dating sites? More...
Pharma companies are eyeing lucrative biotechnology space
(Debasis Mohapatra & Raghuvir Badrinath / Bangalore , 4-Jan-2011 , Business Standard)
Patent protection on the first batch of biotech drugs that entered regulated markets in the late 1980s is set to expire. More...
Pfizer drags DRL to court over Lipitor copy launch
(Khomba Singh , 4-Jan-2011 , The Economic Times)
Pfizer has taken Dr Reddys Laboratories to court to delay the launch of the Indian drug makers low cost version of atorvastatin in the US market. More...
Trailer Agreement on employees can protect Patents IPs of cos: Dr KC Kankanala
(Nandita Vijay, Bangalore , 4-Jan-2011 , Pharmabiz)
With Indian companies increasingly getting into knowledge oriented cutting edge work patents and Intellectual Property are seen as the logical options to protect their interest not only from competition but also from their own employees. More...
SMEs can benefit from use of IPRs: Expert
(ENS Economic Bureau , 4-Jan-2011 , Finance Buzz)
Intellectual property rights are exclusive legal rights granted to a number of distinct types of intangible assets such as inventions over which a patent can be obtained and words and symbols over which a trademark protection can be sought. More...
Govt may cut FDI to 49 per cent in pharma industry
(Sanjay Singh , 4-Jan-2011 , India Today)
Earlier the PMO had also sent a note based on the recommendations submitted by global drugmakers which seeks key changes such as a legislative review of the Indian patent laws data exclusivity and implementation of patent linkages. More...
The pitfalls of bilateral deals
(4-Jan-2011 , Livemint)
As regards intellectual property rights negotiations with the EU have also brought concerns about intellectual property rights arising in particular from the position that Indias intellectual property laws need to be amended to meet the demands of global pharmaceutical majors. More...
Pharma rides high
(Business Standard / New Delhi , 4-Jan-2011 , Business Standard)
Over the next few years a large number of best selling drugs are going to go off patent in the developed countries offering a golden opportunity for a generics player like India. More...
Inflicting bitter medicine
(4-Jan-2011 , Livemint)
For one they have the potential to prevent technology and intellectual property rights transfers to Indian shores from abroad. More...
Elder Pharma gets Japanese approval for API facility
(Press Trust of India / New Delhi , 3-Jan-2011 , Business Standard)
The company has developed two products going off patent in the Japanese market in 2014. More...
Lupin settles litigation with Japanese firm
(Press Trust of India / New Delhi , 03-Jan-2011 , Business Standard)
Drug firm Lupin today said it has settled ongoing litigation over Lunesta tablets used in treating insomnia with Japan based Dainippon Sumitomo Pharma. More...
India rejects Abbot labs patent application
(Press Trust Of India , 03-Jan-2011 , IBN Live)
India has rejected a drug patent application of a US multi national pharma company paving way for easy access to an important life saving medication for HIV patients across the globe. More...
Indian pharma remains top in US generics
(P B Jayakumar / Mumbai , 3-Jan-2011 , Business Standard)
Generics are reverse engineered cheap versions of branded patented drugs. More...
Govt explores capping FDI in pharma
(C.H. Unnikrishnan , 02-Jan-2011 , Livemint)
DIPP had in September come out with a discussion paper on implementing compulsory licensing provisions in the country to ensure the availability of low cost versions of patented drugs in the country. More...
Three sector picks for 2011
(Outperformer , 02-Jan-2011 , Business line)
Expiring patents of global pharma companies More...
Three sector picks for 2011
(Outperformer , 02-Jan-2011 , Business Line)
Expiring patents of global pharma companies More...
Pharma: On a healthy wicket
(Srividhya Sivakumar , 1-Jan-2011 , Business Line)
The year promises to see a higher generic incursion led by expiring patents and receding product pipelines of global pharma companies. More...
The pharma story: A decade of transition
(P B Jayakumar / Mumbai , 31-Dec-2010 , Business Standard)
India enforced process patent in early 1970 which allowed domestic companies to legally copy and manufacture patented drugs. More...
Pharma: Walking the tightrope between affordability profits
(P.T. Jyothi Datta , 31-Dec-2010 , Business Line)
Also upping the ante of stake holders is a host of FTAs India is getting into and domestic drug industry representatives and health advocacy workers urge the Government to keep intellectual property out of trade negotiations More...
Suven Life Sciences gets two patents for their NCEs
(BS Reporter / Mumbai , 30-Dec-2010 , Business Standard)
Suven Life Sciences a biopharmaceutical company was granted patent for two of its products for their New Chemical Entities for the treatment of disorders associated with Neuro degenerative diseases according to the press release filed with the BSE. More...
Sony slaps patent violation complaint against LG Electronics
(PTI , 30-Dec-2010 , The Economic Times)
Japanese major Sony Corp has filed a patent infringement complaint against rival and South Korean conglomerate LG Electronics related to certain mobile phones and modems. More...
Bollywood producers hope to amicably resolve copyright issue
(IANS , 30-Dec-2010 , SpiceZee)
After deferring their Jan 6 strike Bollywood producers Wednesday hoped to soon resolve the raging controversy over the proposed amendment to the Copyright Act that mandates producers sharing 50 percent of music royalties with lyricists and composers. More...
Innovate or perish
(ET Bureau , 29-Dec-2010 , The Economic Times)
So Indian companies will have to make do with either commoditised tech or proprietary technology that is not premium enough for the holder of its intellectual property to monetise it on its own. More...
UPA bosses step in to solve copyright dispute
(Report , 29-Dec-2010 , DNA)
The government has assured the Indian film industry that its grievances over the copyright amendment bill will be addressed and resolved soon. More...
Biocon is at a strong price disadvantage to global players : Kiran Mazumdar Shaw
(ET Now , 29-Dec-2010 , The Economic Times)
That is absolutely the intention and we are reading ourselves for being able to be ready with our product development upon patent expiration. More...
Clinical drug trials on humans set to become more stringent
(Radhieka Pandeya , 28-Dec-2010 , Livemint)
Thats a big loss of time because the patent clock is already ticking for your product. More...
Pharmexcil urges modern ayurvedic drug units to work together to exploit global markets
(Gireesh P K, Hyderabad , 28-Dec-2010 , Pharmabiz)
The Pharmaceuticals Export Promotion Council has urged the pharmaceutical companies and ayurvedic units in the country to join hands to reap the opportunities available for the ayurvedic drugs in the international market. More...
BHEL & Bharat Electronics two PSUs in top R&D spenders in India
(Vivek and Biswarup Gooptu , 28-Dec-2010 , The Economic Times)
Rao is proud of the fact that in the past year BHEL has filed patent and copyright applications at the rate of one every working day. More...
Markets have a subdued closing
(SI Reporter / Mumbai , 28-Dec-2010 , Business Standard)
And drug firm Venus Remedies gained 1.4% at Rs 269 after receiving patent grants for its antibiotic drug Sulbactomax from Russian and Ukrainian authorities. More...
Local engineer patents new technology for engine efficiency
(Himanshu Bhatt , 27-Dec-2010 , The Times of India)
In a depressing environment of spiraling fuel prices the news that a new technology increases power efficiency of two and four stroke engines by 20 to 40 per cent is very inspiring. More...
Venus gets patent for antibiotic drug from Russia Ukraine
(PTI , 27-Dec-2010 , The Economic Times)
Drug firm Venus Remedies today said it has received patent grants for its antibiotic drug Sulbactomax from Russian and Ukrainian authorities. More...
Patent dissatisfaction
(Business Standard / New Delhi , 27-Dec-2010 , Business Standard)
Indias patent laws allow the patent examiners to delay or reject patent applications if they are satisfied that the application or any specifications or attached documents do not comply with the requirements of the Patents Act or Patent Rules. More...
Engineered in India
(D. Murali , 27-Dec-2010 , Business Line)
Indias low R&D spend in fundamental research lack of global product companies and small spend in IP and patent development need to be addressed to compete with developed markets and China to build the product ideation ecosystem. More...
Suven Life Sciences gets 4 product patents
(Our Bureau , 24-Dec-2010 , Business Line)
Suven Life Sciences Ltd has secured four product patents two each from New Zealand and Eurasia for its new chemical entities. More...
Takeda settles diabetes drug patent suits with 11 generic firms
(BS Reporter / Mumbai , 24-Dec-2010 , Business Standard)
Japans Takeda Pharmaceutical Company has settled patent infringement suits out of court with 11 generic drug companies including Ranbaxy Laboratories Torrent Pharmaceuticals Dr Reddys Laboratories Wockhardt and Aurobindo Pharma over its flagship diabetes drug Actos and its variants. More...
Takeda settles diabetes drug patent suits with 11 generic firms
(BS Reporter / Mumbai , 24-Dec-2010 , Business Standard)
Japans Takeda Pharmaceutical Company has settled patent infringement suits out of court with 11 generic drug companies including Ranbaxy Laboratories Torrent Pharmaceuticals Dr Reddys Laboratories Wockhardt and Aurobindo Pharma over its flagship diabetes drug Actos and its variants. More...
Drug panel to recommend some generics have no brand names
(Radhieka Pandeya , 24-Dec-2010 , Livemint)
Consultative committee wants change to apply to single ingredient generics but move may face legal challenge More...
Insights caFE
(P. Raghavan, Rakesh Basant , 24-Dec-2010 , The Financial Express)
Intellectual Property Protection Regulation and Innovation in Developing Economies: The Case of Indian Pharmaceutical Industry More...
Glenmark Generics gets US FDA approvals for three ANDA
(Our Bureau, Mumbai , 23-Dec-2010 , Pharmabiz)
Earlier this Glenmark entered into a settlement and license agreement with Sepracor to resolve a United States patent infringement suit related to Glenmarks filing an ANDA for Eszopiclone with the US FDA. More...
Protect interest of intellectual property inventors: CSIR
(Press Trust of India / New Delhi , 23-Dec-2010 , Business Standard)
Council of Scientific and Industrial Research Director General Samir K Brahmachari today said the interest of the intellectual property inventors should be protected and not that of investors. More...
USV looks to monetising US patent on kidney drug
(P.T. Jyothi Datta , 23-Dec-2010 , Business Line)
Armed with a patent in the US for its improved version of kidney medicine sevelamer the Rs 1020 crore drug maker USV is evaluating its options to take the product further. More...
Dilip Chhabria Design violated trademark
(Agencies , 23-Dec-2010 , Indian Express)
The Madras High Court has granted an injunction to Hinduja group flagship company Ashok Leyland prohibiting two Bangalore and Mumbai based firms from infringing the registered trademark of the company. More...
First healthcare SEZ to go onstream in Jan 2011
(BS Reporter / Chennai , 23-Dec-2010 , Business Standard)
It has so far bagged two patents along with filings completed for another eight patents with the Indian Patent Office he added. More...
Copywrong!
(Vickey Lalwani , 23-Dec-2010 , Mumbai Mirror)
The government is amending its copyright laws to protect singers and lyricists. More...
Teva settles diabetes drug patent litigation
(Globes' correspondent , 23-Dec-2010 , Globes)
Teva Pharmaceutical Industries Ltd.said today that it reached a settlement on two Type 2 diabetes drugs. More...
Ashok Leyland wins LUXURA trademark infringement suit
(Our Legal Correspondent , 22-Dec-2010 , Business Line)
Chennai based commercial vehicles company Ashok Leyland Ltd which has been making and selling buses and trucks for more than six decades has won a suit filed in the Madras High Court against infringement of its registered trade mark LUXURA by two firms one in Bangalore and the other in Mumbai. More...
Unlike generics biosimilars can thwart Indias copycat kings
(Priyanka Golikeri , 21-Dec-2010 , DNA)
While they remain good at the chemistry of molecular tweaking of patented drugs they seem to have run into a high technology wall when trying to do the same with biologic medicines. More...
Petitions to withdraw GI tags for Darjeeling Tea Tirupathi Laddu
(Vinson Kurian , 20-Dec-2010 , Business Line)
A case for removal of the GI entries seems to have been mounted on the basis of lack of proper credentials of the applicant as rightful owner of GI. More...
Generics Glitter
(BV Mahalakshmi , 20-Dec-2010 , MSN)
The loss of exclusivity for some iconic pharmaceutical brands is bringing in a new wave of innovation. More...
Pharma healthcare grew this year on M&As booster dose
(Munish Shekhavat & Ajay Tyagi / PTI , 18-Dec-2010 , Livemint)
Besides hectic activity on the mergers and acquisitions front the Indian pharma firms had to face hostility from European Union authorities seizing generic drug bound for Africa for alleged patent violations. More...
Sitar legend hails change in copyright law
(TNN , 18-Dec-2010 , The Times of India)
Sitar legend Pandit Ravi Shankar has written to the PM congratulating him on amendments to the copyright law that the government plans to introduce shortly. More...
Patent office to start backlog clearance drive of 3749 pending cases soon
(Suja Nair Shirodkar, Mumbai , 17-Dec-2010 , Pharmabiz)
The Indian patents office has initiated a clearance drive to dispose the backlog of the 3749 applications pending with it on or before July 3 2009. More...
Embrace open source philosophy Kalam tells scientists researchers
(Deepa Kurup , 17-Dec-2010 , The Hindu)
In the wake of the failure of market forces in this sector the OSDD is exploring new models of drug discovery and looking at innovative patent regimes Mr. Kalam said. More...
Generex receives Canadian patent for Buccal drug delivery platform technologies
(Worcester, Massachusetts , 17-Dec-2010 , Pharmabiz)
Generex Biotechnology Corporation announced that it has received a new patent for its Buccal drug delivery platform technologies. More...
New policy for pharma firms
(Special Correspondent , 16-Dec-2010 , Business Line)
Inaugurating a conference on Intellectual Property Right challenges and the way forward for pharmaceutical industry he said the new policy would address issues faced by pharmaceutical companies and ensure availability of drugs at the right price. More...
Nokia is suing Apple in Britain Germany and the Netherlands for allegedly infringing its patents with technology used in the iPhone iPad and iPod Touch.
(Press Association , 16-Dec-2010 , Yahoo News)
The actions add 13 further Nokia patents to the 24 already asserted against Apple in the US International Trade Commission and the Delaware and Wisconsin Federal courts the worlds largest handset maker said. More...
Ranbaxy may be on the road to recovery
(Ranju Sarkar / New Delhi , 16-Dec-2010 , Business Standard)
Ranbaxys stock has shot up by more than 50 per cent in a year thanks largely to these off patent launches. More...
Shah Rukh gets HC go ahead to remake Yeh Jo Hai Zindagi
(Sunil Baghel , 15-Dec-2010 , Mumbai Mirror)
Doordarshans Friday night hit to get a makeover Bombay High Courts interim order rejects copyright complaint filed by writer Sharad Joshis daughter More...
Now Merck sues Hetero Drugs over Finasteride
(BV Mahalakshmi , 14-Dec-2010 , The Financial Express)
Global research driven pharmaceutical company Merck & Co has filed a patent infringement case over the active pharmaceutical ingredient Finasteride against Hyderabad based Hetero Drugs in the United States District Court for the District of New Jersey. More...
Handicrafts of the region aspiring for GI tag
(TNN , 13-Dec-2010 , The Times of India)
After the world famous Banarasi and brocade and handmade carpet some other products with specific distinctions of this region of eastern UP are also looking forward to getting the tag of Geographical Indication. More...
EU pledge to India over generics seizures
(Lynne Taylor , 14-Dec-2010 , Pharma Times)
The European Commission has agreed to amend its customs regulations so that Indian made generic drugs bound for Third World countries will no longer be seized while they are in transit through European countries. More...
More than 20,000 patent applications piled up at Chennai office severe shortage of examiners
(Peethaambaran Kunnathoor, Chennai , 13-Dec-2010 , Pharmabiz)
More than 20000 applications scores of them are from abroad for patent registration for pharmaceutical and biotechnology inventions are pending with the Patent Office in Chennai. More...
Anand Sharma & Karel De Gucht: Partners in trade partners for growth
(Anand Sharma & Karel De Gucht , 13-Dec-2010 , Business Standard)
The EU India Summit last Friday sent a clear signal that the European Union and India are jointly tackling one of the key challenges facing us all: how to find new sources of economic growth. More...
Merck scouting for Indian partners
(Khomba Singh , 13-Dec-2010 , The Economic Times)
What is new is that the number of products going off patent in next 3 5 years is unprecedented. More...
CPI(M): why this veil of secrecy over FTA with EU
(Special Correspondent , 12-Dec-2010 , The Hindu)
The Communist Party of India on Saturday expressed concern over the veil of secrecy around negotiations for the India European Union Free Trade Agreement and re emphasised that the Manmohan Singh government did not have the mandate to conduct parleys on it without discussion within the country. More...
Experts highlight importance of patents for college students
(Abhinav Malhotra , 12-Dec-2010 , The Times Of India)
Saying that India was lagging behind China in terms of patent applications country manager IBM Bhooshan Kelkar also pointed out India was on the 20th spot and China ranked sixth on the list of countries that filed the highest number of patents every year for the innovations made. More...
Farmers’ interest safe in India EU pact says PM
(Sachin Parashar , 11-Dec-2010 , The Economic Times)
Both sides agree that the Intellectual Property Rights chapter will be based on and reflect legislative developments in the EU and India More...
EU India FTA by March 2011
(Varghese K George , 10-Dec-2010 , Hindustan Times)
Negotiations between India and the European Union for a Free Trade Agreement are on track and expected to be concluded by March April 2010 said government sources. More...
Pharma cos opt for designer drugs for better brand recall
(Vishal Dutta , 10-Dec-2010 , The Economic Times)
Pharma companies are experimenting with design to distinguish products from round and rectangular pills sold at drug stores. More...
No compromise on IPR in FTA with EU: Govt
(ENS Economic Bureau , 10-Dec-2010 , Indian Express)
India today made it clear that it will make no compromise on intellectual property rights in the on going India EU FTA talks and emphasised that it will not accept any TRIPS plus commitments as initially mooted by the European Union. More...
EU promises to amend norms on seizure of drugs in transit
(Our Bureau , 10-Dec-2010 , Business Line)
The European Union has assured India that it will amend its regulations on the seizure of drugs in transit to Indias satisfaction while ruling out any such confiscation in the meanwhile. More...
Indian generics to be safe from seizure while passing through EU
(Amiti Sen , 10-Dec-2010 , The Economic Times)
Pharmaceutical exporters can breathe easy as the European Union has finally agreed to Indias demand to amend its Customs regulations to stop confiscation of drugs en route to African and Latin American countries. More...
FTA will hurt livelihoods in India, Europe: civil society
(Special Correspondent , 10-Dec-2010 , The Hindu)
Halt ongoing negotiations says open letter More...
EU India close to solving dispute over drug seizures
(Pallavi Aiyar / Brussels , 9-Dec-2010 , Business Standard)
In the clearest indication from the European Commission yet that a resolution to the ongoing dispute between New Delhi and Brussels regarding generic drug seizures had been reached a senior EC official told reporters on Wednesday that the EU was open to changing the offending regulation. More...
ITPC wants India to remove IP clauses on HIV medicines from EU India trade pact
(Our Bureau, Mumbai , 9-Dec-2010 , Pharmabiz)
The current working text of the agreement still contain clauses on intellectual property protection that go beyond Indias obligations under the WTO TRIPS Agreement. More...
Saldanha hits paydirt with a risky strategy
(PB Jayakumar / Mumbai , 9-Dec-2010 , Business Standard)
Glenmark Generics has first to challenge patent opportunities in the case of about six drugs which are going off patent before 2015 in the US. More...
US looks to India to strengthen co-operation in Ayurveda-Siddha Unani herbal and botanical products of global standard
(Nandita Vijay, Bangalore , 9-Dec-2010 , Pharmabiz)
But the reality is that Indian ASU industry is shrugging away from the data generation and protection of Intellectual Property he added. More...
Generic drugs not on India EU trade talks agenda: Khullar
(Our Bureau , 08-Dec-2010 , Business Line)
The Indian Drug Manufacturers Association had told Business Line recently that intellectual property rights related issues should not form part of the FTA. More...
PM leaves for Brussels tomorrow for India EU summit
(PTI , 08-Dec-2010 , The Times of India)
The differences broadly relate to social issues like environment and labour standards as well as intellectual property rights. More...
Venus completes phase III trials of anti bacterial molecule
(Press Trust of India / New Delhi , 08-Dec-2010 , Business Standard)
The molecule is under patent protection in India China and major markets of the world it added. More...
A powerful push for US firms patent
(C.H. Unnikrishnan , 8-Dec-2010 , Livemint)
US commerce secretary writes to Indias Anand Sharma seeking fair consideration of Gileads appeal for drug patent More...
Mumbai firm wins trademark case against Estee Lauder
(P B Jayakumar / Mumbai , 8-Dec-2010 , Business Standard)
Gufic Biosciences a small cap Mumbai based pharmaceutical company has successfully survived a trademark infringement suit in the Supreme Court filed by US based multinational cosmetic major Estee Lauder. More...
Bid to browbeat judiciary not a new trend: retired HC judges
(A Subramani , 8-Dec-2010 , The Times Of India)
Sitting inside a glass bubble we strain every nerve to decipher grievances ranging from common road problems to complex patent issues. More...
EU pact wont be tighter against drugs
(Asit Ranjan Mishra , 8-Dec-2010 , Livemint)
Indias pharma firms and activist groups have been vociferous opponents of the proposed bilateral pact on the grounds that it will require India to make a so called TRIPS plus commitment More...
India, EU reach consensus on TRIPS imbroglio
(Nayanima Basu / New Delhi , 8-Dec-2010 , Business Standard)
Decision to be mentioned in the text of the FTA. More...
Oxycodone boost
(Nitin P Shrivastava , 8-Dec-2010 , DNA)
The stock of Glenmark Pharma has been on a roll driven by improving revenue visibility on account of robust growth in its domestic formulations business and strong product pipeline in the US generic market. More...
EU pact wont hurt generics
(Amiti Sen , 8-Dec-2010 , The Economic Times)
The proposed India EU trade and investment agreement will not curtail Indias right to produce and export cheap life saving medicines. More...
The Mint Report for 07 December 2010
(8-Dec-2010 , Livemint)
Generic drug sales may be safe from trade deal with the EU Air India to finally get fresh bailout funding bank stocks drag down Indian bourses More...
India EU Trade Agreement expected to be ready early 2011
(PTI , 07-Dec-2010 , The Economic Times)
An ambitious Trade and Investment Agreement between India and European Union that could help in increasing bilateral trade by about 40 per cent to touch 100 billion Euros is expected to be finalised early next year. More...
Drug cos want IP issues kept out of pact with EU
(P.T.Jyothi Datta , 7-Dec-2010 , Business Line)
Domestic drug makers are worried that Indias proposed Free Trade Agreement with the European Union would give away more than is beneficial to the country and its pharmaceutical industry. More...
Pharmexcil CIPI to work together to promote pharma exports of SMEs
(Suja Nair Shirodkar, Mumbai , 7-Dec-2010 , Pharmabiz)
The Pharmaceuticals Export Promotion Council of India and Confederation of Indian Pharmaceutical Industry have decided to join hands to work together on promoting of pharma exports of SMEs. More...
Brain League launches reference manual on Indian Patent Law & its Practice
(Our Bureau Bangalore , 07-Dec-2010 , Pharmabiz)
Brain League has launched a reference manual on Indian Patent Law & its Practice. More...
Protecting trade secrets
(Anurag K Agarwal / New Delhi , 6-Dec-2010 , Business Standard)
Violations of business and intellectual property rights are on the rise and pose a huge challenge to corporations and innovators. More...
Reduce software piracy to boost economy create new jobs
(PTI , 05-Dec-2010 , The Economic Times)
Lack of awareness about Intellectual Property Rights and threats posed by pirated software as well as rapid growth of consumer PC markets such as India and China have resulted in increasing software piracy. More...
India regulators need to inspect Chinese production facilities before imports: Dr G.G Nair
(Peethaambaran Kunnathoor, Chennai , 4-Dec-2010 , Pharmabiz)
Indian regulatory authorities should insist on inspection of Chinese manufacturing premises for GMP GLC standards as they do in the case of Indian drug manufacturers said Dr Gopakumar G Nair Patent Attorney & Advisor Pharmexcil. More...
Brainvisa case: Court partly rejects discharge plea
(Ashish Jadhav & Sandip Dighe , 4-Dec-2010 , DNA)
All the five accused are being prosecuted for the offence under section 406 420 to read with 34 of the Indian Penal Code 1860 and section 65 66 of the Information Technology Act 2000 and section 63 63 B of the Indian Copyright Act 1957. More...
Complete formalities on Novartis patent claim: SC
(PTI , 03-Dec-2010 , The Economic Times)
The Supreme Court on Friday directed the Centre pharma major Cipla Ranbaxy Lab Hetero Drugs Natco Pharma and others to complete their pleadings in the matter of Swiss firm Novartis AG challenging denial of patent for its blood cancer drug Glivec. More...
SC quashes Bayer petition to block Cipla generic drug
(Khomba Singh , 2-Dec-2010 , The Economic Times)
The countrys top judicial authority has dismissed German pharmaceutical firm Bayer AGs attempt to block Indian drug regulator from allowing Mumbai based Cipla Ltd to launch a low cost version of its patented cancer medicine . More...
Products built on Indian innovations flowing into world markets
(Kala Vijayraghavan, Lijee Philip and N Shivapriya , 2-Dec-2010 , The Economic Times)
Julia Roberts embracing Hinduism may not exactly be the best case study for reverse innovation but 20 years after yoga and ayurveda went global a medley of products built on Indian innovations are slowly finding their way into world markets. More...
Stay Focussed
(01-Dec-2010 , The Times Of India)
On occasion the issue is patents. More...
EU offers out of WTO settlement on drug seizure row
(Press Trust of India / New Delhi , 1-Dec-2010 , Business Standard)
The Government today said the EU wants to settle the row over seizure of Indian generic drugs by some European Union members without involving WTO. More...
India to dominate world generic market
(Agencies , 01-Dec-2010 , Indian Express)
India and China are all set to dominate the global generic off patent drugs market as low manufacturing and R&D cost would prompt key pharma players to set up their base here a report said. More...
Awareness about HIV yes but what of claims?
(Ashish Jadhav , 01-Dec-2010 , DNA)
On May 2 2007 he had advertised in a prominent daily in Pune saying he had a patent for the treatment in India and Africa. More...
India China set to dominate global generic market: Report
(PTI , 1-Dec-2010 , MSN)
India and China are all set to dominate the global generic off patent drugs market as low manufacturing and R&D cost would prompt key pharma players to set up their base here a report said. More...
Stepped up talks revive hope of India EU FTA
(Pallavi Aiyar / Brussels , 30-Nov-2010 , Business Standard)
With the pressure on for the European Union and India to come up with a significant announcement at the upcoming EU India summit on December 10 a flurry of activity surrounding the ongoing negotiations for a bilateral free trade agreement is giving momentum to the process. More...
Analysts see $250 millon revenues from Ranbaxys Aricept deal
(Our Bureau , 30-Nov-2010 , DNA)
Ranbaxy Laboratories can earn $230-250 million in revenues in the next six months from the US following approval of its off patent version of Alzheimers medicine Aricept by the US Food and Drug Administration say analysts. More...
Protecting innovation
(Lalit Bhasin , 29-Nov-2010 , The Economic Times)
The link between economic growth and innovation is by now well established. More...
Pharma pains not over more revamp on anvil
(Report , 29-Nov-2010 , DNA)
In their latest quarter Pfizer AstraZeneca Eli Lilly laxoSmithKline and Roche reported sales that were hurt by generics and their shares fell signalling their valuations may not have the patent loss impact fully baked in. More...
Immunitor Awarded the Key U.S. Patent Related to Oral Vaccine Technology Platform
(press release , 29-Nov-2010 , Market Watch)
Immune Network Ltd. advises that its potential acquisition Immunitor USA Inc. has been issued a key patent by the U.S. Patent and Trademark Office. More...
CEAT Ltd acquires global rights of Brand CEAT from Pirelli
(PTI , 29-Nov-2010 , The Economic Times)
Pirelli is the owner of the Ceat trademark in the rest of the world. More...
Ranbaxy gets nod for Alzheimers drug
(Radhieka Pandeya, , 29-Nov-2010 , Livemint)
Ranbaxy Laboratories Ltd Indias largest pharmaceutical company by revenue has received the US drug regulators nod to launch its generic version of Pfizer Inc. and Eisai Co. Ltds Alzheimers drug Aricept two people familiar with the development said. More...
Venus gets patent for Vancoplus in South Africa New Zealand
(PTI , 29-Nov-2010 , The Economic Times)
Drug firm Venus Remedies today said it has received patents in South Africa and New Zealand for its product Vancoplus used in treatment of bacterial infections. More...
80% Kullu shawls have made in Ludhiana stamp
(Dinker Vashisht , 29-Nov-2010 , Indian Express)
India had argued at the World Trade Organisation forum that since the basmati variety was endemic to India and Pakistan only these two countries could be allowed a patent it. More...
PhRMA signs cooperation agreement with Chinese pharma assn SINO PhIRDA
(Joseph Alexander, New Delhi , 29-Nov-2010 , Pharmabiz)
After expressing reservations on the regulatory environment and patent laws of India the Pharmaceutical Research and Manufacturers of America representing the powerful multinationals has now tied up with Chinese pharma industry by signing a cooperative framework. More...
Free trade pact with EU making good progress
(Nayanima Basu / New Delhi , 29-Nov-2010 , Business Standard)
Negotiations for the ambitious free trade agreement between India and the 27 nation economic bloc of the European Union are likely to be wrapped up by early next year. More...
Time to patent the Kalenjin champagne
(Lotuliangelech Domolina , 29-Nov-2010 , The Standard)
Over the years Kenya has produced excellent athletes who have excelled in global competitions with the latest being world record holder David Rudisha. More...
Dr Reddys expands horizon
(Ujjval Jauhari / Mumbai , 27-Nov-2010 , Business Standard)
Entry into the penicillin segment would help: the aim is to be further achieved by new launches in low competition products as well as patent challenge ones. More...
Panel for key changes to copyright Bill
(C.H. Unnikrishnan , 26-Nov-2010 , Livemint)
Aparliamentary standing committee headed by Oscar Fernandes which reviewed the proposed Copyright Bill 2010 has suggested key changes in draft amendments based on the feedback it has received. More...
The US model of private health insurers is inefficient expensive
(TNN , 26-Nov-2010 , The Times of India)
I am not against intellectual property. More...
India EU pact wont be ready before Dec summit
(Asit Ranjan Mishra , 26-Nov-2010 , Livemint)
Negotiations have really not taken speed on crucial issues like government procurement intellectual property rights labour standard and sustainable development she said. More...
Blockbusters set to witness new order
(Rupali Mukherjee , 26-Nov-2010 , The Times of India)
While some companies such as Dr Reddys Glenmark Pharmaceuticals and Biocon have fast tracked their research in biosimilars off patent biotech drugs others like Cipla have tied up with Chinese companies to make a foray in the highly complex but fast growing segment. More...
Facebook to patent the word face?
(AGENCIES , 25-Nov-2010 , The Economic Times)
It may sound ridiculous at first but Facebook is planning to trademark the word face because it wants to stop other companies using the term in a way which damages its own brand. More...
Tying the Indo US trade knot
(T S Vishwanath / New Delhi , 25-Nov-2010 , Business Standard)
From a US perspective the important issues would be in the area of intellectual property rights besides other areas such as greater market access in some areas that India may consider sensitive. More...
New GSK plant in US poses multiple challenges to Dr Reddys
(C.H. Unnikrishnan , 25-Nov-2010 , Livemint)
GSK has taken a hit on market share and profitability of the brands after they lost patent protection a few years ago. More...
Oracle wins $1.3 bn from SAP in copyright case
(Bloomberg / San Francisco , 25-Nov-2010 , Business Standard)
Oracle Corp won a $1.3 billion jury verdict against rival SAP AG the worlds largest maker of business application software for copyright infringement by a now defunct software maintenance unit. More...
Healthy portfolio driving profits
(Ram Prasad Sahu / Mumbai , 25-Nov-2010 , Business Standard)
This means that injectables do not face the sharp price erosion as is the case with oraldrugs when products go off patent thus allowing for better margins. More...
US trade representative finds fault with India China intellectual property regimes
(C.H. Unnikrishnan , 24-Nov-2010 , Livemint)
The US trade representative has expressed concern at shortcomings in the intellectual property rights regimes of both China and India when it comes to investment in pharmaceuticals while noting improvements put in place by both Asian countries. More...
Film producers get leg up on copyright row
(Charu Sudan Kasturi , 24-Nov-2010 , Hindustan Times)
The HRD ministry should remove a proposed amendment of the Copyright Act allowing film directors to jointly own movies along with producers the Parliamentary standing committee on HRD has said. More...
Channels get I-T notice over deductingtoo little tax
(Khushboo Narayan & Anushree Chandran , 24-Nov-2010 , Livemint)
Further it is the channel that deducts taxes on IPR intellectual property rights licensed to them and not YRF. More...
Art of the royalty
(RISHIKESH BAHADUR DESAI , 23-Nov-2010 , The Hindu)
Bidri art has gained the Geographical Indication tag to certify that this product cannot be made anywhere else except Bidar. More...
Advair Poses Generics Hurdle
(JEANNE WHALEN , 22-Nov-2010 , The Wall Street Journal)
As Patent Nears End Glaxo Blockbuster Asthma Drug Is Proving Tough to Copy More...
Pharmaceutical Industry Is Facing Biological Warfare
(HESTER PLUMRIDGE , 22-Nov-2010 , The Wall Street Journal)
It is a new battle for the drugs industry and it will be hard fought. More...
Surats rich Zari craft gets Geographical Indication status
(Press Trust Of India , 22-Nov-2010 , Hindustan Times)
After Tangaliya the grand and glittering centuries old Zari making craft of Surat district in Gujarat has been granted Geographical Indication status offering it the much needed succour from infringement. More...
Claris Lifesciences Rs.300 crore IPO to open on November 24
(Our Bureau, Mumbai , 22-Nov-2010 , Pharmabiz)
All of its products are off patent products a significant majority of which are capable of being directly injected into the body and are predominantly used in the treatment of critical illnesses. More...
Sun Pharma loses generic challenge in US court
(Joe C Mathew / New Delhi , 22-Nov-2010 , Business Standard)
Sun Pharmaceutical Industries has lost an opportunity to launch the generic version of a schizophrenia drug that had generated revenue of $4 billion in the United States market in 2009. More...
New centre to help city students file patents
(Snehal Rebello , 21-Nov-2010 , Hindustan Times)
When Jayesh Varavadekar and his classmate Prathamesh Wadekar filed their first patent for a biofuel product last year they spent a month trawling through scientific databases to ensure the product was indeed a first. More...
Fight against HIV virus to don green hues
(Shimona Kanwar , 22-Nov-2010 , The Times Of India)
A patent has been filed as this is the first such compound which has shown a protection rate of 78.17% against the HIV virus the standard percentage is 89.75. More...
Dr Reddys gets USFDA nod
(Express news service , 21-Nov-2010 , Indian Express)
Drug firm Dr Reddys Laboratories on Saturday said it has received approval from US health regulator to launch generic Zafirlukast tablets used for treating asthma in the American market. More...
TVS asked to show it didnt infringe patent
(C.H. Unnikrishnan & Shally Seth , 20-Nov-2010 , Livemint)
A division bench of the Madras high court last week asked TVS Motor Co. Ltd to prove that the technology used in its Flame brand of motorcycles did not infringe on a patent held by Bajaj Auto Ltd. More...
Estee Lauder loses Cliniq trademark case
(Indu Bhan , 20-Nov-2010 , The Financial Express)
The Supreme Court on Friday rejected global cosmetics major Estee Lauders trademark infringement case against Gufic. More...
Karnataka DC cautions SMEs over new regulatory challenges in global markets
(Nandita Vijay, Bangalore , 20-Nov-2010 , Pharmabiz)
Changing dynamics in the global pharma scenario are expected to post serious challenges to the Indian small & medium enterprises players in future. More...
Hey you copy cat!
(20-Nov-2010 , Deccan Chronicle)
One can charge the accused with regards to the Indian Copyright Act 1957 but there needs to be solid proof and this is very difficult when it comes to creative fields. More...
Estee Lauder loses Cliniq trademark case
(Indu Bhan , 20-Nov-2010 , The Financial Express)
The Supreme Court on Friday rejected global cosmetics major Estee Lauders trademark infringement case against Gufic. More...
Indian IT firms look West for patents
(Swati Garg / Kolkata , 17-Nov-2010 , Business Standard)
At a time when the debate on intellectual property rights has taken centre stage globally current Indian patent laws have ensured an outflow of innovation and ownership registration in the information technology sector. More...
Hyderabad Haleem gets geographical copyright
(16-Nov-2010 , MSN News)
Haleem a famous and nutritious dish available in Hyderabad during Ramadan has been awarded geographical copyright. More...
Vidarbha rice innovator gets recognition after 20 long years
(Report , 16-Nov-2010 , DNA)
Experts say the least the government could do now is help him protect his intellectual property. More...
Meet to provide insight into European patenting norms
(TNN , 16-Nov-2010 , The Times Of India)
Experts from European countries will provide their perspectives on the European patenting norms with reference to information technology and automobile sector at an event at the National Chemical Laboratory here on Tuesday at 3.30 pm. More...
Copyright and Patent
(Dr Anu Vaidyanathan , 15-Nov-2010 , Business Line)
A look at the tradeoffs in the software context. More...
As of now India not for WTO dispute body on drug row with EU
(Press Trust of India / New Delhi , 15-Nov-2010 , Business Standard)
On an indication that the drug seizure dispute with the European Union would be resolved has not sought setting up of a settlement body in the World Trade Organisation Parliament was informed today. More...
Ind Swift Labs registers 74% growth in PAT for Q2 of FY 2010 11
(Announcement / Corporate , 15-Nov-2010 , Business Standard)
Ind Swift Laboratories Limited one of Indias leading pharma company reported growth of 74% in net profit for the quarter ended September 30 2010. More...
Big pharmas Brazilian prescription
(Andrew Jack , 14-Nov-2010 , Financial Times)
Mr Pedrosa is seeking regulatory approval for seven products combining low cost off patent drugs. More...
Royalty issue in software
(Mohan R Lavi , 13-Nov-2010 , Business Line)
In a critical judgment the Delhi Tribunal ruled that the income received for supply of software is assessable as royalty under Section 91 vi in the hands of MSS as a copyright subsists in a computer programme and it is also a literary as also a scientific work. More...
Workshop on post GI intervention starts
(TNN , 12-Nov-2010 , The Times Of India)
It may be mentioned here that the Banarasi saree and brocade got the GI status on September 4 2009. More...
Amitabh to move court against copyright infringement
(Indo-Asian News Service , 12-Nov-2010 , Hindustan Times)
Bollywood megastar Amitabh Bachchan seems to be irked by constant copyright infringements and the illegal use of his name for the promotion of products. More...
Lambretta to seek claim from SCL
(Press Trust of India , 12-Nov-2010 , Indian Express)
Italian two wheeler maker Lambretta Consortium on Thursday said it will seek claim of over euro10 million from Scooters India Ltd following a favourable court order in Europe regarding their trademark infringement dispute. More...
Ranbaxy Q3 net jumps to Rs.313 cr on surging sales
(AGENCIES , 12-Nov-2010 , The Times of India)
Valacyclovir an anti herpes drug was a first to file has the right to the grant of a patent for the invention product of the company in the USA. More...
Cong MP cautions govt against more takeovers of Indian pharma cos by MNCs
(Ramesh Shankar, Mumbai , 12-Nov-2010 , Pharmabiz)
Dr Mirdha who is a members of the Parliamentary Standing Committee on Health & Family Welfare reminded the government through her letter that the domestic industry reached the current state of development due to a variety of policy formulations in early 70s such as FERA drug policy process patents etc. More...
Climbing Mount Publishable
(Global science , 11-Nov-2010 , The Economist)
They spent the most published the most and patented the most. More...
EU patent talks end in deadlock
(Nikki Tait in Brussels , 11-Nov-2010 , Financial Times)
Europe was urged by senior politicians and officials to break the political deadlock over a single European Union wide patent regime after ministerial talks failed on Wednesday night. More...
Knowledge on IPR should reach all levels
(Express News Service , 11-Nov-2010 , Express Buzz)
Anyone can create wealth by their own innovations and continuous improvements which will ultimately improve productivity said N R Madhava Menon while inaugurating the national seminar on IPR in the Knowledge Era organised jointly by the Institute of Management in Kerala and the Kerala State Council for Science Technology and Environment at the Science and Technology Museum. More...
CSMCRI in talks with oil companies for manufacturing bio diesel
(Sohini Das / Mumbai/ Ahmedabad , 10-Nov-2010 , Business Standard)
We have recently been granted the US patent for our technology and now we can share our intellectual property rights with an interested party who can manufacture the jatropha based bio diesel on a larger scale informed P K Ghosh director of CSMCRI which has been producing bio diesel on a small scale so far. More...
Green Technology Patent Program Extended for 1 Year by U.S
(Susan Decker , 10-Nov-2010 , Bloomberg)
The U.S. Patent and Trademark Office is extending by one year its program that expedites review of applications for inventions intended to improve the environment and reduce greenhouse gas emissions. More...
Cadila Pharma Files For Seventy Patents In The Us
(BUSINESS STANDARD , 10-Nov-2010 , Business Standard)
Cadila Pharmaceuticals Ltd has applied for 70 product patents in the United States. More...
Global regulatory agencies bogged down by staff shortage to oversee patent expiry drugs
(Nandita Vijay, Bangalore , 10-Nov-2010 , Pharmabiz)
With patent expiry drugs expected to reach record levels in the near future global regulators are expected to vet increased number of applications and their task could only expected to get humongous as these agencies are unable to hire additional manpower to shoulder sudden surge in workload. More...
Exemption Rules To Be Included In Dpco 2002
(BUSINESS STANDARD , 10-Nov-2010 , Business Standard)
According to the new DPCO a copy of which is with the Business Standard the production of a new drug patented under the Patents Act 1970 and not produced elsewhere if developed through indigenous research and development for a period of 15 years from the date of commencement of its commercial production in the country can be exempted from the Order. More...
DuPont to focus on agri energy saving
(Shubham Mukherjee , 10-Nov-2010 , The Times Of India)
Though Dupont Indias R&D centre is yet to receive a patent it has nine applications in the pipeline. More...
An Indian Microsoft or Google is inevitable
(Sujit John , 10-Nov-2010 , The Economic Times)
Within global technology enterprises the youth enthusiasm in their India centres is translating into these centres contributing the most towards potentially patentable ideas. More...
Takeda Pharma says no interest in generic drug mkt
(Ju-min Park , 10-Nov-2010 , Reuters)
In late October Takeda Pharmaceutical reported a 12 percent decline in first half profit as a key drug lost patent protection but it lifted its full year earnings outlook as a stronger yen helped cut overseas costs. More...
India to soon ink trade agreements with Japan European Union
(Priyanka Golikeri & Sreejiraj Eluvangal , 09-Nov-2010 , DNA)
Fresh from an exhilarating visit by US president Barack Obama that created much good will on both sides India seems keen to push its advantage as far as it will go. More...
Corporatised piracy new bug in MS play
(NYT News Service , 9-Nov-2010 , The Economic Times)
As long as intellectual property is the lifeblood of this company we have to go protect it Mr Finn says More...
Public interest groups ask Centre to reject lobbying by Obama administration against generics
(Joseph Alexander, New Delhi , 9-Nov-2010 , Pharmabiz)
Public interest groups in India have called upon the Centre to strongly reject the lobbying by the Obama administration and its industry organisation the US India Business Council against the production of safe effective and affordable generic medicines in India. More...
Glenmark moves closer to HIV drug launch
(ET Bureau , 9-Nov-2010 , The Economic Times)
Indian drugmakers have mastered developing low cost version of off patent drugs and Crofelemer would be the countrys first new drug if it is successfully launched. More...
Develop IPR regime for incremental innovation: Pitroda
(Our Bureau , 9-Nov-2010 , Business Line)
There is a need to develop a global Intellectual Property Rights regime that encourages incremental innovation said Mr Sam Pitroda Advisor to the Prime Minister of India on Public Information Infrastructure and Innovations More...
Glenmark moves closer to HIV drug launch
(ET Bureau , 9-Nov-2010 , The Economic Times)
Indian drugmakers have mastered developing low cost version of off patent drugs and Crofelemer would be the countrys first new drug if it is successfully launched. More...
EU states to push for single patent regime
(Nikki Tait in Brussels , 08-Nov-2010 , Financial Times)
The push to establish a single European Union wide patent regime is set to gain momentum as a group of EU countries asks Brussels to consider introducing the measure even if all 27 member states do not sign up. More...
Patently strategic
(Chitra Narayanan , 8-Nov-2010 , Business Line)
A patent is not just a protective tool but a good business strategy for tech driven or knowledge driven entrepreneurs. More...
Amitabh Bachchan to get copyright
(Mail Today , 8-Nov-2010 , India Today)
The Bachchan baritone is all set to go exclusive. More...
All eyes on Obamas healthcare resolve
(P.T. Jyothi Datta , 8-Nov-2010 , Business Line)
While patents allow a patent holder exclusive monopoly on the product for 20 years a CL allows governments to break the patent and allow a third party to make the same medicine. More...
Chasing pirates: Inside Microsofts war room
(Ashlee Vance, New York Times , 07-Nov-2010 , NDTV)
As long as intellectual property is the lifeblood of this company we have to go protect it More...
Legal support to free and open source software projects
(T. Ramachandran , 07-Nov-2010 , The Hindu)
SFLC will bring to notice violations of licence terms More...
CellTrusts Sean Moshir Responds to Indian Government's Plans for Proxy SIM Cards for Secure Communication
(Lora Friedrichsen , 5-Nov-2010 , PR NewsWire)
CellTrust Corporation the recognized leader in mobile secure messaging and secure applications for mobile phones responded today to the recent announcement by the Indian government that it plans to create guidelines and regulations for using proxy SIM cards for secure communication in the country. More...
Brazil India and South Africa call for flexibility on compulsory drug licensing
(5-Nov-2010 , The Pharma Letter)
Brazil India and South Africa joined forces to reject pressure for the extension of intellectual property rights and called for effective use of flexibilities such as compulsory licensing. More...
Breaking news: IPO releases revised manual of patent practice & Procedure (MPPP).
(07-Nov-2010 , Indian Patent Office)
The Manual is divided into 21 chapters and 3 schedules which represent areas subject to regulation by the IPO. More...
EU issues note to address drug seizure concerns of India
(Amiti Sen , 4-Nov-2010 , The Economic Times)
The European Union has offered fresh suggestions to prevent wrongful confiscation of Indian generic drugs during transit through European countries a move that hints at its seriousness about settling the issue. More...
The upside of plagiarism and why copying isnt going to die
(R Jagannathan , 4-Nov-2010 , DNA)
IPR intellectual property rights is a relatively recent development probably less a few hundred years old. More...
Trade grows but hurdles remain
(Asit Ranjan Mishra , 4-Nov-2010 , Livemint)
Anwarul Hoda professor at the Indian Council for Research on International Economic Cooperation said in a probable free trade agreement between the two sides the high standards that the US may demand in the fields of intellectual property rights labour and environment may be difficult for India to comply with. More...
Drug research heads to Asia as local markets boom
(Ben Hirschler , 3-Nov-2010 , Reuters)
Asian drugmakers traditionally reliant on manufacturing bulk ingredients and making cheap generic medicines are these days pouring money into researching their own products as well as mounting risky patent challenges against brand name drugs. More...
Patent should revert to research firms: Ghulam Nabi Azad
(Vineeta Pandey , 02-Nov-2010 , DNA)
Union health minister Ghulam Nabi Azad feels public funded patents of Indian research organisations which have been sold to Indian private sector companies should go back to the organisations of these companies are taken over by multinationals More...
A Singapore sling
(2-Nov-2010 , Hindustan Times)
The government enacted the Indian Patents Act in 1970. More...
Azad for Revisiting FDI Norms in Pharma Sector
(2-Nov-2010 , Outlook)
He said that the Indian Drugs and Cosmetics Act does not recognise data exclusively and patent linkage. More...
Why European Union seizes Indian drugs
(U S Bhatia , 01-Nov-2010 , Rediff)
Indias status as the pharmacy of the world is at stake says U S Bhatia. More...
Business method patents
(Anu Vaidyanathan , 1-Nov-2010 , Business Line)
Bottom line with innovation is in the patent and IP portfolio.. More...
Parliamentary panel finds 10 to 12 Indian pharma cos seriously into new drug discovery research
(Our Bureau, New Delhi , 1-Nov-2010 , Pharmabiz)
The Parliamentary Standing Committee on Chemicals and Fertilisers assessed that the research and development in the Indian pharma industry was picking up and at least 10 to 12 leading companies are into new drug discovery now. More...
Click through license
(Chanpreet Khurana , 01-Nov-2010 , Indian Express)
But if we are to create a level playing field for Indian technology products companies we need to give them that intellectual property rights or IPR protection. More...
Old knowledge to get India money
(Chetan Chauhan , 31-Oct-2010 , Hindustan Times)
India has already established Traditional Knowledge Digital Library where over 2000 sources have been digitised to check patent of this knowledge in the western world. More...
Nagoya Protocol a big victory for India
(Priscilla Jebaraj , 31-Oct-2010 , The Hindu)
In order to bring the American companies into the ramifications of this agreement the U.N.s Convention on Biological Diversity must be linked to the World Trade Organisations intellectual property agreement. More...
Micromax loses its Bling brand name
(Gulveen Aulakh & Harsimran Julka , 31-Oct-2010 , The Economic Times)
The Delhi High Court has restrained Indias second largest mobile phone brand Micromax from selling or advertising one of its largest selling women oriented mobile phones Bling as it acceded to a trademark violation filed by Delhi based mobile phone maker Bling Telecom. More...
India makes case against ACTA at WTO meet
(BS Reporter / New Delhi , 30-Oct-2010 , Business Standard)
India has made a strong case against Anti Counterfeit Trade Agreement a new international treaty being framed by a group of developed nations in the annual meeting of the World Trade Organizations Council for Trade Related Aspects of Intellectual Property Rights held in Geneva on October 27. More...
Biocon to invest $161 mn in Malaysia
(ET Bureau , 30-Oct-2010 , The Economic Times)
Biosimilars are similar acting copies of original biologic medicine and can enter the market when the originals go off patent they are said to cost much less than the innovator drugs. More...
Poscos patented proposal pipped ArcelorMittal
(Shubhashish / Mumbai , 30-Oct-2010 , Business Standard)
The reason why the Union steel ministry preferred a joint venture between government owned Steel Authority of India Ltd and Koreas Posco in preference to a similar proposal from ArcelorMittal the worlds largest producer in the sector was technology. More...
Why EU seizes Indian drugs
(U S Bhatia , 30-Oct-2010 , Business Standard)
Indias status as the pharmacy of the world is at stake More...
The right medicine
(SWATI PIRAMAL , 29-Oct-2010 , The Financial Express)
Many big pharma companies are facing a patent cliff and on the flip side new drug approval by regulators like USFDA is much more expensive and takes longer. More...
India EFTA FTA likely by year end
(PTI , 29-Oct-2010 , IBN Live)
India and European Free Trade Association comprising Switzerland Iceland Norway and Liechtenstein are likely to firm up a free trade agreement by end of the year. More...
Curbing broadcast signal piracy
(PN Vasanti , 29-Oct-2010 , Livemint)
The Geneva based World Intellectual Property Organization has for long been grappling with the issue of signal piracy and the rights of broadcasting organizations to address it. More...
Juicy bites from Washington
(Rasheeda Bhagat , 29-Oct-2010 , Business Line)
In China too weve faced problems but they had to with intellectual property rights people copying our labels stickers logos More...
Curbing broadcast signal piracy
(MINT , 29-Oct-2010 , IndiaInfoline )
The Geneva based World Intellectual Property Organization has for long been grappling with the issue of signal piracy and the rights of broadcasting organizations to address it. More...
The great patent battle
(The Economist , 28-Oct-2010 , Indian Express)
History buffs still wax poetic about the brutal patent battles a century ago between the Wright brothers and Glenn Curtiss another aviation pioneer. More...
New border measures
(T S Vishwanath , 28-Oct-2010 , Business Standard)
The developed worlds new focus on IPR safeguards and fossil fuel subsidies is sparking fresh concerns in developing nations. More...
India takes lead for guiding developing countries to drive WHO focus on public health instead of IPR
(Joseph Alexander, New Delhi , 28-Oct-2010 , Pharmabiz)
India has taken the lead to get together a number of generic drug producing nations to call for better definitions to ensure quality strengthening of regulatory authorities in the respective countries and bringing focus of the world to public health instead of intellectual property. More...
Glenmark profit rises on India US sales
(C.H Unnikrishnan , 28-Oct-2010 , Livemint)
A first to file generic drug offers market exclusivity for at least six months for a generic company in the US where the law permits a low cost drug to enter the market soon after the expiry of the inventors patent protection. More...
Italian luxury brand Canali strikes the Indian chord
(Moinak Mitra , 27-Oct-2010 , The Economic Times)
It could well be the next geographical indication if the Canali family has its way. More...
Rich reluctant to pay for medicines biodiversity deal stuck
(Patent Firm in Pune , 26-Oct-2010 , Sify)
The issue of these firms patenting what has been traditional knowledge in developing countries for centuries has been an emotive one in India since attempts to patent Basmati rice neem and turmeric hit the headlines. More...
US lobbying for strong IPR regime in India
(PTI , 26-Oct-2010 , The Economic Times)
The US is lobbying for an intellectual property rights regime in India that protects American patents a senior official of the Obama Administration said on Tuesday. More...
PhRMA changes stand on generics says generics cannot be termed as spurious
(Joseph Alexander, New Delhi , 26-Oct-2010 , Pharmabiz)
Toning down its earlier stand on counterfeit drugs issue the Pharmaceutical Research and Manufacturers of America has categorically spelled that the generic medicines cannot be branded as spurious and intellectual property rights issue cannot be mixed up with generic drugs. More...
Obama aide rosy on Indo US trade
(HT Correspondent , 26-Oct-2010 , Hindustan Times)
Kumar who previously headed the worldwide consumer pharmaceuticals business of Johnson & Johnson said there were still some gaps in Indias patent regime although India has done a fabulous job compared to some other countries. More...
Registry moved for removal of GI tag for Tirupati Laddu
(Vinson Kurian , 26-Oct-2010 , Business Line)
An application has been registered with the Geographical Indications Registry seeking removal of the entry pertaining to Tirupati Laddu GI. More...
Tamil writer claims copyright to Enthiran plot
(Express News Service , 26-Oct-2010 , Express Buzz)
Producing copies of the printed text of both publications as proof Tamilnadan urged the police to file a criminal complaint under section 63 of the Indian Copyrights Act. More...
With drugs costing Rs9 lakh should govt invoke compulsory licensing?
(Priyanka Golikeri , 25-Oct-2010 , DNA)
With patented medicines for treatment of HIV AIDS cancer and hepatitis C beyond the reach of many patients due to their exorbitant prices some say there is a case for invoking the provision of compulsory licensing. More...
Cleaning Up the Patent Office
(Nilofer D'Souza , 25-Oct-2010 , Forbes India)
To seed innovation and attract more patent applications India needs an efficient system. More...
Multinationals seeking to control global farming
(Joydeep Gupta , 25-Oct-2010 , Sify)
The gene giants are stockpiling patents that threaten to put a choke hold on the worlds biomass and our future food supply. More...
Biopiracy the new threat to global food supply
(IANS , 25-Oct-2010 , Zee News)
A handful of multinational corporations are pressuring governments to allow what could become the broadest and most dangerous patent claims in history warned the group while releasing a report on the subject at the UN Convention on Biodiversity being held here Oct 18 29. More...
SENSIO Granted Patent in India
(press release , 25-Oct-2010 , MaketWatch)
SENSIO Technologies Inc. today announced that the Indian Patent Office has granted patent no. 242873 covering the SENSIO S2D Switch. More...
Ranbaxy Dr. Reddys Cadila look attractive: Jitendra Sriram HSBC
(ET Now , 25-Oct-2010 , The Economic Times)
The patent expiry cycle is probably going to peak out till another two years out so you will have a lot of drugs which are coming off patent which offers a wide potential for Indian pharma to actually go out and sell in the developed world. More...
Hepatitis B patent brings Asia to BigDNA
(Andrew Bolger, Scotland Correspondent , 24-Oct-2010 , The Financial Times)
BigDNA a Scottish developer of vaccines has been granted a patent in Japan to tackle a disease that could provide access to a huge market in Asia. More...
Obamas visit to Mumbai: Filled with symbolism and business
(Our Bureau , 24-Oct-2010 , Business Line)
But business ties between the two countries are not without concerns the recent anti outsourcing sentiments in the information technology sector and pro Intellectual Property Rights efforts in the pharmaceutical sector to name a few. More...
Higher margins boost Dr Reddys ne
(Mobis Philipose , 24-Oct-2010 , Livemint)
According to Motilal Oswals estimates the stock trades at 31.1 times core earnings estimated for this year and 25.5 times FY12 earnings after adjusting for the DCF value of the upsides from patent challenges low competition opportunities in the US and the impact of bonus debentures. More...
Drug patents
(Govind Diwakar , 23-Oct-2010 , Business Line)
This is with respect to the article on drug patent laws. More...
Trouble ahead as US hints at tighter norms for generics
(ET Bureau & Agencies , 23-Oct-2010 , The Economic Times)
Generic or off patent drugs constitute a major chunk of Indias Rs 40000 crore exports of medicines. More...
Scaled down Acta will still hurt Indian pharma’
(ENS Economic Bureau , 23-Oct-2010 , Indian Express)
An American expert on intellectual properties conceded that even a scaled down version of the Anti Counterfeit Trade Act will make Indian pharmaceutical companies presence difficult to maintain in the international marketplace. More...
Form bloc to oppose new patent regime advises legal guru
(ET Bureau , 23-Oct-2010 , The Economic Times)
India should join forces with other developing countries at the World Trade Organisation to oppose the stringent intellectual property regime being framed by a number of developed countries which could affect exports of generic drugs and software from the country a top legal expert has said. More...
Strong IPR rules must to bring funds: Big Pharma
(fe Bureau , 23-Oct-2010 , The Financial Express)
With around a fortnight to go before Presidentbegins his visit to India USbased pharma giants have warned that New Delhi could lose out in the acute global competition in attracting investment from them if the country refuses to strengthen regulatory protection for patented drugs. More...
PhRMA objects to compulsory licence idea shows concern over enforcement of patent laws
(Joseph Alexander, New Delhi , 23-Oct-2010 , Pharmabiz)
Expressing concerns on many fronts including pending cases of patents in Indian courts and compulsory licence issue the Pharmaceutical Research and Manufacturers of America has urged the Government to create a conducive environment for innovation so that India does not miss out the opportunities in the global competition. More...
PM to meet Wen in Hanoi amid rising tensions
(Elizabeth Roche , 23-Oct-2010 , Livemint)
It covers almost 90% of trade and a vast gamut of services investment intellectual property rights customs and other trade related issues. More...
Measures to derive maximum benefits of GI tag discussed
(TNN , 22-Oct-2010 , The Times Of India)
The seminar was on post GI registration of handmade carpet of Bhadohi. More...
Consumer pharmaceuticals
(22-Oct-2010 , Financial Times)
But as many big selling drugs near the end of their lives the patent cliff has made chief executives rush to diversify away from big name drugs. More...
Rejuvenating Strategic Partnership
(Richard Fontaine , 22-Oct-2010 , The Times Of India)
It should raise its caps on foreign investment enhance its rules for protecting patents and other intellectual property and reduce barriers to defence and other forms of trade all of which would allow a major expansion in the bilateral economic relationship. More...
Govt may make registration of drug brands mandatory
(Khomba Singh , 21-Oct-2010 , The Economic Times)
Delhi based lawyer Prathiba Singh said the Supreme Court had given an order around ten years ago asking the national drug regulator and the trademark office to coordinate registration of drug brands to prevent the confusion. More...
Why drug patents are needed
(Ananda Chakrabarty , 21-Oct-2010 , Business Line)
India has been reluctant to liberalise pharma patent laws losing out on innovation. More...
Indias n bill deviates significantly from global standards
(PTI , 21-Oct-2010 , The Economic Times)
Deal with the problem of intellectual property rights violations Burns said. More...
NGOs, experts seek PM's intervention for imposition of FDI cap of 40% in pharma sector
(Ramesh Shankar, Mumbai , 21-Oct-2010 , Pharmabiz)
In an open letter to prime minister Dr Manmohan Singh the health interest groups and experts expressed the apprehension that the the purpose of the Pharmaceutical Research and Manufacturers of America visit is to discourage the Indian government from applying a cap on FDI in the pharma sector and from issuing compulsory licenses for patented medicines. More...
US drug lobby to meet key govt officials this week
(Joe C Mathew / New Delhi , 21-Oct-2010 , Business Standard)
In a joint response on September 29 PHRMA and its European counterpart had said that a policy to encourage compulsory licences on intellectual property would be counter productive for the domestic drug industry. More...
Attack of the biosimilars
(Pharmaceuticals , 21-Oct-2010 , The Economist)
Although biotech based drugs account for only a fifth or so of global drugs sales they are projected to grow at double digit rates as sales of many conventional drugs decline especially with a large number of patent expirations coming. More...
MNCs set to maximize opportunities as Indian pharma gears up to unlock its inherent strength
(Nandita Vijay, Bangalore , 21-Oct-2010 , Pharmabiz)
In collaboration with Strides Arcolab Pfizer commercializes 40 off patent sterile injectables and oral products in the regulated markets. More...
Medicis says Genzyme sues for patent infringement
(Krishnakali Sengupta in Bangalore , 20-Oct-2010 , Reuters)
Medicis Pharmaceutical Corp said Genzyme Corp had sued it in a U.S. court over its wrinkle treatments accusing Medicis of patent violation. More...
India accounts for only 17% of patent applications globally
(Our Bureau , 20-Oct-2010 , Business Line)
The total number of patents filed in 2010 is likely to touch 40000 of which only 17 per cent account for Indian applications. More...
India sees generic drugs row with EU being settled
(Jonathan Lynn , 20-Oct-2010 , Reuters)
India believes a row with the European Union over seizures of generic drugs will be settled without litigation Trade Minister Anand Sharma said on Wednesday. More...
Indian ayurvedic body slams Colgate for patenting lal dant manjan
(Sagar Malviya & Maulik Vyas , 20-Oct-2010 , The Economic Times)
Lal dant manjan may make many Indians remember the old Dabur commercial featuring a schoolboy named Raju and his Masterji. More...
Traditional Knowledge Digital Library an effective deterrent against biopiracy
(Our Bureau , 20-Oct-2010 , Business Line)
In September 2007 Brazilian firm Ache Laboratories had filed for a patent at the European Patent Office for using grape to treat diabetes obesity and hypertension. More...
Celgene sues Natco Pharma over cancer drug
(Our Bureau , 20-Oct-2010 , Business Line)
Celgene Corporation has filed a lawsuit against Natco Pharma in a US court in connection with the latters filing of an abbreviated new drug application seeking approval to market Lenalidomide Capsules. More...
Pfizer deal highlights Biocons R&D strength
(Srividhya Sivakumar , 20-Oct-2010 , Business Line)
With leading products in this space lined up for patent expiry from 2015 Biocon would stand to benefit significantly from the alliance due to Pfizers marketing strength and worldwide reach. More...
Free online trademark search likely from next month
(PTI , 19-Oct-2010 , MSN)
An entrepreneur wanting a trademark now will be able to search the registry online without any cost whether a particular symbol or design is available and not booked already. More...
PM warns against aping development model of advanced nations
(PTI , 19-Oct-2010 , The Hindu)
Inaugurating the annual meeting of the Academy of Sciences for the Developing World here Singh said the sharing of intellectual property rights was a major a roadblock in collaborative research efforts for commercial applications. . More...
Syndax Pharmas Entinostat receives UK patent
(Waltham, Massachusetts , 19-Oct-2010 , Pharmabiz)
The patent covers the polymorph representing a preferred stable form of entinostat with key claims covering the polymorph form B and the manufacturing process by which it is derived. More...
Biocon Pfizer in $350 million insulin marketing deal
(Our Bureau , 19-Oct-2010 , Business Line)
Biocon already sells insulin and Glargine in the country and is developing two more analogues Aspart and Lispro which go off patent in 2015 and 2017. More...
Pfizer Biocon: Catapulting local alliances into a different league
(P.T. Jyothi Datta , 19-Oct-2010 , Business Line)
The deal to commercialise four of Biocons bio similar insulins reflects Pfizers aggressive outsourcing strategy searching as it is for good bets even as its blockbuster cholesterol drug Lipitor stares at patent expiry later next year. More...
Venus drug gets patent approval from Australia and Ukraine
(PTI , 18-Oct-2010 , MSN)
Drug firm Venus Remedies today said Australian and Ukrainian patent authorities have granted patents for its research product Potentox used in treating pneumonia and febrile neutropenia. More...
Safe Trials
(BV Mahalakshmi , 18-Oct-2010 , MSN)
The other issue of focus is on the need to protect intellectual property of companies which is acquired after years of research. More...
Lupins patent settlement may set new trend in out of court deals
(BS Reporter / Mumbai , 17-Oct-2010 , Business Standard)
Bags right to sell another drug that was not even part of the litigation. More...
Bio drugs a blessing but need regulation
(Shobha John , 17-Oct-2010 , The Times of India)
By 2016 many bio pharmaceuticals will come off patent worldwide and India Brazil and China sense a huge opportunity to manufacture and sell bio similars which reportedly have similar properties. More...
MNCs coming to India to settle copyright cases : SC Judge
(17-Oct-2010 , Hindustan Times)
Many multi nationals are finding India an attractive destination for initiating legal action in regard to Intellectual property rights because of reasonable costs of litigation and speedy disposal of cases according to Supreme Court judge Justice Dalveer Bhandari. More...
India seeks to protect bio diversity at Nagoya meet from October 18
(Urmi Goswami , 17-Oct-2010 , The Economic Times)
As the world faces its worst losses of animal and plant species negotiators from over 190 countries will be meeting in Nagoya Japan between October 18 to 29 to reach an agreement to protect the diversity of the earths natural resources. More...
Measures to tackle bio piracy: Safeguards for Indias traditional medicine and knowledge
(Ketki Angre , 16-Oct-2010 , NDTV)
Not too long ago, India almost choked at the thought of our very own basmati being someone elses patent. More...
India to align copyright norms with global standards
(IANS , 15-Oct-2010 , The Economic Times)
India will align its copyright regulations with international norms to curb rising piracy and violations of intellectual property rights. More...
Wockhardt places its French arm under safeguard proceedings
(Press Trust of India / New Delhi , 15-Oct-2010 , Business Standard)
The company also said earlier it had lost patent protection Diacerin an antiinflammatory analgesics and antipyretic drug through a court challenge it said. More...
India to pitch for comprehensive biodiversity pact
(PTI , 15-Oct-2010 , IBN Live)
India today said it would pitch for a comprehensive protocol to preserve biodiversity and insist on inclusion of human genetic resource and entire value chain of derivative of bioresource in such a document. More...
Infosys applies for 18 patent applications in Q2
(PTI , 15-Oct-2010 , The Economic Times)
Domestic IT major Infosys Technologies today said it has applied for 18 patent applications for its different products and services in India and the US during the second quarter ended September 30 2010. More...
India raises drug seizures issue
(Utpal Bhaskar , 15-Oct-2010 , Livemint)
Proposed EAC legislation does not make a clear distinction between generic and counterfeit drugs More...
National Innovation Foundation spots innovation award winners
(Kinjal Desai , 15-Oct-2010 , DNA)
This year for the first time during the award ceremony students who are going to receive the awards will also get a patent form filled for their ideas. More...
GSK to make India a hub for anti parasite drugs
(BS Reporter / Mumbai , 15-Oct-2010 , Business Standard)
Global drug makers supply select off patent drugs as charity to various WHO programmes against neglected diseases. More...
MSMEs must innovate to grow: Survey
(fe Bureau , 15-Oct-2010 , The Financial Express)
The survey says in order to achieve the Intellectual Property rights policymakers have to be sensitised. More...
Knock Out saved the punch by Bombay high court will be released in theatres today
(Mayura Janwalkar , 15-Oct-2010 , DNA)
After a legal battle that stretched beyond court hours Knock Out the Sanjay Dutt starrer which Hollywood studio 20th Century Fox had charged with copyright infringement will be released in theatres on Friday. More...
Remixing song doesnt amount to copying: Delhi high court
(Kanu Sarda , 14-Oct-2010 , DNA)
In a major relief to music companies which are often pulled up for copyright issues Delhi high court has said that the remixed version of a song does not come under the Copyright Act. More...
Warner Chilcott settles patent dispute with Lupin
(The Associated Press , 14-Oct-2010 , Bloomberg)
Warner Chilcott PLC said Thursday they will settle a pending patent lawsuit over Warners birth control Loestrin 24 and Femcon FE with Lupin Ltd. More...
DIPP paper: Compulsory licence is good for public health say domestic pharma firms
(P.T. Jyothi Datta , 14-Oct-2010 , Business Line)
CLs can ensure patent rights do not prevent access to affordable medicine. More...
Judge watches films to decide if rip off slur valid
(Mayura Janwalkar , 14-Oct-2010 , DNA)
In a case of copyright infringement alleged by 20th Century Fox justice Roshan Dalvi asked the representatives of the litigating parties to be present at the high courts video conference room on Wednesday evening where she would watch Phone Booth and Knock Out. More...
Enertopia Partially Owned Partner Files Additional Patent Applications
(TheNewswire , 14-Oct-2010 , Market Watch)
Enertopia Corporation is pleased to announce that its partially owned clean energy partner Global Solar Water Power Systems has filed additional patent applications in order to safeguard certain intellectual property. More...
Apple gets anti sexting patent
(IANS , 14-Oct-2010 , The Economic Times)
Apple has been granted a patent that allows parents to prevent their children from sending and receiving sexually explicit text messages. More...
Pfizer sues Lupin on anti epilepsy drug
(fe Bureau , 13-Oct-2010 , The Financial Express)
The US based global pharmaceutical giant Pfizer Inc has filed a second suit against Mumbai based drumaker Lupin in the US alleging that the latter by attempting to manufacture a generic version of oral solution with pregabalin is infringing the formers patent coverage on its branded drug Lyrica. More...
India may move WTO as it seeks to resolve EU dispute
(C.H. Unnikrishnan , 13-Oct-2010 , Livemint)
Commerce secretary says consultation process is still on but India reserves right to seek settlement panel More...
Leap from lab idea to business venture NCL paves the way
(Pupul Chatterjee , 13-Oct-2010 , Indian Express)
Apart from starting a company many scientists are also exploring the possibility of possessing intellectual property rights and patents and then licensing them out to already existing commercial houses for projects that may have the potential to be converted into business ideas. More...
Some good news on generics
(Biswajit Dhar , 13-Oct-2010 , Livemint)
Two recent instances of international diplomacy provide relief to Indian firms that manufacture generic drugs More...
GI tag a boost for Uppada sarees
(K Rajani Kanth / Uppada (andhra Pradesh) , 12-Oct-2010 , Business Standard)
The intellectual property right has given weavers a fresh lease of life with the commercial leverage to enhance their incomes More...
WTO and Indian economy
(U. SANKAR , 12-Oct-2010 , The Hindu)
The World Trade Organisation was created on January 1 1995 to promote world trade. More...
Reviving Doha
(Business Standard / New Delhi , 12-Oct-2010 , Business Standard)
A trade deal can provide a new stimulus More...
Eli Lilly sues Dr Reddys over cancer drug patent
( KV Ramana , 12-Oct-2010 , DNA)
Eli Lilly the US pharma giant has sued Dr Reddys Laboratories over an alleged patent infringement involving Gemzar. More...
A regressive idea on patents
(11-Oct-2010 , Livemint)
Ideas such as compulsory licensing of patents mooted by the government has the potential to derail Indias reputation as a market that values and protects innovations More...
India positive on resolution of drug seizure row with EU
(PTI , 11-Oct-2010 , The Economic Times)
India is optimistic about resolution of drug seizure dispute with European Union but reserves the right to seek redressal from the WTO in case the mutual talks do not yield results a senior official said on Monday. More...
Nearly 250 NGOs across world urge PM to reject IP provisions in FTA with EU
(Joseph Alexander, New Delhi , 11-Oct-2010 , Pharmabiz)
Hundreds of public interest groups across the world have jointly urged prime minister Manmohan Singh not to sign the proposed free trade agreement with European Union as the Centres role in medicines supply is under threat due to the intellectual property provisions included in the pact. More...
HC rejects Fulford plea against United Biotech Oscar Remedies
(Sanjay K Singh , 11-Oct-2010 , The Economic Times)
The Bombay high court has dismissed the plea of US drug giant Schering Plough and its India arm Fulford India seeking injunction against United Biotech and Oscar Remedies from using the trademark Netmicin alleging it infringes upon the trademark Netromycin used for its antibacterial drug. More...
Biotechnology stuck in IP warp
(Ananda Chakrabarty , 10-Oct-2010 , Business Standard)
The Indian governments approach to intellectual property rights in the biotechnology sector remains old fashioned More...
Trouble Stays: 40 nations nearing pact on generics seizure
(Khomba Singh , 9-Oct-2010 , The Economic Times)
The drug seizure agreement with the European Union may be an eyewash as another international treaty will allow 40 countries to seize in transit generic medicines. More...
SME NGOs urge for policy measures to ensure issue of compulsory licences
(Joseph Alexander, New Delhi , 8-Oct-2010 , Pharmabiz)
With the debate on the compulsory licensing gathering momentum after the Department of Industry Policy and Promotion brought out a concept paper small scale pharma sector and the NGOs reiterated their demand for policy measures to introduce the same. More...
Build patents regime on fortified law
(Shamnad Basheer & Prashant Reddy , 07-Oct-2010 , The Economic Times)
In a move with significant ramifications for policy making and participatory democracy the ministry of commerce recently threw open the issue of compulsory licensing for public debate. More...
DIPP rejects MNC firms suggestions on patent law
(Joe C Mathew / New Delhi , 7-Oct-2010 , Business Standard)
The Department of Industrial Policy and Promotion has rejected all suggestions made by the multinational drug majors lobby group Organisation of Pharmaceutical Producers of India before the Prime Ministers Office in August More...
Motorola sues Apple for patent violation
(Indo-Asian News Service , 07-Oct-2010 , Hindustan Times)
Motorola has sued Apple for allegedly violating 18 of its patents relating to wireless email antenna design and other technologies used in the companys iPhone and iPod touch devices. More...
India EU dispute on drug seizure resolved
(PTI , 07-Oct-2010 , The Hindu)
India on Thursday said it has resolved a dispute with European Union over seizure of Indian generic drugs by some European countries and will soon withdraw a complaint filed before the WTO on the matter. More...
Biocon shares rise on Pfizer drug deal report
(REUTERS , 07-Oct-2010 , The Economic Times)
Emerging markets are a priority for Western drug companies such as Pfizer as they face slowing sales in their home markets and cheap off patent drugs that can be sold in high volumes under a multinational brand are an attractive market opportunity. More...
HIV+ people lead protests against India EU negotiations on free trade agreement
(Joseph Alexander, New Delhi , 07-Oct-2010 , Pharmabiz)
With India and European Union moving into the final stages of framing the Free Trade Agreement and launching the crucial round of negotiations here a group of public interest organisations and the activists of Delhi Network of Positive People stepped up the campaign against the harmful provisions in the pact. More...
Pharma protests Indian licensing proposal
(Tracy Staton , 07-Oct-2010 , Fierce Pharma)
The Indian pharmaceutical industry has been shaken up lately worried that multinational drugmakers will come in and completely take over their drug market. More...
Apple Motorola Google TiVo Rambus Teva MGA: Intellectual Property
(Ellen Rosen , 07-Oct-2010 , Bloomberg)
A Motorola Inc. unit sued Apple Inc. alleging the maker of the iPad computer tablet and iPhone mobile phone is infringing six of its patents. More...
Activists decry India EU IPR talks
(TNN , 6-Oct-2010 , The Times Of India)
Delhi Network of Positive People is staging a mass demonstration in front of Udyog Bhavan on Wednesday to protest against the inclusion of intellectual property provisions in the EU India free trade agreement which they fear will affect peoples access to affordable HIV AIDS drugs. More...
No interim relief to BharatMatrimony owners in claim against Google others
(Legal Correspondent , 6-Oct-2010 , Business Line)
Case relates to complaint on trademark infringement. More...
Google Seeks Dismissal Of Oracle Patent Infringement Suit
(Scott Morrison , 05-Oct-2010 , The Wall Street Journal)
Google Inc. has fired back at Oracle Corp. denying all seven of the software makers claims of infringement on patents and copyright and arguing that Oracle is now attacking open source licensing policies it used to support. More...
AstraZeneca sues Torrent for patent violation in US
(fe Bureau , 5-Oct-2010 , The Financial Express)
Global pharma giant AstraZeneca has sued Ahmedabad based Torrent Pharma for allegedly infringing its patent coverage related to schizophrenia drug Seroquel XR in the US market. More...
For Reddys Zyprexa is a half billion $ opportunity
(KV Ramana , 5-Oct-2010 , DNA)
Dr Reddys Laboratories is likely to see a major upside coming its way in the form of olanzapine a drug to treat schizophrenia and bipolar disorder. More...
Copycat incentives
(Bibek Debroy , 5-Oct-2010 , Indian Express)
In 2006 we had a Mashelkar Report on patent law issues. More...
ADMA seeks clarification on Rule 158 (B) treating herbal extracts as ayurvedic drugs
(Suja Nair Shirodkar , 5-Oct-2010 , Pharmabiz)
Puranik informed that the amended rule refers that the patent and proprietary drugs would now be allowed to be registered as either nutraceauticals cosmetics or ayurvedic extracts. More...
Microsoft sues Motorola for alleged patent infringement
(PTI , 03-Oct-2010 , The Times of India)
Microsoft Corp has said that it has sued handset maker Motorola Inc for allegedly infringing on the software gaints nine patents in its Android smartphones. More...
The time to cross our own Mason Dixon Line has come
(DEAN WILLIAMS , 03-Oct-2010 , DNA)
The fact that it would eventually become a divide that separated the two warring US ideologies of the abolitionists and slavers was foreseen but only by a fringe. More...
India to move WTO panel against EU
(Nayanima Basu / New Delhi , 1-Oct-2010 , Business Standard)
India may formally approach the World Trade Organizations dispute panel against the European Union following the seizure of low cost generic medicine consignments in European ports meant for other developing countries. More...
Tata Steel bags process technology patent may out license to rival cos
(Rakhi Mazumdar , 1-Oct-2010 , The Economic Times)
Tata Steel has bagged a commercial patent on a widely used for developing iron at steel plants. More...
US research funder licenses HIV patent
(Andrew Jack in London , 1-Oct-2010 , Financial Times)
The largest US funder of medical research has licensed the patent rights on an HIV medicine it helped develop to an international agency a move designed to make treatments more widely available and affordable in the developing world. More...
Performance enhancing drugs for your portfolio
(Ram Prasad Sahu / Mumbai , 30-Sep-2010 , Business Standard)
Rising share in the US generics market and off patent opportunities should benefit top Indian drug makers. More...
Copyright society sends notice to malls auditorium
(TNN , 30-Sep-2010 , The Times of India)
Two malls and an auditorium in the city have been served legal notices by the Indian Performing Rights Society for refusing to pay licence fees before playing music at events to be organised between October 1 and 3. More...
i2india to invest Rs 40 cr in commercialising ideas
(BS Reporter / Mumbai , 30-Sep-2010 , Business Standard)
i2india Holdings Ltd. a company jointly promoted by Tata Sons and Imperial Innovations Plc. of UK among others will invest over Rs 40 crore in the next few months to create commercial value from IPR in India. More...
Kunnath Pharma gets patent for its Musli Power X tra
(Our Bureau, Chennai , 30-Sep-2010 , Pharmabiz)
Kunnath Pharmaceuticals of Moovattupuzha in Kerala has been granted a patent by the Patent Controller of India for its product Musli Power X tra sources from the company informed Pharmabiz. More...
T S Vishwanath: Safeguards against Doha
(T S Vishwanath , 30-Sep-2010 , Business Standard)
The South South trade issue raised by some nations may steer negotiations away from development objectives More...
Nycomed seeks damages from Sun Pharma Teva
(REUTERS , 29-Sep-2010 , The Economic Times)
Unlisted Swiss drugmaker Nycomed is seeking for a patent infringement of Pantoprazole from Indias Sun Pharmaceuticals and Tel Aviv listed an official said on Wednesday. More...
Solvay to open research centre in Guj
(PTI , 29-Sep-2010 , IBN Live)
The centre will focus on high performance polymers organic chemistry nano composite biotechnology and green chemistry and will also host high level competences in the field of science technology patent regulation and procurement Solvay groups region general manager Asia Pacific Roger Kearns said on the ground breaking ceremony of the centre to be worth Rs 45 crore More...
India protests against US trade barriers at WTO
(PTI , 29-Sep-2010 , The Economic Times)
India at today protested against escalating tariff and non tariff barriers imposed by the on Indian goods and services including enhanced visa fee on Indian short term services providers and the ban in Ohio on state outsourcing projects. More...
Department expedites recruitment for IP office
(C.H. Unnikrishnan , 29-Sep-2010 , Livemint)
The move comes after criticism that the IP office is overloaded with work leading to compromises on quality More...
1 million HIV patients in India have no access to treatment
(Press Trust Of India , 28-Sep-2010 , Hindustan times)
Compulsory licensing enables a national government to revoke a license issued to a patent holder and thereby allow other parties to produce and sell a patented product for non commercial purposes. More...
Venus bags contract for anti cancer drug from Thailand
(Press Trust of India / New Delhi , 28-Sep-2010 , Business Standard)
Pharma firm Venus Remedies today said it has bagged a contract from Thailand for an anti cancer drug Docetaxel under the government policy. More...
Gadwal saree gets GI status
(Express News Service , 28-Sep-2010 , Express Buzz)
Gadwal saree now figures in the patented items list after getting the Geographical Indication certificate. More...
Pharmexci's Outstanding Export Performance Awards given to 12 pharma majors 24 cos got patent awards
(Our Bureau, Chennai , 28-Sep-2010 , Pharmabiz)
The Outstanding Export Performance Awards and Patent Awards for 2009 10 instituted by the Pharmaceuticals Export Promotion Council were presented to leading pharma companies in a ceremony organized by the Pharmaexcil as part of Pharma CEOs conclave in Hyderabad last week. More...
Pratt & Whitneys case against Rolls
(Jeremy Lemer , 28-Sep-2010 , Financial Times)
Pratt & Whitney the jet engine maker has filed a lawsuit against Rolls Royce claiming that its British rival has tried to use patent litigation to thwart some of its most critical engine programmes. More...
Punjab Govt warns against unauthorised use of national emblem
(PTI , 28-Sep-2010 , IBN Live)
The spokesman said that no person shall use the national emblem for the purpose of any trade business and profession or in the title of any patent or in any trademark or design. More...
US NGO pushes for Eli Lillys second patent for cancer drug
(Khomba Singh , 27-Sep-2010 , The Economic Times)
A Washington-based NGO has appealed a US court to reverse its order rejecting Eli Lillys second patent for its blockbuster cancer drug Gemzar that could delay the launch of Sun Pharmas generic version in the worlds largest pharma market. More...
CIIs growing proximity with USIBC raises concern among public interest groups
(Ramesh Shankar, Mumbai , 27-Sep-2010 , Pharmabiz)
The Confederation of Indian Industry association with US India Business Council in organizing a Round Table in Delhi on Compulsory Licensing has come in for severe criticism from the public interest groups and experts as they argue that the USIBC has been a vocal opponent of the health safeguards in Indias patent law. More...
India EU take another step towards FTA
(Pallavi Aiyar / Brussels , 25-Sep-2010 , Business Standard)
Intellectual property rights is one of these. More...
Indian pharma alive and kicking
(ET Bureau , 24-Sep-2010 , The Economic Times)
Globally the pharma sector is seeing consolidation with generic players growing bigger and companies driven by patents too getting into generics. More...
Lupin aims for biotech growth; first drug in 2011
(Sachin Kumar , 24-Sep-2010 , Hindustan Times)
Having emerged as a strong player in the global generics market pharmaceuticals major Lupin is now eyeing the biotechnology sector. More...
YouTube wins Spanish copyright case
(Alan Rappeport in New York , 23-Sep-2010 , Financial Times)
A Spanish federal court has dismissed copyright infringement charges against Googles YouTube that could have brought the online video service to a halt by forcing it to monitor every piece of content. More...
Court asks Matrix not to sell generic of Roches cancer drug
(Khomba Singh , 23-Sep-2010 , The Economic Times)
The Madras High Court has asked Hyderabad based Matrix Laboratories not to make or sell the generic version of Swiss major Roches cancer drug erlotinib hydrochloride for the next two months. More...
With the door to Doha closed India opens up windows to the world
(Nayanima Basu / New Delhi , 23-Sep-2010 , Business Standard)
Seeing no progress on the stalled multilateral trade talks potential partners are keen on bilateral pacts with India. More...
Tuning in to GI Blues
(Bachi Karkaria , 23-Sep-2010 , The Times Of India)
Along with Paithanis and Tellicherry pepper lets patent our peculiar peoples traits? More...
HC rejects BMS plea on sale of hepatitis B generic by Ranbaxy
(Khomba Singh , 23-Sep-2010 , The Economic Times)
The Delhi High Court has turned down Bristol Myers Squibbs request to temporarily stop Ranbaxy from selling its generic version of the American firms patented hepatitis B drug Baraclude in India. More...
Celebrities may soon endorse Banarasi silk
(TNN , 23-Sep-2010 , The Times of India)
The handwoven Banarasi saree and brocades got the Geographical Indication tag last year. More...
SC asks HC to resolve Montblanc ADD pen dispute in 3 mnths
(PTI , 23-Sep-2010 , MSN News)
The Supreme Court has directed the Delhi High Court to decide the dispute between German luxury brand Montblanc Simplo GMBH and Mumbai based Add Corporation over trademark infringement within 3 months. More...
Discover the world of IP management
(PATHFINDER , 23-Sep-2010 , Deccan Herald)
Individuals with a degree in physics or any other science subject are at an advantage in the field of Intellectual Property Rights More...
Ranbaxy drug gets US nod
(ET Bureau , 22-Sep-2010 , The Economic Times)
Ranbaxy Laboratories got the exclusive rights to market a generic version of Japanese firm Eisais blockbuster Alzheimers drug in the US for six months starting November end which could potentially earn around $200 million for the company. More...
T Series not affected by copyright royalty
(Ashish Sinha , 22-Sep-2010 , The Financial Express)
T Series is confident to continue generating revenues from the FM radio broadcasters despite the drastic reduction of the music royalty rates recently. More...
Suven Life Sciences gets 2 new US patents
(REUTERS , 21-Sep-2010 , The Economic Times)
Suven Life Sciences said on Tuesday it has won U.S. patents for its two new chemical entities pushing its shares up more than 11 per cent. More...
Merck arm sues Sun over cancer drug
(P B Jayakumar / Mumbai , 21-Sep-2010 , Business Standard)
Schering Corporation part of multinational pharma company Merck & Co and London based Cancer Research Technology Ltd have sued Sun Pharmaceutical for allegedly infringing patent rights on the worlds largest selling brain cancer drug Temodar. More...
India EU drug row heading towards long drawn battle in WTO
(PTI , 20-Sep-2010 , The Economic Times)
Row over seizure of Indian generic drugs by several European countries on the high sea appears to be heading towards a long drawn battle in the WTO as the two sides could not resolve the issue by consultations. More...
Now Africa siding with India in generics battle
(Amiti Sen , 20-Sep-2010 , The Economic Times)
After a high pitch awareness campaign by India leading African nations Uganda Tanzania and Nigeria are reconsidering provisions of their proposed stringent anti counterfeit legislations that would have hampered pharmaceuticals exports to these countries. More...
Drug marketing approvals may be delinked from patent status
(Radhieka Pandeya , 20-Sep-2010 , Livemint)
If the demand is accepted DCGI will issue approvals only on grounds of drug quality and efficacy More...
SC issues notices to Ranbaxy in Capsola trademark case
(PTI , 20-Sep-2010 , The Economic Times)
The Supreme Court on Monday issued notices to Ranbaxy and three others on a petition filed by life sciences and laboratory solutions firm RFCL in a dispute over the trademark for animal feed supplement Capsola. More...
Drug problem
(editorial , 20-Sep-2010 , Indian Express)
Over a 16 month period that ended just over a year ago European Union customs officials seized about 20 shipments of Indian generic drugs as they were passing through various European ports especially Amsterdam and Hamburg while going to Africa and Latin America. More...
Goas Feni gets a makeover marketed abroad
(Smitha Venkateswaran , 17-Sep-2010 , The Economic Times)
Goans now have one more reason to say cheers. More...
When drugs are faked
(P.T. JYOTHI DATTA , 17-Sep-2010 , Business Lines)
There is no escape from implementing anti counterfeiting measures besides hurting the image of the industry and the country. More...
Commerce Ministry to seek Cabinet nod soon for Indo Japan trade pact
(PTI , 16-Sep-2010 , The Economic Times)
The Commerce Ministry will seek the Cabinets approval soon for the India Japan free trade agreement likely to be signed during the Prime Minister Manmohan Singhs forthcoming visit to Tokyo in October. More...
India Brazil to call for dispute settlement panel against EU
(D Ravi Kant , 16-Sep-2010 , MSN News)
India and Brazil are expected to press ahead with a request for establishment of a WTO dispute settlement panel to adjudicate over the seizure of generic drugs on high seas by EU member countries that allegedly violated global trade rules trade diplomats said. More...
CEPA with Japan lacks transparency: Farmer groups
(ET Bureau , 16-Sep-2010 , The Economic Times)
A common platform of several farmers groups the Indian Coordination Committee of Farmers Movements has charged the Central government with complete lack of transparency on the implications of the proposed Comprehensive Economic Partnership Agreement or CEPA with Japan and the inclusion of agriculture on its agenda. More...
India sends 80% of AIDS drugs to poor nations
(Rema Nagarajan , 16-Sep-2010 , The Times of India)
A new study published on Tuesday has established that Indian generic manufacturers supplied more than 80% of donor funded AIDS medicines to developing countries in the last seven years confirming Indias status as the pharmacy of the Third World. More...
EU awards Venus Remedies patents for anti infection drug
(BS Reporter , 16-Sep-2010 , Sify)
Chandigarh based listed pharma player Venus Remedies has obtained the European Union patent for its researched anti infection product Sulbactomax. More...
FTA negotiations to boost trade & investment between EU India
(fe Bureau , 16-Sep-2010 , The Financial Express)
India and the European Union are on track to conclude FTA negotiations by early December. More...
Signs of Recovery Emerge after Economic Crisis Hits Innovation & IP Filings
(ag-IP-news , 15-Sep-2010 , ag-IP-news )
A new report by the World Intellectual Property Organization analyzing Intellectual Property trends in 2008 and 2009 shows that innovative activity and demand for IP rights dipped during the global economic crisis but began to recover this year. More...
Venus Remedies gets EU patent for anti infectant
(Reuters , 15-Sep-2010 , Livemint)
The drugmaker expects Sulbactomax to capture 10% market share of the segment in Europe by 2015 More...
Origin myths
(15-Sep-2010 , The Indian Express )
Would a Mahabaleshwari strawberry by any other name taste as sweet or a Guntur chilli as spicy? More...
Indian IP examiners have worlds highest workload lowest pay
(C.H. Unnikrishnan , 15-Sep-2010 , Livemint)
Quantity linked work assessment system is another reason behind deterioration in the quality of work More...
Freer trade may hurt access to India generic drugs
(Laura MacInnis , 14-Sep-2010 , Reuters)
UNITAID says 80 percent of its AIDS drugs come from India More...
India Japan trade pact to leave IP laws untouched
(Joe C Mathew / New Delhi , 14-Sep-2010 , Business Standard)
The India Japan Comprehensive Economic Partnership Agreement expected to be signed towards the end of this year will not call for any amendments to the existing intellectual property laws in either of the partner countries. More...
Dr Reddys sued over patent infringement
(fe Bureau , 14-Sep-2010 , The Financial Express)
Wyeth a wholly owned subsidiary of US based Pfizer Inc has filed a suit against Hyderabad based Dr Reddys Ltd at the US District Court New Jersey for allegedly infringing formers patent coverage in case of an anti depressant drug Effexor XR Venlafaxine Hydrochloride. More...
Freer trade may hurt access to India generic drugs
(By Laura MacInnis , 14-Sep-2010 , IBN Live)
Freer trade could harm Indias generic drug business which supplies the bulk of the AIDS medicines sent to developing countries a study backed by the drug purchasing body UNITAID said on Tuesday. More...
Pot kettle Local pharma in patent rush
(Priyanka Golikeri , 13-Sep-2010 , DNA)
Domestic drugmakers may challenge a Roche or a Novartis patent claim by filing oppositions and crying hoarse about trivial or evergreening patenting but when it comes to their own molecular or production process tweaks they havent been shy of laying innovation claims either. More...
Troikaa Pharma gets patent approval for Dynapar AQ in CIS
(BS Reporter / Mumbai/ Ahmedabad , 13-Sep-2010 , Business Standard)
Ahmedabad based mid sized pharmaceutical firm Troikaa Pharmaceuticals Ltd has been granted the patent for Dynapar AQ a diclofenac or painkiller injection for the CIS block earlier this week. More...
NGOs patient groups alert PMO not to act on behest of OPPI on patent issues
(Ramesh Shankar, Mumbai , 13-Sep-2010 , Pharmabiz)
A large number of patient groups, groups working on public health and HIV, public interest organizations, experts and concerned citizens have demanded to the Prime Ministers Office to immediately withdraw the biased and one sided notes which the PMO had reportedly circulated to the union ministries of commerce health legal affairs and chemicals at the urging of OPPI to amend key public health safeguards in the Patents Act including Section 3d and asking for patent linkages and data exclusivity. More...
New ventures with foreign partners may get easier
(Asit Ranjan Mishra , 13-Sep-2010 , Livemint)
DIPP now says that the measure patently discriminates against foreign investors who showed confidence in India by investing prior to 2005 and those who came in later. More...
Natco Pharma open to settle cancer drug patent case with US co
(PTI , 10-Sep-2010 , The Economic Times)
Pharma Ltd on Friday did not rule out a settlement over the patent issue with Celgene Corp which has said it would file a complaint against the former for alleged infringement of its cancer drug Revlimid. More...
Copyright suit against top education institution
(Mahesh Buddi , 10-Sep-2010 , The Times Of India )
Police on Thursday night booked criminal cases against the management of a top educational institution for allegedly copying and publishing textbooks of Intermediate brought out by the Telugu Academy. More...
Patents drive up treatment costs of Hepatitis C
(Priyanka Golikeri , 10-Sep-2010 , DNA)
As board member of the Network of Maharashtra People Living with HIV Manoj Pardesi is confronted with the twin challenges of helping people fight HIV and Hepatitis C. More...
Famed Bhadohi carpet gets GI tag
(Binay Singh , 9-Sep-2010 , The Times Of India)
The handmade carpet of Bhadohi was finally granted the Geographical Indication on September 4. More...
Innovation has helped drug firms take on Big Pharma
(Radhieka Pandeya , 9-Sep-2010 , Livemint)
India has also emerged a leader in novel drug delivery systems and custom synthesis of new molecules More...
Sun closes in on Taro with Israeli SC ruling
(ET Bureau , 9-Sep-2010 , The Economic Times)
Any controlling stake in Taro would help Sun boost generics sales in the US where the market is forecast to jump with nearly $96 billion worth of drugs going off patent in the next few years and President Barack Obama pushing for lower healthcare costs. More...
The copyright enforcers
(Samanth Subramanian , 9-Sep-2010 , Livemint)
Extracting copyright fees for music is a tricky business given the unwillingness of establishments to pay collecting the money requires tact and the ability to endure name calling and sometimes worse More...
FAQs on GI
(09-Sep-2010 , The Times Of India)
A trademark is a sign used by an enterprise to distinguish its goods and services from those of other enterprises. More...
Suven Life secures patent in Australia Mexico
(Our Bureau , 9-Sep-2010 , Business Line)
Suven Life Sciences Ltd has secured product patent in Australia and Mexico for one of their new chemical entity for the treatment of disorders associated with neurodegenerative diseases. More...
We will continue to sell our patented drugs with India specific pricing
(Khomba Singh , 8-Sep-2010 , The Economic Times)
The worlds second largest drugmaker Merck & Co is targeting to occupy one of the top two slots in India by 2015. More...
Cancer drug prices stay firmly high despite many not being patented
(Priyanka Golikeri , 8-Sep-2010 , DNA)
At a time when the government is thinking of ways to regulate the price of cancer medicines a research paper by a patient group shows that despite many not on patent ones available their prices remain at stratospheric levels. More...
Revenue of $3 bn by 2013 is a directional target
(Priyanka Pulla and C.R. Sukumar , 8-Sep-2010 , Livemint)
The size of the opportunity remains the same and at the end of it the product does get launched More...
Priyanka Pulla and C.R. Sukumar
(07-Sep-2010 , Sify)
The savoured Haleem dish a mouth watering delicacy of Hyderabad has been awarded the coveted Geographical Indication status clearing the way for a possible patent in the future. More...
Pharmexcil suggests DGFT to provide sops to exporters to develop norms for non infringing process for APIs
(Suja Nair Shirodkar, Mumbai , 7-Sep-2010 , Pharmabiz)
The Pharmaceutical Exports Promotion Council has suggested to the director general of foreign trade to provide incentives to the pharma exporters to develop adhoc norms for non infringing process for bulk drugs to increase the export of pharmaceutical products in the regulated markets. More...
Reckitt sues copycat Bharti Wal Mart JV
(Ratna Bhushan , 6-Sep-2010 , The Economic Times)
Reckitt Benckiser India the maker of Dettol antiseptic soap and Cherry Blossom shoe polish, has served a legal notice to Bharti Walmart demanding that the cash and carry joint company withdraw its Great Value toilet cleaner as it infringes upon the bottle design and cap of Reckitts Harpic brand the domestic market leader in this category. More...
Govt may cap FDI in pharma at 49%
(Sanjay Singh , 06-Sep-2010 , India Today)
The finance ministry as well as the Planning Commission have advised the concerned ministries to expedite the process to ensure that 65 per cent of Indians who according to the World Health Organisation still lack access to essential medicines are not deprived of affordable and high quality medicines. More...
Bio piracy is biggest concern says Jairam Ramesh
(IANS , 06-Sep-2010 , Sify)
Bio piracy which is gradually robbing India of its precious assets and rich bio diversity has emerged as one of the biggest concerns before the union environment and forests ministry. More...
The right path
(SUBHA J RAO , 05-Sep-2010 , The Hindu)
Attorney Sanjai Gandhi on the need to go in for a Geographical Indication certificate and how it protects both manufacturers and consumers. More...
Bull's Eye: Sun Pharma Apollo Tyres Cipla Escorts
(ET Bureau , 05-Sep-2010 , The Economic Times)
Sun announces a final approval to market six dosages of a generic version of Strattera with a 180 day exclusivity. More...
Govt wishes to market low cost cancer drugs
(Press Trust Of India / New Delhi , 4-Sep-2010 , Business Standard)
The government is in talks with pharmaceutical companies for ensuring availability of cancer drugs at a minimal price at their low cost pharmacy chain Jan Aushadhi stores across the country. More...
India keen to add remedial clause in trade agreements
(Ronojoy Banerjee , 4-Sep-2010 , The Financial Express)
Wary of third party free trade agreements impinging upon the countrys interests New Delhi is keen on inserting a remedial clause in all its extant and future FTAs. More...
Celgene seeks to stop Natcos generic Revlimid
(03-Sep-2010 , Reuters)
Celgene Corp said it plans to file a complaint alleging infringement against India's Natco Pharma Ltd which has submitted a request to the U.S. Food and Drug Administration for authorization to make and sell generic versions of Celgenes cancer drug Revlimid in the United States. More...
Avesthagen gets process patent for arthritis drug
(Khomba Singh , 3-Sep-2010 , The Economic Times)
Bangalore based drugmaker Avesthagen has got the Indian patent for the process to make a biosimilar drug of Amgens blockbuster medicine Enbrel that is used to treat rheumatoid arthritis a top company executive said. More...
India seeks to insulate FTAs from IP policies of the West
(KARTIKAY MEHROTRA , 3-Sep-2010 , Indian Express)
Prompted by intellectual property agreements among developed economies including the forthcoming Anti Counterfeiting Trade Agreement Indian agreements will make a point to thwart those trade related intellectual property rights plus policies being enforced around Europe the US and Japan when it comes to trade with India. More...
Govt talks to pharma cos for cancer drugs at Jan Aushadhi
(PTI , 03-Sep-2010 , The Economic Times)
The government is in talks with pharmaceutical companies for ensuring availability of cancer drugs at a minimal price at their low cost pharmacy chain Jan Aushadhi stores across the country. More...
Chidambaram says he doesnt hold patent on saffron terror
(TNN , 02-Sep-2010 , The Times of India)
Home minister P Chidambaram did not exactly use the phrase saffron terrorism but made it clear it was not his patent and in the past UPA and Congress leaders have found it quite expedient to refer to saffronisation of education to target the previous NDA government. More...
The problem with EVMs
(Subramanian Swamy , 02-Sep-2010 , The Hindu)
I have obtained documents from the World Intellectual Property Organisation with its headquarters in Paris to show that ECIL and BEL had applied for a patent for the EVM in 2002. More...
Industry needs to enhance knowledge across domains to tap burgeoning opportunity in global arena: Expert
(Nandita Vijay, Bangalore , 02-Sep-2010 , Pharmabiz)
With drugs going off patent over the next three years valued at around a whopping Rs 320000 crore and also increased penetration of generics in the global market Indian pharmaceutical industry sees a great opportunity and various stakeholders are gearing up to obtain a share in the pie that appears to be lucrative. More...
Alkem Lab develops low cost sweetener
(Khomba Singh , 01-Sep-2010 , The Economic Times)
We have filed an application to patent the product as well as the process to make it in India two months back and are in the process of filing for patent in other international markets said Sharad Kasarle vice president of R&D Nutraceuticals at Alkem More...
Ideal Cures wins patent revocation case against Colorcon Inc. USA
(Our Bureau, Mumbai , 31-Aug-2010 , Pharmabiz)
Mumbai based Ideal Cures has won a landmark victory in a patent revocation case against Colorcon Inc. USA. More...
A modern fold for ancient knowhow
(Biswajit Dhar , 31-Aug-2010 , Livemint)
An October meeting could finally resolve how developing nations get to preserve their traditional knowledge More...
Rajya Sabha clears nuclear liability Bill
(Our Bureau , 31-Aug-2010 , Business Line)
The BJP leader added that inclusion of supplier liability could become a global model pointing out that this is what had happened in the case of the World Trade Organisation and the global patent regime where the country had asserted itself. More...
Zydus Natco launch versions of drug facing court battle
(Joe C Mathew / New Delhi , 30-Aug-2010 , Business Standard)
Ranbaxy which first launched a generic version of Hepatitis B drug Baraclude was taken to court. More...
Govt speaking in two voices on generic medicines
(Priyanka Golikeri , 30-Aug-2010 , DNA)
The governments doublespeak on generic off patent and low cost medicines has the stakeholders in a tizzy. More...
Cancer drugs may become cheaper after govt study
(Joe C Mathew / New Delhi , 30-Aug-2010 , Business Standard)
Dpt of pharma seeks to negotiate patented drug prices before they hit Indian market. More...
Protection of public funded intellectual property bill to be made more transparent
(Joseph Alexander, New Delhi , 30-Aug-2010 , Pharmabiz)
The Ministry of Science and Technology will bring in changes to the Protection and Utilisation of Public Funded Intellectual Property Bill 2008 to make the process of patenting and commercialisation of inventions from public funded projects more flexible and transparent in line with the suggestions from the experts. More...
IPR attorney helps get 10 products GI status
(A Subramani , 29-Aug-2010 , The Times Of India)
Of the 18 Tamil Nadu products enjoying GI security as on date at least 10 of them got the status because of the efforts of Chennai based advocate and IPR attorney P Sanjai Gandhi. More...
Pharma units await clarity on compulsory licensing
(Ramnathsubbu , 29-Aug-2010 , The Hindu)
When the government initiated discussions last week to lay down norms for the issuance of compulsory licensing for medicines under the Indian Patent Act 1970 it rekindled the issue facing the Indian pharmaceutical industry of the affordability of and the access to medicines. More...
Pharma majors pitch for affordable patented drugs
(Khomba Singh , 28-Aug-2010 , The Economic Times)
Indian drugmakers have said the price of patented drugs should be fixed based on the cost of developing and producing the medicine in the country and not in the developed world where it costs more to make such medicines affordable for patients here. More...
Microsoft co founder starts patent lawsuit
(Richard Waters in San Francisco , 28-Aug-2010 , Financial Times)
Paul Allen co founder of Microsoft on Friday mounted a wide ranging patent case against some of the best known internet and technology companies including Google Apple and Facebook. More...
T-series: Ruling the Indian music industry
(Nandini Raghavendra and Vinod Mahanta , 28-Aug-2010 , The Economic Times)
That Intellectual Property Rights was the next frontier for the music industry to be conquered was what son Bhushan Kumar instinctively understood. More...
Indian pharma cos shun EU route goods via SA ports
(KARTIKAY MEHROTRA , 28-Aug-2010 , Indian Express)
Despite Commerce Minister Anand Sharmas assurance that the European Union will amend its laws ceasing the seizure of generic drugs in transit Indian pharmaceutical giants are taking matters into their own hands to ensure safe transit. More...
AIPS to organise seminar on precedential patent cases on September 23
(Our Bureau, Mumbai , 28-Aug-2010 , Pharmabiz)
The Academy of Intellectual Property Studies an institute that has been set up in affiliation with the Indian Drug Manufacturers Association is organising a seminar on precedential patent cases on September 23 at AIPS Goregaon West Mumbai. More...
What is Indian is Indias
(Business Standard , 27-Aug-2010 , Sify)
After successfully contesting a patent dispute with China earlier this year regarding formulations based on pudina mint and kalamegha Andrographis India last week won another legal battle in Malaysia against the use of ponni rice as trademark. More...
Panel on drug prices to meet industry today
(Joe C Mathew , 27-Aug-2010 , Sify)
The committee on price negotiation of patented drugs constituted by the Department of Pharmaceuticals will meet industry representatives on Friday to identify possible negotiation options that can lower the cost of patent protected and imported medicines for life threatening illnesses in the country. More...
EU to rectify laws stop seizure of off patent drugs says Sharma
(shruti Shrivastav , 27-Aug-2010 , Indian Express)
The European Union has assured India that it will amend its laws to stop the seizure of off patent drugs shipped to Africa and Latin American countries commerce and industry minister Anand Sharma today said. More...
Bad medicine
(The Financial Express , 26-Aug-2010 , The Financial Express)
The department of industrial policy and promotion has unveiled a discussion paper on the issue of drug prices. More...
Ranbaxy settles patent dispute with Roche
(ET Bureau , 26-Aug-2010 , The Economic Times)
Daiichi Sankyo owned Ranbaxy Laboratories has settled its patent dispute with Swiss major Roche for the latters drug valganciclovir sold under the brand Valcyte. More...
Drug makers drag PMO into dispute over IPR changes
(C.H. Unnikrishnan , 26-Aug-2010 , Livemint)
Local industry is critical of the PMOs step that seeks amendments to patent law based on foreign firms demands More...
ET in the classroom: Compulsory licencing
(ET Bureau , 26-Aug-2010 , The Economic Times)
ET explains Compulsory licensing a provision that allows governments to override Patent rights More...
Patents are granted to ensure people have access to latest technology or drug: Controller General of Patents
(Our Bureau, Bangalore , 26-Aug-2010 , Pharmabiz)
The Controller General of Patents Designs and Trademarks PH Kurian has said that the key task of granting a patent is to allow people to have access to the latest technology or drug. More...
Indian ministry for compulsory licensing for 3rd party drug making
(PTI , 26-Aug-2010 , The Financial Express)
The Indian Industry Ministry yesterday suggested that local pharma makers should be allowed to produce patented drugs to check medicine prices in wake of acquisition of Indian companies by multinational firms. More...
Allow firms to make patented drugs
(Special Correspondent , 25-Aug-2010 , The Hindu)
The Industry Ministry has suggested putting restrictions on foreign direct investment in the pharmaceutical sector stating that local pharma makers should be allowed to produce patented drugs to check medicine prices in the wake of multinational companies acquiring Indian companies. More...
High drug prices a worry: Govt
(Rupali Mukherjee & Prabhakar Sinha , 25-Aug-2010 , The Times Of India)
Government is considering to bring in tighter foreign investment control in the pharmaceutical sector and to implement compulsory licensing system to check high prices of patented drugs. More...
Compulsory licensing of patented drugs under study
(Bindu D. Menon , 25-Aug-2010 , Business Line)
Recently the Commerce Ministry had raised the issue of acquisition of pharma companies by foreign multinationals and the resultant concerns over its impact on low cost medicines. More...
Local pharma sellout worries industry ministry
(Siddhartha Singh & Sushmi Dey , 25-Aug-2010 , DNA)
These proposals include compulsory licensing that allows other manufacturers to produce patented drugs if needed a significant rise in the number of drugs on the essential list and shifting foreign direct investment in local drug makers from the 100% automatic approval route to the Foreign Investment Promotion Board for better scrutiny. More...
Pharma FDI checks to shield local companies
(ET Bureau , 25-Aug-2010 , The Economic Times)
This spawned an entire industry of local drugmakers which thrived by making copycat versions of expensive patent protected medicines by adopting a different manufacturing process. More...
Government starts review of compulsory licensing norms
(BS Reporter / New Delhi , 25-Aug-2010 , Business Standard)
The Department of Industrial Policy and Promotion has started a discussion on various compulsory licensing provisions enshrined under Indias intellectual property laws. More...
Pill to shield drug makers from MNCs
(Mail Today Bureau , 25-Aug-2010 , India Today)
The department on Industrial Policy & Promotion is in favour of making a provision for allowing Indian pharmaceutical companies to manufacture patented medicines in case prices of these drugs spiral out of control due to collusion among multinational companies. More...
Indias first patent tech auction in Ahmedabad this week
(Vishal Dutta , 25-Aug-2010 , The Economic Times)
A herbal drink that tastes like beer a bio insecticide product that attracts and kills mosquitoes using bird feather a transdermal patch for contraceptives drug delivery and a technology that can make a snake venom into analgesic that can help cure neuropathic pain: these are a few samples of patented technologies that will go on auction in Indias first ever Tech Transfer 2010 showcase exclusively for patented pharma products in Ahmedabad. More...
Lab rats? Drugs for US children tried on Indians
(REUTERS , 24-Aug-2010 , The Times Of India)
A law intended to speed up development of new drugs for US kids has ended up financing clinical trials in poor countries where the medicines might never become available. More...
Foreign in pharma
(Business Standard , 24-Aug-2010 , Sify)
The takeovers can be seen to be a rather hurried attempt by global drug majors to acquire a generics portfolio in order to insure themselves for an immediate future in which the patent pipeline will be running thin and health care cost cutting measures in the developed economies will improve the market for generics players. More...
Industry Min for compulsory licensing for 3rd party drug making
(Press Trust of India / New Delhi , 24-Aug-2010 , Business Standard)
The Industry Ministry today suggested that local pharma makers should be allowed to produce patented drugs to check medicine prices in wake of acquisition of Indian companies by multinational firms. More...
Taiwanese LCD maker files second suit against Sony
(Reuters , 24-Aug-2010 , DNA)
Taiwans Chimei Innolux Corp sued Japans Sony Corp for infringing on patents used in PlayStation3 video game consoles televisions computer notebooks and cameras. More...
Copyright to attract service tax: Govt tells HC
(Vrishti Beniwal / New Delhi , 23-Aug-2010 , Business Standard)
The revenue department has contested the petition filed by PVR Pictures in the Delhi High Court against the governments decision to levy service tax on copyright services such as sale of music rights sale of direct to home satellite TV rights and screening in cinemas. More...
Patently wrong
(The Financial Express , 23-Aug-2010 , The Financial Express)
It isnt quite clear why the Prime Ministers Office decided to stir a debate on the Organisation of Pharmaceutical Producers of India it comprises mostly MNCs operating in India and their partners here demand to dilute Section 3(d) of the Indian Patent Act. More...
Delhi HCs new age lakshman rekha
(Mukesh Butani / August , 23-Aug-2010 , Business Standard)
Ordinarily marketing intangibles include a bundle of intellectual property rights such brands trademarks knowhow that surrounds knowledge of distribution channels and customer relationship. More...
Commerce Ministry may step in to check MNC buys in pharma
(P.T. Jyothi Datta , 23-Aug-2010 , Business Line)
Some industry watchers say that the ground realities started becoming difficult for local drug companies after India implemented the product patent regime in 2005. More...
Man dupes pharmaceutical company to the tune of 96.52 lakhs
(TNN , 23-Aug-2010 , The Times Of India)
The officials from the cyber crime cell of the Pune police on Saturday arrested a technical director of a company manufacturing herbals products for allegedly duping the company to the tune of Rs 96.52 lakh on the pretext of providing patent for the companys 15 products with the help of an Indonesia based pharmaceutical company. More...
Patent law pits MNCs against local drug firms
(HT Correspondent , 22-Aug-2010 , Hindustan Times)
The government is examining a set of proposals by global drug manufacturers seeking changes in Indias intellectual property rights laws to reward innovation triggering howls of protest from domestic pharmaceutical companies who said it would keep prices of many critical medicines perpetually high. More...
Is hybrid model a good long term strategy for drug makers?
(P.T. Jyothi Datta , 21-Aug-2010 , Business Line)
An IMS study reveals an increased pick up in branded innovative products after 2015 as the patent cliff where drugs go off patent is passed and research pipeline matures. More...
Munna Bhai Circuit head to trademark office
(Rasul Bailay,New Delhi , 21-Aug-2010 , Livemint)
Trademark lawyer Neil Mason said the applications suggest Vinod Chopra Films Pvt. Ltd might be looking at licensing both the names for businesses More...
Court declines to stay CATs order
(Special Correspondent , 21-Aug-2010 , The Hindu)
According to the petitioner the CATs order was patently illegal and vitiated by errors of law and facts patent and apparent on the face of the record. More...
Azad takes on PMO over patents?
(Kounteya Sinha , 20-Aug-2010 , The Times Of India)
Dr Gopa Kumar Nair an authority in patents said when a delegation of MNCs meet the PM the latter has to forward the representation received to various ministries. More...
Need for more stringent anti piracy measures: Kurain
(PTI , 20-Aug-2010 , The Economic Times)
The Patent Office on Thrusday called for more stringent anti piracy measures besides developing a societal ecosystem that respects intellectual property rights. More...
FICCI launches IPR Facilitation Centre in Delhi to assist MSMEs
(Our Bureau, Mumbai , 20-Aug-2010 , Pharmabiz)
In keeping with its commitment to empower Indian businesses FICCI has launched an IPR Facilitation Centre at Federation House New Delhi in association with the union Ministry of Micro Small and Medium Enterprises. More...
PMO renews patent debate
(Joe C Mathew / New Delhi , 19-Aug-2010 , Business Standard)
The Prime Ministers Office has sought the opinion of various stakeholder departments on the need for further amendments to the patent law to introduce some of the controversial provisions that were kept out during the previous amendment to the Indian Patent Act five years ago. More...
Right to health medicine to be protected at all cost: Scindia
(ET Bureau , 19-Aug-2010 , The Economic Times)
India has said that it will not compromise on issues related to health and peoples right to medicine in the bilateral trade and investment agreement being negotiated with the European Union. More...
Madurai malli Dindigul lock line up for patent
(Express News Service , 19-Aug-2010 , expressbuzz)
Three weeks after it filed an application to patent the Thanjavur veena the Tamil Nadu State Council for Science and Technology is preparing a list of 10 other indigenous products to make moves for a similar exercise. More...
Chinese man gets patent for quake proof bed
(PTI , 18-Aug-2010 , The Times Of India)
A retired Chinese man has been granted a patent for his innovative design of a bed that can automatically turn into a strongbox and help people survive an earthquake the state media reported today. More...
India wins Ponni rice trademark row in Malaysia
(G. Srinivasan , 18-Aug-2010 , Business Line)
India has won the battle for Ponni rice in a Malaysian court. More...
Biocon CMD refrains from commenting on Biocon Pfizer deal speculation
(Nandita Vijay, Bangalore , 18-Aug-2010 , Pharmabiz)
In fact in 2008 as part of its portfolio development efforts Pfizer set up the Established Product Business Unit which only deals with off patent products new molecules including generics and injectables to be marketed globally More...
Nokia Apple Japan Post Faiza Franek Wal Mart: Intellectual Property
(Victoria Slind-Flor , 18-Aug-2010 , Bloomberg)
Nokia Oyj removed one patent from its complaint against Apple Inc. with the U.S. International Trade Commission company spokesman Mark Durrant said. More...
Satyam wins tax case against Upaid in NY court
(KV Ramana , 17-Aug-2010 , DNA)
Upaid had earlier filed a forgery and fraud case against Satyam involving the issue of patent infringement. More...
Pfizer deal buzz lifts Biocon to 52 wk high
(Bureau , 17-Aug-2010 , The Economic Times)
Lipitor a big Pfizer drug that generates nearly $1.4 billion will go off patent in 2011. More...
Focus on high margin chronic diseases new products to boost Ipcas topline
(Nitin P Shrivastava , 16-Aug-2010 , DNA)
Ipca is looking to increase its abbreviated new drug application filings backed by its own APIs to cash in on the huge generic opportunity arising out of large scale patent expiries in developed countries. More...
Eli Lilly loses patent case to generics majors
(BS Reporter / New Delhi , 14-Aug-2010 , Business Standard)
Generic drugmakers including domestic companies like Sun Pharmaceutical and Aurobindo will gain as Eli Lilly has lost a US court case over its hyperactivity disorder drug Strattera. More...
The purpose of creation
(Pavitra Jayaraman , 14-Aug-2010 , Livemint)
A lawyer an IIT professor a music composer a film maker meet people behind the copy left movement who champion open licensing More...
Patent war: Oracle sues Google
(REUTERS , 14-Aug-2010 , The Times Of India)
Oracle Corp sued Google Inc alleging patent and copyright infringement in the development of the popular Android smartphone software. More...
Regulator working on pharma export norms to check fake drug
(Radhieka Pandeya & Asit Ranjan Mishra , 13-Aug-2010 , Livemint)
Indias drug regulator is drafting guidelines for quality control and packaging of pharmaceutical exports due to concerns about fake medicines. More...
TVS Motor to re start twin spark plug Flame
(M Ramesh , 13-Aug-2010 , Business Line)
In 2008 rival two wheeler manufacturer Bajaj Auto Ltd sued TVS Motor claiming patent infringement holding that the Flame motorcycle had a twin spark plug a feature that Bajaj said it owned the patent for. More...
Pfizer Sues Actavis Group Over U.S. Lipitor Patent to Block Generic Copy
(Phil Milford , 12-Aug-2010 , Bloomberg)
Pfizer Inc. the worlds largest drug company sued Icelands Actavis Group hf asking a judge to block sales of a generic version of the cholesterol drug Lipitor until a patent expires in 2017. More...
Marico Grasim settle trademark case
(Sapna Agarwal , 12-Aug-2010 , Livemint)
Personal care products maker Marico Ltd has settled a trademark infringement case filed against Grasim Industries Ltd out of court. More...
Pharmexcil to conduct global CEO conclave distribute awards on Sept 14
(Our Bureau, Mumbai , 12-Aug-2010 , Pharmabiz)
The Pharmaceutical Exports Promotion Council is planning to organise a global conclave of CEOs of pharma industry and distribute awards for companies excelled in exports and secured patents remarkably for their products on its sixth annual day to be held on September 14 2010. More...
Getting global trademark to get easier
(TNN, , 11-Aug-2010 , The Times Of India)
Rajya Sabha on Tuesday passed the Trademarks amendment Bill of 2009 which enables a person or an enterprise to seek registration of a trademark in any of the 84 member countries of the Madrid Protocol through a single application. More...
Gufic Biosciences wins trademark infringement suit against Estee Lauder in India
(Our Bureau, Mumbai , 11-Aug-2010 , Pharmabiz)
The Mumbai based bioscience company Gufic Biosciences Ltd announced here that it has won a favourable decision from the division bench of the Delhi High Court on a trademark infringement litigation against the US based cosmetic major Estee Lauder on a product Skincliniq Stretch Nil. More...
Panel asks health ministry to ensure big domestic pharma cos remain in Indian hands
(Ramesh Shankar, Mumbai , 11-Aug-2010 , Pharmabiz)
The Parliamentary standing committee on Health and Family Welfare led by Rajya Sabha MP Amar Singh has asked the Union Ministry of Health to take up the issue of major Indian pharma companies being taken over by the multinational pharma companies with the Ministry of Chemicals & Fertilizers without any delay to come up with policy options to ensure that major Indian pharma companies remain in Indian hands. More...
IPRI and the retreat from reforms
(Bibek Debroy , 10-Aug-2010 , Indian Express)
There is something called International Property Rights Index. More...
Lupin sues Ranbaxy in US for patent infringement
(P B Jayakumar / Mumbai , 10-Aug-2010 , Business Standard)
In a twist to the tale of drug patent infringement cases in the United States Indian drug company Lupin has sued Ranbaxy Laboratories which is now controlled by Japanese drug major Daiichi Sankyo in a US court. More...
Dr Reddys launches cheaper anemia drug
(Priyanka Pulla , 10-Aug-2010 , Livemint)
Dr Reddys Laboratories Ltd launched a biosimilar or off patent version of an anemia drug that it says will cut treatment costs by about half More...
Glenmark settles patent dispute with Sepracor
(BS Reporter / Mumbai , 10-Aug-2010 , Business Standard)
Glenmark has entered into a settlement agreement with US based Sepracor on a patent litigation suit related to the generic versions of insomnia drug eszopiclone which Sepracor markets under the brand name Lunesta. More...
After Tatas Sholay makers to sue Greenpeace
(Kanu Sarda , 10-Aug-2010 , DNA)
The makers of the highest grossing film in India Sholay will take legal action against the international environmental non governmental organisation Greenpeace for gross violation of copyright and trademark and for the wrongful use of its characters. More...
Sorry we cant meet you now RIM tells India
(Rishi Raj, Nistula Hebbar , 10-Aug-2010 , The Financial Express)
Even as a possible ban on its BlackBerry services looms officials of Research in Motion the Canada based patent holders of the push mail service have cited protocol issues to explain their inability to meet Indian officials. More...
Bhang to trigger new patent war?
(Chidanand Rajghatta , 9-Aug-2010 , The Times Of India)
An ancient Indian high could soon get bhang alored to the United States if the efforts of an American confectioner prove successful. More...
US firm plans to sell Bhang chocolates seeks trademark
(PTI , 08-Aug-2010 , The Times Of India)
Chocolates as such are considered intoxicating for many and an American entrepreneur now wants to give it a new high by lacing the bitter sweet dessert with very much an Indian intoxicant Bhang and trademark it too. More...
Its official: India foiled Chinas bid to patent pudina
(TNN , 7-Aug-2010 , The Times Of India)
The Union health ministry on Friday confirmed a TOI report on how India foiled Chinas bid to patent the health benefits of pudina. More...
Fortis arm plans full service clinical research foray
(Joe C Mathew / New Delhi , 6-Aug-2010 , Business Standard)
The two statutory studies are needed to prove that a generic medicine is equivalent to its originally discovered and patent protected drug in terms of safety and efficacy. More...
Mexico foreign affairs minister to visit India from Aug 16
(Huma Siddiqui , 6-Aug-2010 , The Financial Express)
The November 8 9 talks are aimed at clarifying rules on sharing future innovations and existing technologies involving contentious intellectual property rights issues. More...
CWG mess: Gill falls back on God evokes nationalism
(ET Bureau , 6-Aug-2010 , The Economic Times)
I plead that in view of the patent failure of the group of ministers to deliver an untainted and effective Games could a high level apex committee on the same lines as the special organising committee which delivered the Asian Games in 1982, be constituted with none other than todays Sardar Dr M S Gill just like Sardar Buta Singh to chair that committee? More...
Beijing could provide the solution
(Venkatesan Vembu , 6-Aug-2010 , DNA)
According to officials at Huashi Future Parking Equipment a Shenzhen based company whose chairman Song Youzhou owns the patent on the superbus transport officials from several countries including India had made enquiries about the project. More...
Military matters
(Aroma Sah, Hindustan Times , 05-Aug-2010 , Hindustan Times)
The military jacket with its trademark button detailing down both sides of the opening is tipped to be a big trend this autumn. More...
Nihilent develops customer loyalty tool for SMEs
(BS Reporter / Mumbai/ Pune , 5-Aug-2010 , Business Standard)
Pune based business consulting and solutions integration company Nihilent has developed a web based tool for the Micro Small and Medium Enterprises that incorporates the patented Customer Loyalty Evaluation methodology and the 14 aspects of customer loyalty. More...
T S Vishwanath So what do NTBs cost?
(T S Vishwanath / August , 5-Aug-2010 , Business Standard)
Interestingly, the issue of slashing tariffs and non tariff barriers under the WTO negotiations is discussed by the same committee on NAMA which is chaired by Ambassador Luzius Walecha of Switzerland. More...
MNCs gaining control on Indian drug market
(04-Aug-2010 , Sify)
The parliamentary standing committee on health has asked the government to pay attention to the selling out of major Indian Pharma companies to multinationals whose increasing hold over the drug market it says will make essential medicines costlier. More...
Zota targets overseas market for its amino acid combo for alcoholism
(Our Bureau, Mumbai , 4-Aug-2010 , Pharmabiz)
The Surat based Zota Healthcare Ltd a pharma manufacturing marketing and exports firm is planning to grab the overseas market for the first of its kind anti oxidant combination targeting liver psoriasis caused by alcoholism. More...
Bitter pill for India EU trade ties
(Biswajit Dhar , 3-Aug-2010 , Livemint)
Indias ongoing negotiations with the European Union have seen differences over intellectual property rights More...
Takeda sues Wockhardt for para IV patent infringement on diabetes drug Actos
(Our Bureau, Mumbai , 3-Aug-2010 , Pharmabiz)
The Japanese drug major Takeda Pharmaceuticals and its US subsidiary has filed a Para IV patent infringement litigation in US against the Mumbai based Wockhardt Ltd and its US subsidiaries Wockhardt USA LLC and Morton Grove Pharmaceuticals Inc for alleged initiatives to manufacture and market the generic version of the oral type 2 diabetes drug Actos. More...
Microsoft Wins Patent Lawsuit That Targeted Xbox Game Systems
(Susan Decker , 3-Aug-2010 , Bloomberg)
Microsoft Corp. the worlds biggest software maker won a court ruling that its Xbox video game system doesnt infringe a patent over multiplayer gaming ending a six year legal battle. More...
About 79k patent applications lying with govt
(Press Trust of India / New Delhi , 2-Aug-2010 , Business Standard)
About 79000 applications are pending before the government for grant of patents with mechanical engineering and chemicals segment accounting for nearly a third of the requests Parliament was informed today. More...
Banarasi silk industry again in danger zone
(Binay Singh , 02-Aug-2010 , The Times Of India)
Whatever may be the reason but there is a need to give serious attention to this sector that got the Geographical Indication tag and joined the league of other GI products like Tirupati laddu and Darjeeling tea a year back. More...
DRL scouts for partners to tap Japanese mkt
(BV Mahalakshmi , 2-Aug-2010 , The Financial Express)
Currently generic or off patent drugs have only a 17% market share in Japan. More...
WHO echoes Indian view of anti counterfeit laws in Africa hit accessibility of generics
(Ramesh Shankar, Mumbai , 2-Aug-2010 , Pharmabiz)
The World Health Organisation has echoed the apprehensions earlier expressed by the developing countries like India that the anti counterfeit legislation that was adopted or that is under consideration in some of the East African countries like Kenya and Uganda threatens the accessibility of affordable generic medicines. More...
Daiichi Sankyo may raise outlook Eisai Q1 jumps
(REUTERS , 30-Jul-2010 , The Economic Times)
Daiichi Sankyo bought a majority stake in Drugmakers including domestic rivals Takeda Pharmaceutical and Astellas Pharma are struggling to develop strong successors to their mainstay drugs which face imminent patent expirations. More...
US court rules Gemzar patent invalid says Sun
(Our Bureau , 30-Jul-2010 , Business Line)
Sun Pharma said that the US Court of Appeals for the Federal Circuit upheld an earlier judgment by another court against Eli Lily stating that certain claims made by Lilly on its cancer drug Gemzar were invalid. More...
First in first out?
(Bhupesh Bhandari / New Delhi , 30-Jul-2010 , Business Standard)
In the United States the worlds largest pharmaceutical market any drug maker who is the first to file an application with the Food & Drug Administration to launch the generic version of a drug once it goes off patent gets exclusive rights to sell it for 180 days. More...
Giving Americans Bhang For Their Buck
(Devin Banerjee , 30-Jul-2010 , The Wall Street Journal)
The U.S. Patent office accepts pot related trademark applications but has never granted one according to a Wall Street Journal report on a short lived medical marijuana specific trademark category. More...
IPR comes in way of Japan FTA
(Amiti Sen , 29-Jul-2010 , The Economic Times)
Negotiations between India and Japan on a pact on trade and investment have got stuck on the issue of intellectual property rights with both sides refusing to budge from their stated positions though most other issues have been resolved. More...
AstraZeneca files patent suit against Indian partner Torrent over blockbuster cholesterol drug Crestor Eli Lilly loses Gemzar patent appeal
(Article , 29-Jul-2010 , The Pharma Letter)
Anglo Swedish drug major AstraZeneca has filed a Para IV patent infringement law suit against the Gujarat based Torrent Pharmaceuticals and its US subsidiary for its alleged move to manufacture and sell a generic version of its blockbuster cholesterol lowering drug Crestor before its patent expiry. More...
Copyright holder can decide on exhibiting movie: Aamir counsel
(Express News Service , 29-Jul-2010 , Indian Express)
Khans counsel said the actors production house is just enforcing its copyright freedom when it comes to releasing its films and the CCI a central government body has no jurisdiction to initiate any inquiry in this regard. More...
Facebook beats back patent infringement claim
(AGENCIES , 28-Jul-2010 , The Economic Times)
Facebook Inc won a legal fight on Wednesday over claims its hugely popular social networking website infringed a patent owned by little known Leader Technologies. More...
Astrazeneca files patent lawsuit against Torrent for blockbuster drug Crestor
(Our Bureau, Mumbai , 28-Jul-2010 , Pharmabiz)
The UK based drug major AstraZeneca has filed a Para IV patent infringement law suit against the Gujarat based Torrent Pharmaceuticals and its US subsidiary for its alleged move to manufacture and sell the generic version of its blockbuster cholestrol lowering drug Crestor before expiry of its patent. More...
US Appeals Court Rules Gemzar(R) Patent Invalid
(press release , 28-Jul-2010 , Market Watch)
Sun Pharma Though Not a First Filer Triggered This Successful Patent Challenge More...
Take Tata logo off game: HC advises Greenpeace
(Utkarsh Anand , 28-Jul-2010 , Indian Express)
Justice S Ravinder Bhat granted the NGOs 10 days to file a written reply in the defamation and trademark infringement suit against a online game Turtle vs Tata modelled on a popular computer game called Pacman. More...
AstraZeneca Gains After FDA Staff Recommends Brilinta
(Catherine Larkin and Trista Kelley , 27-Jul-2010 , Bloomberg BusinessWeek)
AstraZeneca Plc gained in London trading after U.S. regulatory staff said the blood thinner Brilinta is approvable if the drugmaker undertakes a study on its effectiveness in Americans once its marketed. More...
More items to find way into digital library to check biopiracy
(Amiti Sen , 27-Jul-2010 , The Economic Times)
India has begun work to include 220 additional Ayurveda Unani and Siddha text in its Traditional Knowledge Digital Library which will help check rampant biopiracy of the countrys ancient wisdom by developed countries. More...
Forest Laboratories and Merz Pharma GmbH & Co. KGaA Settle NAMENDA Patent Litigation
(ag-IP-news , 27-Jul-2010 , ag-IP-news )
Forest Laboratories Inc. Forest Laboratories Holdings Ltd. Merz Pharma GmbH & Co. KGaA and Merz Pharmaceuticals GmbH announced that they have entered into settlement agreements with all remaining defendants in patent infringement litigation related to Forests NAMENDA immediate release tablets. More...
Gilead Bayer & Genzyme sue Lupin for alleged Para IV patent infringements in US
(Our Bureau, Mumbai , 27-Jul-2010 , Pharmabiz)
The Mumbai based Lupin Ltd and its US subsidiary Lupin Pharmaceuticals Inc have been sued by at least three firms in United States at various courts in the nation within a week starting from July 14 for Para IV patent infringement allegedly by the former attempting to manufacture and sell generic version of products before expiry of patent protection according to reports. More...
Opposition protests disrupt India parliament
(Amy Kazmin in New Delhi , 27-Jul-2010 , Financial Times)
Indias parliament was repeatedly disrupted by opposition protests at high food price inflation on Tuesday raising concerns about further stalling of the Congress party led governments backlogged reform agenda. More...
Tech power to farmers
(Surinder Sud / New Delhi , 27-Jul-2010 , Business Standard)
This change in attitude has come about partly because of new economic realities and the intellectual property rights regime and partly because of the realisation that the old mindset was preventing new technology from showing its potential impact on agriculture. More...
Skinvisibles Invisicare Patent Portfolio Strengthens
(press release , 27-Jul-2010 , Market Watch)
Skinvisible Inc. announced today the Hong Kong Patent Office has issued the Company a patent covering its unique polymer delivery system Invisicare. More...
Sapience a software thatmeasures productivity
(Shraddha Nair , 27-Jul-2010 , Livemint)
InnovizeTech is seeking a global patent for a product that targets banks and insurance firms as consumers More...
Several countries join India EU dispute at WTO as interested or affected parties
(Ramesh Shankar, Mumbai , 27-Jul-2010 , Pharmabiz)
Several countries such as Brazil Equador Canada China Turkey and Japan have joined as interested or affected parties in the on going dispute between India and European Union at WTO on the seizure of generic medicines in transit via ports and airports in EU countries. More...
Head over heart for Singh brothers
(BS Reporter / New Delhi , 27-Jul-2010 , Business Standard)
It was Indias largest pharmaceutical company with an interesting range of patent challenges in the West. More...
ITC Issues Notice of Final Determination in Rambus Matter Regarding NVIDIA Products
(press release , 26-Jul-2010 , Market Watch)
The complaint sought an exclusion order barring the importation sale for importation and sale after importation of products that infringe nine of Rambus patents. More...
Private labels knock at chemist stores
(BV Mahalakshmi, Sudhir Chowdhary , 26-Jul-2010 , The Financial Express)
The Rs 5000 crore domestic market for common off patent drugs commonly called generic medicines and over the counter products which are targeted at a wide variety of common ailments and lifestyle disorders is an obvious enticement for the warring parties. More...
Brain League unveils patent expiry search service
(Madhumathi D.S. , 25-Jul-2010 , Business Line)
Tracking off patent drugs More...
India EU FTA talks begin in Brussels next month
(BS Reporter / New Delhi , 24-Jul-2010 , Business Standard)
Besides discussions on trade and investment the negotiations would also take up issues concerning services intellectual property rights competition policy government procurement and geographical indications among others. More...
Civil Society groups urge State Judicial Academy to restructure agenda for Judges Roundtable meet
(Ramesh Shankar, Mumbai , 24-Jul-2010 , Pharmabiz)
Some of the Civil Society groups in the country have urged the Maharashtra State Judicial Academy to restructure the agenda for the Judges Roundtable on Intellectual Property Rights Adjudication being held in Mumbai on July 24 and 25 to promote public interest and a deeper understanding of intellectual property amongst judicial officers. More...
New hope in stem cell therapy for blindness
(Pushpa Narayan , 23-Jul-2010 , The Times Of India)
The two institutions recently got a patent for the process and are now gearing up for human trials. More...
Chinese origin Made in India fake medicines seized in Nigeria
(P.T. Jyothi Datta , 23-Jul-2010 , Business Line)
It came as a shocker to V S International founder Mr Vidyut Shah when a fake consignment of his flagship Ciprotab brand valued at about Rs 1 crore was seized in Nigeria late last month. More...
Forest settles Alzheimers drug patent suits
(Bill Berkrot and Lewis Krauskopf , 22-Jul-2010 , Reuters)
Forest Laboratories Inc said it and Germanys Merz Pharma reached settlement agreements for all patent litigation over their Namenda Alzheimers drug that will keep cheaper generic versions of the medicine off the U.S. market until January 2015. More...
T S Vishwanath: Trading on environment
(T S Vishwanath , 22-Jul-2010 , Business Standard)
WTO talks on trade in environmental goods are turning into a market access issue for developed countries More...
NGOs call upon EU to halt aggressive push for higher IP protection enforcement
(Ramesh Shankar, Mumbai , 22-Jul-2010 , Pharmabiz)
A string of international NGOs and legal experts who have gathered at the XVIII International AIDS Conference in Vienna have called upon the European Union to immediately stop their aggressive push for higher intellectual property protection and enforcement through various bilateral and multilateral forums that threaten access to safe effective and affordable generic HIV medicines. More...
Bacterial miracle
(Bachi Karkaria , 22-Jul-2010 , The Times Of India)
His Oilzapper fully deserves its formidable reputation its hordes of awards and heaps of patent fees. More...
Vintage Wear
(RICHA BHATIA , 22-Jul-2010 , Indian Express)
Following allegations of trademark infringement the organisers were forced to change the logo supporting it with a disclaimer. More...
India EU officials to meet in Sept on drug seizure issue
(Press Trust of India / New Delhi , 21-Jul-2010 , Business Standard)
In an effort to resolve a dispute on seizure of Indian drugs by some European countries officials of the European Union and the Indian government will meet again at Geneva in September at the instance of the WTO. More...
India may complain to WTO if Acta is enforced: Khullar
(Asit Ranjan Mishra , 21-Jul-2010 , Livemint)
India may complain to the World Trade Organization against the developed nations if they try to enforce intellectual property regulations that go beyond the terms accepted by WTO and the World Intellectual Property Rights Organization. More...
Govt cautions pharma industry against harassment by global players
(PTI , 21-Jul-2010 , The Economic Times)
The government on Tuesday cautioned the domestic pharmaceutical industry against attempts by global giants to harass them through their deep pockets and means outside the WTO. More...
Eisai to cut Aricept costs with move to India
(Tracy Staton , 21-Jul-2010 , Fierce Pharma)
Whats a drugmaker to do when its lead product falls off the patent cliff? More...
Inflation will moderate to 5 6% by year end: Cabinet Secretary
(BS Reporter / New Delhi , 21-Jul-2010 , Business Standard)
The government said it was readying to split the office of the patents and trademarks controller. More...
India hauls Netherlands to WTO
(P. T. Jyothi Datta , 21-Jul-2010 , Business Line)
Files case over drug export seizures. More...
Govt estimates biotech capacity expansion needs Rs700 crore
(C.H. Unnikrishnan , 21-Jul-2010 , Livemint)
Some 48 biopharmaceuticals with a combined sales of $73 billion in 2009 are going off patent in the next 10 years which provides a competitive opportunity for Indian firms though production of biopharmaceuticals is more complicated compared with drugs based on conventional chemistry. More...
Japans Eisai to make key drug in India Nikkei
( Ashutosh Joshi in Bangalore , 21-Jul-2010 , Reuters)
Patents for the drug will expire in the United States this November and then in Japan and Europe by 2012. More...
Access to medicine groups call upon WIPO WTO & WHO to reject IP enforcement initiatives
(Ramesh Shankar, Mumbai , 21-Jul-2010 , Pharmabiz)
International group of access to medicine groups academics and experts who gathered at the University of California at Berkeley Law School have called upon policy makers in governments and international organizations like WIPO WHO and WTO to reject the cynical and dangerous efforts that are being made through the intellectual property enforcement initiatives to prioritize commercial interests over the right to health. More...
Konkan Railway has patent on anti crash device
(TNN , 20-Jul-2010 , The Times Of India)
Even as the Konkan Railway Corporation Ltd. was granted an Anti Collision Device patent in the United States of America for its Track Identification System recently neither the Central nor its counterpart Western Railway has installed it in any of their trains. More...
US court rules against Sun Pharmas appeal
(BS Reporter / Mumbai , 20-Jul-2010 , Business Standard)
Sun Pharmaceutical Industries said the US District Court for New Jersey had denied its appeal to reverse an earlier jury verdict in the patent litigation over the generic version of Wyeths heartburn medicine Protonix. More...
U.N. urged to probe U.S. trade stance on generic drugs
(Doug Palmer , 20-Jul-2010 , Reuters)
Their ire is directed at an annual report produced by the U.S. Trade Representatives office that ranks countries with the worst records on protecting U.S. intellectual property rights for goods ranging from CDs to medicines. More...
Patent for innovative technology crucial Sam Pitroda
(IANS , 20-Jul-2010 , Sify)
Creating an innovative product with new technology is good but to safeguard the patent of such products is far more important said Sam Pitroda the advisor on Public Information Infrastructure and Innovations to Prime Minister Manmohan Singh. More...
Punjab to create IPR awareness in 18 clusters
(Vijay C Roy / Chandigarh , 20-Jul-2010 , Business Standard)
Small and medium enterprises face the challenge of extracting the latent value of their intellectual property and using it effectively in their business strategies. More...
HC asks Singhanias to share Raymond trademark with Chennai pharma co
(Almas Meherally , 19-Jul-2010 , The Economic Times)
Bombay High Court has ordered Raymond the textile company of the Singhania group to share its trademark Raymond with a Chennai based privately held pharmaceutical company Raymond Pharmaceuticals. More...
Sun Pharma says U.S. court denies motion on Protonix
( Bharghavi Nagaraju , 19-Jul-2010 , Reuters)
Sun Pharmaceutical said a U.S. court had denied its motion to reverse a jury verdict of infringement against the Indian firm on Pfizers Protonix acid reflux drug patent that the jury had said was valid. More...
FICCI Maha Judicial Academy to host Judges Roundtable 2010
(Our Bureau, Mumbai , 19-Jul-2010 , Pharmabiz)
Federation of Indian Chambers of Commerce and Industry in association with Maharashtra State Judicial Academy will be organizing Judges Roundtable 2010 at Uttan Bhayander Maharashtra near Mumbai on July 24 and 25 2010. More...
India has formula to zap oil from BP spill
(Sanjay Dutta , 19-Jul-2010 , The Times Of India)
Lal holds the patent for Oilzapper and heads the joint venture between Teri and state run ONGC that markets the formulation. More...
Commerce dept seeks cooperation for IP protection
(Joe C Mathew / New Delhi , 18-Jul-2010 , Business Standard)
The Department of Commerce has called for coordination among various ministries for a consensus on adoption of intellectual property protection measures. More...
Saving yoga from copyright mongers
(Lhendup Gyatso Bhutia , 18-Jul-2010 , DNA)
Somebody in South Korea has filed a patent for baby yoga. More...
Drug dealers venture into production
(PB Jayakumar / Mumbai , 18-Jul-2010 , Business Standard)
Generics are non patented drugs and those without a brand name are referred to as generic generics. More...
Sun Pharma Says U.S. Court Denies Motion Over Protonix Ruling
(Bloomberg , 17-Jul-2010 , Bloomberg BusinessWeek)
The company continues to believe that the patent is invalid and unenforceable and will pursue all available legal remedies including appeals it said. More...
HC boost for innovators orders overhaul of patent process
(Nikhil Kanekal , 17-Jul-2010 , Livemint)
In a much needed relief to innovators the Delhi high court on Thursday passed a landmark judgement which will bring greater transparency to the process of granting patents and crack down on the practice of filing mischievous pre grant opposition. More...
Sun Pharma gets USFDA nod for Flomaxs generic version
(Press Trust of India / New Delhi , 16-Jul-2010 , Business Standard)
The generic version launched by the company is equivalent to Boehringer Ingelheim Pharmaceuticals patented Flomax capsules. More...
Discovery says infringement case v Amazon not new
(Tom Hals , 16-Jul-2010 , Reuters)
A patent infringement lawsuit filed on Wednesday against Amazon.com was a procedural move and not a new lawsuit according to Discovery Communications Inc, which filed the complaint. More...
Time to challenge plus size IPRs
(Prashant Goyal , 15-Jul-2010 , The Economic Times)
In an increasingly competitive world the developed countries are pursuing intellectual property rights route to retain competitive edge over developing countries. More...
Sun Pharma wins legal battle in US against Taro Pharma
(Our Bureau, Mumbai , 15-Jul-2010 , Pharmabiz)
Sun Pharmaceutical Industries Ltd.has received favourable ruling from the United States District Court for the Southern District of New York against Taro Pharmaceutical Industries. More...
Dr Reddy Laboratories sign MoU with Australian pharma
(PTI , 15-Jul-2010 , The Economic Times)
In the EU Arixtra is protected by data exclusivity which will expire in 2012. More...
IDMA seeks Azads intervention in solving several pending issues
(Our Bureau, Mumbai , 15-Jul-2010 , Pharmabiz)
The Indian Drug Manufacturers Association comprising of around 700 drug manufacturers across the country has sought Union health minister Ghulam Nabi Azads intervention to solve several long pending issues being faced by the pharma industry in the country. More...
Gilead Sues Lupin In Patent Infringement Case Over Generic Drug
(DOW JONES NEWSWIRES , 14-Jul-2010 , The Wall Street Journal)
Gilead Sciences Inc. sued Lupin Ltd. in federal court in New Jersey accusing the Indian generic drug maker of infringing its patents for Ranexa an angina treatment. More...
Celgene Novartis sue Sun Pharma on Para IV infringement of its extended release ADHD drug Focalin
(Our Bureau, Mumbai , 14-Jul-2010 , Pharmabiz)
The US based Celgene Corporation and the Swiz pharma major Novartis AG have filed a Para IV patent infringement suit against the US subsidiary of the Mumbai based Sun Pharmaceuticals Industries Ltd with the District Court of New Jersey for allegedly attempting to manufacture and sell the generic version of extended release Focalin used for the treatment of Attention Deficit Hyperactivity Disorder. More...
Games merchandise to hit market this week
(TNN , 14-Jul-2010 , The Times Of India)
According to Bhanot the IPR for the logo and other Games related designs were registered some years ago but were again taken out as a public notice because the OC had received several complaints about copyright infringement. More...
Owner of fake softdrink unit held in Delhi
(PTI , 14-Jul-2010 , Zee News)
A case of infringement of Indian Copyright Act 1957 and Patents Act 1970 has been filed against the accused. More...
Indias patent regime hurting across Asia Pacific
(Priyanka Golikeri , 13-Jul-2010 , DNA)
Sitting in a first floor room of a nondescript school building off Thakurdwar Road at Charni Road in south Mumbai Eldred Tellis is a picture of frustration and agony. More...
Letters: WIPO reforms
(Business Standard / New Delhi , 12-Jul-2010 , Business Standard)
This refers to Developing nations slam WIPO reform suggestions which talks about discussions at the most recent session of the Patent Cooperation Treaty Working Group held in Geneva from June 14 to 18. More...
Tighter import norms: Not just trade use of fakes too a crime
(Deepshikha Sikarwar , 12-Jul-2010 , The Economic Times)
The Central Board of Excise and Customs the apex indirect taxes body has amended a three year old notification to tighten the norms for import of products that have intellectual property rights protection said a government official. More...
Music & video piracy up cops blame lax law
(TNN , 12-Jul-2010 , The Times Of India)
We usually book the accused under the Copyright Act and slap 420 IPC for cheating. More...
Rs.3000 crore venture capital fund to drive pharma growth
(12-Jul-2010 , Sify)
The government is also working on priority basis to build Intellectual Property Rights offices for expeditious approval and rejection of patents. More...
Building an emerging market Bric by Bric
(Priyanka Golikeri , 12-Jul-2010 , DNA)
Other methods such as getting listed on foreign stock exchanges making foreign acquisitions seeking patent protection for innovations in international markets say Khanna and Palepu are other ways for emerging giants to spread their wings round the globe. More...
India capable of producing lower cost HPV vaccine
(10-Jul-2010 , Sify)
Vaccine manufacturers in India and other developing nations can produce a lower cost HPV vaccine despite the complicated array of patent protections on the technology according to an Indian origin scientist at the Duke Institute for Genome Sciences and Policy. More...
NTP files patent suits against technology giants
(9-Jul-2010 , Yahoo News)
NTP a patent holding firm which won a 600 million dollar settlement from Blackberry maker Research in Motion now has Apple Google HTC Corp. LG Electronics Microsoft and Motorola in its sights. More...
Cipla brass to get new shine CEO to step down
(Kiran Kabtta Somvanshi & Deepali Gupta , 09-Jul-2010 , The Economic Times)
Cipla which makes low cost generic version of patented drugs is Indias second largest drug company by market share after Abbott Laboratories recently acquired Piramal Healthcares domestic formulations business to surge ahead of the Indian pharma major. More...
Lupin among top five generic drug companies in US
(P B Jayakumar / Mumbai , 9-Jul-2010 , Business Standard)
A generic drug is one produced and distributed without patent protection. More...
President urges pharmacy sector to get equipped for future
(IANS , 09-Jul-2010 , Sify)
PricewaterhouseCoopers in its recent report has estimated that around $70 billion worth of drugs will go off patent in the US. More...
SC reprieve for Daiichi Sankyo
(BS Reporter / New Delhi , 9-Jul-2010 , Business Standard)
Bio similars are low cost versions of patented biotech products. More...
UN body shows a global dream to weavers
(Adam Halliday , 09-Jul-2010 , Indian Express)
Will hold sensitisation programme next Monday to educate them on UN recognised patents that could turn their products into global brands More...
Shire files patent lawsuit against Cadila
(The Associated Press , 08-Jul-2010 , Bloomberg BusinessWeek)
Irish drugmaker Shire PLC said Thursday it has filed a patent infringement suit against Indian generic drug developer Cadila Healthcare Ltd. over the bowel disorder drug Lialda. More...
Pfizer launches pneumonia prevention vaccine Prevanar 13
(Archana Shukla , 08-Jul-2010 , NDTV Profit)
Prevenar 13 offers superior protection from pneumococcal diseases and Pfizer in turn is looking at that vaccine to protect its global revenues which is expected to see a steep fall in the next two years with its blockbuster drug Lipitor going off patent. More...
Students design device to tackle power theft
(N Dinesh Nayak , 08-Jul-2010 , The Times Of India)
The students have also applied for patent for this first of its kind technology in the country. More...
Ayurvedic drugs too will need to be clinically tested says govt
(C.H. Unnikrishnan , 8-Jul-2010 , Livemint)
These are mainly in the nature of confirmatory trials on the safety and efficacy of patent and proprietary medicines most of which are made by altering approved formulations by adding or removing some ingredients. More...
Fakes a reality check
(K. Gopinathan , 8-Jul-2010 , Business Line)
Counterfeit phones are thriving as consumers find them a cheap and easy way to possess brands by paying just a fraction of the cost of a genuine one. More...
Media companies oppose tax on copyright services
(Vrishti Beniwal / New Delhi , 8-Jul-2010 , Business Standard)
PVR Pictures in its petition alleged that copyrights are treated as goods and the transfer of copyrights are treated as sale of goods which falls within the domain of taxation by states under Article 246 and not the Union. More...
Online Billfight!
(TNN , 8-Jul-2010 , The Times Of India)
They are all a big fraternity during awards but theres a different side to the family when it comes to the proposed amendments to the Copyright Act. More...
International experts claim ACTA to threaten global access to affordable medicines
(Our Bureau, New Delhi , 7-Jul-2010 , Pharmabiz)
Akin to the stand taken by India at the international forum a large number of international experts from across the world have slammed the proposed Anti Counterfeiting Trade Agreement as threat to the public interests and noted that the claims by the negotiators were wrong footed. More...
Foreign parent need not pay for marketing intangibles
(Deepshikha Sikarwar , 7-Jul-2010 , The Economic Times)
The officer also ruled that SMC failed to compensate MSIL for the use of its trademark Suzuki which according to him was then a weak brand in India whereas Maruti was a strong brand. More...
Split royalty
(The Financial Express , 7-Jul-2010 , The Financial Express)
The reported decision of the government to split the royalty from publicly funded research projects between the researchers the institution and the government in the new Protection and Utilisation of Publicly Funded Intellectual Property Bill which is to be reintroduced in the monsoon session of Parliament is a welcome step that can help accelerate the pace of innovations and encourage patenting. More...
Govt expands royalty share in IP Bill to deflect criticism
(Nistula Hebbar , 6-Jul-2010 , The Financial Express)
The Bill to channel more patents from Indian universities for use in industry is now better placed to clear Parliament. More...
Industry urges govt to remove clause on'Patent status in Form 44 of D&C Rules
(Ramesh Shankar, Mumbai , 6-Jul-2010 , Pharmabiz)
The pharmaceutical industry in the country has urged the union health ministry to remove the clause relating to the Patent status of the drug from the Form 44 of Drugs and Cosmetics Rules on the plea that the clause on the patent status of the drug only favours the patent holder to delay the entry of a generic drug in the market. More...
Producers too want rights over film music
(B Ramakrishna / Chennai/ Hyderabad , 6-Jul-2010 , Business Standard)
Telugu film producers have set forth their claim over film music as a piece of intellectual property arguing that such music is composed in the context of a particular film and so forms part of it. More...
Basmati trademark registration delay to hurt exports: growers
(Shahid Shah , 3-Jul-2010 , The News)
Decision of trademark registration of Basmati rice is pending in the Sindh High Court for over two years which is likely to have a negative impact on the rice trade of Pakistan a representative rice growers said on Friday. More...
Fake soft drink unit busted in northeast Delhi
(Indrani Basu , 3-Jul-2010 , The Times Of India)
A case of infringement of Indian Copyright Act 1957 and Patents Act 1970 has been filed against the accused. More...
One man to run the show at Hubli Spices Board
(Vincent D'Souza , 02-Jul-2010 , The Times Of India)
He said the staff crunch will affect the field offices achievements at a time when it is expecting the geographical indication tag for Byadagi chilli. More...
Move to better access to drugs a welcome change
(Pillman , 02-Jul-2010 , DNA)
In India Gilead has entered into manufacturing deals with companies like Emcure and Strides but at the same time it is embroiled in litigations with Cipla over Viread. More...
India foils Danish firms bio piracy bid
(Kounteya Sinha , 2-Jul-2010 , The Times Of India)
After stopping the Chinese from patenting pudinas health benefits India has now foiled a major bio piracy bid by a Danish company to patent ginger jeera cumin onion and turmerics fat burning properties. More...
Natco Pharmas earnings on track
(Jwalit Vyas , 2-Jul-2010 , The Economic Times)
However when a drug goes off patent there is a substantial market size erosion due to the lower price offered for the same drug by several generic manufacturers. More...
AstraZeneca loses ulcer drug appeal
(Nikki Tait in Brussels , 2-Jul-2010 , Financial Times)
On Tuesday the group won an initial court victory in the US in a different patent battle prompting its shares to rise strongly. More...
Hic! Feni fights to regain turf in Goa
(Chandu Gopalakrishnan , 1-Jul-2010 , The Economic Times)
After a very long campaign feni a beverage distilled out of cashew apple got geographical indication in 2009. More...
Delisting pill yet another time
(Ram Prasad Sahu , 1-Jul-2010 , Business Standard)
The Swedish parent company won an international lawsuit on Tuesday which will help it to keep the patent on the drug till 2016. More...
Push to launch EU wide patent
(Nikki Tait in Brussels , 01-Jul-2010 , Financial Times)
Top European Union officials and diplomats on Thursday began a new push to introduce a single EU wide patent a move which could slash costs faced by innovative companies trying to protect their inventions but which has proved politically elusive for decades. More...
New xxx registry has companies worrying over brand poaching
(Surabhi Agarwal , 1-Jul-2010 , Livemint)
The World Intellectual Property Organization decided in favour of the Tata group Makemytrip.com is still contesting the decision. More...
AstraZeneca sues Glenmark Generics in US for patent infringement of Crestor
(Our Bureau, Mumbai , 30-Jun-2010 , Pharmabiz)
The Anglo Swedish drug maker AstraZeneca Pharmaceuticals has filed a fresh Para IV patent infringement law suit against Glenmark Generics Inc the North American division of Mumbai based Glenmark Generics Ltd in the US in June 2010 for attempting to manufacture and sale of generic version of its blockbuster cholestrol lowering drug Crestor before expiry of patent validity More...
Looking Beyond The Hype
(Sumit Bhaduri , 30-Jun-2010 , The Times Of India)
Low cost labour in the developing world and uniformity in patent rights in more than 100 nations are the two factors that have had maximum impact on the innovation process. More...
Kotak Mahindra Bank may edge higher on preferential issue to Japans SMFG
(Capital Market , 30-Jun-2010 , NDTV Profit)
Swiss drugmaker AstraZeneca has reportedly sued Glenmark Pharmaceuticals in the US last week alleging the infringement of its patent on cholesterol lowering drug Crestor. More...
Teva launches generic of AZs breast cancer drug Arimidex
(By Kevin Grogan , 29-Jun-2010 , Pharma Times)
Teva Pharmaceutical Industries says that it has been given the green light by regulators in the USA to sell its generic version of AstraZenecas cancer blockbuster Arimidex. More...
Pharma research outsourcing faces speed bumps
(PB Jayakumar / Mumbai , 29-Jun-2010 , Business Standard)
Venkat Jasti vice chairman and managing director of Suven Life Sciences is an optimist on new drug discovery. More...
Mid size drug cos look for angel investors
(P.T.Jyothi Datta , 28-Jun-2010 , Business Line)
Is intellectual property protection still the domain of big fish in the pharmaceutical industry five years after the country brought in the product patent regime? More...
Venus Remedies gets patent for pneumonia drug in New Zealand
(Press Trust of India / New Delhi , 28-Jun-2010 , Business Standard)
Pharma firm Venus Remedies today said that it has received patent for its anti pneumonia drug in New Zealand and hopes to generate handsome revenues there following the grant. More...
Animation industry seeks IP fund
(BV Mahalakshmi , 28-Jun-2010 , The Financial Express)
But creating intellectual property was not easy due to a lack of understanding the value of intellectual property rights. More...
Cipla in talks with Centre to share cancer drug know how
(Khomba Singh , 28-Jun-2010 , The Economic Times)
The initial discussions are related to 10 off patented cancer drugs said a person familiar with the matter adding that the talks centred on the number of drugs and the processes involved in transferring knowledge. More...
Indian Trademark Rules 2000 Amended
(ag-IP-news , 28-Jun-2010 , ag-IP-news )
Abu Ghazaleh Intellectual Property announced in a press release that the Indian Trademark Rules 2000 have been amended. More...
Indias Sun Pharma to stop selling Eloxatin generic
(Sumeet Chatterjee , 28-Jun-2010 , Reuters)
Sun Pharmaceutical Industries will stop selling generic version of Sanofi Aventis cancer drug Eloxatin in the United States after June 30 following a court order the Indian drugmaker said. More...
Indias growing CRAMS pie a cause of joy for Jubilant
(Nitin Shrivastava , 28-Jun-2010 , DNA)
The Indian pharmaceutical industry is witnessing lot of interest with huge opportunities in the global contract manufacturing and generic space for supply of low cost off patent drugs. More...
Rediff wins cybersquatting case against Pakistani individual
(Press Trust Of India , 28-Jun-2010 , Hindustan Times)
Online services major Rediff.com India Ltd has won a cybersquatting dispute against a Pakistani person who was using an identical domain name and illegally incorporating the Indian firms trademark. More...
India foils Chinese bid to patent pudina
(Kounteya Sinha , 24-Jun-2010 , The Times Of India)
India has foiled a major Chinese bio piracy bid to patent the use of medicinal plants pudina mint and kalamegha andrographis for the treatment of H5N1 avian influenza or bird flu. More...
Trademarks office ushers in glasnost
(C.H. Unnikrishnan , 24-Jun-2010 , Livemint)
Indias Controller General of Patents Designs and Trademarks has placed in the public domain details of pending trademark applications registered trademarks examination reports copy of applications opposition to such applications and other information in a move that is certain to increase transparency into the workings of the department. More...
India asks US to remove ISRO DRDO from banned list
(IANS , 24-Jun-2010 , The Times Of India)
Asked about Kirks calls to India to address longstanding impediments like investment caps agricultural market access barriers high tariffs and intellectual property rights Sharma said he had conveyed that India was fully TRIPS compliant. More...
An odd royalty calculus
(Latha Jishnu / New Delhi , 24-Jun-2010 , Business Standard)
For years now at least since India passed amendments to the Patent Act to allow product patents in 2005 patents on drugs have coloured and overwhelmed the debate on health issues in the country. More...
Mauled Bollywood seeks script change bets on co production
(Nandini Raghavendra , 24-Jun-2010 , The Economic Times)
Depending on deal to deal the intellectual property rights or IPR in a co production could be for perpetuity or for a number of years. More...
Patent expiry may open $90 bn market for Dr Reddys
(Adi Narayan , 23-Jun-2010 , Livemint)
Dr Reddys Laboratories Ltd may be the biggest beneficiary among Indian generic drug makers as $157 billion of medicines including Eli Lilly and Co.s Zyprexa lose patent protection within five years HDFC Securities Ltd said. More...
Developing nations slam WIPO reform suggestions
(Joe C Mathew / New Delhi , 23-Jun-2010 , Business Standard)
The international patent reform plans pursued by the World Intellectual Property Organization have been criticised by several developing countries including India after they felt it may have an impact on the decision making powers of national patent offices More...
Sun Pharmas US outlook improves
(Ravi Ananthanarayanan , 23-Jun-2010 , Livemint)
Sun Pharma received just one approval from the US Food and Drug Administration to market a generic drug More...
Trademark battles catch city firms off guard
(TNN , 23-Jun-2010 , The Times Of India)
This firm got its name registered as a trademark in India in 2005 and applied for the same with the US Patent and Trademark Office. More...
India to be battleground for off patent biotech drugs
(Priyanka Golikeri , 23-Jun-2010 , DNA)
Although the growth opportunity for off patent versions of biotech medicines is huge in the developed world regulatory hurdles there mean India and rest of the developing world could be where the opportunity lies for biopharmaceutical companies. More...
US asks India to address longstanding impediments to trade
(IANS , 23-Jun-2010 , The Times Of India)
US Trade Representative Ron Kirk also listed intellectual property rights and the need for continuing regulatory streamlining and transparency among the impediments at a meeting Tuesday with Indian Commerce and Industry Minister Anand Sharma according to an official US readout. More...
Sun settles patent row over Parkinsons drugs with Orion
(PTI , 22-Jun-2010 , The Economic Times)
Sun Pharmaceutical Industries today said it has settled patent litigation with Finland based Orion over generic versions of Stalevo and Comtan tablets which are used for the treatment of Parkinsons disease. More...
Suven looks for global tie ups for new drugs
(C.H. Unnikrishnan , 22-Jun-2010 , Livemint)
Hyderabad based drug maker Suven Life Sciences Ltd is looking for partnerships with global pharma firms to market new drug candidates after winning discovery patents for treatments of some of the modern worlds most common ailments. More...
Teva execs remark creates furore in Indian pharma
(Joe C Mathew / New Delhi , 22-Jun-2010 , Business Standard)
Domestic drugmakers used to frequent India bashing by research driven global pharmaceutical majors for alleged infringement of patent rights or quality issues were in for a shock last week when the worlds largest generic company Israels Teva made allegations against the industry practices in India and China. More...
Draft legislation ready to spin off trademark division
(C.H. Unnikrishnan , 22-Jun-2010 , Livemint)
The commerce ministry has prepared a draft law to move the trademark wing of the intellectual property office out of the purview of the controller general of patents designs and trademarks. More...
Otsuka sues Zydus for Para IV patent infringement of blockbuster drug Abilify
(Gireesh Babu, Mumbai , 22-Jun-2010 , Pharmabiz)
Zydus has filed ANDA with the US FDA to sell generic products containing 5 10 15 20 and 30 mg of aripiprazole in US market according to the complaint. More...
Lunch with BS: Richard Jefferson
(Latha Jishnu / New Delhi , 22-Jun-2010 , Business Standard)
Appalled by the patent thickets that were stifling biotech research Jefferson decided that the basic tools of biotechnology such as his GUS technology that allowed molecular biologists to monitor exactly what was going on when they were trying to implant foreign genes into an organism should be freely available. More...
Scientist uses waste to make biodegradable plastic sheets
(Kautilya Singh , 22-Jun-2010 , expressindia)
On June 14 Mathuria applied for a patent at the Controller of Patent Office in New Delhi. More...
Drugmakers rush for a lift from US hormones mart
(Priyanka Golikeri , 21-Jun-2010 , DNA)
Indian drugmakers are queuing up to get a piece of the lucrative hormones market in the US which is growing at a fast pace. More...
IIT Bombay streamlines technology licensing
(Mihika Basu , 21-Jun-2010 , DNA)
Whats more for the first time IIT B is also advertising all its intellectual property which can be licensed. More...
Kenyans could soon patent local products
(By MWANIKI WAHOME , 20-Jun-2010 , Daily Nation)
Local producers will for the first time be able to acquire patents for commodities that are unique to their geographical areas once a Bill at the Attorney Generals office is enacted. More...
Tea fights lingerie in patent row
(Zia Haq , 19-Jun-2010 , Hindustan Times)
India continues to fight off attempts by entities around the world from staking claim to Darjeeling tea the worlds most expensive variety. More...
Konkan Railway gets patent for anti collision device in the US
(Prakash Kamat , 19-Jun-2010 , Business Line)
Konkan Railway Corporation Ltd has been granted the anti collision device patent in the US for its Track Identification System recently. More...
US EU cite safety issue in defence of piracy law
(Amiti Sen , 19-Jun-2010 , The Economic Times)
A group of developed nations led by the US and the EU has initiated discussions at the World Trade Organisation on legitimacy of their proposed anti counterfeit agreement. More...
Developing countries reject WIPOs proposal for increasing reliance of national patent offices on ISERs
(Ramesh Shankar, Mumbai , 19-Jun-2010 , Pharmabiz)
Twenty developing countries including India have rejected the World Intellectual Property Organizations proposal for increasing the reliance of national patent offices on international search and examination reports issued by International Search Authorities. More...
US lawmakers rap corporates for preferring China over India
(Lalit K. Jha/PTI / Washington , 19-Jun-2010 , Business Standard)
American corporate giants faced a tough time on the Capitol Hill as lawmakers grilled them as to why they were opting to do business with communist China over a democratic India. More...
The drug lords
(Anika Gupta , 18-Jun-2010 , Livemint)
Most Indian pharma firms dont even dabble in new drug development. More...
Drug developed by RSS body gets US patent
(STAFF WRITER , 18-Jun-2010 , Press Trust Of India)
An anti cancer drug extracted from cow urine and developed by an affiliate of the RSS has got a US patent for the third time for its anti genotoxicity properties a senior official has said. More...
Ready for doosra
(Anupama Chandrasekaran , 18-Jun-2010 , Livemint)
But five years after the first prototype was created and the patent was applied for the product is yet to ring in sales or profits. More...
Glenmark recalls child epilepsy drug in US
(PTI , 17-Jun-2010 , The Economic Times)
Oxcarbazepine is a generic version of Novartis patented drug Trileptal. More...
Big Pharma cuts R&D jobs as generics loom
(REUTERS , 17-Jun-2010 , The Economic Times)
One factor forcing Big Pharma to rethink its business model is the huge number of patents that are set to expire over the next five years. More...
India EU to hold talks on drug dispute next month
(STAFF WRITER , 17-Jun-2010 , Press Trust Of India)
At the instance of the WTO India and the European Union will try to resolve a dispute relating to seizure of Indian drugs by some European countries for alleged patent violations next month. More...
Wipro to provide legal process outsourcing to Microsoft
(Bangalore , 17-Jun-2010 , Hindustan Times)
The business process outsourcing division of Wipro Technologies will provide legal process outsourcing to Microsofts intellectual property and licensing group worldwide the Indian IT bellwether said Wednesday. More...
Suven gets patents for two CNS drugs in Japan
(BS Reporter / Hyderabad , 16-Jun-2010 , Business Standard)
Suven Life Sciences Limited a Hyderabad based biopharmaceutical company has secured two product patents from the Japanese Patent Office for two of its new chemical entities indicated for the treatment of disorders associated with the central nervous system. More...
Cipla aims to sell copies of Roche Amgen biotech drugs
(Adi Narayan , 17-Jun-2010 , Livemint)
Biotechnology drugs account for around 10 15% of the global pharmaceutical market and many of them are off patent or will lose patent protection soon Cipla said. More...
Cipla unveils Rs 300 cr plan to foray into biosimilar space
(BS Reporter / Mumbai , 16-Jun-2010 , Business Standard)
Cipla the largest domestic drug maker today said it would invest $65 million in three years to acquire a 40 per cent stake in an Indian biotech company and 25 per cent stake in a similar company in Hong Kong as part of its foray into biosimilars or generics of off patent biotech drugs. More...
Amendment to copyright law opposed by film producers
(STAFF WRITER , 16-Jun-2010 , Press Trust Of India)
A move to amend a 53 year old law to give independent rights to writers lyricists and singers thereby entitling them to royalty today came in for strong opposition from some film producers More...
AMRI Receives Approval of Preliminary Injunction Against Dr. Reddys
(ag-IP-news , 15-Jun-2010 , ag-IP-news )
The positive outcome of this hearing bolsters our belief in the strength of AMRIs intellectual property rights related to Allegra. More...
Wary investors take refuge in pharma stocks
(Harish Rao , 15-Jun-2010 , The Economic Times)
Mr Jani also says that companies concentrating on the US generics market will see significant price appreciation because patents on many high potential molecules are going to expire in the coming five years giving them a huge opportunity to become global generic players. More...
Abbott sues Sun Ranbaxy on cholesterol drug patents
(Soma Das , 15-Jun-2010 , The Financial Express)
The US based pharma company Abbott has sued two top Indian drugmakers Ranbaxy Labs Ltd and Sun Pharmaceuticals in the US market alleging patent infringement in the cases of two different cholestrol drugs More...
National Pharmaceutical Pricing Authority may cap cancer drug prices via Para 10
(Vivek Seal , 15-Jun-2010 , DNA)
In a bid to control the high cost of cancer related essential drugs the National Pharmaceutical Pricing Authority may enact Para 10 B on specific drugs if negotiations with drug makers to reduce prices fail according to a government official. More...
Bending over backwards to protect Indian yoga
(Hannah Gardner Foreign Correspondent , 14-Jun-2010 , The National)
Foreign countries are trying to patent it. More...
US NGOs urge GWU to stop industry sponsored IP summits in India
(Ramesh Shankar, Mumbai , 14-Jun-2010 , Pharmabiz)
A group of nine non governmental organisations working in the field of health sector have appealed to the George Washington University to stop its industry sponsored intellectual property summits in India as these summits have become a front for a biased industry agenda. More...
China Equador stand by India at WTO
(Amiti Sen , 14-Jun-2010 , The Economic Times)
China and Equador have come out in support of India in its fight against the European Union at the World Trade Organization for wrongful seizure of its generic or off patent drugs in transit to third countries. More...
US court injunction stops launch of Dr Reddys drug
(BS Reporters / Mumbai/ Hyderabad , 13-Jun-2010 , Business Standard)
Analysts were expecting Allegra D24 to generate over $150 million in 3 years. More...
India protests regional pact on intellectual property rights
(Joe C Mathew / New Delhi , 12-Jun-2010 , Business Standard)
India has protested against the Anti Counterfeit Trade Agreement being negotiated by the United States the European Union and other countries on the grounds that it will strengthen the holders of intellectual property rights beyond reasonable measure. More...
India raises concerns on proposed ACTA TRIPS Plus measures at WTO forum
(Joseph Alexander, New Delhi , 12-Jun-2010 , Pharmabiz)
Raising concerns over the efforts by the developed countries to introduce provisions into trade agreements that go beyond the TRIPS agreement India has strongly raised objection to the proposed Anti Counterfeiting Trade Agreement which can adversely affect Indian pharma business. More...
RIM Motorola enter into license pact settle all litigations
(Press Trust Of India , 12-Jun-2010 , Hindustan Times)
Blackberry maker Research In Motion and telecom major Motorola have entered into a global settlement and licensing agreement ending all litigations between them. More...
Venus Remedies gets India patent for painkiller
(Kaustubh Kulkarni & Bharghavi Nagaraju , 11-Jun-2010 , Reuters)
Drug maker Venus Remedies Ltd said on Tuesday it has been granted a patent by Indian authorities for its once a day painkiller Aceclofenac injection. More...
Ranbaxy to start supply of API formulations to AstraZeneca
(Radhieka Pandeya , 11-Jun-2010 , Livemint)
The agreement between the two companies follows from a manufacturing agreement that was part of a bigger patent infringement settlement between Ranbaxy and AstraZeneca in April 2008. More...
Grant in aid status for NIF soon
(Vasundhara Vyas Mehta , 11-Jun-2010 , The Times Of India)
NIF has filed 235 patent applications in India and seven patent applications in US. More...
Pfizer recalls 3 drugs made by Indian pharma company
(Soma Das , 11-Jun-2010 , The Financial Express)
The first glitches in the big pharma generic drug licensing alliance story have surfaced sooner than expected. More...
Gilead Sciences mulls legal action against Lupin
(Sakthi Prasad in Bangalore , 11-Jun-2010 , Reuters)
U.S. biotechnology firm Gilead Sciences Inc said it may take legal action against Lupin Ltd after the Indian firm submitted an abbreviated new drug application to manufacture and market a generic version of its angina drug Ranexa. More...
Publishers plight
(Meethil Momaya , 11-Jun-2010 , Business Standard)
This refers to Copyright copywrong June1. More...
Dream Theatre bags rights for iconic brands
(Bindu D. Menon , 11-Jun-2010 , Business Line)
The licensing industry is set to piggy back on the growth of organised retail with a slew of brands making inroads in India. More...
Lakhnavi zardozi to get GI tag soon?
(Shailvee Sharda , 10-Jun-2010 , The Times Of India)
Metallic wire kora saadi kinari salma badla sequins and stones... lying scattered these sparkling trappings may not mean much. More...
Waking up to ACTA
(Latha Jishnu / New Delhi , 10-Jun-2010 , Business Standard)
It goes well beyond curbing trade in counterfeit goods and is a brazen attempt to create higher stands of intellectual property protection than envisaged in the globally mandated TRIPS agreement of the World Trade Organisation. More...
Glenmark scores over Sanofi Abbott in US patent challenge
(ET Bureau , 9-Jun-2010 , The Economic Times)
Glenmark Pharmaceutical has scored in its patent tussle with Sanofi Aventis and Abbott after the New Jersey district court upheld the challenge by the Indian company for a hyper tension drug. More...
Global drug makers see big business in anti cancer market
(C.H. Unnikrishnan , 09-Jun-2010 , Livemint)
Though patent rights for some of these expensive anti cancer drugs protect the foreign companies from competition a highly price sensitive market in India and emerging competition from local drug makers makes it imperative for them to adopt aggressive market development strategies. More...
AIPS to hold seminars on patent opposition in Mumbai on June 25 and 26
(Our Bureau, Mumbai , 9-Jun-2010 , Pharmabiz)
Academy of Intellectual Property Studies will organise two back to back seminars on Patent Opposition and How the Indian Patent Office Decided in 2009 which are to be held on June 25 and 26 2010 in Mumbai. More...
India China move WTO on Trips plus West agenda
(Amiti Sen , 8-Jun-2010 , The Economic Times)
The two countries have asked the WTOs Trips council to include the issue of Trips plus enforcement trend in the agenda for its meeting this week in order to examine the sanctity of an agreement being planned by a group of countries that goes beyond what they have agreed to under the WTO. More...
Ericsson claims pole position in patents for 4G technology
(Geeta Nair , 8-Jun-2010 , The Financial Express)
Even though 3G has not yet been launched in many markets telecom companies have already focused attention on a next generation mobile technology LTE . More...
Weve nothing to lose
(Hindustan Times , 8-Jun-2010 , Hindustan Times)
When an enterprising American wants a patent on the Paschimottanasana we in India say by all means go and grab that copyright. More...
Differences crop up again at Bonn
(Urmi A Goswami , 8-Jun-2010 , The Economic Times)
The differences over intellectual property regime continue to be hotly contested with the developed world arguing that intellectual property be protected. More...
EU firm on strong IP provision in free trade
(Priyanka Golikeri , 8-Jun-2010 , DNA)
A key provision in the draft of the India European Union free trade agreement may have implications on the affordability of medicines while also hurting the negotiations between the two trading blocs. More...
PM has failed to outline our priorities
(Bharat Jhunjhunwala , 8-Jun-2010 , expressbuzz)
The international dimension of health problems arises mainly through patent laws which enable multinational corporations to charge exorbitant prices for patented drugs. More...
Scent of the jasmine
( K Shashidhar Hemmanna , 8-Jun-2010 , Deccan Herald)
Then theres the issue of patenting these flowers. More...
India to patent yoga asanas
(Madan Jaira , 7-Jun-2010 , Hindustan Times)
The Council for Scientific and Industrial Research has prepared patent formats of nearly 900 yoga asanas to prevent European and American companies involved in fitness related activities from claiming them as their own. More...
House panel suggests drastic changes to innovation Bill
(C.H. Unnikrishnan , 7-Jun-2010 , Livemint)
The new draft proposes to give the government the right to use any invention patented by a state funded institution More...
Karnataka pharma majors bullish over European export prospects
(Nandita Vijay, Bangalore , 7-Jun-2010 , Pharmabiz)
Liquidity crunch and growing uncertainty in the Euro zone have not deterred the Karnataka based pharma companies from expanding their operations and also patent filing in Europe. More...
Trademarks section to move out of IP office
(C.H. Unnikrishnan , 04-Jun-2010 , Livemint)
India plans to spin off the trademark registry from its intellectual property office which currently deals with trademarks patents and designs. More...
Fake drugs are a real menace
(Nick Schulz , 04-Jun-2010 , Livemint)
Quality and safety concerns hurt Indias pharmaceutical promise. More...
Glenmark puts IPO of generics arm on hold
(Radhieka Pandeya , 04-Jun-2010 , Livemint)
Glenmark Pharmaceuticals Ltd has deferred the planned initial public offering of its wholly owned generics arm Glenmark Generics Ltd because it is no longer in desperate need of money. More...
Kenya sees cure in Indian generics now
(Amiti Sen , 03-Jun-2010 , The Economic Times)
The Kenyan health ministry has conceded that the country should not have passed the anti counterfeit law last year and said it would try and make changes to ensure that imports of legitimate generics were not affected. More...
Takeda drags Dr Reddys to court over diabetic drug
(Soma Das , 03-Jun-2010 , The Financial Express)
The largest Japanese drug firm Takeda Pharma has sued Hyderabad based Dr Reddys Labs for allegedly infringing the formers patent coverage on anti diabetic drug Actos by trying to manufacture and market the same in the US. More...
Zydus arm Irish co in patent dispute
(Vishal Dutta , 2-Jun-2010 , The Economic Times)
The Rs 3700 crore Zydus Groups US subsidiary Zydus Pharmaceuticals USA has challenged the Irish company Shire Pharmaceuticals over its patented gastro drug Lialda. More...
Bajaj Auto gets Chinese patent for ExhausTec technology
(PTI , 01-Jun-2010 , The Economic Times)
Two wheeler major Bajaj Auto on Tuesday said its ExhausTec technology used to improve power in single cylinder four stroke engines has been granted a patent in China. More...
News brief
(Hindustan Times , 01-Jun-2010 , Hindustan Times)
The next batch of nine month postgraduate diploma in Intellectual Property Rights and Patent Management will commence on June 17 2010. More...
India gets help in drugs piracy fight
(Amiti Sen , 1-Jun-2010 , The Economic Times)
A number of developing countries from East Asia Latin America and Africa have extended their support to India in its fight against an attempt by developed countries to narrow the difference between fake medicines and counterfeits. More...
GlaxoSmithKline tries a Linux approach to drugs
(Robert A. Guth, The Wall Street Journal , 1-Jun-2010 , Livemint)
Similarly large pharmaceutical companies tightly guard their formulas for drugs and other intellectual property. More...
India to oppose pact by US Europe on counterfeiting
(1-Jun-2010 , Yahoo News)
The commerce ministry is likely to voice its its opposition to the US and Europe Unions Anti Counterfeiting Trade Agreement arguing its passage would create non tariff barriers for the trade of Indian intellectual properties. More...
Copyright copywrong
(Nilanjana S Roy / New Delhi , 1-Jun-2010 , The Economic Times)
The fantasy of any Indian reader whos travelled to countries with bigger and better bookstores is simple: we want to be able to buy the books we love when they come out. More...
As trade pacts kick in farm fears run high
(Priyanka Golikeri , 1-Jun-2010 , DNA)
The objective of UPOV 91 is to protect new plant varieties through intellectual property. More...
Foreign telecom gear cos may get relief
(Joji Thomas Philip , 1-Jun-2010 , The Economic Times)
The review comes after global network vendors and sections of the government including the communications ministry informed the home ministry that the new rules are inconsistent with Indias commitments on intellectual property rights in multilateral global forums such as WTO. More...
Lupin set to acquire?second generics firm in Japan
(C.H. Unnikrishnan , 1-Jun-2010 , Livemint)
The Japanese government plans to convert at least 30% of the countrys prescription drug market to low cost generics or off patent drugs by 2012. More...
More generic cos keen on selling out to MNCs
(Khomba Singh , 31-May-2010 , The Economic Times)
Indian generics companies are an attractive target for overseas multinationals which are faced with loss of revenues due to the expiry of patents worth $70 billion by 2013 and a squeeze on margins. More...
India Big pharmas new battle field
(BV Mahalakshmi, Sudhir Chowdhary , 31-May-2010 , The Financial Express)
Global pharmaceutical companies are living in an era of change. More...
Not many Indian pharma cos are left for sale
(Vishal Dutta , 31-May-2010 , The Economic Times)
The recent takeovers in the pharma space have raised concerns among Indian players. More...
Legally bound
(Business Standard / New Delhi , 31-May-2010 , Business Standard)
Going by official reckoning some 2000 patents related to Indian systems of medicine are granted every year in the US Europe and elsewhere. More...
Union govt ready with draft guidelines for 5th amendment of the D&C Rules 2010 for Ayush drugs
(Nandita Vijay, Bangalore , 31-May-2010 , Pharmabiz)
For the issue of licenses for patent and proprietary drugs safety study report is not required but manufacturers will need to submit a pilot study according to the protocol of Ayurveda Siddha and Unani drugs. More...
Norms for foreign telecom gear cos may be eased
(Joji Thomas Philip , 31-May-2010 , The Economic Times)
The review comes after global network vendors as well as sections of the government including the communications ministry informed the home ministry that the new rules are inconsistent with Indias commitments on intellectual property rights in multilateral global forums such as WTO. More...
Much ado on basics of drug policy
(Indira Kannan / New York , 31-May-2010 , Business Standard)
Cipla arm flexing with US university underscores validity concerns on patent issues. More...
Sellout syndrome
(Sanchita Sharma , 31-May-2010 , Hindustan Times)
Medicines worth over $ 80 billion are going off patent at the US Patent and Trademark Office between 2011 and 2013 making it lucrative for global pharma majors to increase their presence in India which is the largest producer of generic medicines after the US and European Union. More...
India plans front to nip new piracy law
(ET Bureau , 29-May-2010 , The Economic Times)
India will strive to forge a united front against an anti counterfeiting agreement being negotiated by some developed countries which could threaten exports of genuine off patent drugs information technology and other products from emerging markets. More...
Patent linkage impermissible in India: Cipla
(Indu Bhan , 28-May-2010 , The Financial Express)
The dispute between Indian drug companies and the Big Pharma over patent linkage has reached the domain of judiciary. More...
Grape seizures at EU port: India sends delegation to sort out
(Asit Ranjan Mishra , 28-May-2010 , Livemint)
The commerce ministry has sent a delegation to Rotterdam to try and convince officials at the European port that Indian table grapes were being wrongly seized over the alleged presence of chemical preservatives More...
Founders of many Indian pharma companies keen to exit: Malvinder
(Khomba Singh , 28-May-2010 , The Economic Times)
Indian generics companies are an attractive target for overseas multinationals which are faced with loss of revenues due to the expiry of patents worth $70 billion by 2013 and a squeeze on margins. More...
Whos afraid of Synthia
(Latha Jishnu / New Delhi , 27-May-2010 , Business Standard)
Venters patent application for his synthetic cell creation has set off a frenzied debate on monopolies in genetic research More...
Piramal to launch own drug by 2012
(By James Fontanella-Khan and Joe Leahy in Mumbai , 27-May-2010 , Financial Times)
The countrys low cost research and production facilities and traditionally weak intellectual property regime have encouraged the development of a strong generic pharmaceutical industry but local drugs groups are now keen to formulate their own drugs. More...
Government doctors asked to promote generic drugs
(Special Correspondent , 27-May-2010 , The Hindu)
According to the World Health Organisation report prepared for the National Rural Health Mission Promoting Rational Drug Use under NRHM generic drugs which are usually produced when a branded drug loses its patent can tremendously increase the availability affordability and efficient use of medicines. More...
Ranbaxy seeks USFDA approval for new drug
(Khomba Singh , 27-May-2010 , The Economic Times)
RANBAXY Laboratories has sought the US drug regulators approval to sell a new drug in the worlds largest pharma market that has been manufactured in a unit of its Indian factory which is under scrutiny of the US regulator. More...
Should pharma firms sell out?
(Business Standard / New Delhi , 26-May-2010 , Business Standard)
Two for big pharma firms given the patent laws that came into effect in 2005 and given that they have already expanded both geographically and across therapeutic areas it is harder to look at growth rates far in excess of market growth rates. More...
Sun Pharma chief sees more consolidation ahead
(P.T. Jyothi Datta , 26-May-2010 , Business Line)
Sun Pharma has stopped selling Protonix generic pantaprazole in the US despite being confident on its litigation due to abundant caution he explained. More...
Novo sues Lupin to block generic in US
(Khomba Singh , 25-May-2010 , The Economic Times)
Danish company Novo Nordisk has sued Mumbai based drugmaker Lupin to prevent it from launching the low priced version of its patented diabetes medicine sold under the brand Prandimet in US. More...
Tune in for everything on intellectual property
(Madhumathi D.S. , 25-May-2010 , Business Line)
Its a patently different kind of radio. More...
Pharma MNCs will call the shots soon
(Khomba Singh , 25-May-2010 , The Economic Times)
Global MNCs lorded over 75% of the countrys drug market before the Indira Gandhi led government adopted a process of patent regime in 1971. More...
Pharma mergers & acquisition wave has roots in product patent regime
(Priyanka Golikeri , 25-May-2010 , DNA)
It all began on August 28 2006 when the Pennsylvania US based Mylan Inc bought Hyderabad-based Matrix Laboratories for $736 million. More...
Winds of change in pharmaceutical industry
(Muralidharan Nair , 25-May-2010 , The Financial Express)
The interest that big pharma firms have evinced in the Indian pharma market has undergone a sea change over the years More...
Half full half empty
(Business Standard , 25-May-2010 , Sify)
Pharma majors who have a lot of complaints about the patents regime in India nevertheless appear willing to pay a high price to get in. More...
MNCs back in control of 50% of Indian pharma market
(Khomba Singh , 24-May-2010 , The Economic Times)
But global MNCs in the face of shrinking revenues and the prospect of further losses when patents of drugs worth $70 billion expires by 2013 began to amplify their presence in generics from 2008. More...
Discuss FTA talks with EU in Parliament: CPM to govt
(ET Bureau , 24-May-2010 , The Economic Times)
On Intellectual Property it said the EU is asking for TRIPS plus provisions and rewriting of Indian patent and copyright laws. More...
Venus Remedies: Attractive bet among small cap space
(Kiran Kabtta Somvanshi , 24-May-2010 , The Economic Times)
In March 2010 the company got Indian patent for one of its product Sulbactomax and has also filed patent for this product in another 50 countries including the US Europe Australia Japan and Latin American countries. More...
Rise of Big Pharma will make drugs dearer
(Priyanka Golikeri , 23-May-2010 , DNA)
Industry estimates suggest that by 2015 when the Indian pharmaceutical market would be worth $20 billion about 15 per cent of total drugs would be patented molecules. More...
Many Species One Planet One Future
(Narayani Ganesh , 23-May-2010 , The Times Of India)
India is not only being proactive in acknowledging the symbiotic link between biodiversity and climate change it was also trying to bring together the CBD and TRIPPS agreement of the WTO through pushing for an amendment of Article 29. More...
EU seizure of Indian drugs improper: WHO
(Sujay Mehdudia , 23-May-2010 , The Hindu)
In a statement issued in Geneva the WHO on Thursday rapped the EU for seizing the Indian generic drugs in transit for patent violation. More...
India keen to play lead role in Nagoya meet
(ET Bureau , 23-May-2010 , The Economic Times)
Besides the Biological Diversity Act 2002 and the national Biodiversity Authority India has also put in place a traditional knowledge database the Traditional Knowledge Digital Library. More...
Abbott buys Piramals pharma arm for $3.7bn
(TNN , 22-May-2010 , The Times Of India)
The India story is an attractive growth story but globally and in emerging markets there is a new way of selling drugs patented products which we would not have been able to do on our own Ajay Piramal chairman of the Piramal group told TOI. More...
Dr Reddys launches drug to treat organ rejection in US
(Priyanka Pulla , 22-May-2010 , Livemint)
Dr Reddys can expect an additional $25 million in sales in fiscal 2011 from the tacrolimus capsules More...
More foreign suitors expected
(Joe C Mathew / New Delhi , 22-May-2010 , Business Standard)
But acquisitions also likely to get more expensive. More...
Ranbaxy to roll out generic version of Lipitor in Canada
(Press Trust of India , 22-May-2010 , The Financial Express)
Ranbaxy Laboratories on Friday said it has got the approval of Canadian health regulator to market the generic version of cholesterol lowering medicine Lipitor worlds largest selling drug in Canada. More...
Kites flies into copyright controversy
(DNA Correspondent , 22-May-2010 , DNA)
Of the many controversies threatening to ground Hrithik Roshan starrer Kites this one has leapt right out of a storyboard. More...
Piramal deal will give Abbott India size
(Ram Prasad Sahu / Mumbai , 22-May-2010 , Business Standard)
As part of its strategy to move beyond the proprietary or patented drugs business Abbott recently set up the Established Product Business globally. More...
Mango: The King Is Now G.I. Joe
(21-May-2010 , The Times Of India)
According to legend a donkey once walked about a mango tree laden with ripe Dussehris. More...
Gains in crop protection sector stocks may continue
(M.R. Subramani , 21-May-2010 , Business Line)
One of the problems faced by the sector is the lack of patent protection in the country. More...
India asks WHO to drop IMPACT and set up new member driven programme
(Joseph Alexander, New Delhi , 21-May-2010 , Pharmabiz)
India has urged World Health Organisation to replace WHOs involvement in the International Medical Products Anti counterfeiting Taskforce with an effective programme to address the issue of quality safety and efficacy and to ensure that the new programme avoids conflicts of interests. More...
Why MNCs are keen on data protection for pesticides
(Harish Damodaran , 21-May-2010 , Business Line)
The 20 year protection period in India applies only with respect to product patents filed after January 1 1995. More...
German Court Revokes Glaxos Advair Patent
(By STEN STOVALL , 20-May-2010 , The Wall Street Journal)
GlaxoSmithKline PLC said Thursday that Germanys Federal Patents Court revoked its patent for key product Advair handing a victory to generic drug makers Mylan dura GmbH Hexal AG Neolab Ltd. and Ivax International B.V. and highlighting the world wide generic threat to Glaxos blockbuster lung treatment. More...
India seeks new WHO policy for fake drugs
(Soma Das , 20-May-2010 , The Financial Express)
The government has urged the World Health Organisation to address the issue of spurious substandard drugs through an effective alternative instead of clubbing it as a counterfeit issue. More...
India EU ready for consultation to resolve drug seizure issue
(Our Bureau , 20-May-2010 , Business Line)
The seizure of several consignments of medicines was on the patent infringement grounds. More...
India EU consultations on drug seizure to start next week
(Press Trust of India / New Delhi , 19-May-2010 , Business Standard)
India and the European Union will, next week start World Trade Organisation-mandated consultations to resolve a dispute over the seizure of Indian pharmaceutical consignments in Europe. More...
World Health Assembly opens with counterfeit issue as part of agenda
(Joseph Alexander, New Delhi , 19-May-2010 , Pharmabiz)
In response to the Director Generals request for information on use of the term counterfeit medicines and related definitions 55 Member States and the European Commission have so far provided answers and a preliminary summary was presented to the Member States at an open forum held in Geneva on March 26 2010. More...
AstraZeneca Teva settle generic budesonide capsules patent litigation
(London , 19-May-2010 , Pharmabiz)
AstraZeneca has entered into an agreement with Teva Pharmaceuticals USA Inc formerly Barr Laboratories Inc to settle patent litigation regarding Tevas proposed generic version of AstraZenecas Entocort EC capsules More...
Lupin loses battle to launch antibiotic in US
(Soma Das , 18-May-2010 , The Financial Express)
The district court enjoined Lupin from infringement during the extended term of the patent. More...
Venus Remedies gets India patent for painkiller
(Reuters / Mumbai , 18-May-2010 , Business Standard)
Drug maker Venus Remedies Ltd said on Tuesday it secured an Indian patent for its once a day painkiller Aceclofenac injection. More...
Indian Patent Office sets aside patent granted to Roche for valganciclovir
(Our Bureau, Mumbai , 18-May-2010 , Pharmabiz)
In a significant decision the Indian Patent Office at Chennai in its decision on April 30 2010 has set aside the patent granted to Roche for valganciclovir. More...
Indian pharmas emerging foray
(BV Mahalakshmi , 17-May-2010 , The Financial Express)
They are also improving their intellectual property and regulatory markets. More...
Microsoft settles with VirnetX to pay $200 mn
(Reuters / New York , 17-May-2010 , Business Standard)
Microsoft Corp will pay $200 million to VirnetX Holding Corp and obtain a patent licence to settle litigation accusing it of infringing two patents for communicating over the Internet. More...
Ranbaxy Lupin to benefit most from Japans push for generics
(C.H. Unnikrishnan , 16-May-2010 , Livemint)
The firms will have an edge over their Indian counterparts that do not have a Japanese parent or subsidiary More...
EU confronted on herbal medicines & chemicals ban
(Amiti Sen , 15-May-2010 , The Economic Times)
India has taken up with European Union the issue of its traditional medicine and chemical industries that are set to face various import restrictions in the European Union. More...
Strategies for growth and survival
(P.T. Jyothi Datta , 15-May-2010 , Business Line)
This combines with increasing costs and high rates of genericisation drugs going off patent make it a difficult environment for drug companies. More...
Pharma export council to open offices abroad
(P B Jayakumar / Mumbai , 15-May-2010 , Business Standard)
Indias $12 billion Rs 53500 crore pharmaceutical industry earns 40 per cent of its revenue from exports of off patent generic drugs. More...
Police to ensure proper investigation
(Express News Service , 15-May-2010 , express buzz)
In the wake of the increasing incidents of infringement on intellectual property rights the state police are initiating various measures to ensure proper investigation into cases registered under the Copyrights Act. More...
DCGI associates with commerce ministry to reexamine spurious drugs definition
(Nandita Vijay, Bangalore , 15-May-2010 , Pharmabiz)
Drugs Controller General of India in association with Union Ministry of Commerce & Industry has started an exercise to reexamine the definition of spurious drugs in the wake of recent seizures of Indian generic drugs by the EU authorities. More...
A patent shortage
(Business Standard / New Delhi , 14-May-2010 , Business Standard)
India needs a more efficient patents office More...
FTA? Nothing free about it
(Biraj Patnaik , 14-May-2010 , The Times Of India)
Further over the past few years India has developed a patent regime that gives precedence to patient rights over the interests of pharma companies emerging as one of the major sources for cheap generics being used worldwide. More...
Mahabaleshwar strawberry gets GI status
(Hrishikesh Joshi / Mumbai/ Pune , 14-May-2010 , Business Standard)
After Puneri Pagadi Solapurs chadar and towels Yeolas Paithani Alphonso mangoes of Konkan Nashik grapes and wine now Mahabaleshwars Strawberries has joined the illustrious league of Geographical Indication status after receiving the registration from the Ministry of Commerce. More...
Authority sets aside patent gives hope to patient groups
(Rema Nagarajan , 14-May-2010 , The Times Of India)
For the first time in the country patient groups have won the right as interested parties to challenge the patent granted for a medicine. More...
IFPMA defends involvement of IMPACT on counterfeit issue
(Joseph Alexander, New Delhi , 14-May-2010 , Pharmabiz)
Patents have nothing to do with counterfeiting and counterfeiting has nothing to do with patents. More...
Balaramapuram Sarees gets IPR protection
(UNI , 14-May-2010 , indlaw news)
Keralas prestigious Balaramapuram Sarees have become the first handloom product in the state to receive the Intellectual Property Rights protection through Geographical Indications Act. More...
India Brazil drag EU to WTO
(D Ravi Kanth / Geneva , 13-May-2010 , Business Standard)
Raise trade dispute against EU over seizure of generic drugs. More...
Aurobindo gets USFDAs tentative nod for Crestor
(PTI , 13-May-2010 , The Economic Times)
Aurobindo Pharma on Thursday said it has received tentative approval of the US Food and Drug Administration for the generic version of Crestor tablets used in the cardiovascular therapeutic area. More...
The Roche test
(Latha Jishnu / New Delhi , 13-May-2010 , Business Standard)
The Valcyte case is vital as it bars incremental innovation and recognises the right of patient groups to oppose patents More...
Ranbaxy Medicis end drug row
(Soma Das , 12-May-2010 , The Financial Express)
Ranbaxy has reached an out of court settlement with Medicis on acne drug Solodyn minocycline hydrochloride last week. More...
Suven Life gets Canadian and Eurasian patent for NCE
(Our Bureau, Mumbai , 12-May-2010 , Pharmabiz)
Suven Life Sciences has received third product patent from the Canadian Patent office and sixth from Eurasian Patent office corresponding to the New Chemical Entity for treatment of disorders associated with Neurodegenerative diseases. More...
Big pharma aims for reinvention
(Andrew Jack , 12-May-2010 , Financial Times)
With some of his most profitable medicines going off patent and the uncertainty of replacement drugs continuing to rise US healthcare reform has been the least of Andrew Wittys recent worries. More...
Microsoft loses as Toronto firm wins claim over Word patent
(Indo-Asian News Service , 12-May-2010 , Hindustan Times)
Ruling against Microsoft the US Patent and Trademark Office on Tuesday confirmed a patent held by Toronto based i4i Inc. More...
Ranbaxy Labs: Growth strategy fructifies
(Priya Kansara Pandya & Akash Joshi / Mumbai , 12-May-2010 , Business Standard)
The US Food and Drug Administration allows 180 days of exclusive marketing rights to the first company that successfully challenges a patent on a medicine. More...
Glenmark Merck settle patent row over Zetia
(Sachin Kumar , 11-May-2010 , Hindustan Times)
Glenmark Pharmaceuticals and Merck have agreed to settle their patent litigation on Mercks patent covering Zetia a cholesterol lowering drug. More...
Ranbaxys US arm to face patent infringement suit
(Joe C Mathew / New Delhi , 11-May-2010 , Business Standard)
Ranbaxy Pharmaceuticals Inc had applied for marketing approval of a version of Purdues painkiller Oxycodone. More...
Stocks to watch: Tata Power Fortis Healthcare Jindal Steel MMTC Jubilant Foodworks Glenmark
(ET Bureau , 11-May-2010 , The Economic Times)
Merck and Glenmark Pharmaceuticals Inc. and Glenmark Pharmaceuticals have reached an agreement to settle their patent litigation involving Glenmarks challenge to Mercks patent covering ZETIA. More...
Google Yum Mattel PepsiCo: Intellectual Property
(Victoria Slind-Flor , 11-May-2010 , Bloomberg)
GreenShift Corp. a New York based company that developed and commercialized clean technologies sued 15 ethanol producers for patent infringement. More...
Singapore for greater access to Indian generic drugs
(Press Trust of India , 11-May-2010 , NDTV Profit)
India on Tuesday signed a pact with Singapore for greater market access for its generic offpatent drugs in the South East Asian nation. More...
Merck Settles Patent Infringement Case for Zetia® ezetimibe
(EDT , 10-May-2010 , Yahoo Finance)
Merck & Co. Inc. and Glenmark Pharmaceuticals Inc. USA and Glenmark Pharmaceuticals Ltd. have reached an agreement to settle their patent litigation involving Glenmarks challenge to Mercks patent covering ZETIA ® (ezetimibe). More...
MSF welcomes Indias decision to reject drug patent to Roche
(PTI , 10-May-2010 , The Economic Times)
Medicins Sans Frontieres an international medical humanitarian group today welcomed Indias decision to reject a patent granted to Swiss drug multinational Roche for its AIDS related drug Valganciclovir. More...
US rakes up Indian counterfeit drugs issue wants data protection
(Joseph Alexander, New Delhi , 10-May-2010 , Pharmabiz)
Placing India yet again in the priority watch list in 2010 the United States has once again raked up the issue of counterfeit medicines as a grave concern and has strongly sought protection for undisclosed test and other data generated for approval of pharma products. More...
Indian Copyright Act: Whose copy is it?
(Sindhu Manjesh , 8-May-2010 , The Times Of India)
The Indian Copyright Act 1957 has seen a few amendments in the past in the 80s and 90s but it is widely acknowledged that it is far outdated and does not reflect the reality of a rapidly evolving and interconnected global knowledge economy. More...
Sensitisation workshop organised on Intellectual Property Rights
(Special Correspondent , 8-May-2010 , The Hindu)
It targeted Micro Small and Medium Enterprise sectors More...
Digital DImensions
(Sindhu Manjesh , 8-May-2010 , The Times Of India)
Will you be hauled up for making personal copies of your favourite paid for downloads or for converting them to different formats for private use under the provisions of the proposed Copyright Amendment Bill More...
Sun Pharma gets US FDA nod for generic Namenda tablets
(Our Bureau, Mumbai , 07-May-2010 , Pharmabiz)
Sun was amongst the first ANDA applicants to submit a substantially complete ANDA with a paragraph IV certification to the 703 patent. More...
Pharma cos lose out in patent office judiciary stand off
(Deepali Gupta , 7-May-2010 , The Economic Times)
FOR the patent office the past three years have been like the past three overs of a Twenty20 match. More...
Abbott Eli Lilly sues Watson Pharma for patent infringement on dyslipidemia drug and SERM respectively
(Morristown, New Jersey , 07-May-2010 , Pharmabiz)
Watson Pharmaceuticals Inc has confirmed that its subsidiary Watson Laboratories Inc filed Abbreviated New Drug Applications for two products a generic version of Abbotts dyslipidemia drug Simcor and Eli Lillys oral selective estrogen receptor modulator Evista with the US Food and Drug Administration. More...
Orchid to bloom with US deal
(Ravi Ananthanarayanan, Vatsala Kamat and Manas Chakravarty , 6-May-2010 , Livemint)
The real benefits of the Orchids deal with Alvogen Inc. will depend on the rate of success in patent challenges and the ability to go to get final marketing approvals More...
Sun stops anti ulcer drug sale in US
(Press Trust of India , 6-May-2010 , The Financial Express)
Sun Pharmaceutical Industries on Wednesday said it has stopped the sale of the generic version of Protonix an antiulcer drug in the US market. More...
Roches patent on HIV drug is dismissed
(Radhieka Pandeya , 6-May-2010 , Livemint)
The Swiss drug maker has the option of filing an appeal against the patent offices decision on Valcyte with IPAB More...
Glenmark takes patent cover with drug deal
(ET Bureau , 5-May-2010 , The Economic Times)
Glenmark Pharmaceuticals issued exclusive marketing rights for cholesterol control ezetimibe to another generic company Par Pharmaceutical Companies in an effort to strengthen its patent challenge case against Merck. More...
Medicines bought in bulk by govt can help cut costs
(Subodh Varma , 5-May-2010 , The Times Of India)
Patent rights also give a boost to prices as shown by the case of Glivec an anti cancer drug. More...
Public interest groups urge US president to order inquiry into links between USPTO Pfizer in India
(Ramesh Shankar, Mumbai , 5-May-2010 , Pharmabiz)
A slew of public interest groups in India have asked the US president Barak Obama to order a formal investigation into the links between the United States Patents and Trademark Office in India and the multinational pharma major Pfizer and to take necessary action against the officials concerned for misinforming the Indian media and the general public about its own patent laws and public health safeguards. More...
USTR Releases 2010 Special 301 Report on Intellectual Property Rights
(ag-IP-news , 05-May-2010 , ag-IP-news )
The Office of the United States Trade Representative released its annual Special 301 Report on the adequacy and effectiveness of US trading partners protection of Intellectual Property Rights. More...
Seizure of drugs cases: India plans to drag EU to WTO independent of Brazil
(Amiti Sen , 4-May-2010 , The Economic Times)
India is planning to drag the European Union to the World Trade Organisation independently of Brazil despite claims made by the EU that it was changing its customs regulations to prevent seizure of drugs exported by India while in transit to third countries like Brazil and Nigeria. More...
Non trade issues not to hamper trade talks with EU
(Special Correspondent , 04-May-2010 , The Hindu)
In the intellectual property rights chapter of the proposed FTA it will be made clear that there should be no limit on Indias capacity to produce and export life saving medicines Ms. Danielle Smadja said here. More...
Pfizer Wyeth sue Ranbaxy over infringement
(fe Bureau , 4-May-2010 , The Financial Express)
US based Pfizer and its subsidiary Wyeth have sued Ranbaxy Laboratories in a US court claiming that the Daiichi Sankyo owned drugmaker infringed on Wyeths patent coverage of the drug Rapamune. More...
India EU to hold more discussions tackle FTA hurdles
(Asit Ranjan Mishra , 4-May-2010 , Livemint)
Both sides resolve to conclude talks before the next India Europe summit in Oct More...
EU assures FTA wont lead to costlier life saving drugs
(ET Bureau , 4-May-2010 , The Economic Times)
The European Commission has said the proposed free trade agreement negotiations with India will not affect production of cheap life saving medicines in the country. More...
SC notice to Pepsi over TM row with Udaipur firm
(PTI , 03-May-2010 , Yahoo News)
The Supreme Court today issued notice to beverages giant PepsiCo India over a petition filed by an Udaipur based firm challenging the order of the Delhi High Court over a copyright row on the multinationals popular soft drink brand 7Up. More...
Cipla demands apology from US university
(Joe C Mathew / New Delhi , 03-May-2010 , Business Standard)
Cipla the countrys leading drug maker has sent a legal notice to George Washington University of the United States on a recent symposium it had organised in India alleging the meet had attempted to influence a high court case involving Cipla and one of the event sponsors the US based Gilead Sciences. More...
Litigation woes could hit sales hard
(Edelweiss , 03-May-2010 , The Financial Express)
The recent jury decision determining that Nycomeds 579 patent on Protonix DR Tablets is not invalid is a setback to Sun Pharmaceuticalscurrent sales from the product. More...
Counterfeit goods growing problem in India: USTR
(Joe C Mathew / New Delhi , 2-May-2010 , Business Standard)
US watchdog lauds Indias IPR efforts but picks holes in legal framework. More...
Patent application details now available online
(BS Reporter / New Delhi , 2-May-2010 , Business Standard)
Patent application details are available online for free from this week. More...
Pfizer Wyeth sue Ranbaxy over drug
(P B Jayakumar / Mumbai , 2-May-2010 , Business Standard)
Pfizer the worlds largest drug company and Wyeth have sued Daiichi Sankyo owned Ranbaxy Laboratories in a US court for infringing the patent rights of Wyeths drug Rapamune. More...
India 10 others on U.S. watch list for inadequate IPR protection
(PTI , 1-May-2010 , The Hindu)
The United States placed India along with 10 other countries on its priority watch list on Friday for not providing adequate levels of protection or enforcement of Intellectual Property Rights. More...
Keep IPR away from free trade agreements
(P.T.Jyothi Datta , 1-May-2010 , Business Line)
Civil rights groups want the Government to keep Intellectual Property Rights outside the ambit of Free Trade Agreements being negotiated between India and several other regions including the European Union and Japan. More...
India on US watch list for inadequate IPR protection
(Lalit K Jha , 1-May-2010 , Press Trust Of India)
The United States placed India along with 10 other countries on its priority watch list on Friday for not providing adequate levels of protection or enforcement of Intellectual Property Rights. More...
Knowledge library wards off European patents
(Soma Das , 1-May-2010 , The Financial Express)
An electronic facility that India had set up eight years ago to pre empt unfair patenting of the countrys traditional knowledge on curative potency of various biological resources has come handy. More...
India EU discuss all aspects of proposed FTA
(Pallavi Aiyar / Brussels , 1-May-2010 , Business Standard)
The ninth round of free trade agreement talks between India and the European Union concluded in Brussels today. More...
India fights patent claims on traditional cures
(Sanchita Sharma , 30-Apr-2010 , Hindustan Times)
India has challenged 36 attempts by international companies to get patents on Indian traditional knowledge at the European Patents Office over the past one year. More...
Pharma group to oppose patent claims
(Khomba Singh , 30-Apr-2010 , The Economic Times)
A group of Indian pharmaceutical firms will collectively oppose as many as 90 drug patent applications sought by global drugmakers and some local companies terming them as frivolous patent claims. More...
Sanganeri hand block printed textile goods get GI tag
(Our Bureau , 29-Apr-2010 , Business Line)
Sanganeri hand block printed textile products will now be protected as a geographical indication under Geographical Indication of Goods Registration and Protection Act. More...
Orchid Chem settles litigation with Forest Labs
(Kaustubh Kulkarni , 29-Apr-2010 , Reuters)
Orchid Chemicals and Pharmaceuticals Ltd said on Thursday it has settled a patent litigation with Forest Laboratories Inc regarding its generic drug Memantine tablets. More...
To stop patent fights India gives US UK access to database
(Vineeta Pandey , 29-Apr-2010 , DNA)
Having burnt its fingers on long and expensive litigations to prevent foreign companies from patenting neem and turmeric the Indian government has developed a unique process to save its AYUSH knowledge. More...
Strong medicine
(Latha Jishnu / New Delhi , 29-Apr-2010 , Business Standard)
Ecuador is issuing compulsory licences to bring down the cost of patented medicine. More...
Zydus launches Tamsulosin in US
(BS Reporter / Mumbai/ Ahmedabad , 29-Apr-2010 , Business Standard)
Ahmedabad based pharma major Zydus Cadila has launched Tamsulosin capsules in the US following nod from the US health regulator today. More...
CSIR wing objects to Avesthagen patent claim
(Jacob P. Koshy , 28-Apr-2010 , Livemint)
Records also show that the company had paid application renewal fees every year since 2003 but hadnt done so for 2009 the deadline for which was 31 August More...
Suven Life gets patent for NCE from India & New Zealand
(Our Bureau, Mumbai , 28-Apr-2010 , Pharmabiz)
Suven Life Sciences a bio pharmaceutical company has received patent from New Zealand and Indian patent office or its New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and these patents are valid until 2024 and 2025 respectively. More...
Special courts planned to clear backlog of IPR cases
(C.H. Unnikrishnan , 28-Apr-2010 , Livemint)
The move is part of the ongoing intellectual property rights reforms for which the Centre has set aside Rs500 cr More...
Ranbaxy to step up head count launch new drugs
(Khomba Singh , 28-Apr-2010 , The Economic Times)
It attempted to grow by challenging patents of established drugs such as Pfizers cholesterol curer Lipitor to make big profits and focused on the western markets. More...
Economy Govt rules out blanket ban on plastic bags
(PTI , 28-Apr-2010 , Livemint)
Sanganeri hand block printed textile products from Rajasthan will now be protected as a geographical indication which prohibits its duplication. More...
Pharma firms see scope in US patent expiry
(Joe C Mathew / New Delhi , 27-Apr-2010 , Business Standard)
Fortune seekers in the Indian pharmaceutical space will find this irresistible. More...
Pharma cos public health groups want patent issue out of FTA talk with EU
(Soma Das , 27-Apr-2010 , The Financial Express)
Indian pharmaceutical firms and the network of public health groups have separately urged the government to keep patent related issues out of the ongoing talks for the proposed India EU free trade agreement. More...
China court rejects Shaolin temple trademark bid: report
(AGENCIES , 27-Apr-2010 , The Economic Times)
Persistent attempts by Chinas famed Shaolin temple to stamp its trademark on instant noodles and coffee may have hit a brick wall after a court ruled against the move state media said Tuesday. More...
Sun Pharma stocks slip on US court decision
(BS Reporter / Mumbai , 27-Apr-2010 , Business Standard)
In two separate patent cases while a US court asked Sun Pharma to withdraw its version of a cancer drug Eloxatin from the US market another jury which examined patent validity of heart burn drug Protonix ruled against the Indian company More...
Apex court rejects Unilever Australasia plea on trademark
(Indu Bhan , 27-Apr-2010 , The Financial Express)
The Supreme Court on Monday has given the go ahead to a cosmetic firm to proceed against Australian based Unilever Australasia plea in a trademark violation case filed in a Bangalore court. More...
Shire sues Teva over US patent infringement of Intuniv tablet
(Dublin, Ireland , 27-Apr-2010 , Pharmabiz)
Shire LLC subsidiary of Shire plc global specialty biopharmaceutical company has filed a lawsuit in the US District Court for the District of Delaware against Teva Pharmaceuticals USA Inc and Teva Pharmaceutical Industries Ltd for the infringement of US Patent Nos. 6287599 and 6811794. More...
India ropes in US UK to protect traditional knowledge
(IANS , 26-Apr-2010 , Sify)
India has joined hands with the US and Britain to protect thousands of medicinal preparations based on traditional knowledge from piracy and patent controversies. More...
Patent office to hire 500 people this yr: DIPP Secretary
(Press Trust of India / New Delhi , 26-Apr-2010 , Business Standard)
The government will hire about 500 people this fiscal for its intellectual property offices a top official said today. More...
Bio piracy: India wins case against 15 patents
(sujatha gopal , 26-Apr-2010 , Rediff)
The European Patent Office has rejected 15 patent applications of various international companies during the past one year after it found they had used Indias traditional medicinal knowledge to prepare certain products. More...
Emkay reduces Sun Pharmas price target to Rs 1632
(ET Bureau , 26-Apr-2010 , The Economic Times)
In the first case New Jersey jury has ruled that Wyeths patent on Protonix is valid and Sun and Teva Pharma has infringed the patent by launching the drug at risk. More...
Curing the fear of drug patents
(Ranjit Shahani , 26-Apr-2010 , Business Line)
Intellectual Property Day some home truths to separate myths from facts. More...
Indias tryst with TRIPS
(Shamnad Basheer , 26-Apr-2010 , Livemint)
On World Intellectual Property Day India should remember that it still needs to incentivize innovation More...
TELCO loses trade mark battle against T SERIES
(PTI , 25-Apr-2010 , The Economic Times)
TELCO has lost its trademark violation case against the Super Cassettes Industries in the Delhi High Court which allowed the electronics company to use letter T in its T SERIES mark saying it was not its monopoly. More...
MNC domestic pharma lock horns on patents in India
(STAFF WRITER , 24-Apr-2010 , Press Trust Of India)
MNC durgmakers today hit back at their domestic counterparts over frivolous patent issue and said even the local firms are engaged in filing for intellectual rights for incremental innovations that merely improve the safety or efficacy of an already known drug. More...
Low IQ on intellectual property rights
(Binay Singh , 24-Apr-2010 , The Times Of India)
The World Intellectual Property Day has been observed globally on April 26 every year since 2001 but the knowledge of intellectual property right is still in nascent stage particularly in Varanasi which is one of the ancient seats of learning. More...
Folk as intellectual property
(PTI , 24-Apr-2010 , ZeeNews.Com)
Everything folk should be considered as intellectual property to ensure that forms of art like music theatre and dance passed down orally through generations do not vanish feel contemporary folk artists. More...
Pfizer wins Protonix patent case vs Teva
( Bill Berkrot , 23-Apr-2010 , Reuters)
Jury finds Protonix patent infringed by Teva More...
A $5 billion Indian pharma entity may not be too far away
(23-Apr-2010 , DNA)
In the initial analysis it appears that the nightmares of the patent cliff that the big brand companies are confronted with may be offset to a large extent by the majestic emergence of the Asian markets like India and China followed by other growth markets like Mexico Turkey and Brazil. More...
EU approves Novartis Diovan for paediatric use
(Martin de Sa'Pinto , 23-Apr-2010 , Reuters)
Novartis hypertension drug approved for use in EU children More...
IPL cautions Google on copyrighted content
(Our Bureau , 22-Apr-2010 , Business Line)
The Indian Premier League has requested Internet search engine Google to discontinue services to certain Web links that were using its platform to transmit copyrighted content related to the Twenty20 cricket tournament. More...
Like EU Japan FTA also a priority
(Priyanka Golikeri , 22-Apr-2010 , DNA)
Concerns over the Japan FTA include inclusion of strict intellectual property provisions and access to second hand Japanese goods into the Indian market. More...
Number of patent filings declined in FY'10 due to slowdown
(22-Apr-2010 , The Economic Times)
The government on Thursday said filing of patent applications in the country declined by over 6 per cent to 34,496 in 2009-10 over the year-ago period due to the global economic downturn. More...
Contract manufacturing of drugs to grow 10 15%
(Debasis Mohapatra / Chennai/ Bangalore , 22-Apr-2010 , Business Standard)
Contract manufacturing in pharmaceutical industry is set to grow 10 per cent to 15 per cent in the near term and is expected to double in the next five years after the approval of US healthcare bill as the bill has opened up opportunities for the use of more generic drugs in the US market. More...
Ind. engineers receive patent for trailer design
(The Associated Press , 22-Apr-2010 , Business Week)
Two engineers at an Indiana trailer manufacturer have been awarded a patent for a new aerodynamic trailer designed to save fuel. More...
Piramal Health to buy anaesthetic biz of Pune firm
(Reuters / Mumbai , 22-Apr-2010 , Business Standard)
The acquisition gives Piramal access to key intellectual property developed by BSV for the manufacture of injectable anaesthetics products including process based intellectual property and business contracts the filing said. More...
MULTIPLE FILING OF PATENTS
(P A Francis , 21-Apr-2010 , Pharmabiz)
Adoption of the new patent law in 2005 marked the beginning of a new era in the history of pharmaceutical industry in India. More...
Cipla offers govt low cost drug technology to fight cancer AIDS
(C.H. Unnikrishnan , 20-Apr-2010 , Livemint)
Patent holders drugs for the treatment of life threatening diseases such as cancer and AIDS are expensive and their monopoly in the Indian market will result in denial of treatment for Indian patients says Amar Lulla joint managing director of Cipla More...
Draft copyright Bill introduced, could transform film, music biz
(Manish Ranjan and Santosh K. Joy , 19-Apr-2010 , Live Mint)
Draft copyright Bill introduced, could transform film, music biz More...
Disability rights activists oppose copyright regime
(Deepa Kurup , 15-Apr-2010 , The Hindu)
The proposed amendments to the Copyright Act 1957 slated to be tabled in the second phase of the budget session of Parliament that begins on Thursday has disability rights activists up in arms. More...
Beware the EU agenda
(Latha Jishnu / New Delhi , 15-Apr-2010 , Business Standard)
Tough intellectual property rights sought by the EU in its free trade agreement with India have set off global protests More...
US generics to help push Glenmark recovery
(C.H. Unnikrishnan , 15-Apr-2010 , Livemint)
US market for the drug company will grow at 32.7% says an analysis More...
Unilever moves SC seeks stay on trademark case
(Indu Bhan , 14-Apr-2010 , The Financial Express)
Australia based Unilever Australasia on Tuesday moved the Supreme Court seeking a stay on the proceedings of a trademark violation case filed against it in a Bangalore court. More...
Hope floats for India EU free trade pact talks
(Pallavi Aiyar / Brussels , 13-Apr-2010 , Business Standard)
Chapters on government procurement and intellectual property rights the EU is pushing for TRIPS plus protection also remain highly contentious. More...
Infy awaits nod for 224 patent applications
(Press Trust of India , 13-Apr-2010 , NDTV Profit)
IT behemoth Infosys Technologies on Tuesday said it is awaiting approvals for 224 patent applications in India and in the US. More...
No suo motu powers to review ‘wrongly’ granted patents
(C.H. Unnikrishnan , 13-Apr-2010 , Live Mint)
The first Indian Administrative Service officer to head India’s intellectual property office, P.H. Kurian has had a tough time since he took charge in 2009—he has had to work towards creating an efficient and transparent patenting process and reform a system that has previously faced allegations of lack of transparency, indecision, even corruption. More...
Glenmark settles drug patent row with GSK
(13-Apr-2010 , Financial Express)
Close on the heels of Ranbaxy announcing a patent dispute settlement with Japan's Takeda Pharmaceuticals for the generic equivalent of Takeda's drug Actos, Mumbai-based Glenmark Pharmaceuticals said on Monday its US-based group company has settled a patent dispute with GlaxoSmithKline over the launch of a generic version of anti-malaria drug Malarone. More...
CSIR open-source project for TB democratises research
(P.T. Jyothi Datta , 13-Apr-2010 , Business Line)
The average age of scientists on the Council of Scientific and Industrial Research's (CSIR) ‘Connect 2 Decode' project — to map information on the Mycobacterium tuberculosis (Mtb) genome, is “in the 20s”. Not surprising then, the scientific community explains the project, in lay terms, as a sort of “face-book” for scientists! More...
Keikaku set to enter India with furniture brand
(Anandita Singh Mankotia, Ronojoy Banerjee , 13-Apr-2010 , The Financial Express )
The $1.7 billion Japanese retailer Ryohin Keikaku is all set to enter the Indian retail market with its furniture brand Muji. More...
GSK settles malaria drug patent dispute with Glenmark
(Selina McKee , 12-Apr-2010 , Pharma Times)
UK drugmaker GlaxoSmithKline has settled a patent dispute with the US subsidiary of Indias Glenmark Generics over a copycat formulation of its malaria prophylaxix drug Malarone. More...
Indian drugmakers gear up to challenge frivolous MNC patents
(PTI , 11-Apr-2010 , The Economic Times)
Leading domestic drugmakers have decided to collectively challenge frivolous patent applications filed by multinationals in India under the aegis of the Indian Pharmaceutical Alliance. More...
Mycobacterium tuberculosis genome mapping released
(Aarti Dhar , 11-Apr-2010 , The Hindu)
Findings may result in development of urgently needed new TB drugs in India. More...
Suns EPS may take a knock if it stops cancer drug sale
(Deepali Gupta , 10-Apr-2010 , The Economic Times)
The stock of Sun Pharma fell for a fourth day in a row as investors are worried about the companys legal tussle with Sanofi Aventis over cancer drug oxaliplatin. More...
Column : Should drugs be allowed evergreening
(MG Arun , 10-Apr-2010 , The Financial Express)
The issue of evergreening of drugs or obtaining new patents for minor improvements on a product towards its patent expiry has been a subject of debate in India ever since 2005 when India allowed patenting of products in pharmaceuticals as opposed to the earlier process patent regime. More...
Will India take EU drug seizures issue to World Trade Organisation
(Priyanka Golikeri , 10-Apr-2010 , DNA)
The medicines neither enjoyed patent protection in India nor in the countries that were to import them. More...
Indian drug exporters to benefit from change in EC norms
(Press Trust of India / New Delhi , 9-Apr-2010 , Business Standard)
It was alleged that the Indian pharmaceutical products had patent violations in Europe. More...
Cipla makes cancer drug cheaper
(Khomba Singh , 09-Apr-2010 , The Economic Times)
Cipla has launched a copycat version of German pharma company Bayers cancer medicine Nexavar at one tenth the price thumbing its nose again at the pharma multinational by selling drugs at a fraction of the original rates. More...
Malihabadi dussehri is the first branded mango
(DNA Correspondent , 09-Apr-2010 , DNA)
Alphonsos wont be the first mangoes to get a geographical indication. More...
The US healthcare opportunity for India
(Ram Prasad Sahu in Mumbai , 09-Apr-2010 , Rediff)
With larger companies having a pipeline of Abbreviated New Drug Applications some with exclusivity period and drugs worth $80 billion coming off patent over the next five years investors are betting on Indian companies garnering a chunk of this generic opportunity. More...
Know the real hapoos by its Ratnagiri brand
(Neeta Kolhatkar , 09-Apr-2010 , DNA)
The registration process of Ratnagiris special alphonso mangoes for a geographical indication is in its final stages. More...
Through her research MSU student seeks to revive 700 year old craft
(DARSHANA CHATURVEDI , 8-Apr-2010 , The Times Of India)
Her research may or may not fetch her good marks but it will definitely help revive the 700 year old Tangalia craft which is now among the few Gujarati items to have got geographical indication embedded in a sarong like garment worn by the Bharwad women from Motabhai Bharwad community of Saurashtra. More...
MNCs will get market prices for patented drugs only if govt given quota at a discount
(Gireesh Chandra Prasad, KG Narendranath , 08-Apr-2010 , The Financial Express)
The government plans to prevent pharma MNCs from selling their patented drugs which are mostly expensive in India unless they agree to earmark a portion of their supply for public healthcare system at negotiated prices. More...
Tatas create intellectual property clusters in Bangalore Pune
(Rakhi Mazumdar , 8-Apr-2010 , The Economic Times)
The Tatas are no slouches in technology as Tata Steel alone owns a bouquet of 850 patents copyrights and applications. More...
What invalidating breast cancer gene patents implies
(R. PRASAD , 8-Apr-2010 , The Hindu)
Myriad was holding an exclusive licence. More...
LPOs benefit from Microsofts curbs on legal costs
(Adith Charlie , 8-Apr-2010 , Business Line)
Microsofts patent portfolio consistently ranks among the top as it manages nearly 23000 issued and 38000 pending patents worldwide. More...
Court favours Teva in Seasonique patent case against Watson
(Jerusalem , 07-Apr-2010 , Pharmabiz)
The ANDA sought approval to market a generic version of Seasonique in the US before the patent expires on January 30 2024. More...
Pfizer Novartis and Eli Lilly got bulk of contentious patents
(C.H. Unnikrishnan , 7-Apr-2010 , Livemint)
Rules against protection being granted to already known and long ago patented drugs were allegedly violated More...
US opportunity for pharma
(Business Standard / New Delhi , 7-Apr-2010 , Business Standard)
On the export front as far as the regulated markets are concerned the drug majors that have so far relied on their patented blockbusters are rapidly changing their business model in several ways. More...
Are industrial zones a good idea
(Business Standard / New Delhi , 7-Apr-2010 , Business Standard)
corporate houses mint money by using patents to their advantage. More...
Court denies Lillys request in 2 patents litigation case of Gemzar
(Jerusalem , 07-Apr-2010 , Pharmabiz)
Lilly has appealed that decision and oral argument is scheduled for May 7 2010. More...
Taro Pharma Receives Patent For T2007
(RTT Staff Writer , 06-Apr-2010 , RTT News)
Taro Pharmaceutical Industries Ltd. Tuesday said the U.S. Patent and Trademark Office has issued the company a patent for its non sedating barbiturate drug T2007 which is under development. More...
Australia pushes for environment labour IPR in trade pact with India
(Amiti Sen , 5-Apr-2010 , The Economic Times)
The proposed free trade agreement between India and Australia has hit rough waters with the latter insisting that issues including environment labour intellectual property government procurement and competition policy be part of the negotiations. More...
Fresenius Kabi settles patent dispute with Sanofi Aventis
(Marketing , 05-Apr-2010 , Business Line)
Drug firm Fresenius Kabi Oncology previously know as Dabur Pharma on Monday said that it has settled the patent litigation with Sanofi Aventis over the cancer drug Eloxatin. More...
SC admits plea against Cipla on modvat refund claim
(Indu Bhan , 5-Apr-2010 , The Financial Express)
The Supreme Court has admitted the excise departments plea alleging that pharma major Cipla Ltd is not entitled to refund modvat credit paid on its destroyed expired medicines. More...
Unfurling a new life for Chamba rumals
(Reshmi R Dasgupta , 5-Apr-2010 , The Economic Times)
The gaining of GI Geographical Indication status has also earned them protection from cheap knock offs from other regions. More...
The healthcare opportunity
(Ram Prasad Sahu / Mumbai , 5-Apr-2010 , Business Standard)
While generics today have a share just under a fifth in the US market they are likely to grow by over twice that number by 2013 as many of the innovator drugs go off patent and the healthcare bill comes into full effec More...
India reasserts its reservations on counterfeit drugs at WHO meeting
(Joseph Alexander, New Delhi , 5-Apr-2010 , Pharmabiz)
These concerns include its association with trademark and the danger that quality safety and efficacy issues could be viewed through the lens of intellectual property India said terming all this as deliberate confusion on the part of those seeking to increase IP enforcement regimes. More...
In the pink of health
(IIFL , 5-Apr-2010 , The Financial Express)
n Settlement of patent disputes between an innovator company and a generics company with first to file status will be banned if such a settlement involves payment in cash or kind. More...
BusinessEurope pushes for stronger intellectual property terms in FTA
(Priyanka Golikeri , 3-Apr-2010 , DNA)
Fears of tough intellectual property provisions in Indias free trade agreement with EU are only getting stronger. More...
Venus Remedies patent on salbactam with ceftrioxane opposed in Delhi patent
(Ramesh Shankar, Mumbai , 3-Apr-2010 , Pharmabiz)
The product which is manufactured by several companies under different brand names is indicated for infections. More...
Microsoft loses appeal on Word patent verdict
(IANS , 02-Apr-2010 , The Economic Times)
Microsoft had filed a review petition in the US federal court of appeals against the ruling as well as fines. More...
Domestic cos foil global peers rage over patent
(Soma Das , 2-Apr-2010 , The Financial Express)
Global Pharma Companies Campaigning Against A Key Provision In Indias Patent Act More...
Sanofi Aventis settles patent row over cancer drug
(ET Bureau , 2-Apr-2010 , The Economic Times)
French drugmaker Sanofi Aventis settled its patent row in the US over colon cancer drug Eloxatin with several generic companies but made no mention of Indian drugmaker Sun Pharmaceutical Industries that also sells the drug. More...
AstraZeneca ordered to pay attorneys fees to Dr Reddys
(BS Reporter / Mumbai , 2-Apr-2010 , Business Standard)
Drug major AstraZeneca has been ordered to pay attorneys fees by a US court to Dr Reddys Laboratories for bringing a frivolous and baseless patent infringement suit against the latter. More...
Ranbaxy to hire 1500 on expansion to push sales
(Khomba Singh , 1-Apr-2010 , The Economic Times)
The company has run into a spate of patent battles over generic drugs there and its Indian manufacturing units have been under the US drug regulators scanner. More...
Not a nice trait to have
(Latha Jishnu / New Delhi , 01-Apr-2010 , Business Standard)
MMB is bolstering its argument with a new weapon a patent that it holds in India for its Bt technology. More...
India prepared to take EU to WTO over drugs
(Matthias Williams and Manoj Kumar , 31-Mar-2010 , Reuters)
India is ready to launch a formal dispute against the European Union at the World Trade Organization over EU seizures of Indian generic drugs the Indian Trade Secretary said on Wednesday. More...
Drug makers unite to fight frivolous patents
(Joe C Mathew / New Delhi , 31-Mar-2010 , Business Standard)
IPA members to challenge patent applications at pre grant stage More...
Teva exclusive on hypertension drugs challenged
(By Jeremy Pelofsky , 31-Mar-2010 , Reuters)
Two generic pharmaceutical manufacturers have challenged the U.S. Food and Drug Administrations decision to give rival Teva Pharmaceutical Industries Ltd six months of exclusive marketing for generic versions of widely used blood pressure medicines. More...
US court rejects patents on human genes
(BRIDIE SMITH , 31-Mar-2010 , The Age)
A LANDMARK judgment handed down in the US this week on the contentious practice of patenting human genes is expected to send a message to Australian policymakers. More...
Will raise penetration of Indian generic
(ET Bureau , 31-Mar-2010 , The Economic Times)
While the period of data exclusivity for innovators is far longer than the generic players would have wanted the announcements of setting up regulatory pathways in this space is crucial as the value of biologics starting to go off patent from 2014 will be increasingly larger than conventional oral drugs. More...
Sanofi moves to block Wockhardt patent challenge
(P B Jayakumar / Mumbai , 30-Mar-2010 , Business Standard)
Battle in US court on anti allergic drug Allegra. More...
Vested interests behind discussion on patents
(Rema Nagarajan , 30-Mar-2010 , The Times Of India)
Several civil society groups have come together to question the commerce and industry ministrys alleged complicity in allowing meetings and interactions undermining Indias legal position on intellectual property. More...
Indian Patents Act promotes inventions
(Mail Today Bureau , 30-Mar-2010 , India Today)
Concerns raised by US multinational corporations over the Indian Patents Act discouraging innovation have been refuted in a study released on Monday. More...
India asks WHO to stay away from counterfeit issues
(Joe C Mathew / New Delhi , 30-Mar-2010 , Business Standard)
According to Indian representatives counterfeit is a juridical term and is linked to intellectual property rights. More...
Suven secures product patent
(Our Bureau , 30-Mar-2010 , Busines Line)
Suven Life Sciences Ltd has secured a product patent from the European Patent Office for its New Chemical Entity meant for the treatment of neurodegenerative diseases. More...
Indias patent policy is discouraging innovations that can be of help
(Joe C Mathew & Vandana Gombar / Mumbai/ New Delhi , 30-Mar-2010 , Business Standard)
US based Eli Lilly amongst the top 10 global pharmaceutical companies with annual revenues of $21.8 billion in 2009 has planned to continue its focus on innovation driven products instead of opening up to opportunities in off patent generic drugs being tapped by its larger competitors like GSK and Pfizer. More...
High risk: trademark cases on the rise in liquor industry
(Poornima Mohandas , 30-Mar-2010 , Livemint)
Cases of trademark violation have been on the rise in the liquor industry in recent years as companies often copy names bottle and label designs as well as packaging to ride the popularity of other fast moving brands say two industry experts and a trademark lawyer More...
Indoco Remedies inks drug supply pact with Aspen
(BS Reporter / Mumbai , 30-Mar-2010 , Business Standard)
A dwindling new drug pipeline and drugs losing patent protection are now forcing multinational drug companies to take up generic drug selling which they had shunned earlier. More...
For both IPR & access to medicines
(TK Arun , 29-Mar-2010 , The Economic Times)
Stefan Oschmann is president Emerging Markets at Merck the worlds second largest pharmaceuticals company after its 2009 merger with Schering Plough with a combined global revenue in 2009 of $27.4 billion. More...
On course to benefit from patent expiries
(Nitin Shrivastava , 29-Mar-2010 , DNA)
Indian pharmaceutical companies are in for good times with very large generic opportunities awaiting them in regulated markets and a focus on low cost healthcare globally. More...
Pharma cos take patent route to consolidate ops in US
(Reghu Balakrishnan , 29-Mar-2010 , The Financial Express)
Indian pharma firms seem to be in an upbeat mood as far as strengthening their presence in the US via the patent litigation route is concerned. More...
Vested interests behind discussion on patents
(Rema Nagarajan , 29-Mar-2010 , The Times Of India)
Several civil society groups have come together to question the commerce and industry ministrys alleged complicity in allowing meetings and interactions undermining Indias legal position on intellectual property. More...
Startups look to patenting techs
(K Rajani Kanth / Chennai/ Hyderabad , 29-Mar-2010 , Business Standard)
This patent pending technology has been developed by matrimonial site Coupl.in a Hyderabad based start up set up in October 2009. More...
Pharma sector: There is room for value buying
(Kiran Kabtta Somvanshi , 29-Mar-2010 , The Economic Times)
Impending patent expiries regulated markets gradually opening their markets for generic products and the US passing the much awaited Healthcare Bill in order to cut down healthcare costs are turning out to be a boon for generic companies in India. More...
Bio piracy threats
(Editorial , 29-Mar-2010 , DNA)
Indias successful thwarting of an American firms attempts to patent the well known Indian medicinal plant ashwagandha must be applauded. More...
US patent office admits to error in judgment
(Rema Nagarajan , 29-Mar-2010 , The Times Of India)
After joining hands with pharma giant Pfizer to campaign against public health safeguard clauses in the Indian patents law the US Patent and Trademark Office has admitted that they had made a mistake in co sponsoring a programme on patent law in India along with the pharmaceutical giant. More...
Watchdog Blues
(Sudhir Chowdhary, BV Mahalakshmi , 29-Mar-2010 , The Financial Express)
An effective way to manage these complexities is to assemble a strong resource pool with a good understanding of the local market conditions intellectual property regulatory pricing and marketing and distribution. More...
EU MPs oppose corporate interference in FTA talks
(Priyanka Golikeri , 29-Mar-2010 , DNA)
David Martin a MEP part of the campaign, says the EU should not push for provisions in bilateral talks that can impact local manufacturing in developing countries and go beyond what is mandated by the trade related aspects of intellectual property rights agreement of the World Trade Organisation. More...
Roundtable on controversial Section 3 d of Indian Patents Act to be held in Delhi on March 29
(Our Bureau, Mumbai , 27-Mar-2010 , Pharmabiz)
The Federation of Indian Chambers of Commerce and Industry is organizing a Roundtable Conference on the controversial Section 3d of Indian Patents Act in New Delhi on March 29. More...
India beats back US firms bid to patent Ashwagandha formulations
(Kounteya Sinha , 27-Mar-2010 , The Times Of India)
India has foiled a major bio piracy bid on the use of Ashwagandha Indias wonder plant in the treatment of a range of illnesses including depression diabetes insomnia convulsions and gastritis. More...
Genentech Biogen sue GSK on cancer drug Arzerra
(Copenhagen, Denmark , 27-Mar-2010 , Pharmabiz)
US patent No 7682612 was issued to GenentechInc. and Biogen Idec Inc. on March 23 2010 and contains a claim to a method of treating CLL with anti CD20 antibodies wherein the method does not comprise treatment with radiolabeled anti CD20 antibodies. More...
EU may recall India made generic drug
(Reuters / London , 27-Mar-2010 , Business Standard)
However the medicine is off patent in some European markets where Acino is among the companies that have been supplying a cheaper generic version. More...
IPR law firms step up fight against fakes
(Manish Ranjan , 26-Mar-2010 , Livemint)
Lawyers and a former police officer among those who have joined the war on piracy as firms try to plug losses More...
US healthcare bill drives up small pharma
(Apurv Gupta , 26-Mar-2010 , The Economic Times)
The playing field for the domestic pharmaceutical companies changed completely with the advent of product patent regime. More...
Indian market is important for us looking at the sheer growth potential
(C.H. Unnikrishnan , 26-Mar-2010 , Livemint)
However the lack of a strong intellectual property rights regime in a predominantly generics driven Indian market made the going tough for the firm. More...
We have big R&D plans in the pipeline for India
(Soma Das , 26-Mar-2010 , The Financial Express)
Alpna Seth managing director of Biogen Idec one of the top 10 biotech companies globally with annual revenues of $4.4 billion talks about special pricing and patent issues More...
NGOs caution govt on designs of EU through on going FTA negotiations
(Ramesh Shankar, Mumbai , 26-Mar-2010 , Pharmabiz)
Warning the government about the impact of data exclusivity these groups said that if data exclusivity is introduced it will create a new patent like monopoly by blocking the registration of generic medicines. More...
Bayer drags Cipla to court over patent
(Khomba Singh , 25-Mar-2010 , The Economic Times)
German drugmaker Bayer has filed a patent infringement case against Cipla the largest domestic drug seller to stop the Mumbai based company from selling its generic version of controversial cancer medicine Nexavar. More...
Ranbaxy gets a reprieve in generic case
(Khomba Singh , 25-Mar-2010 , The Economic Times)
The Delhi High Court has turned down a plea by US pharma major Bristol Myers Squibb to ban Indias Ranbaxy Laboratories from launching a generic or copycat version of its patented hepatitis B drug Baraclude. More...
No trademark infringement by Google: EU court
(Reuters / Luxembourg/ London , 24-Mar-2010 , Business Standard)
Europes highest court ruled Google Inc did not infringe trademark law by selling keywords to trigger ads after Louis Vuitton and others said the practice undermined their brands. More...
Obamas Health Bill to boost Indian firms
(Bianca Ghose , 24-Mar-2010 , NDTV Profit)
Branded innovators and Indian generic companies often settle patent litigation cases out of court allowing the generic company to have limited exclusivity on a drug along with the branded company. More...
Piramal buys Ciplas i Pill for Rs 95 crore
(TNN , 24-Mar-2010 , The Times Of India)
In an announcement to the exchange Piramal Healthcare said the company had signed a definitive agreement for the purchase of all intellectual property rights in India related to the brand. More...
Albany Molecular seeks injunction against Dr Reddys
( Vidya L Nathan in Bangalore , 23-Mar-2010 , Reuters)
Albany Molecular Research Inc along with Sanofi Aventis SAs U.S. unit sought a preliminary injunction against Indias Dr Reddys Laboratories Ltd from distributing a copycat version of allergy drug Allegra D. More...
Skinvisible Granted Patent for South Korea
(ET , 23-Mar-2010 , CNN Money)
Skinvisible Inc. announced today that the South Korean patent office has granted a patent for Invisicare® the companys polymer delivery system for topical dermatology products. More...
Suven gets patent for Alzheimer Parkinson compound
(Press Trust of India / New Delhi , 23-Mar-2010 , Business Standard)
Suven Life Sciences today said it has received patent from the US Patent Office for a compound used in the treatment of neuro diseases like Alzheimer and Parkinson. More...
EU trade pact wont hit Indian generic drug cos: Sharma
(Reuters , 23-Mar-2010 , The Financial Express)
The warning highlighted one of the most sensitive issues in trade the extent to which firms intellectual property rights can be waived to help poor countries and whether that stifles research and innovation. More...
US Healthcare Law: Indian drug firms are not celebrating yet
(P B Jayakumar / Mumbai , 23-Mar-2010 , Business Standard)
Further the provisions in the legislation to allow 12 year exclusivity to new biologics or patented biotech drugs would delay plans of Indian companies to launch generic biologics in the US market say industry circles and analysts. More...
Lupins US arm gets USFDA nod for insomnia tablets
(PTI , 23-Mar-2010 , Livemint)
The company has received a tentative approval for the companys abbreviated new drug application for Eszopiclone tablets from the USFDA Lupin said in a filing to the BSE More...
Approach to GM foods should be promotional but cautious: Mashelkar
(Express News Service , 23-Mar-2010 , Indian Express)
Speaking on the issue of intellectual property rights Mashelkar who won the IPR battle for India over Basmati and turmeric which led to the revocation of US patents on these products said that people understand physical property but intellectual property is a product of the mind and the person whose idea it is should have a right to exploit the idea for a certain period of time. More...
Dish Big TV wrestle over trademark
(Ashish Sinha , 23-Mar-2010 , The Financial Express)
According to sources recently ADAG applied for the registration of Big Dish TV to the office of the trade mark registry in Mumbai. More...
Indian pharma patents to surge with US expiries
(Priyanka Golikeri , 22-Mar-2010 , DNA)
Between 2010 and 2015 drugs worth a mindboggling $157 billion are set to go off patent in the US according to industry estimates. More...
Planned EU deal not to hit generic drug cos: Anand Sharma
(REUTERS , 22-Mar-2010 , The Economic Times)
Back in 2005 India granted patents on medicines to respect international trade rules and MSF said a new free trade agreement now under negotiation would tighten these rules. More...
India ready to move WTO against EU Customs laws
(Amiti Sen , 22-Mar-2010 , The Economic Times)
We are very clear that customs officials in the EU countries bent WTO rules when they seized good quality off patent medicines being shipped from India. More...
Kesar mango from Gir all set to rub shoulders with Darjeeling tea
(Hiral Dave , 22-Mar-2010 , Indian Express)
Is the only agri product from Gujarat to get registered with Geographical Indication Registry More...
FICCI to establish IP Facilitation Centres across the country for MSMEs
(Ramesh Shankar, Mumbai , 22-Mar-2010 , Pharmabiz)
The IP Facilitation Centres will be well equipped to offer quality services in all areas of intellectual property rights and comprises of technical and legal experts having extensive knowledge in the field of intellectual property rights. More...
Motherson poised to ride auto boom
(Nitin Shrivastava , 22-Mar-2010 , DNA)
The Visiocorp acquisition lifts Motherson to tier 1 status and arms it with superior technology as Visiocorp has more than 330 patents in its name. More...
India proposes stringent laws for IP offenders
(Joe C Mathew / New Delhi , 21-Mar-2010 , Business Standard)
Audio video piracy to be included under prevention of dangerous activities Act. More...
Weekly News Round Up
(by M J Madhavan , 21-Mar-2010 , Busines Line)
Ranbaxy Laboratories Ltd on Monday said that it has reached an agreement with Japanese pharma major Takeda Pharmaceutical Company Ltd and Takeda Pharmaceuticals North America resolving outstanding patent litigation related to generic version of diabetes drug Actos. More...
New process patent granted to IIT Madras and MIN for a drug used in dialysis patients with chronic kidney disease
(Joseph Alexander, New Delhi , 21-Mar-2010 , Pharmabiz)
Two Indian patents have been filed jointly by IIT Madras and MIN on these new developments in 2006 and one patent has already been granted recently. More...
Teva drags Famy Care to US court over patent infringement
(fe Bureaus , 20-Mar-2010 , The Financial Express)
Mumbai based oral & injectable contraceptive maker Famy Care was sued in a US courtalong with partner Mylan Labs by the largest generic company Teva last week for alleged infringement of Tevas patent for oral contraceptive pills Seasonique and LoSeasonique. More...
Celebrities using trademark route to check name misuse
(Rasul Bailay , 20-Mar-2010 , Livemint)
Bollywood actress Kajol was shocked to discover television news channels last month running reports on derogatory remarks she purportedly made against the Shiv Sena on Twitter. More...
Sales data Obama push healthcare pulse on BSE
(Joe C Mathew & P B Jayakumar / New Delhi/mumbai , 20-Mar-2010 , Business Standard)
Over $86 billion worth of medicines are expected to go off patent in the next two to three years in the US. More...
DRL gets nod for Allegra D 24 generic
(Radhieka Pandeya , 19-Mar-2010 , Livemint)
Patent litigation over the drug between DRL and Sanofi is still unresolved More...
Malihabad mangoes under bug threat
(Swati Mathur , 19-Mar-2010 , The Times Of India)
With the newly acquired Geographical Indication to the Malihabadi Dussehri coming as a boost to farmers in the area the expectation of large yields could help the trade even further. More...
Apple patent and trademark skirmishes through the years
(by Erica Ogg , 19-Mar-2010 , cnet news)
Sometimes it doesnt take more than a cease and desist letter or some good backroom negotiating skills for Apple to get what it wants. More...
Piracy a serious threat to Indian film industry
(fe Bureau , 19-Mar-2010 , The Financial Express)
Strong legislative and enforcement responses are needed to tackle the issue of copyright theft. More...
Indian firms overtake US in FDA drug filings
(C.H. Unnikrishnan , 18-Mar-2010 , Livemint)
A significant portion of filings from India has been made since 2008 More...
Commerce Health ministries initiate to delink trademark aspects from quality of drugs
(Joseph Alexander, New Delhi , 18-Mar-2010 , Pharmabiz)
The move in general is to suggest required amendments so that trademark and patent issues do not get mixed up in the quality aspect of drugs. More...
Column: Astra versus Sun
(VIVEKA ROYCHOWDHRY , 18-Mar-2010 , The Financial Express)
This time AstraZeneca has filed two separate cases against Sun Pharma to block a Para IV filing on Nexium its best selling drug. More...
Lets hear it for Brazil
(Latha Jishnu / New Delhi , 18-Mar-2010 , Business Standard)
Brazil plans to break IP rights on American drugs music software and movies as retaliation for its cotton subsidies More...
Idea in soup over paperless ad
(Ratna Bhushan & Joji Thomas Philip , 17-Mar-2010 , The Economic Times)
Ideas trademark Sirji campaign shows Abhishek Bachchans image on a tree advocating the use of mobiles and saving paper to save the planet. More...
Indian pharma industry should strive to make India number one in volume of production in 5 years Dr Sivathanu Pillai
(Peethaambaran Kunnathoor, Chennai , 17-Mar-2010 , Pharmabiz)
Regarding pharma industrys growth he said the Indian Patent Act of 1970 has helped rapid expansion of domestic market market development and market orientation research. More...
Pfizer drops Viagra infringement case against Lilly
(Tom Hals in Wilmington and Ransdell Pierson in New York , 17-Mar-2010 , Reuters)
Pfizer Inc agreed to drop an eight year old patent infringement lawsuit against Eli Lilly & Co over Viagra after a U.S. government agency rejected part of the male impotence drugs patent. More...
SmartMetrics Lawsuit Against Visa and MasterCard
(ET , 17-Mar-2010 , CNN Money)
For an order pursuant to 35 U.S.C. section 271 declaring that each Defendant has infringed one or more claims of the 464 patent More...
Court bars Cadila from selling drug
(Indu Bhan , 16-Mar-2010 , The Financial Express)
With the Supreme Court refusing to give any relief to Cadila Healthcare Ltd on Monday the pharma major cannot sell its anti depressant drug Venz OD for another three months. More...
Patent dispute resolution a booster for Ranbaxy
(SI Reporter / Mumbai , 16-Mar-2010 , Business Standard)
Ranbaxy Laboratories has firmed up after settling a patent dispute with Takeda Pharmaceutical Company regarding a generic version of the Japanese companys diabetes drug Actos in the United States. More...
Overburdened FDA can scupper a rising bounty
(Priyanka Golikeri , 16-Mar-2010 , DNA)
Drugs with sales of $157 billion are going off patent in the next couple of years in the US. More...
Ranbaxy Daiichi combining synergies to boost growth
(Bianca Ghose , 16-Mar-2010 , NDTV Profit)
What Ranbaxy gets is access to Daiichis patent protected products. More...
Ranbaxy settles spat with Takeda over Actos
(Priyanka Golikeri , 16-Mar-2010 , DNA)
Ranbaxy Labs has resolved its patent litigation with Takeda Pharma related to its generic version of Actos. More...
Setback for Zydus Cadila in trademark case
(ET Bureau , 15-Mar-2010 , The Economic Times)
In a setback to Ahmedabad based drug maker Zydus Cadila the Supreme Court on Monday declined to interfere with a Madras High Court order which prevented the company from selling its anti depressant drug Venz. More...
Venus Remedies gets patent for Sulbactomax
(Corporate , 15-Mar-2010 , Busines Line)
Pharma Company Venus Remedies Ltd on Monday said it has received a product patent for its antibiotic drug Sulbactomax in the country. More...
Column: Against Tide but at what cost to Rin
(Latha R Nair , 13-Mar-2010 , The Financial Express)
An audacious advertisement campaign for Rin started by Hindustan Unilever Limited by pitching and comparing it with Tide Naturals a Procter & Gamble product has become a hot topic of discussion for intellectual property rights enthusiasts. More...
AstraZeneca in deal with generic drugs maker
(Rhys Blakely , 12-Mar-2010 , Times Online)
The deal with Torrent Pharmaceuticals gives the Anglo Swedish group access to a fresh portfolio of cheap medicines to sell in developing markets at a time when it faces the loss of patents on several of its blockbuster brands. More...
Indian pharma eyes $60B in lost patents
(Tracy Staton , 12-Mar-2010 , FiercePharma)
While Big Pharma bewails the forthcoming loss of patent protection on many top selling drugs the knock off drug business is rubbing its hands in anticipation. More...
LG infringed Whirlpool patent jury finds
(Dhanya Skariachan , 12-Mar-2010 , Reuters)
A U.S. jury found that LG Electronics infringed on a Whirlpool patent for ice storage bins in some of its refrigerators Whirlpool said on Friday. More...
Pharma drools as US patent expiries
(Priyanka Golikeri , 11-Mar-2010 , DNA)
After a brief lull caused by the slowdown the US has once again emerged as El Dorado for Indian drug makers. More...
Medicines for all
(Business Standard / New Delhi , 11-Mar-2010 , Business Standard)
This is difficult to understand as there is no intellectual property to guard against foreign takeover the Indian industry being entirely generic. More...
Climate change
(by Atty. Adrian S. Cristobal Jr. , 11-Mar-2010 , BusinessMirror)
One concern especially of developing countries is that the intellectual property system may hinder access to these technologies. More...
GlaxoSmithKline stays confident on patent regime
(Reghu Balakrishnan , 10-Mar-2010 , The Financial Express)
At a time when multinational innovator drug companies and global pharma associations cry hoarse over the intellectual property regime in India GlaxoSmithKline the second largest pharma firm in the world remains confident over the countrys patent scenario. More...
IPR is tool for wealth creation
(BS Reporter , 10-Mar-2010 , Sify)
The Uttar Pradesh government has advocated preparing a blueprint of not only creating awareness towards Intellectual Property Rights but also wealth creation by the stakeholders. More...
Natco Pharma looks to relaunch breast cancer drug in India
(Radhieka Pandeya , 10-Mar-2010 , Livemint)
Natco said it has tied up with Dr Reddys Laboratories Ltd to take this product to the US market where they are looking to challenge Abraxis patent. More...
Culinary manifesto
(ET Bureau , 10-Mar-2010 , The Economic Times)
One recent occasion was the donning of geographical indication protection by the venerable Tirupati ladoo. More...
Bidding War Pits Pfizer Against Teva
(Mergers & Acquisitions , 10-Mar-2010 , The New York Times)
In 2008 it created a division called the established products business unit to sell medications that have lost their patent protection. More...
Our Indian operations are a great success story
(P B Jayakumar / Mumbai , 10-Mar-2010 , The Economic Times)
The patent pool is a good option for finding a cure for these diseases as drugs can be made available to people in least developed countries. More...
Sun wins first roundover Wyeths Protonix
(Radhieka Pandeya , 10-Mar-2010 , Livemint)
The case was filed by US based Wyeth Pharmaceuticals which had sued Sun and Caraco for claiming that their heartburn drug was a generic version of its Protonix drug More...
AstraZeneca Sues Sun Pharma For Patent Infringement
(Pharmaceutical Business Review , 9-Mar-2010 , Pharmaceutical Business Review)
AstraZeneca has filed a patent infringement complaint against India based Sun Pharma for planning to market a generic formulation of its intravenous acid reflux disease treatment Nexium IV. More...
$280000 a year job offer for Chennai patent holder
(IANS , 9-Mar-2010 , The Economic Times)
Patent under the US law is awaited Shivaraman told IANS talking about his innovative polymer templated lithography process which allows fabrication of patterned magnetic media with density of around 30 TB. More...
Glaxo chief Witty says ready to ramp up play
(Priyanka Golikeri , 9-Mar-2010 , DNA)
Experts feel depleting new molecule pipelines and impending patent expiries are increasing the desperation of pharma biggies such as Pfizer and GSK to rapidly expand their presence in India. More...
FICCI to organise Roundtable on controversial section 3 d of Indian Patents Act
(Ramesh Shankar, Mumbai , 9-Mar-2010 , Pharmabiz)
Even as the multinational pharma companies are making an orchestrated efforts to remove the controversial section 3d of the Indian Patents Act which prevents incremental pharmaceutical innovations from receiving patent protection the Federation of Indian Chambers of Commerce and Industry is organizing a Roundtable Conference on the issue in New Delhi on March 22. More...
AstraZeneca takes Sun Pharma to court
(TNN , 9-Mar-2010 , The Times Of India)
A generic company files an abbreviated new drug application with a Para IV certification before a patented product goes off patent. More...
Glaxo chief Witty says ready to ramp up play
(Priyanka Golikeri , 9-Mar-2010 , DNA)
Experts feel depleting new molecule pipelines and impending patent expiries are increasing the desperation of pharma biggies such as Pfizer and GSK to rapidly expand their presence in India. More...
Dept of pharma wants review of FDI rules
(Surajeet Das Gupta & Joe Mathew / New Delhi , 8-Mar-2010 , Business Standard)
The Alliance has also pointed out that there are serious new entry barriers in the international market such as seizure in transit ever growing intellectual property rights enforcement and protection and attacks on Indias brand equity. More...
Public interest groups object to disguised lobbying with judges policymakers by GWU and CII
(Ramesh Shankar, Mumbai , 8-Mar-2010 , Pharmabiz)
Several public interest groups in the country have asked the central government to take immediate steps to put a stop to the industry sponsored lobbying with judges and policymakers in the country as part of the of Summits on Intellectual Property being organised in different cities in India jointly by the US based George Washington University and the Confederation of Indian Industry with funding from multinational pharmaceutical companies industry associations and corporate law firms. More...
India to submit IPR report to US trade representative
(Joe C Mathew / New Delhi , 07-Mar-2010 , Business Standard)
India will submit a status report on the progress it has made on intellectual property rights protection and enforcement during the last year to the United States Trade Representative. More...
India-US to sign key trade pact on Mar 17
(STAFF WRITER , 07-Mar-2010 , Press Trust Of India)
The US has been seeking greater market access in India and raising concern over protection of the intellectual property rights. More...
India tops exporting generic medicines
(Nageshwar Patnaik , 07-Mar-2010 , The Economic Times)
The word generic is used to describe a product particularly a drug which does not have a trademark. More...
UP slack in claiming its intellectual rights
(TNN , 6-Mar-2010 , The Times Of India)
Despite being a repository of rich biodiversity Uttar Pradesh is one of the poorest performers when it comes to protecting their traditional knowledge. More...
AstraZeneca sues Sun Pharma in us court
(BS Reporter / Mumbai , 5-Mar-2010 , Business Standard)
Sun had challenged the patent on Nexium IV in the US market. More...
Ranbaxy may still gain from Flomax
(Radhieka Pandeya , 5-Mar-2010 , Livemint)
The company may get a one time payment for enabling the launchof its generic versionin the US market More...
Natco moves SC against Novartis drug
(Indu Bhan , 5-Mar-2010 , The Financial Express)
Natco Pharma has approached the Supreme Court challenging a part of the Intellectual Property Appellate Boards decision that said Swiss drug maker Novartis blood cancer drug Glivec was novel and inventive. More...
Pharma cos filing multiple patents for same drug
(Priyanka Golikeri , 5-Mar-2010 , DNA)
In September 2009 a patent application for AIDS drug darunavir was rejected as it did not meet patentability criteria laid down in the Indian Patent Act. More...
How pharma can use deduction as addition
(Gireesh Chandra Prasad , 5-Mar-2010 , The Financial Express)
The US allows a six month exclusive marketing right to the first generic copy that enters the market without infringing the patent protecting the original drug or by proving that the patent was invalid. More...
Strides buys Aspen unit for $75 m
(Priyanka Golikeri , 5-Mar-2010 , DNA)
The acquisition is believed to facilitate the contract that Strides signed with US behemoth Pfizer in January 2010 whereby the two companies struck a deal to deliver 40 off patent products mainly injectable cancer medicines and oral medicines to patients in the US. More...
Kolhapuri chappals scale new heights
(Sujata Reddy , 04-Mar-2010 , Hindustan Times)
In an effort to protect intellectual property rights of the popular Kolhapuri Chappals Shivaji University Kolhapur had decided to apply for Intellectual Property Rights close to five years back. More...
Ranbaxy faces more trouble in US
(Joe C Mathew / New Delhi , 4-Mar-2010 , Business Standard)
Local arm faces lawsuit for alleged marketing of products with false patent claims. More...
IIT drug to treat kidney diseases gets patent
(TNN , 4-Mar-2010 , The Times Of India)
An indigenous drug, developed by scientists at the Indian Institute of Technology Madras which can remove toxic phosphorous from the body of a patient with chronic kidney failure has been awarded a process patent. More...
Insidious India project
(Latha Jishnu / New Delhi , 4-Mar-2010 , Business Standard)
MNC backed IP summits try to influence sitting judges on patent law enforcement issues pending in Indian courts More...
EU trade chief sees progress in India FTA talks
(by Bate Felix , 04-Mar-2010 , Reuters)
Disagreements over market access intellectual property rights a dispute over generic drugs and the EUs desire to include issues such as climate change and child labour have stalled the talks. More...
Copyright content to pinch pockets of FM TV channels
(Pradipta Mukherjee & Swarup Chakraborty / Kolkata/mumbai , 4-Mar-2010 , Business Standard)
According to the Bill service tax will be levied on any temporary transfer of copyright or permitting the use or enjoyment of any copyright defined in the Copyright Act 1957 except the following: original literary dramatic musical and artistic works Section 13 a of the Copyright Act 1957]. More...
Ranbaxy loses out on FDA delay
(Khomba Singh , 3-Mar-2010 , The Economic Times)
Ranbaxy the Indian unit of Japanese drugmaker Daiichi Sankyo was to launch the generic version of the Japan based Astellas Flomax on March 2 in the US eight weeks before the drugs patent expires in the US following an out of court settlement in 2007. More...
Apple sues rival HTC as phone competition rises
(Corporate News , 3-Mar-2010 , Livemint)
Apple said HTC has infringed on 20 of its patents covering aspects of the iPhones user interface and hardware More...
Supreme Court admits Bayer patent linkage plea
(Priyanka Golikeri , 2-Mar-2010 , DNA)
The Supreme Court has admitted a special leave petition filed by Bayer seeking introduction of patent linkage system in India. More...
A Passage to India
(Bhupesh Bhandari / New Delhi , 2-Mar-2010 , Business Standard)
The absence of product patents had made them experts in reverse engineering. More...
A few extramural research projects under ICMR get patents set for commercialisation
(Joseph Alexander, New Delhi , 2-Mar-2010 , Pharmabiz)
A number of extramural research projects going on in different institutes under the Indian Council for Medical Research and in Universities with the support of ICMR have reached laboratory scale stage and in the process of being commercialized after having granted patents. More...
FM injects new life into pharma
(TNN , 01-Mar-2010 , The Times Of India)
From this year on companies will also be allowed to claim the weighted deduction benefit on expenses incurred on clinical trials and product patent registrations. More...
Budget could push R&D spend by 25 50%: pharma players
(Sohini Das / Mumbai/ Ahmedabad , 01-Mar-2010 , Business Standard)
Troikaa Pharma is in the process of getting patent approvals for its novel drug delivery system for Diclofenac injections Dynapar AQ from several countries. More...
No interim stay on Ciplas Nexavar clone
(Khomba Singh , 01-Mar-2010 , The Economic Times)
The Supreme Court on Friday turned down a request by German drugmaker Bayer AG to stop Mumbai based Cipla from launching the low cost version of Bayers patented cancer medicine Nexavar while admitting the case. More...
Bayh Dole in India: Not a great idea
(Dwijen Rangnekar , 28-Feb-2010 , Business Standard)
In recent times the making of intellectual property law in India has been ironically tarnished by claims of plagiarism. More...
Copyright panel cancels meet
(Bharati Dubey , 28-Feb-2010 , The Times Of India)
The joint committee of producers and writers formed by the HRD ministry has cancelled its meeting scheduled for Sunday after Bollywood producers abstained from attending it. More...
No interim relief for Bayer: Supreme Court
(Manish Ranjan , 27-Feb-2010 , Livemint)
The apex court refused to stay a Delhi HC order of 10 Feb which rejected Bayers attempt to block the DCGI from allowing Cipla to market its generic version of Nexavar More...
Pharma sector gets booster dose for innovation
(fe Bureau , 27-Feb-2010 , The Financial Express)
For instance a biotech company must file international patents in order to protect its IP and to conduct clinical trials which are all legitimate R&D expenses that would need to be covered under the weighted deduction scheme. More...
Desi Viagra likely to roll out of Kerala institute
(IANS , 26-Feb-2010 , The Times Of India)
TBGRI director A. Subramonian principal investigator of the project undertaken for the past three years said they were in the process of applying for a patent. More...
Customs duty move to help media gaming firms in India
( by Shilpa Jamkhandikar and Bharghavi Nagaraju , 26-Feb-2010 , Reuters)
The governments move to simplify the customs duty on imported films will help the entertainment industry cut costs but imposing service tax on intellectual property rights could be a dampener officials said. More...
Big Pharma starts believing in outside innovation
(Pillman , 25-Feb-2010 , DNA)
One business development executive felt that the approvals from the FDA are coming at a faster speed now and so there could be big drugs in the offing but another remained skeptical saying that newer approaches to research like patent pools and collaborative work may fetch better dividends. More...
Bayer drags Cipla to SC over anti cancer drug patent
(Indu Bhan , 25-Feb-2010 , The Financial Express)
German drug major Bayer AG on Wednesday approached the Supreme Court seeking protection for its drug Nexavar even as Ciplas plea for marketing approval for Sorafenib the generic version of its kidney cancer drug is pending with the regulatory authorities. More...
More delay in supplies to AstraZeneca may hit Ranbaxy revenue
(Radhieka Pandeya , 25-Feb-2010 , Livemint)
The accord between the two companies follows from a manufacturing agreement that was part of a bigger patent infringement settlement between Ranbaxy and AstraZeneca in April 2008. More...
Patent office to recruit 257 new examiners to clear huge backlog of applications
(Suja Nair-Shirodkar, Mumbai , 25-Feb-2010 , Pharmabiz)
Faced with a huge backlog of more than 70000 patent applications that are in the pipeline for process and examination in the country the government has decided to recruit another 257 patent examiners to expedite the process of patent scrutiny and its disposal. More...
Ambanis now fighting over trademarks
(rasul.b , 24-Feb-2010 , Livemint)
Rival Reliance groups that had turned a blind eye to conflicting names in the past spar over Finance and Financial More...
Infosys expects increase in patent filings
(Kirtika Suneja / New Delhi , 24-Feb-2010 , Business Standard)
Infosys Technologies expects an increase in its patent filings on the back of new technologies like cloud computing analytics and emerging information and communication technologies. More...
Polymed gets to sell IV device in Germany
(Khomba Singh , 24-Feb-2010 , The Economic Times)
Indian law allow patent holders to have exclusive marketing rights for 20 years. More...
Host Analytics expands presence in India to support rapid product innovation
(Businesswire India , 24-Feb-2010 , The Financial Express)
Host Analytics Indian engineering team has made important contributions to the companys intellectual property and patent portfolio as well as its industry leading analyst recommended financial performance solutions. More...
Pharma sector wants govt to cut excise duty on bulk drugs to 4%
(Rediff Business , 23-Feb-2010 , Rediff)
At the same time they are also entering into generic business segment by tie up with low manufacturing countries as block buster drugs worth of USD 100 billion are expected to come out of patent in the next five years. More...
Govt considers liberalizing merger and acquisition norms
(Sangeeta Singh , 23-Feb-2010 , Livemint)
Industry has also suggested that acquisition of dead or dormant companies of intangibles such as intellectual property rights and companies primarily into exports be exempt from CCI ratification. More...
Indian FTAs may hit SE Asian ryots
(Priyanka Golikeri , 23-Feb-2010 , DNA)
While India mulls another free trade agreement with Australia and New Zealand its FTAs with European Union and Japan remains shrouded in uncertainty with its decisions regarding intellectual property rights likely to impact not just India but other developing South East Asian countries as well. More...
Indian exporters breathe easy as East African nations reject draft
(C.H. Unnikrishnan , 23-Feb-2010 , Livemint)
The new legislation in East Africa was mainly aimed at stopping affordable generic drugs from India More...
Copyright ya wrong
(M Suganth , 22-Feb-2010 , The Times Of India)
Now that Aamir Khan is back on the HRD ministrys copyright panel which is debating the amendment to copyright laws it is time to step away from the brouhaha and focus on the matter at hand amending our archaic copyright laws governed by the Copyright Act 1957. More...
Protecting pharma patents
(Ronald A. Cass / WSJ , 22-Feb-2010 , Livemint)
Degrading patents has serious side effects. More...
Poly Medicure gets Germany nod for safety IV Cannula
(fe Bureaus , 22-Feb-2010 , The Financial Express)
In these preliminary injunctions the German court had found that the attacked products infringed the German part of the European Patent 1 911 486. More...
We should do R&D in India
(Joe C Mathew / New Delhi , 21-Feb-2010 , Business Standard)
Medical technology is not like pharmaceuticals where a single chemical has been patented and no one can come out with that product. More...
GI marker of Tirupati laddus gets nod
(Express News Service , 20-Feb-2010 , express buzz)
The Geographical Indication Registry has not committed any illegality by registering Tirupati laddus as a geographical indication the Registry has submitted in its counter affidavit filed in the Madras High Court on Friday. More...
Does Cong have a patent in visiting Dalit homes asks BJP
(PTI , 20-Feb-2010 , The Hindu)
Taking strong exception to Congress remark that its chief Nitin Gadkari was aping Rahul Gandhi by visiting Dalit households BJP today asked if any particular party has a patent to do so. More...
Biogen to bring its global drug portfolio to India
(Khomba Singh , 19-Feb-2010 , The Economic Times)
We have sought patents for these drugs in India and the country will be part of future global launches of all our drugs Ms Seth added. More...
Sun Pharmas cancer drug application gets EMA backing
(PTI , 19-Feb-2010 , The Economic Times)
The development comes at a time when Sun is up against a suit by Sanofi Aventis in the US alleging patent infringement and asking the US Food and Drug Administration not to grant approval to market it in America. More...
Does India Want Drug Innovation or Not?
(By RONALD A. CASS , 18-Feb-2010 , The Wall Street Journal)
A string of recent court decisions degrading patent rights suggests the answer is no. More...
Book building worries
(Latha Jishnu / New Delhi , 18-Feb-2010 , Business Standard)
Googles project to digitise the worlds books raises complex issues of copyright fair use and fears of monopoly power. More...
Patent offices need more staff
(Special Correspondent , 18-Feb-2010 , The Hindu)
70000 patent applications in the pipeline for process: Controller General of Patents More...
Berry enterprising
(By Siddharth Gadkari , 18-Feb-2010 , Mumbai Mirror)
Not wanting to let farmers from other regions fool consumers into buying their strawberries by saying they are from Mahabaleshwar producers of the original fruit have applied for a patent More...
Experts NGOs oppose CII GWU summit on IP for strong patent regime in India
(Ramesh Shankar, Mumbai , 18-Feb-2010 , Pharmabiz)
Even as the Confederation of Indian Industry two day Summit on IP in association with the George Washington University has got underway in Mumbai several public interest groups and experts have raised eyebrows expressing apprehensions that the one sided focus of IP Summit is detrimental to Indian interests. More...
Patents weapon of biopirates of the West
(Gokul Chandrasekar , 18-Feb-2010 , express buzz)
Biodiversity is in the air: 2010 is being observed as its international year and an international biodiversity summit will be held in Nagoya in October. More...
Industry can handle todays problem but need us for tomorrows science
(Joe C Mathew & Vandana Gombar , 18-Feb-2010 , Business Standard)
CSIR gets patents but doesnt sell these exclusively exclusivity reaches only the rich. More...
70000 patent applications lying due to shortage of examiners
(PTI , 17-Feb-2010 , The Hindu)
Over 70000 patent applications are in the pipeline for examination and may need at least 3 4 years for approval under the Intellectual Property Rights Act due to shortage of examiners a senior government official said. More...
Drug induced speculation in India
(By HARSH JOSHI , 17-Feb-2010 , The Wall Street Journal)
For blockbuster drugs like Lipitor and Plavix the patent expiration schedule is even more front loaded. More...
Delhi HC dismisses B Brauns appeal for interim injunction against Poly Medicure
(Gireesh Babu, Mumbai , 17-Feb-2010 , Pharmabiz)
A division bench of the High Court of Delhi has dismissed an appeal filed by the Germany based B Braun Melsungen AG and its Indian subsidiary against the New Delhi based Poly Medicure Ltd seeking an interim injunction restraining the latter from manufacturing and selling a needle guard product for which the company claims to have an Indian patent. More...
Northern SMEs gear up to file for patents
(Komal Amit Gera / Chandigarh , 16-Feb-2010 , Business Standard)
Taking inspiration from their bigger brothers small and medium units in the northern region are gearing up to seek patents for their products in the international market. More...
GSK to increase headcount introduce more products
(P.T. Jyothi Datta , 16-Feb-2010 , Busines Line)
Two of the drugs are patented and the medicines will be priced differently in the local market he said adding that the price had not yet been decided. More...
While Bayer pushes patent EU parliamentary group opposes
(Priyanka Golikeri , 16-Feb-2010 , DNA)
While German firm Bayer has adopted a try till you succeed stance on pursuing patent linkage in India on the other hand a European parliamentary group is planning to call on the EU and European Commission the executive arm of the EU to not push for provisions such as patent linkage in developing countries. More...
Biotech industry pushes for fiscal sops, duty exemption
(K Ramnath Shenoy/PTI / Bangalore , 16-Feb-2010 , Business Standard)
This is short sighted in view of the fact that international patent filings are key to the biotech sector she said. More...
Indian drug makers worried by East Africas legal proposals
(C.H. Unnikrishnan , 16-Feb-2010 , Livemint)
Countries such as Uganda and Tanzania are taking their cue from a Kenyan law against fakes More...
India EU FTA gets flak in Europe
(Priyanka Golikeri , 15-Feb-2010 , DNA)
Intellectual property in trade agreements could endanger the poor mans access to affordable medicines according to a veteran member of the European Parliament. More...
Drug trials begin for cancer Alzheimers
(IANS , 14-Feb-2010 , The Times Of India)
We re into research that can give us patents. More...
Indian cotton products may soon carry US trademark seal
(Amit Mitra , 13-Feb-2010 , Busines Line)
Indian consumers of cotton apparel and home furnishings may soon have an additional point of interest to pick up their favourite products from retail stores. More...
Indian pharma in midst of corporate transformation
(P B Jayakumar / Mumbai , 13-Feb-2010 , Business Standard)
Industry sources also said Ahmedabad based Cadila Pharmaceuticals is also planning to appoint a CEO with strong background in biological drug development as the company is planning to develop a large portfolio of copycat off patent biologic drugs. More...
IPR policy resolves issues in knowledge sharing
(Vinson Kurian , 13-Feb-2010 , Busines Line)
Proposes commons licence for traditional knowledge. More...
US patent for Avanir Pharmas low dose quinidine formulations of Zeniva
(Aliso Viejo, California , 13-Feb-2010 , Pharmabiz)
Avanir Pharmaceuticals Inc announced that the United States Patent and Trademark Office has issued the company a new patent for its lead drug candidate Zenvia extending the period of patent protection in the United States into late 2025. More...
Market flooded with Smartphone look-alikes
(Writankar Mukherjee & Debjoy Sengupta , 13-Feb-2010 , The Economic Times)
While it is a conscious business decision to launch models which are look alike of bigger brands we do make certain design modifications to ensure that there are no IPR or legal issues. More...
Drug Makers Decry Indian Patent Law
(GEETA ANAND , 12-Feb-2010 , The Wall Street Journal)
Multinational drug companies have pushed big time into India in recent years after the country agreed to respect intellectual property rights for pharmaceutical products. More...
Renault likely to take charge of Logan revival
(Murali Gopalan , 12-Feb-2010 , Busines Line)
Sources say that the most likely solution will result in M&M divesting its 51 per cent stake in favour of Renault which by the end of the day holds the intellectual property rights for the Logan. More...
Indian pharma cos to grow 12% will witness more deals
(fe Bureaus , 12-Feb-2010 , The Financial Express)
The pharmaceutical industry globally is facing a period of significant drug patent expiries which expands the addressable market for generics companies. More...
Glaxo Voltas in brand war
(Joe C Mathew / New Delhi , 11-Feb-2010 , Business Standard)
Volmax vs Voltas dispute back with Intellectual Property Board More...
Every generic drug is not spurious says court
(P.T. Jyothi Datta , 11-Feb-2010 , Busines Line)
Observations made in Bayer patent link case. More...
Book famine
(Atty. Adrian S. Cristobal Jr. , 11-Feb-2010 , BusinessMirror)
In one of the committee hearings concerning amendments to the copyright laws at the House of Representatives there was a contingent of blind people led by an advocate who participated in the discussions on House Bill 4217 sponsored by Rep. Irwin Tieng. More...
HC rejects Bayers patent plea on cancer drug
(BS Reporter / New Delhi , 10-Feb-2010 , Business Standard)
A bench of the High Court here today dismissed an appeal by Bayer the German pharmaceutical company on an earlier decision to allow marketing of generic versions of its patented drug. More...
US pharma cos sue Lupin for patent infringement
(fe Bureau , 10-Feb-2010 , The Financial Express)
US based Purdue Pharma Products LP and UK based Napp Pharmaceutical Group have sued Lupin Ltd and its US subsidiary Lupin Pharma Inc claiming that their attempt to manufacture and market the generic version of the analgesic tramadol ER infringes patent coverage of the innovator. More...
Parliament panel wants govt review on Innovation Bill
(C.H. Unnikrishnan , 10-Feb-2010 , Livemint)
Critics say there is a disconnect between its objectives and the efficacy of a Bayh Dole structure More...
Danone begins marketing flavoured milk
(Ratna Bhushan , 10-Feb-2010 , The Economic Times)
The Wadia Group had sued Groupe Danone in a Singapore court claiming violation of its intellectual property rights of the Tiger brand. More...
HC rejects petition of UCB Franchim
(STAFF WRITER , 10-Feb-2010 , Press Trust Of India)
The Delhi High Court has rejected the petition of global biopharma major UCB Farchim against the Indian drugmaker Cipla and the countrys patent authority over rejection of its patent of a new anti allergic drug and directed it to approach sectoral tribunal IPAB. More...
Everyones connected
(Manju Menon and Kanchi Kohli Manju Menon and Kanchi Kohli , 09-Feb-2010 , Hindustan Times)
In one of the meetings in 2007 126 approvals for Intellectual Property Rights from the Council for Scientific and Industrial Research were approved. More...
UK court overturns GSK patent for lupus drug
(By Andrew Jack in London , 09-Feb-2010 , Financial Times)
The UK courts on Tuesday overturned a patent on belimumab a treatment for the auto immune disease lupus under joint development by GlaxoSmithKline and Human Genome Sciences. More...
Approach patents body first: HC to pharma firms
(BS Reporter / New Delhi , 9-Feb-2010 , Business Standard)
Delhi High Court dismisses six petitions of drug majors. More...
Court throws out pharma cos patent claim
(Manish Ranjan , 9-Feb-2010 , Livemint)
The patents authority had rejected the claim saying The claimed invention covered by the subject application lacks inventive steps More...
Sambalpuri Bastralaya moves for patenting
(Express News Service , 9-Feb-2010 , express buzz)
Sambalpuri Bastralaya Handloom Co operative Society Limited has filed a patent application on textile weaving technology and design application on wall hanging made by it using the new technology. More...
China fifth in UN patent filings India way behind
(D Ravi Kanth / Geneva , 9-Feb-2010 , Business Standard)
China is on its way to become a global leader in scientific research while India has a long way to go according to data issued by a Geneva based organisation on international patent filings. More...
Dispute on patent adds to Toyotas problems
(By Bernard Simon in Toronto , 09-Feb-2010 , Financial Times)
As if Toyota did not have enough on its plate with a series of damaging recalls the Japanese carmaker is embroiled in a long running patent infringement dispute in the US involving a key part of the technology that drives its hybrid petrol electric vehicles. More...
Purdue Pharma sues Lupin following Para IV filing on controlled release painkiller drug
(Our Bureau, Mumbai , 9-Feb-2010 , Pharmabiz)
The US based Purdue Pharma Products LP and its UK based partner Napp Pharmaceutical Group Ltd has filed a para IV patent infringement suit against the Mumbai based Lupin Ltd and its US subsidiary for the latters move to manufacture and market the generic version of the narcotic painkiller drug Ultram ER. More...
CRISIL assigns IPO grade 4/5 to Glenmark Generics
(ET Bureau , 09-Feb-2010 , The Economic Times)
According to estimates by CRISIL Research drugs worth an estimated $137 billion is scheduled to go off patent in the US and Europe over the next five years which implies significant generics opportunity for India. More...
Lupin goes all out to make up for lost chances
(Satish John & , 8-Feb-2010 , Livemint)
An ANDA filing is an application with the US Food and Drug Administration for permission to introduce a generic version of an already patented drug in the market. More...
Troikaa drug to get US patent
(Press Trust of India , 8-Feb-2010 , The Financial Express)
Troikaa Pharmaceuticals a Gujarat based fast growing healthcare company is likely to get US patent for its novel drug delivery form of Diclofenac injections Dyanapar AQ. More...
Google book project US stance firm but not enough for Indian writers
(Lison Joseph , 8-Feb-2010 , Livemint)
In its Friday submission the department told the court the US government believes that the court lacks authority to approve a proposed settlement agreement as it involved the rights of many foreign copyright owners too. More...
Indian SMEs keep pharma prices under check: Study
(Joe C Mathew / New Delhi , 8-Feb-2010 , Business Standard)
A global study by Health Action International a non government body on the price variations of Ciproflaxin a commonly used medicine in 93 countries found the price charged by Bayer the originator of the drug to be the lowest in India. More...
Scientists want changes in innovation Bill
(Anika Gupta , 8-Feb-2010 , Livemint)
The scientists presented complaints regarding the proposed Protection and Utilization of Public Funded Intellectual Property Bill 2008. More...
Jaggi Vasudev hits out at Bt brinjal
(Express News Service , 8-Feb-2010 , express buzz)
Pointing out that the Western multinational companies hold patent for these GM foods he said, when the farmers in the country tend to use these genetically engineered seeds the royalties for it would go to the European countries. More...
Fears regarding amendments to Copyright Act will diminish
(ET Bureau , 6-Feb-2010 , The Economic Times)
HRD Minister Kapil Sibal in an interview with ET says talks at length about the proposed amendments to Copyright Act. More...
Zari industry set to regain lost lustre
(Melvyn Thomas , 05-Feb-2010 , The Times Of India)
The industry is likely to be registered under the Geographical Indication Act of Government of India which stipulates protection of the market of the producers and safeguards the interests of the consumers of the unique product by mid 2010. More...
China tops India comes in third in IPR violations
(T.E. Raja Simhan , 5-Feb-2010 , Busines Line)
For the US China remains the top trading partner for IPR violations followed by Hong Kong in the second place and India third during 2009 according to the US Customs and Border Protection and the Immigration and Customs Enforcement. More...
Foreign drug makers may lose monopoly
(C.H. Unnikrishnan , 5-Feb-2010 , Livemint)
Patent office can revoke monopoly rights if firms cannot prove obligations were met within their 3 year window More...
Swedens generic drive to help Indian pharma cos
(Soma Das , 5-Feb-2010 , The Financial Express)
If buyers choose to pay the difference between the cheapest available option and the brand prescribed in case of an off patent drug they could buy the latter. More...
IPL: SET Max & organisers to check ambush marketing
(Monica Behura , 5-Feb-2010 , The Economic Times)
Six IPL franchisee teams have also protected their Intellectual Property Rights and Trademark rights in India and eight other cricket playing nations for their merchandise and logos. More...
India reluctant to relent on greater market access to EU
(Asit Ranjan Mishra , 5-Feb-2010 , Livemint)
Leena Menghaney campaign coordinator for access to essential medicines Medecins Sans Frontieres raised concerns about the EUs insistence on stringent TRIPS plus trade related aspects of intellectual property rights measures. More...
Kiris market pie gets bigger but debt weighs
(Ramkrishna Kashelkar , 5-Feb-2010 , The Economic Times)
The buyout entailed purchase of 17 manufacturing facilities out of Dystars 19 along with all brands patents and intellectual property rights. More...
BlackBerry wins patent battle with Motorola in Britain
(IANS , 04-Feb-2010 , The Economic Times)
BlackBerry maker Research In Motion Wednesday won its patent battle in Britain with Motorola when a court in London ruled in favour of the Canadian wireless giant based at Waterloo near here. More...
Wed restrict filings to those of high quality
(Jacob P. Koshy , 4-Feb-2010 , Livemint)
The chief patent counsel for Microsoft Corp. Bart Eppenauer spoke in an interview about his companys growing engagement with Indian patent offices and law firms to strengthen its intellectual property portfolio in the country More...
Cautionary tale of trolls
(Latha Jishnu / New Delhi , 4-Feb-2010 , Business Standard)
Patent trolls and not patent holders are raking in money from lawsuits and firms are desperately seeking a way out More...
Governments move to relax Copyright Act lacks vision
(Manish Ranjan , 3-Feb-2010 , Livemint)
People with visual handicaps can read printed material only when it is converted into older formats such as Braille or newer and more flexible audio and electronic formats More...
Delhi HC stays patent revocation of Abbotts drug
(Joe C Mathew / New Delhi , 3-Feb-2010 , Business Standard)
The Delhi High Court has stayed a decision to revoke the patent granted to Abbott Laboratories blockbuster rheumatoid arthritis drug Humira adalimumab. More...
Informatica reports record quarterly revenues of $151 mn and 25 pct license revenue growth
(Businesswire India , 2-Feb-2010 , The Financial Express)
This compares to $39.5 million in income from operations in the fourth quarter of 2008 which included the one time benefit of $11.5 million from patent related litigation proceeds net of patent contingency accruals. More...
Court relief for city firm in copyright case
(Kartikeya , 01-Feb-2010 , The Times Of India)
In a significant judicial order aimed at protecting intellectual property rights of internet driven and telephonic services the Delhi high court has restrained a website from using a directory of telephone numbers originally compiled by a Mumbai based dial up firm. More...
Sun gets a boost as FDA rejects rival Osmoticas plea
(ET Bureau , 1-Feb-2010 , The Economic Times)
As Sun and Osmoticas drugs are in the form of tablets and therefore not replicas of Wyeths drug capsulesthese companies do not have to wait for the Pfizer group companys patent to expire later this year. More...
FE Editorial: Google booked
(The Financial Express , 1-Feb-2010 , The Financial Express)
After all intellectual property issues didnt really gain global traction till the last part of the twentieth century at which point they exploded all across a host of commerce verticals ranging from pharmaceutical to artistic works. More...
Boston Scientific reaches $1.73 bn patent settlement with J&J
(Press Trust of India / New York , 01-Feb-2010 , Business Standard)
US medical devices maker Boston Scientific Corp today said it will pay $1.73 billion to settle three patent disputes with healthcare firm Johnson & Johnson. More...
Secretly India talked free trade agreement with EU again
(Priyanka Golikeri , 1-Feb-2010 , DNA)
There is absolutely no word on how Indias concerns on intellectual property tariffs on agriculture second hand goods etc would get addressed said a source closely associated with the government. More...
Apeda initiates registration process of basmati under GI
(Sandip Das , 1-Feb-2010 , The Financial Express)
After much delay the process of registration of basmati rice famaous across the globe for aroma and long grain under the geographical indications certification has started in the country. More...
Drugs companies face deeper cuts in research
(Carl Mortished, World Business Editor , 1-Feb-2010 , Times Online)
The extent to which the recession has cut into high value research and development jobs in the pharmaceutical industry will be laid bare this week as job losses in the industry climb to 12000. More...
Eco labelling norms for ornamental fish formulated
(fe Bureaus , 1-Feb-2010 , The Financial Express)
The task force also looked in to the geographical indications of each species and requirements needed for import of exotic species. More...
Frivolous patents make drugs costly
(TNN , 30-Jan-2010 , The Times Of India)
Many pharma companies are making huge money just by making minor changes over existing technologies or drugs a patent expert said More...
Indian authors publishers take Google to court on book deal
(Our Bureau , 30-Jan-2010 , Busines Line)
Claim violation of copyright laws. More...
Strong patent law may lead to rise in costs
(Express News Service , 30-Jan-2010 , express buzz)
A strong patent law may lead to increase in the costs of essential supplies including the inputs for improved agricultural and industrial production thereby raising the cost of living of the poor and the marganilised said N R Madhava Menon member of the Commission on Centre State Relations. More...
A journey without maps
(Pratik Kanjilal , 30-Jan-2010 , Hindustan Times)
Any cultural nationalist can tell you that like all good things multiculturalism originated in India and we have a patent on it. More...
Farmers chip in against Bt Brinjal
(Swati Mathur , 30-Jan-2010 , The Times Of India)
Even as scientists and farmers cry foul over the ill effects of genetically modified crops an equally large community of scientists and patent holders are making a strong case in favour of Bt brinjal. More...
HC to hear pharma patent issue on Monday
(Indu Bhan , 29-Jan-2010 , The Financial Express)
The Delhi High Court will hear on Monday a batch of petitions filed by global pharma majors seeking quashing of the patent offices decision that rejected their applications for grant of patents for their respective drugs. More...
Pharma research: Pool of skills and low costs fosters growth
(By Amy Kazmin in Bangalore , 28-Jan-2010 , Financial Times)
Indias pharmaceutical industry cut its teeth in the 1970s fostered by local patent laws that only protected the unique processes of synthesising a drug molecule rather than the molecules themselves. More...
India asks Kenya to change law making generics illegal
(Amiti Sen & Khomba Singh , 28-Jan-2010 , The Economic Times)
The Kenyan legislation lays down that all generics will be treated as counterfeits and rejected in case a patent holder in a third country files a dispute. More...
Merck loses temozolomide patent infringement suit against Teva in US court
(Whitehouse Station, New Jersey , 28-Jan-2010 , Pharmabiz)
Merck & Co Inc announced that the US District Court for the District of Delaware ruled against the company in a patent infringement suit against Teva Pharmaceuticals USA Inc. More...
Microsoft joins network designed to counter patent trolls
(By John Letzing , 27-Jan-2010 , MarketWatch)
Microsoft Corp. a technology giant that wins thousands of patents every year has joined RPX Corp. a start up network aimed at aggregating intellectual property to shield its members from what are known as patent trolls. More...
Drug patent regime has led to high prices: US Study
(Joe C Mathew / New Delhi , 27-Jan-2010 , Business Standard)
Other reasons include transfer of marketing rights to larger companies and mergers and acquisitions among drug companies. More...
Cipla asks UNITAID to address all related issues to make patent pool workable & realistic
(Ramesh Shankar, Mumbai , 27-Jan-2010 , Pharmabiz)
Indian pharma major Cipla has expressed apprehensions on achieving the goal of the UNITAIDs patent pool initiative which was recently created for HIV AIDS drugs unless and until the terms and reference objectives and all issues of patent pool are spelt out clearly. More...
The problem with patents
(Shamnad Basheer , 27-Jan-2010 , Livemint)
The 2008 Protection and Utilization of Public Funded Intellectual Property Bill popularly called the Indian Bayh Dole Bill since it draws inspiration from the US Bayh Dole Act of 1980 is currently undergoing scrutiny by a parliamentary select committee. More...
Claris talking to 3 more pharma majors for Pfizer type deal
(P B Jayakumar / Mumbai , 27-Jan-2010 , Business Standard)
Claris and Pfizer had entered into a deal in May last year for supply of sterile injectable drugs that are off patent and have lost exclusivity in the US Canada Australia New Zealand and Europe. More...
Virgin Atlantic files case in UK against Jet
(P.R. Sanjai , 27-Jan-2010 , Livemint)
Virgin founded by Richard Branson holds the patent and design rights for the flatbed seating system in several countries including in the UK More...
New vaccine may help cure multiple diseases
(Sohini Das & Maulik Pathak / Ahmedabad , 27-Jan-2010 , Business Standard)
A brainchild of Pawan Saharan chairman of Mumbai based Biomix Network the active pharmaceutical ingredient is patented in India as Radha 108. More...
Bajaj Auto gets European patent for ExhausTEC
(Corporate , 25-Jan-2010 , Busines Line)
Leading auto maker Bajaj Auto on Monday said its technology ExhausTEC which help improve performance of a two wheeler has been granted a patent by the Munich headquartered European Patent Office. More...
Traditional knowledge: Concern on access pact
(Vinson Kurian , 25-Jan-2010 , Busines Line)
The access agreement that India has signed with foreign patent offices to share Traditional Knowledge Digital Library in the form of a prior art could undermine its confidentiality. More...
DIPP in mysterious pact on patents with Wipo
(Latha Jishnu / New Delhi , 25-Jan-2010 , Business Standard)
Agreement mentions Indias IP strategy and action plan but govt declines to reveal what these contain. More...
We need to step up research in IPR regime
(VR Kaundinya , 25-Jan-2010 , The Financial Express)
The use of technology is helping breeders around the world to maximise the potential for crops to become a source of renewable energy food and feed while minimising the environmental impact. More...
Still in the trial phase
(Ram Prasad Sahu / Mumbai , 25-Jan-2010 , Business Standard)
The company wants to set up an unit at the SEZ get the clearances from European and US federal authorities and market off patent drugs in those geographies. More...
Student innovations have no takers in India
(TNN , 25-Jan-2010 , The Times Of India)
Around six lakh students graduate from technical institutes every year in our country and none of their innovative project works is considered worthy of a patent. More...
Google wins domain name dispute against Indian cybersquatter
(PTI , 24-Jan-2010 , The Economic Times)
Internet search engine Google has won a domain name dispute against an Indian cybersquatter at the World Intellectual Property Organisation. More...
Lawsuit against Salman in HC seeks stay on screening of Veer
(PTI , 23-Jan-2010 , DNA)
Choudary has sought damages of Rs20 lakh from the producer and the director of the film for alleged violation of his copyright for making illegal gains by lifting a portion from his book Trilogy of Wisdom. More...
Anand Sharma pins hopes on concluding Doha Round
(ET Bureau , 23-Jan-2010 , The Economic Times)
CIIs two day 16th partnership summit began in Chennai on Saturday under the theme global partnerships: More...
Immigrants in US see better prospects back home
(Vivek Wadhwa , 23-Jan-2010 , The Economic Times)
My research teams at Duke University calculated that foreign nationals were named as inventors or co inventors in one quarter of WIPO patent applications filed from the US in 2006. More...
Domestic pharma cos fare well in patent litigation tests
(Soma Das , 22-Jan-2010 , The Financial Express)
In the legal mesh of pharma patent litigations in the largest drug market the US Lupin Pharma Sun Pharma Ranbaxy Labs Ltd and Dr Reddys Ltd top the list of domestic pharma companies which have best battled the court cases in the last decade. More...
Scientists fume over new patent bill
(Rema Nagarajan , 22-Jan-2010 , The Times Of India)
Thousands of scientists working in government supported research institutes and labs in India are seething over a proposed law which makes it mandatory to patent all new innovations generated by public funded research. More...
The curious case of patent agents
(FEROZ ALI , 21-Jan-2010 , The Hindu)
Patent Agents are hybrid professionals whose area of practice is at the intersection of law and science. More...
India issues demarche to China on trade barriers
(Dhiraj Nayyar , 21-Jan-2010 , The Financial Express)
The demarche also demands the removal of local content requirement and recognition of the international IPR registration regime in order to create a favourable investment environment in wind non conventional energy. More...
Perils of the US model
(Latha Jishnu / New Delhi , 21-Jan-2010 , Business Standard)
Copying the Bayh Dole legislation to promote the culture of innovation in India can be counterproductive More...
Flexible pricing pays off for drugs groups
(By Andrew Jack in London , 22-Jan-2010 , Financial Times)
GSK which also has a significant presence in China remained in India when many of its foreign peers cut back during the nationalisations and weakening of patent rules in the 1970s. More...
US to curb delay in entry of generic drugs
(Joe C Mathew & P B Jayakumar / New Delhi/mumbai , 20-Jan-2010 , Business Standard)
Indian pharmaceutical companies which are increasingly choosing to settle patent litigation with global drug majors in the US would have to be more cautious now. More...
With 219 patents pending Infosys awaits a non linear push
(Amit Tripathi , 20-Jan-2010 , DNA)
Infosys Technologies which surprised analysts with a 6.1% volume growth for the quarter ended December is betting on its 219 pending patent applications in India and the US for a sustained non linear growth. More...
4 brokerages predict strong growth for top drug makers
(C.H. Unnikrishnan and Radhieka Pandeya , 20-Jan-2010 , Livemint)
The Rs90000 crore drug industry sells more than one third of its production in the international market More...
Ranbaxy to buy biotech firm Biovel Lifesciences
(Press Trust of India , 20-Jan-2010 , The Financial Express)
Ranbaxy Laboratories on Tuesday said it would acquire Bangalore based Biovel Lifesciences for an undisclosed amount. More...
Lupin cant sell pill in US Teva files patent suit
(Khomba Singh & Vishal Dutta , 20-Jan-2010 , The Economic Times)
Israeli drugmaker Teva Pharma has filed a patent infringement suit in the US against Lupin that prevents the Indian pharma company from selling the generic or copycat version of Tevas birth control drug LoSeasonique for 30 months in a key market. More...
Pharma tops in patent suits
(Joe C Mathew in New Delhi , 19-Jan-2010 , Rediff, Business Standard)
Pharmaceutical patents are just over a fourth of all patents granted in the country but domestic drug makers account for almost all post grant patent opposition filed official data reveals. More...
Nokia victory in IPCom patent suit
(By Andrew Ward in Stockholm and Jane Croft in London , 19-Jan-2010 , Financial Times)
Nokia the worlds largest maker of mobile phones yesterday won an important court victory in a longrunning patent dispute with German based IPCom as it braced itself for fresh legal conflict with Apple of the US. More...
Fake mineral water plant unearthed in Lodhika
(Express News Service , 19-Jan-2010 , Indian Express)
In a joint operation officers of the local police and Enforcers of Intellectual Property Rights unearthed a duplicate manufacturing plant of a standard mineral water company at Lodhika in Rajkot district on Monday. More...
Pharma sector looks at inventory correction gradual restocking
(Reghu Balakrishnan , 19-Jan-2010 , The Financial Express)
Aventis Pharma Ltd will be one of the key beneficiaries of the patent regime as the parent company has a strong R&D pipeline. More...
Could copyright be wrong?
(V. Raghunathan , 18-Jan-2010 , Livemint)
Much media attention has gone into how much Vidhu Vinod Chopras movie 3 Idiots has borrowed from Chetan Bhagats novel Five Point Someone. More...
Torrent has reach product mix edge
(Nitin Shrivastava , 18-Jan-2010 , DNA)
Torrentd revenues would be driven by steady growth in its domestic formulation segment increasing presence in developing markets and huge opportunities on account of newer product introduction and expiry of patents on large number of products in developed markets. More...
Indian cos grab 32% of total ANDAs approved by US FDA in 2009
(Sanjay Pingle, Mumbai , 18-Jan-2010 , Pharmabiz)
Research based Indian pharmaceutical companies and their subsidiaries are increasingly cornering a large percentage of approvals for ANDAs from the US FDA during the last three years as per a compilation did by Pharmabiz. More...
For a new approach to China
(Nick Schulz , 18-Jan-2010 , Livemint)
Life for innovation intensive businesses is difficult in countries where there is scant respect for liberty More...
McSuppiahs Uttapam
(Saritha Rai , 17-Jan-2010 , Indian Express)
McDonalds sued him for trademark violation. More...
Intellectual bottlenecks
(AMIT SHOVON RAY, SABYASACHI SAHA , 16-Jan-2010 , The Financial Express)
Indias strive towards self reliance shaped its post independence policy agenda in all spheres. More...
Pharma tops in patent suits
(Joe C Mathew / New Delhi , 16-Jan-2010 , Business Standard)
Pharmaceutical patents are just over a fourth of all patents granted in the country but domestic drug makers account for almost all post grant patent opposition filed official data reveals. More...
Drug cos patent settlements to cost Americans $3.5 bn annually
(PTI , 14-Jan-2010 , The Economic Times)
Under such deals innovator companies have entered into agreements with the generic firms to delay the launch of generic version of patented drugs. More...
Bharti Walmart flagship brand faces opposition
(Rasul Bailay , 14-Jan-2010 , Livemint)
The management will fight to protect intellectual property of its Great Value label applications filed in 08. More...
Dr Reddys Nexium plan faces hurdle
(KV Ramana , 14-Jan-2010 , DNA)
Dr Reddys Laboratories plans to get a pie of the $4 billion market of generic Nexium are likely to be cut short by the patent holder of the drug AstraZeneca. More...
Wockhardt gets US FDA tentative nod for Levofloxacin tablets
(PTI , 13-Jan-2010 , The Economic Times)
The Mumbai based pharmaceutical firm will launch the product immediately upon expiration of the patent on June 20 2011 it said. More...
Copenhagen to Nagoya
(Business Standard / New Delhi , 13-Jan-2010 , Business Standard)
India being one of the worlds most biodiversity rich countries has been a victim of bio piracy despite the existence of the CBD and agreement on trade related intellectual property rights. More...
A generic giant juggernaut called Teva Pharma
(Pillman , 14-Jan-2010 , DNA)
Within the biosimilars sphere Teva has said $115 billion worth of products will go off patent by 2015. More...
IBM May Not Be the Patent King After All
(By Steve LeVine , 13-Jan-2010 , Business Week)
No one beats IBM on patents. More...
Drug patent settlements to come under EU scanner
(Pallavi Aiyar / Brussels , 13-Jan-2010 , Business Standard)
Patent settlements between pharmaceutical companies that make original drugs and their generic manufacturing rivals are to come under renewed scrutiny from the European Unions competition regulation authority as part of an ongoing probe into the sector. More...
Suven Life gets two patents
(Our bureau , 13-Jan-2010 , Busines Line)
Suven Life Sciences Ltd has been granted two product patents for its New Chemical Entities in China and Russia. More...
Pharmas Govt join for $80 bn off patent market
(Sanchita Sharma , 13-Jan-2010 , Hindustan Times)
Pfizers Viagra will be among 61 drugs worth over US $ 80 billion that will go off patent at the US Patent and Trademark Office between 2011 and 2013 and the Indian pharmaceutical industry is gearing to make the most of it. More...
Patent office begins data compilation on working patents in India
(Ramesh Shankar, Mumbai , 13-Jan-2010 , Pharmabiz)
For the first time in the history of patents in the country the government has started the gargantuan process of compilation of data regarding the status of the valid patents granted during the last over 20 years in the country. More...
Ministers in retreat over copyright law
(By Jean Eaglesham, Chief Political Correspondent , 13-Jan-2010 , Financial Times)
Ministers last night retreated from a proposed sweeping power to change copyright law amid increased political wrangling over digital piracy and internet regulation. More...
Infosys awaits nod for 219 patent applications in India US
(Press Trust of India / New Delhi , 12-Jan-2010 , Business Standard)
IT behemoth Infosys Technologies which today came out with its third quarter earnings is awaiting approval for 219 patent applications in India and the US. More...
Pharma looks up to fresh opportunities in generics market
(Venkata Ramana , 12-Jan-2010 , DNA)
Several drugs going off patent some markets such as Japan trying to encourage generics penetration and the agreements the global pharma companies are forging with the Indian pharmaceutical companies are expected to add strength to the Indian generic pharma story a chief operating officer of a pharma company said on condition of anonymity. More...
Spurious drugmakers harm countrys image says Azad
(Staff Reporter , 11-Jan-2010 , The Hindu)
In the event of drugs worth $80 billion going off patent Mr. Azad urged industry heads to seize the day and harness the fullest benefit from this opportunity to the advantage of the Indian economy. More...
Patent expiries set to knock drug group profits
(By Andrew Jack in London , 11-Jan-2010 , Financial Times)
Patent expiries in the coming years on some of the worlds top selling medicines will have an unexpectedly large impact on profits because of margins which can reach nearly 90 per cent a US investment analyst has warned. More...
Biodiversity Forum expresses concern over biopiracy
(Roy Mathew , 11-Jan-2010 , The Hindu)
According to an official release of the Union Ministry for Environment and Forests about 2000 patents related to the Indian Systems of Medicine are granted every year in the U.S. Patent and Trademark Office the European Patent Office and other overseas patent offices. More...
Novartis gains on getting patent right
(BS Reporter / Mumbai , 11-Jan-2010 , Business Standard)
Novartis finally ended with a Rs 21 or 3.6% gain at Rs 590. More...
Dr. Reddys AstraZeneca may settle patent case out of court
(PTI , 11-Jan-2010 , The Hindu)
Dr Reddys Laboratories long standing patent dispute with Europes AstraZeneca over a drug to treat heartburn may be resolved out of court following a similar settlement between the European drug maker and Israels Teva feel market watchers. More...
Novartis gets patent for cancer drug
(PB Jayakumar / Mumbai , 11-Jan-2010 , Business Standard)
Swiss drug manufacturer Novartis AG has been granted patent protection in India for Nilotinib a superior version of blood cancer drug Gleevec. More...
Trademarks and their licensing to preserve the distinctiveness of the brand
(AZB and Partners , 11-Jan-2010 , Livemint)
A major criterion for choosing a specific brand is the goodwill that the brand has More...
Natco to launch cancer drug as min stays DCGI order
(Khomba Singh , 11-Jan-2010 , The Economic Times)
Natco has filed a pre grant opposition on Abraxis patent for its drug in India. More...
Mahableshwar strawberry awaits its special status
(Anuradha Mane, Gitesh Shelke , 11-Jan-2010 , DNA)
Nearly 1500 strawberry farmers from Mahabaleshwar and surrounding areas have applied for a geographical indication status for their strawberries. More...
Japan may open up to Indian generics
(Amiti Sen & Khomba Singh , 11-Jan-2010 , The Economic Times)
Japan has veered round to considering Indias demand to open up its over $100 billion pharmaceutical market to Indian generic or off patent drug producers after four years of dogged resistance a government official involved in the talks said. More...
NSE seeks trademark for currency derivatives label
(Press Trust of India / New Delhi , 10-Jan-2010 , Business Standard)
The National Stock Exchange has applied before authorities for registration of trademark for its Currency Derivatives label. More...
India: A nation develops
(By Joe Leahy , 10-Jan-2010 , The Financial Times)
During the same decade the number of patent applications soared to 500 a year by 2007 the study found. More...
Rush begins to become patent agents
(Joe C Mathew / New Delhi , 10-Jan-2010 , Business Standard)
There has been a sharp increase in the number of graduates who want to qualify as patent agents the intermediates between patent applicants and the patent office. More...
NRIs invited to invest in pharmaceutical sector
(Our Bureau , 10-Jan-2010 , Business Line)
Azad points to drugs worth $80 going off patent. More...
Delhi HC rejects B Brauns plea
(Khomba Singh , 9-Jan-2010 , The Economic Times)
The German company was granted patent for manufacturing and marketing safety IV cannula in India in September 2007. More...
Roches cancer drug loses protection
(Joe C Mathew / New Delhi , 9-Jan-2010 , Business Standard)
Likely test case with courts yet to rule on patent challenge from generic manufacturers. More...
Creative rights v/s copyright
(Subhash K Jha , 9-Jan-2010 , The Times Of India)
Its about creative rights copyright the relationship between cinema and literature and between the world of words and visuals. More...
Counterfeiting piracy leave deep holes in firms pockets
(BS Reporter / Chennai/ Bangalore , 9-Jan-2010 , Business Standard)
The industry estimates that 20 per cent of the drugs available in the market today are spurious. More...
AstraZeneca heads off Nexium threat with Teva deal
(Ben Hirschler , 8-Jan-2010 , Livemint)
Anglo Swedish drug maker AstraZeneca Plc settled a US patent row over Nexium with Israels Teva Pharmaceutical Industries Ltd on Thursday protecting its top selling heartburn drug from immediate generic competition. More...
Microsoft appeals Word patent case once more
( by Bill Rigby , 08-Jan-2010 , Reuters)
Microsoft asks full panel of judges to review case. More...
Pfizer Strides Arcolab enter pact to sell generic drugs in US
(C.H. Unnikrishnan , 8-Jan-2010 , Livemint)
The move would further bolster Pfizers stake in the generics market 40 off patent products expected to be delivered. More...
Challenges to domestic drug patents grow
(Joe C Mathew / New Delhi , 8-Jan-2010 , Business Standard)
Domestic drug companies who have been challenging drug patents in the US and Europe are now taking the first steps to challenge patents granted in India to companies based there. More...
Robust growth in auto sales may fuel fake components market
(Aveek Datta and Tarun Shukla , 8-Jan-2010 , Livemint)
Pankaj Chadha director of automotive practice at Ernst and Young India says the spread of fake parts is the biggest disincentive for a multinational to step into India because it loses control over its intellectual property rights. More...
Government creates patent watchdog
(By Jonathan Moules , 08-Jan-2010 , The Financial Times)
The government has created an intellectual property regulator to ensure that those using lawyers to set up patent and trade mark protection get a fair service and appropriate redress when things go wrong. More...
Stay awake drugs second act focus on battling jet lag
(Andrew Pollack , 8-Jan-2010 , Livemint)
For Cephalon a drug company in Frazer Pennsylvania with a reputation for aggressive business tactics the approval for jet lag is part of a plan to extend the patent protection for its core franchise in stay awake drugs. More...
Wockhardt gets tentative nod from US FDA
(Press Trust of India / New Delhi , 7-Jan-2010 , Business Standard)
The patent covering this product is under litigation in the US courts. More...
Pharma industry urges govt to withdraw WHO study on data exclusivity
(Ramesh Shankar, Mumbai , 7-Jan-2010 , Pharmabiz)
This the industry feels is an attempt on the part of the multinational companies to get monopoly by creating a new IP Right. More...
Copyrights and wrongs
(Latha Jishnu / New Delhi , 7-Jan-2010 , Business Standard)
The 3 Idiots spat is not really about violation of authors rights by filmmakers moral or otherwise. More...
We dont want MNCs to patent Indian traditional knowledge
(Rediff , 07-Jan-2010 , Rediff Business)
Multinational companies will now find it very difficult to patent products made by using Indian traditional knowledge of science. More...
Pfizer to source 40 off patent cancer care drugs from Strides
(BS Reporter / Bangalore , 7-Jan-2010 , Business Standard)
Global pharma major Pfizer is to source source 40 off patent cancer care products from Bangalore based Strides Arcolab and sell the products in the United States. More...
India for one binding deal on use of bio resources
(Our Bureau , 6-Jan-2010 , Business Line)
Bio piracy is going to be the new battle ground for the rich and poor countries. More...
Dr Reddys poised to gain from new drug
(Ravi Ananthanarayanan and Manas Chakravarty , 6-Jan-2010 , Livemint)
The drug will lose patent protection in the US in 2011. More...
SC rejects Pernod Ricards plea in trademark violation case
(Indu Bhan , 6-Jan-2010 , The Financial Express)
In a set back to global alcoholic giant Pernod Ricard SA France the Supreme Court has rejected its claim of exclusivity over usage of the word Imperial thus allowing other liquor manufacturers to use it in their respective brands. More...
Free copyright control to help blind students: Xaviers Resource Centre
(Mayura Janwalkar , 6-Jan-2010 , DNA)
An amendment in copyright laws is needed to bring about this awareness. More...
Why piling eye drops high can make a lot of sense to Novartis
(Dominic Walsh: Tempus , 5-Jan-2010 , TimesOnline)
However a quick glance at the likely patent expiries among the leading pharmaceutical companies in 2010 explains why Novartis may pay top dollar for eye drops. More...
Novartis to get leg up in India with Alcon buy
(P B Jayakumar & Praveen Bose / Mumbai/ Bangalore , 5-Jan-2010 , Business Standard)
Will get access to large distribution network in eyecare segment. More...
India documents traditional formulations yoga postures
(STAFF WRITER , 5-Jan-2010 , Press Trust Of India)
TKDL is an effort to protect our traditional knowledge mainly traditional medicine and yoga postures from misappropriation through patents granted abroad as had happened with the use of neem and haldi Environment Minister Jairam Ramesh told reporters. More...
CA rules in PALs favor in infringement case
(Joel R. San Juan / Reporter , 05-Jan-2010 , Business Mirror)
THE Court of Appeals has ordered the dismissal of the 18 year old infringement case filed against flag carrier Philippine Airlines by a textile manufacturer for the alleged illegal use of her patented shell designs on table linens and placemats in its commercial flights. More...
Marico acquires Malaysian hair care brand Code 10 from Colgate
(ET Bureau , 5-Jan-2010 , The Economic Times)
The acquisition by Maricos Malaysian unit estimated to be about Rs 25 crore by analysts also gets intellectual property rights related to the brand from Colgate Palmolive. More...
Rich & poor countries now dont agree on biodiversity
(ET Bureau , 5-Jan-2010 , The Economic Times)
Some 2000 patents related to the Indian system of medicine are granted every year by the US Trade and Patents Office European Patents Office and other overseas patent offices. More...
Indias Cipla in drug supply talks with GSK Teva
(By Farah Master , 04-Jan-2010 , Reuters)
But Hamied said that WTO regulations which since 2005 have prevented Indian generic drug firms from copying patented drugs mean Indian generic companies have to change their business model or risk being swallowed up by multinational firms. More...
Ranbaxy launches dermatological product Lulifin
(BS Reporter / Mumbai , 04-Jan-2010 , Business Standard)
It is well recognised that in the post patent era licensing would be the key strategy to bring new chemical entities to India. More...
Web portal owner held for uploading Jaggubai
(Express News Service , 4-Jan-2010 , Express Buzz)
The CCC deleted the film from all from the websites and arrested the owner of www.cine-entertainment.com Shankerganesh in Coimbatore on Saturday and booked him under the Indian Information Technology Act and the Indian Copyright Act. More...
Indian drug makers maintain pace of US marketing approvals
(P B Jayakumar / Mumbai , 4-Jan-2010 , Business Standard)
Twenty five Indian generic drug makers got a little over 200 approvals from the US Food and Drug Administration in 2009 half a dozen more than the number approved in 2008. More...
Copyrights mired in grey
(Alisha Coelho , 03-Jan-2010 , Mid-Day)
3 Idiots controversy has opened the intellectual property rights can of worms. Lifting plots or tunes is punishable... but its still only on paper say lawyers More...
Puneri Pagdi obtains geographical indication status
(By Shivaji (ANI) , 03-Jan-2010 , Yahoo News)
Shree Puneri Pagdi Sangha recently managed to obtain geographical indication status for the famed Puneri Pagadi the traditional headgear of Maharashtrians and thus ensure its conservation. More...
A prescription for soul
(Jumana Shah & Himansh Dhomse , 03-Jan-2010 , DNA)
Now I have a vision that India and particularly Cadila should work on new molecules and patent them. More...
Patent regime set for fresh changes
(Joe C Mathew / New Delhi , 03-Jan-2010 , Business Standard)
Quality of applications to improve as most old applications have been cleared. More...
Pharma cos see opportunity in India
(P.T. Jyothi Datta , 2-Jan-2010 , Business Line)
This year marks five years since the Patent Law was amended to respect product patents. More...
News on Royalty payment brings cheer in new year
(Kumkum Sen / New Delhi , 2-Jan-2010 , Business Standard)
The Patent Act 1970 was conducive to methods such as reverse engineering and incremental adaptation leading to inefficient and unrealistic self reliance. More...
A new prescription
(Radhieka Pandeya , 01-Jan-2010 , Livemint)
In what is referred to as the patent cliff starting in 2010 and running up to 2012 innovator pharmaceutical companies are set to lose billions of dollars from patent expiries of some of their hottest drugs. More...
Paris Hilton sued by shoe company
(ANI , 31-Dec-2009 , DNA)
According to documents filed last week New York based firm Gwyneth Shoes are suing Hilton for trademark and patent infringement. More...
Innovation culture still absent
(P.T. JYOTHI DATTA , 31-Dec-2009 , Business Line)
Protecting intellectual property can be an incentive to spur innovative work which helps drive research in areas where few others tread. More...
U.S. panel to probe Richtek patent charges
(by Diane Bartz , 31-Dec-2009 , Reuters)
A U.S. trade court has agreed to investigate Richtek Technology Corps charges that Advanced Micro Devices and other companies violated its patents for power supply regulating devices. More...
India EU free trade talks enter key phase
(Asit Ranjan Mishra , 31-Dec-2009 , Livemint)
Small groups have already met on sanitary and phyto sanitary measures investment and intellectual property rights he said. More...
Google plays games after patent application
(Martin Waller: City Diary , 31-Dec-2009 , TimesOnline)
Is YouTube the worlds biggest online video portal also planning on setting up some sort of gaming service? More...
Top grosser 3 Idiots to fund real life inventors
(Samar Halarnkar , 31-Dec-2009 , The Hindustan Times)
Its generated 220 patent applications in India and one in the US. More...
Reliance Life ups stake in GeneMedix to 79%
(Sreejiraj Eluvangal , 31-Dec-2009 , DNA)
GeneMedix is primarily into making biosimilars biopharmaceutical drugs that have emerged out of their patent period and was acquired by Mukesh Ambani in 2007 with an eye to on two of its products EPO and GCSF. More...
No copyright music without licence this year
(Amit Sharma , 30-Dec-2009 , The Economic Times)
Pubs and discotheques will have to dance to the tune of the music industry to go ahead with their high voltage New Year parties thanks to a Bombay High Court order on Wednesday that barred hotels and other commercial establishments in the city from playing copyright music without licence. More...
Geographical Indication move to boost Ceylon Tea
(By Nizla Naizer , 30-Dec-2009 , Daily Mirror)
The tea industry in Sri Lanka is moving one step closer to protecting the value of Ceylon Tea by deciding to obtain a Geographical Indication for the commodity from the World Trade Organisation. More...
Nokias latest patent strike on Apple a risk but may pay off
(Brett Young , 30-Dec-2009 , Reuters)
Nokias latest patent strike against Apple underscores the changing dynamics of the cell phone market with the sector leader no longer holding the whip hand over rivals in terms of product development. More...
South Korean trade pact with India going into effect
(IANS , 30-Dec-2009 , Sify News)
The agreement which is similar to a free trade agreement and covers trade in goods and services and investments along with chapters on competition and intellectual property rights also includes phased eliminations of other tariffs most notably in the car industry. More...
Drugmaker has unique model to compete with rivals
(By John O'Doherty , 30-Dec-2009 , The Financial Times)
But Jordan based Hikma has managed to create a business from selling both generic medicines and drugs that are still under patent to other pharma groups. More...
Industry flays IPR pact with WIPO
(Gireesh Chandra Prasad, KG Narendranath , 30-Dec-2009 , The Financial Express)
The governments plan to take the help of the World Intellectual Property Organisation a UN arm to put into action an intellectual property rights strategy has met with strong disapproval from a section of the local pharma industry which suspects the arrangement would benefit only multinational patent holders. More...
Nokia steps up smartphone patent battle
(By Joseph Menn in San Francisco and Maija Palmer in,London , 30-Dec-2009 , The Financial Times)
Nokia escalated its patent dispute with rival Apple over smartphone technology yesterday filing a complaint with the US International Trade Commission. More...
US Bill a challenge for Indian generic firms
(Manas Chakravarty, Ravi Ananthanarayanan and Vatsala Kamat , 30-Dec-2009 , Livemint)
Initially companies were fighting the patent challenge battles in court. More...
Depomed files second Para IV infringement suit against Lupin on Glumetza patent
(Gireesh Babu, Mumbai , 30-Dec-2009 , Pharmabiz)
The US based Depomed Inc has filed one more Para IV patent infringement suit against the Mumbai based Lupin Pharmaceuticals and its US subsidiary alleging infringement of four patents on its anti diabetic pill Glumetza in the District Court of Maryland. More...
Indian sweets drinks and clothes get copyrights
(Siddharth Kumar/PTI / New Delhi , 29-Dec-2009 , Business Standard)
Places famous for their food drink or clothes like Tirupati Ladu Goa Feni and Banarsi Saree from much before the days of copyrights and trademarks won the exclusive right to use these names in 2009. More...
Music industry cheers royalty bonanza
(Indo Asian News Service , 29-Dec-2009 , Yahoo News)
The Rs.740 crore Rs.7.4 billion Indian music industry is cheering the cabinets decision to amend the Copyright Act of 1957 that will fetch royalty to composers singers lyricists et al. More...
Lupin eyes acquisitions to gain market share
(Radhieka Pandeya , 29-Dec-2009 , Livemint)
We will get there through the organic and inorganic growth route and in licensing products especially patented products that have no presence in India said Chakraborty. More...
Global mobile market turns into a legal battleground
(New York Times , 29-Dec-2009 , The Economic Times)
When Nokia the worlds largest maker of mobile phones sued Apple Samsung LG and eight other competitors within six weeks beginning in October it said it was conducting a routine defense of its intellectual property. More...
CSIR set to recruit patent examiners
(C.H. Unnikrishnan , 29-Dec-2009 , Livemint)
The patent office had been so far relying on govt agencies for recruitment More...
Spreadsheet
(fe Bureau , 29-Dec-2009 , The Financial Express)
This is because the patent law has limited the number of patented medicines which has reduced the scope of import of formulations. More...
Fairchild Infineon settle patent lawsuits
(by Divya Sharma in Bangalore , 29-Dec-2009 , Reuters)
Fairchild Semiconductor International Inc said it reached a patent settlement deal with Infineon Technologies and that it entered into a cross license deal with the company. More...
Emerging Middle Class Nations
(Sanjaya Baru / New Delhi , 28-Dec-2009 , Business Standard)
Goldman Sachs may want to patent its term BRIC for Brazil Russia India and China that lie at the core of the new middle. More...
Pharma PSUs: Caught between public interest and commercial goals
(Gireesh Chandra Prasad , 28-Dec-2009 , The Financial Express)
Secondly if the government has to break a patent held by a private company that refuses to sell a drug at an affordable price it should have a state entity to rely on for making a copy of the costly private sector brand. More...
Roche eyes acquisitions in India
(P B Jayakumar / Mumbai , 27-Dec-2009 , Business Standard)
What holds us back is the patent protection system in the country which needs improvement Agarwal points out. More...
India gives EU another chance to settle drug seizure case
(Amiti Sen , 26-Dec-2009 , The Economic Times)
These seizures violate the international patent agreement Trips as the drugs being confiscated are off patent both in India and the countries it was being exported to the official said. More...
Generics cos in the cold as big pharma has its way in US
(REUTERS , 26-Dec-2009 , The Economic Times)
The massive US Senate healthcare reform measure passed on Thursday with support from the multibillion drug industry but makers of cheaper generic rivals are feeling left out in the cold. More...
Amgen wins recombinant erythropoietin patent dispute against Roche
(Thousand Oaks, California , 26-Dec-2009 , Pharmabiz)
Amgen announced that the United States District Court in Boston has entered final judgment and a permanent injunction against Roche prohibiting Roche from infringing Amgens patents on recombinant erythropoietin thus bringing the five year patent infringement dispute to an end. More...
Two GM varieties of wheat developed by Indian co registered
(Prabha Jagannathan , 26-Dec-2009 , The Economic Times)
The new wheat varieties are being registered under the Protection of Plant Varieties and Farmers Rights Act which meets all the requirements under the TRIPS agreement for intellectual property rights for plants. More...
Govt in pre Xmas reforms drive
(BS Reporter / New Delhi , 25-Dec-2009 , Business Standard)
The amendments to the domestic Copyright Act would bring it in conformity with the World Intellectual Property Organisation Internet Treaties WIPO Copyright Treaty and WIPO Performances and Phonograms Treaty which have set the international standards in these spheres. More...
New bill to amend copyright laws music to creators ears
(Indo Asian News Service , 24-Dec-2009 , Yahoo News)
Musicians writers and film directors who were earlier exploited by producers and music companies can now hope to reclaim commercial rights to their works and earn royalty from them. More...
Indoco eyes US Europe markets; will sign four contract research treaties soon
(Reghu Balakrishnan , 24-Dec-2009 , The Financial Express)
The company is in the process of submitting abbreviated new drug applications ANDAs with the USFDA for the products proposed for marketing. More...
Patent office braces for surge in applications
(P.T. Jyothi Datta , 24-Dec-2009 , Business Line)
The Indian Patent Office is set to address the shortage in patent examiners and the standardised implementation of the Patents Amendment Act 2005 as it braces for the increasing flood of patent applications. More...
Eisai bets big on India
(BV Mahalakshmi , 24-Dec-2009 , The Financial Express)
Incidentally the companys flagship product Aricept used for treating Alzheimers diseases and contributing close to $3.2 billion of the total revenue of $8.6 billion is going off patent in 2010. More...
AFDIL sues Fizikem Labs for trademark infringement of its Beplex Forte
(Our Bureau, Bangalore , 24-Dec-2009 , Pharmabiz)
Anglo French Drugs & Industries Limited has resorted to legal proceedings against the Baddi based Fizikem Laboratories for trademark infringement of its flagship brand Beplex Forte. More...
Copyright aggression
(Latha Jishnu / New Delhi , 24-Dec-2009 , Business Standard)
Microsofts methods of protecting copyright have been slammed by the court as abuse of its money power. More...
Citys top pubs hotels served notices for not paying music licence fee
(Express News Service , 24-Dec-2009 , Indian Express)
Under the statutory sanction of section 35 of the Indian Copyright Act playing commercial music in public without paying the requisite licence fee is liable to contempt of court. More...
Top drug firms take in licensing route to up sales
(P B Jayakumar / Mumbai , 24-Dec-2009 , Business Standard)
Most of the in licensed products by Indian companies are niche innovative patented drugs that are selling well in the US and Europe and are made by medium scale players in those countries. More...
Indian American works new way to save refineries billions
(IANS , 23-Dec-2009 , The Economic Times)
Purdue has filed a patent application for the new crude distillation sequences. More...
Do drug prices need control?
(BS Bureau , 23-Dec-2009 , Rediff)
This is essential for the proper implementation of Indian patent law safeguards that facilitate the local production of low cost generic versions of patented medicines and vaccines through government use licences. More...
Troikaa Pharma to put Sanand plan on hold till December 2010
(Sohini Das / Mumbai/ Ahmedabad , 23-Dec-2009 , Business Standard)
Expects to get patent approvals for Dynapar AQ in 99 countries in six months More...
Opposition slams government on Copenhagen Accord
(Gargi Parsai , 23-Dec-2009 , The Hindu)
Mr. Yechury described the financial commitments under the accord as woolly and said the Intellectual Property Rights regime on transfer technology was effectively negated in the accord. More...
WTO rules against China; Victory for US
(Press Trust Of India / Washington , 23-Dec-2009 , Business Standard)
The WTO Appellate Body yesterday held that China was obstructing trade by forcing foreign suppliers to distribute certain copyright intensive products through state owned companies which is inconsistent with the Beijings obligations with the WTO. More...
Pharma cos want govt to question European seizure statistics
(Soma Das , 23-Dec-2009 , The Financial Express)
Apart from goading the Centre to move the WTO against the recent drug seizures in Europe the domestic pharma industry is also urging the government to officially question the statistical claims of the European Commission that project India as a major source of counterfeit drugs. More...
Lupin settles litigation with Forest Labs for Alzheimers drug
(BS Reporter / Mumbai , 23-Dec-2009 , Business Standard)
Lupin Ltd has settled all its ongoing patent litigation with US based Forest Laboratories on the Alzheimers disease treatment drug Namenda memantine tablets. More...
Microsoft Loses Lawsuit But Word Likely to Stay
(David Coursey , 22-Dec-2009 , Yahoo News)
First the good news: No you won have to turn in your copies of Office 2007 even now that Microsoft has lost its appeal of a lawsuit brought by the Canadian company i4i. More...
Pharma 2009: No medicine to cure adversity
(Press Trust of India / New Delhi , 22-Dec-2009 , Business Standard)
Indian pharma industry found that it had no medicine to cure adversities that came its way in 2009 when it battled shipment seizures by EU authorities tightened US regulations Chinese drug piracy and currency fluctuations. More...
Sanofi to acquire Chattem expand presence in US
(Bloomberg , 22-Dec-2009 , The Economic Times)
Hes also looking beyond branded drugs and the search for new blockbusters to businesses that are less subject to patent expirations More...
Five years on patent regime implementation still needs work
(P.T.Jyothi Datta , 22-Dec-2009 , Business Line)
It was on the eve of January 2005 that an Ordinance was issued to amend the Patent Act 1970 and bring in a regime that would honour product patents. More...
Abbott Sues Sandoz Over Patent for Muscle Relaxant Nimbex
(By Phil Milford , 22-Dec-2009 , Bloomberg)
Abbott Laboratories a diversified healthcare product maker accused Sandoz Inc. of infringing a patent for the muscle relaxant Nimbex by seeking approval to market a generic copy of the drug in the U.S. More...
Outsourcing steroid for Indian pharma firms
(B G Shirsat & P B Jayakumar / Mumbai , 21-Dec-2009 , Business Standard)
Daiichi Sankyo owned Ranbaxy Laboratories struggling with its US business due to manufacturing discrepancies at two of its Indian units is also likely to recover in future with drug supply deals and exclusivities as part of patent case settlements with drug majors said analysts. More...
India to be part of patent pool for HIV drugs clarifies UNITAID
(Joseph Alexander, New Delhi , 21-Dec-2009 , Pharmabiz)
UNITAID which hast just voted to create a patent pool for HIV AIDS drugs with the aim of bringing down the prices of medicines for this dreaded disease has clarified that India will also be included in the pool. More...
Dr Reddys plans to launch Lipitors generic version in US
(Press Trust Of India / Hyderabad , 21-Dec-2009 , Business Standard)
Under the new drug application submitted to the US drug regulators approval Para IV filing are those which seeks nod for launching the drug before expiry of patent. More...
HC permits Madras Fertilizers agent to use trade name Vijay Agro
(Our Legal Correspondent , 19-Dec-2009 , Business Line)
The Madras High Court in its interim order on an original application of the State owned Madras Fertilizers Ltd has permitted a firm in Erode district of Tamil Nadu to use the trade name Vijay Agro from February 1 2010 in selling its product mixture fertiliser. More...
Lok Sabha nod to amended trademark law
(Press Trust of India / New Delhi , 18-Dec-2009 , Business Standard)
A person seeking global trade mark now need not apply for it in several countries incurring a big cost as Lok Sabha today amended the trade mark law to simplify the procedures. More...
U.S. Patents Take a Fall
(By Michael Arndt , 17-Dec-2009 , BusinessWeek)
Hurt by smaller R&D budgets and offshoring U.S. patent applications fell this year and Yankees are winning fewer grants than non residents More...
The Indian Dream
(Vivek Wadhwa , 16-Dec-2009 , Hindustan Times)
We calculated that foreign nationals residing in the US were named as inventors or co inventors in one quarter of WIPO patent applications filed from the US in 2006. More...
Cipla in talks to supply drugs to Germanys BI
(Khomba Singh , 16-Dec-2009 , The Economic Times)
Global innovator pharma majors are expected to see a drop in sales in the next 2 3 years because the patent on their top selling drugs would expire and they dont have a strong research pipeline to supplement the revenue loss. More...
Patent pool for AIDS gets UNITAIDs approval
(Radhieka Pandeya , 16-Dec-2009 , Livemint)
In a relief for civil society and stakeholders from India Unitaid the international facility for the purchase of drugs against HIV AIDS has included middle income countries such as India in the pool More...
HUL to pay 1% of net sales as trademark royalty
(TNN , 16-Dec-2009 , The Time Of India)
Hindustan Unilever Ltd has entered into a fresh trademark licence agreement with its parent company Unilever under which the Indian subsidiary will pay royalty of 1% on net sales of specific brands whose trademark is owned by the Anglo Dutch parent company. More...
Health Ministrys nod to WHO for a study on data exclusivity raises concern
(Ramesh Shankar, Mumbai , 16-Dec-2009 , Pharmabiz)
The union health ministrys move has raised eyebrows among the patient community and the public interest groups in the country as they view that data exclusivity could prevent the registration of low cost quality generic versions of medicines even when there is no patent on a medicine when a drug does not meet the standards for patentability. More...
Trademark case: Interim injunction favours Witco
(Our Bureau , 15-Dec-2009 , Business Line)
Witco a multi-brand travel accessories retailer with stores in Chennai Bangalore and Kerala has got a breather from the Madras High Court in a trademark infringement case. More...
India fourth largest illegal downloader
(IANS , 15-Dec-2009 , The Economic Times)
According to their findings India trails only the US Britain and Canada in online copyright infringement. More...
Glenmark may settle with Merck on cholesterol drug
(C.H. Unnikrishnan , 15-Dec-2009 , Livemint)
Glenmark Pharmaceuticals Ltd may settle with US firm Merck Schering Plough Pharmaceuticals Llc resulting in the withdrawal of patent litigations related to the launch of a copy of the latters $1.6 billion in sales drug ezetimibe in the US market next year according to a report released by First Global Securities Ltd last week. More...
FM III may say whats not news
(Nivedita Mookerji , 15-Dec-2009 , DNA)
The HRD ministry was late in giving its input over issues related to copyright and intellectual property rights a source pointed out. More...
Court pulls up Microsoft for forum hiring
(Our Bureau , 15-Dec-2009 , Business Line)
The Delhi High Court has asked software major Microsoft to shell out Rs 8 lakh as cost security for deliberately choosing Delhi to file copyright violation cases despite having offices in cities where the offences were allegedly committed by opposite parties. More...
Suven Life gets patent in Canada for two new chemical entities
(Press Trust of India / New Delhi , 14-Dec-2009 , Business Standard)
Drug maker Suven Life Sciences today said it has recieved patent for two new chemical entities used in the treatment of diseases like Parkinson and schizophrenia from the Canadian Intellectual Property Office. More...
Technology transfer development pact to be feather on Indias cap
(Urmi A Goswami , 14-Dec-2009 , The Economics Times)
The poorer countries will also get support for the deployment and diffusion of environmentally safe and sound technologies efforts to leverage public and private investment in technology incremental costs of soft and hard technologies for implementation of adaptation and mitigation purchasing of licences and other intellectual property rights issues. More...
Consideration for use of copyright is not royalty
(HP Agarwal / New Delhi , 14-Dec-2009 , Business Standard)
In many cases foreign companies grant access to Indian companies for using their data base and other copyrighted material. More...
Bangalore scores an A in Biotech
(Kiran Mazumdar-Shaw , 14-Dec-2009 , DNA)
Offering fiscal incentives to the tune of Rs400 crore and benefits such as investment promotion subsidy interest free loan on VAT and financial support for patent registration the policy goes to show the strong support the sector receives from the government. More...
Wipo goes green for domain name dispute resolution
(PTI , 14-Dec-2009 , The Economics Times)
Amid the ongoing global debate on climate change the World Intellectual Property Organisation has said it will launch paperless procedures in matters relating to domain name dispute from Monday. More...
India to maintain edge in generics
(BS Reporter / Chennai/ Hyderabad , 14-Dec-2009 , Business Standard)
Bad reputation on quality of medicines exported from India and weak combat mechanisms from the government to weed out counterfeit medicines in the international society are the bottlenecks for the Indian pharmaceutical companies to grow in Japan according to Kenji Toda chairman Japan Pharmaceutical Manufacturers Association. More...
Indian drugs face EU music
(Joe C Mathew / New Delhi , 13-Dec-2009 , Business Standard)
Indian medicine accounted for over 50 per cent of all drug seizures in Europe for intellectual property rights violation last year. More...
NGOs slam move to keep India out of patent pool
(BS Reporter / New Delhi , 13-Dec-2009 , Business Standard)
Indian civil society organisations have opposed a reported move by global drug procurement agency UNITAID to exclude countries such as China Brazil and India from a proposed patent pool for AIDS drugs. More...
Indian pharma industry can improve share in global market
(Express News Service , 13-Dec-2009 , Indian Express)
The Indian pharmaceutical companies are already lining up the US FDA office to get patent on the first to file basis of the drugs which will get off patented in 2012. More...
Recession hits patent filings in US fall 2.3% in 09
(Press Trust of India , 13-Dec-2009 , NDTV)
The financial crisis has not only rattled the US economy but seems to have also choked innovations among the Americans with patent filings declining for the first time in over a decade in 2009. More...
Apple hits back at Nokia in patent war
(By Joseph Menn in San Francisco and Andrew Parker in,London , 12-Dec-2009 , The Financial Times)
Applefiled a countersuit against Nokia yesterday claiming that the Finnish company has pursued anti competitive practices and infringed 13 of its patents. More...
History of Jeans Modi'fied Denim Denim ka Bandhan
(TNN , TOI Crest , 12-Dec-2009 , The Times Of India)
He teamed up with Strauss and the two received US Patent 139121 for their rivetted and rivetting product. More...
Pfizer sues Dr Reddys over Lipitor patent
(Phil Milford / Bloomberg , 11-Dec-2009 , Livemint)
Dr Reddys had notified Pfizer in October that it was seeking US Food and Drug Administration permission to sell copies of Lipitor and that the patent wasnt infringed according to the lawsuit More...
IT firms focus on patents to widen revenue window
(Surabhi Agarwal , 11-Dec-2009 , The Financial Express)
This is a game changer for the companies showing how far they have traveled from just adapting software off the shelves as they aggressively try to acquire intellectual property rights to fuel future revenue growth. More...
FTAs could hurt farmers too
(Priyanka Golikeri , 11-Dec-2009 , DNA)
After generic drugmakers its the farmers who are feeling the heat of the intellectual property regime. More...
Who owns the eggplant?
(Latha Jishnu / New Delhi , 10-Dec-2009 , Business Standard)
What would be the nature of intellectual property rights that the developers would enjoy given that the technology is owned by Mahyco a company in which Monsanto has a 26 per cent stake and how soon would the universities be allowed to release their seeds? More...
Satyam Upaid in $70 million settlement Deloitte is auditor
(Lison Joseph , 10-Dec-2009 , Livemint)
The settlement requires the British firm to give Mahindra Satyam a worldwide royalty free licence to all its patents besides withdrawing all pending legal actions initiated by it. More...
Ranbaxy admits to infringement of Purdues Oxcontin patent in US
(Gireesh Babu, Mumbai , 10-Dec-2009 , Pharmabiz)
Ranbaxy Pharmaceuticals Inc the US subsidiary of the Gurgaon based Ranbaxy Laboratories has reportedly admitted infringement of the US based Purdue Pharmas patent for the blockbuster drug Oxycontin in the District Court for the Southern District of New York US. More...
Do we need data exclusivity ?
(Business Standard / New Delhi , 9-Dec-2009 , Business Standard)
The term DE is new to India as it does not figure in the Trade Related Intellectual Property Rights Agreement of the WTO. More...
HIV patent pool hobbles as drug firms want India China excluded
(Priyanka Golikeri , 9-Dec-2009 , DNA)
Efforts to bring together nine global drugmakers to pool their HIV patents in order to make available treatment to millions living with HIV AIDS in the developing world seem to have faltered over a crucial issue the inclusion of middle income countries such as India and China in the list of beneficiaries. More...
Indian IP firm adjudged best in Asia Pacific
(Our Bureau , 9-Dec-2009 , Business Line)
J Trivedi & Co an Ahmedabad based law firm specialising in intellectual property rights and patent related issues has emerged the Highly Commended Law Firm of the Year in the Asia Pacific region at the 2009 World Leaders International IP Awards. More...
US Gilead appeals against patent rejection of AIDS drug Viread
(Khomba Singh , 8-Dec-2009 , The Economics Times)
US drug company Gilead Sciences has filed an appeal in the Indian Intellectual Property Appellate Board to challenge a recent order by an Indian Patent Office that rejected two patent claims for its best seller drug Viread tenofovir disoproxil fumarate. More...
Trademarks sans borders
(Editorial , 8-Dec-2009 , Business Line)
It is only logical that countries that adhere to a philosophy of open trade must also recognise trademarks registered in one country to be universally applicable across markets. More...
Our growth does not depend on acquisitions’
(BV Mahalakshmi , 7-Dec-2009 , The Financial Express)
Established products are medicines that have lost patent exclusivity or are close to losing exclusivity. More...
Bill seeks to make trademark registrations easier
(Our Bureau , 7-Dec-2009 , Business Line)
A Bill seeking to amend the Trade Marks Act 1999 with a view to enabling Indian nationals as well as foreign nationals to secure simultaneous protection of trademarks in other countries was tabled in Parliament on Friday. More...
India to take on EU over drug seizures
(C.H. Unnikrishnan , 7-Dec-2009 , Livemint)
The seizures were made for alleged patent law violations as some of these drugs are still under protection in European countries. More...
Column : Buzz in pharma biz
(MG Arun , 7-Dec-2009 , The Financial Express)
Their profitability is under pressure owing to patent expiries challenges in pricing and falling R&D productivity. More...
Intellectual Property Right is a social crime
(DNA,Ahmedabad , 06-Dec-2009 , DNA)
There was a time when knowledge was imparted freely. More...
Data exclusivity study draws flak from Indian drug industry
(Khomba Singh , 06-Dec-2009 , The Economics Times)
A WHO official asking not be named as he is not the authorised spokesman said: Neither the TRIPs or the Doha declaration mention data exclusivity. More...
Cephalon files patent lawsuit against Teva for armodafinil tabs
(Frazer, Pennsylvania , 5-Dec-2009 , Pharmabiz)
Cephalon Inc has filed a lawsuit in US District Court in Delaware against Teva Pharmaceuticals USA Inc for infringement of US Patent Nos. 7132570 the 570 Patent 7297346 the 346 Patent and RE37516 the 516 Patent for the Cephalon product Nuvigil armodafinil Tablets. More...
News broadcasters oppose amendment of copyright laws
(Ashish Sinha / New Delhi , 5-Dec-2009 , Business Standard)
The issue of proposed amendments to the existing Copyright Act 1957 is becoming a flash point between broadcasters and the Ministry of Human Resource Development with news broadcasters asking the government to take them into confidence before undertaking any amendment to the law. More...
Our negotiating position has strengthened: Jairam
(Nitin Sethi , 5-Dec-2009 , The Times Of India)
The same IPR issues that dominated the pharmaceutical debate are now coming to dominate the climate change debate. More...
Drug trial data issue invites pharma fire
(Joe C Mathew / New Delhi , 5-Dec-2009 , Business Standard)
The controversial issue of exclusivity of drug trial data which saw overseas multinational companies and Indian pharma companies taking opposite positions is back on the table. More...
Data exclusivity study draws flak from Indian drug industry
(Khomba Singh , 5-Dec-2009 , The Economics Times)
The industrys main objection is the fact that the study is being carried out by the Delhi based law firm Anand and Anand who has regularly represented global pharma companies in patent disputes besides being a member of the Satwant Committee an industry excessive said. More...
Kodak Sells OLED Business To LG, Cos Will Share Patents
(DOW JONES NEWSWIRES , 04-Dec-2009 , CNN Money)
Eastman Kodak Co. agreed to sell its organic light emitting diode business to a group of South Koreas LG companies and also said it has an agreement with LG Electronics Inc. that will allow each company broad access to the others patent portfolio. More...
Bata drags Relaxo to court over brand infringement
(Press Trust of India / New Delhi , 04-Dec-2009 , Business Standard)
Footwear major Bata today dragged its rival Relaxo Footwear before the Delhi High Court alleging infringement of one of its popular brand Sparx. More...
Bridging the gap on clean technology
(Padmaparna Ghosh , 04-Dec-2009 , Livemint)
Developed nations say it will destroy the incentive for innovation. More...
Commerce ministry plans to add booster dose to border scrutiny to check spurious drug exports
(Soma Das , 04-Dec-2009 , The Financial Express)
After the health ministry declared the domestic pharma market largely free of spurious and substandard drugs the commerce ministry now wants to step up the vigil at the checkpoints to scrutinise pharma export consignments and assess the quantum of spurious drugs that could be leaving the country and ascertain whether such channels of spurious drugs exist. More...
Technology Of Hope
(Kiran Mazumdar-Shaw , 3-Dec-2009 , The Times Of India)
A large number of blockbuster drugs are also set to go off patent giving the sector here tremendous opportunities. More...
Pfizer Cipla in Aurobindo redux plan
(K V Ramana , 2-Dec-2009 , DNA)
Drug maker Cipla could soon be supporting the strategies of global pharma giant Pfizer for expanding its footprint and protecting its business interests as many of its drugs go off patent. More...
Doha progress only with new market access: US
(D Ravi Kanth / Geneva , 2-Dec-2009 , Business Standard)
Meanwhile India Brazil and South Africa yesterday decided to pool their energies for adopting common positions on all issues pertaining to WTO and World Intellectual Properties Organization. More...
Japans top pharma comes calling
(MG Arun , 2-Dec-2009 , The Financial Express)
In March this year Pfizer entered into an agreement with Aurobindo Pharma to market drugs that are no longer patent protected and dont have market exclusivity in the US and Europe. More...
Copyright draft is tough on covers
(Nivedita Mookerji , 2-Dec-2009 , DNA)
Broadcasting organisations will have to give prior notice to the Copyright Board for airing published literary or musical work. More...
Japans largest drug maker Takeda plans India foray
(Press Trust of India / New Delhi , 02-Dec-2009 , Business Standard)
Besides Takedas best selling anti diabetic anti diabetic medicine Actos will lose patent protection in 2011. More...
Sunny re rating of pharma companies
(B G Shirsat & Ashok Divase / Mumbai , 2-Dec-2009 , Business Standard)
It is aiming at entering the market with a new biotech product off patent and with a market size of $5 billion. More...
Gilead set to benefit from HIV guidelines
(By Andrew Jack in London , 02-Dec-2009 , The Financial Times)
Yusuf Hamied head of Cipla the Indian generics company that is one of the largest providers of stavudine and other HIV treatments dismissed the financial impact pointing out that he could also sell Gileads principal drug in developing countries after overturning the US companys patent on tenofovir in India. More...
Cipla in drug supply talks with Pfizer
(C.H. Unnikrishnan , 02-Dec-2009 , Livemint)
Pfizer after sluggish growth in its speciality and patented pharmaceutical business in the developed markets has been aggressive on the generic or off patented drugs business. More...
Troikaa Pharma gets patent in Australia for Diclofenac painkiller injections
(Our Bureau, Mumbai , 01-Dec-2009 , Pharmabiz)
Troikaa Pharmaceuticals Ltd a fast growing healthcare company has been granted patent in Australia for its novel drug delivery form of Diclofenac injections Dynapar AQ the worlds first painless painkiller injection. More...
Fake medicine sale rampant cops helpless
(Express News Service , 1-Dec-2009 , Indian Express)
Fake drugs are sold rampantly in the state. More...
Suven gets patents from EPO for 3 drugs
(Press Trust of India / Mumbai , 30-Nov-2009 , Business Standard)
Pharmaceutical firm Suven Life Sciences today said the European Patent Office has issued three patents to its chemical entities which are used in treating nerve disorders. More...
Depomed sues Indias Lupin for patent infringement
(Esha Dey in Bangalore , 30-Nov-2009 , Reuters)
Drug developer Depomed Inc said it filed a lawsuit in a U.S. federal court against Indias Lupin Ltd alleging that Lupins application to market a generic version of Depomeds diabetes drug Glumetza infringed its patents. More...
Abbott gives Teva TriCor rights as early as 2011
( The Associated Press , 30-Nov-2009 , CNBC)
Pharmaceutical and medical products maker Abbott Laboratories and Laboratories Fournier SA granted intellectual property rights for the cholesterol medication TriCor to Teva Pharmaceutical Laboratories Ltd. according to a Securities and Exchange Commission filing Monday. More...
Revised Copyright Act to pinch broadcasters pockets
(Ashish Sinha / New Delhi , 30-Nov-2009 , Business Standard)
These included tinkering with the fair use provisions of Section 52 insertion of Section 33A and changes in Section 31 among others. More...
City techie receives patent for anti virus software
(SiddharthKelkar , 30-Nov-2009 , Indian Express)
A system that can curtail virus attacks on computer networks as well as minimise false alerts of attacks invented by city based computer expert received central government patent recently. More...
The reality of free
(Rajan Anandan , 30-Nov-2009 , The Economics Times)
The company is the worlds largest holder of IP rights with 13400 patents worldwide but it also spends billions on its open innovation efforts under which it is working with the open source software community to facilitate faster and easier access to Microsoft technologies and IP. More...
Avon to gain from nod to Ranbaxys drug
(P B Jayakumar / Mumbai , 29-Nov-2009 , Business Standard)
The company will supply the main active pharmaceutical ingredient for Valtrex. More...
Many ills in draft Copyright Act
(ET Bureau , 28-Nov-2009 , The Economics Times)
The HRD ministrys proposals for amending the Copyright Act which are slated to be discussed by the Cabinet shortly contain provisos that will hurt the interests of artists and reduce the accountability of copyright societies. More...
The fall of the worlds best selling drug
(By Andrew Jack , 28-Nov-2009 , The Financial Times)
Once its patents expire in 2011 generic drug manufacturers will be able to sell it far more cheaply. More...
Patent worries
(Business Standard / New Delhi , 27-Nov-2009 , Business Standard)
Few people in this country understand how seriously Indias development as those of other Third World countries would be impacted by a stifling intellectual property regime. More...
Supply of fake drugs grossly overstated
(Radhieka Pandeya , 27-Nov-2009 , Livemint)
Two intellectual property right issues are not involved. More...
Ranbaxy set for Rs 1000 cr boost from Valtrex clone
(K V Ramana , 27-Nov-2009 , DNA)
Gurgaon based Ranbaxy Laboratories has launched generic Valtrex tablets in the US over two years after it settled a patent dispute with GlaxoSmithKline and secured a 180 day sales exclusivity for it. More...
Pfizer pins hopes on Aurobindo does not rule out Indian buys
(C.R. Sukumar , 27-Nov-2009 , Livemint)
To counter competition from generic drugs and impact of patent expiry Pfizer is implementing a three pronged strategy. More...
Broadcasters protest move to amend Copyright Act
(TNN , 26-Nov-2009 , The Times Of India)
Indian broadcasters have demanded immediate consultation on proposed amendments in the Copyright Act which they feel will completely skew the field against television and radio industries in fact could even jeopardise their survival while spelling windfall gains for monopolistic music companies and copyright societies. More...
The WIPO knife edge
(Latha Jishnu , 26-Nov-2009 , Business Standard)
For well over a decade the chirpy sounding acronym for the WTOs agreement on intellectual property rights TRIPS has rolled familiarly off tongues albeit with fear and loathing in the developing world. More...
Govt may give sops to drug exports avoiding Europe
(Press Trust of India / New Delhi , 25-Nov-2009 , Business Standard)
The European Union has been seizing Indian generic drugs en route Latin America and Africa citing patent violations. More...
Glenmark signs licensing deal with US firm
(C.H. Unnikrishnan , 25-Nov-2009 , Livemint)
A Glenmark official said on condition of anonymity that the company is exploring opportunities to licence out the newly patented acne treating antibiotic to firms in the European market. More...
Chennai HC records 17 issues on Bajaj TVS dispute
(T E Narasimhan / Chennai , 25-Nov-2009 , Business Standard)
Some of the issues raised by TVS include whether they infringe Bajajs patent if TVS is entitled to question the patent and if so, whether Bajajs patent is valid if Bajaj is entitled to claim damages whether a lean air fuel mixture combustion constitutes an essential element in the patent and so on. More...
Increased trade okay but FTA a difficult task
(fe Bureaus , 25-Nov-2009 , The Financial Express)
The US has very high expectations on compliance of intellectual property rights which goes beyond the prevision of the TRIPS agreement said RS Ratna professor Indian Institute of Foreign Trade. More...
EU ends four year probe into Qualcomm
(By Nikki Tait in Brussels , 25-Nov-2009 , Financial Times)
Europes top competition regulator has ended a four year inquiry into patent royalty rates charged by Qualcomm after the remaining companies that had brought a complaint against the US mobile chipmaker withdrew. More...
Tread cautiously on bilateral investment treaties
(PRABHASH RANJAN , 25-Nov-2009 , Business Line)
For example most BITs and this includes BITs entered by India bind the host nation not to discriminate between foreign and national investments allow full repatriation of income in foreign exchange to the home country of the investor provide an extremely wide definition of foreign investment which includes portfolio investment and intellectual property rights and provide very high compensation criteria for both direct and indirect expropriations with very limited manoeuvrability to the host state. More...
Lupin moves to block rival generics
(K V Ramana , 25-Nov-2009 , DNA)
However after expiry of the patent that year the company took the drug off the market following which Lupin started selling its generic version. More...
Novo Nordisk to launch range of insulin products in India
(Sohini Das / Mumbai/ Ahmedabad , 25-Nov-2009 , Business Standard)
Denmark based Novo Nordisk a world leader in diabetes care is bullish on setting up robust clinical research functions and also leveraging the India opportunity in related fields such as data management and studying the patent situation of the medicines under development as well as shared services. More...
Pharmexcils 2nd Patent Facilitation Centre to be set up at NIPER Mohali
(Gireesh Babu, Mumbai , 25-Nov-2009 , Pharmabiz)
The Pharmaceuticals Export Promotion Council will launch its second Patent Facilitation Centre at National Institute of Pharmaceutical Education and Research Mohali by the end of the month to provide patent related information for the exporters in Northern Region. More...
India US ink pacts on Intellectual Property Rights
(Betwa Sharma in Washington , 24-Nov-2009 , Rediff Business)
India and United States on Monday signed two inter governmental agreements on Intellectual Property Rights to help prevent misappropriation of traditional knowledge through mistaken issuance of patents. More...
Spencer Stuart Perspectives Leadership challenge looms for generics firms
(Filomena Leonardi, Sachin Rajan and Claudia Schütz , 23-Nov-2009 , Livemint)
With generic medicines already representing a large and growing share of the pharmaceutical market these companies are looking ahead to the patent expirations of tens of billions of dollars of branded drugs over the next several years. More...
In the mesh of FTAs whither generics?
(Priyanka Golikeri , 23-Nov-2009 , DNA)
All the three blocs are pressing for a measure called data exclusivity a period during which the innovator drug companys clinical trial data cannot be relied upon to register a generic exact off patent version of the innovator drug which is 40 80% cheaper. More...
Medicis takes Lupin to US court on patent charge
(Joe C Mathew / New Delhi , 23-Nov-2009 , Business Standard)
Alleges infringement of patent for dermatology medicine. More...
Drug seizure Govt to drag EU to WTO
(Amiti Sen , 23-Nov-2009 , The Economics Times)
India is preparing to file a case against the European Union at the World Trade Organisation for wrongful seizure of high quality Indian drugs at its ports while in transit to other destinations a commerce department official has said. More...
AYUSH to take home remedies out to market
(Aditya Dev , 23-Nov-2009 , The Times Of India)
If those are found effective in subsequent trials the department will try to get the person forwarding it the methods patent and also devise ways to market the idea. More...
Fake Chinese drugs deluge mkt with Made in India tag
(Soma Das , 23-Nov-2009 , The Financial Express)
Barely four months after China made fake drugs with deceptive Made in India labels were seized in Nigeria more cases of spurious drugs are surfacing in the Indian market with alleged links to China. More...
Experts confirm that RP had not reneged on its IP commitments
(Economy , 23-Nov-2009 , Business Mirror)
THE recently enacted Intellectual Property Code of the Philippines and the Quality and Affordable Medicine Act passed into law late last year are compliant with the countrys commitments to the World Trade Organization. More...
Fake Vicks Vaporabs tablets worth Rs 30L seized from medical stores in Karanj Shahpur
(TNN , 22-Nov-2009 , The Times Of India)
The Enforcers of Intellectual Property Rights officials working against copyright and trademark violations had got a tip off about infringement of the P&G products in Ahmedabad. More...
Patent Volume Isnt the Best Innovation Gauge
(Michael Arndt , 22-Nov-2009 , BusinessWeek)
Patent volume based on new analysis isnt necessarily a valid proxy for innovation. More...
In healthcare we can at best play catch up with China
(Pillman , 20-Nov-2009 , DNA)
Dan Vasella the chief executive of Swiss firm Novartis which has been struggling for the last five years to secure the patent rights in India on Glivec its therapy for a rare form of blood cancer called chronic myeloid leukemia has spoken again on the alleged gaps in the Indian patent system. More...
Dabur accuses US firm of infringing on its trademark
(Press Trust Of India / New Delhi , 19-Nov-2009 , Business Standard)
FMCG major Dabur has alleged that US based company Aveda which manufactures and sells Ayurvedic cosmetic products is infringing on the trademark of its skincare range. More...
EU blamed for breaking Doha Declaration denying access to cheaper medicines to poor nations
(Joseph Alexander, New Delhi , 19-Nov-2009 , Pharmabiz)
Alleging that the European Unions trade agenda has taken a wrong turn and charging the EU with breaking its commitment under the Doha Declaration on TRIPS three leading international organizations have sought corrections in the existing policies and a new approach towards the issue. More...
Wockhardt Sun get US okay for generic drug
(BS Reporter / Mumbai , 19-Nov-2009 , Business Standard)
The patents covering this product had expired yesterday. More...
90% of local patents applied for and granted come from nonresidents
(Max V. de Leon / Reporter , 18-Nov-2009 , Business Mirror)
THE countrys patent landscape continues to be dominated by foreign owners with data both from the World Intellectual Property Organization and the Intellectual Property Office of the Philippines indicating that over 90 percent of the patents applied for and granted here were from nonresidents. More...
Supreme Court: When Do Ideas Deserve Patents
(By Adi Narayan , 18-Nov-2009 , TIME)
It all started in 1997 when a little known company wanted to patent a method for letting customers of utility companies pay a fixed predictable sum each month. More...
Bayers patent case hearing in HC today
(TNN , 18-Nov-2009 , The Times Of India)
Drug multinational Bayers appeal against rejection of its petition in the Delhi high court indirectly seeking patent linkages will come up for hearing on November 18. More...
Mahindra Satyam could service M&M
(Shweta Bhanot, Rachana Khanzode , 18-Nov-2009 , The Financial Express)
According to Natarajan the firm currently helps its clients in the intellectual property IP space for designing products working out new regulations industrial products for emission fuel efficiency & fuel cost reduction and safety aspects in aerospace area. More...
Protectionism by another name
(Business Standard / New Delhi , 18-Nov-2009 , Business Standard)
The India European Union Joint Customs Cooperation Committee has met in New Delhi and failed to resolve the issue over Indian generic drugs being seized when they are in transit through European ports. More...
Suven Life Sciences plans to raise funds for clinical trials
(C.R. Sukumar , 18-Nov-2009 , livemint)
Its chairman and CEO Venkat Jasti said SUVN 502 is intended for the symptomatic treatment of Alzheimers disease schizophrenia and other disorders of memory and cognition More...
NGOs warn against proposal to link marketing approval with patent status
(Joseph Alexander, New Delhi , 18-Nov-2009 , Pharmabiz)
The public interest groups have again warned the Health Ministry against any attempt to link marketing approval with patent status as being pushed by the multinational companies saying that it would turn the drug regulator into Indias patent police. More...
Intel withdraws suit against govt
(PTI , 17-Nov-2009 , The Economic Times)
The worlds largest chip maker Intel Corporation today withdrew its suit before the Delhi High Court against the government trademark registry and the two small firms which have got registered its trademark till 2017. More...
TRIPS flexibilities sacred no plans to touch them
(KG Narendranath , 17-Nov-2009 , The Financial Express)
Francis Gurry the director general of the World Intellectual Property Organisation was in the capital recently amid the controversies over multilateral bodys plans to reform the Patent Cooperation Treaty which some quarters allege would lead to infringing upon the powers of national governments in matters of patent examination and grant. More...
Medicis deal generic biz to boost financials
( Kiran Kabtta Somvanshi , 17-Nov-2009 , The Economic Times)
Glenmark has also settled a patent litigation with the same company over the latters two products. More...
Plea to protect intellectual property rights
(LESLEY STONES , 17-Nov-2009 , Business Day)
SA NEEDS to protect the intellectual property rights of companies more vigorously to spark greater innovations that will benefit the economy says the Free Market Foundation. More...
Purdue Pharma sues Sun Pharma following Para IV patent filing on pain killer drug
(Gireesh Babu, Mumbai , 17-Nov-2009 , Pharmabiz)
The US based Purdue Pharma products LP and its partner Napp Pharmaceutical Group Ltd have filed a patent infringement petition against Sun Pharmaceuticals and its US arms following a para IV certification filed by the latter to manufacture and market generic version of the formers pain killer Ryzolt tramadol hydrochloride extended release drug. More...
Tangaliya gets GI status
(Rupam Singh Gupta , 16-Nov-2009 , The Times Of India)
The Tangaliya shawl which uses a unique weaving technique and was almost on the verge of extinction has been given GI recognition by the Central government. More...
TVS Bajaj case adjourned to Wednesday
(ET Bureau , 16-Nov-2009 , The Economic Times)
Barely days after TVS Motor re launched the contentious TVS Flame 125 cc motorcycle fitted with twin spark plug on the back of a Supreme Court order the battle between the company and Bajaj Auto made a comeback to the Madras High Court. More...
Garmin says has not infringed Pioneers patents
(by Savio D'Souza in Bangalore , 16-Nov-2009 , Reuters)
U.S. navigation device maker Garmin denied it infringed any patents and said it intended to defend itself against a patent suit filed by Japanese consumer electronics maker Pioneer Corp a Garmin spokesperson told Reuters. More...
Now Zydus moves court against Sun
(ET Bureau , 16-Nov-2009 , The Economic Times)
The battle lines have been drawn between Mumbai based Sun Pharmaceutical and its Ahmedabad based rival Zydus Cadila. More...
Glenmark Generics settles litigation with Medicis
(REUTERS , 16-Nov-2009 , The Economic Times)
Glenmark Generics Inc the US unit of Glenmark Generics Ltd on Monday said that it has settled all pending litigation with Medicis Pharmaceutical Corp relating to patent actions regarding Fluocinonide. More...
Govt to free tech tie ups trademark use
(Anindita Dey / Mumbai , 16-Nov-2009 , Business Standard)
In a move that would help Indian companies access technology and trademarks more freely the government has decided to free the pricing for import of technology and use of trademark. More...
Affordable innovation in healthcare
(Kiran Mazumdar-Shaw , 16-Nov-2009 , The Economic Times)
Perhaps the most poignant present day paradox is that even as medical knowledge advances and global wealth grows health inequity between the rich and the poor is widening. More...
Drug Makers Raise Prices in Face of Health Care Reform
(By DUFF WILSON , 15-Nov-2009 , The New York Times)
But drug companies say they are having to raise prices to maintain the profits necessary to invest in research and development of new drugs as the patents on many of their most popular drugs are set to expire over the next few years. More...
Cash crunch hits intellectual property office reforms
(Gunjan Sharma , 14-Nov-2009 , The Financial Express)
The Controller General of Patents Design and Trademarks PH Kurian has said that budget constraints are hindering the reforms in the functioning of the Intellectual Property Office. More...
Endo Pharma to pay US$ 23 mn to LecTec to settle patent litigation
(Chadds Ford, Pennsylvania , 14-Nov-2009 , Pharmabiz)
Endo Pharmaceuticals has reached a settlement with LecTec Corporation on outstanding patent litigation related to LecTecs US Patent Nos. 5536263 and 5741510. More...
No cure in sight for India EU drug seizure controversy
(Pallavi Aiyar / Brussels , 14-Nov-2009 , Business Standard)
Last month the Indian mission to the World Trade Organization in Geneva informed a TRIPS council meeting that widespread and repeated seizures were having an adverse impact on the legitimate trade of generic medicines universal access to medicines in developing countries and national public health budgets. More...
Top drug firms growth to come from Russia Brazil and India
(C.H. Unnikrishnan , 13-Nov-2009 , livemint)
In the past half a decade big pharmaceutical firms havent developed any new blockbuster drugs the lifeblood for them. More...
Venus bags another product patent for Potentox from South Africa
(Our Bureau, Mumbai , 13-Nov-2009 , Pharmabiz)
Venus Remedies a research based pharma company has received fifth product patent in the current year. More...
Now cosmetics from cow
(Ramu Bhagwat , 13-Nov-2009 , The Times Of India)
The research centre situated at Deolapar 65 km from here has already won patents from the United States and China for its cow urine distillate. More...
Astellas Pharma set to launch Prograf in India works on marketing strategy
(Gireesh Babu, Mumbai , 13-Nov-2009 , Pharmabiz)
The product has been enjoying the top ranks in the segment in the US market till it lost the patent protection. More...
WIPO Director General Pledges Support for Indias Visually Impaired Community
(ag-IP-news ,GENEVA , 12-Nov-2009 , ag-IP-news)
The World Intellectual Property Organization Director General Francis Gurry met representatives of Indias visually impaired community at a conference on the Right to Read of persons with print disabilities and copyright challenges. More...
Valuing intangible property
(By Anuradha Salhotra , 12-Nov-2009 , Indian Express Finance )
Over the past few years businesses have given more and more prominence to intellectual property. More...
Cipla offers to step up swine flu drug supplies
(Our Bureau , 12-Nov-2009 , Business Line)
Cipla has offered to sell generic Oseltamivir the generic version of Roches anti viral drug Tamiflu to the US said Cipla Chairman and Managing Director Dr Y.K. Hamied adding however that at present it does not sell to the US and Europe because the drug is patent protected in these markets. More...
Method mania
(Latha Jishnu / New Delhi , 12-Nov-2009 , Business Standard)
A US Supreme Court case on the patenting of business methods draws pharma and software giants into the battle. More...
Rs 55k cr domestic drug mkt largely spurious free claims health ministry
(By Soma Das , 12-Nov-2009 , Indian Express Finance )
The much awaited official word of the government on the penetration of counterfeit drug in the domestic market is out. More...
Novartis puts R&D activities in India on hold
(Nina Mehta , 12-Nov-2009 , The Economic Times)
Frustrated with patent challenges Swiss pharma giant Novartis has put its research and development activities in India on the back burner its CEO Daniel Vasella said. Mr Vasella who was in town to attend the Pepsico board meet said the intellectual property protection was not up to the mark in India. More...
E7 the new El Dorado for pharma
(Priyanka Golikeri , 12-Nov-2009 , DNA)
Even for biosimilars off patent versions of biopharmaceutical drugs potential lies in Latin America and Asia says Kiran Mazumdar Shaw CMD of Bangalore based biotechnology player Biocon. More...
Outsourcing arm of Dr Reddys expects 10 15% revenue growth
(Sumeet Chatterjee , 12-Nov-2009 , livemint)
Analysts say growth in the sector will also be boosted by the biggest loss of patent protection in history in the next couple of years depriving global pharma firms of exclusivity on some of the worlds most famous and profitable medicines. More...
MNCs working against Indian drug firms Anand Sharma tells WIPO chief
(PTI , 11-Nov-2009 , The Times Of India)
India on Wednesday complained to the UN intellectual property rights body WIPO that some multinational firms have launched campaign against countrys pharmaceutical industry which has broken their cartel in the generic drugs. More...
Daiichi to leverage Ranbaxy abroad
(Mohit Bhalla & Khomba Singh , 11-Nov-2009 , The Economic Times)
Japans Daiichi Sankyo which controls Ranbaxy Laboratories will use the Indian company as a launch pad to sell its patented drugs in Europe China and the US and will work together in developing new products a senior company official said. More...
AstraZeneca sues Lupin for infringing on drug patent
(fe Bureau , 11-Nov-2009 , The Financial Express)
Anglo Swedish drug giant AstraZeneca has sued the Mumbai based pharma company Lupin Ltd in the US District Court of New Jersey charging it of infringing the innovators patent coverage by attempting to manufacture and market anti ulcer drug Nexium one of the top five blockbuster drugs globally. More...
Lupin issues notice to Depomed Inc relating to Glumetza patent
(Our Bureau, Mumbai , 11-Nov-2009 , Pharmabiz)
Lupin Ltd a Rs 3775 crore fifth largest Indian pharma major has issued a Paragraph IV certification notice to Depomed Inc regarding filing of an ANDA with the US FDA for a generic version of Glumetza 500 mg and 1000 mg strengths. More...
Mahabaleshwar seeks GI tag for its strawberries
(ET Bureau , 11-Nov-2009 , The Economic Times)
After the Puneri pagdi Tirupati laddoo basmati rice the Mahabaleshwar strawberry is seeking geographical identification status. More...
Medicis files another patent infringement suit against Glenmark
(Gireesh Babu, Mumbai , 11-Nov-2009 , Pharmabiz)
The US based Medicis Pharmaceutical Corp the specialty pharmaceutical company focusing on dermatological and aesthetic products has sued the Mumbai based Glenmark Generics Ltd and its US subsidiary in the District Court of New Jersey for alleged infringement of its patent rights on antifungal agent Loprox Gel. More...
HC stops Zydus drug sale on Sun petition
(BS Reporters / Mumbai/chennai , 11-Nov-2009 , Business Standard)
Unlike patent litigation trademark cases can be filed anywhere in India where the company sells the drug explained Gopakumar Nair an expert on patents and managing director of Patent Gurukul. More...
Dr Reddys unit rev to grow 10 15pct in FY10
(By Sumeet Chatterjee , 11-Nov-2009 , Reuters)
Analysts say growth in the sector will also be boosted by the biggest loss of patent protection in history in the next couple of years depriving global pharma majors of exclusivity on some of the worlds most famous and profitable medicines. More...
Patent disputes give global biggies the jitters
(Bloomberg , 10-Nov-2009 , The Economic Times)
The US Supreme Court on Monday considers a patent dispute that will determine how much legal protection is afforded abstract business innovations and has drawn in companies including Microsoft Google and Novartis. More...
Access to US biosimilars market set to get tougher
(Priyanka Golikeri , 10-Nov-2009 , DNA)
The US is considering a measure that would prevent the US Food and Drug Administration from approving a biosimilar off patent version of a biopharmaceutical drug until 12 years have passed since the innovator biologic was first approved. More...
Indian generic firms to gain from Obamas healthcare bill
(Khomba Singh , 10-Nov-2009 , The Economic Times)
In return for patents which are valid for 20 years innovator companies have to share the research work of their new drugs so that other companies can use the knowledge to develop copies of the drug when the original drugs patent expires. More...
AstraZeneca sues Lupin to protect patent rights of anti ulcer drug Nexium
(Gireesh Babu, Mumbai , 10-Nov-2009 , Pharmabiz)
AstraZeneca the Anglo Swedish drug major has filed a patent infringement lawsuit at the US District Court of New Jersey against the Mumbai based Lupin Ltd and its US subsidiary to curb the latters move to manufacture and market the generic version of its blockbuster acid reflux drug Nexium. More...
IP rights create a secure environment for investment in innovation
(Francis Gurry , 9-Nov-2009 , The Hindu)
The sustained growth of Indias IT sector is a further example of what can be achieved through strategic use of IP. More...
Generics Gateway
(BV Mahalakshmi, Sudhir Chowdhary , 9-Nov-2009 , The Financial Express)
The global generics market driven by a series of growth factors such as increasing genericisation favourable government support significant patent expiries and an ageing population is projected to grow at an attractive rate. More...
Brain League set to tap start up
(Nandita Vijay, Bangalore , 9-Nov-2009 , Pharmabiz)
BrainLeague a knowledge management and Intellectual Property consultancy company has now started a special service for pharma biotech start ups where it will offer IP generation protection management and commercialization advise. More...
Centre protests copyright violation by Google Books
(Rituparna Bhuyan , 9-Nov-2009 , The Financial Express)
The portal has led to numerous class action suites by authors and publishers in the US France and Germany for offering this facility in alleged violation of copyrights laws. More...
Barkha Dutt wins domain dispute against Hyderabad based entity
(STAFF WRITER , 08-Nov-2009 , Press Trust Of India)
Barkha Dutt a noted journalist and Group Editor of NDTV news channel has won an internet domain dispute at the World Intellectual Property Organisation against a Hyderabad based entity. More...
Generic drug cos see a bitter pill in counterfeit label
(Soma Das , 7-Nov-2009 , The Financial Express)
The fear of generic drugs coming under the definition of counterfeit drugs is haunting the Indian pharma industry yet again. More...
Dr Reddys develops generic version of Pfizers Lipitor
(P B Jayakumar / Mumbai , 7-Nov-2009 , Business Standard)
With this the Indian drug maker has joined the club of only a few generic companies hoping to grab a share of the cholesterol lowering drugs market when its patent expires from next year. More...
Biocon hums with plans pitches for global top 3 slot
(P B Jayakumar / Mumbai , 7-Nov-2009 , Business Standard)
About $25 billion worth of biological drugs are losing patent protection by 2016 and it is predicted that seven of the 10 top selling drugs will be biologics by 2020. More...
India EU to resolve generic drugs exports tangle
(IANS , 06-Nov-2009 , The Economic Times)
These shipments were for third countries so they did not violate either TRIPS Trade Related Intellectual Property Rights agreement or other existing laws. More...
Indian drug cos need to focus on niche segments in US generic market: Pharmexcil Study
(Gireesh Babu, Mumbai , 6-Nov-2009 , Pharmabiz)
The Indian pharma companies should focus more on complex chemistry biotech based medicines and advance formulations to tap the lucrative US generic market in future suggests a study conducted by Pharmaceuticals Exports Promotion Council the apex body governing pharma exports under the Union Ministry of Commerce. More...
EU to resolve drugs seizure issue soon
(ET Bureau , 6-Nov-2009 , The Economic Times)
Since the beginning of the year the EU have been confiscating Indian generic drugs that are on transit to Africa and Latin America on the ground that it violated the EUs patent regime. More...
Salix Pharma gets US patent for Rifaximin
(Raleigh, North Carolina , 06-Nov-2009 , Pharmabiz)
Salix Pharmaceuticals Ltd announced that the US Patent and Trademark Office has issued US Patent No. 7612199 entitled Polymorphic Forms Alpha Beta and Gamma of Rifaximin. More...
FTA negotiation tops agenda at India EU bilateral summit
(fe Bureaus , 5-Nov-2009 , The Financial Express)
It is at a critical phase as it will involve bargaining on duty cuts market access on services sector IPR as well as toning down non tariff barriers. More...
EU review mechanism on customs laws not likely to cover drug seizure issue
(Joseph Alexander, New Delhi , 5-Nov-2009 , Pharmabiz)
Even as the repeated seizure of drugs by the European authorities raised resentment and the EU claimed to be reviewing the contentious regulatory clause relating to the issue India has expressed apprehension about the review and its chances of resolving the matter permanently. More...
Core group for promoting local mfg of telecom infra
(Press Trust of India / New Delhi , 04-Nov-2009 , Business Standard)
The meeting also discussed issues such as investments manufacturing and Indian intellectual property rights. More...
India takes drug seizure issue to WTO council
(Joe C Mathew / New Delhi , 4-Nov-2009 , Business Standard)
The seizure of another consignment of Indian generic drugs in transit has pushed India to drag the issue to the TRIPS Council a high level body of the World Trade Organization dealing with intellectual property issues. More...
Pharma firms now need to shift focus to marketing: PwCs Friend
(C.H. Unnikrishnan , 4-Nov-2009 , livemint)
Big pharmaceutical companies such as Pfizer Inc. Novartis AG and GlaxoSmithKline Plc have followed a strategy to invest in the research and development of new drugs to feed their market needs driven by speciality and patent protected products. More...
Quick fix solution
(M J Antony / New Delhi , 4-Nov-2009 , Business Standard)
Two judgments of the Supreme Court delivered in recent weeks are significant as they highlight the problem of long delays in cases involving intellectual property rights and the quick fix solution suggested by the court. More...
Indian drugs may get safe EU passage
(Amiti Sen , 4-Nov-2009 , The Economic Times)
Pharma exports from India are likely to be promised safe passage by the European Union after India took up the issue following seizure of two consignments while in transit through the region. More...
Share tech to manage climate change
(Urmi Goswami , 3-Nov-2009 , The Economic Times)
The failure to arrive at a consensus on the issue of sharing IPRs could well be one of the hurdles to an outcome at the Copenhagen summit. More...
Not the right medicine
(Business Standard / New Delhi , 3-Nov-2009 , Business Standard)
Big global pharmaceutical firms seeking to buy into prominent Indian generic players is in fact a vindication of the Indian pharmaceutical story which began with the decision by Indira Gandhi to rein in the cost of medicines and allow process and not product patents. More...
No fair play in pharma industry
(MM Sharma Head , 3-Nov-2009 , The Economic Times)
These drugs contain same active ingredients as the original formulations invented by the originator companies mostly from Europe or United States and in most cases the usual life 20 years of the patents have expired or are about to expire. More...
ABLEs fourth biotech investor forum to kick off in Mumbai on Nov 5
(Our Bureau, Bangalore , 3-Nov-2009 , Pharmabiz)
The deliberation will focus on partnering & alliances opportunities from Intellectual Property sharing risk and explore other avenues to generate revenues which include monetizing assets licensing opportunities & services. More...
EU seizes another generic package
(Priyanka Golikeri , 3-Nov-2009 , DNA)
In yet another instance of attacks on Indian generics in the European Union a consignment of 1.74 million tablets of anti platelet drug clopidogrel from Mumbai based Macleods Pharma to Venezuela is learnt to have been seized at the Paris airport in October on grounds of patent violation. More...
ICFAI told to pay $1 million for infringing trademark in US
(Kalpana Pathak / Mumbai , 3-Nov-2009 , Business Standard)
The Hyderabad based Institute of Chartered Financial Analysts of India has been asked to pay over $1 million to the US based Chartered Financial Analyst Institute in damages for using the CFA trademark in the US. More...
Experts suspect Cotonou Declaration another attempt by developed nations to push counterfeit agenda
(Ramesh Shankar , 3-Nov-2009 , Pharmabiz)
Recently the WHO South East Asia Regional Office passed a resolution stressing the need to separate issues related to intellectual property enforcement from the safety quality and efficacy of medicines. More...
Novartis Venture Funds looking at innovative India opportunities
(P. T. Jyothi Datta , 3-Nov-2009 , Business Line)
Also working in favour of target companies was strong intellectual property and capital efficiency he added. More...
India ready to face WTO over wines spirits duties
(Nayanima Basu / New Delhi , 3-Nov-2009 , Business Standard)
Negotiations to create a trade and investment agreement were initiated on June 2007 covering trade in goods services investment intellectual property rights competition policy and geographical indications among others. More...
India in talks with US PTO for granting access to TKDL data to curb bio piracy
(Joseph Alexander, New Delhi , 2-Nov-2009 , Pharmabiz)
After sharing the database of Traditional Knowledge Digital Library with European countries India is now in talks with more countries including the US for similar agreement to grant access to the details in a bid to prevent wrong patents across the world on Indian medicinal plants. More...
Popular cold pain drugs face ban
(Rupali Mukherjee , 31-Oct-2009 , The Times Of India)
Popular and widely used medicines like phenylpropanolamine or PPA found in cough and cold remedies like Vicks Action 500 Solvin Wincold gastrointestinal tegaserod anti bacterial gatifloxacin and painkiller nimesulide are under government scanner on concerns raised about their adverse reactions. More...
Sanofi sues Sandoz for infringing cancer drug patent
(Tom Hals , 31-Oct-2009 , Reuters)
French drugmaker Sanofi Aventis SA asked a U.S. federal court to block a Novartis unit from selling a generic version of its cancer drug in the United States because it infringes a patent according to court documents. More...
Bumpy road ahead for India EU FTA
(Nirmala Ganapathy , 31-Oct-2009 , The Economic Times)
Though Ms Smadja said the priority in the negotiations remained issues like tariff market access non tariff barriers government procurement and IPR she also maintained that non trade issues were also important. More...
Takeda holds forecast drugs outlook still tough
(by Nobuhiro Kubo , 30-Oct-2009 , Reuters)
Takedas sales may drop from next year on as patents of some drugs will expire and most investors are wondering how Takeda will deal with the problem. More...
Sun Pharma net profit dips 11.5%
(BS Reporter / Mumbai , 29-Oct-2009 , Business Standard)
Analysts said despite regulatory issues in the US for its subsidiary Caraco growth in domestic business Caracos better sales than what was clocked in the immediate previous quarter and the patent settlement with Forest Laboratories during the recent quarter helped the company post better than expected profits. More...
Prof Baker too finds fault with Mashelkars revised report after Correas objections
(Ramesh Shankar, Mumbai , 29-Oct-2009 , Pharmabiz)
Close on the heels of international patent expert professor Carlos Correas criticism of the revised Mashelkar Committee report another international patent expert professor Brook K Baker has lambasted the Mashelkar Committee report stating that the revised version underestimates Indias right to define patentability. More...
Seeds of trouble
(Latha Jishnu / New Delhi , 29-Oct-2009 , Business Standard)
Last week the debate on intellectual property rights on seeds became more contentious when Olivier de Schutter the UNs Special Rapporteur on the Right to Food warned that the increasing dependency on commercial seed varieties controlled by a handful of very powerful multinational companies could have a severe impact on small farmers in developing countries. More...
Music industry wins Indias biggest plea bargaining case: IMI
(Chitra Unnithan / Mumbai/ Ahmedabad , 29-Oct-2009 , Business Standard)
In a significant case of copyright infringement under the concept of plea bargaining the Indian Music Industry won a compensation amount of Rs 12 lakhs in a copyright case. More...
Watson and Barr Settle Lawsuit Over Oxytrol
(CORONA, Calif , 29-Oct-2009 , PRNewswire)
Watson Pharmaceuticals Inc. a leading specialty pharmaceutical company announced today that its subsidiary Watson Laboratories Inc. has reached a settlement with Barr Laboratories Inc. on outstanding patent litigation related to Watsons Oxytrol® product. More...
Proposed PCT II revisions in WIPO against developing countries: IDMA
(Our Bureau, Mumbai , 28-Oct-2009 , Pharmabiz)
Now WIPO proposes a new treaty for a Global Patenting Order. More...
India may ask exporters to boycott KLM to deter EU for holding up drug cargo
(Ramesh Shankar, Mumbai , 28-Oct-2009 , Pharmabiz)
Even as the Indian government is planning to file a complaint with World Trade Organisation against the European Union on the issue of seizure of Indian drug shipments at EU ports the government is also exploring other options to pressurise the EU nations to change the patent laws amended some time back to make them more stringent. More...
Allergan wins brimonidine patent infringement case against Exela PharmSci & Apotex
(Irvine, California , 27-Oct-2009 , Pharmabiz)
Innovation in medicine has improved lives reduced suffering and advanced the quality of patient care and our intellectual property embodies our commitment to and investment in medical innovation said Douglas S Ingram Allergans executive vice president chief administrative officer and secretary. More...
Pfizers Handa is new MD of Wyeth India
(fe Bureaus , 27-Oct-2009 , The Financial Express)
Pfizer has launched five patented products in India since 2005 Vfend Viagra Lyrica Caduet and Macugen. More...
Glenmark Generics launches first four products in UK market
(Our Bureau, Mumbai , 27-Oct-2009 , Pharmabiz)
Of the four products launched Topiramate Tablets 25mg 50mg 100mg 200mg was launched on September 24 2009 which was day 1 of patent expiry in the UK market. More...
India seeks help from global NGOs to dissuade African nations enacting anti counterfeit laws
(Ramesh Shankar, Mumbai , 26-Oct-2009 , Pharmabiz)
The Indian government has asked the NGOs about the need to segregate twin issues of Intellectual Property and counterfeit drugs. More...
Nokia may seek up to$1 billion from Apple
(Tarmo Virki , 26-Oct-2009 , livemint)
Apple a latecomer to the cellphone industry has won a considerable share of the higher end of the market but it has limited intellectual property assets compared with rivals when all vendors work under cross licensing agreements. More...
Govt gives overt & covert support to US stand on climate CPI M
(Press Trust Of India , 25-Oct-2009 , Hindustan Times)
It also said India should work for freeing of technology transfers from restrictions of Intellectual Property Rights regime. More...
Biocon starts reaping benefits of Mylan pact
(Joe C Mathew / New Delhi , 25-Oct-2009 , Business Standard)
Under the partnership Biocon is to develop four biosimilar products low cost versions of patented biotechnology products and supply them to Mylan for selling globally. More...
Allergan wins ruling in patent case against 2 drugmakers
(By Robert Daniel , 25-Oct-2009 , MarketWatch)
Allergan Inc. won a ruling in federal court that its patents on Alphagan which lowers pressure in the eye in patients with open angle glaucoma and ocular hypertension were infringed. More...
Sun to stop making Alzheimers drug after losing patent battle
(ET Bureau , 24-Oct-2009 , The Economic Times)
Sun Pharmaceuticals has agreed not to manufacture and market the generic version of Alzheimers drug of Forest Laboratories after it lost patent battle with the US drugmaker on Thursday. More...
Pfizer scans India for shopping options
(Khomba Singh , 23-Oct-2009 , The Economic Times)
Pfizer has approached several Indian drugmakers for possible alliances as part of moves to try and bolster revenues threatened by the expiry of patents on key blockbuster drugs in the next three years three persons with direct knowledge of the matter said. More...
The new pharmaceutical order
(Bhupesh Bhandari / New Delhi , 23-Oct-2009 , Business Standard)
All of them not so long ago shared a common dream quickly capture the market for drugs that have gone off patent in the west. More...
BJP may soon claim patent on poll defeat
(Devesh Kumar , 23-Oct-2009 , The Economic Times)
For BJP tasting defeats in electoral battles has by now become routine. More...
It was only growth that eluded us
(Business Standard / New Delhi , 23-Oct-2009 , Business Standard)
We at Nasscom are looking at monitoring of patents as many companies now have to declare their patents in India. More...
Biocon banks on biosimilars novel drugs
(Priyanka Golikeri , 23-Oct-2009 , DNA)
Estimates suggest that by 2016 about $25 billion worth of biologics would lose patent protection. More...
India rejects draft WTO services schedule by US
(D Ravi Kanth / Geneva , 23-Oct-2009 , Business Standard)
India along with other countries today shot down a concerted move by the United States Australia and Canada to prepare draft scheduling of commitments in Doha services negotiations based on signals made by trade ministers during the failed ministerial meeting last year a trade envoy told Business Standard. More...
Nokia sues Apple for patent infringement
(REUTERS , 22-Oct-2009 , The Economic Times)
The worlds top cellphone maker Nokia Oyj on Thursday charged Apple with infringing Nokia patents in its iPhone. More...
India need to develop strong legal system against bio piracy Prof. K V Krishnamurthy
(Peethaambaran Kunnathoor, Chennai , 22-Oct-2009 , Pharmabiz)
The usurping of indigenous knowledge or traditional knowledge including medical knowledge without any benefit to the owner society is called bio piracy or gene robbing. More...
RA Mashelkar For me its national interest that comes first
(C.H. Unnikrishnan , 22-Oct-2009 , livemint)
Former director general of the Council of Scientific and Industrial Research R. A. Mashelkar who chaired the technical experts group on patent law constituted by the government has been dragged into a fresh controversy. More...
Indias patent progress
(Science|Business reporting , 22-Oct-2009 , Science|Business )
The reform of Indias patent system has given foreign companies the confidence that they can protect their intellectual property rights but the economic boom is yet to translate through to a surge in home grown innovation according to the latest research from the market analyst Evalueserve. More...
ImmunoCellular seeks US patent protection for intellectual property relating to novel glycosylated epitopes
(Los Angeles, California , 21-Oct-2009 , Pharmabiz)
ImmunoCellular Therapeutics Ltd a clinical stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers has filed a provisional patent application at US Patent Office seeking protection of intellectual property relating to novel glycosylated epitopes present in lung cancer pancreatic cancer and colon cancer that are targeted by the Companys ICT 109 monoclonal antibody product candidate. More...
Patenting Landscape in India
( Stephen Albainy-Jenei , 21-Oct-2009 , Patent Barista)
In recent years India has witnessed rapid changes in its patenting landscape as a result of the growing economic activity and reforms. More...
International public interest groups slam EU on double standards on drug laws
(Joseph Alexander, New Delhi , 21-Oct-2009 , Pharmabiz)
International public interest organizations have charged the European Union with adopting double standards vis à vis poor and developed countries and blocking the access to essential medicines across the world especially in the underdeveloped countries. More...
FDA seizes spurious drugs worth Rs10 lakh
(Ninad Siddhaye , 21-Oct-2009 , DNA)
Drug inspectors of the state Food and Drug Administration have seized a huge stock of spurious drugs from a godown in MIDC Turbhe. More...
GI protection Gain for some pain for others
(Vandana Gombar & Ch Prashanth Reddy / New Delhi/hyderabad , 21-Oct-2009 , Business Standard)
Early next month the Madras High Court will hear a unique case a petition challenging the geographical indications protection given to the famous Tirupati laddu produced by the Tirumala Tirupati Devasthanam. More...
Dont dilute Right To Information Act with amendments
(Ashutosh Shukla , 21-Oct-2009 , DNA)
The amendments to the RTI Act proposed by the central government have made activists as well as the public information commissioners increasingly unhappy. More...
Bisleri told to stop using Maaza trademark
(Press Trust Of India / New Delhi , 21-Oct-2009 , Business Standard)
The Delhi High Court today asked Bisleri International not to sell its mango flavoured soft drink under the trade name Maaza in India. More...
India to lodge complaint with WTO against seizure of drug exports at EU ports
(Ramesh Shankar, Mumbai , 20-Oct-2009 , Pharmabiz)
The government so far failed to cut much ice with the EU authorities in relaxing regulations on patent and trade mark issues so that at least the drug shipments on transit cannot be seized at the EU ports on charges of counterfeiting and patents infringement. More...
Health Discovery Corporation Announces Additional Issued Patents and Notices of Allowance to Its Intellectual Property Portfolio
(Matthew Swetonic , 19-Oct-2009 , Reuters)
Health Discovery Corporation is pleased to announce numerous additional issued patents and Notices of Allowance since its last press release describing its intellectual property portfolio. More...
Generics face uniform patent norms threat
(Priyanka Golikeri , 17-Oct-2009 , DNA)
Patients suffering from swine flu in India have a choice of buying the medicine oseltamivir from Natco Pharma Hetero Drugs and Strides Arcolab etc all of whose brands are available in the market. More...
Teva sues Mylan alleging Copaxone patent infringement
(Esha Dey in Bangalore , 17-Oct-2009 , Reuters)
Generic drugmaker Teva Pharmaceutical Industries Ltd sued rival Mylan Inc alleging that Mylans application to market a copycat version of Tevas multiple sclerosis drug Copaxone was infringing certain patents. More...
Made in India dominates US AIDS scheme
(P B Jayakumar / Mumbai , 16-Oct-2009 , Business Standard)
Even patent protected drugs are procured for supply with a tentative approval in the countries covered under the programme. More...
US Court rules Ranbaxys generic valganciclovir does not infringe Roches Valcyte patent
(Gireesh Babu, Mumbai , 16-Oct-2009 , Pharmabiz)
The verdict is on a complaint filed by Roche alleging Ranbaxy of patent infringement of the formers US Patent No 6083953 following an Abbreviated New Drug Application filed by Ranbaxy on amorphous form of valganciclovir with the US Food and Drug Administration in 2006. More...
Darjeeling tea closes in on Europe
(Sachin P Mampatta , 16-Oct-2009 , DNA)
The Indian application for a Geographical Indication mark for Darjeeling tea has entered a crucial six month period after which it would be given the same status as products such as Roquefort cheese and Napa Valley wines. More...
EUs latest moves on counterfeit drugs cause fresh concerns to Indian pharma
(Joseph Alexander, New Delhi , 15-Oct-2009 , Pharmabiz)
The recent moves by the developed countries especially the European Union on the counterfeit medicines issue have caused fresh worries among the Indian generic exporters prompting them to take recourse with the authorities for renewed efforts including international intervention along with other developing countries. More...
USFDA tells Glenmark to withdraw drug
(BS Reporter / Mumbai , 15-Oct-2009 , Business Standard)
The US Food and Drug Administration has directed Glenmarks US arm Glenmark Generics Inc and three other manufacturers to stop the marketing of unapproved codeine sulphate tablets in the US market. More...
EC seeks views on Darjeeling tea patent
(PTI , 15-Oct-2009 , The Economic Times)
The European Commission has invited public comments on a proposal from India seeking protection for Darjeeling tea against grant of patent for the beverage leaves grown in the hilly region of West Bengal. More...
Better monitoring of clinical research an imperative
(Pillman , 15-Oct-2009 , DNA)
In truth the largest benefit of globalised trials comes from faster time to market reducing development time by half results in nearly two thirds reduction in overall development cost and provides a longer post approval patent term in which to recoup the investment. More...
Suven Lifes Alzheimers Drug Gets Patents
(By RUMMAN AHMED , 14-Oct-2009 , The Wall Street Journal)
Suven Life Sciences Ltd. said Wednesday it has secured product patents in nine regions for its experimental drug for treating Alzheimers disease and schizophrenia. More...
Pharma industry seeks new technical committee in place of Mashelkar panel
(Joseph Alexander, New Delhi , 14-Oct-2009 , Pharmabiz)
Pharma industry has called for further amendment to the Patents Act to strengthen the criteria of patent protection and constitution of a fresh technical expert committee on the scope of patentability of pharma products as the earlier panel headed by Dr R A Mashelkar has run into controversy yet again. More...
The campaign against that pesky 3 d
(Latha Jishnu / New Delhi , 14-Oct-2009 , Business Standard)
Section 3 d is a singular provision aimed at preventing the evergreening of patents by drug inventors. More...
Sun acquisitions on hold will resume
(C.H. Unnikrishnan , 14-Oct-2009 , livemint)
Dilip Shanghvi Suns chairman and managing director has put the companys new expansion plans on hold as he battles over Taro and tries to sort out US subsidiary Caraco Pharmaceutical Laboratories Ltd. which has had operations halted by the US FDA. More...
Indian excipients market expected to grow 15 to 18% in near future say experts
(Gireesh Babu, Mumbai , 14-Oct-2009 , Pharmabiz)
Owing to the large chunk of drugs going off patent in the coming years the experts expect a growth rate of Indian excipients market at around 15 to 18 per cent annum as against the global growth rate. More...
We dont have space for more partnerships
(Joe C Mathew & Vandana Gombar / New Delhi , 14-Oct-2009 , Business Standard)
Piramal Healthcare Ltd the countrys fourth largest drug company has been focusing on international partnerships and collaborations instead of following the high risk route of patent challenges to grow revenues. More...
EMPOWERING SMEs
(P A Francis , 14-Oct-2009 , Pharmabiz)
With the amendment of Indian Patent Act in 2005 allowing product patent Indian pharmaceutical market has become very attractive to MNCs. More...
Glenmark Pharma plans to list its generics subsidiary
(Nina Mehta , 14-Oct-2009 , The Economic Times)
Glenmark Pharmaceuticals is planning to list its generics subsidiary Glenmark Generics and has filed a draft red herring prospectus with SEBI. More...
Phytogen develops a range of modified dosage nutraceuticals scouts for marketing par
(Nandita Vijay, Bangalore , 14-Oct-2009 , Pharmabiz)
All the products have gone in for trademark clearances. More...
Mashelkar clarifies on patent report conclusions
(Joe C Mathew / New Delhi , 13-Oct-2009 , Business Standard)
Nearly two months after Argentine patent expert Carlos M Correa complained about the misinterpretation of his observations to conclude an expert group report on Indian patent laws the chairman of the Technical Expert Group R A Mashelkar clarified that the reports conclusions were not based on Correas views but on TEGs own interpretations. More...
Panel on pricing of patented drugs undecided on formula with no data on imported drugs
(Joseph Alexander, New Delhi , 12-Oct-2009 , Pharmabiz)
The panel set up by the chemicals ministry in February 2007 to suggest a framework to fix prices of imported drugs through negotiations still could not muster enough support for its formula. More...
Outlook for pharmaceutical companies looks good
(Manas chakravarty, Ravi Ananthanarayanan and Vatsala Kama , 12-Oct-2009 , livemint)
IMS Health a global pharmaceutical market research company has released its latest forecast for 2010 in which it projects the global pharmaceutical market to grow by 4 6%. More...
US District Court approves sanofi aventis Sun Pharma patent settlement on Eloxatin
(Gireesh Babu, Mumbai , 12-Oct-2009 , Pharmabiz)
The District Court has now ruled that since the terms of the agreement were explained in both the letter of intent and the term sheets the agreement is enforceable without considering whether all the required signatures are obtained or not. More...
Storm over drug patent linkage after court rejects Bayer petition
(AZB and Partners , 12-Oct-2009 , livemint)
Bayer contended DCGI should not approve any application for a generic drug if the original has been patented. More...
Big Pharma targets emerging mkts
(Joe C Mathew /New Delhi , 12-Oct-2009 , Business Standard)
According to a recent KPMG study drugs worth $65 70 billion are expected to go off patent in five years while there are very few new drugs that can generate similar revenues. More...
The end of a drug alliance
(Shamnad Basheer , 12-Oct-2009 , livemint)
Recent alliances such as Ranbaxy Daiichi Indian generics firms are now acquiring dual personalities and speaking the language of patents and innovation. More...
Improved product mix margins make Atul a good long term bet
(Ujjval Jauharri , 12-Oct-2009 , DNA)
Atul also plans to introduce new products coming off patent. More...
Carlos Correa accuses Mashelkar for misinterpreting his quotes in revised report
(Ramesh Shankar, Mumbai , 12-Oct-2009 , Pharmabiz)
The government had set up a technical expert group with Dr R A Mashelkar as its chairman and four other members on April 5 2005 on the twin issues of evergreening of patents and excluding micro organism from patentability. More...
Lupin eyes $200 mn opportunity in US contraceptives market
(PTI , 11-Oct-2009 , The Economic Times)
Mumbai based pharmaceutical firm Lupin is gearing to tap opportunities to the tune of up to $200 million in the US oral contraceptives market despite patent litigation from rivals on its plans to sell generic drugs there. More...
Lupin pills hit legal wall in United States
(PB Jayakumar / Mumbai , 11-Oct-2009 , Business Standard)
Teva Womens Health of Israel and Warner Chilcott of Puerto Rico have sued Indias Lupin in separate patent infringement cases in the US. More...
Indian scientists develop sulphur free sugar
(Shivani Vig , 10-Oct-2009 , The Times Of India)
Before this we would be filing a patent for the developed sugar within a month and once through it would be the biggest achievement for the sugar industry and for NSI as well concluded Prof Narendra Mohan. More...
Court directive to Texmo on trade mark issue
(Our Legal Correspondent , 10-Oct-2009 , Business Line)
The Madras High Court has directed the Madhya Pradesh based Texmo Pipes & Products Ltd to print or project in its publication advertisement pertaining to public issue of 50 lakh equity shares of Rs 10 each that its right to use the trade mark Texmo had nothing to do with the plaintiffs firm viz. Aqua Pump Industries or its trade mark Texmo Aqua. More...
Scanner at shops multi coloured pills to detect counterfeit medicines
(Nina Mehta & Prashant Mahesh , 09-Oct-2009 , The Economic Times)
The company has filed several patent applications for this technology which it says can be easily integrated into a pharma companys manufacturing process. More...
Uganda Tanzania Zambia too planning anticounterfeit legislations despite Indias caution
(Joseph Alexander, New Delhi , 9-Oct-2009 , Pharmabiz)
In the World Trade Organization Agreement on Trade Related Aspects of Intellectual Property Rights TRIPS counterfeit is defined as pertaining to trademark infringement. More...
Pharma cos build immunity against counterfeiters
(Nina Mehta & Prashant Mahesh , 9-Oct-2009 , The Economic Times)
The company has filed several patent applications for this technology which it says can be easily integrated into a pharma companys manufacturing process. More...
Basic Research Loses Some Allure
(By DON CLARK and CHRISTOPHER RHOADS , 08-Oct-2009 , The Wall Street Journal)
Last year 70% of its patents were for software and services reflecting its shift away from computers and semiconductors where pure science plays a bigger role. More...
Brazil may team up with India against EC
(Asit Ranjan Mishra , 8-Oct-2009 , livemint)
India is appealing against EC at WTO for seizure of in transit consignments citing patent infringement. More...
EU officials raid Ranbaxy French unit
(ET Bureau , 8-Oct-2009 , The Economic Times)
Generic companies make the low cost version of original drugs and they challenge the patent of original drugmakers so that they are able to launch their drugs before patent expiry. More...
Patent experts pool being set up to advise courts
(C.H. Unnikrishnan , 8-Oct-2009 , livemint)
Move to assist the judiciary which is not yet fully conversant with the technical aspects of patent cases. More...
Developing nations gain victory at WIPO against patent harmonization agenda
(Ramesh Shankar, Mumbai , 8-Oct-2009 , Pharmabiz)
The member states of the WIPO have reached an agreement on a renewed and strengthened mandate for the Intergovernmental Committee on IP on Genetic Resources Traditional Knowledge and Folklore which would now undertake text based negotiations on an international legal instrument aimed at protecting these resources. More...
Glaxo eyes Dr Reddys as Big Pharma hunts in India
(By Ben Hirschler and Quentin Webb , 07-Oct-2009 , Reuters)
But attitudes are changing fast as slowing markets at home and a cliff of patent expiries has forced Big Pharma to explore new business models. More...
Lupin outlicences drug delivery tech to Salix
(Our Bureau , 6-Oct-2009 , Business Line)
According to the agreement Lupin and Salix have also entered into an exclusive agreement in the US for supply of Rifaximin active pharmaceutical ingredient. More...
Astellas US sues Wockhardt for alleged patent infringement of Adenoscan
(Gireesh Babu, Mumbai , 6-Oct-2009 , Pharmabiz)
Astellas US LLC the US subsidiary of the Japanese drug major Astellas Pharma has sued the Mumbai based Wockhardt Ltd and its US subsidiary for alleged infringement of its patent on pharmacological stress agent Adenoscan adenosine injection as the latter has filed an abbreviated new drug application for generic version of the product. More...
Glenmark Generics listing unlocks value for parent
(Ravi Ananthanarayanan , 6-Oct-2009 , livemint)
GGL has also focused on niche segments where there is lower competition and on drugs where there are patent challenge opportunities. More...
India may file case against EU at WTO
(Amiti Sen , 5-Oct-2009 , The Economic Times)
Its illegal as it not only violated the international intellectual property agreement but was also against the GATT provisions on transit a commerce department official told ET requesting anonymity. More...
PCT reforms at WIPO will benefit Indian innovators exporters OPPI
(Ramesh Shankar, Mumbai , 5-Oct-2009 , Pharmabiz)
The Organisation of Pharmaceutical Producers of India which represents multinational pharma companies in the country has joined issue with the forces who are opposing the efforts of the developed nations at WIPO for the patent harmonization which is feared to undermine the flexibilities available under TRIPS. More...
Indian formulation mkt to cross $13.7 billion by 2013
(R Ravichandran , 5-Oct-2009 , The Financial Express)
Global investors are under pressure due to growing patent expiries of major blockbuster drugs price restrictions and slowdown in new product approvals and launches. More...
Cordis enters pact with Boston to settle selected stent litigation cases
(3-Oct-2009 , Pharmabiz)
Cordis Corporation has reached an agreement with Boston Scientific resolving its Palmaz infringement suit relating to Bostons NIR stent settling several other cardiology related cases relating to patents in the Ding Kastenhofer Palmaz and Fontirroche patent families and exchanging paid up licenses for certain intellectual properties. More...
Plea filed in apex court against GI tag for Tirupati Laddu
(Vinson Kurian , 3-Oct-2009 , Business Line)
A public interest petition has been filed in the Supreme Court seeking suo motu action against the grant of intellectual property right protection to Tirupati Laddu which is a temple offering. More...
Big Pharma urged to pool HIV patents
(Priyanka Golikeri , 3-Oct-2009 , DNA)
Médecins Sans Frontières an international humanitarian organisation has called upon nine global pharma giants to pool their HIV patents in order to make available treatment to millions living with HIV AIDS. More...
Geographical indicators and beyond
(RAJESH HALDIPUR , 3-Oct-2009 , Business Line)
GIs are just one stop in a long journey to strengthen the intellectual property rights of traditional and artisan products. More...
Actavis launches generic Lipitor in Spain
(By Kevin Grogan , 02-Oct-2009 , PharmaTimes)
Actavis said that atorvastatin tablets are subject to widely varying patent situations around the world which is why Medis has invested significantly in different forms of the molecule. More...
China way ahead of India in patent filings
(Our Bureau , 1-Oct-2009 , Business Line)
The Indian Patent Office ranks 9th in the number of patents filed and 12th in the number of patents granted according to the World Intellectual Property Organisations latest data. More...
The promise of WIPOs development plan
(By John Tarpey , 1-Oct-2009 , The Economic Times)
A group of states known as the Friends of Development launched a far reaching proposal in 2004 to put development at the heart of the activities of the World Intellectual Property Organization. More...
Taro files new lawsuit against Sun Pharma
(BS Reporters / New Delhi/mumbai , 1-Oct-2009 , Business Standard)
Recent action by the USFDA against Suns majority owned US subsidiary Caraco Laboratories Inc. More...
Developing IPR is not a zero sum scenario
(Joe C Mathew / New Delhi , 30-Sep-2009 , Business Standard)
The Geneva based World Intellectual Property Organization a specialised agency of the United Nations aims at developing a balanced and accessible international intellectual property system among its 184 member countries. More...
Bharat Biotech gets patent for Lysostaphin
(BS Reporter / Hyderabad , 30-Sep-2009 , Business Standard)
Hyderabad based vaccines and biotherapeutics manufacturer Bharat Biotech International announced on Wednesday that its anti staphylococcal molecule Lysostaphin had secured patent rights in US Europe China Australia and other nations. More...
Reverse innovation isnt optional. It is oxygen
(Vivek Kaul , 30-Sep-2009 , DNA)
Multinational companies need to change the very way they conduct business suggests Vijay Govindarajan noted expert on strategy & innovation and author of the international bestseller Ten Rules for Strategic Innovators. More...
Recession and the global patent effect
(Latha Jishnu / New Delhi , 30-Sep-2009 , Business Standard)
What happens when the apex patents organisation brings an economist sorry a chief economist on board More...
Encourage innovation in pharma and healthcare
(Our Bureau , 29-Sep-2009 , Business Line)
Participating at a panel discussion on pharma and biotech industry the Chairman and Managing Director Bharat Biotech Dr Krishna M. Ella said the absence of laws protecting intellectual property rights was discouraging innovation. More...
Public interest groups urge India to oppose moves at WIPO to harmonise patent administration
(Joseph Alexander, New Delhi , 29-Sep-2009 , Pharmabiz)
A number of public interest organizations mainly in the health sector have urged the Centre to oppose any effort at WIPO General Assembly on harmonization of patent administration as it can fundamentally change the way in which substantive decisions about granting patents are taken by the patent offices in developing countries. More...
Lunch with BS Anand Burman
(Bhupesh Bhandari / New Delhi , 29-Sep-2009 , Business Standard)
Burman 57 is a scientist his father and the grand old man of Dabur A C Burman never got to finish college with over 40 patents against his name. More...
Indo Jap FTA Data exclusivity threat to generics
(Priyanka Golikeri , 29-Sep-2009 , DNA)
According to intellectual property experts keeping close tabs on the FTA Japan is pressing amongst other thing for data exclusivity which could increase costs and delay the process of bringing low cost generic drugs to the market if it is granted. More...
D Ravi Kanth Doha drifts again
(D Ravi Kanth / New Delhi , 29-Sep-2009 , Business Standard)
We sail within a vast sphere ever drifting in uncertainty driven from end to end is what the G20 leaders conveyed to their trade negotiators at the Pittsburgh summit last Friday. More...
Lupin buys cholesterol drug for $39 million
(PB Jayakumar & Joe C Mathew / Mumbai/delhi , 29-Sep-2009 , Business Standard)
The drug has strong brand equity with primary care physicians and has patent protection till 2020. More...
Indian drug market to triple to $ 20 bn by 2015 Report
(ET Bureau , 27-Sep-2009 , The Economic Times)
The report notes that In 2015 India could be a potential USD 8 billion market for MNCs with patented drugs accounting for nearly 8 10 % of the total market. More...
Not such a patent misfit
(Shyam Sunder,S. Subramanyan,Karan Thakur , 27-Sep-2009 , livemint)
Commercialization of patents in India remains weak is because the enforcement mechanism. More...
Ideal Cures bags Pharmexcil awards
(Our Bureau, Mumbai , 26-Sep-2009 , Pharmabiz)
Bagging the Government of India Patents Ideal Cures was honoured with the prestigious Government of India Patents Award and the Outstanding Export Performance Award in Drugs and Pharmaceuticals for the year 2008 09 by the Pharmexcil apex body under Ministry of Commerce and Industry Government of India on Friday September 25 2009 at the Indo Africa Pharma Business Meet at the Convention Centre Hotel Marriot in Hyderabad. More...
Orchid wins US court battle against Wyeth
(fe Bureaus , 26-Sep-2009 , The Financial Express)
Wyeths plea for a TRO was in connection with its lawsuit against the USFDA as it challenged the regulators approval of Orchids abbreviated new drug applications for its generic products Piperacillin and Tazobactam for injections. More...
India objects efforts of developed nations to undermine flexibilities in TRIPS at WIPO
(Ramesh Shankar, Mumbai , 26-Sep-2009 , Pharmabiz)
India has taken strong objection to the efforts being made by the developed nations through the World Intellectual Property Organization to undermine the flexibilities available under TRIPS by stretching the definition of counterfeiting. More...
Pharmaceutical exports up 17%
(BS Reporter / Chennai/ Hyderabad , 26-Sep-2009 , Business Standard)
The government is working to provide a conducive policy environment through flexible patent legislation to make the sector self reliant he said. More...
Sanofi Aventis scans India for acquisitions
(Nina Mehta & George Smith Alexander , 26-Sep-2009 , The Economic Times)
The absence of blockbuster patented drugs is forcing these companies to increase their revenues by buying up generic companies in developing markets which are growing exponentially because of economic prosperity. More...
Merck vaccine move signals shift in Big Pharma
(Pillman , 25-Sep-2009 , DNA)
We have come a long way since the days when vaccines were considered a business of marginal interest for multinational companies. More...
TVS set to make twin spark plug Flame
(fe Bureau , 25-Sep-2009 , The Financial Express)
The company statement added that in the patent dispute between Bajaj Auto Limited vs TVS Motor Company Limited the Supreme Court in its order dated September 16 has allowed TVS to sell the twin spark plug TVS Flame. More...
Consolidation will happen in the domestic drug industry
(P B Jayakumar / Mumbai , 25-Sep-2009 , Business Standard)
India has moved to product patents has a huge middle class its healthcare and insurance systems are improving and it has a good branded generics market. More...
Pharma M&As sounding death knell for low cost drugs
(Priyanka Golikeri , 24-Sep-2009 , DNA)
Indian companies which have been actively pursuing pre grant and post grant oppositions against the patents of MNCs would become less aggressive after being acquired by Big Pharma and their focus would shift more towards the generic markets in the US and the EU from India say healthcare and legal experts working in the area of access to medicines. More...
Wockhardt gets award for patents
(Press Trust of India / New Delhi , 24-Sep-2009 , Business Standard)
Drug maker Wockhardt today said it has been chosen as the pharmaceutical company for the maximum number of patent filings and grants from India. More...
Eli Lilly Wins Ruling on Evista Patent Validity in Teva Case
(By Edvard Pettersson , 24-Sep-2009 , Bloomberg)
Eli Lilly & Co. won a ruling on the validity of patents for its Evista osteoporosis treatment blocking an attempt by Teva Pharmaceutical Industries Ltd. to sell a generic version of the bone loss drug. More...
Venus Remedies Korean firm sign out licensing deal
(Press Trust of India / Mumbai , 23-Sep-2009 , Business Standard)
The company has also received patent for Sulbactomax from South African authorities and is scouting for partner to market the drug in the country. More...
Glaxo eyes Piramal Dr Reddys Labs
(C.H. Unnikrishnan and Baiju Kalesh , 23-Sep-2009 , livemint)
At least $70 billion worth of patented drugs will go off patent by 2012. More...
GSK drug deal talk lifts DRL scrip
(ET Bureau , 23-Sep-2009 , The Economic Times)
Shares of Dr Reddys Laboratories touched an intra day high of Rs 878.70 amid speculation that the Indian drug maker is in preliminary talks with UK based GlaxoSmithKline to market Red Heart Pill used to treat those with heart ailments. More...
An idea thats a patent misfit
(Views , 23-Sep-2009 , livemint)
Indias intellectual property rights regime can barely be improved by blindly transplanting a three decade old US law. More...
Resolvyx gets US patent for first Resolvin therapeutic to enter human trials
(Bedford, Maryland , 22-Sep-2009 , Pharmabiz)
Resolvyx Pharmaceuticals Inc. the leading Resolvin therapeutics company announced that the US Patent and Trademark Office has granted a patent covering composition of matter for RX 10045 the first Resolvin therapeutic to enter clinical trials. More...
Growing pharma market makes India a clinical trial destination Report
(Our Bureau , 22-Sep-2009 , Business Line)
By 2015 MNCs with patented drugs could account for $8 billion in the domestic pharmaceutical market nearly 8 10 per cent of the total market. More...
When patenting is in question
(K M Gopakumar , 22-Sep-2009 , The Economic Times)
The report of the Technical Expert Group on Patent Law Issues also known as the Mashelkar Committee Report has once again created controversy. More...
SC order on IPR violations may have left door open for misuse
(Manish Ranjan , 22-Sep-2009 , livemint)
Analysts say in some cases especially those with evidence of literal copying temporary relief may be required. More...
Brazil India to oppose EU at WTO
(D Ravi Kanth / Geneva , 22-Sep-2009 , Business Standard)
Indian generic drug companies have been charged with violating EUs patent laws. More...
Govt begins efforts to establish Indian pharmacy chains in Africa to counter issue of fake drugs with made in India label by China
(Ramesh Shankar, Mumbai , 21-Sep-2009 , Pharmabiz)
In an effort to effectively counter the complex issue of spurious drugs with made in India label but were produced by Chinese companies to tarnish the image of Indian generic drugs in the African countries the Indian government has started initiatives to establish a chain of pharmacies in African countries by the reputed Indian pharmacy chains like Apollo Group and Hetero Group. More...
Proposed patent Bill is flawed say experts
(C.H. Unnikrishnan , 21-Sep-2009 , livemint)
A patent and intellectual property rights Bill modelled on a 1980 Act of the US Congress and due to be tabled in the Parliaments December session is drawing criticism from researchers and academics for not addressing key issues and jeopardizing public interest. More...
OSI Pharma receives reissued patent for Tarceva
(Melville, New York , 21-Sep-2009 , Pharmabiz)
OSI Pharmaceuticals Inc announced that the US Patent & Trademark Office has issued a Notice of Allowance in OSIs reissue application for US Patent No.5747498 composition of matter patent for Tarceva. More...
Pharma market may touch $20 billion by 2015
(PTI , 21-Sep-2009 , The Economic Times)
Patent products may capture 8 10% share of the total market by 2015 the report said. More...
Developing countries express concern over WIPOs hidden agenda of pushing patent harmonization
(Ramesh Shankar, Mumbai , 21-Sep-2009 , Pharmabiz)
Even as the World Intellectual Property Organisations two day Global Symposium of IP Authorities is underway in Geneva the developing countries are expressing concern on the larger agenda of the organisation controlled by US EU and Japan on pushing a patent harmonization agenda. More...
Indian global pharma firms find it worthwhile to join hands
(Ravi Anathanarayanan , 21-Sep-2009 , livemint)
Companies began by selling generic drugs in India and other non regulated markets also invested in the US branded generic drugs market targeting drugs that went off patent and also challenging some patents. More...
Pharma market in global top 10 by 2015 Report
(BS Reporter / New Delhi , 21-Sep-2009 , Business Standard)
A report by the Federation of Indian Chambers of Commerce and Industry with Ernst and Young states that India could be a potential $8 billion market for multinational companies with patented drugs accounting for 8 10 per cent of the total market. More...
Sun Pharma to file 30 applications for generic drugs
(PTI , 21-Sep-2009 , livemint)
The company would file these applications along with its US based subsidiary Caraco which is facing trouble due to non compliance of current good manufacturing practice of the US drug regulator. More...
Innovation the key for winning organisations
(Our Bureau , 20-Sep-2009 , Business Line)
Innovation is all about research and development turned into an application and needs to come from all levels within an organisation. More...
Now an Invention Inventors Will Like
(By STEVE LOHR , 20-Sep-2009 , The New York Times)
The world can be a rough place for independent inventors. More...
Patented drugs market in India to touch $8 bn by 2015 Report
(Press Trust Of India , 20-Sep-2009 , Hindustan Times)
The increasing population of higher income group in the country will open a potential $ 8 billion market for multi national companies selling costly patented drugs by 2015 a FICCI Ernst & Young study said. More...
Merck to launch 13 innovator drugs here
(Khomba Singh , 19-Sep-2009 , The Economic Times)
Besides the drugs launch we would go to smaller towns and cities where nobody has gone.Our growth will be driven by patented drugs. More...
Glaxo seen eyeing 5% stake in Dr Reddys
(REUTERS , 18-Sep-2009 , The Economic Times)
Dr Reddys will get a lot of mileage in terms of selling their products in new markets while Glaxo will get access to a basket of generics at a time when a large numbers of drugs are going off patent. More...
Banarasi silk sarees get copyright cover
(Binay Singh , 18-Sep-2009 , The Times Of India)
Banarasi silk products have now joined the league of Pochampalli Tirupati laddu and Darjeeling tea under the registered name of Banaras Brocades and Sarees by securing Geographical Indication rights. More...
Reliance Life trims pharma plans to keep cash in hand
(C.H. Unnikrishnan , 18-Sep-2009 , livemint)
The pharma arm will now focus on selected high value but low volume specialty drugs. More...
Skype founders file a copyright suit against eBay
(New York Times , 18-Sep-2009 , The Economic Times)
The founders of Skype are escalating their legal battle with eBay. More...
Appeals court affirms patent infringement rulings against Roches peg EPO product
(Thousand Oaks, California , 18-Sep-2009 , Pharmabiz)
Amgen announced that the Court of Appeals for the Federal Circuit affirmed the Massachusetts District Courts decision that Roches peg EPO product Mircera infringes four Amgen patents relating to recombinant erythropoietin and processes for making it. More...
The Apex Court of India Sets Guidelines for All IP Litigation in Lower Courts
(ag-IP-news Agency , 17-Sep-2009 , ag-IP-news )
A landmark Judgment has been passed by the Supreme Court of India which could change the course of Intellectual Property litigation in India. More...
Dr Reddys Promoter exit wont come cheap
(Pillman , 17-Sep-2009 , DNA)
The one off windfall gains through patent challenges of the last few years are also not so much talked about as more and more companies increasingly shake hands and call truce to save spiralling litigation costs. More...
View Good candidate for GI status
(Amrith Lal , 17-Sep-2009 , The Times Of India)
After Darjeeling tea champagne and Florida oranges its the turn of Tirupati laddus to get a geographical indications patent. More...
Counterview A laddu is a laddu is a laddu
(Amrith Lal , 17-Sep-2009 , The Times Of India)
But these are not convincing reasons to claim that the Tirupati laddu is an exceptional item like the Darjeeling tea or Goan feni to have geographical indications patent rights. More...
TVS can sell Flame with twin spark plug
(Press Trust Of India / New Delhi , 17-Sep-2009 , Business Standard)
A Supreme Court Bench asks the Madras High Court to decide the matter before November 30. More...
Sun Pharma Caraco plan to file 30 patent pleas for generics
(BS Reporter / Mumbai , 17-Sep-2009 , Business Standard)
Sun Pharmaceutical Industries and its troubled US subsidiary Caraco Pharmaceuticals plan to together file 30 Abbreviated New Drug Applications with the US Food and Drug Administration to market generic drugs despite regulatory issues for the US company. More...
India has immense potential to take on global pharma markets
(PTI , 16-Sep-2009 , The Economic Times)
Primary problems faced by the Indian pharma sector today are issues of intangibles namely lack of skilled manpower lack of consistency and quality lack of clarity on IPR and patenting regulatory failures and a highly fragmented sector it said. More...
Centre plans action against EU customs rules
(Amiti Sen , 16-Sep-2009 , The Economic Times)
India is not willing to take the European Commissions verbal assurances on sorting out the issue of seizure of Indian drugs at European ports. More...
SC reserves judgement on Bajaj TVS patent case
(Legal , 16-Sep-2009 , Business Line)
The Supreme Court on Tuesday reserved its judgement on the patent case between two wheeler rivals Bajaj Auto and TVS Motor. More...
Tirupati laddu gets global patent
(TNN , 16-Sep-2009 , The Times Of India)
Temple sources said the Tirupati laddu got the patent rights under the Geographical Indications of Goods Registration and Protection Act on Tuesday. More...
Vedi asked not to use Le Passage trademark
(Manish Ranjan , 16-Sep-2009 , livemint)
Delhi high court on Tuesday restrained Vedis International Tours and Travels from infringing on the registered trademark and the domain name of another tour operator Le Passage to India Tours and Travels. More...
The IPR icing on Brazils cotton victory
(Latha Jishnu / New Delhi , 16-Sep-2009 , Business Standard)
The more significant aspect of the arbitration panels ruling is that it allows cross retaliation by Brazil against intellectual property rights which is protected by the WTOs Agreement on Trade Related Aspects of Intellectual Property Rights TRIPS or on services. More...
India Wins European Patent Battle For Jute
(FE Reporter , 15-Sep-2009 , The Financial Express)
In a major victory for the ailing jute industry Jute Manufacturers Development Council successfully fought to revoke a UK based firms patent for use of hessian cloth to cover waste and dumping grounds. More...
DRL faces patent suit in US over allergy generic
(ET Bureau , 15-Sep-2009 , The Economic Times)
NYSE listed Dr Reddys Laboratories is embroiled in a fresh patent infringement row with US based drug discovery firm Albany Molecular Research. More...
Mega deals boost pharma in crisis
(Rupali Mukherjee , 15-Sep-2009 , The Times Of India)
With the so called patent cliff and stagnating pipelines of big pharma companies are trying to augment their portfolios and revenues like Pfizer gets the biotech and OTC business of Wyeth to augment revenues. More...
Patent expiry to open huge opportunity for Indian pharma
(PTI , 15-Sep-2009 , The Economic Times)
Patent expiry will be a major avenue of growth for the Indian pharmaceutical industry as products worth $235 billion are going off patent within horizon of five years from 2009 to 2014 a top pharma company official said here today. More...
Major growth will come from generics business
(C.R. Sukumar , 15-Sep-2009 , livemint)
Dr. Reddys Laboratories Ltds vice chairman and chief executive G.V. Prasad shares the drug makers future ambitions. More...
WHO SEARO rejects counterfeit agenda of pharma MNCs
(Ramesh Shankar, Mumbai , 15-Sep-2009 , Pharmabiz)
The meeting noted that the term and definition of counterfeit relates to infringement of intellectual property rights and should not be equated with substandard medical products. More...
Suven gets two US patents for neurodegenerative disorder drugs
(Our Bureau, Mumbai , 14-Sep-2009 , Pharmabiz)
Suven Life Sciences Ltd announced that the US Patent Office has issued two Patents US 7507835 and US 7388024 corresponding to two New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid until 2022 & 2024 respectively. More...
Lupin Novartis end patent row for Lotrel
(Khomba Singh, , 12-Sep-2009 , The Economic Times)
Mumbai based pharma firm Lupin has reached an out of court settlement with Swiss pharma major Novartis for the latters hypertension drug sold under the brand name Lotrel which will allow the Indian firm to launch the generic version of the drug ahead of its patent expiry in 2017 and get a one time revenue upside said a person familiar with the development. More...
Fake drugs WHO body rejects MNC argument
(Rupali Mukherjee , 12-Sep-2009 , The Times Of India)
The World Health Organisation regional committee has rejected the counterfeit drugs agenda propagated by developed countries and pharma MNCs which is already threatening the entry of legitimate generics exported from India. More...
Biocon joins hands with US co Amylin for diabetes drug
(ET Now , 12-Sep-2009 , The Economic Times)
Even as Amylin will own the intellectual property rights to the molecule and phybrid technology Biocon will hold the IP for manufacturing. More...
SC issues notices in Novartis patent case
(Manish Ranjan , 12-Sep-2009 , livemint)
The apex court sought replies from the commerce ministry the comptroller general of patents the Cancer Patient Aid Association and the four pharma firms that state their objections on why the patent should not be granted to Novartis. More...
IPRS issues notices to hotels mall for copyright violation
(BS Reporter / Mumbai/ Ahmedabad , 12-Sep-2009 , Business Standard)
We have sent legal notices to the hotels and the mall for violating copyright under Section 33 of the Copyright Act 1957. More...
Pfizer Indias new strategy for emerging markets
(Manas Chakravarty and Ravi Ananthanarayan , 12-Sep-2009 , livemint)
Profitability improvements would come from a higher share of products that have patent protection. More...
IPA calls for amendment to D&C Act to exclude IPR issues from Sec 17
(Joseph Alexander, New Delhi , 12-Sep-2009 , Pharmabiz)
In a recent meeting jointly held by different departments including health pharma and commerce on the issue the IPA has suggested that the terms of counterfeit and spurious be defined separately and the IPR related issues e.g misbranded should be removed from Section 17 of the Drugs and Cosmetic Act. More...
SC notices to Centre pharma companies on Novartis petition
(PTI , 11-Sep-2009 , The Times Of India)
The Supreme Court on Friday issued notices to the Centre pharma major Cipla Ranbaxy Lab Hetero Drugs Natco Pharma and others on a pettion filed by Swiss firm Novartis AG challenging the denial of patent for its blood cancer drug Glivec in beta crystal form. More...
Mid cap pharma firms focus on LatAm market
(Nina Mehta , 11-Sep-2009 , The Economic Times)
Indian companies faced with increased competition in developed markets and stiff standards set by the US Food and Drug Administration are looking to markets where rules are less stringent as governments focus on affordability of healthcare rather than defending patents on billions of dollars of drugs. More...
Pfizer plans major push into generics
(C.H. Unnikrishnan , 11-Sep-2009 , livemint)
Pfizer Ltd the Indian subsidiary of the worlds largest drug maker Pfizer Inc. is making an aggressive play in the Indian generics or off patent drugs market. More...
Marico Agro Tech in trademark tussle
( T Knight Ridder/Tribune , 09-Sep-2009 , BusinessWeek)
Marico India the maker of cooking oils Saffola and Sweekar has sued Agro Tech Foods an affiliate of American foods giant ConAgra Foods over what it believes is trademark violation by the latter. More...
India patent rejections welcomed by HIV AIDS groups
(By Bappa Majumdar , 09-Sep-2009 , Reuters)
Indias rejection of patent applications on two life saving HIV AIDS drugs last week has been welcomed by health officials who say it will ensure wider access to the medicines. More...
Suven gets milestone payment from Eli Lilly
(KV Ramana , 8-Sep-2009 , DNA)
Once it is launched we will keep getting the royalty till the drug is covered by the patent he said. More...
DCGI asks states to effect fake drug norms
(Sushmi Dey , 8-Sep-2009 , The Economic Times)
The recent amendments in the Drugs & Cosmetics Act prescribes stricter punishment for companies guilty of manufacturing adulterated or spurious drugs. More...
Cipla to produce biotech drugs
(BS Reporter / New Delhi , 8-Sep-2009 , Business Standard)
Cipla the countrys second largest drug company will foray into the production of biotechnology medicines soon. More...
McDonalds loses trademark fight against McCurry
(The Associated Press , 8-Sep-2009 , CNBC)
U.S. fast food giant McDonalds lost an eight year trademark battle to prevent local restaurant McCurry from using the Mc prefix in a precedent setting judgment by Malaysias highest court. More...
3 provisions helped India cull frivolous patents study
(C.H. Unnikrishnan , 8-Sep-2009 , livemint)
Three patent provisions that have come under flak from foreign companies and governments for not being compliant with global intellecutual property regimes have actually helped India weed out frivolous patents since 2005 when the country moved to a new patent regime. More...
Venus Remedies gets Indian patent for Potentox
(Our Bureau, Mumbai , 08-Sep-2009 , Pharmabiz)
Venus Remedies a mid cap Rs 260 crore plus Chandigarh based pharma company has received first ever injectable FDC product patent for Potentox a research product of the company from the Indian Patent Office Government of India. More...
U.S. court backs Synthes in U.S. patent case
(by Lisa Jucca , 07-Sep-2009 , Reuters)
Switzerland based medical device maker Synthes Inc has won a key ruling in an ongoing U.S. patent case against U.S. competitor Medtronic the Swiss company said on Monday. More...
Innovation can benefit Indian drug industry
(ENS Economic Bureau , 07-Sep-2009 , express buzz)
Extending patent protection to incremental pharmaceutical innovation should encourage Indian pharmaceutical companies to expand further their investment in innovation and ultimately become major sources of new products for both the Indian and global markets. More...
Pfizer India arm to launch 2 3 generic drugs by Dec
(MUMBAI (Reuters) , 07-Sep-2009 , Reuters)
Drug maker Pfizer Ltd plans to launch two or three generic drugs in India by December as part of its efforts to widen its portfolio and market share its managing director said late on Friday. More...
IT dept takes drug companies to court
(Khushboo Narayan and C.H. Unnikrishnan , 7-Sep-2009 , livemint)
Barring the top 300 pharma firms most of the 15000 drug units operating in India are engaged in contract manufacturing. More...
EU will take steps to resolve drug seizure cases says Ashton
(ET Bureau , 06-Sep-2009 , The Economic Times)
The EU has assured India that it will take steps to resolve the issue related to the recent cases of life saving generic or off patent medicines exported from India to other countries being seized at European ports. More...
Process Ciplas licence for Soranib HC
(Press Trust Of India / New Delhi , 5-Sep-2009 , Business Standard)
The Delhi High Court today directed the Drug Controller General of India to process the licence application of Cipla for production and sale of the generic version of global pharma major Bayer Corporations liver and kidney cancer drug Nexavar. More...
Bayers bid to stay Cipla cancer drug foiled next hearing on Oct 6
(ET Bureau , 5-Sep-2009 , The Economic Times)
Germanys largest drug maker Bayer failed to get a court stay on Cipla from seeking permission to launch the European companys copycat of cancer treating drug Nexavar in India. More...
Toyota patent trade case
(Bloomberg / Washington , 5-Sep-2009 , Business Standard)
Toyota Motor Corp the world’ biggest seller of autos powered by a combination of gasoline and electricity faces a patent infringement claim that may result in a US import ban on its Prius and other hybrid models. More...
Process Ciplas licence for Soranib HC
(Press Trust Of India / New Delhi , 5-Sep-2009 , Business Standard)
The Delhi High Court today directed the Drug Controller General of India to process the licence application of Cipla for production and sale of the generic version of global pharma major Bayer Corporations liver and kidney cancer drug Nexavar. More...
Ayurvedic remedies gain ground in India
(Saikat Chatterjee and Arush Chopra / Bloomberg , 4-Sep-2009 , livemint)
Residents have switched to traditional Ayurvedic healing used for hundreds of years to boost immunity as well as unproven remedies being sold to take advantage of the outbreak More...
Revamping legal mechanism alone cant stop spurious drug makers
(Pillman , 4-Sep-2009 , DNA)
Excessive pressure from global agencies pushed India to make significant changes in the Drugs and Cosmetics Act that will now subject perpetrators of spurious drugs to harsher punishments. More...
India rejects patent claims on two HIV AIDS drugs
(R. Prasad , 04-Sep-2009 , The Hindu)
The Indian Patent Office has rejected applications from two US pharmaceutical companies on grounds of evergreening raising hopes of a further lowering of prices of two life saving drugs used by HIV AIDS patients in the country. More...
Protecting the Patent System for Entrepreneurs
(By Scott A. Shane , 04-Sep-2009 , The New York Times)
Recently a number of companies from the information technology and financial services sectors have been pushing Congress to change the patent system. More...
HC asks DGCI to grant licence to Ciplas anti cancer drug
(Press Trust of India / New Delhi , 04-Sep-2009 , Business Standard)
The Delhi High Court today directed the drug regulator of the country to go ahead with the process of granting a licence to Cipla for producing a generic version of the anti cancer medication Nexavar against which global drug maker Bayer Corp is fighting a legal battle. More...
NGO asks govt to further amend Patent Act to avoid frivolous patent filings
(Ramesh Shankar, Mumbai , 03-Sep-2009 , Pharmabiz)
The National Working Group on Patent Law an NGO working on patent issues in the country has asked the government to further amend the Amended Patent Act 1970 to avoid frivolous and questionable patent claims being filed by the industry and are being granted by the Patent Offices. More...
Govt may move WTO on EU drug seizures
(Priyanka Golikeri , 3-Sep-2009 , DNA)
The government plans to file a complaint to the World Trade Organisation against seizures of its legitimate low cost generic drugs by the European Union according to people in the know. More...
Setting aside Bayers spurious claims
(Latha Jishnu / New Delhi , 2-Sep-2009 , Business Standard)
Two weeks ago Justice S Ravindra Bhat of the Delhi High Court dismissed with costs the writ petition filed by the German pharmaceuticals giant Bayer Corporation against the Union of India the Drug Controller General of India and Cipla. More...
India refuses patent protection for AIDS drug of US company
(Joe C Mathew / New Delhi , 2-Sep-2009 , Business Standard)
More appeals pending domestic manufacturing some way off. More...
Bayer CropScience Wins Patent Litigation
(By Staff Reporter , 01-Sep-2009 , Pharmaceutical Business Review)
Under the settlement Tian Rong and Hua Dong to cease the infringing acts. More...
Novartis Glivec case to be heard by another Bench
(Our Bureau , 01-Sep-2009 , Business Line)
Swiss drug maker Novartis challenge in the Supreme Court on being denied a patent for its cancer drug Glivec will now be re assigned to another Bench by the Chief Justice of India. More...
Britannia to sharpen focus on global biz
(BS Reporter / Kolkata , 01-Sep-2009 , Business Standard)
Biscuits major Britannia Industries plans to focus on strengthening its international business and expand its brand presence in the aftermath of its settlement with Danone on the intellectual property rights issue over the Tiger brand. More...
Swiss NGO flays Novartis Glivec appeal
(Priyanka Golikeri , 01-Sep-2009 , DNA)
A Switzerland based NGO has come out strongly against Swiss pharma giant Novartis appeal to the Supreme Court last week over the rejection of its patent for cancer drug Glivec. More...
SC to hear Novartis case next week
(Press Trust of India / New Delhi , 31-Aug-2009 , Business Standard)
The Supreme Court will hear Swiss drug maker Novartis AGs plea against denial of patent for its blood cancer drug Glivec next week. More...
Britannia settles Tiger brand tangle with US firm
(IANS , 31-Aug-2009 , sifynews)
The Nusli Wadia led Britannia was embroiled in a bitter intellectual property right violation litigation with its partner Groupe Danone after the Indian company charged the French dairy major with using its Tiger trademark a key intellectual property in the overseas market without prior consent. More...
Big multinationals dumping excess vendor baggage
(Shelley Singh , 31-Aug-2009 , The Economic Times)
Companies doing R&D remotely also try to limit the number of third party vendors to protect intellectual property and any infringements of patents. More...
GSK plans to launch H1N1 drug in India
(Press Trust Of India / New Delhi , 31-Aug-2009 , Business Standard)
UK based drug maker GlaxoSmithKline is in talks with the Indian government for introducing its patented drug Relenza which is used for the treatment of Influenza A H1N1. More...
DRL seeks USFDA help to make cancer drug clone
(Sai Deepika Amirapu , 31-Aug-2009 , The Economic Times)
Dr Reddys Laboratories Indias second largest drug maker by sales has approached the US Food and Drug Administration to overcome impediments in making the generic version of Revlimid an expensive drug used to treat blood cancer. More...
Insurance firm told to pay up
(BS Reporter / New Delhi , 31-Aug-2009 , Business Standard)
The Supreme Court will on Monday hear Swiss drug maker Novartis AGs plea against denial of patent for its blood cancer drug Glivec in its beta crystal form. More...
Lack of clarity in drugs Act may hit generic companies
(Nina Mehta , 31-Aug-2009 , The Economic Times)
Ambiguity in the amended Drugs and Cosmetics Act over the definition of the terms adulterated and spurious drugs could affect Indian generic drug players. More...
Tata Sons wins trademark case against MakeMyTrip
(Shubhra Tandon , 30-Aug-2009 , Business Line)
Tata Sons recently won a trademark case at the World Intellectual Property Organisation against New Delhi based travel portal MakeMyTrip for the use of the word TATA in the latters sister Web site okaytatabyebye.com an online networking forum for the travel community. More...
Govt curbs sale of flu drug Zanamivir
(Khomba Singh , 29-Aug-2009 , The Economic Times)
The government is set to put Zanamivir the only swine flu drug that is freely available in the market currently under restricted sale category. More...
Cipla calls off marketing alliance with Avesthagen
(Nina Mehta , 29-Aug-2009 , The Economic Times)
Cipla has terminated its marketing agreement with Avesthagen and is looking at selling its 5.8% stake in the Bangalore based company. More...
Novartis moves SC in Glivec patent case
(ET Bureau , 29-Aug-2009 , The Economic Times)
Swiss major Novartis AG has moved the Supreme Court challenging Intellectual Property Appellate Board decision to reject its patent application of blood cancer drug Glivec in India. More...
Sharma to take up drug seizures issue with EU commissioner
(Asit Ranjan Mishra and Radhieka Pandeya , 29-Aug-2009 , livemint)
According to European Commission laws if a consignment of drugs is not patented either in the country of origin or its final destination it could be seized. More...
Cipla gets relief as SC rejects Roche plea
(ET Bureau , 29-Aug-2009 , The Economic Times)
The Supreme Court on Friday rejected Swiss drugmaker Roches petition to stop Indian firm Cipla from selling the generic version of its cancer drug Tarceva to ensure that Indians have access to the medicine at a lower cost till the Delhi High Court decides on Ciplas patent challenge plea. More...
Encouraging drug innovation
(Shamnad Basheer , 28-Aug-2009 , livemint)
The Mashelkar committee report on drug patent law may have stirred controversy but it sets the right tone More...
GSK to launch promecta in India by 2009 end
(Agencies , 27-Aug-2009 , The Financial Express)
Glaxo SmithKline Pharmaceutical said it is looking at launching its patented medicine promecta used in treatment of depleted platelet count in India by this year end or early next year. More...
Patent regime poses new challenges for health Minister
(IANS , 27-Aug-2009 , SamayLive)
Minister of State for Health Dinesh Trivedi Thursday called for taking a serious look at the intellectual property rights regime so that Indian patients are not adversely affected. More...
Even European Union doesnt link regulatory approval for generics to innovator patent
(Priyanka Golikeri , 27-Aug-2009 , DNA)
German healthcare giant Bayer is determined to introduce in India a system that can prevent early entry of low cost generics despite the Delhi High Court quashing its plea to link regulatory approval to last week saying the company was trying to tweak public policy. More...
Incremental pharma innovation in patent regime to benefit local firms
(fe Bureaus , 27-Aug-2009 , The Financial Express)
Expanding the scope of Indias current patent regime to include incremental pharma innovation would benefit the domestic pharma players according to a study commissioned by the US India Business Council which was released on Wednesday. More...
Drug Biotech Research Spending Hangs Tough
(By Emily Thornton and Frederick Jespersen , 27-Aug-2009 , BusinessWeek)
With billions of dollars worth of branded drugs losing their patent protection the pharmaceutical industry is under pressure to boost its pipeline of innovative new drugs. More...
Indian patent laws not conducive to domestic R&D OPPI
(Agencies , 26-Aug-2009 , The Financial Express)
The countrys pharmaceutical industry today said the present patent laws do not value incremental innovations and are not conducive to the research and development activities of domestic firms. More...
Biocon mulls listing of two of its arms by next yr
(Press Trust of India / Chennai , 26-Aug-2009 , Business Standard)
Biocons patent portfolio totals close to 942 applications worldwide with over 182 granted patents. More...
Stringent IP enforcement will limit access to generic drugs
(fe Bureaus , 26-Aug-2009 , The Financial Express)
Civil society organisations led by Centre for Trade and Development have sent a strong missive to the Confederation of Indian Industry urging it to be careful about associating with multinational corporations and developed countries that are keen to push more stringent intellectual property enforcement laws in India . More...
US pharma association disapproves Customs seizure of generics
(Joe C Mathew / New Delhi , 26-Aug-2009 , Business Standard)
The response comes after 17 consignments of genuine generic medicines from India were recently seized at various European ports alleging intellectual property violations. More...
Sanofi sues Sun Pharma over Taxotere generic
(Bloomberg , 26-Aug-2009 , livemint)
Sun is pursuing approval from the US FDA to market two dosage forms of the drug before the patents expire in 2012 according to the complaint filed by Sanofi Aventis SA. More...
Concerns of WIPOs members and its customers differ
(D G Shah , 25-Aug-2009 , The Economic Times)
WIPO like other UN organisations is a member driven organisation. More...
The treaty is a cornerstone of multilateral cooperation
(Claus Matthes , 25-Aug-2009 , The Economic Times)
Recently articles have surfaced in the Indian press about international efforts to reform the Patent Cooperation Treaty an agreement that binds 141 countries in a pact that facilitates the process of seeking protection for an invention in multiple countries. More...
Govt should not succumb to the WIPO pressure
(Dr.Y.K.Hamied , 25-Aug-2009 , The Economic Times)
I strongly subscribe to the view that the ongoing reform of the Patent Cooperation Treaty at the behest of WIPO is an attempt to undermine the sovereign rights of the Indian government to make laws to suit its domestic needs. More...
Verva licenses FGFR intellectual property rights to Isis Pharma to treat obesity & other diseases
(Geelong, Australia , 24-Aug-2009 , Pharmabiz)
Verva Pharmaceuticals Ltd and Isis Pharmaceuticals Inc announced the completion of an agreement providing Isis an exclusive license to Vervas intellectual property rights targeting the Fibroblast Growth Factor Receptor with antisense technology for the treatment of diseases including obesity and other metabolic disorders. More...
Stem cell therapy market picking up as 4 new firms look to expand
(C.H. Unnikrishnan , 24-Aug-2009 , livemint)
The recent government decision to allow patenting of micro organisms and its processes and increased awareness about cord blood cell banking are giving a boost to the new therapy. More...
The R&D debacle
(Ram Prasad Sahu / Mumbai , 24-Aug-2009 , Business Standard)
One of the four is the anti malarial drug Malarone on which the company is facing a patent infringement suit by Smithkline Beecham. More...
India Infoline maintains Reduce rating on Sun Pharma
(ET Bureau , 24-Aug-2009 , The Economic Times)
The company received US FDA approval for Eloxatin only to be suspended soon after on account of continuing patent litigation. More...
Dump the Mashelkar report
(Business Standard / New Delhi , 24-Aug-2009 , Business Standard)
Even as the government accepts the revised report of the technical expert group on patent law issues headed by RA Mashelkar a key conclusion of the group has run into fresh controversy over the reasoning on which it is based. More...
North Indian pharma Focusing on R&D and tie ups to meet challenging conditions
(Sanjay Pingle, Mumbai , 24-Aug-2009 , Pharmabiz)
It has set up five R&D centers and got 24 product patents valid in more than 60 countries worldwide. More...
We must look to avoid grant of frivolous patents at all costs
(Priyanka Golikeri , 22-Aug-2009 , DNA)
With the government accepting the Mashelkar Committee Report on pharmaceutical patents the stage is now set for a new battle over patents and public health. More...
Hetero bags deal for 10 m Tamiflu
(Khomba Singh , 22-Aug-2009 , The Economic Times)
Roches application seeking patent for Tamiflu in India was rejected in March allowing Indian companies to market the generic versions in India and other countries where Roche does not hold the patent. More...
Govt plans retail clamp on Ciplas Tamiflu substitute
(Joe C Mathew & Pb Jayakumar / New Delhi , 22-Aug-2009 , Business Standard)
Relenza a pre 1995 molecule lacks patent protection in India and legally Cipla can manufacture and sell the drug. More...
Drug makers face penalty for overcharging
(Sushmi Dey , 21-Aug-2009 , The Economic Times)
Drug manufacturing companies such as Cipla Ranbaxy Johnson & Johnson and Dr Reddys Laboratories may have to pay over Rs 2038 crore to the government for overcharging consumers on price controlled medicines. More...
Merck wins Singulair patent infringement suit against Teva
(Whitehouse Station, New Jersey , 21-Aug-2009 , Pharmabiz)
Merck & Co Inc announced that the US District Court for the District of New Jersey has ruled in Mercks favour in a patent infringement suit against Teva Pharmaceuticals USA Inc. More...
Mashelkar report runs into fresh controversy
(Joe C Mathew / New Delhi , 21-Aug-2009 , Business Standard)
Patent expert says his views were misinterpreted to support conclusion that Indias patent laws could not be tightened. More...
Bayer beaten in Indian court over patent law
(By Kevin Grogan , 20-Aug-2009 , Pharma Times)
Bayer has suffered a setback after a court in India dismissed the German firms attempt to prevent the countrys regulator from approving a generic version of its kidney and liver cancer drug Nexavar that is being prepared by Cipla. More...
Sun Pharma wins Gemzar patent case
(NewsWire18 , 20-Aug-2009 , livemint)
The US district court for the eastern district of Michigan delivered a partial summary judgement on Monday invalidating Eli Lillys patent for method of use for Gemzar. More...
Sun wins US court ruling in Eli Lilly patent challenge
(BS Reporter / New Delhi , 20-Aug-2009 , Business Standard)
Clears way for low cost cancer drug launch in 2010. More...
Incremental innovations
(ET Bureau , 20-Aug-2009 , The Economic Times)
It is hard to quibble with the Mashelkar Committees report on patenting of pharmaceutical substances for its main theme that it is wrong to deny patents to incremental innovations if they have significantly better safety and efficacy standards over the known molecule. More...
M&M wins disputed internet site case at WIPO
(Press Trust Of India / New Delhi , 20-Aug-2009 , Business Standard)
Mahindra & Mahindra has won a cybersquatting case at the World Intellectual Property Organisation against a US based person who was using the name Mahindra in an internet domain. More...
Big Pharma must mend its ways to succeed in India
(Pillman , 20-Aug-2009 , DNA)
Close on the heels of the Intellectual Property Appellate Board halting Novartis Glivec patent application and linking it to threatening public disorder on account of its high prices, the Delhi High Court has dealt a body blow to German drug maker Bayers ambitions to monopolise the Indian market with its kidney cancer drug Nexavar. More...
Bayers attempt to stop Cipla drug sale fails
(BS Reporter / New Delhi , 19-Aug-2009 , Business Standard)
Court rejects bid to introduce a linkage between regulatory approval of a medicine and its patent status More...
Glenmark faces patent infringement case in US
(Press Trust Of India / Mumbai , 19-Aug-2009 , Business Standard)
Drug maker Glenmark Pharmaceuticals today said it was facing a lawsuit in a US District Court for a patent infringement case of an anti malaria product. More...
Govt in talks with Roche for cheaper Tamiflu
(Soma Das , 19-Aug-2009 , The Financial Express)
Last month Roche the patent holder of Tamiflu not in India started a new initiative to supply the anti viral drug to select developing countries at a reduced cost of $2.80 and $8.50 in consultation with the WHO. More...
Courts being used to stifle generic challengers
(Joe C Mathew / New Delhi , 19-Aug-2009 , Business Standard)
Patent fights are becoming more difficult for domestic pharmaceutical companies as multinational drug giants which obtain patent protection for medicines that are vulnerable to post grant oppositions are increasingly approaching Indian courts to stall competition from low cost local manufacturers. More...
Microsofts Patent Dust Ups
(Aaron Ricadela , 19-Aug-2009 , Business Week)
For the past half dozen years Microsoft has been busily getting its patent house in order. More...
Daiichi Sankyo Lupin in talks for marketing tie up
(Radhieka Pandeya , 19-Aug-2009 , livemint)
Today MNCs are looking at how they can create opportunities after patent expiry and joining hands with generic companies. More...
Lilly shares fall after court invalidates patent
(by Toni Clarke , 18-Aug-2009 , Reutres)
Shares of Eli Lilly & Co fell 1.4 percent in premarket trading on Tuesday after a court invalidated a key patent governing its cancer drug Gemzar. More...
Major win for Indian pharma cos as HC dismisses Bayer petition
(ET Bureau , 18-Aug-2009 , The Economic Times)
In a major win for Indian pharmaceutical companies the Delhi High Court on Tuesday dismissed German drug major Bayer Healthcares attempt to stop Drug Controller General of India from giving marketing approval to Indian company Cipla for the generic version of Bayers patented kidney cancer drug Nexavar. More...
We have filed a world patent for a new energy saving technology
(Business Standard / New Delhi , 18-Aug-2009 , Business Standard)
Deepak Pahwa Managing Director of Pahwa Enterprises Indias largest private sector SME in the HVAC&R heating ventilation air conditioning and refrigeration industry tells Business Standard that some of his key customers are pharma units and since dehumidification machines are at the heart of pharma units his company was unaffected by the downturn. More...
Govt accepts panel report against narrowing of Indian patent law
(BS Reporter / New Delhi , 18-Aug-2009 , Business Standard)
The central government has accepted the recommendations of an expert committee headed by former Council of Scientific and Industrial Research chief R A Mashelkar on patent laws. More...
Govt wont tweak drug patent rules
(Khomba Singh & Sushmi Dey , 18-Aug-2009 , The Economic Times)
The commerce ministrys decision to accept the Mashelkar committees revised report that recommends not to restrict patenting to new drugs has come in for strong criticism from health activists and some generic drugmakers even as patent experts supported the move thats in line with international norms. More...
Indian generics profit from Glaxo patent expiry
(P B Jayakumar / Mumbai , 18-Aug-2009 , Business Standard)
GlaxoSmithKline Plcs anti migraine drug brand Imitrex is turning out to be a good revenue earner for Indian generic companies as the US Food and Drug Administration has given almost half of the final approvals for the reverse engineered or generic versions of the drug made by Indian pharmaceutical companies following its patent expiry. More...
Patently right
(The Indian Express ,Mashelkar report , 17-Aug-2009 , Indian Express)
Should patents be granted to incremental changes on existing drugs not just to completely new medical and chemical entities Yes said the government appointed Mashelkar Committee report and yes says the Centre by accepting the reports findings. More...
Maker of fake drugs has fled to Hong Kong
(S Balakrishnan , 17-Aug-2009 , The Times Of India)
Chairman and MD of Phikon Biotech Pvt Ltd D J Vaidya who is allegedly involved in the manufacture of fake drugs for heart ailments and cancer has fled to Hong Kong. More...
Big pharma companies join outsourcing queue
(PB Jayakumar / Mumbai , 17-Aug-2009 , Business Standard)
Diminishing numbers of new drugs as against existing drugs going off patent high research and development costs and pressure to reduce healthcare costs are forcing Big Pharma to rope in strategic partners to contain manufacturing and drug development expenses. More...
Pharma patents Mashelkar report gets Centre approval
(Amitabh Sinha , 16-Aug-2009 , Indian Express)
Mashelkar as head of a Technical Expert Group that had four other members had been asked by the government in 2005 to examine whether the grant of patents for pharmaceutical substances could be limited only to new chemical entities and new medical entities involving one or more inventive steps or they could be granted to incremental innovations on existing drugs as well. More...
Novartis reportedly sues GlaxoSmithKline over patent
(By Polya Lesova , 16-Aug-2009 , MarketWatch)
Swiss drugmaker Novartis AG has filed a legal action against rival GlaxoSmithKline over a vaccine patent according to a media report Sunday. More...
Remedy for a malady
(By Andrew Jack , 14-Aug-2009 , Financial Times)
He cites as symptomatic the large scale takeovers this year of Wyeth by Pfizer and Schering Plough by Merck which he argues were primarily designed to defer patent expiries and cut costs rather than provide a solution to falling research productivity. More...
Allow retail sale of drug say domestic pharma players
(P B Jayakumar & Joe C Mathew / Mumbai & New Delhi , 14-Aug-2009 , Business Standard)
The central governments decision to continue controlling supply of the swine flu drug oseltamivir will help the drug innovator Swiss multinational Hoffmann La Roche and its Indian licencee Hetero Drugs maintain their effective monopoly in the country even as the drug lacks patent protection in India fear domestic industry circles. More...
Macro gain for ASEAN micro pain for India
(G. Srinivasan , 14-Aug-2009 , Business Line)
Effectively this implies that India has less than 50 60 items in its negative list for each ASEAN country a patent asymmetric pact from negotiation angle leaving legions of domestic industries vulnerable to dumping and material injury. More...
Sun Pharmas US arm reliant on generic launches
(Manas Chakravarty and Mobis Philipose , 13-Aug-2009 , livemint)
In the previous year two such Para IV filings for abbreviated new drug applications which challenge an existing patent in order to launch a slightly different generic version of the same product with one off revenue potential accounting for 57% of revenues. More...
Orchid settles Schering lawsuit
(Our Bureau , 13-Aug-2009 , Business Line)
Orchid Chemicals and Pharmaceuticals has reached an out of court settlement with the US based Schering Plough Corporation on a 2006 patent lawsuit regarding allergy medicines Clarinex and Clarinex Reditabs. More...
IDMA urges law makers to initiate measures to save Indian generic drugs
(Ramesh Shankar, Mumbai , 13-Aug-2009 , Pharmabiz)
The products had no Patent or Trade Mark problem either in India origin country or the destination country. More...
Stricter law on fake drugs now in force
(Radhieka Pandeya , 13-Aug-2009 , livemint)
India finally has a law to combat the menace of fake and adulterated drugs and not all pharma companies are happy with it. More...
Information on Swine Flu - I
(12-Aug-2009)
Government Authorized Hospitals For Treatment Of Swine Flu
Courtesy: Mr. Amit Didwania, Drishya Holidays Pvt. Ltd. More...
Information on Swine Flu - II
(12-Aug-2009)
Important Information on Swine Flu H1N1.
Courtesy: Mr. Amit Didwania, Drishya Holidays Pvt. Ltd. More...
Swine Flu H1N1- Prevention & Treatment
(12-Aug-2009)
There is no vaccine available right now to protect against novel H1N1 virus. However, a novel H1N1 vaccine is currently in production and may be ready for the public in the fall. As always, a vaccine will be available to protect against seasonal influenza. There are everyday actions that can help prevent the spread of germs that cause respiratory illnesses like influenza.
Courtesy: Jimmy George More...
India emerging global pharma outsourcing hub Study
(Our Bureau , 12-Aug-2009 , Business Line)
Of the total global outsourcing custom manufacturing phase IIb to the off patent stage including intermediates API and formulations contributes almost 65 per cent of the $51 billion market in 2008. More...
Sun Pharma gets US nod for two generic drugs
(REUTERS , 12-Aug-2009 , The Economic Times)
Sun Pharmaceutical Industries has got the US Food and Drug Administrations approval to launch its generic version of GlaxoSmithKlines Imitrex tablets to treat migraine the Indian drugmaker said. More...
Ranbaxy gets USFDA nod for Sumatriptan Succinate Tablets
(Agencies , 11-Aug-2009 , The Financial Express)
The office of generic drugs USFDA has determined that the Ranbaxy formulations to be bio equivalence and have same therapeutic effect as that of GlaxoSmithKlines patented drug Imitrex Ranbaxy said. More...
China admits its companies involvement in fake drugs case
(PTI , 11-Aug-2009 , The Economic Times)
China has admitted that its pharmaceutical companies were involved in shipping fake drugs labeled Made In India to Nigeria. More...
Novartis hits Astellas with transplant drug generic
(Yumiko Nishitani , 11-Aug-2009 , Reutres)
Astellas lost U.S. patent protection for Prograf in April 2008 but until now has not faced any generic competition. More...
Strides Arcolab ready to supply Swine Flu drug
(PTI , 11-Aug-2009 , The Economic Times)
Oseltamivir Capsules are the generic version of Roches patented drug Tamiflu. More...
Schering settles final Clarinex patent litigation
(LOS ANGELES , 11-Aug-2009 , Reutres)
Drugmaker Schering Plough Corp SGP.N said on Tuesday it settled patent litigation with Orchid Chemicals & Pharmaceuticals Ltd related to generic versions of its allergy medication Clarinex. More...
Swiss firm moves apex court against Cipla
(C.H. Unnikrishnan , 11-Aug-2009 , livemint)
Swiss drug maker F. Hoffmann La Roche Ltd has petitioned the Supreme Court against a Delhi high court order in a patent violation lawsuit regarding its cancer drug Tarceva with Indian pharma firm Cipla Ltd. More...
immatics gets European patent for IMA901 product & US patent for MUC 1 peptide
(Martinsried, Munich , 11-Aug-2009 , Pharmabiz)
immatics biotechnologies GmbH has obtained European patent protection for the composition of matter for its drug candidate IMA901. More...
HC returns appeal on dual SIM card case
(C.H. Unnikrishnan , 11-Aug-2009 , livemint)
The Madras high court on Friday returned an appeal filed by Madurai Tamil Nadu based electronics engineer S. Ramkumar to the Customs Appellate Tribunal in a case related to his patent on dual SIM card mobile phones. More...
India warned on moving WTO over drug seizures
(Joe C Mathew / New Delhi , 11-Aug-2009 , Business Standard)
Even as India considers the European Union directive that allows seizure of goods in transit by its member countries as violative of the World Trade Organizations TRIPS trade related aspects of intellectual property rights agreement legal experts caution against the central governments plans to approach the dispute settlement body of WTO. More...
Azad says wont wait for desi swine flu vaccine will import
(Kounteya Sinha , 11-Aug-2009 , The Times Of India)
At present only one US based company Biosystem has the patent of the real time PCR kits for detection of H1N1 being used globally. More...
US Patent and Trademark Office Issues Key Patent For OncoGenexs OGX 011
(By Staff Reporter , 10-Aug-2009 , Pharmaceutical Business Review)
US Patent and Trademark Office has issued US Patent Number 7569551 entitled Chemo and Radiation sensitization of Cancer by Antisense TRPM 2 Oligodeoxynucleotides on the method of using OncoGenexs OGX 011 to treat certain cancers. More...
Indian companies may pitch in with generic version of Tamiflu
(Khomba Singh & Sushmi Dey , 10-Aug-2009 , The Economic Times)
Cipla and other Indian pharma majors can now legally manufacture generic versions of Tamiflu after the patent office in Delhi last month rejected a patent application by Swiss company Roche which markets the antiviral in India. More...
GI tags sought for veena lock
(Our Correspondent , 10-Aug-2009 , Business Line)
The Tamil Nadu State Council has taken steps to get Geographical Indication Tags of Thanjavur Veena and Dindigul Lock establishing their place of origin. More...
Human clinical trials for stem cell research on cards
(Vishal Dutta , 10-Aug-2009 , The Economic Times)
StemCyte has patented the plasma depletion technology that helps in collecting higher volume of stem cells and better cell counts resulting in successful therapeutic applications for over 70 diseases. More...
Low costs a draw for foreign drug makers
(C.H. Unnikrishnan , 09-Aug-2009 , livemint)
Low costs high technical capabilities and a skilled work force are making India an attractive destination for research and contract manufacturing of drugs. More...
Old medicine new patents
(Gaurav Choudhury , 08-Aug-2009 , Hindustan Times)
Slowly but surely India Inc is waking up to the virtues of traditional wisdom. More...
HC bans MNS Pharma from lipid control drug sale
(Khomba Singh , 8-Aug-2009 , The Economic Times)
Rosuva is a registered trademark of Ranbaxy. More...
Oppn to officials taking up plum posts in WTO WIPO
(Joe C Mathew / New Delhi , 8-Aug-2009 , Business Standard)
Civil society groups have complained against the practice of senior commerce ministry officials taking up plum posts with international agencies such as the World Trade Organization and World Intellectual Property Organisation with whom they have been involved in direct negotiations on issues of national interest. More...
Top Article Log On To The Power Of Ideas
(R A Mashelkar , 8-Aug-2009 , The Times Of India)
Due to the limitations in Indias patent laws the phytopharmaceutical breakthrough medicine on psoriasis by an Indian company will be commercialised first in the West not in India. More...
US court to hear Glenmarks patent dispute on Aug 19
(ET Bureau , 7-Aug-2009 , The Economic Times)
Glenmark Pharmaceuticals patent challenge against Schering Ploughs cholesterol lowering drug Zetia will come up for hearing in the US district court of New Jersey on August 19. More...
Pfizer agrees to cut price of TB drug
(By Andrew Jack in London , 7-Aug-2009 , Financial Times)
Mylan will reduce the price of four HIV drugs that are off patent atazanavir ritonavir tenofovir and lamivudine to $475 a year falling to $425 a year from 2010 which is 28 per cent less than current prices. More...
GSK to up output of inhaler drug
(Nina Mehta , 7-Aug-2009 , The Economic Times)
GSK and Biota which invented the drug and holds the patent till the end of 2014 are not the only ones who have been approached to supply the drug. More...
Roche will only help itself by making drugs affordable
(Pillman , 7-Aug-2009 , DNA)
In a recent judgment by the Intellectual Property Appellate Board on Novartis Glivec the need to make the drug affordable was emphasised. More...
BR Films pays up Rs1 crore in copycat case
(Anshika Misra, Mumbai , 6-Aug-2009 , DNA)
Bollywood will now think twice before getting inspired by Hollywood again. BR Films,which was dragged to court by Twentieth Century Fox for alleged plagiarism, on Wednesday agreed to pay a settlement amount of $200,000 (a little less than Rs1 crore)to the American studio. More...
Ailing drugmakers may seek foreign cure
(By Pratish Narayanan , 6-Aug-2009 , Reutres)
Global heavyweight Pfizer is seen as the most likely suitor of Indian rivals as it looks to replace revenue lost from the lapse of key patents while Merck and Sanofi Aventis may also seek to shake hands with Indian producers analysts said. More...
Lupin to launch more branded generics in US
(Khomba Singh , 6-Aug-2009 , The Economic Times)
Branded generics are rip off versions of off patent drugs but since they incorporate added advantages such as lower dosages the US drug regulator allows them to be sold under a brand. More...
India may get its first novel drug by 2014
(Priyanka Golikeri , 6-Aug-2009 , DNA)
From the last few years almost every Indian company worth its name is talking of having novel molecules new chemicals entities and a few new biological entities in its kitty. More...
US exclusivity law may hit Indian biotech cos
(Nina Mehta , 6-Aug-2009 , The Economic Times)
These companies will have to choose their products carefully and focus on those products which are already off patent or scheduled to go off patent soon said Sanjay Singh associate director KPMG. More...
Nigerian drug regulator to open Indian offices
(ET Bureau , 05-Aug-2009 , The Economic Times)
Reacting to the seizure of fake Chinese drugs carrying a made in India tag the Nigerian drug regulator has decided to set up its offices in India. More...
A singular victory for open innovation
(Latha Jishnu / New Delhi , 5-Aug-2009 , Business Standard)
At the conference sponsored by the World Intellectual Property Organisation on July 13 and 14 he would launch his Initiative for Open Innovation globally to promote transparency in the patent system a disruptive democratising cyber infrastructure to make it possible to turn the patent system into a transparent fixable part of society as he called it in his letter. More...
MNCs eye Indian pharma
(ET Bureau , 5-Aug-2009 , The Economic Times)
Till a few years ago it was believed Indian pharma companies highly profitable generic business model they were able to corner a large share of market for drugs going off patent and occasionally challenged patents through Para IV filings in the US would allow them to build financial muscle. More...
Interpol scans fake drugs with Made in India label
(PTI,New Delhi , 04-Aug-2009 , livemint)
Recently fake drugs carrying the Made in India label were seized in Nigeria but were allegedly manufactured in China. More...
India may move WTO to protest drug seizures
(Joe C Mathew / New Delhi , 4-Aug-2009 , Business Standard)
The government is planning to approach the dispute settlement body of the World Trade Organization against frequent seizure of Indian medicines at various European ports. More...
Roche prepares to defend local patent for Valcyte
(C.H. Unnikrishnan , 04-Aug-2009 , livemint)
Firm facing at least five post grant oppositions at Chennai patent office it has cut price of the drug by 35% More...
Combating spurious drugs
(Pharmaceutical , 4-Aug-2009 , Business Line)
The whistle blower scheme outlined by the Union Health Minister is a workable idea but only a consistent multi level approach can snuff out spurious drug makers. More...
India grants 3500 pharma patents in three yrs
(Press Trust of India / New Delhi , 03-Aug-2009 , Business Standard)
The Indian Patent Office has granted 3506 patents relating to pharmaceutical innovations over the last three years the government said today. More...
A patent case for invention
(P. V. INDIRESAN , 3-Aug-2009 , Business Line)
India needs improved patent laws that will protect genuine inventors better and minimise disputes on trivial grounds. More...
Daiichi wins court battle against Mylan Matrix
(Press Trust of India / Tokyo/ New Delhi , 03-Aug-2009 , Business Standard)
Japanese drug major Daiichi Sankyo said today a US Court has ruled in its favour in a patent litigation related to the anti hypertensive drug Benicar against Mylan Inc and its Indian subsidiary Matrix Laboratories. More...
India set to sign pharma export deal with Nigeria
(Sushmi Dey & Gireesh Chandra Prasad , 3-Aug-2009 , The Economic Times)
The government is set to sign an exhaustive deal with Nigeria to boost pharmaceutical exports to its eighth largest global consumer where the reputation of Indian drugs was recently dented by fake drugs from China bearing Made in India labels. More...
Indias Sun Pharma MedImmune settle on ethyol
(by Bharghavi Nagaraju , 3-Aug-2009 , Reutres)
Indias Sun Pharmaceutical Industries Ltd said on Monday it has settled a patent dispute with AstraZenecas MedImmune unit for generic version of Ethyol resolving all litigation between them. More...
Copycat Indian drug cos turn MNC partners
(Khomba Singh , 3-Aug-2009 , The Economic Times)
This seems to be the strategy of multinational pharmaceutical companies vis a vis the highly Top 10 Drugmakers by sales successful Indian drug industry that makes a living out of copying off patent blockbuster drugs. More...
The French connection
(BV Mahalakshmi, Sudhir Chowdhary , 3-Aug-2009 , The Financial Express)
The fact that Shantha Biotech was able to attract Sanofi with its intellectual property and good manufacturing facilities is a sign of the maturity of the Indian vaccine industry. More...
$70 bn worth drugs to go off patent benefiting India Report
(PTI , 02-Aug-2009 , The Economic Times)
The Indian drug industry would make huge gains as over $70 billion worth of drugs are expected to go off patent in the US the worlds largest pharma market in the next three years according to a report. More...
Takeda swings back to profit keeps forecast
(By Yumiko Nishitani , 31-Jul-2009 , Reutres)
Takeda launched Kapidex ahead of the patent expiration in November for its predecessor drug Prevacid in the United States but analysts expect competition to keep Kapidex from compensating fully for a likely drop in Prevacid sales. More...
SemBioSys shares soar after insulin patent granted
(by Nina Lex , 30-Jul-2009 , Reutres)
Shares of SemBioSys Genetics Inc soared as much as 74 percent on Thursday morning after the company announced it had been granted a U.S. patent for commercial production of insulin by using oil from the seeds of safflower plants. More...
India Patent Rights and Wrongs
(By ROGER BATE , 29-Jul-2009 , The Wall Street Journal)
India promised to protect intellectual property when it signed up to the World Trade Organizations rules in 2005. More...
Sanofi profits soar prepared for Plavix Taxotere patent losses
(By Kevin Grogan , 29-Jul-2009 , Pharma Times)
Sanofi Aventis has posted a strong set of figures for the second quarter this morning and says it has laid the groundwork to cope with patent expiries. More...
Right and wrong medicines
(Business Standard / New Delhi , 29-Jul-2009 , Business Standard)
One recent step has been to hire more inspectors another to float the idea of a quality mark for generic medicines which have no patent cover. More...
GITAM varsity plans IPR cell
(Our Bureau , 28-Jul-2009 , Business Line)
The GITAM Institute of International Business is setting up an intellectual property rights IPR cell with the assistance of the National Research and Development Corporation according to Prof V.K Kumar the Director. More...
Drug sector fears bias in Tamiflu sourcing
(P.T.Jyothi Datta , 28-Jul-2009 , Business Line)
India did not grant a patent to innovator Gilead on Oseltamivir. More...
Lunch with BS Malvinder Mohan Singh
(Bhupesh Bhandari / New Delhi , 28-Jul-2009 , Business Standard)
What made you sell I ask Malavs friends say the patent litigations switched him off pharmaceuticals such litigation can be expensive and nerve wracking. More...
IT firms speed up patent filing
(Vishwanath Kulkarni,Shamik Paul , 28-Jul-2009 , Business Line)
Stepping up efforts to commercialise their intellectual property IP Indian IT services firms have accelerated their patent filing process. More...
An incubator that takes care of everything
(Deepti Chaudhary , 27-Jul-2009 , livemint)
In India i2india has signed patent agreements with institutions such as Indian Institutes of Technology and Indian Institute of Science. More...
Sanofi Aventis to acquire Indian vaccine company
(PARIS , 27-Jul-2009 , Business Week)
It aims to refill a development pipeline that analysts see as woefully light on new drugs to replace those that will soon go off patent and face competition from cheaper copies. More...
Global drug cos set sights on Indias veterinary market
(Nina Mehta , 27-Jul-2009 , The Economic Times)
Animal healthcare in India is no longer an afterthought as global pharmaceutical companies facing loss in revenues due to expiring drug patents are looking for new growth markets. More...
Anna University IPR centre files 53 patents
(D Suresh Kumar , 27-Jul-2009 , The Times Of India)
Inventors and innovators including college students who are keen on getting their work patented no longer need to spend time and money undertaking a taxing documentation process or familiarising themselves with legal jargons. More...
How pharma companies can be better long term bets
(Kiran Kabtta Somvanshi and Santanu Mishra , 27-Jul-2009 , The Economic Times)
Over dependence on cost competitiveness however comes with its own set of risks increased scrutiny and clamps from drug regulators legal risks in challenging patented drugs and rising pricing pressure as regulated markets overhaul their healthcare systems. More...
Quality stamp for drugs in works
(Sushmi Dey , 27-Jul-2009 , The Economic Times)
A generic drug is not protected by patents and can be manufactured without paying royalty. More...
Ranbaxy net jumps 30 fold to Rs 693 cr
(ET Bureau , 25-Jul-2009 , The Economic Times)
FTFs are the main growth drivers for most leading Indian companies that make generic versions of expensive drugs that have gone off patent. More...
Teva J&J settle oral contraceptive patent case
(By Lewis Krauskopf , 24-Jul-2009 , Reutres)
Teva Pharmaceutical Industries Ltd said on Friday it settled a patent infringement lawsuit with Johnson & Johnson over Tevas U.S. generic version of J&Js Ortho Tri Cyclen Lo birth control pill. More...
Non market strategies making a comeback in West
(Dibeyendu Ganguly , 24-Jul-2009 , The Economic Times)
A blood cancer drug called Glivec has been a money spinner for Novartis all over the world except in India where the patent authorities have turned down the Swiss companys application for a product patent on the grounds that it does not offer sufficient improved efficacy over its predecessor. More...
Give info on counterfeit drugs get rewarded
(Kounteya Sinha , 23-Jul-2009 , The Times Of India)
Informing the government about spurious drugs could soon earn you big money. More...
Moser Baer Philips settle patent dispute
(BS Reporter / New Delhi , 23-Jul-2009 , Business Standard)
Global technology company Moser Baer has settled a patent and licence dispute with global electronics giant Philips. More...
Costly drugs prompt exclusivity debate
(Andrew Pollack , 23-Jul-2009 , livemint)
For starters whatever the exclusivity period biologic drugs would also continue to be protected from copycats by patents. More...
Sun Pharma arm faces class action suit in US
(Khomba Singh and Nina Mehta , 23-Jul-2009 , The Economic Times)
Caraco Pharmaceuticals the US arm of Sun Pharma has been slapped with a class action suit in the United States for allegedly Top 10 Drugmakers by sale not disclosing adequate information about US regulatory action that hurt its shares rendering Indias most valuable drugmaker vulnerable to the prospect of hefty payouts as damages. More...
Barking up the wrong tree
(By René B. Azurin , 23-Jul-2009 , BusinessWorld)
For the pharmaceutical companies that own patents to various drugs this meant that they are deemed to have no further legal claims insofar as the resale of their products is concerned. More...
DSM in talks to supply Lipitor ingredient
(Khomba Singh , 23-Jul-2009 , The Economic Times)
Pfizers patent for Lipitor in the US expires in 2011. More...
Cadila loses Mexate trademark case
(BS Reporter / Mumbai/ Ahmedabad , 21-Jul-2009 , Business Standard)
Ahmedabad based Cadila Healthcare Ltd has lost the case in a civil suit which it had filed for its brand Mexate against Wallace Pharmaceuticals Pvt Ltd. More...
Incidence high in countries where access to medicines is poor
(Tapan Ray , 21-Jul-2009 , The Economic Times)
Incidents like recent detention in transit of DRL shipment of the generic version of Losartan in the Netherlands or a consignment of Amoxicillin at the Frankfurt airport on the ground of patent infringement cannot be considered as attempts of MNCs to brand Indian generic drugs as counterfeit medicines. More...
18230 patents granted in 2008 09
(Press Trust of India / New Delhi , 21-Jul-2009 , Business Standard)
The Indian Patent Office has granted 18230 new patents in 2008 09 Lok Sabha was informed today. More...
Its an MNC agenda to prevent competition
(Anand Grover , 21-Jul-2009 , The Economic Times)
The recent anti counterfeiting measures worldwide seizures of generic drugs in Holland the proposals in the WHO the moves in the East African Anand Grover Director Lawyers Collective HIV AIDS Unit region and in the Andean community to criminalise patent infringements etc. More...
A Trips plus agenda at WIPO
(D Ravi Kanth , 21-Jul-2009 , Business Standard)
Those who cannot remember the past are condemned to repeat it is a timely reminder for key actors who are bent on pushing failed agendas. More...
Earnings Preview: Pfizer preps for Wyeth deal
(By LINDA A. JOHNSON , 20-Jul-2009 , Forbes)
It also broadened its partnership with an Indian generic drugmaker and started a new one with an Indian maker of injected medicines part of an effort to boost sales of off patent drugs and of products in developing countries. More...
Dual SIM dispute highlights flaws in Indias patent process
(C.H. Unnikrishnan , 20-Jul-2009 , livemint)
Patent experts expressed surprise that Ipab passed an interim order instead of deciding the patents validity More...
Novartis to challenge IPABs patent decision on Glivec
(Nina Mehta , 20-Jul-2009 , The Economic Times)
The Indian subsidiary of Swiss drugmaker Novartis will challenge a decision by the Intellectual Property Appellate Board IPAB that said its cancer drug Glivec was not patentable. More...
Novartis set to appeal move on Glivec
(Our Bureau , 18-Jul-2009 , Business Line)
Novartis looks set to appeal the recent decision by the Intellectual Property Appellate Board IPAB against its cancer drug Glivec. More...
IT firms push for IPR multiple standards for e gov projects
(Vivek Seal , 18-Jul-2009 , DNA)
There are a couple of points in the policy that I think needs further debate one is single standard versus multiple standard and the role of intellectual property rights IPR. More...
Govt orders recall as Natco cancer drug fails toxin test
(Sushmi Dey , 18-Jul-2009 , The Economic Times)
Natco has filed pre grant opposition on the patents in India which are yet to be granted. More...
Pvt equity venture capital cos turning to healthcare Report
(Our Bureau , 17-Jul-2009 , Business Line)
Another issue is the high risk of failure especially in new drug discovery competition from within and outside India as well as patent related issues. More...
Patents will only benefit patients claim drug cos
(Priyanka Golikeri , 17-Jul-2009 , DNA)
As the issue of patent protection assumes centrestage not only in India but also in the countrys free trade agreements with different countries multinationals are dredging up a number of reasons to support their demand for patent protection. More...
Roche set to move SC against high court ruling on Tarceva
(C.H. Unnikrishnan , 16-Jul-2009 , livemint)
Roche had appealed against a ruling that allowed Cipla to continue selling a generic version of the cancer drug Tarceva despite having a patent of it in India. More...
Madras HC stays appellate board order on dual SIM patent
(Niranjana Ramesh , 16-Jul-2009 , The Economic Times)
The Madras High Court on Wednesday set aside an interim order passed by the Intellectual Property Appellate Board suspending the patent held by Madurai based engineer Somasundaram Ramkumar for the technology that enables usage of more than one SIM card in mobile handsets popularly called a dual SIM. More...
IPL teams to now bat for trademark rights
(Monica Behura , 16-Jul-2009 , The Economic Times)
All eight franchises of the Indian Premier League including Shahrukh Khans Knight Riders Deccan Chargers and Delhi Daredevils have filed applications before government authorities in 12 13 cricket playing countries seeking exclusive trademark rights for their names. More...
US amendment may leave Indian biopharma cos shaken & stirred
(Nina Mehta , 16-Jul-2009 , The Economic Times)
Once a patent is filed it takes a company almost 10 years to develop the product and reach the market. More...
Indian pharma firms swallow bitter pill in US Europe
(PB Jayakumar / Mumbai , 16-Jul-2009 , Business Standard)
Regulators tighten net on safety grounds More...
Bisleri Coke may smoke peace pipe
(Monica Behura , 16-Jul-2009 , The Economic Times)
Last year the Delhi High Court was prima facie of the view that Coca Cola was the owner of the Maaza trademark in India. More...
R&D gets a boost
(ET Bureau , 15-Jul-2009 , The Economic Times)
In tandem whats required is to promptly update the norms on royalty payment for use of trademark or brand and fees for technology transfer. More...
Retailer Knockoffs Abound in India
(By HEATHER TIMMONS , 15-Jul-2009 , The New York Times)
The United States has long tussled over intellectual property rights with China where counterfeiters crank out knockoffs of designer bags and iPhones and manufacturers have even made entire vehicles that look just like foreign cars. More...
Kenya gives clean chit to imported drugs from India
(Sushmi Dey , 14-Jul-2009 , The Economic Times)
The legislation recognises intellectual property rights registered in any country of the world and not necessarily in Kenya. More...
Sun Pharma A dose of good news
(Shobhana Subramanian / Mumbai , 14-Jul-2009 , Business Standard)
The US authorities still need to bless the settlement that Sun Pharma has entered into with Forest Laboratories Holdings over the patent litigation for Lexapro an anti depressant. More...
PE & VC firms bullish on Healthcare investments
(ET Bureau , 14-Jul-2009 , The Economic Times)
In the Life Sciences segment investors concerns are focused on the high risk of failure especially in new drug R&D stiff competition from inside and outside India as well as patent related issues. More...
Merck to revise labelling on cervical cancer vaccine
(P.T. Jyothi Datta , 14-Jul-2009 , Business Line)
Multinational drug major Merck Sharp & Dohme will revise the labelling on its cervical cancer vaccine Gardasil after it informs the Indian drug regulatory authority later this month. More...
Sun Pharma up on patent deal with Forest Labs
(BS Reporter / Mumbai , 14-Jul-2009 , Business Standard)
Sun Pharma rose 2.6 per cent to Rs 1149.75 after the company and its subsidiary Caraco Pharma entered into agreement with Forest Labs and H Lundbeck over Lexapro. More...
West uses Africa in war against generic drugs
(Priyanka Golikeri , 14-Jul-2009 , DNA)
Now the developed world is using this vulnerability and turning it into a campaign against legitimate generics by branding them counterfeits which has to do more with IPR and patent violations than quality. More...
India Inc finds stem cells a healthy business
(PB Jayakumar / Mumbai , 14-Jul-2009 , Business Standard)
The company already owns seven patents. More...
Sun Pharmaceutical Rises Most in Three Weeks on Suit Settlement
(By Rajhkumar K Shaaw , 13-Jul-2009 , Bloomberg)
Sun Pharmaceutical Industries Ltd. rose the most in three weeks after it reached an agreement with Forest Laboratories Inc. to drop a lawsuit challenging patents on the antidepressant Lexapro. More...
We have a conservative generic policy
(Nina Mehta , 13-Jul-2009 , The Economic Times)
We do make generic versions of our previously patented products. More...
Delhi HC rejects German pharma cos plea
(Legal,NEW DELHI , 13-Jul-2009 , Business Line)
The Delhi High Court has rejected the plea of German pharma company B Braun Melsungen AG claiming patent rights to an item sold by healthcare products manufacturer Eastern Medikit. More...
Team heads to Africa on quality mission
(Amiti Sen , 13-Jul-2009 , The Economic Times)
Africa accounts for over 15% of Indias total generic off patent drugs exports worth Rs 30000 crore annually. More...
Foreign copycats rattle Gujarat brands
(Vishal Dutta , 11-Jul-2009 , The Economic Times)
The US trademark office turned down the Patel familys request for registration. More...
Efficacy point in Glivec ruling impractical
(Pillman , 11-Jul-2009 , DNA)
The controversy over patent to Novartis magic bullet Glivec continues to deepen. More...
Ranbaxy plans to launch growth hormone drug
(Mohit Bhalla , 11-Jul-2009 , The Economic Times)
Ranbaxy Laboratories is planning a new growth hormone product to target the emerging global market for new versions of patent expired biotech drugs a person familiar with the development said. More...
Dark clouds loom on Big Pharma horizon
(By Sam Cage , 10-Jul-2009 , Reuters)
Consolidation was the major theme of early 2009 as some companies tried to escape the patent crunch by splashing the cash aiming for synergies to offset the depressed outlook for growth over the next few years. More...
Pfizer CEO Braces For Changes
(Arlene Weintraub , 10-Jul-2009 , Business Week)
Thats particularly a challenge in light of drugs going off patent. More...
STOCKS TO WATCH Infosys Matrix Labs Ranbaxy
(ET Bureau , 10-Jul-2009 , The Economic Times)
Matrix Laboratories has filed an application against Israeli drugmaker Teva Pharmaceuticals Industries challenging a process patent used to make Tevas blockbuster drug Copaxone. More...
Forest Lundbeck settle patent row over Lexapro
(by Lewis Krauskopf , 10-Jul-2009 , Reuters)
Forest Laboratories Inc and H Lundbeck AS have settled patent infringement litigation with two generic drugmakers on their blockbuster Lexapro anti depressant the companies said on Friday. More...
Ranbaxy recalls drug in US
(Khomba Singh , 10-Jul-2009 , The Economic Times)
Industry experts say consumer litigation are unlikely for such drug recalls. More...
Cipla gets notices for alleged overcharging
(Our Bureau , 10-Jul-2009 , Business Line)
The issue has been under litigation for over five years and the total alleged overcharging amount on Cipla at present is over Rs 1000 crore. More...
Matrix drags Israeli co Teva to court over patent issue
(Chandra Ranganathan & Sai Deepika Amirapu , 10-Jul-2009 , The Economic Times)
The dust hasnt settled yet on the Novartis case and another patent dispute has emerged in the pharma space. More...
Lupin 2 others face Europe anti trust probe
(Our Bureau , 10-Jul-2009 , Business Line)
The investigation is still at an early stage and the EC has said that the publication of its statement does not imply it has proof of an infringement of the competition rules Lupin told the media. More...
Europe Is Studying Delays in Access to Generic Drugs
(By JAMES KANTER , 09-Jul-2009 , The New York Times)
Commission officials said that generic versions of drugs often were unavailable for at least seven months after the patent on the original version expired a factor that drove costs up by at least 3 billion euros from 2000 to 2007 in 17 European Union countries. More...
3 Indian pharma cos face EU anti trust probe
(fe Bureau, Agencies , 09-Jul-2009 , The Financial Express)
In April 2007 Lupin had sold certain patent and intellectual property rights of perindopril to French firm Laboratories Servier for Rs 115.31 crore euro 20 million. More...
Drug firms come under EU lens over antitrust practices
(Foo Yun Chee / Reuters , 09-Jul-2009 , livemint)
The EU executive said it would examine current EU rules on price and reimbursement urged European countries to introduce legislation to facilitate the entry of generics and stress the need for a Europe wide patent. More...
Knotted patent litigations inflict medical devices mkt
(Soma Das , 9-Jul-2009 , The Financial Express)
The lucrative domestic medical devices industry estimated to touch $1.7 billion in 2010 and expected to grow at an annual growth rate of around 23% is getting mired in entangled patent litigation cases with companies dragging each other to courts. More...
Teva Servier Face EU Antitrust Probe for Drug Delays
(By Matthew Newman and Naomi Kresge , 9-Jul-2009 , Bloomberg)
The commission called for a community patent that would be valid in all of the EUs 27 member states. More...
Lupin Matrix face antitrust probe in EU
(BS Reporter / Mumbai , 9-Jul-2009 , Business Standard)
The Commission said it would continue to probe whether use of patents to delay generics violated antitrust rules as companies used a variety of techniques to delay introduction of generics. More...
EU raps Big Pharma Indian copycat kings boosted
(Priyanka Golikeri , 9-Jul-2009 , DNA)
Though it does not actually mention the term evergreening it details the primary patents and secondary patents which Big Pharma seek said an intellectual property expert based in New Delhi who is closely monitoring the report. More...
Nestle Takeda sue Lupin Torrent over patents
(PB Jayakumar / Mumbai , 9-Jul-2009 , Business Standard)
Cases aimed at stopping approval of new generics More...
Ranbaxy faces new legal trouble in US
(Radhieka Pandeya , 9-Jul-2009 , livemint)
Ranbaxy Laboratories Ltd whose share price has been roiled by its troubles with the US drug regulator suffered a further blow with Canadian generic or off patent drug maker Apotex Inc. questioning in court the companys ability to launch two generic drugs on schedule. More...
Dilemma on traditional knowledge
(Latha Jishnu / New Delhi , 8-Jul-2009 , Business Standard)
Last Friday the World Intellectual Property Organisation ended a five day meeting of the Inter governmental Committee on Intellectual Property and Genetic Resources Traditional Knowledge and Folklore without Indias participation. More...
Alnylam Joins GSK in Donating IP to Patent Pool
(CAMBRIDGE, MASS & LONDON , 08-Jul-2009 , ag-IP-news )
GlaxoSmithKline and Alnylam Pharmaceuticals Inc. announced on July 8 2009 that Alnylam will contribute more than 1500 issued or pending patents on its RNA interference technology patent estate to the patent pool established by GSK earlier this year according to Alnylam. More...
Alnylam Joins GSK In Patent Pool For Neglected Tropical Diseases
(By Staff Reporter , 8-Jul-2009 , Pharmaceutical Business Review)
Alnylam shall contribute more than 1500 issued or pending patents on its RNA interference technology patent estate to the patent pool established by GlaxoSmithKline. More...
Glivec patent ruling a welcome turn for Novartis
(Priyanka Golikeri & KV Ramana , 8-Jul-2009 , DNA)
The rejection of Novartis patent application for the beta crystalline version of cancer drug Glivec by the Intellectual Property Appellate Board on the ground that it is priced beyond the reach of the common man may have given the company new ground to challenge Indian patent rules. More...
Teva stops shipping generic birth control pill
(The Associated Press , 7-Jul-2009 , Business Week)
The worlds largest generic drug maker said it agreed to stop shipping the drug pending a preliminary injunction hearing in a patent infringement lawsuit from Johnson & Johnson. More...
DOJ Shifts Policy on Generic Drug Patent Settlements
(By BRENT KENDALL , 7-Jul-2009 , The Wall Street Journal)
The U.S. Department of Justice on Monday took a skeptical view on the legality of pharmaceutical patent settlements that delay the introduction of generic drugs the latest change in antitrust policy under the Obama administration. More...
Star Scientific seeks to overturn Reynolds verdict
(By Ian Sherr , 07-Jul-2009 , Reuters)
Tobacco company Star Scientific Inc is seeking reversal of a jury ruling that cleared a Reynolds American Inc unit of violating a Star patent for reducing cancer causing agents in tobacco. More...
U.S. court to rehear spat over patent office rules
(by Diane Bartz , 07-Jul-2009 , Reuters)
A U.S. appeals court has said it would rehear a fight between drugmaker GlaxoSmithKline Plc and the patent office over new rules aimed at cutting a backlog of patent applications. More...
Astellas wins OK for broader use of key drug in Japan
(by Yumiko Nishitani , 07-Jul-2009 , Reuters)
In the United States where Prograf lost patent protection in April last year Astellas expects competition from a generic rival in the financial year ending in March 2010. More...
Dor BioPharma Receives European Patent For Drug Delivery Technology
(By Staff Reporter , 8-Jul-2009 , Pharmaceutical Business Review)
Dor BioPharma has received a European patent for its Lipid Polymer Micelle technology for the improved oral delivery of drugs. More...
A Prescription for Saving Big Drugmakers
(By Mark Schneider , 6-Jul-2009 , Business Week)
But concerns over patent expirations of blockbuster drugs generic drug competition regulatory problems and a lack of promising new products are giving investors caution. More...
Takeda Sues Torrent to Stop Generic Copy of Actos Diabetes Pill
(By Susan Decker , 06-Jul-2009 , Bloomberg)
Takeda Pharmaceutical Co. sued Indias Torrent Pharmaceuticals Ltd. to prevent it from selling a copy of the Actos diabetes pill in the U.S. until 2016. More...
Precision BioSciences Issues Update Regarding Recent U.S. Patent Office Action Concerning Cellectis Patents
(RESEARCH TRIANGLE PARK, N.C (BUSINESS WIRE) , 06-Jul-2009 , Biocompare)
The United States Patent and Trademark Office is reexamining two currently issued U.S. patents owned by the Institut Pasteur and the Universite Pierre et Marie Curie and licensed to Cellectis SA. More...
Fake drugs reach Kenya now
(Amiti Sen , 6-Jul-2009 , The Economic Times)
Africa is an important market for Indian drug producers as it accounts for over 15% of Indias total generic off patent drugs exports worth Rs 30000 crore annually. More...
Novartis may challenge verdict denying patent for cancer drug
(C.H. Unnikrishnan , 6-Jul-2009 , livemint)
The Indian tribunal had cited non compatibility with domestic patent laws and unaffordable pricing as reasons More...
Emami plans to make 50 Ayurvedic drugs from Zandu stable
(Aveek Datta , 6-Jul-2009 , livemint)
The company had even tried to secure patent for some of its formulations but couldnt because of unfriendly patent offices Bhatt added. More...
Bitter Pill Novartis patent plea for cancer drug Gilvec rejected
(REUTERS , 05-Jul-2009 , The Economic Times)
Novartis Indias application to patent its cancer drug Glivec has been rejected by the Intellectual Property Appellate Board IPAB. More...
Ayurveda drug for cancer Experts
(Minati Singha , 03-Jul-2009 , The Times of India)
Lavekar said they have the credit of obtaining as many as 22 patents including one international patent right on drugs. More...
Biotechnology can be the next big driver for the pharma sector
(Pillman , 03-Jul-2009 , DNA)
The authors of the study noted The fact that a biotech product will assume Lipitors crown in 2012 after the cholesterol lowering drug phenomenon goes off patent is indicative of the increasing dominance of biotech products and specifically cancer antibodies. More...
Glenmark gets first to file status for 3 drugs in US
(Nina Mehta , 3-Jul-2009 , The Economic Times)
First to file status typically recognises a generic company as being the first to file a para IV application challenging a particular patent and seeking to manufacture generic versions of a drug which at present does not have generic competition. More...
Bayer Files Lawsuit Against Teva
(By Staff Reporter , 02-Jul-2009 , Pharmaceutical Business Review)
Bayer Schering and Bayer HealthCare together with Schering have filed a patent infringement lawsuit in the US Federal Court in the District of Delaware against Teva Pharmaceuticals and Teva Pharmaceutical Industries. More...
Dish wins stay in TiVo patent fight
(The Associated Press , 02-Jul-2009 , Business Week)
Dish Network satellite TV customers can keep using their digital video recorders while a court battle continues with TiVo Inc. More...
Pharma not IT is Indias next big thing
(Pallavi Aiyar , 2-Jul-2009 , Business Standard)
Indian companies know they cant survive on the generic model alone forever. So once they have a serious self interest in protecting patents that will be the tipping point. More...
LG and Hitachi Settle Patent Fights Over TVs and Servers
(By Susan Decker , 2-Jul-2009 , Bloomberg)
Hitachi Ltd Japans largest electronics maker and South Koreas LG Electronics Inc. have settled their U.S. patent disputes over plasma televisions computer servers and car radio and navigation systems. More...
U.S. group questions AstraZenecas Crestor patent
(by Diane Bartz , 1-Jul-2009 , Reuters)
A U.S. patent research group says it has uncovered evidence that could be used to declare AstraZeneca Plcs patent for its cholesterol fighter Crestor invalid. More...
Abbott Loses Drug Patent Suit
(By THE ASSOCIATED PRESS , 30-Jun-2009 , New York Times)
A unit of Johnson & Johnson said Monday that a jury has ordered Abbott Laboratories to pay $1.67 billion in a patent infringement suit over rheumatoid arthritis drugs. More...
Collegium Pharmaceutical Announces the Sale of AllerNaze to Lupin
(CUMBERLAND, R.I. , 30-Jun-2009 , Business Wire)
COL 003 is a tamper resistant formulation of extended release oxycodone that utilizes the Companys patented DETERx™ delivery technology. More...
Biocon Mylan team up for global biogenerics play
(C Chitti Pantulu , 30-Jun-2009 , DNA)
An initial list of products has been identified that includes a basket of biologics that will go off patent by 2016 he said. More...
Sun Pharma Inclement weather
(Shobhana Subramanian / Mumbai , 30-Jun-2009 , Business Standard)
Sales of Para IV products those abbreviated new drug applications that face a patent challenge fetch a larger amount estimated at $150 million. More...
Aurobindo Pharma sues SA govt over AIDS drug bids
(BV Mahalakshmi , 30-Jun-2009 , Indian Express)
The balance was awarded to the patent holding companies. More...
Jury returns $1.67B drug verdict against Abbott
(by Ransdell Pierson and Jonathan Spicer , 29-Jun-2009 , Reuters)
A U.S. federal jury returned a $1.67 billion verdict against Abbott Laboratories in a patent suit brought by Johnson & Johnson related to arthritis treatments the drug companies said on Monday. More...
Indian firm sues South Africa after losing AIDS drug contract
(AGENCIES,JOHANNESBURG , 29-Jun-2009 , The Economic Times)
An Indian manufacturer of drugs to treat HIV AIDS is suing the South African government after failing to clinch a $400 million tender South African media reported on Monday. More...
Make it a criminal violation Japan
(Priyanka Golikeri , 29-Jun-2009 , DNA)
But a bigger demand from Japan is stringent enforcement of intellectual property laws including criminal procedures against patent infringement. More...
14 years of data exclusivity is crazy
(Nina Mehta , 29-Jun-2009 , The Economic Times)
Founder of the generic trade association in the US William Haddad chairman and CEO of Biogenerics initiated and negotiated the Drug Price Competition and Patent Restoration Act Hatch Waxman. More...
US study wants India to allow frivolous patenting
(Priyanka Golikeri , 29-Jun-2009 , DNA)
Multinational drug makers seem hell bent upon forcing the government to alter the patent regulations in their favour. More...
India needs a brilliant wave of entrepreneurs
(ET Bureau , 29-Jun-2009 , The Economic Times)
Koshy has been working towards his dream for seven years now and had applied for a patent as well. More...
Glenmark banks on new drugs to recover losses
(C.H. Unnikrishnan , 29-Jun-2009 , livemint)
While the generics or off patent drug business of Glenmark has been growing it had to write off in the March quarter at least Rs130 crore on account of stock withdrawals following delayed US market approvals and Rs117 crore for price erosion of distributor stock after the expiry of US market exclusivity of its anti epilepsy drug oxcarbazapine. More...
Now Kinnauri shawl to get a patent
(Pratibha Chauhan , 28-Jun-2009 , Tribune News Service )
After the Kullu shawl Kangra tea and the Chamba rumaal it is now the turn of the Kinnauri shawl to acquire a patent and a GI Geographical Indication stamp a hallmark for quality and authenticity. More...
Takeda shares down on diabetes drug setback
(by Mayumi Negishi , 28-Jun-2009 , Reuters)
Actos patent expires in 2011. More...
Takeda fails to get US approval for diabetes drug
(by Leika Kihara , 27-Jun-2009 , Reuters)
Takeda Pharmaceutical Japans largest drugmaker said on Saturday a key diabetes drug had failed to get approval from U.S. regulators who had asked for additional safety tests a process the company predicts could take at least two years. More...
The Real Reason Big Pharma Mergers Are Wise
(Charles Farkas and Tim van Biesen , 26-Jun-2009 , Forbes)
Thats important because of the looming patent cliff as blockbuster drugs lose their patent protection faster than new ones can emerge. More...
Irish court invalidates patent on Glaxos top drug
(by Ben Hirschler , 26-Jun-2009 , Reuters)
An Irish court has ruled that a key patent protecting GlaxoSmithKlines biggest selling medicine is invalid the British based drugmaker said on Friday. More...
Japan approves first generic biotech drug
(Reuters , 25-Jun-2009 , The Financial Express)
Biosimilars are viewed as a promising new market given the pent up demand for cheaper versions of extremely expensive biotech drugs some of which are coming to the end of their patent life. More...
Sharp may appeal ruling in patent row with Samsung
(by Mayumi Negishi in TOKYO and Diane Bartz in WASHINGTON , 25-Jun-2009 , Reuters)
Sharp Corp said it may appeal a ruling by a US trade panel that said the Japanese electronics maker had violated an LCD patent held by South Koreas Samsung Electronics. More...
Drug patent pool proposal gets a push
(P. T. Jyothi Datta , 25-Jun-2009 , Business Line)
Concerned over the changing intellectual property environment where medicines are getting patented across the world UNITAID had proposed a patent pool to make drugs more accessible. More...
Vicious sting in the tail of FTAs
(Latha Jishnu / New Delhi , 24-Jun-2009 , Business Standard)
Because FTAs have more stringent provisions than those mandated by the World Trade Organisation under the TRIPS for protecting the intellectual property rights IPRs of the developed world such agreements can directly impact access to affordable medicines More...
DRDO records jump in patents filing
(General , 24-Jun-2009 , Business Line)
The Defence Research and Development Organisation DRDO has registered a substantial jump in filing patents and set a 10 per cent growth target for the current year. More...
Actavis Launches Finasteride As Patent Expires In France
(By Staff Reporter , 24-Jun-2009 , Pharmaceutical Business Review)
Actavis has launched Finasteride in France just one day before the patent expired. More...
CEL SCI Files Patent Application For LEAPS Immune Therapy Drugs
(By Staff Reporter , 24-Jun-2009 , Pharmaceutical Business Review)
CEL SCI has filed a provisional US patent application covering its LEAPS immune therapy drugs vaccines. More...
A global patenting model for India
(PK Vasudeva , 24-Jun-2009 , The Financial Express)
The United Nations arm on intellectual property is planning to implement a global patenting model which will pave the way for global firms to obtain patents in India easily. More...
UNITAID to meet Indian drug manufacturers
(Press Trust of India / New Delhi , 23-Jun-2009 , Business Standard)
The UNITAID patent pool initiative seeks to ensure that patents do not prevent the production of generic ARVs particularly the development and production of fixed dose combinations and AIDS medicines for children. More...
U.S. Patent Infringement Lawsuit Filed by Aperio Technologies Inc.
(David A. Leinwand , 23-Jun-2009 , Biocompare)
A U.S. patent infringement lawsuit was filed on June 10 2009 against Hamamatsu Photonics K.K. Hamamatsu Corporation and Olympus America Inc. More...
Ericsson signs LTE patent deals
(by Sven Nordenstam , 22-Jun-2009 , Reuters)
Swedish telecom equipment maker Ericsson has signed its first license agreements for LTE technology patents allowing other companies to use the technology an Ericsson official said on Monday. More...
ION sues WesternGeco for patent infringement
(by Arup Roychoudhury in Bangalore , 22-Jun-2009 , Reuters)
ION Geophysical Corp said it filed a patent infringement lawsuit against privately held WesternGeco LLC over technology related to steering devices and control systems for marine seismic streamers. More...
A Scholar Activist Challenges US Patent Law
(By Michael Orey , 22-Jun-2009 , Business Week)
John Duffy wants courts to rethink what can be patented and how to calculate damages. More...
Intellectual property issues in school franchising
(Anuradha Salhotra , 22-Jun-2009 , The Financial Express)
Emergence of school franchises bodes well for the several thousand students all over the country who scramble to study in well known schools. More...
i2india hopes to bridge industry academia gap
(L.N. Revathy , 22-Jun-2009 , Business Line)
i2india an IPR Intellectual Property Rights commercialisation and investment company is striving to bridge the gap between the industry and academia by providing the nucleus for growing such companies in India. More...
Pharma sector told to focus on improving HR quality
(22-Jun-2009 , Business Line)
Finishing schools in the information technology industry are creating more awareness towards the Intellectual Property Rights environment and the pharma industry should emulate it said panellists at the Bangalore Bio 2009 here Saturday. More...
Pfizer charges Sun with another patent violation
(Nina Mehta , 22-Jun-2009 , The Economic Times)
A legal battle between US pharma giant Pfizer and Indian company Sun Pharmaceutical has escalated with the worlds largest maker of medicines alleging in court filings that in addition to the original patent that it claims Sun violated it infringed another patent when it sought approval for its generic version of Lyrica a blockbuster drug used to treat seizures. More...
Chavez may end patents on medicine in Venezuela
(by Frank Jack Daniel , 21-Jun-2009 , Reuters)
President Hugo Chavez has vowed to shake up the rules governing intellectual property rights on medicines and other products in Venezuela the socialists latest move against the private sector. More...
Cannabis Science To File Patent For Cannabis Processing and Drug Delivery Systems
(By Staff Reporter , 19-Jun-2009 , Pharmaceutical Business Review)
Cannabis Science has announced that patent filings are expected for two of its key innovations. More...
Advinus seeks approval for trials of new diabetes molecule
(Our Bureau , 19-Jun-2009 , Business Line)
Advinus Therapeutics has filed its first investigational new drug application with the Drugs Controller General of India to start clinical trials on humans for a new diabetes type 2 molecule. More...
Prices of essential drugs may drop by 30 70%
(Gireesh Chandra Prasad & Sushmi Dey , 19-Jun-2009 , The Economic Times)
The government is likely to revise the plan to have a comprehensive new drug policy which would extend a milder form of price control to 354 essential medicines. More...
Madras HC stays customs order on dual SIM phones
(C.H. Unnikrishnan , 19-Jun-2009 , livemint)
The leading parties in the legal case were Samsung India Electronics Ltd and Hansum India Ltd which were arguing against Madurai based engineer S. Ramkumar who holds a patent for dual SIM phones in India. More...
Elder signs deal with US co for human trials of anti cancer drug
(Sushmi Dey , 19-Jun-2009 , The Economic Times)
The company follows the non infringing business model of either in licensing products of innovator companies or manufacturing off patented drugs. More...
Generic cos board biosimilars wagon
(Priyanka Golikeri , 19-Jun-2009 , DNA)
Move over off patent chemical drugs. More...
Pfizer Wins Canadian Patent Protection for Viagra
(By Joe Schneider , 19-Jun-2009 , Bloomberg)
Pfizer Inc the worlds biggest drugmaker has a valid Canadian patent on the impotence pill Viagra a federal judge ruled dismissing a bid by Novopharm Ltd to introduce a generic version of the drug. More...
Big Pharma comes calling to India
(P B Jayakumar / Mumbai , 19-Jun-2009 , Business Standard)
Thanks to the favourable patent regime in India till 2005 his team of scientists and he worked in small research and development laboratories in Hyderabad and successfully reverse engineered patented drugs of multinationals to make low cost generic drugs. More...
Novartiss Sandoz Sued by J&J Over Contraceptive Pill Patent
(By Susan Decker , 19-Jun-2009 , Bloomberg)
J&Js Ortho McNeil Janssen Pharmaceuticals unit wants a federal judge to prevent Sandoz from getting regulatory approval until a patent expires in 2019. More...
Sanofi says US court ruled against it on Eloxatin
(by Deena Beasley , 18-Jun-2009 , Reuters)
Sanofi Aventi SA on Thursday said a US court ruled against the French pharmaceutical company by granting summary judgment motions brought by generic drugmakers in patent litigation over the cancer drug Eloxatin. More...
US firm files patent infringement case against Ranbaxy
(18-Jun-2009 , Business Standard)
Medicis Pharmaceutical Corporation, a US-based skincare drug manufacturer, has filed a lawsuit against Daiichi Sankyo-owned Ranbaxy Pharmaceuticals for alleged infringement of its patent on Solodyn, a minocycline hydrochloride extended-release tablet used to treat acne. More...
Drug industry expects final EU probe report July 8
(By Ben Hirschler , 17-Jun-2009 , Reuters)
There could also be a couple of positive recommendations he added such as backing for a common European patent applicable in all EU countries and the introduction of a specialised patent litigation system. More...
India losing 2,000 patents every year: Jairam Ramesh
(17-Jun-2009 , Business Standard)
India is losing about 2,000 patents every year in the US and Europe on traditional formulations as the knowledge on these is not documented, said union minister of state for environment and forests Jairam Ramesh More...
MicroFluidic Systems Receives Patent for Method to Selectively Process Different Biological Cell Types for Analysis.
(M. Allen Northrup,MicroFluidic Systems , 16-Jun-2009 , Biocompare)
Microfluidic Systems a privately held company announced today that they received patent number 7541166 entitled Sonication to Selectively Lyse Different Cell Types. More...
DuPont fires back at Monsantos patent lawsuit
(By ERNEST SCHEYDER , 16-Jun-2009 , Forbes)
DuPont fired back at Monsantos patent lawsuit Tuesday telling a federal court it did not err in combining its genetically modified soybeans with Monsantos herbicide product. More...
Martek European regulator upholds patent with narrower claims
(by Jennifer Robin Raj in Bangalore , 16-Jun-2009 , Reuters)
Martek Biosciences Corp a health and nutritional supplements maker said the European Patent Office upheld its arachidonic patent granted in 2007 but with narrower claims. More...
Report on pharma innovation to be released at USIBC meet
(Lalit K Jha , 16-Jun-2009 , Business Standard)
A report identifying a broad range of potential benefits of incremental pharmaceutical innovation for India would be released later this week by the US India Business Council (USIBC). Commissioned by the USIBC and Coalition for Healthy India (CHI), and funded by the US Chamber of Commerce's Innovation, Development and Employment Alliance, the report 'The Value of Incremental Pharmaceutical Innovation: Benefits for Indian Patients and Indian Business' was produced by White & Case LLP and Dua Consulting. More...
US Patent Office Provides Re Examination Office Action for US Patent No 5735844
(press release , 15-Jun-2009 , MarketWatch)
Palomar also added 27 new claims to the 844 patent and the PTO confirmed these new claims as patentable. More...
Sharp wins US patent fight with Samsung
(by Diane Bartz , 15-Jun-2009 , Reuters)
Japanese electronics maker Sharp Corp has won a fight with South Koreas Samsung Electronics Co over patented technology for liquid crystal displays according to an administrative law judges ruling from the US International Trade Commission. More...
Apex Court overrules HC order favouring Gufic Ltd
(15-Jun-2009 , Business Standard)
The Supreme Court today set aside the Delhi high court order which had allowed the Indian company, Gufic Ltd, to use the name ‘Cliniq’ in its skin care product. The bench headed by Justice B Sudershan Reddy vacated the order on the appeal of Clinique Laboratories against the high court order. More...
RPT Pfizer eyes deals to raise emerging markets presence
(By John Irish , 14-Jun-2009 , Reuters)
Pfizer which posted $48 billion in revenue last year faces severe sales declines in the coming years from patent expirations to its own products including its blockbuster Lipitor cholesterol treatment. More...
Satoris Receives Patent Allowance for Use of Plasma Biomarkers in Alzheimers Disease Detection
(PRWeb , 12-Jun-2009 , Biocompare)
Patent acknowledges utility of blood biomarkers in diagnosing Alzheimers. More...
Take strong action against fake drugs India to China
(BS Reporter , 12-Jun-2009 , Business Standard)
India has asked China to take strong action against Chinese pharma manufacturers who are exporting fake drugs under Made in India label. More...
EU seeks greater commitment on IPR
(Radhieka Pandeya and Asit Ranjan Mishra , 12-Jun-2009 , livemint)
The EU is also demanding that India should extend the monopoly accorded by a patent for up to 5 additional years in order to compensate for the time required for the marketing approval of a medicinal product More...
Watson Files ANDA For Generic Mucinex D
(By Staff Reporter , 11-Jun-2009 , Pharmaceutical Business Review)
Watson has filed an Abbreviated New Drug Application with the FDA seeking approval to market its guaifenesin pseudoephedrine HCI extended release 600mg 60mg and 1200mg 120mg tablets prior to the expiration of patents owned by Reckitt Benckiser. More...
India to prepare case on drug confiscations at European ports
(Amiti Sen & Deepshikha Sikarwar , 11-Jun-2009 , The Economic Times)
India is preparing its case on the repeated seizures at European ports of its consignments containing off patent drugs meant for other developing nations before it moves the European Union and the World Trade Organisation according to a commerce ministry official. More...
Collegium Pharmaceutical Inc Announces Submission of a Request for Special Protocol Assessment to FDA for Pivotal Trial for Tamper Resistant Extended Release Opioid COL 003
(CUMBERLAND, R.I , 10-Jun-2009 , Business Wire)
COL 003 is a tamper resistant formulation of extended release oxycodone that incorporates the Companys patented DETERx™ delivery technology. More...
Solvay challenged in US on male hormone therapy
(Aaron Gray-Block , 10-Jun-2009 , Reuters)
Solvay said Perrigo Israels application with the US Food and Drug Administration challenged a United States patent relating to its treatment Androgel which runs through the next decade. More...
Vitro Obtains US Adult Stem Cell Patent
(By Staff Reporter , 10-Jun-2009 , Pharmaceutical Business Review)
Vitro declared that it has received US Patent number 7527971 entitled Generation and Differentiation of Adult Stem Cells. More...
BUY OR SELL Daiichi Sankyo to rebound from rocky Ranbaxy ride
(By Yumiko Nishitani , 10-Jun-2009 , Reuters)
Analysts reckon Daiichi Sankyo is the top long term pick among Japans drug stocks with Takeda Pharmaceutical and Astellas Pharma more exposed to the impact of patent expirations on key drugs. More...
Access Pharmaceuticals Receives Two US Patents For MuGard
(By Staff Reporter , 10-Jun-2009 , Pharmaceutical Business Review)
Access Pharmaceuticals has announced that the company has received issue notifications from the US Patent and Trademark Office that two US patents relating to MuGard the companys approved oral rinse product for the management of mucositis will issue in June as US Patent numbers 7544348 and 7547433. More...
Pfizer exec reinforces companys generic drug plancos
(Associated Press , 10-Jun-2009 , Forbes)
Dave Simmons Pfizers president of established products told analysts at Goldman Sachs Healthcare Conference in New York that part of the companys strategy includes focusing on the off patent marketplace. More...
New Mashelkar report has well little new
(Priyanka Golikeri , 10-Jun-2009 , DNA)
The Mashelkar committee report on pharmaceutical and micro organism patents has reared its controversial head again. More...
India can become a global pharma innovation hub experts say
(PTI,WASHINGTON , 09-Jun-2009 , The Economic Times)
William Chin Vice President Discovery Research & Clinical Investigation Eli Lilly felt the pharma industry is under siege with flood of patent expiries higher safety hurdles and pricing pressure. More...
Impliant granted two new US patents successfully defends European patent
(Medical Patent News , 09-Jun-2009 , News-Medical.Net)
Impliant Inc a developer of novel spine arthroplasty alternatives to fusion surgery today announced that the European Patent Office has confirmed the validity of one of its key patents following an Opposition by Archus Orthopedics Inc that concluded with oral proceedings on May 12 2009 in Munich Germany. More...
Purdue KV settle OxyContin drug patent dispute
(Edwin Chan , 09-Jun-2009 , Reuters)
Purdue Pharma LP has settled a patent dispute over OxyContin with KV Pharmaceutical agreeing to let KV sell generic versions of the popular painkiller on a limited basis in the United States. More...
Bulk pharma imports to go under DCGI scanner
(Radhieka Pandeya , 9-Jun-2009 , livemint)
Regulator acts after evidence of attempts to evade import duty and bring in spurious drugs to Mumbai Chennai More...
Pharma firms continue to face patent violation charges in Europe
(Rupali Mukherjee , 8-Jun-2009 , The Economic Times)
Even after India raised concerns with EU troubles of generic companies which export drugs to developing countries through Europe are far from over as seizures by Dutch customs still continue. More...
IITs to market patents with help from investment firms
(Kalpana Pathak & Shivani Shinde / Mumbai , 8-Jun-2009 , Business Standard)
Sitting on a pool of close to 900 patents the Indian Institutes of Technology are for the first time planning to monetise these intellectual properties by exploring tie ups with firms that invest in inventions. More...
Row over generic drugs intensifies after seizure in Germany
(Khomba Singh , 8-Jun-2009 , The Economic Times)
German authorities last month seized a large consignment of antibiotic Amoxicillin made by Chennai based Medopharm during transit at Frankfurt over alleged trademark infringement in the latest incident of European Union nations interfering in legitimate trade of generic medicine. More...
16 out of 17 drug consignment seizures in the Dutch were from India
(P.T. Jyothi Datta , 8-Jun-2009 , Business Line)
There were 17 incidents of drug seizure last year in the Netherlands on the grounds of patent infringement and 16 of them were Indian medicine exports says Health Action International a Dutch network that works on increasing access to medicines. More...
Vizio files TV patent suit against LG in US
(by Rhee So-eui , 07-Jun-2009 , Reuters)
US TV brand Vizio Inc has filed a patent infringement suit against South Koreas LG Electronics Inc seeking an injunction to ban LG from importing and selling certain TVs in the United States. More...
Playing defense on patents
(By Kenneth Klee , 5-Jun-2009 , Reuters)
The idea of developing patents as a kind of asset class is still new and controversial. More...
Neuralstem Receives Patent Allowance for Compounds That Promote Neurogenesis
(ROCKVILLE, Md.(BUSINESS WIRE) , 05-Jun-2009 , Biocompare)
Neuralstem Inc announced today it received a notice of allowance from the US Patent and Trademark Office for a patent on four new chemical entities that boost the generation of new neurons. More...
Curbs on Amul Vadilal to use American Dry Fruits trade name for their products
(Virendra Pandit , 5-Jun-2009 , Business Line)
About Vadilals argument that the plaintiff had not obtained registration of trademark till date Mr Sheikh observed that evidence proved that the company had obtained proprietary rights to use trade name and it cannot be termed as pirator of trade name. More...
Takeda to delay European application for key drug
(By Yumiko Nishitani , 04-Jun-2009 , Reuters)
Actos accounts for roughly a quarter of Takedas revenues and will lose US patent protection in 2011. More...
Crash boom bax the rise & fall of Ranbaxy
(Radhieka Pandeya , 4-Jun-2009 , livemint)
And the Ranbaxy story is as characteristic of what happens in most family owned and run businesses in India as it is of the Indian pharma industrys evolution from makers of cheap illegal copycat drugs and suppliers of raw material to respected manufacturers of generics legal copies of off patent drugs and ultimately to research driven firms. More...
J&J upbeat on drugs business cites new medicines
(By Ransdell Pierson , 04-Jun-2009 , Reuters)
J&J whose first quarter earnings fell slightly due to generic competition for its Risperdal schizophrenia drug and waning demand for its anemia medicines is now under even greater pressure due to the expiration in March of the US patent on its $2.5 billion a year Topamax epilepsy drug. More...
German market for Indian drugs shrinks
(C.H. Unnikrishnan , 4-Jun-2009 , livemint)
Orchid is currently focusing on products that enjoy patent protection but once they go off patent the company will be affected. More...
Agilent wins patent fight with Affymetrix
(by Maggie Fox and Diane Bartz , 04-Jun-2009 , Reuters)
A US patent appeals court ruled on Thursday in favor of Agilent Technologies which had been involved in a patent fight with Affymetrix Inc. More...
Vical Receives US Patent For Universal Influenza Vaccine Approach
(By Staff Reporter , 3-Jun-2009 , Pharmaceutical Business Review)
Vical has received US Patent No 7537768 covering the use of influenza virus gene sequences in a universal vaccine that could provide protection against circulating seasonal strains as well as emerging pandemic strains of influenza viruses. More...
Mylan Again Calls for an End to Authorized Generics During 180 Day Exclusivity Period
(PITTSBURGH , 3-Jun-2009 , PRNewswire)
The committees hearing Pay to Delay Are Patent Settlements That Delay Generic Drug Market Entry Anticompetitive was called to gather information about the effects of settlements. More...
Almirall gets FDA approval for migraine drug
(by Tracy Rucinski , 3-Jun-2009 , Reuters)
Almiralls patent on Almotriptan in the United States has been extended to November 2015. More...
Novocell Obtains US Patent for Drug Screening Human Embryonic Cell Derived Endoderm Cells
(SAN DIEGO , 3-Jun-2009 , Business Wire)
Novocell Inc a stem cell engineering company today announced that it has received US Patent No 7541185 with method claims covering the use of endoderm cells derived from human embryonic stem cells for drug discovery. More...
Rallis India seeks patent for three new biomolecules
(C.H. Unnikrishnan , 3-Jun-2009 , livemint)
In a move that could help extend its presence in the global crop protection market Rallis India Ltd a Tata group agrochemical company has developed at least three new biomolecules for use in fungicides More...
ARIAD Announces Updates On NF kB Patent Appeals
(CAMBRIDGE, MASS , 03-Jun-2009 , ag-IP-news )
ARIAD Pharmaceuticals Inc and its co plaintiffs announced that they are filing a petition for an en banc rehearing of an April decision by the US Court of Appeals for the Federal Circuit in its patent infringement case against Eli Lilly and Company. More...
Echostar To Pay TiVo Another $103 Million In Patent Case
(By Rory Maher , 03-Jun-2009 , Reuters)
In the latest chaper of a patent infringement case on its DVR technology that dates back to 2004 TiVo was awarded an additional $103 million by the United States District Court in Texas after a failed appeal by Echostar. More...
Vical Announces Issuance of US Patent for Universal Influenza Vaccine Approach
(SAN DIEGO , 03-Jun-2009 , ag-IP-news )
Vical Incorporated announced in a Wednesday press release the issuance of US Patent No 7537768 covering the use of influenza virus gene sequences in a universal vaccine that could provide protection against circulating seasonal strains as well as emerging pandemic strains of influenza viruses. More...
Denial of patent to Gilead beneficial for Indian firms
(BS Reporter / Mumbai , 3-Jun-2009 , Business Standard)
The Indian Patent Offices decision to reject a product patent for Gilead Sciences Incs adefovir dipivoxil variant a new form of its Hepatitis B drug Hepsera has come as a boon for Indian copy cat drug makers such as Ranbaxy Cipla and Sun Pharma. More...
Top court to hear business method patent case
(By Diane Bartz , 2-Jun-2009 , Reuters)
The Supreme Court said on Monday that it would hear the Bilski patent case which will tell high tech and software companies how far they can go in patenting software financial strategies and other abstract processes. More...
Nvidia US patent office rejects Rambus claims
(SANTA CLARA, Calif. , 2-Jun-2009 , Business Week)
Nvidia Corp said Tuesday the US Patent and Trademark Office has rejected 41 claims against the chip maker brought by Rambus Inc a company that licenses semiconductor technology. More...
They opposed Novartis on Glivec but now seek patent
(Priyanka Golikeri , 02-Jun-2009 , DNA)
If you thought only multinational drugmakers were monopolistic and fought fiercely to secure patents for new forms of known molecules you are so wrong. More...
InterDigital Nokia finish patent fight hearing
(By Diane Bartz , 02-Jun-2009 , Reuters)
Wireless technology firm InterDigital and the worlds top cellphone maker Nokia wrapped up hearings on Tuesday at the International Trade Commission in a battle over four patents said InterDigital spokesman Jack Indekeu. More...
Zydus Teva end patent disputes
(Nina Mehta , 2-Jun-2009 , The Economic Times)
Ahmedabad based ZydusCadila and Israeli generic major Teva have settled their patent disputes over active pharmaceutical ingredients used to make generic versions of GlaxoSmithKlines heart drug and Johnson & Johnsons anti psychotic drug. More...
Microsoft Lucent battle in huge patent case
(by Diane Bartz , 02-Jun-2009 , Reuters)
Microsoft Corp argued before an appeals court on Tuesday that its Outlook calendar date picker tool did not infringe an Alcatel Lucent patent and asked for a $358 million jury verdict to be overturned. More...
GraphOn Announces Settlement Resolving Legal Dispute with Google
(SANTA CRUZ, Calif , 1-Jun-2009 , Business Wire)
GraphOn Corporation today announced a settlement that resolves the legal dispute between GraphOn and Google Inc. More...
BASF Sues DuPont for Patent Infringement
(Mark Stephenson, BASF Corporation , 1-Jun-2009 , Biocompare)
BASF Plant Science GmbH seeks an injunction and damages against DuPont and its subsidiary Pioneer Hi Bred International for this unlawful use of BASFs patented technology. More...
Sanofi has winning cancer drug but short patent
(By Ben Hirschler , 1-Jun-2009 , Reuters)
Sanofi Aventis may have bagged a winning cancer drug when it agreed to buy privately held BiPar Sciences for up to $500 million in April but a short patent could limit the French groups scope to cash in on sales. More...
First Product Patent Granted to Venus Remedies in South Korea
(ag-IP-news ,HARYANA , 1-Jun-2009 , ag-IP-news )
The Korean Intellectual Property Office has granted a Product Patent to one of the research products of Venus used for the treatment of pneumonia. More...
Top court to hear business method patent case
(by Diane Bartz , 1-Jun-2009 , Reuters)
The Supreme Court said on Monday it would hear the Bilski patent case which would tell high tech and software companies how far they could go in patenting software financial strategies and other abstract processes. More...
Medtronic announces appeal decision in patent case with DePuy Spine
(Medical Patent News , 01-Jun-2009 , News-Medical.Net)
Medtronic Inc has announced results from a Federal Circuit Court review of a December 2007 patent infringement verdict regarding the Vertex line of multiaxial screws which are no longer on the market. More...
Supreme Court to Review Business Method Patents
(By Michael Orey , 01-Jun-2009 , Business Week)
The high court will decide if such things as financial products and Internet commerce systems deserve intellectual property protection More...
Venus Remedies gets patent for anti pneumonia drug
(Corporate,NEW DELHI , 01-Jun-2009 , Business Line)
Pharmaceutical firm Venus Remedies on Monday said it has received a patent right in South Korea for its drug which is used for the treatment pneumonia. More...
Unigen's First Site Directed Bone Growth Patent Issues
(BOONTON, NJ , 30-May-2009 , ag-IP-news )
Unigene Laboratories Inc reported that its first patent covering its Site Directed Bone Growth technology has been issued a press release by Unigene stated. More...
Citigroup upgrades Sanofi Aventis to buy
(By Sarah Turner , 29-May-2009 , MarketWatch)
They noted that data at the upcoming ASCO meeting could be significant and that patent challenges are not insurmountable. More...
Indian court uses blog reference to solve TVS Bajaj patent issue
(Soumya Shanker & Malathi Nayak , 29-May-2009 , livemint)
Ablog post by a student was instrumental in TVS Motor Co Ltds victory over Bajaj Auto Ltd in their recent legal skirmish over patent infringement issues setting a precedent for the use of blog content by the countrys courts. More...
Osteologix Receives Key US Patent Allowance for Novel Osteoporosis Drug
(GLEN ALLEN, Va. BUSINESS WIRE , 28-May-2009 , Biocompare)
Osteologix Inc today announced that is has received a Notice of Allowance from the US Patent and Trademark Office for its US Patent Application Number 11269289 titled Water Soluble Strontium Salts for Use in Treatment of Cartilage and or Bone Conditions reporting allowance of claims covering the treatment of osteoporosis and related bone conditions using NB S101 the Companys lead osteoporosis drug candidate. More...
US reexamines Mercks Singulair patent
(By Ransdell Pierson , 28-May-2009 , Reuters)
Merck & Co said on Thursday the US Patent Office is reexamining the patent on its biggest product $4.5 billion a year asthma treatment Singulair. More...
New US patent issued for Limbrel in osteoarthritis
(Medical Patent News , 27-May-2009 , News-Medical.Net)
Primus Pharmaceuticals Inc has announced the issuance of a new composition of matter patent for Limbrel the first prescription medical food product to safely meet the distinctive nutritional requirements of patients with osteoarthritis. More...
Your genes Not on your life
(Latha Jishnu / New Delhi , 27-May-2009 , Business Standard)
In a first of its kind a motley group of interests from cancer patients and civil liberties activists to clinic pathologists and researchers have challenged the gene patents granted to a US biopharmaceutical company. More...
Bajaj Auto to move SC on TVS issue
(T E Narasimhan & Swaraj Baggonkar / Chennai/mumbai , 27-May-2009 , Business Standard)
The High Courts ruling had come as a big relief for TVS Motor which was restricted by an earlier verdict from the same court that did not allow the company to produce or sell the disputed motorcycle Flame a 125cc bike sporting twin spark plugs as Bajaj Auto held patent rights for the same. More...
Medicis Announces New Patents for SOLODYN
(SCOTTSDALE, ARIZ , 26-May-2009 , ag-IP-news )
Medicis announced in a Tuesday press release that the United States Patent and Trademark Office has advised the company that US Patent No 7541347 directed to the use of SOLODYN in 90mg tablet form will issue on June 2 2009 and that US Patent No 7544373 directed to SOLODYN in 90mg tablet form will issue on June 9 2009. More...
US District Court Orders Hynix to Post Security for Infringing Rambus Patents
(LOS ALTOS, Calif , 26-May-2009 , Business Wire)
Rambus Inc today announced that the US District Court for the Northern District of California has ordered Hynix Semiconductor to secure the judgment amount of approximately $397 million through a combination of a bond and a lien on a Hynix property in South Korea for infringing Rambus patents. More...
Samsung may win dual SIM patent case
(C.H. Unnikrishnan , 26-May-2009 , livemint)
The Chennai patent office had in January 2008 granted a patent to Ramkumar for mobile phones with the capability of using two SIM cards. More...
Ranbaxy shares spurt 20% on BSE
(BS Reporter / Mumbai , 26-May-2009 , Business Standard)
Daiichi Sankyo has strength in developing patented products for lifestyle diseases such as hypertension diabetes mellitus autoimmune disorders hyperlipidemia or atherosclerosis and bacterial infections More...
Advaxis Receives US Patent and Trademark Office Approval on Act A Protein Patent Pending Rights
(NORTH BRUNSWICK, N.J , 26-May-2009 , Business Wire)
The US Patent and Trademark office approved Advaxis Incorporated patent application Compositions and Methods for Enhancing the Immunogenicity of Antigens Application US20050118184 A1. More...
Supplies delay Ranbaxy may take $50 mn hit
(Radhieka Pandeya , 26-May-2009 , livemint)
This follows from a manufacturing agreement that was part of a bigger patent infringement settlement between Ranbaxy and AstraZeneca in April 2008. More...
Fake drugs
(Sudhir Chowdhary , 25-May-2009 , The Financial Express)
Recently enforcement officials of the European Union seized a consignment of fake drugs which included not just Viagra but also other serious medicines such as anti cholesterols anti osteoporosis and anti hypertensives. More...
Television brands turn tangible
(Shuchi Bansal / New Delhi , 25-May-2009 , Business Standard)
Piracy that is infringement of IPR is our other challenge in the market place adds Jibi George. More...
AAU for patent of mechanised production of basundi
(Shubhlakshmi Shukla , 25-May-2009 , Indian Express)
Anand Agriculture University authorities plan to patent the mechanised production of basundi. More...
Epistar Soars to 16 Month High After Winning Patent Appeal
(By Weiyi Lim , 25-May-2009 , Bloomberg)
Epistar Corp. jumped to its highest in 16 months after winning its appeal in a patent infringement case in which Royal Philips Electronics NV s Lumileds unit was trying to block the Taiwanese companys chips from US markets. More...
Amsterdam authorities release Ind Swift exports
(P.T. Jyothi Datta , 23-May-2009 , Business Line)
Diplomacy and legal channels have helped the Chandigarh based Ind Swift get its export consignment released from customs authorities in Amsterdam about six months after it was seized. More...
Viral Genetics issued patent for novel cancer therapies
(Medical Patent News , 22-May-2009 , News-Medical.Net)
Biotechnology firm Viral Genetics Inc has been issued a patent for novel cancer therapies. More...
Conceptus files patent suit against Hologic
(by Anand Basu , 22-May-2009 , Reuters)
Conceptus Inc a maker of contraception devices filed a lawsuit against Hologic Inc alleging that the medical diagnostics companys sterilization system will infringe several US patents owned by Conceptus. More...
Drug regulator to expand survey on fake medicines
(Thomas K. Thomas , 22-May-2009 , Business Line)
The Drug Controller General of India plans to widen the survey to map the prevalence of counterfeit drugs in the country with larger number of samples. More...
We do not foresee much implication of Toshiba suit Moser Baer
(Our Bureau , 22-May-2009 , Business Line)
The Moser Baer India Chairman Mr Deepak Puri said Thursday that he does not foresee much implication of the Toshiba lawsuit and that as per his preliminary reading the infringement allegations pertain to optical media disk drives whereas his company is into manufacturing of optical storage media. More...
Pfizer to market off patent injectables with Claris
(BS Reporter / Ahmedabad , 21-May-2009 , Business Standard)
Leading pharmaceutical company Pfizer Inc has entered into a partnership with Ahmedabad based Claris Lifesciences Ltd to commercialise sterile injectible drugs that are off patent and have lost exclusivity in the United States Canada Australia New Zealand and Europe. More...
Pfizer strikes deals in generics emerging markets
(By Lewis Krauskopf , 20-May-2009 , Reuters)
The deals announced by Pfizer on Wednesday with Aurobindo Pharma Ltd and Claris Lifesciences Ltd substantially increase Pfizers offerings in medicines that have lost patent protection in markets around the world. More...
Qualcomm others found to infringe Tessera patents
(By Diane Bartz , 20-May-2009 , Reuters)
Qualcomm and others infringed Tessera Technologies patents for methods to package semiconductor chips so they are protected inside portable devices the US International Trade Commission said on Wednesday. More...
Indian pharma players to benefit from generic drugs in US
(Nina Mehta , 20-May-2009 , The Economic Times)
According to GPhAs analysis high growth rates were driven by factors such as increase in the overall percentage of generic utilisation and loss of patent protection by several brand name blockbusters such as Pravachol Ambien Fosamax Zoloft and Zocor. More...
Microsoft ordered to pay $200 million in patent case
(by Bill Rigby , 20-May-2009 , Reuters)
Microsoft Corp said on Wednesday a Texas federal jury ordered the company to pay Canadian software firm i4i Ltd $200 million in damages for infringing a patent. More...
GenVault Receives Four Critical US and EU Patent Allowances for Key Biosample Management Technologies
(Bret Dash , 20-May-2009 , Biocompare)
GenVault Corporation is pleased to announce notice of allowance for four key patents in its growing portfolio. More...
Court grants AstraZeneca preliminary injunction against Apotex in PULMICORT RESPULES patent litigation
(Wilmington, DE , 20-May-2009 , AstraZeneca )
No trial date for the patent litigation has been set. More...
HC lifts stay against TVS on Flame
(Agencies, fe Bureau , 20-May-2009 , The Financial Express)
TVS has been a licencee of patent dated May 25 2000 and Bajaj held the patent as of July 1 2002. More...
Avigen Granted AV411 Patent for Neuropathic Pain
(ALAMEDA, CA - , 20-May-2009 , ag-IP-news )
Avigen Inc announced in a press release that it has been granted United States Patent No 7534806 entitled Method for Treating Neuropathic Pain and Associated Syndromes. More...
Resverlogix files two patents on compounds for inflammatory diseases
(Medical Patent News , 20-May-2009 , News-Medical.Net)
Two new patent applications have been filed for novel compounds and their use in regulating inflammatory markers. More...
SanDisk Samsung talking over patents
(By Anupreeta Das , 19-May-2009 , Reuters)
SanDisk Corp continues to negotiate with rival Samsung Electronics Co Ltd over renewing their patent licensing agreement that is set to expire this August SanDisk Chief Executive Eli Harari said. More...
DVD patent violation Toshiba sues Moser Baer
(Corporate,NEW DELHI , 19-May-2009 , Business Line)
Japanese electronics major Toshiba Corporation has filed a lawsuit against optical storage device maker Moser Baer India for alleged DVD patents infringement. More...
Bulk drug firms want pollution norms relaxed
(B Krishna Mohan / Hyderabad , 19-May-2009 , Business Standard)
Bulk drug manufacturers see a business opportunity arising when many drug patents expire next year. More...
Intradigm Announces Issuance of RNA Interference Patent Covering Potent siRNA Sequence
(Intradigm Corporation , 19-May-2009 , Biocompare)
Intradigm Corporation a leading developer of targeted systemic RNA interference therapeutics today announced the issuance of United States patent 7534878 titled Composition and Methods of RNAi Therapeutics for Treatment of Cancer and Other Neovascularization Diseases. More...
A patent attempt at cultural sensitivity
(Leslie D`Monte / New Delhi , 19-May-2009 , Business Standard)
You may soon get an email with a colour that suits your culture and nerves now that IBM the over $100 billion IT giant which has a current active portfolio of about 26000 patents in the US and over 40000 patents worldwide has applied for a patent to cover a method for customising colour in an email message based on the cultural perspective of each recipient. More...
Atherotech receives patent for ApoB measurement for determining heart disease risk
(Medicinal Patent News , 19-May-2009 , News-Medical.Net)
Atherotech Inc developer of the VAP Cholesterol Test has announced it has received a patent on its method to derive and report apolipoprotein B100 using the Vertical Auto Profile technology. More...
Madras HC allows TVS to use Bajajs patented tech
(T E Narsimhan & Swaraj Baggonkar / Chennai/mumbai , 19-May-2009 , Business Standard)
The Madras High Court today set aside its earlier order restraining countrys third largest two wheeler manufacturer TVS Motors from manufacturing and marketing vehicles with twin spark technology. More...
US firm sues Lupin over patent infringement
(By fe Bureau , 19-May-2009 , Indian Express Finance )
Lupin Pharmaceuticals the US subsidiary of Indian pharma major Lupin has been sued by US firm Genzyme. More...
Wealth of microbes
(Surinder Sud / New Delhi , 19-May-2009 , Business Standard)
Many feel that microbes being live forms should not be patented as these are the creations of nature and not of man. More...
Calcutta HC Bench admits ITC appeal
(Our Bureau , 18-May-2009 , Business Line)
ITC had moved the High Court against Godfrey Phillips alleging infringement of copyright and illegal use of a registered trademark of ITC products. More...
22 patent department officers transferred
(C.H. Unnikrishnan , 18-May-2009 , livemint)
However the transfers have drawn criticism from within the office on the grounds that some of the officials are wrong targets More...
USPTO Upholds StemCells Patents
(PALO ALTO, CA , 16-May-2009 , ag-IP-news )
StemCells Inc announced in a press release that the US Patent and Trademark Office has upheld the validity of the remaining two neural stem cell patents which were subjected to reexamination proceedings commenced by Neuralstem Inc. More...
Indian drug seizure by EU may force firms to change routes
(Press Trust Of India / New Delhi , 16-May-2009 , Business Standard)
Frequent seizure of Indian drug consignments in Europe may force domestic pharmaceutical firms to avoid the European sea routes to destinations in Africa and Latin America Commerce Secretary G K Pillai said. More...
Competitive Technologies wins new patent for nanoparticle bone biomaterial
(By Staff Reporter , 15-May-2009 , Pharmaceutical Business Review)
Third patent supports first two patents and provides additional claims regarding the preparation of the primary components of bone cement More...
UCB stock rises as US clears arthritis drug
(By Philip Blenkinsop and Antonia van de Velde , 14-May-2009 , Reuters)
The news will reduce UCBs reliance on older drugs some of which have lost patent protection and is a vindication of its investment in biotechnology. More...
Gilead sues Teva in Atripla patent dispute
(Associated Press , 14-May-2009 , Forbes)
Gilead Sciences Inc said Thursday it is suing Teva Pharmaceuticals Industries Ltd over the drugmakers plans to make a generic version of the blockbuster HIV treatment Atripla. More...
Piramal Healthcare launches ActiPatch for pain therapy
(PTI , 14-May-2009 , The Economic Times)
Its unique delivery system using patented technology provides a cost effective patient friendly method to reduce soft tissue pain and swelling Piramal said. More...
Teva wins a round in court in Protonix fight
(by Diane Bartz , 14-May-2009 , Reuters)
A US appeals court refused on Thursday to give drugmakers Altana AG and Wyeth a preliminary injunction in a patent fight with Teva Pharmaceutical Industries over the ulcer drug Protonix. More...
Indian group to sell copy of Tamiflu
(By Andrew Jack in London , 14-May-2009 , Financial Times)
An Indian pharmaceutical company is gearing up to sell a cheap version of Tamiflu the leading patented antiviral flu drug to emerging economies in a move that will pit intellectual property rights against affordable access to drugs. More...
Bajaj gets patent for multi spring shock absorbers
(PTI , 14-May-2009 , The Economic Times)
Pune based Bajaj Auto today said it has received patent for its invention multi spring vehicle shock absorber used in its motorcycles with which it hopes to counter cheap Chinese copycats. More...
Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel
(The Procter & Gamble Company , 13-May-2009 , Biocompare)
Today the United States Court of Appeals for the Federal Circuit ruled in favor of The Procter & Gamble Company in the patent infringement lawsuit filed by P&G against Teva Pharmaceuticals USA Inc. More...
ACLU and PUBPAT Challenge Patents on Breast Cancer Genes
(ag-IP-news Agency , 13-May-2009 , ag-IP-news )
The American Civil Liberties Union and the Public Patent Foundation at Benjamin N Cardozo School of Law filed a lawsuit charging that patents on two human genes associated with breast and ovarian cancer stifle research that could lead to cures and limit womens options regarding their medical care. More...
OMAX Announces Settlement in Patent Litigation
(KENT, Wash , 13-May-2009 , PRNewswire)
OMAX has announced the settlement of the outstanding patent litigation with Flow Corporation along with the cessation of merger negotiations with the company. More...
Satyam Upaid get chance to try out of court settlement
(Andy Mukherjee & Jessica Mehroin Irani , 13-May-2009 , The Economic Times)
Satyam Computer Services and UK based mobile solutions company Upaid have been offered a chance to settle their dispute out of court. More...
Global HIV AIDS initiative to help Indian pharma
(PB Jayakumar / Mumbai , 13-May-2009 , Business Standard)
Global healthcare aid agencies such as UNITAID and Medicines Sans Frontieres have begun to lobby for a patent pool of HIV AIDS drugs. More...
Cancer Patients Challenge the Patenting of a Gene
(By JOHN SCHWARTZ , 12-May-2009 , The New York Times)
On Tuesday Ms Girard 39 who lives in the Austin Tex area filed a lawsuit against Myriad and the Patent Office challenging the decision to grant a patent on a gene to Myriad and companies like it. More...
Japans Daiichi says deep in red due to Ranbaxy deal
(REUTERS , 12-May-2009 , The Economic Times)
Ranbaxy which derives 80 percent of its sales from abroad has grown by selling cheap copies of branded drugs that have gone off patent and through successful challenges to patents owned by Western companies. More...
Lupin settles antidepressant drug litigation with Wyeth
(BS Reporter / Mumbai , 12-May-2009 , Business Standard)
Lupin a generic drug maker has settled all patent litigation with US drug maker Wyeth for Effexor XR capsules the US firms branded anti depressant. More...
Concert Pharmaceuticals Granted Patents on Deuterium Modified Compounds
(LEXINGTON, Mass , 11-May-2009 , Business Wire)
Concert Pharmaceuticals Inc announced today that its first patents have been granted by the US Patent and Trademark Office. More...
WIPO clarifies
(IST,NEW DELHI , 11-May-2009 , The Economic Times)
This is with reference to the story Global model to give instant patent relief to drug cos which purports to relate to matters under discussion this week in the Patent Cooperation Treaty Working Group at WIPO. More...
AstraZeneca shares jump on blood thinner drug study
(Val Brickates Kennedy , 11-May-2009 , MarketWatch)
Plavix is due to lose patent protection in late 2011. More...
Nanosys Licenses Nanowire Technology to QuantuMDx Group for Next Generation Diagnostic and Sequencing Technologies
(PALO ALTO, Calif. and LONDON,PRNewswire , 11-May-2009 , Biocompare)
Nanosys Inc and QuantuMDx Group today announced that QMDx has signed a non exclusive license agreement with Nanosys for several patents and patent applications related to the use of nanowires for biosensors. More...
SISVEL Patent Pool for 3G Long Term Evolution LTE
(TURIN, Italy , 11-May-2009 , Business Wire)
Following talks with the stakeholders in the LTE field worldwide that began last year and culminated in April 2009 in a presentation on the benefits of an LTE patent pool delivered to the IPR Plenary Assembly of the Next Generation Mobile Network Alliance today SISVEL issued a call for patents and patent applications that are essential to the LTE standard. More...
Takeda Q4 profit more than doubles sees growth ahead
(by Yumiko Nishitani , 11-May-2009 , Reuters)
Joining other drugmakers using acquisitions to stave off earnings declines on patent expirations Takeda bought US biotech firm Millennium Pharmaceuticals and absorbed its part of former US joint venture TAP Pharmaceuticals. More...
Pharma cos seek rise in prices of regulated drugs
( Khomba Singh & Sushmi Dey , 11-May-2009 , The Economic Times)
The domestic pharma industry is going to seek an upward revision in drug prices by submitting a report on the increase in conversion and packaging costs to the Indian drug price regulator National Pharmaceutical Pricing Authority. More...
Drug to curb Diabetes gets patent rights
(KAKINADA,TNN , 11-May-2009 , The Times of India)
Chintaluru village in East Godavari district which had become a popular place in the state for the manufacture of ayurvedic drugs for several decades has earned a rare distinction of getting patent rights for one of its product meant for curbing diabetes. More...
India asks Africa to keep doors open to generic drug imports
(Addis Ababa (IANS) , 10-May-2009 , The Hindu)
India has urged African countries not to put barriers on the production and import of generic drugs to the continent especially in the current economic slowdown which could adversely affect the purchasing power of patients. More...
The Court Supports Bavarian Nordics Decision to Start Patent Infringement Case Against Oxford BioMedica
(Bavarian Nordic , 9-May-2009 , Biocompare)
Oxford Biomedicas second attempt to dismiss Bavarian Nordics patent infringement suit in the United States has failed. More...
Cadila expects Rs 100 cr revenue from Policap
(PTI,NEW DELHI , 9-May-2009 , The Economic Times)
Ahmedabad based Cadila Pharmaceuticals on Saturday said it is expecting a revenue of Rs 100 crore from the sale of its patented combination drug Policap which it expects to launch by the middle of next month. More...
Pfizer counters Dr Reddys claims against its anti smoking drug
(ET Bureau , 9-May-2009 , The Economic Times)
Pfizer has responded to the post grant opposition filed by Dr Reddys Laboratories against its anti smoking drug Champix. More...
The war for intellectual property
(Latha Jishnu / New Delhi , 9-May-2009 , Business Standard)
At the Geneva headquarters of the World Intellectual Property Organisation skirmishes between rich nations and the developing world take place with predictable regularity. More...
Gene Network Sciences wins new US patent
(By Datamonitor staff writer , 08-May-2009 , Pharmaceutical Business Review)
Gene Network Sciences a biotechnology company has received a US patent that covers the companys core model learning and simulation platform REFS. More...
Gucci sues Guess for trademark infringement
(Bloomberg / New York , 8-May-2009 , Business Standard)
Guess Inc was sued by Gucci Groups US unit for trademark infringement over allegations the Los Angeles based apparel company uses a network of wholesale buyers to sell imitations of Guccis best selling designs. More...
Wyeth sues Sun and its US subsidiary over Protonix drug
(Radhieka Pandeya , 8-May-2009 , livemint)
US based Wyeth Pharmaceuticals has sued Mumbai based Sun Pharmaceutical Industries Ltd and its US subsidiary Caraco Pharmaceutical Laboratories Ltd for claiming that their heartburn drug was a generic version of its Protonix drug. More...
Indian pharma cos upbeat on biogenerics
(Joe C Mathew / Bangalore , 8-May-2009 , Business Standard)
Even as the substitutability of biogeneric or biosimilar medicines with their original patented counterparts continues to be a matter of debate world over Indian drug companies which have introduced biogeneric products or copies of biotechnology drugs in the country are bullish over the marketing prospects of biogenerics after patents expire in developed markets. More...
India pips US UK in IP laws enforcement practices
(PTI , 7-May-2009 , DNA)
Indian has been ranked top globally for enforcing intellectual property laws ahead of some of the most advanced nations like the United States and the United Kingdom a survey says. More...
China drug maker Zensun eyes Nasdaq listing in 2011
(by David Lin , 7-May-2009 , Reuters)
Zhou also the chief executive of the firm said that he is in talks with several US pharmaceutical firms to sell the patent of Neuregulin and hopefully to gain the Food and Drug Administrations approval to sell it in the United States. More...
IL wins patent infringement lawsuit against Diagnostica Stago
(By Datamonitor staff writer , 07-May-2009 , Pharmaceutical Business Review)
Instrumentation Laboratory and its parent company Instrumentation Laboratory SpA or IL have reported that the Paris First Level Civil Court has determined that Diagnostica Stago infringed the French counterparts of two European patents licensed exclusively to IL and committed acts of unfair competition due to denigrating advertisements. More...
Wi LAN settles patent litigation with Infineon
(by Krishna Chaithanya , 07-May-2009 , Reuters)
Technology licensing firm Wi LAN Inc said it settled a patent litigation with German chipmaker Infineon Technologies AG for an undisclosed amount. More...
Wockhardt seeks to sell animal healthcare biz
(BS Reporter / Mumbai , 7-May-2009 , Business Standard)
Wockhardt has one of the largest number of off patent biotech drugs under development in India. More...
10 Q PAR PHARMACEUTICAL COMPANIES INC
(EDGAR Online via COMTEX , 6-May-2009 , MarketWatch)
Certain statements in this Report constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including those concerning managements expectations with respect to future financial performance trends and future events particularly relating to sales of current products and the development approval and introduction of new products. More...
Teva says Parkinsons drug patent extended to 2017
(Associated Press , 06-May-2009 , Forbes)
Drugmaker Teva Pharmaceutical Industries Ltd said Wednesday that one of the patents on Azilect its Parkinsons disease drug has been extended by five years into 2017. More...
Pharma cos seek retail opening for swine flu drug
(Nina Mehta & Khomba Singh, , 6-May-2009 , The Economic Times)
This time though the timely rejection of Roches patent in March has allowed Indian companies to manufacture the product and sell it in India and the countries where Roche does not have patent protection. More...
Pfizer sues Sun Wockhardt Lupin in US
(Joe C Mathew / Bangalore , 6-May-2009 , Business Standard)
Files patent infringement suits against generic versions of best selling nerve drug. More...
Global model to give instant patent relief to drug cos
(Khomba Singh , 6-May-2009 , The Economic Times)
In what will pave the way for global pharma firms to obtain patents in India easily the United Nations arm on intellectual property is planning to implement a global patenting model that will mandate all member countries including India to grant patent to drugs approved by any two international patent offices. More...
Patent law again
(Business Standard / New Delhi , 6-May-2009 , Business Standard)
The revised report of the technical expert group on patent law issues is not very different from the one that the group had to withdraw in 2007. More...
Biotech Pharma Docket
(By Suresh Pillai , 5-May-2009 , Patent Docs)
In the lawsuit filed in July 2008 Norvartis alleges that Roxane infringed Novartis patents covering Famvir a treatment for genital and oral herpes. More...
Warner Chilcott files new patent infringement lawsuit against Mylan
(By Datamonitor staff writer , 05-May-2009 , Pharmaceutical Business Review)
Warner Chilcott a Bermuda based specialty pharmaceutical company has reported that one of its subsidiaries and Mayne Pharma International have filed a second lawsuit against Mylan Pharmaceuticals Inc and Mylan Inc in the District Court of New Jersey for infringement of Maynes US patent which covers Doryx a tetracycline class oral antibiotic. More...
NanoLogix Inc to Exhibit at The American Society for Microbiology General Meeting in Philadelphia Announces Two New Patents
(Carol Surrena , 05-May-2009 , Biocompare)
NanoLogix recently received two patents. More...
3 Monsanto DuPont bicker over herbicide tolerant tech
(By Steve James , 05-May-2009 , Reuters)
This violates Monsantos contract rights and US patents it said in the suit demanding DuPont honor its agreements and respect patented technologies. More...
Takeda Lilly Lead $28.5 Billion in Biotech Deals Report Says
(By Lisa Rapaport , 05-May-2009 , Bloomberg)
Drugs with about $24 billion in annual sales are set to lose patent protection this year according to IMS Health Inc the Norwalk Connecticut based research firm. More...
India may ask Kenya to review drug law
(Amiti Sen & Sushmi Dey, , 05-May-2009 , The Economic Times)
India is likely to ask Kenya to make amendments in its recent anti counterfeit law to protect Indian pharmaceutical exports. More...
Hetero bags mega chunk of govts anti flu drug deal
(Khomba Singh , 5-May-2009 , The Economic Times)
Roche does not hold a patent for Tamiflu in India. More...
Indian drugmakers facing takeover threat says Govt panel
(PTI , 04-May-2009 , The Economic Times)
With a large number of drugs going off patent in developed markets like the US and Europe Indian companies are expected to garner a lions share in the segment. More...
Acclarent Inc Granted Key Patent Covering Balloon Sinuplasty Technologies
(MENLO PARK, Calif , 04-May-2009 , PRNewswire)
Acclarent Inc the pioneer of Balloon Sinuplasty technologies for use in the treatment of chronic sinusitis announced today that the US Patent and Trademark Office awarded US Patent Number 7500971 entitled Devices Systems and Methods for Treating Disorders of the Ear Nose and Throat to the company. More...
Hetero Drugs close to receiving orders for its swine flu medicines
(Khomba Singh , 04-May-2009 , The Economic Times)
Its patent application was rejected by the India patent office in March 2009 which paved the way for Indian companies to legally manufacture and sell their generic version of the drug. More...
Pharma The 10 Most Promising New Drugs
(By Arthur Wong , 04-May-2009 , Business Week)
The pharmaceutical industry continues to march toward the patent cliff in 2010 2012 when a record amount of drug sales will lose patent protection in the US. More...
IPL brands work on intellectual property bouquets
(Malathi Nayak , 04-May-2009 , livemint)
Rodney D Ryder partner at law firm Kochhar and Co refers to the Indian Premier League the popular Twenty20 cricket tournament as the intellectual property league. More...
20th Century Fox sues B R Films for plagiarism
(Press Trust of India / Mumbai , 3-May-2009 , Business Standard)
Hollywoods famous studio Twentieth Century Fox has moved the Bombay High Court against B R Chopra Films seeking Rs 7 crore damages and an injunction against the release of the Hindi film Banda Yeh Bindaas Hai alleging it was a remake of Oscar winning My Cousin Vinny. More...
Google and other firms sued over use of Android name
(TEL AVIV , 3-May-2009 , MarketWatch)
An Illinois software developer sued some four dozen companies including Google Inc claiming that they infringed his trademark on the word Android weekend media reports said. More...
India to move WTO against EU MNCs blocking its generics
(Sushmi Dey , 02-May-2009 , The Economic Times)
India along with Brazil will lodge a complaint with the World Trade Organisation against the European Union alleging that Europe based multinational pharmaceutical firms are persuading African nations to enact anti counterfeit laws. More...
Patent office lets Roche keep Hepatitis C drug
(Priyanka Golikeri , 02-May-2009 , DNA)
According to the World Health Organisation as many as 180 million people worldwide have been infected by the hepatitis C virus with 3 4 million being added to the list every year. More...
Ranbaxy recalls Nitrofurantoin capsules from US market
(ET Bureau,NEW DELHI , 2-May-2009 , The Economic Times)
Indias largest drug company by sales Ranbaxy Laboratories is voluntarily recalling its entire lots of Nitrofurantoin 100 mg capsules from the US retail market after it was discovered that the drugs did not meet the US drug manufacturing standards. More...
Indian pharma emerges big player in Japan
(PB Jayakumar / Mumbai , 2-May-2009 , Business Standard)
Leading Indian drug makers such as Ranbaxy Lupin Zydus Cadila and Dishman which forayed into Japan in the past three years have emerged as important players in the generic or copycat drug business of patented medicines in that market the second largest in the world. More...
Gileads Hepatitis patent plea rejected
(Khomba Singh, , 2-May-2009 , The Economic Times)
The Delhi Patent Office has rejected American company Gilead Sciences plea to patent its Hepatitis B drug adefovir dipivoxil sold under the brand name Hepsera. More...
ImmunoCellular Therapeutics wins new patent for monoclonal antibody technology
(By Datamonitor staff writer , 01-May-2009 , Pharmaceutical Business Review)
ImmunoCellular Therapeutics a biotechnology company has received a new US patent relating to the companys monoclonal antibody therapeutics. More...
New Delhi rejects American firms plea to patent Hepatitis B drug
(Khomba Singh , 01-May-2009 , The Economic Times)
The Delhi Patent Office has rejected American company Gilead Sciences plea to patent its Hepatitis B drug adefovir dipivoxil sold under the brand name Hepsera. More...
Warner Chilcott Files New Lawsuit for Infringement of DORYX Patent
(HAMILTON, Bermuda , 01-May-2009 , PRNewswire)
Warner Chilcott Limited announced today that one of its subsidiaries and Mayne Pharma International Pty Ltd have filed a second lawsuit against Mylan Pharmaceuticals Inc and Mylan Inc in the District Court for the District of New Jersey for infringement of Maynes US Patent No 6958161 which covers DORYX a tetracycline class oral antibiotic. More...
Ready to supply anti flu drug at short notice says Ranbaxy
(ET Bureau , 30-Apr-2009 , The Economic Times)
The timely rejection of Gileads other patent application for Tamiflu in India has come as a shot in the arm for Indian generic players. More...
Wockhardt may get rights for two Parkinsons drugs
(BS Reporter / Mumbai April 30 , 30-Apr-2009 , Business Standard)
Settles 3 patent infringement cases out of court. More...
The Patent Reform Act Means Progress
(by Senator Patrick Leahy , 30-Apr-2009 , BusinessWeek)
Ingenuity and innovation have been cornerstones of the American economy from the time Thomas Jefferson issued the first patent. More...
FDAs Tamiflu move to spur generics mkt
(Reghu Balakrishnan , 30-Apr-2009 , The Financial Express)
Earlier this month the Delhi patent office had rejected the patent application for Tamiflu filed by Gilead Sciences while considering the pre grant opposition of Cipla. More...
The Patent Reform Act Means Progress
(by Senator Patrick Leahy , 29-Apr-2009 , Business Week)
Ingenuity and innovation have been cornerstones of the American economy from the time Thomas Jefferson issued the first patent. More...
McCurry beats McDonald in Malaysia lawsuit
(David Chance, Kuala Lumpur , 29-May-2009 , Reuters)
Fast food chain McDonald's lost a lawsuit in Malaysia on Wednesday after an appeals court overruled a decision that its trademark had been infringed by a local restaurant called McCurry. More...
i2 Files Intellectual Property Lawsuit
(DALLAS--(BUSINESS WIRE) , 29-Apr-2009 , StreetInsider )
i2 Technologies Inc announced today that it has filed a suit for patent infringement against Oracle Corporation. More...
Watson Confirms Filing of Abbreviated New Drug Application for Generic Enablex
(CORONA, Calif , 28-Apr-2009 , PRNewswire)
Watson Pharmaceuticals Inc a leading specialty pharmaceutical company today confirmed that it has filed an Abbreviated New Drug Application with the US Food and Drug Administration seeking approval to market its darifenacin hydrobromide extendedrelease 7.5 mg and 15 mg product prior to the expiration of a patent owned by Novartis AG. More...
Dr Reddy launches anti acne drug Nexret in India
(Agencies , 28-Apr-2009 , The Financial Express)
Pharmaceutical firm Dr Reddy said it has launched a variety of gel Nexret used in the treatment of skin diseases. More...
NicOx to acquire NO donating patents from Nitromed
(By Datamonitor staff writer , 28-Apr-2009 , Pharmaceutical Business Review)
France based NicOx has agreed to purchase US based Nitromeds unlicensed patent estate covering nitric oxide donating compounds. More...
AVI BioPharma Receives Key Patents
(PORTLAND, OR , 28-Apr-2009 , ag-IP-news )
AVI BioPharma Inc a developer of RNA based drugs announced in a Tuesday press release the issuance of the second of two key US patents covering the companys candidate drug for the treatment of Ebola Zaire infection. More...
Watson and Novartis battle over Enablex patent
(Associated Press , 28-Apr-2009 , Forbes)
Watson Pharmaceuticals Inc is disputing the patent on Novartis AGs extended release overactive bladder treatment Enablex Watson said Tuesday. More...
US approval for Glenmark cholesterol drug
(BS Reporter / Mumbai , 28-Apr-2009 , Business Standard)
Sources said Zetia had sales of $1.5 billion in 2008 and the main patent for this drug would expire in 2014. More...
US watch list on patents irks India
(PTI ,New Delhi , 28-Apr-2009 , The Financial Express)
India has conveyed its big disappointment to the US for retaining New Delhi on the Priority Watch List which binds Washington to exert pressure on Americas trade partners to improve their copyright and patent regimes. More...
Local drug cos may chip in to treat swine flu
(Khomba Singh & Sushmi Dey , 28-Apr-2009 , The Economic Times)
Cipla and other Indian pharma majors can now legally manufacture generic versions of Tamiflu after the patent office in Delhi last month rejected a patent application by Swiss company Roche which markets the antiviral in India. More...
Cipla ready to supply generic drug to West
(Corporate Bureau , 28-Apr-2009 , The Financial Express)
Early this month the Delhi patent office had rejected the application of Gilead Sciences the manufacturer of Tamiflu for a patent considering Ciplas arguments that the drug lacked inventiveness. More...
L&T unit files for 108 patents in 2008 09
(Our Bureau , 28-Apr-2009 , Business Line)
Mumbai April 27 Larsen and Toubros Electrical and Electronics Division has filed 108 patents applications in 2008 09 for its electrical and electronic products. More...
Sinobiopharma Secures Rights to Seven Key Patents
(NANJING, China , 27-Apr-2009 , PRNewswire)
The patents that will significantly enhance Sinobiopharmas ability to execute on its mission of bringing safe low cost high efficacy biopharmaceuticals to market. More...
FTC focused on drug pay for delay settlements
(By Diane Bartz , 27-Apr-2009 , Reuters)
The FTC while watching legislative efforts to ban the practice of big drug companies paying off generics as part of patent lawsuits has challenged the deals in court with mixed success. More...
Qualcomm and Broadcom Settle Patent
(Corporate News , 27-Apr-2009 , StreetInsider)
Qualcomm Incorporated and Broadcom Corporation entered into a settlement and multi year patent agreement with Qualcomm paying Broadcom $891 million over a four year period. More...
Not too enticing
(Ram Prasad Sahu / Mumbai , 27-Apr-2009 , Business Standard)
Going ahead although there are issues pertaining to patent registration and pricing if the company does manage to sort out these and use the listed arm for new launches sales could witness a jump considering its presence in high growth areas of anti diabetic cardiovascular gynaecology and anti ulcerants. More...
Sanofi Rebuffed by US High Court on Lovenox Patent
(By Greg Stohr and Susan Decker , 27-Apr-2009 , Bloomberg.com)
The US Supreme Court rejected an appeal by two Sanofi Aventis SA units refusing to reinstate a patent that prevented generic competition to the companys top selling product the blood thinner Lovenox. More...
Govt to create 1380 patent examiners posts
(Our Bureau , 27-Apr-2009 , Business Line)
The Centre plans to create 1380 patent examiners posts during the 11th Plan period of which 414 will be filled up this year alone. More...
Govt gives diplomatic push to pharma exports to Africa
(Amiti Sen & Sushmi Dey , 25-Apr-2009 , The Economic Times)
India has started a diplomatic exercise to counter a propaganda by multinational pharmaceutical companies against Indian generics or off patent drugs exported to Africa. More...
Cipla gets HC relief in Roche case
(Radhieka Pandeya , 25-Apr-2009 , livemint)
In a ruling that could encourage more generic or off patent drug makers here to challenge patents held my multinational pharma firms the Delhi high court dismissed a patent infringement suit filed by Swiss pharma company Hoffman La Roche Ltd for its lung cancer drug Tarceva thereby allowing Indian drug maker Cipla Ltd to continue marketing the generic version of the drug. More...
J&J Wins Approval to Sell Arthritis Drug in US
(By Shannon Pettypiece and Alex Nussbaum , 24-Apr-2009 , Bloomberg.com)
Remicades patent will expire in 2018 said Brian Kenney a spokesman for J&Js Centocor Ortho Biotech unit. More...
Delhi High Court dismisses Roche plea on patent
(PTI , 24-Apr-2009 , The Economic Times)
The Delhi High Court on Friday allowed Indian pharmaceutical company Cipla to manufacture and sell the generic version of patented lung cancer drug Erlotinid of Swiss pharma firm Hoffman La Roche Ltd. More...
Intellectual property report favours conditional patenting of micro organisms
(P.T. Jyothi Datta , 24-Apr-2009 , Business Line)
Mumbai April 23 Without much ado the Technical Expert Group on Patent Law Issues headed by Dr R A Mashelkar has resubmitted its report to the Union Ministry of Commerce. More...
Teva to appeal against preliminary injunction for Generic Evista update
(by RTT Staff Writer , 23-Apr-2009 , RTT News)
Teva Pharmaceutical Industries Ltd said Thursday that it plans to appeal the Courts order in the litigation with Eli Lilly & Co. More...
Gilead to challenge Tamiflu verdict
(Reghu Balakrishnan , 23-Apr-2009 , The Financial Express)
The patent office had recently rejected Gileads patent application owing to lack of inventiveness in the drug. More...
Teva Glenmark call an end to patent dispute
(Nina Mehta , 23-Apr-2009 , The Economic Times)
Israeli generic major Teva and Mumbai based Glenmark Pharmaceuticals have settled a patent dispute over various generic versions of Corega drug used for treating congestive heart failure out of court. More...
NicOx acquires Nitromeds NO donating patents
(SOPHIA ANTIPOLIS, FRANCE, MARKET WIRE , 23-Apr-2009 , StreetInsider)
NicOx SA today announced it has agreed to purchase Nitromeds unlicensed patent estate covering nitric oxide donating compounds. More...
Lilly says judge prevents launch of generic Evista
(by Deena Beasley , 22-Apr-2009 , Reuters)
Eli Lilly and Co said on Wednesday that a federal judge issued a preliminary injunction preventing the launch of a generic version of osteoporosis drug Evista. More...
Piramal Health eyes acquisitions in US Europe
(Reuters , 22-Apr-2009 , livemint)
Piramal Healthcare and a related firm Piramal Life Sciences Ltd would together invest about Rs1 billion during the 12 months to March 2010 mostly on new drug development and research. More...
IMS Health Cuts Pharma Growth Forecast
(By Catherine Arnst , 22-Apr-2009 , BusinessWeek)
Big Pharma isnt so immune to the recession after all. More...
Dr Reddys launches Redispar in India
(Press Trust of India / Mumbai , 22-Apr-2009 , Business Standard)
Pharmaceutical firm Dr Reddys Laboratories today said it has launched Redispar drugs used in the treatment of chronic kidney diseases in the country. More...
The US Is Losing Its Lead in Patents
(By Michael Arndt , 22-Apr-2009 , BusinessWeek)
Innovation is coming from abroad these days and foreign applications are coming faster and faster. More...
ACTA to fight copyright infringement
(PK Vasudeva , 22-Apr-2009 , The Financial Express)
The US is considering bringing an Anti Counterfeiting Trade Agreement. More...
Glaxo Pfizers patent claims turned down
(ET Bureau , 22-Apr-2009 , The Economic Times)
Indian authorities have rejected the patent applications of GlaxoSmithklines anti diabetic drug Avandia and Pfizers cholesterol lowering drug Caduet allowing other companies to sell generic versions of these drugs. More...
Big Pharma evergreening nixed
(Priyanka Golikeri , 22-Apr-2009 , DNA)
Introducing highly expensive patented drugs that show little or no improvement over existing ones or attempts to evergreen patents is getting tougher for multinationals. More...
Glaxo Pfizer HIV research JV may harm generic cos
(Nina Mehta , 22-Apr-2009 , The Economic Times)
Ranjit Kapadia a pharma analyst with HDFC Securities said that the formation of the new firm will affect Indian companies if they are violating or challenging patents. More...
Par Pharma settles patent dispute with Reliant
(Associated Press , 21-Apr-2009 , Forbes)
Generic drug developer Par Pharmaceutical Cos said Tuesday it settled a patent dispute with Reliant Pharmaceuticals Inc over the abnormal heart rhythm treatment Rythmol SR. More...
Covidien Files Patent Infringement Lawsuit over Davols Mesh Fixation Device and Applier
(NORTH HAVEN, Conn , 21-Apr-2009 , Business Wire)
The lawsuit contends that Davols recently released Sorbafix device infringes multiple claims of Covidiens US Patent Number 6562051. More...
Expert committee suggests patenting microorganisms too
(C.H. Unnikrishnan , 21-Apr-2009 , livemint)
An expert group has suggested significant changes to Indias patent regime that will address contentious provisions that barred the issue of patents to anything that isnt a new chemical or medical entity and to drugs built around microorganisms. More...
Glaxo to buy skin care firm for at least $2.9 billion
(By Steve Goldstein , 20-Apr-2009 , MarketWatch)
Companies in the sector have been looking for deals to boost their stable of new products as the patent protection for older medications expire. More...
Achillion wins new US patent
(By Datamonitor staff writer , 20-Apr-2009 , Pharmaceutical Business Review)
Achillion Pharmaceuticals a US based biopharmaceutical company has announced that the US Patent & Trademark Office has granted Achillion a US patent related to the companys NS4A antagonists to treat the hepatitis C virus. More...
IPR course for women
(STAFF REPORTER , 20-Apr-2009 , The Hindu)
The training is aimed at having a pool of resources trained in scientific and technical aspects of intellectual property rights. More...
Indian lawyer turns IPR into a board game
(Malathi Nayak , 20-Apr-2009 , livemint)
The game is the brainchild of Pravin Anand one of Indias best known IPR lawyers. More...
Drug firms may exceed growth targets
(PB Jayakumar / Mumbai , 20-Apr-2009 , Business Standard)
Despite forex losses and currency fluctuations impacting profitability leading Indian drug companies such as Cipla Sun Pharma Dr Reddys Laboratories and Wockhardt are likely to exceed revenue growth targets set for financial year 2008 09. More...
Scope to improve in big markets where the firm is already present
(Radhieka Pandeya , 20-Apr-2009 , livemint)
Russia has been a good market for us. It is a branded generics market and we have been in the market for long More...
Govt protests as generic drugs get bitter pill in Africa
(Arun S , 20-Apr-2009 , The Financial Express)
India has called an extraordinary meeting of the ambassadors of all African countries in the Capital this week to register its strong protest against a recently passed Anti Counterfeit Act in Kenya that could severely restrict the market for Indian generic drugs into Africa. More...
Pharma companies headed for slower earnings growth analysts
(C.H. Unnikrishnan and Radhieka Pandeya , 20-Apr-2009 , livemint)
Average growth in sales for the quarter likely to be less than 11% compared with 14% in the year ago period More...
Pharma MNCs ask DCGI to liaison with patent offices
(Reghu Balakrishnan , 19-Apr-2009 , The Financial Express)
In the backdrop of Wednesdays Delhi High Court verdict that allowed Cipla to manufacture and sell a patented cancer drug in India multinational pharma companies plan to urge the Drug Controller General of India to improve its co ordination with patent offices across the country. More...
Indian pharma industry may gain $18.4 bn from global mkt
(PTI,NEW DELHI , 19-Apr-2009 , The Economic Times)
With the global pharmaceutical market likely to witness products worth 123 billion dollars loosing patents by 2012 the generics driven Indian drugs industry could get benefit of around 18.4 billion dollars about Rs 91576 crore from those products. More...
Sepracor Announces Patent Interference Proceedings Against Wyeth
(MARLBOROUGH, MASS , 18-Apr-2009 , ag-IP-news )
Sepracor Inc announced that the Board of Patent Appeals and Interferences of the US Patent and Trademark Office has combined three patent interferences into a single interference between Sepracor and Wyeth and set a date for oral arguments. More...
Adcocks plan to buy Medpro hits Cipla hurdle
(ET Bureau , 18-Apr-2009 , The Economic Times)
South African company Adcock Ingrams plans to buy Cipla Medpro with whom Indian pharma major Cipla has a 20 year drugsupply agreement has run into trouble with the Mumbai based company opposing the $228 million takeover. More...
Drug patents India to take EU to WTO
(Arun S , 18-Apr-2009 , The Financial Express)
The patents battle between India and the European Union in the pharmaceutical space will soon reach the dispute settlement body of the World Trade Organisation. More...
Glaxo Pfizer to merge HIV drug units in challenge to Gilead
(Bloomberg / London , 18-Apr-2009 , Business Standard)
GlaxoSmithKline Plc once the worlds biggest maker of AIDS drugs will form a new company with rival Pfizer Inc to increase its share of the $12.3 billion HIV market now dominated by Gilead Sciences Inc. More...
Nobel Biocare wins patent ruling in Germany
(Katie Reid , 17-Apr-2009 , Reuters)
Swiss dental implant maker Nobel Biocare said on Friday it had won a German court ruling in a patent infringement case brought by Materialise Dental in relation to Nobel Biocares NobelGuide software. More...
Patentholder asks Noida excise dept to cancel Samsung licence
(C.H. Unnikrishnan , 17-Apr-2009 , livemint)
A Madurai based engineer has asked authorities to cancel Samsungs licence to manufacture dual SIM mobile phones as he holds the local patent for such mobiles More...
Sepracor disputes patent on Wyeths Pristiq
(Associated Press , 17-Apr-2009 , Forbes)
Sepracor Inc on Friday took a step toward a potential challenge of patents supporting Pristiq an antidepressant marketed by Wyeth. More...
Roches Hepatitis drug patent upheld
(Joe C Mathew / Bangalore , 17-Apr-2009 , Business Standard)
The patent office has upheld the validity of Roches patent rights over Pegasys pegylated interferon alfa2a a Hepatitis C medicine. More...
Rib X granted patent for novel oxazolidinone in China
(Medical Patent News , 16-Apr-2009 , News-Medical.Net)
Pharmaceuticals Inc has announced the issuance of a key antibiotic patent in China. More...
Court Grants AstraZeneca Temporary Restraining Order Against Apotex in PULMICORT RESPULES Patent Litigation
(AstraZeneca , 16-Apr-2009 , Biocompare)
On 16 April 2009 the US District Court for the District of New Jersey granted AstraZenecas request for a temporary restraining order barring Apotex from launching a generic version of AstraZenecas PULMICORT RESPULES until further order of the court. More...
Pig patent row upsets top EU producer Germany
(By Brian Rohan , 16-Apr-2009 , Reuters)
A test to check pigs for a gene that makes them produce more meat has sparked a row in Germany where farmers ecologists and politicians filed objections to its patent before an appeals deadline on Thursday. More...
Piramal gets injunction in drug trademark case
(C.H. UnnikRishnan , 16-Apr-2009 , livemint)
The injunction temporarily restrains these companies from using brand names similar to Esgipyrin for marketing the same drug combination More...
AstraZeneca India announces CRESTOR tablets launch
(Sushmi , 16-Apr-2009 , The Economic Times)
AstraZeneca India announced the launch of CRESTOR rosuvastatin 5 10 20 and 40 mg tablets today. More...
Troikaa Pharma launches cancer drug
(Our Bureau , 16-Apr-2009 , Business Line)
The lozenges and their holders are indigenously designed and patented. More...
New drug research is a high risk game
(P B Jayakumar / Mumbai , 16-Apr-2009 , Business Standard)
Lupin Ltd one of the top five drug companies in India grew over 30 per cent yearly in the past four years and maintained 38 per cent growth in turnover and 49 per cent growth in profits in the first nine months of 2008 09. More...
India rejects patent to Glivecs second variant
(Joe C Mathew / Bangalore , 15-Apr-2009 , Business Standard)
Ruling intended to prevent patenting of inventions known earlier. More...
CORRECT Sales forecast haunts Abbott shares
(By Val Brickates Kennedy , 15-Apr-2009 , MarketWatch)
Abbott Laboratory shares moved notably lower Wednesday as investors reacted negatively to news that sales growth for the companys popular rheumatoid arthritis drug Humira might not be as robust as previously expected. More...
Peregrine wins new US patent
(By Datamonitor staff writer , 15-Apr-2009 , Pharmaceutical Business Review)
Peregrine Pharmaceuticals a biopharmaceutical company has received a new US patent that is expected to strengthen the companys intellectual property in the field of phospholipid targeting agents for the treatment of life threatening diseases. More...
Rib X Granted Key Antibiotic Patent in China
(NEW HAVEN, Conn. , 15-Apr-2009 , PRNewswire)
Rib X Pharmaceuticals Inc a development stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic resistant infections today announced the issuance of a key antibiotic patent in China. More...
Samsung files appeal against dual SIM
(Bettina Wassener , 15-Apr-2009 , livemint)
Prateek Garg a 26 year old software engineer who lives in Delhi has been unemployed since September and has had only two job interviews since then. More...
Mylan Confirms First To File Patent Challenge Relating To Xeloda Cancer Treatment
(Mylan Inc. , 14-Apr-2009 , Biocompare)
Mylan Inc today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc have been sued by Hoffmann La Roche Inc in connection with the filing of an Abbreviated New Drug Application with the US Food and Drug Administration for Capecitabine Tablets 150 mg and 500 mg the generic version of Xeloda Tablets a chemotherapy treatment for breast and colorectal cancer. More...
Mylan challenges patent sued by Roche
(Associated Press , 14-Apr-2009 , Forbes)
Mylan Inc said Tuesday it is being sued by Roche after challenging the Swiss drug developers patent on the cancer treatment Xeloda. More...
Zydus Pharma sued in US over anti depressant
(Reghu Balakrishnan , 14-Apr-2009 , The Financial Express)
Zydus Pharma Inc the US subsidiary of the Ahmedabad based pharma major Zydus Cadila has been sued by US major Wyeth following the latters paragraph IV ANDA submission for the marketing approval of Effexor a leading anti depressant drug with $4 billion sales revenue owned by Wyeth in the US market. More...
We should properly evaluate these combination drugs
(M Venkateswarlu, , 14-Apr-2009 , The Economic Times)
Any drug before being permitted for marketing in the country for the first time undergoes a series of scientific studies pre clinical studies or M Venkateswarlu Former Drugs Controller General of India animal model studies and clinical trials carried out in three phases. More...
These are quality medicines Indias success formula
(Daara B Patel, , 14-Apr-2009 , The Economic Times)
Fixed Dose Combinations have been manufactured successfully in India and abroad for many years. More...
Alcatel Patent in $358 Million Suit Rejected by US
(By Susan Decker , 14-Apr-2009 , Bloomberg.com)
An Alcatel Lucent SA patent that resulted in a $358 million jury verdict against Microsoft Corp was rejected by the US Patent and Trademark Office after the agency took a second look at the invention. More...
US rejects Alcatel patent could affect award
(Bill Rigby , 13-Apr-2009 , Reuters)
The US Patent and Trademark Office has rejected two patents claimed by French telecoms equipment Alcatel Lucent which could end up nullifying a multi million dollar damages award against software maker Microsoft Corp. More...
CoolTouch Inc Settles Diomed Lawsuit Files Re examination Request for Cynosure 873 Patent
(CoolTouch Inc. , 13-Apr-2009 , Biocompare)
ROSEVILLE Calif PRNewswire On April 7 2009 the Boston District Court dismissed the Diomed lawsuit between Endolaser Associates LLC and CoolTouch Inc after CoolTouch signed a settlement agreement with Dr Luis Navarro. More...
Indias Sun Pharma gets FDA nod for generic Roxicodone
(Prashant Mehra , 13-Apr-2009 , Reuters)
The generic oxycodone hydrochloride tablets are used as a painkiller. More...
Cadila looking at global tie ups for Polycap
(Press Trust Of India / New Delhi , 13-Apr-2009 , Business Standard)
Ahmedabad based Cadila Pharmaceuticals is looking for global tie ups to market its new patented product Polycap a combination of five medicines that prevents heart attack. More...
HC to hear dual SIM patent case today
(Niranjana Ramesh, , 13-Apr-2009 , The Economic Times)
The Madras High Court will hear a petition filed by a Madurai based engineer Somasundaram Ramkumar seeking the enforcement of patent protection for his invention the dual SIM card technology used in mobile phones. More...
Sun loses US patent case for lucrative drug
(PB Jayakumar / Mumbai , 12-Apr-2009 , Business Standard)
Sun Pharmaceutical Industries has lost a patent infringement case in the US on Cardene a drug for controlling high blood pressure. More...
Defensive pharma promises solid Q1 results
(Ben Hirschler and Lewis Krauskopf , 12-Apr-2009 , Reuters)
A looming cliff of patent expiries growing political pressure in the United States and elsewhere and a lack of new drugs coming out of research labs mean drug companies are struggling with over capacity just like other industries. More...
J&J expected to report lower earnings
(Val Brickates Kennedy , 12-Apr-2009 , MarketWatch)
J&Js pharmaceutical division once its core business has been hit in recent quarters by the loss of patent exclusivity on such brand names as Risperdal and Topamax. More...
HP Files Appeal in Patent Dispute with Cornell University
(PALO ALTO, CA , 12-Apr-2009 , ag-IP-news )
HP announced in a press release that it has filed an appeal in its patent dispute with Cornell University and the Cornell Research Foundation Cornell. More...
Daiichi Sankyo Files Patent Infringement Actions Against 11 Generics Companies
(ag-IP-news , 11-Apr-2009 , ag-IP-news )
Daiichi Sankyo Ltd announced in a press release that it has brought patent infringement litigations against 11 generics companies for the substance patent 2008845 and usage patent 1659502 for Levofloxacin Hydrate brand name Cravit tablets and Cravit fine granules. More...
United Treatment Centers Inc Acquires a Stake in Bel Ea Co and Its Trademarks
(ASTORIA, NEW YORK -- (MARKET WIRE) , 10-Apr-2009 , StreetInsider)
United Treatment Centers Inc today announced it has acquired a 50% stake of Bel Ea Co from an existing shareholder. More...
We will be back to normal soon
(P. T. Jyothi Datta , 10-Apr-2009 , Business Line)
Wockhardt watchers also observe that the company like many corporates in and outside the pharmaceutical segment went on an acquisition over kill and worse funded it through debt when the going was good. More...
Wockhardt to foray into biosimilar market
(Nina Mehta,MUMBAI , 10-Apr-2009 , The Economic Times)
Wockhardt is planning to tap the $33 billion biosimilar market and focus on products that lose patent protection in 2013 2015. More...
Natco Lupin tie up for generic drug to treat kidney failure
(Our Bureau , 10-Apr-2009 , Business Line)
Natco Pharma Ltd has tied up with Lupin Ltd to jointly commercialise generic equivalents of Lanthanum Carbonate tablets used to treat kidney failure. More...
Samsung files appeal with board against dual SIM patent
(C.H. Unnikrishnan , 10-Apr-2009 , livemint)
The firm filed a petition with IPAB asking it to revoke the existing patent for issued toan Indian inventor More...
Novartis retailers lock horns over direct sales
(Khomba Singh, , 10-Apr-2009 , The Economic Times)
An open battle has erupted between drug retailers in Mumbai and Novartis a Swiss company and its subsidiary Sandoz. More...
Cipla can benefit if Medpro acquisition goes through
(P.T. Jyothi Datta , 10-Apr-2009 , Business Line)
Mumbai based drug maker Cipla Ltd can look to expand its presence in South Africa and indeed other parts of the region if South Africa s Adcock Ingram Healthcare Ltds $233 million proposal to acquire generic drugs player Cipla Medro goes through. More...
Takeda takes back Actos rights from Lilly
(Yumiko Nishitani , 9-Apr-2009 , Reuters)
Like its peers Takeda Japans largest drugmaker faces pressure from the economic slowdown in the United States the biggest market for Actos and it will lose patent protection on the drug there in 2011. More...
Wockhardt to hive off biotech division
(P B Jayakumar / Mumbai , 9-Apr-2009 , Business Standard)
Wockhardt has one of the largest off patent biotech drugs under development in India. More...
Aurobindo gets nod from Swissmedic
(Agencies , 8-Apr-2009 , The Financial Express)
Drug maker Aurobindo Pharma on Wednesday said it has received approval from the Switzerland government for marketing Finasteride APL a drug used for treating enlarged prostate in men. More...
Mylan Announces Clarinex Settlement Agreement
(Mylan Inc. , 8-Apr-2009 , Biocompare)
Mylan Inc today announced the settlement of all patent litigation relating to Desloratadine Tablets 5 mg the generic version of Schering Ploughs Clarinex allergy medication. More...
Microsoft ordered to pay Uniloc $388 million
(SEATTLE , 08-Apr-2009 , BusinessWeek)
A federal judge on Monday ordered Microsoft Corp to pay $388 million in damages after finding the worlds largest software maker infringed on a patent held by Uniloc Inc. More...
Are Patent Problems Stifling US Innovation
(Damian Joseph. , 08-Apr-2009 , BusinessWeek)
The US Patent and Trademark Office is drowning in applications while its budget shrinks. More...
Affitech wins new European patent for antibody screening technology
(By Datamonitor staff writer , 08-Apr-2009 , Pharmaceutical Business Review)
Affitech an antibody R&D company has reported that the European Patent Office has granted a European patent on the use of phagemid particles having an antibody coliphage pIII fusion protein to identify tumor associated antigens on cells by negative selection. More...
Many Drug Prescriptions are Now Going Unfilled
(By JONATHAN D. ROCKOFF , 08-Apr-2009 , The Wall Street Journal)
That isnt good news for drug makers already struggling to replace the sales of top selling medicines losing patent protection over the next several years. More...
Pfizer reorganizes units for Wyeth buy
(Shannon Pettypiece , 8-Apr-2009 , livemint)
Pfizer the worlds biggest drug maker needs to ramp up new drug development as it braces to lose $10 billion in annual sales in 2011 when patent protection ends for its cholesterol pill Lipitor analysts said. More...
Re evaluating pharma
(Business Standard / New Delhi , 8-Apr-2009 , Business Standard)
The last avenue has been opened up with patent protection taking root in India. More...
Indian drug makers welcome to join patent pool prog GSK
(PTI , 07-Apr-2009 , The Economic Times)
Global drug major GlaxoSmithKline has said Indian drug makers and research firms can join its patent pool programme aimed at developing low cost drugs for 16 neglected tropical diseases. More...
AstraZeneca Files Suit Against Apotex
(LONDON , 07-Apr-2009 , ag-IP-news )
AstraZeneca has filed a lawsuit in the US District Court for the District of New Jersey against Apotex seeking a declaration of patent infringement a press release by AstraZeneca stated. More...
Gilead Sciences Announces Notification of ANDA Filing for Atripla
(BUSINESS WIRE , 07-Apr-2009 , Biocompare)
Gilead Sciences Inc today announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application to the US Food and Drug Administration requesting permission to manufacture and market a generic version of Atripla. More...
Rambus Buys Inapac Patents
(Corporate News , 07-Apr-2009 , StreetInsider)
Rambus Inc announced it has acquired a number of patents from Inapac Technology Inc to broaden its offerings for the mobile memory market. More...
Impax Confirms Patent Challenge Relating to Renvela
(HAYWARD, CA , 07-Apr-2009 , ag-IP-news )
Impax Laboratories Inc confirmed that it has initiated a challenge of the patents listed by Genzyme Corporation in connection with its Renvela 800 mg tablets a press release by Impax stated. More...
Ex Bristol Myers Executive Pleads Guilty In Plavix Patent Case
(DOW JONES NEWSWIRES , 6-Apr-2009 , CNNMoney.com)
Andrew Bodnar a former executive of Bristol Myers Squibb Co pleaded guilty Monday to a charge related to his role in a patent deal the drug maker struck to keep a generic competitor to its popular blood thinning drug Plavix off the market. More...
Teva Pharma A Safe Prescription
(RTTNews , 6-Apr-2009 , RTT News)
Hit by a triple whammy of pipeline woes an onslaught of blockbuster patent expiries and regulatory stringency the once invincible branded drugs giants are engulfed in a fog of uncertainty. More...
Arrow Coated Products gets patent for specialised films
(BS Reporter / Mumbai , 06-Apr-2009 , Business Standard)
Arrow Coated Products Ltd one of Indias leading and pioneering manufacturers of pressure sensitive adhesive coated films has been granted patent for Embedded Water Soluble Films by Australian Patent office Patent Grant No 2002356417 till October 07 2022 the company said in a BSE filing. More...
Sepracor files NDA for seizure drug
(By Datamonitor staff writer , 06-Apr-2009 , Pharmaceutical Business Review)
Sepracor a research based pharmaceutical company has submitted a new drug application to the FDA for the use of eslicarbazepine acetate as adjunctive therapy in the treatment of partial onset seizures in adults with epilepsy. More...
Impax sued by Genzyme in patent challenge
(Associated Press , 06-Apr-2009 , Forbes)
Drug developer Impax Laboratories Inc said Monday it is being sued by Genzyme Corp over a patent challenge to that companys kidney condition drug Renvela. More...
Gilead Reviews Tevas Generic Application May File Suit
(DOW JONES NEWSWIRES , 06-Apr-2009 , CNNMoney.com)
Gilead Sciences Inc said it is reviewing a notice letter and has 45 days to file a patent infringement lawsuit against Teva Pharmaceutical Industries Ltd following Tevas submission to manufacture and market a generic version of HIV drug Atripla. More...
Five Indian inventions win US patent
(NEW DELHI (Xinhua) , 5-Apr-2009 , The Hindu)
Five inventions by a New Delhi resident named Anadish Pal have won patent from the United States government Navbharat Times reported on Sunday. More...
Nomadix Wins Patent Enforcement Action Against Second Rule LLC
(NEWBURY PARK, CA , 4-Apr-2009 , ag-IP-news )
DOCOMO interTouch announced that its subsidiary Nomadix Inc has won a patent enforcement action against Second Rule LLC the maker of the IP3 NetAccess gateway a press release by Nomadix stated. More...
Patent to Bajaj will not affect us TVS Motor
(Our Bureau , 4-Apr-2009 , Business Line)
Mumbai April 3 TVS Motor Company has stated that the grant of the ExhausTEC patent to Bajaj Auto does not in any way impact its products in the market. More...
AstraZeneca sues Apotex over generic asthma drug
(Bill Berkrot , 03-Apr-2009 , Reuters)
Pulmicort had US sales of $982 million in 2008 with about 90 percent of that coming from the form of the medicine that is being disputed in the patent case. More...
Boston Scientific announces key rulings in stent litigation with J&J
(By Datamonitor staff writer , 03-Apr-2009 , Pharmaceutical Business Review)
Boston Scientific a developer manufacturer and marketer of medical devices has reported that the Court of Appeals for the Federal Circuit has issued a positive ruling in the companys stent litigation with Johnson and Johnson or J&J. More...
Court rules for Lilly in patent fight with Ariad
( Diane Bartz , 03-Apr-2009 , Reuters)
Eli Lilly did not infringe a patent owned by Ariad Pharmaceuticals when it made its Evista osteoporosis drug and Xigris sepsis treatment a US appeals court said on Friday. More...
Acquisition overdose Worries over future of pharma industry
(P.T. Jyothi Datta , 3-Apr-2009 , Business Line)
Challenges are in store for local drug companies also in the form of patent related challenges in India and abroad. More...
What is the Satyam Upaid case about
(Raghuvir Srinivasan , 3-Apr-2009 , Business Line)
Armed with the patent Upaid filed a suit against Qualcomm and Verizon Wireless in 2005 alleging that they were using the patented technology. More...
Patent to Bajaj could mean trouble for TVS
(Shally Seth , 3-Apr-2009 , livemint)
Indias patents office has granted exclusive rights to an engine technology Bajaj Auto Ltd uses in all its motorcycles which could land its rival TVS Motor Co Ltd into trouble since it also uses the same technology in some of its bikes. More...
Better protection of intellectual property to boost indigenous innovation
(Ayushman Baruah , 3-Apr-2009 , The Financial Express)
According to a BSA IDC global software piracy study the Indian software industry lost around $2 billion due to software piracy last year. More...
MNC drug makers eye generics in India other emerging countries
(PB Jayakumar / Mumbai , 3-Apr-2009 , Business Standard)
Multinational drug makers such as Pfizer and GlaxoSmithkline are planning large scale forays into generic manufacturing or the reverse engineered cheap drugs business threatening the growth prospects and survival of Indian generic companies such as Ranbaxy Laboratories Dr Reddys Laboratories and Sun Pharma and global generic leaders like Teva Sandoz and Mylan. More...
Shire Files Lawsuit Against Natco Pharma for Infringement of FOSRENOL Patents
(Shire Plc , 2-Apr-2009 , Biocompare)
Shire plc announces that it has filed a lawsuit in the US District Court for the Southern District of New York against Natco Pharma Limited for infringement of two of Shires patents US Patent No 5968976 and US Patent No 7381428. More...
Watson Does Not Infringe Patent Related to Generic Version of Concerta
(CORONA, CA , 2-Apr-2009 , ag-IP-news )
Watson Pharmaceuticals Inc announced in a press release that the United States District Court for the District of Delaware has ruled that Watsons generic version of Concerta does not infringe United States Patent No 6919373 and that the 373 Patent is invalid. More...
US Senate panel approves patent reform
(By Diane Bartz , 02-Apr-2009 , Reuters)
The Senate Judiciary Committee voted on Thursday to approve a patent reform bill that has had drug high tech and other industries at loggerheads for several years. More...
US senators agree on patent changes
(By Diane Bartz , 01-Apr-2009 , Reuters)
Leaders of the US Senate Judiciary Committee said on Wednesday they had reached agreement on key elements of a bill to revise US patent law. More...
Mylan confirms four first to file ANDA lawsuits
(By Datamonitor staff writer , 01-Apr-2009 , Pharmaceutical Business Review)
Believes it to be the first to have filed substantially complete ANDAs containing Paragraph IV certification. More...
District Court decision received in Concerta patent sase
(Medical Patent News , 01-Apr-2009 , News-Medical.Net)
The US has rendered a decision in the patent litigation between Alza Corporation McNeil PPC Inc and Andrx Pharmaceuticals LLC McNeil Pediatrics Division of Ortho McNeil Janssen Pharmaceuticals Inc which markets Concerta Extended Release Tablets CII said the court held that the patent in suit is not valid or infringed by the filing of Andrxs Abbreviated New Drug Application. More...
Glenmark to stop sale of its pain killer in US
(Radhieka Pandeya , 01-Apr-2009 , livemint)
Glenmark Pharmaceuticals Ltd said it will stop selling its morphine sulfate drug in the US complying with a warning by that countrys drugs regulator More...
Clearance for only one Ranbaxy site
(Radhieka Pandeya , 1-Apr-2009 , livemint)
Information provided by Ranbaxy Laboratories Ltd in filings to the stock exchanges and a press release issued on 23 March has led some analysts and at least one international news agency into assuming that the companys Paonta Sahib facility censured by the US Food and Drug Administration had been subsequently given the all clear by the drug regulators of the UK and Australia. More...
Delaware Court Rules That Watson Does Not Infringe Patent Related to Generic Version of Concerta and Declares Patent Invalid
(Patty Eisenhaur , 31-Mar-2009 , Biocompare)
Watson Pharmaceuticals Inc a leading specialty pharmaceutical company announced today that the United States District Court for the District of Delaware has ruled that Watsons generic version of Concerta does not infringe United States Patent No 6919373 and that the 373 Patent is invalid. More...
Eli Lilly looks to make more deals
(INDIANAPOLIS , 31-Mar-2009 , BusinessWeek)
Lilly will lose patent protection for its best selling drug the antipsychotic Zyprexa in 2011. More...
Matrix Labs gets USFDA nod for HIV infection tablets
(PTI,MUMBAI , 31-Mar-2009 , The Economic Times)
Drug manufacturer Matrix Laboratories on Tuesday said it has received US regulators approval for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets used in controlling HIV infection. More...
US FDA warns firms selling unapproved narcotics
(Lisa Richwine , 31-Mar-2009 , Reuters)
US regulators warned nine companies on Tuesday to stop selling 14 unapproved narcotic pain medicines part of an ongoing effort to rid the market of drugs without proper clearance. More...
Aurobindo Pharma gets tentative US nod for HIV drug
(REUTERS , 31-Mar-2009 , The Economic Times)
Drug maker Aurobindo Pharma said on Tuesday it secured a tentative approval from the US Food and Drug Administration to sell its emtricitabine and tenofovir disproxil fumarate combination drug in tablet form. More...
Amicus Therapeutics wins new US patent
(By Datamonitor staff writer , 31-Mar-2009 , Pharmaceutical Business Review)
Amicus Therapeutics a biopharmaceutical company has received a new US patent isofagomine the active ingredient in the companys investigational drug Plicera and its use for the treatment of Gaucher disease. More...
New Cadila combo pill may cut risk of stroke by half
(Sangeeta Singh,New Delhi , 31-Mar-2009 , livemint)
Medical professionals have long theorized on the benefits of a combination pill in cardiac disorders but it wasnt known if such a drug could be formulated and at the same time be effective More...
Eli Lilly eyes acquisitions WSJ
(Ajay Kamalakaran , 31-Mar-2009 , Reuters)
Lillys best selling drug the antipsychotic Zyprexa loses patent protection in 2011. More...
Unichem Lab gets FDA nod for Topiramate tablets
(Agencies ,Mumbai , 30-Mar-2009 , The Financial Express)
Pharma company Unichem Laboratories on Monday said it has received US regulatory approval for Topiramate tablets used for the treatment of epilepsy. More...
Ranbaxy Aurobindo get US FDA nod for epilepsy drug
(PTI , 30-Mar-2009 , The Economic Times)
Pharma firm Ranbaxy on Monday said it has received US regulatory approval for Topiramate tablets used in the treatment of epilepsy. More...
Cadila Pharma to launch product to curb sudden cardiac death
(BS Reporter / Mumbai/ Ahmedabad , 30-Mar-2009 , Business Standard)
Leading pharma company Cadila Pharmaceuticals in collaboration with McMaster University of Hamilton Canada has announced its plans to launch a product worldwide to bring down cardiovascular morbidity and mortality. More...
US FDA approves Suns new drug to market Topamax topiramate
(PTI,MUMBAI , 29-Mar-2009 , The Economic Times)
Sun Pharma today said the US Food and Drug Administration has granted an approval for its abbreviated new drug application to market generic Topamax topiramate tablets. More...
Local companies blocked from selling cheap lifesaving drug
(Janet Silvera , 29-Mar-2009 , The Gleaner)
JAMAICAN pharmaceutical company Indies Pharma is gearing up for a court battle with international drug manufacturing giant Pfizer USA over local distribution of hypertension medication used by thousands of Jamaicans living with the debilitating illness. More...
BCCI Zee fight over Twenty20 trademarks
(Rasul Bailay & , 28-Mar-2009 , livemint)
Over the past 15 months the Essel Group popularly referred to as Zee Group after the television channels it runs has filed at least four dozen applications with the countrys trademark office seeking registration of various combinations of Twenty20. More...
Teva gets FDA approval on version of J&Js Topamax
(Associated Press , 27-Mar-2009 , BusinessWeek)
The drugs key patents expired in March. More...
UK discovers counterfeit Novo Nordisk insulin pens
(Ben Hirschler , 27-Mar-2009 , Reuters)
Britains medicines watchdog said on Friday it had discovered a batch of counterfeit Novo Nordisk insulin pen needles circulating in the country and urged diabetics not to use them. More...
Pantaloon 1 a or 2 the names mine
(Rasul Bailay , 26-Mar-2009 , livemint)
Firm seeks cancellation of registrations granted to R Adag for using the Reliance Big Bazar trademark More...
India may drag EU to WTO on seizure of drugs in transit
(ET Bureau , 26-Mar-2009 , The Economic Times)
EU authorities have been seizing cargoes of drugs from India because they believe these medicines infringe local patent laws while transiting from its customs. More...
New diabetes drug approved without trial
(Radhieka Pandeya , 26-Mar-2009 , livemint)
A new drug to combat diabetes which is administered orally and not injected was given a marketing approval by the Drugs Controller General of India without being put through the mandatory human clinical trials highlighting a possible lapse in Indian laws dealing with the testing and approval of drugs. More...
Ranbaxy gets Australia nod for antipsychotic drug
( Devidutta Tripathy , 25-Mar-2009 , Reuters)
Indian drug maker Ranbaxy Laboratories said on Wednesday it had received the Australian drug regulators approval to market a generic version of Johnson & Johnsons antipsychotic drug Risperdal. More...
Foreign drug companies gain sales muscle following mergers
(C.H. Unnikrishnan , 25-Mar-2009 , livemint)
The growth of local drug firms had actually begun in the 1970s following the abolition of the product patent regime.Coincidentally foreign drug makers are set to gain market share after the reversal of the patent regime in 2005. More...
Patent for Making Combination Chemotherapy Work Better
(NexGen Biomedical, Inc , 24-Mar-2009 , Biocompare)
Patent 7507704 issued on 03 24 09 to NexGen Biomedical Inc founder Mark Zamoyski of San Jose California discloses an improved method of treating lung brain pancreatic breast and colon cancers that are driven by a mutation known as HER1 overexpression. More...
Allergan soars on Glaxo takeover speculation
(Val Brickates Kennedy , 24-Mar-2009 , MarketWatch)
An Allergan buy would immediately bolster Glaxos lucrative migraine headache franchise as a key patent for Imitrex is set to expire this year. More...
Plexxikon wins key patents for new drug compounds
(By Datamonitor staff writer , 24-Mar-2009 , Pharmaceutical Business Review)
Plexxikon a developer of small molecule pharmaceuticals has received key composition of matter patents covering novel compounds discovered through the companys Scaffold based Drug Discovery platform. More...
Glaxo pools 800 patents cuts drug prices for poor
(Ben Hirschler , 24-Mar-2009 , Reuters)
GlaxoSmithKline Plc will share more than 800 of its patents with others seeking to develop new medicines for neglected tropical diseases and slash the cost of many of its drugs in poor countries from next week. More...
Court Denies Wyeth Bid For Patent Extension On Cydectin
(By Brent Kendall , 24-Mar-2009 , CNNMoney.com)
A US trial judge on Monday denied Wyeths bid for a 10 month extension on its patent rights to Cydectin an animal health drug. More...
Lillys Zyprexa Prozac combo wins expanded use
(Lewis Krauskopf , 23-Mar-2009 , Reuters)
US regulators have expanded the approval of Eli Lilly and Cos Symbyax which combines the active ingredients of its Zyprexa antipsychotic and Prozac antidepressant for treatment resistant depression the company said on Monday. More...
American Bio Medica to receive two new US patents
(By Datamonitor staff writer , 23-Mar-2009 , Pharmaceutical Business Review)
American Bio Medica a biotechnology company has received notification from the US Patent & Trademark office that it will be granted two new patents one for its oral fluid drug testing product line and the other for its all inclusive urine point of collection drug test cup product line. More...
Cubist Pharma Files Patent Infringement Lawsuit Against Teva Update
(by RTT Staff Writer , 23-Mar-2009 , RTT News)
Monday drug maker Cubist Pharmaceuticals Inc said it filed a patent infringement lawsuit against Teva Parenteral Medicines Inc or TPM Teva Pharmaceuticals USA Inc alleging violation of its US patents related to daptomycin. More...
Patent filing facility soon
(Shastry V. Mallady , 23-Mar-2009 , The Hindu)
Micro Small and Medium Enterprises in the State will soon have a patent filing facility as the Tamil Nadu State Council for Science and Technology is launching an initiative in this direction. More...
Drug makers get ready to work on vaccine for cervical cancer
(P.T. Jyothi Datta , 23-Mar-2009 , Business Line)
Gennovas patent team had given the research team the go ahead Dr Singh said responding to whether their vaccines could infringe the innovators patents. More...
Ricoh and Taisei Join Eco Patent Commons
(Press Releases , 23-Mar-2009 , StreetInsider)
Ricoh Company Ltd a global leader in office solutions and Taisei Corporation a leading engineering construction company have joined the Eco Patent Commons a first of a kind business effort coordinated by the World Business Council for Sustainable Development to help the environment by pledging environmentally beneficial patents to the public domain. More...
Pharma lobby wants a probe into delayed orders
(C.H. Unnikrishnan, , 23-Mar-2009 , livemint)
The Indian Pharmaceutical Alliance or IPA has sought an investigation into several delayed orders in patent opposition cases. More...
Sepracor sues to suppress generic copies of Lunesta
(Bloomberg News , 21-Mar-2009 , boston.com)
Sepracor Inc said it filed a lawsuit to prevent companies from selling generic versions of its top selling sleep drug Lunesta. More...
Appeals Court Revives Some Patent Rules Attacked By Glaxo
(Dow Jones,WASHINGTON , 20-Mar-2009 , CNNMoney.com)
GlaxoSmithKline PLC and an independent inventor challenged the rules before they went into effect arguing that Congress had not given the patent office the authority to make substantive changes to the patent process. More...
US court rules largely for patent office on Glaxo
(By Diane Bartz , 20-Mar-2009 , Reuters)
A US appeals court largely overturned on Friday GlaxoSmithKline Plcs summary judgment win in a fight against new patent office rules. More...
Epix Pharmaceuticals wins new US patent
(Datamonitor staff writer , 20-Mar-2009 , Pharmaceutical Business Review)
The granted claims of this patent are directed to the highly selective 5HT4 small molecule agonist, PRX03140, and to compositions that include PRX03140 as one of the active ingredients. Epix also has pending patent applications relating to compositions and methods of using PRX03140. More...
Global pharma consolidates
(ET Bureau , 20-Mar-2009 , The Economic Times)
Big pharma is set to lose nearly $100 billion in sales as many blockbuster drugs are set to lose patent protection over the next five years. More...
Dr Reddys to exit small generic drug markets abroad
(Our Bureau , 20-Mar-2009 , Business Line)
Dr Reddys Laboratories Ltd has decided to exit from the small distributor driven markets in its global generics business. More...
OSI Pharma files suit against Teva Mylan
(Helen Chernikoff , 19-Mar-2009 , Reuters)
OSI Pharmaceuticals Inc on Thursday announced that it filed two lawsuits against rival drug companies regarding patents associated with Tarceva OSIs cancer drug the company said in a statement. More...
Warner Chilcott sues Impax over acne drug Doryx
(NEW YORK , 19-Mar-2009 , Associated Press)
Warner Chilcott Ltd said Thursday it is suing Impax Laboratories Inc accusing Impax of infringing a patent supporting 150 milligram tablets of Warner Chilcotts acne medication Doryx. More...
Chennai tops in filing of trademarks
(Our Bureau , 19-Mar-2009 , Business Line)
In India the Chennai branch of the Patent and Trademark Office has the highest number of trademarks filed and Bangalore stands first in the e filing of trademarks More...
US bill may dent Dr Reddys growth plans
(Amriteshwar Mathur , 19-Mar-2009 , The Economic Times)
Dr Reddys Laboratories could be affected if a recent US bill that seeks ban on MNC pharma companies from transferring authorised generics to third parties becomes a law. More...
Strides Acrolab receives US FDA approval
(Kiran Kabtta Somvanshi , 18-Mar-2009 , The Economic Times)
Amidst stringent US Food & Drug Administration compliance Bangalore based Strides Acrolab has reasons to cheer. More...
EU Patent Court drug rulings must consider public interest
(By Lynne Taylor , 18-Mar-2009 , PharmaTimes)
The European Union Patent Court proposed by the European Commission must crucially take due care of the public interest in its considerations regarding pharmaceutical patents say generic drugmakers. More...
Merck gives malaria drug to non profit group
(Ben Hirschler , 18-Mar-2009 , Reuters)
Last month GlaxoSmithKlines chief executive urged the creation of a voluntary patent pool to spark development of new treatments for neglected diseases including malaria. More...
Cadila moves SC against Dabur Baidyanath on trademark
(Press Trust of India / New Delhi , 18-Mar-2009 , Business Standard)
Pharma major Cadila Healthcare has moved the Supreme Court seeking to restrain Dabur India and Shree Baidyanath Ayurved from using its trademark Sugar free used for artificial sweeteners. More...
Medicis Teva end dispute relating to Solodyn
(Helen Chernikoff , 18-Mar-2009 , Reuters)
Israels Teva the worlds largest generic drugmaker confirmed that Medicis patents relating to Solodyn Extended Release Tablets are valid and enforceable and has agreed to stop all further shipments of its generic version of the drug. More...
Genzyme sues Impax in patent fight
(Bloomberg News ,WASHINGTON , 18-Mar-2009 , boston.com)
Genzyme Corp the worlds largest maker of drugs for rare genetic disorders sued Impax Laboratories Inc for allegedly infringing a patent used for its Renagel kidney medicine. More...
Hope is a patent troll for IIT Bombay
(Latha Jishnu / New Delhi , 18-Mar-2009 , Business Standard)
The patent trolls main activity is seen as litigation and thus the reason for its unsavoury reputation. More...
Samsung to file fresh petition in dual SIM case
(C.H. Unnikrishnan , 18-Mar-2009 , livemint)
The firm is challenging a law that linked a patent enforcement provision in import rules under which Samsung mobile phones that use double SIM were seized in Mumbai and Chennai More...
First to file Para IV suits on steady rise along with patent settlements
(Kiran Kabtta Somvanshi , 17-Mar-2009 , The Economic Times)
A latest study conducted in US by Stanford Group Company a member of the Stanford Financial Group shows that patent challenges as well as settlements continue to be on the rise. More...
Warner Chilcott faces new patent dispute
(Associated Press , 17-Mar-2009 , Forbes)
Warner Chilcott Ltd said Tuesday Impax Laboratories has challenged the drug developers patent on another dose of the antibiotic Doryx. More...
Shire Files Lawsuit Against Barr for Infringement of FOSRENOL Patents
(WASHINGTON, DC , 17-Mar-2009 , ag-IP-news )
Shire plc announced in a press release that it has filed a lawsuit in the US District Court of the Southern District of New York against Barr Laboratories Inc for infringement of three of Shires patents US Patent No 5968976 US Patent No 7381428 and US Patent No 7465465. More...
Drug Firms Bet Big on High Risk Deals
(By RON WINSLOW and AVERY JOHNSON , 17-Mar-2009 , The Wall Street Journal)
Amid the biggest financial crisis since the Great Depression drug giants Pfizer Inc Merck & Co and Roche Holding AG are pulling off an impressive feat More...
USPTO Grants Reissue Patent Relating to Lipitor
(NEW YORK , 17-Mar-2009 , ag-IP-news )
Pfizer Inc announced in a press release that the US Patent and Trademark Office has granted reissue patent RE40667 relating to Lipitor. More...
IIT B to encash its intellectual bonds
(Mumbai , 17-Mar-2009 , DNA)
Converting their ideas into monetary value will now become easier for the IIT Bombay faculty thanks to a partnership between the institute and Intellectual Ventures IV. More...
Patent offices asked to clear opposition cases by 31 March
(C.H. Unnikrishnan , 17-Mar-2009 , livemint)
The new controller general of patents designs and trademarks has ordered the heads of all four regional offices to issue final orders in some 600 patent and trademark opposition cases by 31 March. More...
Natco successfully opposes patent application
(BS Reporter / Hyderabad , 16-Mar-2009 , Business Standard)
Hyderabad based Natco Pharma limited said that it had successfully opposed a patent application in India that covers the composition of Glatiramer Acetate the generic version of Teva Pharmaceutical Industries Copaxone. More...
Tatas seek patent security for Nano against copycats
(Kala Vijayraghavan & Lijee Philip , 16-Mar-2009 , The Economic Times)
Tata Motors has applied for patent protection for over 37 inventions and innovations linked to its high profile affordable car Nano aggressive move to protect the brand against imitation in the ultra competitive car industry. More...
Pfizer to give data on smoking cessation drug impact in India
(C.H. Unnikrishnan , 16-Mar-2009 , livemint)
Indian drug regulator has askedPfizer Ltd the Indian arm of the worlds largest drug maker Pfizer Inc to submit data of a compulsory post sales study on its smoking cessation drug Champix More...
Glaxo proposes patent pool for new treatment of neglected diseases
(REUTERS , 15-Mar-2009 , The Economic Times)
GlaxoSmithKline Plcs chief executive urged creation of a voluntary patent pool to spark development of new treatments for neglected diseases in the worlds poorest countries. More...
Dr Reddys wins drug patent case in US
(Our Bureau , 14-Mar-2009 , Business Line)
Hyderabad March 13 A US District Court has granted a summary judgment that pharma major Dr Reddys Laboratories Ltd does not infringe the patents in its Abbreviated New Drug Application for Omeprazole. More...
Govt to spend $2 b annually till 20 on drug discovery
(ET Bureau,AHMEDABAD , 14-Mar-2009 , The Economic Times)
We have ability of backward engineering but we lack innovation he added Mr Kumar said about $103 billion worth of patented drugs will go off patent in the years to come. More...
Pfizer says CEOs 2008 pay over $13 mln
(By Ransdell Pierson , 13-Mar-2009 , Reuters)
Pfizers biggest challenge comes in 2011 when its $12 billion a year Lipitor cholesterol fighter loses US patent protection and confronts cheaper generic competition. More...
Strides Arcolab to launch over 25 products this year
(Dow Jones , 13-Mar-2009 , Business Line)
Bangalore Mumbai 12 Pharmaceutical company Strides Arcolab Ltd expects new product launches mainly in the US and Europe to drive its revenue growth this year its Vice Chairman and Chief Executive said. More...
Pharma MNCs want to take a shot at Indias vaccine market
(Nina Mehta,MUMBAI , 12-Mar-2009 , The Economic Times)
MSD Pharmaceuticals GlaxoSmithKline Novartis and Pfizer are some of the companies that want to be a part of this story. More...
Sepracor Inc Reaches Xopenex Deal with Teva Pharmaceutical Industries Limited
(MARLBOROUGH, Mass,BUSINESS WIRE , 12-Mar-2009 , Biocompare)
Sepracor Inc today announced that it has entered into a Settlement and License Agreement with Teva Pharmaceuticals USA Inc and Barr Laboratories Inc a wholly owned subsidiary of Teva to resolve the patent litigation against Barr involving Sepracors XOPENEX brand levalbuterol HCl Inhalation Solution products and to grant a license to Barr and Teva. More...
Mercks Schering Plough buy is a win win deal
(Pillman,Mumbai , 12-Mar-2009 , DNA)
To make the going tough patent expiries burnt a major hole into Mercks revenues. More...
India Brazil protest seizure of generic drugs by Dutch
(Sheila Mathrani,GENEVA , 11-Mar-2009 , The Economic Times)
India and Brazil have expressed their deep concern over the public health implications of the seizure of generic drugs in transit by European nations and its systemic implications. More...
Moodys cuts Pfizer as Lipitor patent nears expiry
(Karen Brettell,NEW YORK , 13-Mar-2009 , Reuters)
Moodys Investors Service on Wednesday cut its ratings on Pfizer citing declining credit quality at the pharmaceutical company due to the upcoming expiration of its patent for cholesterol drug Lipitor. More...
Merck deal puts pressure on drugmakers AstraZeneca Sanofi J&J
(Bloomberg / New Delhi , 11-Mar-2009 , Business Standard)
The worlds biggest drugmakers armed with about $100 billion in cash and short term investments are seeking acquisitions to replace $84 billion in sales from products nearing the end of their patent life. More...
USPTO Issues Notice of Final Determination for Patent Term Extension for NAMENDA
(Forest Laboratories , 10-Mar-2009 , Biocompare)
Forest Laboratories Inc Forest Laboratories Holdings Ltd Merz Pharma GmbH & Co KGaA and Merz Pharmaceuticals GmbH announced today that the US Patent and Trademark Office has issued a Notice of Final Determination granting the full five years of patent term extension for US Patent No 5061703 which is listed in the US Food and Drug Administration Orange Book for NAMENDA. More...
Cordex files patent application for anti arrhythmic drug
(By Datamonitor staff writer , 10-Mar-2009 , Pharmaceutical Business Review)
Cordex Pharma a developer of cardiovascular medicines has filed a formulation patent covering its lead product ATPace. More...
Tax free bonds to fund drug research venture
(Sushmi Dey & Gireesh Chandra Prasad , 10-Mar-2009 , The Economic Times)
Much of Indias strengths in this sector are in making copycat versions of popular drugs discovered abroad and making medicines whose patents have expired. More...
Pfizer Aurobindo pact may expand to CIS Asian markets
(Joe C Mathew / New Delhi , 10-Mar-2009 , Business Standard)
Pfizer the worlds largest drug maker which announced a licensing and supply pact on March 3 with Aurobindo Pharma to source over 50 generic medicines for sale in the US and Europe will expand this to about 30 countries in Asia and the CIS region soon. More...
Ranbaxy gets USFDA nod for heart drug
(Our Bureau ,New Delhi , 09-Mar-2009 , Business Line)
Ranbaxy Laboratories Ltd announced on Monday that it has received an approval from the US Food and Drug Administration to market and manufacture cardiovascular drug Ramipril Capsules More...
Drug Mergers Killers for Research
(By Catherine Arnst , 09-Mar-2009 , BusinessWeek)
Further out however Merck may find itself in the same wobbly boat its in now No big drugs to replace the best sellers that are on the verge of losing patent protection. More...
Merck Schering Plough deal What happens to subsidiaries
(P.T. Jyothi Datta , 09-Mar-2009 , Business Line)
Early days yet to map how the acquisition will pan out in India. More...
For Big Pharma the playfields here
(Priyanka Golikeri & C Chitti Pantulu , 9-Mar-2009 , DNA)
Multinational drugmakers are taking Masefield a little too seriously. They are fast moving eastward with India in the periscope. More...
Indias Ranbaxy gets US FDA nod for ramipril
(Janaki Krishnan , 9-Mar-2009 , Reuters)
Indian drug maker Ranbaxy Laboratories Ltd said on Monday it had received approval from the US Food and Drug Administration to manufacture and market ramipril capsules. More...
Takeda stock sold off on key drug approval concerns
(Nathan Layne , 9-Mar-2009 , Reuters)
Shares of Japanese drugmaker Takeda Pharmaceutical Co were untraded due to a glut of sell orders on news that US regulators have asked for more data to complete a review of a key diabetes drug candidate. More...
Watson to pay $18 million to Elan to settle patent suit
(By Kathy Shwiff , 7-Mar-2009 , MarketWatch)
Watson Pharmaceuticals Inc will pay $18 million to Elan Corp PLC to settle patent litigation related to Watsons generic version of Naprelan or naproxen sodium tablets. More...
UN agency protests Dutch seizure of Indian HIV drugs
(Radhieka Pandeya , 7-Mar-2009 , livemint)
The purchase by the Clinton Foundation through UNITAID was confiscated at Amsterdams Schiphol airport on 12 November on grounds that it contained counterfeit goods and infringed IPRs More...
New drug regulatory norms on cards
(Gireesh Chandra Prasad , 7-Mar-2009 , The Economic Times)
The government is putting finishing touches on a new regulatory regime for the countrys pharmaceutical sector that will seek to catapult domestic drug makers into the global league of inventors from being successful copiers of expensive multinational brands. More...
Ranbaxy gets approval to market anti fungal drugs in Australia
(PTI,NEW DELHI , 6-Mar-2009 , The Economic Times)
Drug major Ranbaxy Laboratories on Friday said it has received approval from the Australian health regulator to market its anti fungaltablets Serbifin Terbinafine in that country. More...
Watson Pharmaceuticals and Elan Settle Lawsuit Over Naproxen Sodium
(CORONA, Calif. , 6-Mar-2009 , PRNewswire)
Watson Pharmaceuticals Inc a leading specialty pharmaceutical company announced today that it has reached a settlement with Elan Corporation Plc on outstanding patent litigation related to Watsons generic version of Naprelan tablets. More...
Indian firms expect US FDAs local office to speed up approvals
(Nina Mehta , 6-Mar-2009 , The Economic Times)
The US Food and Drugs Administrations new office in India could likely boost local pharma companies efforts to process their applications and speed up approvals for marketing in the global market. More...
Slowdown pill chokes Reliance Pharma
(C.H. Unnikrishnan , 6-Mar-2009 , livemint)
Reliance Pharmaceuticals Pvt Ltd a generics or off patent drug manufacturing and exporting firm that is being set up at a cost of at least Rs1000 crore may start functioning later than originally envisaged. More...
USFDA door wide open for Indian pharma cos
(Joe C Mathew / New Delhi , 6-Mar-2009 , Business Standard)
The trend is likely to continue as Indian companies account for 35 per cent of all ANDA approvals given by the FDA in the first two months of 2009. ANDA is an application for a generic drug approval for an existing licensed medication or an approved drug. More...
Pharma to get new regulatory regime
(Gireesh Chandra Prasad , 05-Mar-2009 , The Economic Times)
Drug makers in the country will get a new regulatory regime that is more friendly for investing heavily into high risk research testing experimental drugs on animals protecting the costly research data shared with the regulators and everything needed to lead them to the global league of drug inventors. More...
Aussie regulator puts Ranbaxy under scanner
(ET Bureau,NEW DELHI , 5-Mar-2009 , The Economic Times)
The Australian drug regulator Therapeutic Goods Administration said it is reviewing 62 drugs sold in the country which are made by Ranbaxy at its Paonta Sahib plant. More...
Cordex Pharma Files ATPace Formulation Patent
(LA JOLLA, Calif , 04-Mar-2009 , PRNewswire)
Cordex Pharma Inc announced today that it has filed a formulation patent covering its lead product ATPace. More...
Way to go New patents for old drugs
(Latha Jishnu / New Delhi , 04-Mar-2009 , Business Standard)
It is one of the great ironies of this country that regulations put together after careful thought and debate to prevent their misuse by smart companies are carelessly flouted by the implementing agency. More...
Aurobindo gets USFDA nod for anti depressant
(ET Bureau,MUMBAI , 04-Mar-2009 , The Economic Times)
Drug major Aurobindo Pharma on Wednesday said it has got tentative USFDA approval to market escitalopram oxalate tablets. More...
Pfizer to license 50 generics from Aurobindo
(BS Reporter / New York , 4-Mar-2009 , Business Standard)
Pfizer Inc has agreed to license an array of generic pills and injectable medicines from Indias Aurobindo Pharma Ltd as the worlds largest drugmaker looks to off patent medicines for growth. More...
Congress takes up patent redo damages fight looms
(WASHINGTON , 3-Mar-2009 , Reuters)
Senior US lawmakers launched a new patent reform attempt on Tuesday with controversial legislation that would reduce damages paid for infringement. More...
Basilea Pharmaceutica files claims against Johnson & Johnson
(By Datamonitor staff writer , 03-Mar-2009 , Pharmaceutical Business Review)
Basilea Pharmaceutica has filed claims in arbitration against Johnson & Johnson and affiliated companies related to delays in approval of ceftobiprole. More...
Pfizer Expands Portfolio of Generic Medicines in the US and Europe
(NEW YORK , 03-Mar-2009 , ag-IP-news )
Pfizer Inc announced that it has entered into a series of agreements with Aurobindo Pharma Ltd a pharmaceutical company based in India to commercialize medicines that are no longer patent protected and have lost market exclusivity in the United States and Europe further progressing its Established Products Business Unit strategy. More...
Jubilant gets Canadian nod for anti heart disease generic
(Agencies ,Mumbai , 02-Mar-2009 , The Financial Express)
Drug maker Jubilant Organosys on Monday said its Canadian subsidiary has received approval from Canadian health regulator for its anti heart disease generic Sestamibi in that country. More...
SC asks Chennai patent office to hear Roche
(Khomba Singh , 02-Mar-2009 , The Economic Times)
The Supreme Court on Monday asked the Chennai patent office to hear and take a final view for all post grant oppositions for a patent it had granted to Swiss company Roche for its anti infection drug Valcyte . More...
SC asks Roche not to pursue Cipla case until patent examination
(Khomba Singh , 02-Mar-2009 , The Economic Times)
The Supreme Court has asked Swiss company Roche not to pursue the patent violation case against the generic version of Ciplas anti infection drug Valcept until the Chennai patent office re examines the patent granted to Roche. More...
DoJ files suit against KV Pharma
(BANGALORE , 02-Mar-2009 , Reuters)
The US Department of Justice said it sued KV Pharmaceutical Co to block the drugmaker from making and distributing adulterated and unapproved drugs. More...
AstraZeneca FDA approves Symbicort
(Edited Press Release , 02-Mar-2009 , MarketWatch)
AstraZeneca Monday announced that the US Food and Drug Administration has approved SYMBICORT 160 45 mcg for the twice daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease including chronic bronchitis and emphysema. More...
Another jolt for Ranbaxy Labs
(BS Reporter / Mumbai , 28-Feb-2009 , Business Standard)
Ranbaxy Laboratories which has been charged by the US Food and Drug Administration with falsifying data has agreed to a Canadian governments request to quarantine all drugs coming into Canada from its drug making facility in Himachal Pradesh. More...
Pfizer generics chief eyes licensing injectables
(By Lewis Krauskopf , 27-Feb-2009 , Reuters)
Pfizer Inc is seeking licensing deals to help turn its burgeoning business focused on generic drugs into a growth engine for the worlds largest drug maker over the next several years. More...
Kissei and Takeda win Japanese approval for diabetes treatment
(By Datamonitor staff writer , 27-Feb-2009 , Pharmaceutical Business Review)
Japan based Kissei Pharmaceutical and Takeda Pharmaceutical Company have announced that an additional indication of combination therapy with insulin sensitizer for Glufast 5mg tablet and 10mg tablet which is being co marketed by both the companies was approved by the regulatory authorities in Japan. More...
Obama calls for generic biotech drugs
(By RICARDO ALONSO-ZALDIVAR, , 27-Feb-2009 , Associated Press)
President Barack Obamas budget aims to foster generic competition for costly biotech drugs used to treat cancer and other intractable ailments. More...
USFDA action against Ranbaxy based on false drug stability data
(Our Bureau , 27-Feb-2009 , Business Line)
The action by the US Food and Drug Administration against Ranbaxy on Wednesday was triggered after it was found out that the company had given incorrect data to prove drugs are stable over a certain time period. More...
Suit against Amgen for drug marketing unsealed
(LOS ANGELES,Reuters , 27-Feb-2009 , Reuters)
A whistle blower lawsuit accusing Amgen Inc of illegally marketing its blockbuster drugs Enbrel and Aranesp has been unsealed a company spokesman said on Friday. More...
Daiichi Ranbaxy form joint team to counter FDA charges
(BS Reporters / New Delhi/mumbai , 27-Feb-2009 , Business Standard)
Daiichi Sankyo which owns Indias biggest drug maker said it had formed a team with Ranbaxy Laboratories to address the data falsification charges levied by the US Food and Drug Administrationeven as analysts foresaw more trouble for the drug maker. More...
Pfizer close to deal with Nigeria in drug lawsuit
(By Mike Oboh , 27-Feb-2009 , Reuters)
Nigeria is close to a settlement in a multi billion dollar lawsuit against Pfizer Inc over a 1996 drug trial it says caused the death of 11 children and left dozens more disabled lawyers said on Friday. More...
Ranbaxy to isolate Canada bound drugs from HP unit
(Press Trust of India / Toronto , 27-Feb-2009 , Business Standard)
Indian pharmaceutical firm Ranbaxy has agreed to a Health Canada request to quarantine all drugs coming into the North American country from the Paonta Sahib manufacturing facility in Himachal Pradesh Canadian Press reported on Thursday quoting the company. More...
Genentech Receives Final Notification Upholding Cabilly Patent in Reexamination Proceeding
(SOUTH SAN FRANCISCO, Calif.(BUSINESS WIRE) , 26-Feb-2009 , Biocompare)
Genentech Inc today announced that the US Patent and Trademark Office has issued a Notice of Intent to Issue a Reexamination Certificate confirming the patentability of all claims of the Cabilly et al patent US Patent No 6331415 of which claims 21 through 32 were amended in a manner that does not affect the commercial importance of the patent. More...
VIA Pharmaceuticals Announces Grant of New Patent
(SAN FRANCISCO, CA , 26-Feb-2009 , ag-IP-news )
VIA Pharmaceuticals Inc announced the issuance of United States Patent No 7495024 entitled Phenylalkyl N Hydroxyureas for Combating Atherosclerotic Plaque covering the use of VIAs lead compound VIA 2291 for the treatment of atherosclerosis. More...
Will continue to cooperate with USFDA Ranbaxy
(BS Reporter / Mumbai , 26-Feb-2009 , Business Standard)
Ranbaxy has just received a letter and information indicating that all pending and approved ANDAs from Ranbaxys Paonta Sahib facility have been added to a list maintained under a policy entitled Application Integrity Policy or AIP. More...
Cipla opposes GSKs patent on Tykerb in India
(Anju Ghangurde , 25-Feb-2009 , SCRIP)
Cipla has filed a post grant opposition against GlaxoSmithKline s patent on the breast cancer drug Tykerb in India. More...
Endo and Penwest settle litigation with Actavis
(By Datamonitor staff writer , 25-Feb-2009 , Pharmaceutical Business Review)
Endo and Penwest have agreed to dismiss their suit with prejudice and Actavis has agreed to dismiss its counterclaims with prejudice. More...
Genentech says US patent office upholds key patent
(Bill Berkrot, New York , 24-Feb-2009 , Reuters)
Genentech Inc said on Tuesday that the US Patent and Trademark Office has confirmed its claims of the validity of a key patent that governs the biotechnology company's method of producing some of its drugs. More...
US companies get Cuba trademarks wait for change
(Esteban Israel, Havana , 24-Feb-2009 , Reuters)
As recently as December the Cuban Office of Intellectual Property registered trademarks for new products for Coca-Cola, Google and Ford Motor Co. More...
Pharma cos may face penalties for overpricing
(Sushmi Dey,NEW DELHI , 24-Feb-2009 , The Economic Times)
Drugmakers such as Dr Reddys Laboratories Wyeth GlaxoSmithKline Pharmaceuticals and Alkem Laboratories may now have to face state officials for failing to pay up penalties for overpricing. More...
Sun Taro chiefs meet for out of court settlement
(BS Reporter / Mumbai , 24-Feb-2009 , Business Standard)
Sun Pharmaceutical Industries and Israel based Taro Pharmaceutical have started fresh rounds of negotiations to settle their differences over a takeover by the Indian company out of court. More...
LG Electronics asks for patent suit against Kodak
(Diane Bartz, Washington , 23-Feb-2009 , Reuters)
LG Electronics has asked a trade panel to investigate possible digital camera patent infringement by Eastman Kodak, the International Trade Commission announced. More...
Cordex files amended SPA for tachycardia drug to FDA
(By Datamonitor staff writer , 23-Feb-2009 , Pharmaceutical Business Review)
Cordex Pharma a developer of new cardiovascular medicines has submitted to the FDA an amended Phase III protocol for ATPace to be reviewed as a special protocol assessment. More...
Gen Next turns its back on small medium pharma companies
(P B Jayakumar / Mumbai , 23-Feb-2009 , Business Standard)
India was import dependent on drugs till 1970 when Indira Gandhi the then prime minister decided to amend the Patent Act to legalise process patenting or copying of drugs innovated by multinationals. More...
Merck girds to battle Tevas generic Singulair
(By Ransdell Pierson , 22-Feb-2009 , Reuters)
Although many analysts expect the larger Merck to prevail in the trial at federal court in Trenton New Jersey a victory by Teva could allow the Israeli company to launch its generic well before Singulairs US patent lapses in August 2012. More...
Daiichi Sankyo to launch flu preventive drug
(Nikkei,TOKYO , 22-Feb-2009 , Reuters)
Japans Daiichi Sankyo Co plans to launch as early as 2011 a new influenza preventive drug that could be effective against a strain unresponsive to widely used Tamiflu of Roche the Nikkei business daily said. More...
Aurobindo gets nod for HIV drug
(Our Bureau , 21-Feb-2009 , Business Line)
Aurobindo Pharma Ltd has received tentative approval for Tenofovir Disoproxil Fumarate tablets in 300 mg dosage from the US Food & Drug Administration. More...
Pharma companies eye new markets to drive sales
(Joe C Mathew / New Delhi , 21-Feb-2009 , Business Standard)
Indian pharmaceutical companies whose global revenues were affected by their exposure to foreign currencies and slump in the US sales have seen significant revenue growth in the newer or emerging markets across continents. More...
Patent office to dispose of all pending cases by March end
(PTI, New Delhi , 20-Feb-2009 , Live Mint)
Though the all India numbers of the pending cases were not disclosed but an official said that in Delhi alone there are roughly 154 cases More...
USV to sell generic version of cancer drug bicalutamide in US
(P.T. Jyothi Datta , 20-Feb-2009 , Business Line)
USV Ltd will be able to see its generic version of bicalutamide the active pharmaceutical ingredient in Astra Zenecas prostate cancer drug Casodex when the patent on this drug expires in the US in April. More...
Endo and Penwest Pharmaceuticals Settle Opana ER Litigation with Actavis South Atlantic LLC
(Corporate News , 20-Feb-2009 , StreetInsider)
Endo Pharmaceuticals and Penwest Pharmaceuticals have settled litigation with Actavis South Atlantic LLC regarding the production and sale of generic formulations of Opana ER Extended Release Tablets CII. More...
Tweaking inputs no ground for raising drug prices NPPA
(Sushmi Dey & Khomba Singh , 20-Feb-2009 , The Economic Times)
The drug price regulator has ruled that pharma companies cannot unilaterally increase prices of medicines that are under price control by merely tweaking their composition. More...
Schering Takeda Unit Sue Teva Over Snake Drug Patent
(By Phil Milford , 19-Feb-2009 , Bloomberg.com)
Schering Corp and Takeda Pharmaceutical Cos Millennium unit accused Israels Teva Pharmaceutical Industries Ltd of infringing their US patent for Integrilin anti clotting agent made from rattlesnake venom. More...
Pharma industry may see more consolidation
(C.H. Unnikrishnan & Nesil Staney , 19-Feb-2009 , livemint)
3 multinationals said to be looking to expand India businesses GlaxoSmithKline Sanofi Aventis Merck More...
Vion files new drug application for leukemia drug
(By Datamonitor staff writer , 19-Feb-2009 , Pharmaceutical Business Review)
Onrigin injection a single agent for remission induction treatment for acute leukemia More...
GSK Pharma scouts for domestic buys
(P B Jayakumar / Mumbai , 19-Feb-2009 , Business Standard)
GlaxoSmithKline Pharmaceuticals the Indian arm of global drug major GlaxoSmithKline is scouting for acquisitions in the domestic market to consolidate its Indian business. More...
Most trials conducted under strict FDA European rules
(C.H. Unnikrishnan , 19-Feb-2009 , livemint)
India has been a preferred destination for clinical trials ever since pharmaceutical outsourcing picked up at the start of the decade. More...
To GSK with awe and some scepticism
(Latha Jishnu / New Delhi , 18-Feb-2009 , Business Standard)
Pharmaceutical giant GlaxoSmithKline appears to have knocked almost everyone into a cocked hat with its announcement last week of slashing prices of drugs for the poorest countries and sharing part of the profits with these countries to beef up health facilities. More...
Teva to seek US approval for Neupogen biosimilar
(By Lewis Krauskopf , 18-Feb-2009 , Reuters)
Teva Pharmaceutical Industries Ltd hopes to seek US approval for its version of Amgen Incs Neupogen this year company officials said on Wednesday as it seeks to establish leadership in the emerging field of generic biotech medicines. More...
Gilead Receives Response From US FDA on Companys Request for Formal Dispute Resolution for Aztreonam for Inhalation Solution
(FOSTER CITY, Calif , 18-Feb-2009 , StreetInsider)
Gilead Sciences Inc today announced that the company has received a response from the US Food and Drug Administrationto its appeal submitted under the formal Dispute Resolution process regarding the Agencys Complete Response Letter for its New Drug Application for aztreonam for inhalation solution. More...
Pirate Bay copyright test case begins in Sweden
(Simon Johnson, Stockholm , 19-Feb-2009 , Reuters)
A copyright test case involving one of the world's biggest free file-sharing websites that could help music and film companies recoup millions of dollars in lost revenues started on Monday in Stockholm. More...
Alnylam wins new patent for RNAi therapeutics
(By Datamonitor staff writer , 16-Feb-2009 , Pharmaceutical Business Review)
Alnylam Pharmaceuticals an RNAi therapeutics company has announced the first grant for the Kay & McCaffrey patent an early fundamental patent in the RNAi therapeutics field. More...
New norms for MNC drug prices
(Sushmi Dey , 16-Feb-2009 , The Economic Times)
In a move that would prevent MNCs such as GlaxoSmithKline Eli Lilly Roche and Pfizer from selling their drugs at a huge premium in India the government may soon finalise norms for monitoring prices of costly imported patented medicines for diseases such as diabetes arthritis obesity cancer and heart diseases. More...
Piramal Glaxo deal may trigger top level exits
(Mahima Puri , 16-Feb-2009 , The Economic Times)
Many top executives of Mumbai based generic drug maker Piramal Healthcare and the Indian arm of British pharma company GlaxoSmithKline Formula for successful business are exploring exit options following reports of a possible acquisition of the Indian firm according to head hunters. More...
As valuations dip Sun Pharma is in M&A mode
(Ruchita Saxena , 16-Feb-2009 , The Economic Times)
With valuations in the Indian pharmaceutical sector correcting in the last few months Sun Pharmaceutical is aggressively looking for an acquisition. More...
FDA nod key to drug cos US growth
(P B Jayakumar / Mumbai , 16-Feb-2009 , Business Standard)
Ranbaxy Dr Reddys and other Indian drug makers which earn a third of their earnings from selling products in the US need higher drug approvals from the Food and Drug Administration of that country in the next financial year to maintain 20 per cent sales growth. More...
GlaxoSmithKline vows cheap medicine for the poor
(AFP,LONDON , 14-Feb-2009 , The Times of India)
The head of British drugs giant GlaxoSmithKline said in a British newspaper Saturday he would cut prices for medication in developing countries and share knowledge of patented treatments. More...
Glaxo proposes patent pool for neglected diseases
(By Lisa Richwine , 13-Feb-2009 , Reuters)
GlaxoSmithKline Plcs chief executive urged creation of a voluntary patent pool to spark development of new treatments for neglected diseases in the worlds poorest countries. More...
Cubist plans to file patent infringement lawsuit against Teva
(By Datamonitor staff writer , 13-Feb-2009 , Pharmaceutical Business Review)
Cubist Pharmaceuticals a biopharmaceutical company has said that it intends to file a patent infringement lawsuit against Teva Parenteral Medicines in response to the abbreviated new drug application filing that TPM had submitted to the FDA for approval to market a generic version of Cubicin. More...
Teijin Pharma and Takeda Announces ULORIC Received FDA Approval for the Chronic Management of Hyperuricemia in Patients with Gout
(TOKYO & OSAKA, Japan , 13-Feb-2009 , StreetInsider)
Teijin Pharma Limited and Takeda Pharmaceutical Company Limited announced today that on February 13 2009 Teijin Pharmas US licensee for febuxostat and Takedas wholly owned subsidiary Takeda Pharmaceuticals North America Inc received FDA marketing approval for ULORIC for the chronic management of hyperuricemia in patients with gout. More...
Dr Reddys Losing the edge
(Shobhana Subramanian & Varun Sharma , 12-Feb-2009 , Business Standard)
The upside from generic Imitrex will be lower with Ranbaxy also selling the 100mg dosage in the US market. More...
Global drug majors slow R&D offshoring to India
(P B Jayakumar , 12-Feb-2009 , Business Standard)
New drug discovery and contract research have taken a back seat as global drug majors have slowed down their research and development offshoring to India. More...
OSI Pharmaceuticals Announces Notification of ANDA Filing for Tarceva
(MELVILLE, NY , 11-Feb-2009 , ag-IP-news )
OSI Pharmaceuticals Inc announced the receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals USA Inc submitted an Abbreviated New Drug Application to the US Food and Drug Administration requesting permission to manufacture and market a generic version of Tarceva. More...
Ranbaxy gets USFDA approval for migraine drug
(Khomba Singh , 10-Feb-2009 , The Economic Times)
The company had earlier missed its December 2008 launch date as it did not get approval from the US drug regulator. More...
Wockhardt launches Sanofis Lantus generic in India
(REUTERS , 10-Feb-2009 , The Economic Times)
Drugmaker Wockhardt Ltd said on Tuesday it has launched a new insulin Glaritus in India for the treatment of diabetes. More...
Geneart wins European patent for new screening system
(By Datamonitor staff writer , 10-Feb-2009 , Pharmaceutical Business Review)
Geneart a provider for DNA engineering and processing services has received a patent from European patent office for a new screening system based on synthesized virus like reporter genes with which a new class of antiviral drug candidates may be identified. More...
Wockhardt launches Sanofis Lantus generic in India
(REUTERS , 10-Feb-2009 , The Economic Times)
Drugmaker Wockhardt Ltd said on Tuesday it has launched a new insulin Glaritus in India for the treatment of diabetes. More...
Antarctic patents strain goals of shared science
(Alister Doyle, Environment Correspondent, Rothera Base, Antarctica , 05-Feb-2009 , Reuters)
An increasing number of companies developing new products through biological discovery or "bioprospecting" are trying to file patents on Antarctic organisms or molecules for items from cosmetics to medicines, putting new strains on the treaty. More...
EpiCept receives permission to file leukemia drug NDA
(By Datamonitor staff writer , 04-Feb-2009 , Pharmaceutical Business Review)
EpiCept a specialty pharmaceutical company has announced that the FDA indicated that the company has the necessary pivotal data to file a new drug application for Ceplene in conjunction with interleukin-2 as a remission maintenance treatment of acute myeloid leukemia. More...
Cipla export consignment too seized at Amsterdam
(P.T. Jyothi Datta , 04-Feb-2009 , Business Line)
It is not just drug makers Ind-Swift and Dr Reddy’s Laboratories’ export consignments that were confiscated by Customs authorities in Amsterdam in the last three-odd months on the grounds of patent infringement. More...
The IAS grabs the patent office too
(Latha Jishnu , 04-Feb-2009 , Business Standard)
India’s patents office, or the Office of the Controller General of Patents, Designs and Trademarks to give its full title, was one of those dreary government departments, badly-equipped and poorly-staffed, its decrepit state of little interest to officialdom — or to the media — till January 1, 2005. More...
India, Brazil slam Dutch govt for seizing drugs
(D Ravi Kanth , 04-Feb-2009 , Business Standard)
India and Brazil today strongly denounced the Netherlands Customs authorities at the World Trade Organization for seizing several consignments of generic medicines from the two countries. More...
Intellectual property rights issues stall Bhel-NTPC project
(Utpal Bhaskar , 04-Feb-2009 , livemint)
New Delhi: An alleged dispute over intellectual property rights has stalled a joint initiative between Bharat Heavy Electricals Ltd (Bhel) and NTPC Ltd to build less-polluting power generation plants. More...
US lawmakers propose bill to stop generic drug patent deals
(Diane Bartz, Washington , 3-Feb-2009 , Reuters)
Two senior senators have introduced a bill that would make it illegal for pharmaceutical companies to pay generic drugmakers to keep lower priced alternatives off the market. More...
New Trademarks Act in Force in Dominica
(ROSEAU , 3-Feb-2009 , ag-IP-news )
The final deadline by which granted UK marks can be registered in Dominica will expire on February 1, 2010 - one year from the date of entry into force of the new legislation. More...
FTC challenges Par Solvay patent settlement
(Vidya L Nathan, Bangalore , 2-Feb-2009 , Reuters)
Par Pharmaceutical Cos Inc said federal and state regulators filed an antitrust lawsuit against it related to its patent settlement over Belgian drugmaker Solvay's testosterone gel, AndroGel. More...
India to move WTO on Dutch drug seizure
(New Delhi , 31-Jan-2009 , The Economic Times)
India and Brazil have decided to mount a joint offensive at the World Trade Organisation against the Netherlands for seizing a consignment in transit, which was on its way from India to Brazil. More...
Shah Rukh in legal soup over copyright
(Vignesh Iyer, Mumbai , 31-Jan-2009 , Hindustan Times)
A petition has been filed against Shah Rukh Khans Red Chillies Private Ltd, TV channel NDTV Imagine and Sunanda Oberai by Neha Joshi for making a serial Ghar Ki Baat, based on the script written by her father, Sharad, for a comedy serial called Yeh Jo Hai Zindagi, without obtaining any prior permission and violating the Copyright Act More...
Warner Chilcott files patent suit against Actavis
(Hamilton, Bermuda , 30-Jan-2009 , News Release Warner Chilcott )
Warner Chilcott Limited announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne") have filed a lawsuit against Actavis Elizabeth LLC ("Actavis") in the District Court for the District of New Jersey for infringement of Mayne's U.S. Patent No. 6,958,161 (the "'161 Patent") which covers DORYX, a tetracycline-class oral antibiotic. More...
Pfizer pancreatic cancer drug fails, trial halted
(NEW YORK , 30-Jan-2009 , Reuters)
Pfizer Inc (PFE.N), in its latest research setback, said on Friday it stopped a late stage study of an experimental drug to treat advanced pancreatic cancer after an independent monitoring board found no evidence that it prolongs survival. More...
Seattle Genetics's lymphoma drug wins orphan designation
(By Datamonitor staff writer , 30-Jan-2009 , Pharmaceutical Business Review)
Seattle Genetics, a clinical stage biotechnology company, has announced that its antibody-drug conjugate SGN-35 has received the orphan drug designation from the European Medicines Agency for the treatment of Hodgkin lymphoma and anaplastic large cell lymphoma, or ALCL, and from the FDA for the treatment of ALCL. More...
Patents grant for mere change under scanner
(C.H. Unnikrishnan , 30-Jan-2009 , livemint)
Mumbai: The Mumbai patent office has initiated an inquiry into alleged violations in granting patents for modified forms of existing drugs, even as newly available documents related to these present evidence of negligence. More...
Pfizer's acquisition of Wyeth brings scale but will fail to deliver sustainable sales growth
(By Datamonitor staff writer , 30-Jan-2009 , Pharmaceutical Business Review)
The Pfizer-Wyeth merger will create a prescription pharmaceutical company of unprecedented scale. The combined entity would have recorded total company sales in excess of $70 billion and prescription pharmaceutical sales of over $60 billion in 2008. More...
Merck eyes Indian drug biggie, brands
(P B Jayakumar / Mumbai , 30-Jan-2009 , Business Standard)
Germany-based Merck KGaA, the world’s oldest multinational pharmaceutical company, is eyeing to acquire a prominent Indian pharmaceutical company and established drug brands. More...
Cadila to strengthen US reach with fresh approvals
(BS Reporter / Mumbai/ Ahmedabad , 30-Jan-2009 , Business Standard)
Ahmedabad based pharma major Zydus Cadila has got a shot in the arm as it has received three product approvals from the United States Food and Drug Administration (USFDA) in quick succession. More...
Medarex announces allowance of IND application for antibody-drug conjugate, MDX-1203
(Pharmaceutical News , 29-Jan-2009 , News-Medical.Net)
Medarex, Inc. has announced the allowance of an investigational new drug (IND) application filed with the U.S. Food & Drug Administration (FDA) for MDX-1203, the Company's first Antibody-Drug Conjugate (ADC) candidate generated from its proprietary technology. More...
Mylan receives final FDA approvals for generic Lamictal tablets
(Pharmaceutical News , 29-Jan-2009 , News-Medical.Net)
Mylan Inc has announced that its subsidiaries Mylan Pharmaceuticals Inc. and Genpharm ULC received final approvals from the U.S. Food and Drug Administration (FDA) for their Abbreviated New Drug Applications (ANDAs) for Lamotrigine Tablets. More...
Drug prices increased
(Our Bureau ,New Delhi , 28-Jan-2009 , Business Line)
Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has revised the price of 174 formulation packs and three bulk drugs. Prices of most of the drugs have been revised upward. More...
Jannssen-Cilag's Stelara approved in EU for psoriasis
(Katie McQue- Reporter , 28-Jan-2009 , SCRIP)
The European Commission has approved Janssen-Cilag's (Johnson & Johnson) novel human monoclonal antibody drug Stelara (ustekinumab) for the treatment of moderate-to-severe plaque psoriasis in adults who have failed to respond to, are intolerant to, or have a contraindication to other systemic therapies including ciclosporin, methotrexate and psoralen plus ultraviolet light (PUVA). More...
Pfizer-Wyeth may climb to No 2 spot
(P B Jayakumar / Mumbai , 28-Jan-2009 , Business Standard)
The merger of Pfizer and Wyeth is expected to create the second-biggest drug maker among multinational companies in India. The world's largest drug maker Pfizer yesterday announced a $68-billion acquisition of US-based Wyeth. More...
WHO won't redefine fake drugs
(Sushmi Dey & Khomba Singh , 27-Jan-2009 , The Economic Times)
NEW DELHI: In a major victory for India's cheap but high quality generic drug industry, the World Health Organisation (WHO) has decided to shelve its plans of redefining counterfeit medicines-a move that could have posed a threat to sale and export of legitimate generic medicines, a government official said. More...
Indian arms of Pfizer, Wyeth to merge soon
(BS Reporter / New Delhi , 27-Jan-2009 , Business Standard)
The decision of Pfizer to acquire rival drugmaker Wyeth in a $68-billion cash-and-stock deal will also see merger of the listed Indian subsidiaries of both US multinationals soon. More...
'Ranbaxy's investments in Indian drug cos yet to pay off'
(Khomba Singh , 27-Jan-2009 , The Economic Times)
NEW DELHI: Ranbaxy Laboratories' strategic investments in Indian drug companies have so far not delivered desired results, feel industry analysts. More...
Stromedix awarded U.S. patent for antibody-based therapeutics
(Medical Patent News , 26-Jan-2009 , News-Medical.Net)
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and fibrotic organ failure, has announced that the U.S. Patent Office has granted patent number US 7,465,449, which broadly covers monoclonal antibodies to integrin ávβ6, including compositions related to its lead product, STX-100. More...
Pfizer, Wyeth close to deal: reports
(AP / PTI / New York , 26-Jan-2009 , Business Standard)
Drugmakers Pfizer and Wyeth are closing in on a deal worth $68 billion that could be announced before the markets open today, according to published reports. More...
A Pfizer-Wyeth Merger Isn't the Cure-All
(By Catherine Arnst , 24-Jan-2009 , BusinessWeek)
Buying Wyeth would boost Pfizer's revenues, but it won't help with the litany of marketing challenges and other problems plaguing Big Pharma More...
GeoPharma settles patent litigation with Schering and Sepracor
(Datamonitor staff writer , 23-Jan-2009 , Pharmaceutical Business Review)
GeoPharma has reached an agreement with Schering, Sepracor and the University of Massachusetts settling all Hatch-Waxman litigation relating to desloratadine tablets 5mg, with the company receiving a license under all relevant patents. More...
GSK wins European positive opinion for pneumococcal vaccine
(By Staff Writer , 23-Jan-2009 , Pharmaceutical Business Review)
GlaxoSmithKline has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion and recommended the approval of GSK's pediatric pneumococcal candidate vaccine Synflorix. More...
Lilly, Bristol withdraw FDA Erbitux lung cancer application
(By Wallace Witkowski , 23-Jan-2009 , MarketWatch)
SAN FRANCISCO (MarketWatch) -- ImClone Systems, which was recently acquired by Eli Lilly & Co.and Bristol-Myers Squibb Co. said Friday they decided to withdraw a Food and Drug Administration application to market cancer drug Erbitux for a type of advanced lung cancer. More...
Ranbaxy losses mount on forex hit
(BS Reporter / New Delhi , 23-Jan-2009 , Business Standard)
Ranbaxy Laboratories, India’s biggest drug maker, posted a loss for the second straight quarter on adverse foreign exchange fluctuations. More...
Alnylam Provides Update on Kreutzer-Limmer Patent Family
(CAMBRIDGE, MASS , 22-Jan-2009 , ag-IP-news )
Alnylam Pharmaceuticals Inc., a leading RNAi therapeutics company, announced in a press release that the European Patent Office (EPO) has ruled in favor of the opposing parties in oral proceedings before the European Opposition Board related to the '945 (EP 1214945) patent in its Kreutzer-Limmer patent estate. More...
GSK wins European approval for weight loss drug
(By Staff Writer , 22-Jan-2009 , Pharmaceutical Business Review)
GlaxoSmithKline has received a non-prescription license for alli, a drug indicated for weight loss in adults, with a BMI 28kg/m2 or more, when used along with a reduced calorie, lower-fat diet. More...
Drugs regulator issues warning letters to Wyeth pharma, GVK
(Radhieka Pandeya , 22-Jan-2009 , livemint)
Office of the drugs controller general of India issued warning letters asking for explanations, based on the audit findings More...
Silence Therapeutics announces favorable ruling in European patent lawsuit
(By Staff Writer , 21-Jan-2009 , Pharmaceutical Business Review)
Silence Therapeutics, a UK-based RNAi-focused biotechnology company, has announced that a second member of the Kreutzer-Limmer patent family has been revoked in its entirety. More...
HC allows CPAA to join Bayer-Cipla case
(Khomba Singh & Sushmi Dey , 21-Jan-2009 , The Economic Times)
NEW DELHI: The Delhi High Court (HC) has allowed cancer patient group Cancer Patients Aid Association (CPAA) to join the Bayer AG and Cipla case. The German drugmaker Bayer AG had sued the Indian government, its drug regulator and domestic drug company Cipla for giving marketing approval to Cipla for Bayer's patented cancer drug Nexavar. More...
GeoPharma Announces Settlement of Clarinex ANDA Patent Litigation
(LARGO, FLA , 21-Jan-2009 , ag-IP-news )
GeoPharma, Inc. announced in a Wednesday press release that it has reached agreement with the Schering Corporation, and Sepracor Inc. and the University of Massachusetts settling all Hatch-Waxman litigation relating to Desloratadine tablets (5 mg), with the Company receiving a license under all relevant patents. More...
King Pharma Has A Patent Problem
(Lisa LaMotta , 21-Jan-2009 , Market Scan,Forbes.com)
King Pharmaceuticals was looking a little less than regal Wednesday when a court invalidated two patents for its best-selling drug. More...
Dr Reddy's Labs back in the black
(BS Reporter / Mumbai , 21-Jan-2009 , Business Standard)
Dr Reddy’s Laboratories, India’s biggest drug maker by sales, said it turned to profit in the third-quarter, helped by higher sales of an authorised generic drug in the US, even as it set aside money for foreign exchange losses. More...
Geneart wins new European patent
(By Staff Writer , 20-Jan-2009 , Pharmaceutical Business Review)
Geneart, a provider of DNA engineering and processing solutions, has received a new patent for selective evolution of proteins from the European Patent Office. More...
Corgenix Receives Two Additional Patents on AtherOx® Technology
(Corgenix Medical Corporation , 20-Jan-2009 , Biocompare)
Corgenix Medical Corporation , a worldwide developer and marketer of diagnostic test kits, has received notification of two new patents for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan. More...
Alexza Pharmaceuticals (ALXA) Initiates AZ-104 Phase 2b Clinical Trial in Patients With Migraine Headaches
(Corporate News , 20-Jan-2009 , StreetInsider)
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced that it has initiated a Phase 2b clinical trial with AZ-104 (Staccato loxapine) in patients with migraine headaches. More...
CSL Behring's bleeding disorder drug RiaSTAP gets US FDA marketing nod
(King of Prussia, Pennsylvania , 20-Jan-2009 , Pharmabiz)
US Food and Drug Administration (FDA) has granted marketing approval to CSL Behring for RiaSTAP, the first and only treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. More...
Oscient and Ethypharm file lawsuit against Lupin
(Datamonitor staff writer , 19-Jan-2009 , Pharmaceutical Business Review)
Oscient Pharmaceuticals, a commercial-stage pharmaceutical company, has announced that the company, its wholly owned subsidiary Guardian II Acquisition, and its licensor, Ethypharm, have filed a lawsuit against Lupin Limited and its subsidiary Lupin Pharmaceuticals in the US District Court of Maryland for the infringement of a US patent which covers Antara (fenofibrate) capsules. More...
Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent
(HAMILTON, Bermuda , 19-Jan-2009 , PRNewswire,Biocompare)
Warner Chilcott Limited announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne"), a subsidiary of Hospira, Inc., have filed a lawsuit against Sandoz Inc. ("Sandoz") in the District Court for the District of New Jersey for infringement of Mayne's U.S. Patent No. 6,958,161 (the "'161 Patent") which covers DORYX, a tetracycline-class oral antibiotic. More...
'Uniform patent policy needed for cheaper drugs'
(AHMEDABAD , 18-Jan-2009 , The Times of India)
Chief justice of Gujarat High Court, KS Radhakrishnan has called for a uniform patenting policy in order to curtail price rise of life saving drugs. More...
Drug cos concerned over definition of counterfeits
(P.T. Jyothi Datta,Mumbai , 18-Jan-2009 , Business Line)
The seizure of a transiting export consignment belonging to Dr Reddy’s Laboratories by customs authorities in Netherlands, barely two months after another local drug-maker Ind-Swift faced a similar situation, has the domestic pharmaceutical industry concerned about what they say are efforts to block the movement of generic drugs. More...
No antidote to stop copies of patented drugs: Health min
(Khomba Singh & Sushmi Dey , 17-Jan-2009 , The Economic Times)
NEW DELHI: The health ministry has said it is not equipped with technical expertise to stop domestic pharmaceutical companies from copying patented drugs. More...
India to drag EU to WTO over the issue of patents
(PTI , 16-Jan-2009 , The Economic Times)
NEW DELHI: The tussle between Indian generic drug industry and western innovative pharmaceutical firms is set to get stronger as India is considering dragging the European Union to WTO on the issue. More...
Oscient files patent lawsuit against another drug firm
(Boston Globe Business Team , 15-Jan-2009 , boston.com)
Oscient Pharmaceuticals Corp. of Waltham said it has filed a patent infringement lawsuit against Lupin Pharmaceuticals Inc., which is seeking to market a generic version of one of Oscient's drugs. More...
Dr Reddy’s consignment of drugs to Brazil seized
(Radhieka Pandeya , 15-Jan-2009 , livemint.com)
This is the first time a shipment of a large Indian company has been held on charges of patent infringement More...
Not a patent process
(New Delhi , 15-Jan-2009 , Business Standard)
Our patent regime is yet to gain full credibility although the patent law conforms to global norms More...
Eli Lilly Said to Be Near $1.4 Billion U.S. Settlement
(By GARDINER HARRIS and ALEX BERENSON , 14-Jan-2009 , The New York Times)
Eli Lilly, the drug company, is expected to agree as soon as Thursday to pay $1.4 billion to settle criminal and civil charges that it illegally marketed its blockbuster antipsychotic drug Zyprexa for unauthorized use in patients particularly vulnerable to its risky side effects. More...
China Pharma wins approval for Tiopronin enteric-coated capsules
(By Staff Writer , 14-Jan-2009 , Pharmaceutical Business Review)
China Pharma Holdings, a developer, manufacturer and marketer of specialty pharmaceuticals, has received approval from China's State Food and Drug Administration for the production of Tiopronin enteric-coated capsules. Tiopronin is listed in the National Medical Insurance Program, thus allowing patients to obtain reimbursement. More...
Vical Announces Issuance of New US Patent
(SAN DIEGO , 14-Jan-2009 , ag-IP-news )
Vical Incorporated announced in a Wednesday press release the issuance of US Patent No. 7,470,675 covering the composition, delivery and use of gene-based interferon-omega. More...
Oncolytics Biotech issued new U.S. patent "Reovirus for the Treatment of Neoplasia"
(Medical Patent News , 14-Jan-2009 , News-Medical.Net)
Oncolytics Biotech Inc. has announced that it has been granted its 31st U.S. Patent, # 7,476,382, entitled "Reovirus for the Treatment of Neoplasia." More...
Bavarian Nordic's patent infringement suit against Oxford BioMedica
(Medical Patent News , 13-Jan-2009 , News-Medical.Net)
Bavarian Nordic owns several United States patents relating to an attenuated strain of the company's core technology, MVA-BN(R), which is the basis for its smallpox vaccine, IMVAMUNE(R). More...
Dey L.P. Granted Three Additional US Patents
(PITTSBURGH , 13-Jan-2009 , ag-IP-news )
Mylan Inc. announced in a Tuesday press release that its subsidiary Dey L.P. has been issued several additional US patents protecting the company's Perforomist Inhalation Solution, a chronic obstructive pulmonary disease (COPD) treatment. More...
VIVUS Announces Issuance of Key European Patent for Qnexa
(MOUNTAIN VIEW, CA , 13-Jan-2009 , ag-IP-news )
VIVUS Inc.announced in a Tuesday press release that the European Patent Office has granted a patent for Qnexa, an investigational, oral weight loss product for the treatment of obesity and related conditions. More...
Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin® 24 and Femcon® Fe Patent Litigation
(Watson Pharmaceuticals, Inc.; Warner Chilcott Limited , 12-Jan-2009 , Biocompare)
Watson Pharmaceuticals, Inc. and Warner Chilcott Limited announced today that they have entered into Settlement and License Agreements to resolve pending patent litigation related to Warner Chilcott's oral contraceptive products, Loestrin® 24 and Femcon® Fe. Separately, Warner Chilcott and Watson have entered into a Co-Promotion Agreement relating to Warner Chilcott's Femring® product and License and Supply Agreements relating to a Warner Chilcott development-stage oral contraceptive product. More...
Genta Announces Issuance of Two Key US Patents
(BERKELEY HEIGHTS, NJ , 10-Jan-2009 , ag-IP-news )
Genta Incorporated announced in a press release that two new patents related to the company's franchise in gallium-containing products have issued in the United States. More...
Silence Therapeutics Granted New Patent
(LONDON , 10-Jan-2009 , ag-IP-news )
Silence Therapeutics plc, the leading European biopharmaceutical company focused on RNA interference, announced that the European Patent Office (EPO) has granted a patent to Silence that covers the company‘s lead product candidate, Atu027, a press release by the company stated. More...
Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication
(SOUTH SAN FRANCISCO , 9-Jan-2009 , PRNewswire)
Anesiva, Inc. (Nasdaq: ANSV) today announced that the U.S. Food and Drug Administration (FDA) has approved Anesiva's supplemental New Drug Application (sNDA) to expand the indication for Zingo(TM) to treat the pain associated with blood draws to include adults. Zingo (lidocaine hydrochloride monohydrate) powder intradermal injection system was previously approved to treat the pain associated with peripheral IV insertions and blood draws in children three to 18 years of age. The notification was received according to PDUFA deadlines. More...
Adhezion wins FDA clearance for SurgiSeal topical skin adhesive
(By Staff Writer , 8-Jan-2009 , Pharmaceutical Business Review)
Adhezion Biomedical, a medical device company, has announced that the FDA has provided marketing clearance for its SurgiSeal topical skin adhesive. More...
Marshall Edwards wins IND approval for cancer drug
(By Staff Writer , 8-Jan-2009 , Pharmaceutical Business Review)
Marshall Edwards, an oncology company, has received an investigative new drug approval from the FDA to undertake clinical studies with triphendiol as a chemosensitizing agent in combination with gemcitabine. More...
Sun Pharmaceutical receives FDA approvals for 4 generics
(Pharmaceutical News , 7-Jan-2009 , News-Medical.Net)
Pharmaceutical Industries Ltd. announced that together with its subsidiaries, it has received final approval from U.S. FDA for several Abbreviated New Drug Applications (ANDA). More...
Pfizer Wins New Lipitor Patent Expiring in June 2011
(Susan Decker , 6-Jan-2009 , Bloomberg)
Pfizer Inc. won new protection on the cholesterol pill Lipitor, the world's best-selling drug, after the U.S. agreed to reissue a patent on the drug's key ingredient that had been invalidated by an appeals court. The U.S. Patent and Trademark Office today said it would reissue a patent that expires in June 2011 after the company altered what an appeals court had called inconsistent language that made the patent invalid. More...
Warner Chilcott and Dong-A Sign U.S. License Agreement For Erectile Dysfunction Treatment
(Warner Chilcott Limited , 06-Jan-2009 , Biocompare)
Warner Chilcott Limited today announced that it has signed an agreement with Dong-A PharmTech Co. Ltd., based in Korea, to develop and market their orally-administered udenafil product, a phosphodiesterase type 5 (PDE5) inhibitor for the treatment of erectile dysfunction (ED) in the United States. Dong-A has successfully completed Phase 2 studies of the product in the United States. More...
Pronova BioPharma ASA Files a Terminal Disclaimer
(LYSAKER, NORWAY , 06-Jan-2009 , ag-IP-news)
Pronova BioPharma ASA announced in a Tuesday press release that it has filed a Terminal Disclaimer in US Patent No. 5,656,667 ('667 Patent) with the US Patent and Trademark Office. More...
Alexion and PDL BioPharma Resolve Patent Dispute
(NCLINE VILLAGE, NEV., and CHESHIRE, CONN , 05-Jan-2009 , ag-IP-news )
PDL BioPharma Inc. and Alexion Pharmaceuticals Inc. today jointly announced that the companies have entered into a definitive license agreement and settlement agreement that resolve the legal disputes between them relating to Alexion's humanized antibody, Soliris (eculizumab) and PDL's patents known as the Queen et al. patents. More...
Orexigen Therapeutics Issued a Key Fourth US Patent
(SAN DIEGO , 05-Jan-2009 , ag-IP-news )
Orexigen Therapeutics Inc. announced in a Monday press release that the United States Patent and Trademark Office (USPTO) has issued a patent for what the company refers to as the "Weber/Cowley methods patent" (US Patent No. 7,462,626), which provides coverage for Contrave, the company's lead obesity product candidate now in Phase 3 clinical trials. More...
Acura and King Pharmaceuticals file NDA for pain drug
(By Staff Writer , 05-Jan-2009 , Pharmaceutical Business Review)
Acura Pharmaceuticals and King Pharmaceuticals have submitted a new drug application for Acurox tablets to the FDA including a request for priority review. More...
Imitrex delay: Ranbaxy's loss may be Dr Reddy's gain
(Press Trust Of India / New Delhi , 5-Jan-2009 , Business Standard)
The delay in Ranbaxy Laboratories getting approval from the USFDA for launching the generic version of GlaxoSmithKline’s (GSK) migraine and headache drug Imitrex could turn out to be a gain for Dr Reddy’s Laboratories, which has already launched the drug in the United States. More...
FDA extends review of King Pharmaceuticals
(By Staff Writer , 05-Jan-2009 , Pharmaceutical Business Review)
King Pharmaceuticals has announced that the FDA is continuing its review of the company's new drug application for Embeda extended release capsules. It is likely that this review will extend into early 2009. More...
FDA extends review of King Pharmaceuticals's Embeda extended release capsules
(By Staff Writer , 2-Jan-2009 , Pharmaceutical Business Review)
King Pharmaceuticals has announced that the FDA is continuing its review of the company's new drug application for Embeda extended release capsules. It is likely that this review will extend into early 2009. More...
Labopharm wins FDA approval for pain drug
(By Staff Writer , 02-Jan-2009 , Pharmaceutical Business Review)
Labopharm, a Canadian specialty pharmaceutical company, has announced that the FDA has approved Ryzolt, the company's once-daily formulation of the analgesic tramadol. More...
Ranbaxy misses deadline for migraine drug launch
( Khomba Singh, ET Bureau , 2-Jan-2009 , The Economic Times)
NEW DELHI: India's largest drugmaker, Ranbaxy Laboratories, has missed its December 2008 deadline to launch an anti-migraine drug as the US regulator has yet to give its approval. Ranbaxy was expecting to earn almost $100 mn from the drug, a low-cost version of GlaxoSmithKine-owned Imitrex. More...
Cipla pips Ranbaxy in domestic market
(P B Jayakumar , 2-Jan-2009 , Business Standard)
Veteran industrialist Y K Hamied-led Cipla has edged out Daiichi-Sankyo-owned Ranbaxy Laboratories as the largest player in the domestic pharmaceutical market in the January-November period, according to data compiled by ORG-IMS.. More...
IMPAX Sued Based on ANDA for Generic Doryx®
(HAYWARD, Calif.(BUSINESS WIRE) , 01-Jan-2009 , Biocompare)
IMPAX Laboratories, Inc. today announced that Warner Chilcott Laboratories Ireland Limited, Warner Chilcott Company, Inc., Warner Chilcott (US) LLC, and Mayne Pharma International PTY. LTD have filed suit for patent infringement in the United States District Court for the District of New Jersey based on the Company’s submission of Abbreviated New Drug Application (“ANDA”) for doxycycline hyclate delayed-release tablets (75 and 100 mg), generic of Doryx®, to the Food and Drug Administration. In connection with this ANDA, IMPAX provided notice that its submission includes a Paragraph IV certification stating the Company believes its product does not infringe U.S. Patent No. 6,958,161, or the patent is invalid or unenforceable. More...
Akorn-Strides, LLC Announces FDA Approvals for Sterile Vancomycin HCl USP, 500 mg/Vial; 1 g/Vial and Sterile Vancomycin HCl USP, 5 g/Vial Pharmacy Bulk Package
(LAKE FOREST, Ill.(BUSINESS WIRE) , 31-Dec-2008 , StreetInsider)
Akorn-Strides, LLC today announced that the U.S. Food and Drug Administration has granted approvals for two Abbreviated New Drug Applications (ANDAs) for Sterile Vancomycin HCl USP, 500 mg/vial, 1 g/vial and Sterile Vancomycin HCl USP, 5 g/vial Pharmacy Bulk Package. Akorn-Strides, LLC is a Joint Venture that was formed in 2004 by Akorn, Inc. (NASDAQ: AKRX) and Strides Arcolab Limited (NSE: STAR) (BSE: 532531). The primary mission for the Joint Venture is to develop liquid, lyophilized and dry powder formulations of generic injectable products targeting several therapeutic markets with a major focus on anti-infectives, analgesics and CNS medicines. More...
Novartis Girds for the Day Blockbuster Loses Patent
(LONDON , 31-Dec-2008 , The Wall Street Journal)
Sales of Novartis's blockbuster drug, Diovan, are expected to tumble when the high-blood-pressure pill's patent expires in four years More...
Bayer sues Abbott, alleging patent infringement
(By LINDA A. JOHNSON , 31-Dec-2008 , Associated Press)
Pharmaceutical and chemical maker Bayer AG has filed a federal lawsuit alleging that drugmaker Abbott Laboratories' best-selling drug, Humira, infringes on a decade-old Bayer patent. More...
Aurobindo Pharma gets US nod for Stavudine
(Reuters,Mumbai , 31-Dec-2008 , The Financial Express)
Drug firm Aurobindo Pharma said on Wednesday it received the final nod from the US Food and Drug Administration for its stavudine tablets and oral solution. More...
Apeda moves Sindh HC against basmati trademark
(Chennai , 30-Dec-2008 , The Hindu Business Line)
The Agricultural and Processed Food Products’ Export Development Authority (Apeda) has moved the Sindh High Court in Pakistan against the trademark right given by the Registrar of Trademark, Karachi, to Basmati Growers’ Association, Lahore, for basmati rice. The registrar, in fact, has allowed only the growers to use the trademark. The case is slated to come up for hearing in January. More...
Cree Settles Patent Litigation with Bridgelux
(DURHAM, NC , 30-Dec-2008 , ag-IP-news)
Cree Inc. announced in a press release that the company and Boston University have agreed with Bridgelux Inc. to settle the parties’ patent infringement litigation and to dismiss all claims and counterclaims in the suits. More...
US’ Alcon wins case against Ajanta Pharma
(Paramita Chatterjee & Khomba Singh, ET Bureau , 29-Dec-2008 , The Economic Times)
US’ Alcon wins case against Ajanta Pharma 29 Dec 2008, 0022 hrs IST, Paramita Chatterjee & Khomba Singh, ET Bureau Print EMail Discuss Share Save Comment Text: NEW DELHI: US-based drugmaker Alcon has won a trademark case against its Indian counterpart Ajanta Pharma preventing the latter from selling its popular eyedrop under the brand ‘Travaxo’ here. The Bombay High Court (HC) granted an injunction in favour of Alcon, restricting Ajanta Pharma from using its product Travaxo on grounds of trademark infringement. The medicine directly competes with Alcon’s Travatan in the highly competitive Rs 33,000-crore drug retail market. More...
Dr Reddy's resolves patent litigation with Schering and Sepracor
(Datamonitor staff writer , 28-Dec-2008 , Pharmaceutical Business Review)
Dr Reddy's Laboratories has entered into agreements with Schering and Sepracor which is expected to allow Dr Reddy's to manufacture and market generic versions of the Clarinex-D 12 hour and Clarinex-D 24 hour products, with six months marketing exclusivity, and the Clarinex Reditabs product, with six months marketing co-exclusivity, starting in 2012. More...
Bristol-Myers to pay $1.1 million as settlement charges in Plavix case
(By Staff Writer , 26-Dec-2008 , Pharmaceutical Business Review)
Bristol-Myers Squibb has agreed to pay $1.1 million as part of settlement charges in the Plavix case, which was being investigated by the New York State Attorney General's Office, reported Reuters More...
Bill to change Apeda Act to protect trade mark interests
(G. Srinivasan, New Delhi , 25-Dec-2008 , The Hindu Business Line)
Indias case for safeguarding its specified agricultural and processed food products such as basmati rice, Darjeeling tea or Alfonso mango which have been increasingly challenged by other countries would get a real booster dose once the Agricultural and Processed Food Products Export Development Authority (Amendment) Bill introduced in the just-ended Parliament session gets into the statute More...
Teva wins approval for generic Seroquel tablets
(By Staff Writer , 24-Dec-2008 , Pharmaceutical Business Review)
Teva Pharmaceutical Industries has announced that the FDA has granted tentative approval for the company's abbreviated new drug application to market its generic version of AstraZeneca's antipsychotic agent Seroquel tablets, equivalent to 25mg base, 50mg base, 100mg base, 150mg base, 200mg base, 300mg base and 400mg base. More...
Warner Chilcott Files Lawsuits for Infringement of DORYX Patent
(ST. DAVID'S, BERMUDA , 24-Dec-2008 , ag-IP-news )
Warner Chilcott Limited (WCRX) announced in a press release that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne"), a subsidiary of Hospira, Inc., have filed lawsuits against each of Mutual Pharmaceutical Company Inc. (Mutual), Mylan Pharmaceuticals Inc. (Mylan) and Impax Laboratories Inc. (Impax). More...
Aurobindo Pharma gets Canada nod for Terbinafine
(Reuters,Mumbai , 24-Dec-2008 , The Financial Express)
Drug maker Aurobindo Pharma said on Wednesday it received the Canadian regulatory approval to sell terbinafine hydrochloride tablets in multiple strengths. More...
Bill to amend Apeda Act in LS
(New Delhi , 23-Dec-2008 , The Hindu Business Line)
A Bill seeking to amend the Agricultural and Processed Food Products Export Development Authority (Apeda) Act 1985 to empower the Authority to undertake steps for registration and protection of intellectual property rights in respect of specified agricultural and processed food products, including basmati rice, was introduced in the Lok Sabha on Monday. More...
Sun Pharmaceutical extends tender offer for Taro
(By Staff Writer , 23-Dec-2008 , Pharmaceutical Business Review)
India-based Sun Pharmaceutical Industries has announced that its subsidiary Alkaloida Chemical Company Exclusive Group has extended the expiration date of the tender offer for the purchase of all outstanding ordinary shares of US-based Taro Pharmaceutical Industries. More...
AVI BioPharma Strengthens Its Patent Position in RNA Therapeutics
(PORTLAND, OR - AVI BioPharma Inc. , 23-Dec-2008 , ag-IP-news )
PORTLAND, OR - AVI BioPharma Inc. (AVII), a developer of RNA–based drugs, announced the issuance of a US patent protecting the composition of matter of its RNA–based therapeutic agent AVI–5126. More...
Glenmark may beat rivals in novel chemical entity sale
(P B Jayakumar / Mumbai , 23-Dec-2008 , Business Standard)
Glenmark Pharmaceuticals, India’s 11th biggest drug maker by sales, may beat bigger rivals, including Ranbaxy, Dr Reddy’s and Nicholas Piramal, in selling an original drug, or novel chemical entity (NCE), by 2010. More...
AstraZeneca submits sNDA for NEXIUM (esomeprazole magnesium)
(Pharmaceutical News , 22-Dec-2008 , News-Medical.Net)
AstraZeneca has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for NEXIUM(R) (esomeprazole magnesium) to seek approval for the short-term (up to 6 weeks) treatment of gastroesophageal reflux disease (GERD) in pediatric patients ages 0 to 1 year old. More...
AstraZeneca and MAP Pharmaceuticals announce collaboration on Unit Dose Budesonide
(Pharmaceutical News , 22-Dec-2008 , News-Medical.Net)
AstraZeneca and MAP Pharmaceuticals, Inc. have announced an exclusive worldwide agreement to develop and commercialize Unit Dose Budesonide (UDB), MAP Pharmaceuticals' proprietary nebulized formulation of budesonide. More...
Pressure BioSciences, Inc. And Battelle Memorial Institute Sign Exclusive Patent License Agreement
(Pressure BioSciences, Inc. , 22-Dec-2008 , Pressure BioSciences, Inc.)
Pressure BioSciences, Inc. ("PBI" or the "Company") today announced that they have entered into an exclusive patent license agreement with the Battelle Memorial Institute ("Battelle"). The licensed technology is described in the patent application filed by Battelle on July 31, 2008 (US serial number 12/183,219). This application includes subject matter related to a method and a system for improving the analysis of protein samples, including through an automated, in-line system utilizing pressure and a pre-selected agent to obtain a digested sample in a significantly shorter period of time than current methods, while maintaining the integrity of the sample throughout the preparatory process. More...
FDA approves Gleevec (imatinib mesylate) to prevent gastrointestinal stromal tumor
(Pharmaceutical News , 21-Dec-2008 , News-Medical.Net)
The U.S. Food and Drug Administration has approved Gleevec (imatinib mesylate) for a new indication - keeping cancer from growing in patients following surgical removal of a gastrointestinal stromal tumor or GIST. More...
Transcept: Intermezzo accepted for review by the FDA
(By Charlotte Dumezy , 18-Dec-2008 , Pharmaceutical Business Review)
Transcept's insomnia drug, Intermezzo, has been accepted for review by the FDA. This sublingual reformulation of zolpidem, designed for the treatment of middle-of-the-night awakenings, provides a fast onset of action and maintains sleep for only four hours. It is not clear that Intermezzo fulfils a significant unmet need and Datamonitor believes the market for such a treatment will be limited. More...
Gilead Sciences Files Patent Infringement Lawsuit Against Teva Pharmaceuticals
(FOSTER CITY, Calif , 15-Dec-2008 , BUSINESS WIRE)
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that it has filed a lawsuit in U.S. District Court in New York against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd. for infringement of U.S. Patent Numbers 6,642,245 and 6,703,396. Both patents are associated with emtricitabine, a component of Truvada(R) (emtricitabine and tenofovir disoproxil fumarate), and are licensed exclusively to Gilead Sciences by Emory University. Truvada is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults. More...
Sanofi-Aventis (France) (SASY.PA) And Bristol-Myers Squibb Company (BMY) Prevail Before the U.S. Court of Appeals for the Federal Circuit in the U.S Plavix(R) Patent Infringement Case
(PARIS & NEW YORK , 14-Dec-2008 , BUSINESS WIRE)
Sanofi-aventis (Paris Bourse: EURONEXT: SAN; and New York: NYSE: SNY) and Bristol-Myers Squibb (New York: NYSE: BMY) announced today that the U.S. Court of Appeals for the Federal Circuit has upheld the June 19, 2007 decision by the U.S. District Court for the Southern District of New York holding the U.S. patent 4,847,265 covering clopidogrel bisulphate, the active ingredient in Plavix®, valid and enforceable. As a result of this ruling, the ‘265 patent protection for this product is maintained in the United States until November 2011. More...
Gilead accuses Teva of patent infringement
(Foster City-based Gilead , 12-Dec-2008 , Silicon Valley / San Jose Business Journal)
Foster City-based Gilead (NASDAQ:GILD) said the suit, filed in U.S. District Court in New York, centers on patents associated with emtricitabine, a component of Truvada and licensed exclusively to Gilead by Emory University. More...
Alnylam Pharmaceuticals (ALNY) Strengthens Intellectual Property Estate through Acquisition of Nucleonics Inc. Patent Assets
(CAMBRIDGE, Mass , 8-Dec-2008 , BUSINESS WIRE)
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY - News), a leading RNAi therapeutics company, announced today that it has acquired the intellectual property (IP) assets of Nucleonics, Inc., a privately held biotechnology company. The Nucleonics IP estate includes over 100 active patent filings, including 16 that have granted worldwide and 6 that have been granted in the U.S., Europe, or Japan – the world’s largest pharmaceutical markets. More...
Roche wins European approval for hepatitis drug
(By Staff Writer , 5-Dec-2008 , Pharmaceutical Business Review)
Roche has announced that the European Commission has approved Pegasys plus Copegus for the re-treatment of hepatitis C patients who were not successfully treated with an initial course of interferon alpha, either alone or in combination with ribavirin. More...
Cephalon, Inc. (CEPH) and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals, Inc. (MYL) and Barr Pharmaceuticals, Inc. (BRL)
(FRAZER, Pa. and PHILADELPHIA , 26-Nov-2008 , PRNewswire)
FRAZER, Pa. and PHILADELPHIA, Nov. 26 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH - News) and Eurand, Inc. (Nasdaq: EURX - News) today announced that they have filed a lawsuit in U.S. District Court in Delaware against Mylan Pharmaceuticals, Inc. and its subsidiary, Mylan, Inc., and Barr Pharmaceuticals, Inc. and its subsidiary, Barr Laboratories, Inc., for infringement of Eurand's U.S. Patent Number 7,387,793. More...
.
.